Citrus Sinensis ID: 007427
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M9C5 | 670 | Probable leucine-rich rep | yes | no | 0.915 | 0.825 | 0.368 | 1e-102 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.913 | 0.842 | 0.375 | 1e-99 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.940 | 0.868 | 0.377 | 1e-91 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.870 | 0.799 | 0.382 | 1e-91 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.913 | 0.880 | 0.355 | 2e-90 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.913 | 0.853 | 0.350 | 9e-89 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.869 | 0.820 | 0.355 | 1e-86 | |
| C0LGU0 | 662 | Probable LRR receptor-lik | no | no | 0.915 | 0.835 | 0.338 | 3e-84 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.885 | 0.835 | 0.352 | 9e-84 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.903 | 0.807 | 0.313 | 7e-81 |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 374 bits (960), Expect = e-102, Method: Compositional matrix adjust.
Identities = 228/618 (36%), Positives = 346/618 (55%), Gaps = 65/618 (10%)
Query: 30 LLQIRDSLNSTANLHSRW--TGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGF 87
LL + + +ST L+S W T PC W GVSC+ + L LE+I L G +
Sbjct: 35 LLNFKLTADSTGKLNS-WNTTTNPC-----QWTGVSCNRNRVTRLVLEDINLTGSISSLT 88
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
+ LSL++N LSG +PNL+NL L+ +FLS N FS P L +L +L+L
Sbjct: 89 SLTSLRV--LSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLS 146
Query: 148 ENYLDGQIPP------------------------FNQTSLIDFNVSYNNLDGPIPQTRVV 183
N GQIPP N + L DFNVS NN +G IP + +
Sbjct: 147 FNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS--L 204
Query: 184 QSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIP--------------PPSPPPPPKED 229
FP S F N LCG PL K +S P P P P SP D
Sbjct: 205 SQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGD 264
Query: 230 KKKSL-KIWSVALIAA--GSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHL-SEK 285
K + +I +++LIA G ++ V LL + C+ + + K + EG + S
Sbjct: 265 KSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSN 324
Query: 286 KMPDSWSMEDPER-----RVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLES 340
P S + + + ++ FF+ T F+L+DLLRASAE+LGKG G+ YKA LE
Sbjct: 325 PYPTSTQNNNNQNQQVGDKGKMVFFEGT-RRFELEDLLRASAEMLGKGGFGTAYKAVLED 383
Query: 341 GAVVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399
G VAVKR+K+ + KKEF QQM++LG+L+H NL + ++Y+++EEKL++Y+++PNGS
Sbjct: 384 GNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGS 443
Query: 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459
LF LLH +RG GR PL WTTRL I A+GLAF+H + + K+ H ++KS+N+L+ R
Sbjct: 444 LFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSG 503
Query: 460 DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
+ A++++FG PS+ +++ R+PE +G++ T K+DVY FG++LLE++TG+
Sbjct: 504 N---ARVSDFGLSIFAPSQTVAKSNGY-RAPELIDGRKHTQKSDVYSFGVLLLEILTGKC 559
Query: 520 PGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIA 579
P G++ + DL WV+ VV +W+ ++ D+E++ ++ + EM+ L ++A+ CT +A
Sbjct: 560 PNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVA 619
Query: 580 PEKRPKMSEVLRRIEEIQ 597
+ RPKM V++ IE+I+
Sbjct: 620 ADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 237/632 (37%), Positives = 342/632 (54%), Gaps = 80/632 (12%)
Query: 25 AERYDLLQIRDSLNSTANLHSRWT---GPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAG 81
A+R LL +R ++ RW PC NW GV C + + +L L + L+G
Sbjct: 35 ADRTALLSLRSAVGGRT---FRWNIKQTSPC-----NWAGVKCESNRVTALRLPGVALSG 86
Query: 82 ILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIP-------- 132
+P G N+T L LSLR N LSGSLP +L+ NL ++L N FS IP
Sbjct: 87 DIPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSH 146
Query: 133 ----------------FGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGP 176
G+ +L KLK L L+ N L G IP + L+ FNVS N+L+G
Sbjct: 147 LVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLD-LPLVQFNVSNNSLNGS 205
Query: 177 IPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIP-----PPSPPPPPKEDKK 231
IP+ +Q F S SF S LCG+PL KLCP PS PPS ++ KK
Sbjct: 206 IPKN--LQRFESDSFLQTS-LCGKPL-KLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKK 261
Query: 232 KSLKIWSVALIAAGSAL-VPFLVMLLFWCCYKKVH--------------------EKEKS 270
L ++A I G + +V++L C KK + +KE
Sbjct: 262 NKLSGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAV 321
Query: 271 NEGQAGEGSAHLSEKKMPDSWSMED--PERRVELEFFDKTIPVFDLDDLLRASAEVLGKG 328
+ G SA + + + E P + +L FF VFDL+DLLRASAEVLGKG
Sbjct: 322 DNGNVYSVSAAAAAAMTGNGKASEGNGPATK-KLVFFGNATKVFDLEDLLRASAEVLGKG 380
Query: 329 KVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK 388
G+ YKA L++ VVAVKR+K++ ++ KEF ++++L+G + HENL + ++Y+S++EK
Sbjct: 381 TFGTAYKAVLDAVTVVAVKRLKDV-MMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEK 439
Query: 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL 448
L++Y+F+P GSL LLH +RG GR PL W R I A+GL +LH H N+
Sbjct: 440 LLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHS--QGTSTSHGNI 497
Query: 449 KSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTHKADVYCF 507
KSSNIL+ + +D AK+++FG L+ S + N A G R+PE + KR++ K DVY F
Sbjct: 498 KSSNILLTKSHD---AKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSF 554
Query: 508 GIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEML- 566
G++LLE+ITG+ P N NE DL WV+ V ++W ++ D E+L+ + EM+
Sbjct: 555 GVVLLELITGKAPSNSVM--NEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMA 612
Query: 567 RLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
+ +L LECT P++RP+MSEV+R++E ++P
Sbjct: 613 EMVQLGLECTSQHPDQRPEMSEVVRKMENLRP 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 233/618 (37%), Positives = 352/618 (56%), Gaps = 50/618 (8%)
Query: 10 VVLVASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSC-SNGH 68
V S IAD ++R LL S+ L+ T C +W GV+C S+G
Sbjct: 33 VTTTFCSYAIADLN-SDRQALLAFAASVPHLRRLNWNSTNHIC----KSWVGVTCTSDGT 87
Query: 69 IV-SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNH 126
V +L L I L G +PP L + L LSLR+NLLSG+LP ++ +L +L+ ++L N+
Sbjct: 88 SVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNN 147
Query: 127 FSD----------------------GIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLI 164
FS IP + +L +L L LQ N L G +P + SL
Sbjct: 148 FSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLR 207
Query: 165 DFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPS--PAIP-PPS 221
N+S N+L+G IP + FPSSSF N+ LCG PL+ C S PPPS P I PP
Sbjct: 208 RLNLSNNHLNGSIPS--ALGGFPSSSFSGNTLLCGLPLQP-CATSSPPPSLTPHISTPPL 264
Query: 222 PPPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAH 281
PP P KE K+ L + ++ IAAG A + L+ ++ CC K +K + + +
Sbjct: 265 PPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT---- 320
Query: 282 LSEKKMPDSWS-MEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLES 340
L+EK + S +++PE+ +L FF+ FDL+DLLRASAEVLGKG G+ YKA LE
Sbjct: 321 LTEKAKQEFGSGVQEPEKN-KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE 379
Query: 341 GAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399
V VKR+K + A K+EF QQM+++ ++ H ++ + ++YYSK+EKL++ ++ P G+
Sbjct: 380 STTVVVKRLKEV-AAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGN 438
Query: 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459
L LLH +RG + PL W +R+ I AKG+A LH K H N+KSSN+++ +E+
Sbjct: 439 LSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAA-GGPKFSHGNIKSSNVIMKQES 497
Query: 460 DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
D A +++FG PL+ A A R+PE E ++ THK+DVY FG+++LE++TG+
Sbjct: 498 D---ACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKS 554
Query: 520 PGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIA 579
P SP ++ DL WV+ VV +W++++ D+E++ + + EM+++ ++A+ C
Sbjct: 555 PVQ-SPSRDDMV-DLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQV 612
Query: 580 PEKRPKMSEVLRRIEEIQ 597
PE RP M +V+R IEEI+
Sbjct: 613 PEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 224/586 (38%), Positives = 321/586 (54%), Gaps = 60/586 (10%)
Query: 54 DNVSNWFGVSCSNGH--IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-N 110
D+ NW GV C++ I SL L L G +P G L +T L LSLR+N LSG +P +
Sbjct: 51 DSACNWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSD 110
Query: 111 LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIP-------------- 156
+NL +L +++L N FS P + L L +L++ N G IP
Sbjct: 111 FSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFL 170
Query: 157 ---------PFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCP 207
P L+DFNVS NNL+G IP + + F + SF N LCG PL K C
Sbjct: 171 GNNGFSGNLPSISLGLVDFNVSNNNLNGSIPSS--LSRFSAESFTGNVDLCGGPL-KPCK 227
Query: 208 --ISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVH 265
P PSP++ PS K+ K I VA+I A + + L+ LL + C +K
Sbjct: 228 SFFVSPSPSPSLINPSNRLSSKKSKLSKAAI--VAIIVASALVALLLLALLLFLCLRK-- 283
Query: 266 EKEKSNEGQAGE---------------GSAHLSEKKMPDSWSMEDPERRVELEFFDKTIP 310
+ SNE + + G++ E+ S M R +L F + +
Sbjct: 284 -RRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVY 342
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL 370
FDL+DLLRASAEVLGKG VG++YKA LE G V VKR+K++ A SKKEF QM+++GK+
Sbjct: 343 SFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMA-SKKEFETQMEVVGKI 401
Query: 371 KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
KH N+ + ++YYSK+EKL++++F+P GSL LLH SRG GR PL W R+ I A+G
Sbjct: 402 KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARG 461
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP 490
LA LH S K+ H N+K+SNIL+ D ++++G L + LA +P
Sbjct: 462 LAHLHV---SAKLVHGNIKASNILLHPNQDTC---VSDYGLNQLFSNSSPPNRLAGYHAP 515
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
E E +++T K+DVY FG++LLE++TG+ P S G E DL WV VV +W+ ++
Sbjct: 516 EVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLG--EEGIDLPRWVLSVVREEWTAEV 573
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
DVE++ + EM++L ++A+ C P++RP M EVLR IE++
Sbjct: 574 FDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 217/610 (35%), Positives = 333/610 (54%), Gaps = 58/610 (9%)
Query: 25 AERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILP 84
++R LL +R+S+ L + PC NW GV C G + +L L L G LP
Sbjct: 28 SDRRALLAVRNSVRGRPLLWNMSASSPC-----NWHGVHCDAGRVTALRLPGSGLFGSLP 82
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
G + N+T L LSLR N LSG +P + +NLV L ++L N FS IP LP + +
Sbjct: 83 IGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLFTLPSIIR 142
Query: 144 LELQENYLDGQIP--------------PFNQTS---------LIDFNVSYNNLDGPIPQT 180
+ L EN G+IP NQ S L FNVS N L+G IP +
Sbjct: 143 INLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLPLQQFNVSSNQLNGSIPSS 202
Query: 181 RVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVA 240
+ S+P ++FE N+ LCG+PL+ C P A P +PP DK + I +
Sbjct: 203 --LSSWPRTAFEGNT-LCGKPLDT-CEAESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIV 258
Query: 241 LIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEG--SAHLSEKKMPDSWSMEDPER 298
+ +V L++LL C + +KE++ + E +A S +P + P
Sbjct: 259 I----GCVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPA 314
Query: 299 RV----------ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKR 348
+ +L FF K+ FDLD LL+ASAEVLGKG VGS+YKA+ E G VVAVKR
Sbjct: 315 KATGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKR 374
Query: 349 VKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESR 408
++++ + +KEF +++ +LG + H NL ++++Y+S++EKL+++E++ GSL +LH ++
Sbjct: 375 LRDV-VVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNK 433
Query: 409 GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468
G GR PL W TR I A+ +++LH H N+KSSNIL+ +D Y AK+++
Sbjct: 434 GNGRTPLNWETRAGIALGAARAISYLHS--RDGTTSHGNIKSSNILL---SDSYEAKVSD 488
Query: 469 FGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN 528
+G P++ S A + R+PE + ++++ KADVY FG+++LE++TG+ P + N
Sbjct: 489 YGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQL--N 546
Query: 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAR-EGQNEMLRLTELALECTDIAPEKRPKMS 587
E DL WV+ V + +D+LD E+ + EG ++RL ++ + CT P+ RP M+
Sbjct: 547 EEGVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMA 606
Query: 588 EVLRRIEEIQ 597
EV R IEE+
Sbjct: 607 EVTRLIEEVS 616
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 9e-89, Method: Compositional matrix adjust.
Identities = 220/628 (35%), Positives = 333/628 (53%), Gaps = 76/628 (12%)
Query: 25 AERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILP 84
A++ LL R ++ L PC NW GV C G + +L L L+G +P
Sbjct: 33 ADKSALLSFRSAVGGRTLLWDVKQTSPC-----NWTGVLCDGGRVTALRLPGETLSGHIP 87
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
G N+T L LSLR N L+GSLP +L + +L ++L N FS IP L L +
Sbjct: 88 EGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVR 147
Query: 144 LELQENYLDGQIPPF--NQTSL---------------------IDFNVSYNNLDGPIPQT 180
L L EN G+I N T L FNVS N L+G IP++
Sbjct: 148 LNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQFNVSNNLLNGSIPKS 207
Query: 181 RVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIP----PPSPPPPPKEDKKKSLKI 236
+Q F S SF S LCG+PL +C PS I P + ++ K+K L
Sbjct: 208 --LQKFDSDSFVGTS-LCGKPL-VVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKKLSG 263
Query: 237 WSVALIAAGSAL-VPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMP-DSWSME 294
++A I G + + +VM+L KK +E+ ++ + + E ++P + ++E
Sbjct: 264 GAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAID----LATIKHHEVEIPGEKAAVE 319
Query: 295 DPERRV---------------------ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGST 333
PE R +L FF VFDL+DLLRASAEVLGKG G+
Sbjct: 320 APENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTA 379
Query: 334 YKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393
YKA L++ +VAVKR+K++ ++ +EF ++++++G + HENL + ++YYS +EKL++Y+
Sbjct: 380 YKAVLDAVTLVAVKRLKDVT-MADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYD 438
Query: 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453
F+P GSL LLH ++G GR PL W R I A+GL +LH H N+KSSNI
Sbjct: 439 FMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHS--QDPLSSHGNVKSSNI 496
Query: 454 LIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTHKADVYCFGIILL 512
L+ +D A++++FG L+ + + N A G R+PE + +R++ KADVY FG++LL
Sbjct: 497 LLTNSHD---ARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLL 553
Query: 513 EVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAR---EGQNEMLRLT 569
E++TG+ P N NE DL+ WV V +W ++ D E+++ + EM +
Sbjct: 554 ELLTGKAPSNSVM--NEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEML 611
Query: 570 ELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+L ++CT+ P+KRP M EV+RRI+E++
Sbjct: 612 QLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 206/579 (35%), Positives = 317/579 (54%), Gaps = 54/579 (9%)
Query: 57 SNWFGVSCS----NGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NL 111
S+W G++C +V++ L + L G +PP L + L LSLR+N L G+LP ++
Sbjct: 59 SSWIGITCDESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDI 118
Query: 112 TNLVNLETVFLSQNHFSD--------------------------GIPFGYIDLPKLKKLE 145
+L +LE ++L N+FS IP G +L ++ L
Sbjct: 119 LSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLY 178
Query: 146 LQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKL 205
LQ N DG I + S+ N+SYNNL GPIP+ ++ P SF NS LCG PL
Sbjct: 179 LQNNSFDGPIDSLDLPSVKVVNLSYNNLSGPIPEH--LKKSPEYSFIGNSLLCGPPLNA- 235
Query: 206 CPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVH 265
C PS +P P +++S K + +A++ S V FL ++ C KK
Sbjct: 236 CSGGAISPSSNLPRPLTENLHPVRRRQS-KAYIIAIVVGCSVAVLFLGIVFLVCLVKKTK 294
Query: 266 EKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVL 325
++E EG + S+K ++DPE+ +L FF++ FDL+DLL+ASAEVL
Sbjct: 295 KEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKN-KLFFFERCNHNFDLEDLLKASAEVL 353
Query: 326 GKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS 384
GKG G+ YKA LE V VKR++ + A SKKEF QQM+++GK+ +H N ++++YYS
Sbjct: 354 GKGSFGTAYKAVLEDTTAVVVKRLREVVA-SKKEFEQQMEIVGKINQHSNFVPLLAYYYS 412
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
K+EKL++Y+++ GSLF ++H +RG + W TR+ I T+K +++ LHS K
Sbjct: 413 KDEKLLVYKYMTKGSLFGIMHGNRGDRGVD--WETRMKIATGTSKAISY----LHSLKFV 466
Query: 445 HANLKSSNILIFREND--IYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKA 502
H ++KSSNIL+ + + + L LP R N +PE E +R++ ++
Sbjct: 467 HGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYN-----APEVIETRRVSQRS 521
Query: 503 DVYCFGIILLEVITGRIPGNGSPG--NNETSGDLSDWVRMVVDNDWSTDILDVEILAARE 560
DVY FG+++LE++TG+ P PG + DL WVR VV +W+ ++ DVE+L +
Sbjct: 522 DVYSFGVVILEMLTGKTPLT-QPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQN 580
Query: 561 GQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599
+ EM+++ +LAL C PE RPKM EV R IE+++ +
Sbjct: 581 IEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRL 619
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 210/621 (33%), Positives = 312/621 (50%), Gaps = 68/621 (10%)
Query: 30 LLQIRDSLN-STANLHSRWTG--PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPG 86
+L+ ++SL N + W PPC W GV C+ G + L++E ++L+G +
Sbjct: 38 ILKFKESLVVGQENALASWNAKSPPC-----TWSGVLCNGGSVWRLQMENLELSGSIDIE 92
Query: 87 FLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLS----------------------- 123
L +T L LS NN G P+ L L++++LS
Sbjct: 93 ALSGLTSLRTLSFMNNKFEGPFPDFKKLAALKSLYLSNNQFGGDIPGDAFEGMGWLKKVH 152
Query: 124 --QNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTR 181
QN F+ IP LPKL +L L N G+IP F L N+S N L GPIP++
Sbjct: 153 LAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEH-QLHLLNLSNNALTGPIPESL 211
Query: 182 VVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIP-PPSPPPPPKEDKKKSLKIWSVA 240
+ FE N GL G+PLE C SP I PP PK + L I A
Sbjct: 212 SMTD--PKVFEGNKGLYGKPLETECD------SPYIEHPPQSEARPKSSSRGPLVI--TA 261
Query: 241 LIAAGSALVPFLVMLLFWCCYKK------VHEKEKSNEGQAG--EGSAHLSEKKMPDSWS 292
++AA + L+ V+ L YK V S + + G E ++K D
Sbjct: 262 IVAALTILIILGVIFLLNRSYKNKKPRLAVETGPSSLQKKTGIREADQSRRDRKKADHRK 321
Query: 293 MEDPERRV---------ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAV 343
+R+ +L F + FDL DLL+ASAE+LG G G++YKA L SG +
Sbjct: 322 GSGTTKRMGAAAGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKAVLSSGQM 381
Query: 344 VAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDL 403
+ VKR K MN + EF + M+ LG+L H NL IV++YY KEEKL++ +F GSL
Sbjct: 382 MVVKRFKQMNNAGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAERGSLAIN 441
Query: 404 LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463
LH ++ +G+ L W TRL I+K AKGL +LHQ L S PH +LKSSN+L+ + +
Sbjct: 442 LHSNQSLGKPSLDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLTK---TFE 498
Query: 464 AKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
LT++G +PL+ KA ++A RSPE+ + +R+T K DV+ GI++LE++TG+ P N
Sbjct: 499 PLLTDYGLIPLINQEKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKFPANF 558
Query: 524 SPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR 583
S + E DL+ WV W+ + D + + ++L+L + L C + EKR
Sbjct: 559 SQSSEE---DLASWVNSGFHGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDVEKR 615
Query: 584 PKMSEVLRRIEEIQPMIEEND 604
+ + + +IEE++ ++D
Sbjct: 616 LDIGQAVEKIEELKEREGDDD 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 9e-84, Method: Compositional matrix adjust.
Identities = 210/596 (35%), Positives = 327/596 (54%), Gaps = 61/596 (10%)
Query: 44 HSR---W--TGPPCIDNVSNWFGVSCS--NGHIVSLELEEIQLAGILPPGFLQNITFLNK 96
HSR W T P C ++W G++CS N + +L L L G LP + + L
Sbjct: 41 HSRKLNWNSTIPIC----ASWTGITCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRI 96
Query: 97 LSLRNNLLSGSLPNLT--------------------------NLVNLETVFLSQNHFSDG 130
+SLR+N L G++P++ LVNL+ LS N S
Sbjct: 97 ISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPVLSHRLVNLD---LSANSLSGN 153
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSS 190
IP +L +L L LQ N L G IP L N+S+NNL+G +P + V+SFP+SS
Sbjct: 154 IPTSLQNLTQLTDLSLQNNSLSGPIPNL-PPRLKYLNLSFNNLNGSVPSS--VKSFPASS 210
Query: 191 FEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPP----KEDKKKSLKIWSVALIAAGS 246
F+ NS LCG PL CP + PSP+ P+ P + KK L ++ IA G
Sbjct: 211 FQGNSLLCGAPLTP-CPENTTAPSPSPTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGG 269
Query: 247 ALVPFLVM-LLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFF 305
+++ F+++ ++ CC KK + S + S+ K + S + +L FF
Sbjct: 270 SVLLFIILAIITLCCAKKRDGGQDST--AVPKAKPGRSDNKAEEFGSGVQEAEKNKLVFF 327
Query: 306 DKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQ 365
+ + FDL+DLLRASAEVLGKG G+TYKA LE G V VKR+K + A K+EF QQM+
Sbjct: 328 EGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEV-AAGKREFEQQME 386
Query: 366 LLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSII 424
+G++ H N+A + ++Y+SK+EKL++Y++ G+ LLH + GR L W TRL I
Sbjct: 387 AVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRIC 446
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL 484
+ A+G++ +H + K+ H N+KS N+L+ +E + +++FG PL+ +
Sbjct: 447 LEAARGISHIH-SASGAKLLHGNIKSPNVLLTQELHVC---VSDFGIAPLMSHHTLIPSR 502
Query: 485 AIG-RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543
++G R+PE E ++ T K+DVY FG++LLE++TG+ G + +E DL WV+ VV
Sbjct: 503 SLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTT--GHEEVVDLPKWVQSVVR 560
Query: 544 NDWSTDILDVEILAAREG-QNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
+W+ ++ DVE++ + + EM+++ ++A+ C P+ RP M EV+ +EEI+P
Sbjct: 561 EEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRP 616
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 202/645 (31%), Positives = 316/645 (48%), Gaps = 99/645 (15%)
Query: 22 YYPAERYDLLQIRDSLNSTANLHSRWTG-PPCIDNV---SNWFGVSCSNGHIVSLELEEI 77
Y + LL+ + SL + ++L +G PPC + S W GV CSNG + +L LE +
Sbjct: 25 YGDGDADALLKFKSSLVNASSLGGWDSGEPPCSGDKGSDSKWKGVMCSNGSVFALRLENM 84
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFS---DG--- 130
L+G L L +I L +S N G +P + LV+L ++L+ N F+ DG
Sbjct: 85 SLSGELDVQALGSIRGLKSISFMRNHFEGKIPRGIDGLVSLAHLYLAHNQFTGEIDGDLF 144
Query: 131 -------------------IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYN 171
IP LPKL +L L++N G+IP F Q +L+ NV+ N
Sbjct: 145 SGMKALLKVHLEGNRFSGEIPESLGKLPKLTELNLEDNMFTGKIPAFKQKNLVTVNVANN 204
Query: 172 NLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKK 231
L+G IP T + + + F N GLCG PL C + PP
Sbjct: 205 QLEGRIPLTLGLMNI--TFFSGNKGLCGAPLLP-CRYTRPP------------------- 242
Query: 232 KSLKIWSVALIAAGS-ALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAH--------- 281
++V L+A A+V + + L C + K + G G H
Sbjct: 243 ----FFTVFLLALTILAVVVLITVFLSVCILSRRQGKGQDQIQNHGVGHFHGQVYGQPEQ 298
Query: 282 --LSEKKMPDSWSME-------------------------DPERRVE---LEFFDKTIPV 311
SEK DS D ++R + L F
Sbjct: 299 QQHSEKSSQDSKVYRKLANETVQRDSTATSGAISVGGLSPDEDKRGDQRKLHFVRNDQER 358
Query: 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK 371
F L D+LRASAEVLG G GS+YKA L SG V VKR + M+ + ++EF M+ +G+L
Sbjct: 359 FTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLS 418
Query: 372 HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
H NL +++FYY KEEKL++ ++ NGSL +LLH +R G++ L W RL I++ +GL
Sbjct: 419 HPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGL 478
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE 491
A+L++ +PH +LKSSN+L+ + + LT++ +P++ ++ + + ++PE
Sbjct: 479 AYLYRVFPDLNLPHGHLKSSNVLL---DPNFEPLLTDYALVPVVNRDQSQQFMVAYKAPE 535
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
F + R + ++DV+ GI++LE++TG+ P N +L+ WV V +W+ D+
Sbjct: 536 FTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVESVARTEWTADVF 595
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
D E+ A +E + +ML+L ++ L C D EKR ++ E + RIEE+
Sbjct: 596 DKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV 640
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| 224116506 | 619 | predicted protein [Populus trichocarpa] | 0.975 | 0.951 | 0.675 | 0.0 | |
| 359489936 | 633 | PREDICTED: probable leucine-rich repeat | 0.965 | 0.921 | 0.646 | 0.0 | |
| 255569389 | 610 | serine-threonine protein kinase, plant-t | 0.958 | 0.949 | 0.648 | 0.0 | |
| 297737197 | 654 | unnamed protein product [Vitis vinifera] | 0.965 | 0.891 | 0.625 | 0.0 | |
| 224076900 | 587 | predicted protein [Populus trichocarpa] | 0.966 | 0.994 | 0.662 | 0.0 | |
| 356529399 | 591 | PREDICTED: probable inactive receptor ki | 0.968 | 0.989 | 0.603 | 0.0 | |
| 357499011 | 615 | Nodulation receptor kinase [Medicago tru | 0.990 | 0.972 | 0.578 | 0.0 | |
| 395146525 | 803 | hypothetical protein [Linum usitatissimu | 0.925 | 0.696 | 0.582 | 1e-176 | |
| 326496162 | 652 | predicted protein [Hordeum vulgare subsp | 0.933 | 0.865 | 0.435 | 1e-134 | |
| 223949209 | 647 | unknown [Zea mays] gi|414870951|tpg|DAA4 | 0.920 | 0.859 | 0.436 | 1e-131 |
| >gi|224116506|ref|XP_002331914.1| predicted protein [Populus trichocarpa] gi|222874586|gb|EEF11717.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/594 (67%), Positives = 468/594 (78%), Gaps = 5/594 (0%)
Query: 13 VASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSL 72
V S Q ++P ER L+QIRDS++ST +LH WTGPPC N W G+ CSN H+V L
Sbjct: 29 VHSLYQTKVFFPEERDALMQIRDSVSSTLDLHGNWTGPPCNQNSGRWAGIICSNWHVVGL 88
Query: 73 ELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIP 132
LE IQL G LPP FLQNITFL LS RNN + G LPNL+NLV LE+VF S N F+ IP
Sbjct: 89 VLEGIQLTGSLPPTFLQNITFLAYLSFRNNSIYGPLPNLSNLVLLESVFFSYNRFTGPIP 148
Query: 133 FGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFE 192
YI+LP L++LELQ+NYLDG+IPPF+Q +L FNVSYN+L G IP T V+Q F SS++
Sbjct: 149 SEYIELPNLEQLELQQNYLDGEIPPFDQPTLTLFNVSYNHLQGSIPDTDVLQRFSESSYD 208
Query: 193 HNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFL 252
HNS LCG PLE CP+ P + IPPPSPP P + KK+ L IW V L+A S LV +
Sbjct: 209 HNSNLCGIPLEP-CPVLPL--AQLIPPPSPPISPPQSKKRKLPIWIVVLVAVVSTLVALM 265
Query: 253 VMLLFWCCYKKVHEKEKSNEGQAGE-GSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPV 311
VM +F CCYKK EKE E QAGE GS+ ++KK S S EDPER VEL+FFDK IPV
Sbjct: 266 VMFVFLCCYKKAQEKETPKEHQAGEDGSSEWTDKKTAYSRSAEDPERSVELQFFDKNIPV 325
Query: 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK 371
FDLDDLLRASAEVLGKGK+G+TYKA LESGAV++VKRV+ M++LSKKEF+QQMQLLGK++
Sbjct: 326 FDLDDLLRASAEVLGKGKLGTTYKANLESGAVISVKRVEYMDSLSKKEFIQQMQLLGKMR 385
Query: 372 HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
HENL +I+SFYYSKEEKLI+YEF+P GSLF+LLHE+RGVGRIPL W R SIIK AKG+
Sbjct: 386 HENLVQIISFYYSKEEKLIVYEFVPGGSLFELLHENRGVGRIPLNWAARFSIIKDIAKGM 445
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE 491
AFLHQ+L SHKVPHANLKSSN+LI R+ Y KLTN+GFLPLLPSRK SE LA+GRSPE
Sbjct: 446 AFLHQSLPSHKVPHANLKSSNVLIRRDRLSYHTKLTNYGFLPLLPSRKLSERLAVGRSPE 505
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP-GNNETSGDLSDWVRMVVDNDWSTDI 550
F +GK+LTHKADVYCFGIILLEVITG+IPG SP GN E + DLSDWVRMVV+NDWSTDI
Sbjct: 506 FCQGKKLTHKADVYCFGIILLEVITGKIPGGTSPEGNYEKADDLSDWVRMVVNNDWSTDI 565
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
LDVEILA+REG NEM++LTE+AL+CTD+APEKRPKMSEVL RIEEI ND
Sbjct: 566 LDVEILASREGHNEMMKLTEIALQCTDMAPEKRPKMSEVLIRIEEIDRTNRGND 619
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489936|ref|XP_002267180.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1978), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/585 (64%), Positives = 455/585 (77%), Gaps = 2/585 (0%)
Query: 21 DYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLA 80
+Y+P ER L+QIRD +N+T +LH WTGPPC ++VS WFG++CS GHI+ + LE I+L
Sbjct: 42 EYFPDEREALMQIRDIVNATVDLHKNWTGPPCQEDVSKWFGITCSKGHIIRIVLEGIELT 101
Query: 81 GILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140
G PP FLQ I FLN +S +NN + G +PNLT L++LE+VF SQN+FS IP YI LP
Sbjct: 102 GSFPPAFLQKIAFLNTVSFKNNSVFGPIPNLTGLIHLESVFFSQNNFSGSIPLDYIGLPN 161
Query: 141 LKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGR 200
L LELQEN L G IPPF+Q +L FNVSYN+L+GPIP+T V+Q FP SS++HNS LCG
Sbjct: 162 LTVLELQENSLGGHIPPFDQPTLTTFNVSYNHLEGPIPETPVLQRFPESSYDHNSHLCGL 221
Query: 201 PLEKLCPISPPPPSPAIPPPSP-PPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWC 259
PL K+CP PP P+ A PP P P ++KKK L+IW VALI A + LVP LVM++F C
Sbjct: 222 PLGKVCPAFPPAPATATAPPPHISPNPSKEKKKGLEIWGVALIVAAATLVPVLVMVVFLC 281
Query: 260 CYKKVHEKEKSNEGQAG-EGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLL 318
Y+K KE + Q G GS +EK+ S DPER V LEFFDK IPVFDLDDLL
Sbjct: 282 YYRKSQRKEATTGQQTGMSGSVEWAEKRRHSWESRGDPERTVALEFFDKDIPVFDLDDLL 341
Query: 319 RASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
RASAEV+GKGK+G+TYKATLESG+ VAVKR+K++N LSKKEFVQQMQLLGK +HENL +I
Sbjct: 342 RASAEVMGKGKLGTTYKATLESGSAVAVKRLKDLNGLSKKEFVQQMQLLGKTRHENLVEI 401
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
VSFYYSKEEKL++YEF+P+GSLF+LLHE+RG R+PL W+ RLSIIK AKGL FLHQ+L
Sbjct: 402 VSFYYSKEEKLVVYEFVPHGSLFELLHENRGAARVPLNWSRRLSIIKDIAKGLTFLHQSL 461
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRL 498
SHKVPHANLKSSN+LI +KL +FGFLPLLPSRK+SE LA+ +SPEF GK+L
Sbjct: 462 PSHKVPHANLKSSNVLIHSTGQNCHSKLVDFGFLPLLPSRKSSEKLAVAKSPEFALGKKL 521
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
T KADVYCFGII+LEVITGRIPG SPG N T DLSDWVR V+NDWSTD+LDVEI+AA
Sbjct: 522 TQKADVYCFGIIILEVITGRIPGEASPGINATVEDLSDWVRTAVNNDWSTDVLDVEIVAA 581
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
REG +EML+LT +ALECTD PEKRPKM+EVLRRI+EI+ M E+
Sbjct: 582 REGHDEMLKLTGIALECTDTTPEKRPKMTEVLRRIQEIEDMGEKQ 626
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569389|ref|XP_002525662.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223535098|gb|EEF36780.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/586 (64%), Positives = 462/586 (78%), Gaps = 7/586 (1%)
Query: 14 ASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLE 73
SS +YYP ER LLQ+R+S+ S+ NLHS WTGPPCI N+S WFGV CS+ H+ L
Sbjct: 23 VSSFHFNEYYPGERDALLQLRNSMTSSFNLHSNWTGPPCIGNLSRWFGVVCSDWHVTHLV 82
Query: 74 LEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPF 133
LE IQL+G LPP FL +ITFL LS NN + G LPNLT+L +L++V LS N F+ IP
Sbjct: 83 LEGIQLSGSLPPAFLCHITFLTTLSFTNNSIFGPLPNLTSLAHLQSVLLSYNRFAGSIPS 142
Query: 134 GYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEH 193
YI+LP L++LELQ+NYL GQIPPFNQ++LIDFNVSYN L G IP+T V++ FP +SF
Sbjct: 143 DYIELPSLQQLELQQNYLQGQIPPFNQSTLIDFNVSYNYLQGSIPETDVLRRFPETSFS- 201
Query: 194 NSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFLV 253
N +CG PL+ PPP PP P +D+KK L IWS+ IA +AL+ FL+
Sbjct: 202 NLDVCGFPLKLCPVPPPPPAILPPPPIIP----PKDRKKKLPIWSIVSIAVAAALITFLL 257
Query: 254 MLLFWCCYKKVHEKEKSNEGQAGE-GSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVF 312
+ +CCYK+ H+KE + E +AG SA ++KK+ S EDPERRVELEFFD+ IPVF
Sbjct: 258 AFICFCCYKQAHKKETAKEPEAGATSSAGWTDKKLTLSQRTEDPERRVELEFFDRNIPVF 317
Query: 313 DLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH 372
DLDDLLR+SAEVLGKGK+G+TYK+ LES AVVAVKRVKNMN LSKKEF+QQMQLLGKL+H
Sbjct: 318 DLDDLLRSSAEVLGKGKLGTTYKSNLESNAVVAVKRVKNMNCLSKKEFIQQMQLLGKLRH 377
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
ENL I+SFYYSKEEKL+IYE++PNG+LF+LLH++RGVGR+PL W RLS++K A+GLA
Sbjct: 378 ENLVHIISFYYSKEEKLVIYEYVPNGNLFELLHDNRGVGRVPLNWAARLSVVKDVARGLA 437
Query: 433 FLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFLPLLPSRKASENLAIGRSPE 491
FLH++L SHKVPHANLKSSN+LI + YR+KLTN+GFLPLLPS+K S+ LAIGRSPE
Sbjct: 438 FLHRSLPSHKVPHANLKSSNVLIHQNGPQSYRSKLTNYGFLPLLPSKKYSQRLAIGRSPE 497
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
F GK+LTHKADVYCFGIILLEVITGRIP SPGN+E DLSDWV+ V+NDWSTDIL
Sbjct: 498 FSSGKKLTHKADVYCFGIILLEVITGRIPSEVSPGNDEREDDLSDWVKTAVNNDWSTDIL 557
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
DVEI+A REG ++ML+LTE+ALECTD+APEKRPKM+EVLRRIEEI+
Sbjct: 558 DVEIMATREGHDDMLKLTEIALECTDVAPEKRPKMTEVLRRIEEIE 603
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737197|emb|CBI26398.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/606 (62%), Positives = 456/606 (75%), Gaps = 23/606 (3%)
Query: 21 DYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLA 80
+Y+P ER L+QIRD +N+T +LH WTGPPC ++VS WFG++CS GHI+ + LE I+L
Sbjct: 42 EYFPDEREALMQIRDIVNATVDLHKNWTGPPCQEDVSKWFGITCSKGHIIRIVLEGIELT 101
Query: 81 GILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140
G PP FLQ I FLN +S +NN + G +PNLT L++LE+VF SQN+FS IP YI LP
Sbjct: 102 GSFPPAFLQKIAFLNTVSFKNNSVFGPIPNLTGLIHLESVFFSQNNFSGSIPLDYIGLPN 161
Query: 141 LKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGR 200
L LELQEN L G IPPF+Q +L FNVSYN+L+GPIP+T V+Q FP SS++HNS LCG
Sbjct: 162 LTVLELQENSLGGHIPPFDQPTLTTFNVSYNHLEGPIPETPVLQRFPESSYDHNSHLCGL 221
Query: 201 PLEKLCPISPPPPSPAIPPPSP-PPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWC 259
PL K+CP PP P+ A PP P P ++KKK L+IW VALI A + LVP LVM++F C
Sbjct: 222 PLGKVCPAFPPAPATATAPPPHISPNPSKEKKKGLEIWGVALIVAAATLVPVLVMVVFLC 281
Query: 260 CYKKVHEKEKSNEGQA----------------------GEGSAHLSEKKMPDSWSMEDPE 297
Y+K KE + Q GEGS +EK+ S DPE
Sbjct: 282 YYRKSQRKEATTGQQTVFHFLKRLVLDFISFFSLYYWTGEGSVEWAEKRRHSWESRGDPE 341
Query: 298 RRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSK 357
R V LEFFDK IPVFDLDDLLRASAEV+GKGK+G+TYKATLESG+ VAVKR+K++N LSK
Sbjct: 342 RTVALEFFDKDIPVFDLDDLLRASAEVMGKGKLGTTYKATLESGSAVAVKRLKDLNGLSK 401
Query: 358 KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAW 417
KEFVQQMQLLGK +HENL +IVSFYYSKEEKL++YEF+P+GSLF+LLHE+RG R+PL W
Sbjct: 402 KEFVQQMQLLGKTRHENLVEIVSFYYSKEEKLVVYEFVPHGSLFELLHENRGAARVPLNW 461
Query: 418 TTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477
+ RLSIIK AKGL FLHQ+L SHKVPHANLKSSN+LI +KL +FGFLPLLPS
Sbjct: 462 SRRLSIIKDIAKGLTFLHQSLPSHKVPHANLKSSNVLIHSTGQNCHSKLVDFGFLPLLPS 521
Query: 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW 537
RK+SE LA+ +SPEF GK+LT KADVYCFGII+LEVITGRIPG SPG N T DLSDW
Sbjct: 522 RKSSEKLAVAKSPEFALGKKLTQKADVYCFGIIILEVITGRIPGEASPGINATVEDLSDW 581
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
VR V+NDWSTD+LDVEI+AAREG +EML+LT +ALECTD PEKRPKM+EVLRRI+EI+
Sbjct: 582 VRTAVNNDWSTDVLDVEIVAAREGHDEMLKLTGIALECTDTTPEKRPKMTEVLRRIQEIE 641
Query: 598 PMIEEN 603
M E+
Sbjct: 642 DMGEKQ 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076900|ref|XP_002305040.1| predicted protein [Populus trichocarpa] gi|222848004|gb|EEE85551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/593 (66%), Positives = 464/593 (78%), Gaps = 9/593 (1%)
Query: 13 VASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSL 72
V S Q +++P ER L+QIRD ++ST +LH WTGPPC N S W G++CSN H+V L
Sbjct: 3 VHSLYQSKEFFPEEREALMQIRDLVSSTLDLHGNWTGPPCHKNSSQWSGITCSNWHVVGL 62
Query: 73 ELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIP 132
LE +QL G LPP FLQNIT L LS RNN + G LPNL+NLV+LE+VF S N + IP
Sbjct: 63 VLEGVQLTGSLPPAFLQNITILANLSFRNNSIYGPLPNLSNLVHLESVFFSYNRLTGSIP 122
Query: 133 FGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFE 192
YI+LP LK+LELQ+NYLDG+IPPFNQ +L FNVSYN+L G IP T V++ F SS++
Sbjct: 123 SEYIELPNLKQLELQQNYLDGEIPPFNQPTLTLFNVSYNHLQGSIPDTDVLRRFSESSYD 182
Query: 193 HNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFL 252
HNS LCG PLE P PP+P +PPPSPP P ++KK+ L IW +ALI ALVP +
Sbjct: 183 HNSNLCGIPLE---PCPVLPPAPLVPPPSPPVSPPQNKKRKLPIWIIALIVVVVALVPLM 239
Query: 253 VMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVF 312
VM +F CCYKK E E E QA ++KKMP S S EDPERR+EL+FFDK IPVF
Sbjct: 240 VMFVFLCCYKKAQEVETPKERQA-----EWTDKKMPHSQSTEDPERRIELQFFDKNIPVF 294
Query: 313 DLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH 372
DLDDLLRASAEVLGKGK+G+TY A LESGAVVAVKRVK MN+LSKKEF+QQM LLG+++H
Sbjct: 295 DLDDLLRASAEVLGKGKLGTTYSANLESGAVVAVKRVKYMNSLSKKEFIQQMLLLGRMRH 354
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
ENL I+SFYYSK+EKLI+YEF+P+GSLF+LLHE+R GR+PL W RLSIIK AKG+A
Sbjct: 355 ENLVHIISFYYSKQEKLIVYEFVPDGSLFELLHENREAGRVPLNWAARLSIIKDIAKGMA 414
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF 492
FLHQ+L SHKVPHANLKSSN+LI R+ Y +KLTN+ FLPLLPSRK+SE LAIGRSPEF
Sbjct: 415 FLHQSLPSHKVPHANLKSSNVLIHRDRQSYHSKLTNYSFLPLLPSRKSSERLAIGRSPEF 474
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIPGNGSP-GNNETSGDLSDWVRMVVDNDWSTDIL 551
+GK+LTHKADVYCFGIILLEVITG+IP SP GN E DLS+WVRMVV+NDWSTDIL
Sbjct: 475 CQGKKLTHKADVYCFGIILLEVITGKIPEETSPAGNEEKVDDLSEWVRMVVNNDWSTDIL 534
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
DVEILA+ G NEML+LTE+AL+CTD+ PEKRPKMSEVLRRIEEI +END
Sbjct: 535 DVEILASSAGHNEMLKLTEIALQCTDMEPEKRPKMSEVLRRIEEIDRTNQEND 587
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529399|ref|XP_003533281.1| PREDICTED: probable inactive receptor kinase At1g48480-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/590 (60%), Positives = 449/590 (76%), Gaps = 5/590 (0%)
Query: 17 VQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEE 76
+++ +YYP ER L+ IRDSLNS+ NLH WTGPPCIDN S W G++CSN H+V + LE
Sbjct: 5 IELEEYYPEERDALMLIRDSLNSSVNLHGNWTGPPCIDNHSRWIGITCSNWHVVQIVLEG 64
Query: 77 IQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI 136
+ L+G LP FL NITFL++L RNN LSG LP+L NL+ LE V LS N+FS IP Y+
Sbjct: 65 VDLSGYLPHTFLLNITFLSQLDFRNNALSGPLPSLKNLMFLEQVLLSFNNFSGSIPVEYV 124
Query: 137 DLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSG 196
++P L+ LELQENYLDGQIPPF+Q SL FNVSYN+L GPIP+T V+Q FP S++ +NS
Sbjct: 125 EIPSLQMLELQENYLDGQIPPFDQPSLASFNVSYNHLSGPIPETYVLQRFPESAYGNNSD 184
Query: 197 LCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALI--AAGSALVPFLVM 254
LCG PL KLCPI PP PSP++ PP P P KK + W VALI AA L+ +++
Sbjct: 185 LCGEPLHKLCPIEPPAPSPSVFPPIPALKPN---KKRFEAWIVALIGGAAALFLLSLIII 241
Query: 255 LLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDL 314
+ F C ++ + KE + AG ++K + + + + ER LEF +K +PVFDL
Sbjct: 242 IAFMLCKRRTNGKESTRNDSAGYVFGAWAKKMVSYAGNGDASERLGRLEFSNKKLPVFDL 301
Query: 315 DDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN 374
DDLLRASAEVLG+G +G TYKATLE+G VVAVKR+ +MN +SKKEF+QQMQ LG++KHEN
Sbjct: 302 DDLLRASAEVLGRGNLGITYKATLETGTVVAVKRINHMNEVSKKEFIQQMQSLGQMKHEN 361
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
L +I+SFY+S+E+KLIIYEF +G+LF+LLHE RG+GR+PL WTTRLS+IK AKGL FL
Sbjct: 362 LVEIISFYFSEEQKLIIYEFTSDGTLFELLHEGRGIGRMPLDWTTRLSMIKDIAKGLVFL 421
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPE 494
H +L H+VPHANLKSSN+LI +++ Y KLT+ GFLPLL +++ +E LAI RSPEF E
Sbjct: 422 HHSLPQHRVPHANLKSSNVLIHQDSKGYHCKLTDCGFLPLLQAKQNAEKLAIRRSPEFVE 481
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554
GK+LTHKADVYCFGII+LE+ITGRIPG+ ET+ DLSDWVR VV+NDWSTDILD+E
Sbjct: 482 GKKLTHKADVYCFGIIMLEIITGRIPGHILGEIEETTNDLSDWVRTVVNNDWSTDILDLE 541
Query: 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
ILA +EG + ML+LTELALECTD+ PEKRPKM+ VL RIEEI+ M +END
Sbjct: 542 ILAEKEGHDAMLKLTELALECTDMTPEKRPKMNVVLVRIEEIEQMRKEND 591
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357499011|ref|XP_003619794.1| Nodulation receptor kinase [Medicago truncatula] gi|355494809|gb|AES76012.1| Nodulation receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/610 (57%), Positives = 449/610 (73%), Gaps = 12/610 (1%)
Query: 1 MVSVLLPKNVVLVASSVQIADYYPAERYDLLQIRDSLNSTA-NLHSRWTGPPCIDN-VSN 58
M +L N+VL ++I D++P ER LL IRDSLNS++ NLH WTGPPCI+N +S
Sbjct: 12 MFLFILSLNIVLCIE-IEIKDFHPQERDALLLIRDSLNSSSINLHRNWTGPPCIENNLSI 70
Query: 59 WFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLE 118
WFG++CSN H+V + ++ + L+G LP FLQNITFL ++ RNN L G LPNLT LV LE
Sbjct: 71 WFGIACSNWHVVHITIQGVNLSGYLPSTFLQNITFLRQIDFRNNALFGLLPNLTGLVFLE 130
Query: 119 TVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
V LS NHFS IP Y++L L LELQENYLDG+IPPF+Q SLI FNVSYN+L G IP
Sbjct: 131 EVKLSFNHFSGSIPLEYVELYNLDILELQENYLDGEIPPFDQPSLISFNVSYNHLVGKIP 190
Query: 179 QTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSP-AIPPPSPPPPPKEDKKKSLKIW 237
+T ++Q FP SSF+ NS LCG+PL+K C P P P AI P S E K + +W
Sbjct: 191 ETSLLQRFPKSSFDDNSDLCGKPLDKSCSAESPAPLPFAIAPTSS----METNKTRIHVW 246
Query: 238 SVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPE 297
+ALIA +AL FL+++ F C +K E+ A ++K + + ED E
Sbjct: 247 IIALIAVVAALCIFLMIIAFLFCKRKARGNEERINDSARYVFGAWAKKMVSIVGNSEDSE 306
Query: 298 RRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSK 357
+ +LEF +K VFD+DDLLRASAEVLG G G TYKATLE+G VVAVKR+ MN LSK
Sbjct: 307 KLGQLEFSNKKFQVFDMDDLLRASAEVLGGGDFGVTYKATLETGNVVAVKRLGYMNDLSK 366
Query: 358 KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAW 417
KEF+QQMQLLG++KHEN+A+I+SF++S+++KL+IYE + +G+L +LLHE RG+GRIPL W
Sbjct: 367 KEFIQQMQLLGEIKHENVAEIISFFHSEDQKLVIYELVSDGTLSELLHEGRGIGRIPLDW 426
Query: 418 TTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477
TTRL+IIK AKGL FLHQ L SHKVPHANLKSSN+LI ++N Y +KLT++GFLPLL S
Sbjct: 427 TTRLAIIKDIAKGLDFLHQFLSSHKVPHANLKSSNVLIHQDNQGYHSKLTDYGFLPLLSS 486
Query: 478 R-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGN--NETSGDL 534
K +E L+I +SPEF + K+LTHK DVYCFGII+LE+ITG+IPG+ GN ETS DL
Sbjct: 487 SMKNAEKLSISKSPEFVKRKKLTHKTDVYCFGIIMLEIITGKIPGH-ILGNEVEETSNDL 545
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
SDWVR VV+NDWSTDI D+EILA ++G + ML LTE+ALECTD+ PEKRPKMS VL+RIE
Sbjct: 546 SDWVRTVVNNDWSTDIFDLEILAEKDGHDAMLNLTEIALECTDMMPEKRPKMSLVLKRIE 605
Query: 595 EIQPMIEEND 604
EI+ M+++N+
Sbjct: 606 EIEQMMKDNE 615
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|395146525|gb|AFN53680.1| hypothetical protein [Linum usitatissimum] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1608), Expect = e-176, Method: Compositional matrix adjust.
Identities = 336/577 (58%), Positives = 414/577 (71%), Gaps = 18/577 (3%)
Query: 11 VLVASSVQIAD--YYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGH 68
+L + SV +D +YP ER LLQIRDS+ STANLH+ WTGPPC N S W G++C NGH
Sbjct: 21 ILCSFSVVDSDNGFYPDERNALLQIRDSVPSTANLHALWTGPPCRGNSSRWAGIACRNGH 80
Query: 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS 128
+V L L+ I L G LP GFL+NITFL KLSL NN +SGSLPNLT LV +E V LS N F+
Sbjct: 81 VVHLVLQGINLTGNLPTGFLRNITFLTKLSLVNNSISGSLPNLTGLVRMEQVILSSNSFT 140
Query: 129 DGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPS 188
IP Y LP L+ LEL+ N L+G IP FNQ+ L FNVSYN L GPIPQT + FP
Sbjct: 141 GSIPPDYTSLPNLEFLELELNSLEGPIPSFNQSGLTRFNVSYNRLGGPIPQTETLGRFPK 200
Query: 189 SSFEHNS-GLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSA 247
SSF+HNS GLCG PL P P P P PSPP +K+ +W + +IA G+A
Sbjct: 201 SSFDHNSDGLCGPPLAACPVFPPLLPPPQPPKPSPP---VGGRKRRFNLWLIVVIALGAA 257
Query: 248 LVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHL--SEKKMPDSWSMEDPERRVELEFF 305
++ FL+++L C + ++ K + Q EG +++ SE + S S DPE+ VEL+FF
Sbjct: 258 ILAFLIVML---CLIRFRKQGKLGK-QTPEGVSYIEWSEGRKIYSGSGTDPEKTVELDFF 313
Query: 306 DKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQ 365
K IP+FDL+DLLRASAEVLGKGK GSTYK TLESG+VVAVKR++ +N L KEFVQQMQ
Sbjct: 314 VKEIPIFDLEDLLRASAEVLGKGKNGSTYKTTLESGSVVAVKRLRKVNVLPHKEFVQQMQ 373
Query: 366 LLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
LLG LKH NLA ++SFYYS ++KLIIYEF+P G+L +LLHE+RG+GR+PL WT RLSIIK
Sbjct: 374 LLGNLKHHNLAPVISFYYSPDQKLIIYEFIPGGNLHELLHENRGMGRMPLDWTARLSIIK 433
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA 485
AKGLA+LH +L SH+ PH NLKSSN+L+ RE Y KLT++G LPLL S+K SE LA
Sbjct: 434 DIAKGLAYLHNSLPSHRAPHGNLKSSNVLVQREGLNYYCKLTDYGLLPLLQSQKVSERLA 493
Query: 486 IGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP------GNNETSGDLSDWVR 539
+GRSPE+ GKRLTHKADVYCFGI+LLE ITG+IP +G P + DLS WVR
Sbjct: 494 VGRSPEYGLGKRLTHKADVYCFGIVLLEAITGKIPDDGPPPQQRDKEGTTSMEDLSGWVR 553
Query: 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECT 576
V++DWSTDILD+EI+ +REG EM +LT+LALECT
Sbjct: 554 SAVNSDWSTDILDLEIMQSREGHGEMFQLTDLALECT 590
|
Source: Linum usitatissimum Species: Linum usitatissimum Genus: Linum Family: Linaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326496162|dbj|BAJ90702.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 268/615 (43%), Positives = 374/615 (60%), Gaps = 51/615 (8%)
Query: 26 ERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSC-SNGHIVSLELEEIQLAGILP 84
ER L+ +RD L S +LHS WTGPPC S W+GVSC +G +V + L+ +QL G LP
Sbjct: 44 ERGGLVALRDGLRSAKDLHSNWTGPPCHGGRSRWYGVSCDGDGRVVGVRLDGVQLTGALP 103
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKK 143
G L+ + L LSLR+N + G+LP L L L + LS N FS IP Y LP L++
Sbjct: 104 AGALRGVARLATLSLRDNAIHGALPGLAGLDRLRVIDLSSNRFSGPIPRRYAAALPALRR 163
Query: 144 LELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLE 203
LELQ+N L+G +P F Q L FNVSYN L G +P TR ++ FP+S+F HN LCG +
Sbjct: 164 LELQDNLLNGTVPAFTQGELTVFNVSYNFLQGEVPDTRALRRFPASAFGHNLKLCGETVN 223
Query: 204 KLCPISPPPPSPA-----------IPPPS---PPPPPKEDKKKSLKIWSVALIAAGSALV 249
C + P + + L WSV IA +A+V
Sbjct: 224 AACRSGSTSTDDGGRAAGNRDDRVVRPEDNGDGGRAARNSRHFKLAAWSVVAIALIAAMV 283
Query: 250 PFLVMLLFWCCYKKVHEKEKSNEGQAG-----EGSAHLSEK----KMPDSWSMEDPERR- 299
PF +L+F +H+ +KS E + G G+ + +K K+ S S R
Sbjct: 284 PFAAVLIF------LHQTKKSREVRLGGRATPTGAPDIKDKAEQGKLSGSGSGSSSGSRN 337
Query: 300 --VELEFFDKTIPV-FDLDDLLRASAEVLGKGKVGSTYKATLESG-AVVAVKRVKNMNAL 355
+L FF P FDLDDL R++AE+LGKG++G TY+ TLE+G AVV VKR++NM +
Sbjct: 338 AQAQLHFFRADKPAGFDLDDLFRSTAEMLGKGRLGITYRVTLEAGPAVVVVKRLRNMGHV 397
Query: 356 SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPL 415
+K+F MQLLGKL+HEN+ ++V+ Y+SKEEKL +YE +P SLF+LLHE+RG GR+PL
Sbjct: 398 PRKDFAHTMQLLGKLRHENVVEVVACYHSKEEKLAVYEHVPGRSLFELLHENRGEGRMPL 457
Query: 416 AWTTRLSIIKQTAKGLAFLHQTL-HSHKVPHANLKSSNILIF-RENDIYRA-----KLTN 468
W RLSI K A+GLA+LH+++ H+ PH NLKSSN++I + N Y+ KLT+
Sbjct: 458 PWPARLSIAKGMARGLAYLHRSMPFFHRPPHGNLKSSNVIILSKPNGKYQHPHVVPKLTD 517
Query: 469 FGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN 528
+GF PLLP + LA + PE+ GKR + +ADV+CFG++LLEV+TG++P +
Sbjct: 518 YGFHPLLPHH--AHRLAAAKCPEYARGKRPSSRADVFCFGLVLLEVVTGKLP------VD 569
Query: 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSE 588
E GD+++W R+ + ++WSTDILDVEI+ E +MLRLTE+AL C + P++RPKM +
Sbjct: 570 EADGDMAEWARLALSHEWSTDILDVEIVGELERHGDMLRLTEVALMCAAVEPDRRPKMPD 629
Query: 589 VLRRIEEIQPMIEEN 603
V+R I+EI +E
Sbjct: 630 VVRMIDEIGGDADER 644
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|223949209|gb|ACN28688.1| unknown [Zea mays] gi|414870951|tpg|DAA49508.1| TPA: putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1223), Expect = e-131, Method: Compositional matrix adjust.
Identities = 265/607 (43%), Positives = 370/607 (60%), Gaps = 51/607 (8%)
Query: 26 ERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSC-SNGHIVSLELEEIQLAGILP 84
ER DLL +RD+L S +LHS WTGPPC S W GVSC +G +V + L+ QL G LP
Sbjct: 45 ERRDLLVLRDTLRSALDLHSNWTGPPCHGERSRWHGVSCDGDGRVVGVSLDGAQLTGTLP 104
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGY-IDLPKLKK 143
L+ ++ L LSLR N L G+LP L L L V LS N FS IP GY L +L +
Sbjct: 105 RSALRGVSRLEALSLRGNALHGALPGLDGLSRLRAVDLSSNRFSGPIPRGYATSLWELAR 164
Query: 144 LELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLE 203
LELQ+N L+G +P F Q L+ FNVSYN L G +P TR ++ FP+S+F+HN LCG +
Sbjct: 165 LELQDNLLNGTLPAFEQHGLVVFNVSYNFLQGEVPGTRALRRFPASAFDHNLRLCGEVVN 224
Query: 204 KLCPIS---PPPPSPAIPPPSPPPPPKEDKKKS--------LKIWSVALIAAGSALVPFL 252
C P +PA SP P D ++ L WSV I +ALVPF
Sbjct: 225 ADCRDQEGLPSSGAPAYGSSSPVVRPAGDGGRAARKHLRFRLAAWSVVAICLIAALVPFA 284
Query: 253 VMLLFWCCYKKVHEKEKSNE---GQAGEGSAHLSEKK-MPDSWSME----------DPER 298
+ +F +H K+KS E G GSA ++ + + D +E + +
Sbjct: 285 AVFIF------LHHKKKSQEVRLGGRASGSATVTAAEDIKDKVEVEQGRGSGSRSTESGK 338
Query: 299 RVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKK 358
EL+ F FDLD+L R++AE+LGKG++G TY+ L++G VV VKR++NM+ + ++
Sbjct: 339 GAELQLFRADGASFDLDELFRSTAEMLGKGRLGITYRVALQAGPVVVVKRLRNMSHVPRR 398
Query: 359 EFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWT 418
+F MQLLGKL+HEN+ +V+ +YSKEEKL++YE +P SLF LLH +RG GR PL W
Sbjct: 399 DFTHTMQLLGKLRHENVVDLVACFYSKEEKLVVYEHVPGCSLFQLLHGNRGEGRTPLPWP 458
Query: 419 TRLSIIKQTAKGLAFLHQTL-HSHKVPHANLKSSNILIF------RENDIYRAKLTNFGF 471
RLS+ + +GLA+LH++L + H+ PH NLKSSN+L+F ++ KLT+ GF
Sbjct: 459 ARLSVAQGMVRGLAYLHKSLPYFHRPPHGNLKSSNVLVFFSAPNGKQQKQAVPKLTDHGF 518
Query: 472 LPLLPSRKASENLAIGRSPEFP--EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529
PLLP + LA + PEF G+RL+ +ADVYC G++LLE++TG++P E
Sbjct: 519 HPLLPHH--AHRLAAAKCPEFARRGGRRLSSRADVYCLGLVLLELVTGKVP-------VE 569
Query: 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589
GDL++W R+ + ++WSTDILDVEIL R +MLRLTE+AL C + P++RPK+ +V
Sbjct: 570 EDGDLAEWARVALSHEWSTDILDVEILGDRGRHGDMLRLTEVALLCAAVEPDRRPKLQDV 629
Query: 590 LRRIEEI 596
+R I++I
Sbjct: 630 IRMIDDI 636
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.776 | 0.724 | 0.363 | 5.7e-84 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.480 | 0.442 | 0.446 | 7.4e-82 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.844 | 0.775 | 0.378 | 6.6e-81 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.594 | 0.534 | 0.420 | 1.1e-80 | |
| TAIR|locus:2196464 | 663 | AT1G10850 [Arabidopsis thalian | 0.766 | 0.698 | 0.348 | 5.8e-80 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.769 | 0.711 | 0.375 | 2.1e-77 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.839 | 0.792 | 0.352 | 2.5e-74 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.773 | 0.729 | 0.363 | 4e-74 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.759 | 0.732 | 0.355 | 1.7e-73 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.769 | 0.694 | 0.351 | 7.5e-73 |
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 5.7e-84, Sum P(2) = 5.7e-84
Identities = 185/509 (36%), Positives = 286/509 (56%)
Query: 116 NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175
NL + L++N FS I G+ +L +LK L L+ N L G + + SL FNVS N L+G
Sbjct: 144 NLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLD-LSLDQFNVSNNLLNG 202
Query: 176 PIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXK--EDKKKS 233
IP++ +Q F S SF S LCG+PL +C + E+KKK
Sbjct: 203 SIPKS--LQKFDSDSFVGTS-LCGKPLV-VCSNEGTVPSQPISVGNIPGTVEGSEEKKKR 258
Query: 234 LKIWSVALIA------AGSALVPFLVMLLFW-----------CCYKKVHEKEKSNEG--- 273
K+ A+ G +L+ ++M+LF K HE E E
Sbjct: 259 KKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAV 318
Query: 274 QAGEGSAHLSEKKMPDSWSME-DPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGS 332
+A E ++++E ++E + +L FF VFDL+DLLRASAEVLGKG G+
Sbjct: 319 EAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGT 378
Query: 333 TYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY 392
YKA L++ +VAVKR+K++ ++ +EF ++++++G + HENL + ++YYS +EKL++Y
Sbjct: 379 AYKAVLDAVTLVAVKRLKDVT-MADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVY 437
Query: 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSN 452
+F+P GSL LLH ++G GR PL W R I A+GL +LH H N+KSSN
Sbjct: 438 DFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHS--QDPLSSHGNVKSSN 495
Query: 453 ILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTHKADVYCFGIIL 511
IL+ +D A++++FG L+ + + N A G R+PE + +R++ KADVY FG++L
Sbjct: 496 ILLTNSHD---ARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVL 552
Query: 512 LEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAR---EGQNEMLRL 568
LE++TG+ P N NE DL+ WV V +W ++ D E+++ + EM +
Sbjct: 553 LELLTGKAPSNSVM--NEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEM 610
Query: 569 TELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+L ++CT+ P+KRP M EV+RRI+E++
Sbjct: 611 LQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
Identities = 134/300 (44%), Positives = 199/300 (66%)
Query: 301 ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEF 360
+L FF VFDL+DLLRASAEVLGKG G+ YKA L++ VVAVKR+K++ ++ KEF
Sbjct: 353 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDV-MMADKEF 411
Query: 361 VQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR 420
++++L+G + HENL + ++Y+S++EKL++Y+F+P GSL LLH +RG GR PL W R
Sbjct: 412 KEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVR 471
Query: 421 LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480
I A+GL +LH H N+KSSNIL+ + +D AK+++FG L+ S
Sbjct: 472 SRIAIGAARGLDYLHS--QGTSTSHGNIKSSNILLTKSHD---AKVSDFGLAQLVGSSAT 526
Query: 481 SENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539
+ N A G R+PE + KR++ K DVY FG++LLE+ITG+ P N NE DL WV+
Sbjct: 527 NPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVM--NEEGVDLPRWVK 584
Query: 540 MVVDNDWSTDILDVEILAAREGQNEML-RLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
V ++W ++ D E+L+ + EM+ + +L LECT P++RP+MSEV+R++E ++P
Sbjct: 585 SVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRP 644
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.6e-81, P = 6.6e-81
Identities = 204/539 (37%), Positives = 289/539 (53%)
Query: 72 LELEEIQLAGILPPGFLQNITFXXXXXXXXXXXXXXXXXXXXXVN-LETVFLSQNHFSDG 130
L L +L+G +P F N+T +N L + +S N+F+
Sbjct: 96 LSLRSNRLSGQIPSDF-SNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGS 154
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSS 190
IPF +L L L L N G +P + L+DFNVS NNL+G IP + + F + S
Sbjct: 155 IPFSVNNLTHLTGLFLGNNGFSGNLPSIS-LGLVDFNVSNNNLNGSIPSS--LSRFSAES 211
Query: 191 FEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXKEDKKKSLKIWSVALIAAGSALVP 250
F N LCG PL K C K K K VA+I A SALV
Sbjct: 212 FTGNVDLCGGPL-KPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVA-SALVA 269
Query: 251 FLVM--LLFWCCYKK-----VHEKEKSNEGQAGE------GSAHLSEKKMPDSWSMEDPE 297
L++ LLF C K+ K+ G A G++ E+ S M
Sbjct: 270 LLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGET 329
Query: 298 RRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSK 357
R +L F + + FDL+DLLRASAEVLGKG VG++YKA LE G V VKR+K++ A SK
Sbjct: 330 ERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMA-SK 388
Query: 358 KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAW 417
KEF QM+++GK+KH N+ + ++YYSK+EKL++++F+P GSL LLH SRG GR PL W
Sbjct: 389 KEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDW 448
Query: 418 TTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477
R+ I A+GLA LH S K+ H N+K+SNIL+ D ++++G L +
Sbjct: 449 DNRMRIAITAARGLAHLHV---SAKLVHGNIKASNILLHPNQDTC---VSDYGLNQLFSN 502
Query: 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW 537
LA +PE E +++T K+DVY FG++LLE++TG+ P S G E DL W
Sbjct: 503 SSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLG--EEGIDLPRW 560
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
V VV +W+ ++ DVE++ + EM++L ++A+ C P++RP M EVLR IE++
Sbjct: 561 VLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 1.1e-80, Sum P(2) = 1.1e-80
Identities = 164/390 (42%), Positives = 233/390 (59%)
Query: 232 KSLKIWSVALIAAGSALVPFLVMLLF-WCCYKKVHEKEKSNEGQA-------GEGSAHLS 283
+ +K +A + G V LV F +CC + E+S G GEG S
Sbjct: 264 RGIKPGIIAAVIGGCVAVIVLVSFGFAFCCGRLDRNGERSKSGSVETGFVGGGEGKRRSS 323
Query: 284 --EKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESG 341
E D+ S D R V FF++ F+LDDLL+ASAE+LGKG +G+ YKA L+ G
Sbjct: 324 YGEGGESDATSATDRSRLV---FFERR-KQFELDDLLKASAEMLGKGSLGTVYKAVLDDG 379
Query: 342 AV-VAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400
+ VAVKR+K+ N +KEF Q M+++G+LKH+N+ K+ ++YY+KEEKL++YE+LPNGSL
Sbjct: 380 STTVAVKRLKDANPCPRKEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNGSL 439
Query: 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460
LLH +RG GRIPL WTTR+S++ A+GLA +H K+PH N+KSSN+L+ R N
Sbjct: 440 HSLLHGNRGPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDR-NG 498
Query: 461 IYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+ A + +FG LL A L R+PE E KRL+ KADVY FG++LLEV+TG+ P
Sbjct: 499 V--ALIADFGLSLLLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAP 556
Query: 521 GN-GSPGNNETSG------------DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR 567
SP ++ DL WVR VV +W+ ++ D E+L + + EM+
Sbjct: 557 SIFPSPSRPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVA 616
Query: 568 LTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ + L C PEKRP M+EV++ +EEI+
Sbjct: 617 MLHIGLACVVPQPEKRPTMAEVVKMVEEIR 646
|
|
| TAIR|locus:2196464 AT1G10850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 175/502 (34%), Positives = 266/502 (52%)
Query: 117 LETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGP 176
L+T+FLS N S IP + L +L L +++N G IPP NQTSL FNVS N L G
Sbjct: 144 LKTIFLSGNRLSGRIPSSLLRLSRLYTLNVEDNLFTGSIPPLNQTSLRYFNVSNNKLSGQ 203
Query: 177 IPQTRVVQSFPSSSFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXKEDKKKSLKI 236
IP TR ++ F SSF N LCG + C K+ K K + I
Sbjct: 204 IPLTRALKQFDESSFTGNVALCGDQIGSPCGISPAPSAKPTPIPKS----KKSKAKLIGI 259
Query: 237 WSVALIAAGSALVPFLVMLLFWCCYKK----VHEKEKSNEGQA-GEGSA------HLSEK 285
+ + +A G ++ L+ LL C +K +++ +G A EG+ + K
Sbjct: 260 IAGS-VAGGVLVLILLLTLLIVCWRRKRRNQAPREDRKGKGIAEAEGATTAETERDIERK 318
Query: 286 KMPDSWSMEDPERRVELEFFD-----KTIPVFDLDDLLRASAEVLGKGKVGSTYKATLES 340
SW + L F +T+ + ++DLL+ASAE LG+G +GSTYKA +ES
Sbjct: 319 DRGFSWERGEEGAVGTLVFLGTSDSGETVVRYTMEDLLKASAETLGRGTLGSTYKAVMES 378
Query: 341 GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400
G +V VKR+KN +EF + +++LG+LKH NL + +++ +KEE+L++Y++ PNGSL
Sbjct: 379 GFIVTVKRLKNARYPRMEEFKRHVEILGQLKHPNLVPLRAYFQAKEERLLVYDYFPNGSL 438
Query: 401 FDLLHESR--GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458
F L+H +R G G+ PL WT+ L I + A L ++HQ + + H NLKSSN+L+ +
Sbjct: 439 FTLIHGTRASGSGK-PLHWTSCLKIAEDLASALLYIHQ---NPGLTHGNLKSSNVLLGPD 494
Query: 459 NDIYRAKLTNFGFLPLLPSRKASENLAIG---RSPEFPEGKRL-THKADVYCFGIILLEV 514
+ + LT++G L E A+ ++PE + ++ T ADVY FG++LLE+
Sbjct: 495 ---FESCLTDYGLSTLHDPDSVEETSAVSLFYKAPECRDPRKASTQPADVYSFGVLLLEL 551
Query: 515 ITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-LTELAL 573
+TGR P E D+S WVR V + + T+ + + E E L+ L +A
Sbjct: 552 LTGRTPFQDLV--QEYGSDISRWVRAVREEE--TESGEEPTSSGNEASEEKLQALLSIAT 607
Query: 574 ECTDIAPEKRPKMSEVLRRIEE 595
C I P+ RP M EVL+ + +
Sbjct: 608 VCVTIQPDNRPVMREVLKMVRD 629
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 183/487 (37%), Positives = 285/487 (58%)
Query: 117 LETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGP 176
L + LS N F+ IP + +L +L L LQ N L G +P + SL N+S N+L+G
Sbjct: 160 LNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSNNHLNGS 219
Query: 177 IPQTRVVQSFPSSSFEHNSGLCGRPLEKLCXXXX---XXXXXXXXXXXXXXXXKEDKKKS 233
IP + FPSSSF N+ LCG PL+ C KE K+
Sbjct: 220 IPSA--LGGFPSSSFSGNTLLCGLPLQP-CATSSPPPSLTPHISTPPLPPFPHKEGSKRK 276
Query: 234 LKIWSVALIAAG-SALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWS 292
L + ++ IAAG +AL+ + +++ CC KK K+K + + L+EK + S
Sbjct: 277 LHVSTIIPIAAGGAALLLLITVIILCCCIKK---KDKREDSIVKVKT--LTEKAKQEFGS 331
Query: 293 -MEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKN 351
+++PE+ +L FF+ FDL+DLLRASAEVLGKG G+ YKA LE V VKR+K
Sbjct: 332 GVQEPEKN-KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKE 390
Query: 352 MNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGV 410
+ A K+EF QQM+++ ++ H ++ + ++YYSK+EKL++ ++ P G+L LLH +RG
Sbjct: 391 V-AAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGS 449
Query: 411 GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
+ PL W +R+ I AKG+A LH K H N+KSSN+++ +E+D A +++FG
Sbjct: 450 EKTPLDWDSRVKITLSAAKGIAHLHAA-GGPKFSHGNIKSSNVIMKQESD---ACISDFG 505
Query: 471 FLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530
PL+ A A R+PE E ++ THK+DVY FG+++LE++TG+ P SP ++
Sbjct: 506 LTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQ-SPSRDDM 564
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
DL WV+ VV +W++++ D+E++ + + EM+++ ++A+ C PE RP M +V+
Sbjct: 565 V-DLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVV 623
Query: 591 RRIEEIQ 597
R IEEI+
Sbjct: 624 RMIEEIR 630
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 750 (269.1 bits), Expect = 2.5e-74, P = 2.5e-74
Identities = 188/534 (35%), Positives = 284/534 (53%)
Query: 72 LELEEIQLAGILPPGFLQ--NITFXXXXXXXXXXXXXXXXXXXXXVNLETVFLSQNHFSD 129
L L L G LP L ++ + L + LS N S
Sbjct: 103 LSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSG 162
Query: 130 GIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSS 189
IP G +L ++ L LQ N DG I + S+ N+SYNNL GPIP+ ++ P
Sbjct: 163 NIPSGLRNLSQITVLYLQNNSFDGPIDSLDLPSVKVVNLSYNNLSGPIPEH--LKKSPEY 220
Query: 190 SFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXKEDKKKSLKIWSVALIAAGSALV 249
SF NS LCG PL C +++S K + +A++ S V
Sbjct: 221 SFIGNSLLCGPPLNA-CSGGAISPSSNLPRPLTENLHPVRRRQS-KAYIIAIVVGCSVAV 278
Query: 250 PFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWS-MEDPERRVELEFFDKT 308
FL ++ C KK ++E EG + ++ KK D S ++DPE+ +L FF++
Sbjct: 279 LFLGIVFLVCLVKKTKKEEGGGEGVRTQMGG-VNSKKPQDFGSGVQDPEKN-KLFFFERC 336
Query: 309 IPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLG 368
FDL+DLL+ASAEVLGKG G+ YKA LE V VKR++ + A SKKEF QQM+++G
Sbjct: 337 NHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVA-SKKEFEQQMEIVG 395
Query: 369 KL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQT 427
K+ +H N ++++YYSK+EKL++Y+++ GSLF ++H +RG + W TR+ I T
Sbjct: 396 KINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRGVD--WETRMKIATGT 453
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFREND--IYRAKLTNFGFLPLLPSRKASENLA 485
+K +++LH S K H ++KSSNIL+ + + + L LP R N
Sbjct: 454 SKAISYLH----SLKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYN-- 507
Query: 486 IGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG--NNETSGDLSDWVRMVVD 543
+PE E +R++ ++DVY FG+++LE++TG+ P PG + DL WVR VV
Sbjct: 508 ---APEVIETRRVSQRSDVYSFGVVILEMLTGKTPLT-QPGLEDERVVIDLPRWVRSVVR 563
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+W+ ++ DVE+L + + EM+++ +LAL C PE RPKM EV R IE+++
Sbjct: 564 EEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVR 617
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 4.0e-74, P = 4.0e-74
Identities = 179/493 (36%), Positives = 282/493 (57%)
Query: 115 VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174
VNL+ LS N S IP +L +L L LQ N L G IP L N+S+NNL+
Sbjct: 141 VNLD---LSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNL-PPRLKYLNLSFNNLN 196
Query: 175 GPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXX----XXXXXKEDK 230
G +P + V+SFP+SSF+ NS LCG PL C +
Sbjct: 197 GSVPSS--VKSFPASSFQGNSLLCGAPLTP-CPENTTAPSPSPTTPTEGPGTTNIGRGTA 253
Query: 231 KKSLKIWSVALIAAGSALVPFLVM-LLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPD 289
KK L ++ IA G +++ F+++ ++ CC KK + S + S+ K +
Sbjct: 254 KKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTA--VPKAKPGRSDNKAEE 311
Query: 290 SWS-MEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKR 348
S +++ E+ +L FF+ + FDL+DLLRASAEVLGKG G+TYKA LE G V VKR
Sbjct: 312 FGSGVQEAEKN-KLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKR 370
Query: 349 VKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHES 407
+K + A K+EF QQM+ +G++ H N+A + ++Y+SK+EKL++Y++ G+ LLH +
Sbjct: 371 LKEV-AAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGN 429
Query: 408 RGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467
GR L W TRL I + A+G++ +H + K+ H N+KS N+L+ +E + ++
Sbjct: 430 NEGGRAALDWETRLRICLEAARGISHIHSASGA-KLLHGNIKSPNVLLTQELHVC---VS 485
Query: 468 NFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG 526
+FG PL+ + ++G R+PE E ++ T K+DVY FG++LLE++TG+ G + G
Sbjct: 486 DFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGK-TTG 544
Query: 527 NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREG-QNEMLRLTELALECTDIAPEKRPK 585
+ E DL WV+ VV +W+ ++ DVE++ + + EM+++ ++A+ C P+ RP
Sbjct: 545 HEEVV-DLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPS 603
Query: 586 MSEVLRRIEEIQP 598
M EV+ +EEI+P
Sbjct: 604 MEEVVNMMEEIRP 616
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
Identities = 173/487 (35%), Positives = 272/487 (55%)
Query: 122 LSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTR 181
L +N FS IP +L L L+ N L G IP L FNVS N L+G IP +
Sbjct: 145 LGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEIT-LPLQQFNVSSNQLNGSIPSS- 202
Query: 182 VVQSFPSSSFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXKEDKKKSLKIWSVAL 241
+ S+P ++FE N+ LCG+PL+ C K+D K L ++
Sbjct: 203 -LSSWPRTAFEGNT-LCGKPLDT-CEAESPNGGDAGGPNTPPE--KKDSDK-LSAGAIVG 256
Query: 242 IAAGSALVPFLVMLLFWC-CYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRV 300
I G + L++L+ +C C K+ E+ + +A S +P + P +
Sbjct: 257 IVIGCVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKA 316
Query: 301 ----------ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVK 350
+L FF K+ FDLD LL+ASAEVLGKG VGS+YKA+ E G VVAVKR++
Sbjct: 317 TGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLR 376
Query: 351 NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGV 410
++ + +KEF +++ +LG + H NL ++++Y+S++EKL+++E++ GSL +LH ++G
Sbjct: 377 DV-VVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGN 435
Query: 411 GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
GR PL W TR I A+ +++LH H N+KSSNIL+ +D Y AK++++G
Sbjct: 436 GRTPLNWETRAGIALGAARAISYLHS--RDGTTSHGNIKSSNILL---SDSYEAKVSDYG 490
Query: 471 FLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530
P++ S A + R+PE + ++++ KADVY FG+++LE++TG+ P + NE
Sbjct: 491 LAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQL--NEE 548
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAR-EGQNEMLRLTELALECTDIAPEKRPKMSEV 589
DL WV+ V + +D+LD E+ + EG ++RL ++ + CT P+ RP M+EV
Sbjct: 549 GVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEV 608
Query: 590 LRRIEEI 596
R IEE+
Sbjct: 609 TRLIEEV 615
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 7.5e-73, P = 7.5e-73
Identities = 173/492 (35%), Positives = 285/492 (57%)
Query: 116 NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNN--L 173
+L T+ L N FS IP I+L L+ + N +GQIP N S +V N L
Sbjct: 163 HLLTLRLESNRFSGQIP--NINLSDLQDFNVSGNNFNGQIP--NSLSQFPESVFTQNPSL 218
Query: 174 DG-PIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCXXXXXXXXXXXXXXXXXXXXKEDKKK 232
G P+ + + S P+ GRP E K +
Sbjct: 219 CGAPLLKCTKLSSDPTKP--------GRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTS 270
Query: 233 SLKIWS-VALIAAGSALVPFLVMLLFWCCYKKVH-EKEKSNEGQAGEGSAHLSEKKMPDS 290
+ S +A+I ++ F+ +LL++C +++ K+K ++ GE + S +
Sbjct: 271 RISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPYPTST 330
Query: 291 WSMEDPERRV----ELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAV 346
+ + ++V ++ FF+ T F+L+DLLRASAE+LGKG G+ YKA LE G VAV
Sbjct: 331 QNNNNQNQQVGDKGKMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAV 389
Query: 347 KRVKN-MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLH 405
KR+K+ + KKEF QQM++LG+L+H NL + ++Y+++EEKL++Y+++PNGSLF LLH
Sbjct: 390 KRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLH 449
Query: 406 ESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465
+RG GR PL WTTRL I A+GLAF+H + + K+ H ++KS+N+L+ R + A+
Sbjct: 450 GNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGN---AR 506
Query: 466 LTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP 525
+++FG PS+ +++ R+PE +G++ T K+DVY FG++LLE++TG+ P
Sbjct: 507 VSDFGLSIFAPSQTVAKSNGY-RAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVET 565
Query: 526 GNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK 585
G++ + DL WV+ VV +W+ ++ D+E++ ++ + EM+ L ++A+ CT +A + RPK
Sbjct: 566 GHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPK 625
Query: 586 MSEVLRRIEEIQ 597
M V++ IE+I+
Sbjct: 626 MGHVVKLIEDIR 637
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M9C5 | Y1680_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3689 | 0.9155 | 0.8253 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_184000037 | hypothetical protein (619 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 604 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 7e-43
Identities = 144/535 (26%), Positives = 242/535 (45%), Gaps = 77/535 (14%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDG 130
L+L Q +G +P +++ L +L L N LSG +P+ L++ L ++ LS N S
Sbjct: 480 LDLSRNQFSGAVPRKLG-SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPS 188
IP + ++P L +L+L +N L G+IP N SL+ N+S+N+L G +P T + +
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598
Query: 189 SSFEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSAL 248
S+ N LCG S PP K +K + + L
Sbjct: 599 SAVAGNIDLCGGD-----------------TTSGLPPCKRVRKTPSWWFYIT-----CTL 636
Query: 249 VPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFD-K 307
FLV+ L G + + + +E+ + EL+FFD K
Sbjct: 637 GAFLVLAL------------------VAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678
Query: 308 TIPVFDLDDLLRASAE--VLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQM 364
++D+L + E V+ +GK G++YK ++++G VK + ++N++ E
Sbjct: 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-- 736
Query: 365 QLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSII 424
+GKL+H N+ K++ S++ +I+E++ +L ++L L+W R I
Sbjct: 737 --MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIA 786
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL 484
AK L FLH S V NL I+I D +L+ LP ++
Sbjct: 787 IGIAKALRFLHCRC-SPAVVVGNLSPEKIII-DGKDEPHLRLS-------LPGLLCTDTK 837
Query: 485 AIGRS----PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540
S PE E K +T K+D+Y FG+IL+E++TG+ P + G + + + +W R
Sbjct: 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARY 894
Query: 541 VVDNDWSTDILDVEILA-AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
+ +D I QNE++ + LAL CT P RP ++VL+ +E
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVSFY 382
LG+G G+ Y A ++G VA+K +K ++ S E + + +++L KL H N+ K+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ ++ E+ GSL DLL E+ G L+ L I+ Q +GL + LHS+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEY----LHSNG 112
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPE-FPEGKR 497
+ H +LK NIL+ +N + KL +FG LL S K+ +G +PE
Sbjct: 113 IIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 498 LTHKADVYCFGIILLE 513
+ K+D++ G+IL E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE--FVQQMQLLGKLKHENLAKIV 379
LG G G+ YKA +G +VAVK +K + SKK+ +++++L +L H N+ +++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ K+ ++ E+ G LFD L PL+ I Q +GL + LH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEY----LH 115
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAIGRSPEF--PE- 494
S+ + H +LK NIL+ + K+ +FG L S + + +P + PE
Sbjct: 116 SNGIIHRDLKPENILLDENGVV---KIADFGLAKKLLKSSSSLTTFVG---TPWYMAPEV 169
Query: 495 ---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529
G K DV+ G+IL E++TG+ P +G ++
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ 207
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E LG+G G Y A ++G +VA+K +K +E + + +++L KLKH N+ ++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ +++ ++ E+ G LFDLL + GR+ ++Q L + LHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEA--RFYLRQILSALEY----LHS 115
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA----IGRSPEF--PE 494
+ H +LK NIL+ + + KL +FG +R+ +G +PE+ PE
Sbjct: 116 KGIVHRDLKPENILLDEDGHV---KLADFGL-----ARQLDPGEKLTTFVG-TPEYMAPE 166
Query: 495 ---GKRLTHKADVYCFGIILLEVITGRIP 520
GK D++ G+IL E++TG+ P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 42/288 (14%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAK 377
+ LG+G G YK L+ VAVK +K + +K+F+++ +++ KL H N+ +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP----LAWTTRLSIIKQTAKGLAF 433
++ +E ++ E++ G L D L +SR V P L+ LS Q AKG+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
L S K H +L + N L+ + K+++FG + G+
Sbjct: 121 ----LASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
+PE + T K+DV+ FG++L E+ T G P G N E L R+
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYRLPKPEYC 232
Query: 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
++ EL L C + PE RP SE++ R+E
Sbjct: 233 PDEL------------------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 57/291 (19%)
Query: 323 EVLGKGKVGSTYKATL-----ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+ LG+G G YK TL + VAVK +K + ++EF+++ ++ KL H N+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+++ E I+ E++P G L D L + L L + Q AKG+ +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEY--- 117
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF---P 493
L S H +L + N L+ K+++FG + G+ P P
Sbjct: 118 -LESKNFVHRDLAARNCLVTENL---VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 494 E---GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E + T K+DV+ FG++L E+ T G P +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------------------------YP-G 207
Query: 550 ILDVEILAAREGQNEMLR-------LTELALECTDIAPEKRPKMSEVLRRI 593
+ + E+L E + R L EL L+C PE RP SE++ +
Sbjct: 208 MSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +GKG G YKA +G VA+K +K + K++ + ++Q+L K KH N IV +
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN---IVKY 62
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y Y K+++L I+ EF GSL DLL + + + + K+ KGL + L
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQIA--YVCKELLKGLEY----L 114
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
HS+ + H ++K++NIL+ KL +FG L KA + +G +PE
Sbjct: 115 HSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTM-VGTPYWMAPEVIN 170
Query: 495 GKRLTHKADVYCFGIILLEVITGRIP 520
GK +KAD++ GI +E+ G+ P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSK--KEFVQQMQLLGKLKHENLAKIV 379
+++G+G G YK LE+G VA+K++ + K +Q++ LL LKH N+ K +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI--IKQTAKGLAFLHQT 437
+ + II E+ NGSL ++ + G P L + Q +GLA+LH+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKF---GPFP----ESLVAVYVYQVLQGLAYLHE- 117
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFP 493
V H ++K++NIL ++ + KL +FG L + +G +PE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVV---KLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIP 520
E + +D++ G ++E++TG P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 64/294 (21%)
Query: 323 EVLGKGKVGSTYKATLE-----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLA 376
+ LG+G G YK L+ VAVK +K + +EF+++ +++ KL H N
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN-- 62
Query: 377 KIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+V +E I+ E++ G L L ++R ++ L+ LS Q A+G+ +
Sbjct: 63 -VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--PKLSLS--DLLSFALQIARGMEY 117
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKASENLAIGR- 488
L S H +L + N L+ K+++FG L RK L I R
Sbjct: 118 ----LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYRKRGGKLPI-RW 169
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
+PE + + T K+DV+ FG++L E+ T G P +
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-------------------------Y 204
Query: 547 STDILDVEILAAREGQNEMLR-------LTELALECTDIAPEKRPKMSEVLRRI 593
+ + E+L + + + L +L L+C PE RP SE++ +
Sbjct: 205 P-GMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ +GKG G Y G + +K + NM+ +++ + ++++L KL H N I+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN---II 62
Query: 380 SFYYSKEEK---LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+Y S EEK I+ E+ G L + + + G+ P L Q L +
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK-PFPEEQILDWFVQLCLALKY--- 118
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-------- 488
LHS K+ H ++K NI + + KL +FG S+ S + + +
Sbjct: 119 -LHSRKILHRDIKPQNIFLTSNGLV---KLGDFGI-----SKVLSSTVDLAKTVVGTPYY 169
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
SPE + K +K+D++ G +L E+ T + P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 65/295 (22%)
Query: 323 EVLGKGKVGSTYKATL-----ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLA 376
+ LG+G G YK TL VAVK +K + +EF+++ +++ KL H N
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN-- 62
Query: 377 KIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
IV +E +I+ E++P G L D L ++R L+ + LS Q A+G+ +
Sbjct: 63 -IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEY 118
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKASENLAIGR- 488
L S H +L + N L+ K+++FG L + L I R
Sbjct: 119 ----LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYKVKGGKLPI-RW 170
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
+PE + + T K+DV+ FG++L E+ T G P PG
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPG-------------------- 207
Query: 547 STDILDVEILAAREGQNEMLR--------LTELALECTDIAPEKRPKMSEVLRRI 593
+ + + L L +L L+C PE RP SE++ +
Sbjct: 208 ----MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV-------KNMNALSKKEFVQQMQLLGKLKHEN 374
E+LG+G GS Y A ++G ++AVK V + + AL ++E ++L L+H N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREI----RILSSLQHPN 60
Query: 375 LAKIVSFYYSKEEK-----LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429
IV +Y S+ ++ I E++ GSL LL + G++P + + +Q +
Sbjct: 61 ---IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYT--RQILE 112
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR- 488
GLA+LH S+ + H ++K +NIL+ + KL +FG +++ +
Sbjct: 113 GLAYLH----SNGIVHRDIKGANILVDSD---GVVKLADFGC-----AKRLGDIETGEGT 160
Query: 489 ----------SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE G+ AD++ G ++E+ TG+ P
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 324 VLGKGKVGSTYKATL-ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
VLG+G G YK +G + A+K++ + + +K+ +++++ L + +V
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY---VVKC 64
Query: 382 Y---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y Y + E I+ E++ GSL DLL + + LA I +Q KGL +LH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKR 119
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
H + H ++K SN+LI + ++ K+ +FG +L + N +G SPE +
Sbjct: 120 H---IIHRDIKPSNLLINSKGEV---KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 495 GKRLTHKADVYCFGIILLEVITGRIP 520
G+ ++ AD++ G+ LLE G+ P
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 43/281 (15%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+GKG+ G G VAVK +K+ ++ + + F+ + ++ L+H NL +++
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
I+ E++ GSL D L SRG I LA +L +G+ + L
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLA--QQLGFALDVCEGMEY----LEEKN 122
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEFPEGK 496
H +L + N+L+ E+ + AK+++FG +++AS+ G+ +PE K
Sbjct: 123 FVHRDLAARNVLV-SEDLV--AKVSDFGL-----AKEASQGQDSGKLPVKWTAPEALREK 174
Query: 497 RLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555
+ + K+DV+ FGI+L E+ + GR+P P L D V V
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPHVEKG---------YR 217
Query: 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ A EG + ++ +C ++ P KRP ++ ++ I
Sbjct: 218 MEAPEGCPP--EVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +G+G G YKAT +G VA+K+++ + +K+ + ++ ++ KH N IV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPN---IVDY 80
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y Y ++L ++ E++ GSL D++ ++ + + + ++ +GL + L
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEY----L 132
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
HS V H ++KS NIL+ ++ + KL +FGF L K+ N +G +PE +
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSV---KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 495 GKRLTHKADVYCFGIILLEVITGRIP 520
K K D++ GI+ +E+ G P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 323 EVLGKGKVGSTYKATLES-GAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+GKG G +K ++ V A+K++ MN ++E + + ++L KL + +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ K + I+ E+ NG L LL RG +P R I Q GLA LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRG-RPLPEDQVWRFFI--QILLGLAH----LH 118
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEG 495
S K+ H ++KS N+ + +++ K+ + G LL N +G SPE E
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNV---KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
K K+DV+ G++L E TG+ P
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGK 369
VFD+ E LG+G GS YKA E+G VVA+K V L E ++++ +L +
Sbjct: 4 VFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ--EIIKEISILKQ 54
Query: 370 LKHENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQ 426
IV +Y Y K L I+ E+ GS+ D++ + L +I+ Q
Sbjct: 55 CDSPY---IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITN---KTLTEEEIAAILYQ 107
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
T KGL +LH S+K H ++K+ NIL+ N+ +AKL +FG L A N I
Sbjct: 108 TLKGLEYLH----SNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVI 160
Query: 487 GR----SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
G +PE + +KAD++ GI +E+ G+ P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 50/273 (18%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G + T VAVK +K +S + F+Q+ Q++ KL+H+ L ++ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+E I+ E++ GSL D L G L + + Q A+G+A+L S
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLE----SRNYI 125
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----------SPEFPE 494
H +L + NIL+ EN + K+ +FG +R ++ R +PE
Sbjct: 126 HRDLAARNILV-GENLVC--KIADFGL-----ARLIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 495 GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDLSDWVRMVVDNDWSTDIL 551
R T K+DV+ FGI+L E++T GR+P PG N E + RM
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP---YPGMTNREVLEQVERGYRMP---------- 224
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRP 584
N L +L L+C D PE+RP
Sbjct: 225 --------RPPNCPEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.3 bits (217), Expect = 9e-19
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHE-NLAKI 378
LG+G G Y A +VA+K + KE F++++Q+L L H N+ K+
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
F+ + ++ E++ GSL DLL + G + + L I+ Q L + L
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA--LFILAQILSALEY----L 117
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----------R 488
HS + H ++K NIL+ R+ + KL +FG LLP ++ ++
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRV--VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 489 SPEFPEGKRL---THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545
+PE G L + +D++ GI L E++TG P G ++ TS + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPS 234
Query: 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
++ + + ++L + P+ R S L
Sbjct: 235 LASPLSP------SNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 56/301 (18%)
Query: 325 LGKGKVGSTYKATLE-----SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
LGKG GS + +G VVAVK++++ A ++F +++++L L+H+N+ K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 380 SFYYS--KEEKLIIYEFLPNGSLFDLL--HESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
YS + ++ E+LP GSL D L H R R L + + Q KG+ +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS------QICKGMEY-- 123
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI---GRSPEF 492
L S + H +L + NIL+ EN R K+ +FG +LP K E + G SP F
Sbjct: 124 --LGSKRYVHRDLATRNILVESEN---RVKIGDFGLTKVLPQDK--EYYKVREPGESPIF 176
Query: 493 ---PEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
PE + + +DV+ FG++L E+ T + SP ++++RM+ ++
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPP--------AEFMRMMGNDKQ 227
Query: 547 STDILDVEILAAREGQNEMLRLT----------ELALECTDIAPEKRPKMSEVLRRIEEI 596
I+ I + RL + EC + P +RP SE+ ++E I
Sbjct: 228 GQMIVYHLIELLKNNG----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
Query: 597 Q 597
+
Sbjct: 284 R 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 77/266 (28%), Positives = 127/266 (47%), Gaps = 37/266 (13%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G + T VAVK +K +S + F+++ Q++ KL+H+ L ++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVV-S 71
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+E I+ E++ GSL D L + G GR L + + Q A G+A++ + + H+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKD--GEGR-ALKLPNLVDMAAQVAAGMAYIERMNYIHR-- 126
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRLT 499
+L+S+NIL+ D K+ +FG L+ +R+ ++ +PE R T
Sbjct: 127 --DLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 500 HKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
K+DV+ FGI+L E++T GR+P G N E + RM D
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRMPCPQDCP----------- 229
Query: 559 REGQNEMLRLTELALECTDIAPEKRP 584
+ L EL L+C PE+RP
Sbjct: 230 -------ISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G ++ + VAVK +K + K+F+ + Q++ KL+H L ++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+E I+ E + GSL + L G + L + + Q A G+A+ L +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG-RALKL--PQLIDMAAQVASGMAY----LEAQNYI 125
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----------SPEFPE 494
H +L + N+L+ EN+I K+ +FG +R E++ R +PE
Sbjct: 126 HRDLAARNVLV-GENNIC--KVADFGL-----ARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 495 GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG 526
R + K+DV+ FGI+L E++T GR+P G
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G + AT VAVK +K ++S + F+ + ++ L+H+ L K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
KE II EF+ GSL D L G + PL S Q A+G+AF+ Q + H+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFS--AQIAEGMAFIEQRNYIHR-- 126
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLP-----SRKASENLAIGRSPEFPEGKRLT 499
+L+++NIL+ + K+ +FG ++ +R+ ++ +PE T
Sbjct: 127 --DLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 500 HKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
K+DV+ FGI+L+E++T GRIP G N E L RM + ++ ++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRPENCPEELYNI----- 235
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
+ C PE+RP E ++ + +
Sbjct: 236 -------------MMRCWKNRPEERPTF-EYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 42/281 (14%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ LG G+ G + VA+K +K ++S + F+ + L+ +L+H L ++ +
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
++E II E++ NGSL D L G I L + + Q A+G+AF+ + + H+
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP-----SRKASENLAIGRSPEFPEGKR 497
+L+++NIL+ ++ K+ +FG L+ +R+ ++ +PE
Sbjct: 127 ----DLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 498 LTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDLSDWVRMVVDNDWSTDILDVE 554
T K+DV+ FGI+L E++T GRIP PG N E +L RM +
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP---YPGMTNPEVIQNLERGYRMPRPD---------- 226
Query: 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
N L EL C PE+RP E LR + E
Sbjct: 227 --------NCPEELYELMRLCWKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 60/222 (27%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G + + VAVK +K +S + F+++ L+ L+H+ L ++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+E II E++ GSL D L G G++ L S Q A+G+A++ + + H+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFS--AQIAEGMAYIERKNYIHR-- 127
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRLT 499
+L+++N+L+ ++ K+ +FG ++ +R+ ++ +PE T
Sbjct: 128 --DLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 500 HKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRM 540
K+DV+ FGI+L E++T G+IP G N++ L RM
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGM-SNSDVMSALQRGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 48/285 (16%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +GKG G YK L+ VAVK + + K++F+Q+ ++L + H N+ K++
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
K+ I+ E +P GSL L + + R+ + ++S+ A G+ +L S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSL--DAAAGMEYLE----SK 112
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI---GR--------SP 490
H +L + N L+ N + K+++FG SR+ + G +P
Sbjct: 113 NCIHRDLAARNCLVGENNVL---KISDFGM-----SREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E R T ++DV+ +GI+L E + G P G N +T R +++ +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQT--------RERIESGYR-- 213
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
+ A + E + L L+C PE RP SE+ ++
Sbjct: 214 ------MPAPQLCPEEIY--RLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 43/269 (15%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG+G G + T VA+K +K +S + F+Q+ Q++ KL+HE L ++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 385 KEEKLIIYEFLPNGSLFDLLH-ESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+E I+ E++ GSL D L E R+P + + Q A G+A++ + + H+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMNYVHR- 126
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRL 498
+L+++NIL+ + K+ +FG L+ +R+ ++ +PE R
Sbjct: 127 ---DLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 499 THKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDLSDWVRMVVDNDWSTDILDVEI 555
T K+DV+ FGI+L E+ T GR+P PG N E + RM +
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVERGYRMPCPPECPES------ 231
Query: 556 LAAREGQNEMLRLTELALECTDIAPEKRP 584
L +L +C PE+RP
Sbjct: 232 ------------LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 315 DDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKH 372
DDL LG G G K +G ++AVK ++ +N +K+ ++++ +L K
Sbjct: 1 DDLEYLG--ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS 58
Query: 373 ENLAKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429
IV FY Y+ + I E++ GSL +L E +G RIP ++++ K
Sbjct: 59 PY---IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--RIPERILGKIAV--AVLK 111
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA---I 486
GL +LH HK+ H ++K SNIL+ I KL +FG S + +LA +
Sbjct: 112 GLTYLH---EKHKIIHRDVKPSNILVNSRGQI---KLCDFGV-----SGQLVNSLAKTFV 160
Query: 487 G----RSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
G +PE +G + K+D++ G+ L+E+ TGR P
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG+G G + T VA+K +K + + F+Q+ Q++ KL+H+ L + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+E I+ EF+ GSL D L E G L + + Q A G+A++ + + H+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIERMNYIHR-- 126
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRLT 499
+L+++NIL+ D K+ +FG L+ +R+ ++ +PE R T
Sbjct: 127 --DLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 500 HKADVYCFGIILLEVIT-GRIPGNG 523
K+DV+ FGI+L E++T GR+P G
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 80/299 (26%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVK--RVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G G G Y A L++G ++AVK R+++ + + KE +M++L LKH NL K
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63
Query: 382 YYSKE---EKLIIY-EFLPNGSLFDLLHESRGVGRI-PLAWTTRLSIIKQTAKGLAFLHQ 436
YY E EK+ I+ E+ G+L +LL GRI + Q +GLA+LH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYT--LQLLEGLAYLH- 116
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN-LAIGR------- 488
SH + H ++K +NI + I KL +FG + K N +G
Sbjct: 117 ---SHGIVHRDIKPANIFLDHNGVI---KLGDFG-----CAVKLKNNTTTMGEEVQSLAG 165
Query: 489 -----SPEFPEGKRLTHK---ADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540
+PE G + AD++ G ++LE+ TG+ P W +
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP----------------WSEL 209
Query: 541 VVDNDWS---------TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
DN++ + + + EG++ + R C + P+KRP SE+L
Sbjct: 210 --DNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR-------CLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+ +G G G YKA + +G +VA+K +K + Q++ +L + +H N IV++
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN---IVAY 65
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ Y + +KL I+ E+ GSL D+ V R PL+ + ++T KGLA+LH+T
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLSELQIAYVCRETLKGLAYLHET- 120
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
K+ H ++K +NIL+ + D+ KL +FG L + A IG +PE
Sbjct: 121 --GKI-HRDIKGANILLTEDGDV---KLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 495 GKRL---THKADVYCFGIILLE 513
+R K D++ GI +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 56/283 (19%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LGKG GS YK L A+K V +M+ +++ V ++++L + H N I+S+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN---IISY 64
Query: 382 YYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
KE L I+ E+ P G L + + + + + I Q +GL
Sbjct: 65 ---KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRK-LIPEQEIWRIFIQLLRGL---- 116
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE 491
Q LH K+ H +LKS+NIL+ ND+ K+ + G +L A IG +PE
Sbjct: 117 QALHEQKILHRDLKSANILLV-ANDLV--KIGDLGISKVLKKNMA--KTQIGTPHYMAPE 171
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM----VVDNDWS 547
+G+ ++K+D++ G +L E+ T P + DL V+ + +S
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-----RSMQDLRYKVQRGKYPPIPPIYS 226
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
D L + P+ RP ++L
Sbjct: 227 QD------------------LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 57/205 (27%), Positives = 107/205 (52%), Gaps = 22/205 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFV-QQMQLLGKLKHENLAKIVS 380
E +G+G G+ Y A + +G VA+K++ N+ KKE + ++ ++ + KH N+ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHES-RGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
Y +E ++ E+L GSL D++ E+ G+I ++ ++ + L F LH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF----LH 132
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEG 495
S++V H ++KS NIL+ + + KLT+FGF + ++ + +G +PE
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
K K D++ GI+ +E++ G P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIV 379
V+G+G G K +G +VA+K+ K + KK ++++++L +L+HEN+ +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ K +++E++ +L +LL S G G P A R S I Q + +A+ H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPG-GLPPDA--VR-SYIWQLLQAIAY----CH 117
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS---ENLAIG--RSPEFPE 494
SH + H ++K NIL+ E+ + KL +FGF L +R AS + +A R+PE
Sbjct: 118 SHNIIHRDIKPENILV-SESGV--LKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 495 GKRLTHKA-DVYCFGIILLEVITGR--IPG 521
G K DV+ G I+ E++ G PG
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG G G YKA E+G A K ++ + ++F+ ++ +L + KH N+ + Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+ + I+ EF G+L ++ E + R L + +Q + L FLH SHKV
Sbjct: 73 YENKLWILIEFCDGGALDSIMLE---LER-GLTEPQIRYVCRQMLEALNFLH----SHKV 124
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--PE------- 494
H +LK+ NIL+ + D+ KL +FG S + IG +P + PE
Sbjct: 125 IHRDLKAGNILLTLDGDV---KLADFGVSAKNKSTLQKRDTFIG-TPYWMAPEVVACETF 180
Query: 495 -GKRLTHKADVYCFGIILLEVITGRIP 520
+KAD++ GI L+E+ P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 63/275 (22%), Positives = 119/275 (43%), Gaps = 37/275 (13%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
+G G+ G + VA+K ++ A+S+++F+++ Q++ KL H L ++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+ +++EF+ +G L D L RG + T L + +G+A+L + V
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESS----NVI 122
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRLT 499
H +L + N L+ EN + K+++FG + S ++ SPE + +
Sbjct: 123 HRDLAARNCLV-GENQV--VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 500 HKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
K+DV+ FG+++ EV + G+ P N+E ++ R+ S +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENR-SNSEVVETINAGFRLYKPRLASQSVY------- 231
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
EL C PE RP S +L ++
Sbjct: 232 -----------ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 325 LGKGKVGSTYKATLE-----SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G + +G VAVK + + + +F +++++L L HEN+ K
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 379 VSFYYSKEEK--LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ +I E+LP+GSL D L R +I L L Q KG+ +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLK--RLLLFSSQICKGMDY--- 124
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK---ASENLAIGRSPEF- 492
L S + H +L + NIL+ E+ + K+++FG +LP K + G SP F
Sbjct: 125 -LGSQRYIHRDLAARNILVESEDLV---KISDFGLAKVLPEDKDYYYVKEP--GESPIFW 178
Query: 493 --PEG---KRLTHKADVYCFGIILLEVIT 516
PE + + +DV+ FG+ L E+ T
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E +GKG G YKA + VVA+K + A + E +QQ +Q L + + I
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY---ITK 63
Query: 381 FY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+Y + K KL II E+ GS DLL L T I+++ GL +LH
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH-- 115
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFP 493
H ++K++NIL+ E D+ KL +FG L S + N +G +PE
Sbjct: 116 --EEGKIHRDIKAANILLSEEGDV---KLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIP 520
+ KAD++ GI +E+ G P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G G ++ ++ VA+K +K+ + L +++F +++Q L +L+H++L + +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 385 KEEKLIIYEFLPNGSLFDLLH--ESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
E II E + GSL L E + + L + + Q A+G+A+ L
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAY----LEEQN 124
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP-SRKASENLAIG---RSPEFPEGKRL 498
H +L + NIL+ + K+ +FG L+ S + I +PE
Sbjct: 125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 499 THKADVYCFGIILLEVIT-GRIPGNG 523
+ K+DV+ FGI+L E+ T G++P G
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 46/281 (16%)
Query: 324 VLGKGKVGST--YKATLESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
VLGKG G Y+ T E ++V K V N+ LS+KE + ++ +L L+H N I
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPN---I 61
Query: 379 VSFYYSKEEK---LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+++Y + LI E+ G+L+D + +G L + Q ++++H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH 118
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE 491
+ + H ++K+ NI + + I KL +FG +L S + +G SPE
Sbjct: 119 KA----GILHRDIKTLNIFLTKAGLI---KLGDFGISKILGSEYSMAETVVGTPYYMSPE 171
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
+G + K+D++ G +L E++T + + + + + V +V ++ T ++
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--------NPLNLVVKIVQGNY-TPVV 222
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592
V L L PEKRP EVL +
Sbjct: 223 SVYSSE----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 51/204 (25%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFV-QQMQLLGKLKHENLAKIVS 380
E +G+G G+ + A + +G VA+K++ N+ KKE + ++ ++ +LK+ N+ +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ +E ++ E+L GSL D++ E+ + ++ ++ + L F LH+
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEF----LHA 133
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
++V H ++KS N+L+ + + KLT+FGF + ++ + +G +PE K
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
K D++ GI+ +E++ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 324 VLGKGKVGSTYKA--TLESGAV---VAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAK 377
VLG G G+ YK E V VA+K ++ + + KE + + ++ + H ++ +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
++ S + +LI + +P G L D + + + L+ Q AKG+++L +
Sbjct: 74 LLGICLSSQVQLIT-QLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE- 127
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP------E 491
++ H +L + N+L+ + K+T+FG LL + + G+ P E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHV---KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 492 FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG 526
+ THK+DV+ +G+ + E++T G P G P
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 52/289 (17%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVK------NMNALSKKEFVQQMQLLGKLKHENL 375
EV+G G Y A L + VA+KR+ +++ L K+ VQ M H N
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKE--VQAMSQC---NHPN- 60
Query: 376 AKIVSFYYS---KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+V +Y S +E ++ +L GSL D++ S G + A +++K+ KGL
Sbjct: 61 --VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA--IIATVLKEVLKGLE 116
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG-----FLPLLPSRKASENLAIG 487
+LH S+ H ++K+ NIL+ + + K+ +FG +RK + +G
Sbjct: 117 YLH----SNGQIHRDIKAGNILLGEDGSV---KIADFGVSASLADGGDRTRKVRKTF-VG 168
Query: 488 R----SPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV 542
+PE E KAD++ FGI +E+ TG P + P + + +
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--------MKVLMLTL 220
Query: 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
ND + + + +M+ L C P KRP E+L+
Sbjct: 221 QNDPPSLETGADYKKYSKSFRKMISL------CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +GKG+ G G VAVK +KN + + F+ + ++ +L+H NL +++
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 383 YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
++ L I+ E++ GSL D L R GR L L + + +L ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE----AN 121
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTH 500
H +L + N+L+ +N AK+++FG S + + L + +PE K+ +
Sbjct: 122 NFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 501 KADVYCFGIILLEVIT-GRIP 520
K+DV+ FGI+L E+ + GR+P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKK--EFVQQMQLLGKLKHENLAKIV 379
E++G+G G+ Y+ + +G VVA+K + N++ + +++ LL +L+ I
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 380 SFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+Y Y K +L II E+ GS+ L+ P+A II++ L ++H+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK 119
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE- 491
V H ++K++NIL+ ++ KL +FG LL + + +G +PE
Sbjct: 120 V----GVIHRDIKAANILVTNTGNV---KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIP 520
EGK KAD++ GI + E+ TG P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVK--NMNALSK---KEFVQQMQLLGKLKHENLA 376
E+LG G GS Y+ L+ G AVK V + + K+ Q++ LL KL+H N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 377 KIVSFYYSK--EEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
IV + ++ E+ L I+ E +P GSL LL + + TR Q GL +
Sbjct: 64 -IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEY 117
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG------FLPLLPSRKASENLAIG 487
LH H ++K +NIL+ + KL +FG S K S
Sbjct: 118 ----LHDRNTVHRDIKGANILVDTNGVV---KLADFGMAKQVVEFSFAKSFKGS---PYW 167
Query: 488 RSPEF--PEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE +G AD++ G +LE+ TG+ P
Sbjct: 168 MAPEVIAQQGGY-GLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 56/205 (27%), Positives = 107/205 (52%), Gaps = 22/205 (10%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFV-QQMQLLGKLKHENLAKIVS 380
E +G+G G+ Y A + +G VA+K++ N+ KKE + ++ ++ + K+ N+ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHES-RGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
Y +E ++ E+L GSL D++ E+ G+I ++ ++ + L F LH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALDF----LH 132
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEG 495
S++V H ++KS NIL+ + + KLT+FGF + ++ + +G +PE
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
K K D++ GI+ +E++ G P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 58/223 (26%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-----MQLLGKLKHENLA 376
E LG+G G YKA ++G +VA+K+++ N ++E + + LL +LKH N+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIV 61
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
K++ +++ + +++E+ L L + G + SI+ Q +GLA+ H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLI--KSIMYQLLRGLAYCH- 115
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGK 496
SH++ H +LK NILI R+ + KL +FG LA R+ P +
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVL---KLADFG-------------LA--RAFGIPL-R 153
Query: 497 RLTHK---------------------ADVYCFGIILLEVITGR 518
TH+ D++ G I E+ITG+
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G YKA +G +VA+K++K + K +++++LL +L H N+ K++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ K + +++EF+ DL + R L + S + Q +GLAF H SH
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQR-GLPESLIKSYLYQLLQGLAFCH----SH 117
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--PSRKASENLAIG--RSPEFPEGKR 497
+ H +LK N+LI E + KL +FG P R + + R+PE G +
Sbjct: 118 GILHRDLKPENLLINTEGVL---KLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 498 L-THKADVYCFGIILLEVITGRI--PG 521
+ D++ G I E+++ R PG
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPG 201
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 56/205 (27%), Positives = 107/205 (52%), Gaps = 22/205 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFV-QQMQLLGKLKHENLAKIVS 380
E +G+G G+ Y A + +G VA++++ N+ KKE + ++ ++ + K+ N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHES-RGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
Y +E ++ E+L GSL D++ E+ G+I ++ ++ + L F LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF----LH 133
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEG 495
S++V H ++KS NIL+ + + KLT+FGF + ++ + +G +PE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
K K D++ GI+ +E+I G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEF----VQQMQLLGKLKHENLAKIV 379
+G+G G YKA ++G +VA+K+++ N K+ F +++++LL KL+H N+ ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 380 SFYYSKEEKLI--IYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
SK + I ++E++ DL L +S V + +KQ +GL +LH
Sbjct: 65 EIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLH 117
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE--NLAIG---RSP 490
S+ + H ++K SNILI N+ KL +FG R +++ N I R P
Sbjct: 118 ----SNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 491 EFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529
E G R + D++ G IL E+ G+ G+ E
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPI---FQGSTE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 47/283 (16%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E+LGKG G +K TL+ VAVK K ++ K +F+ + ++L + H N+ K++
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
++ I+ E +P G L + + + + ++ A G+A+ L S
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFAL--DAAAGMAY----LESK 112
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----------SPE 491
H +L + N L+ N + K+++FG SR+ + + +PE
Sbjct: 113 NCIHRDLAARNCLVGENNVL---KISDFGM-----SRQEDDGIYSSSGLKQIPIKWTAPE 164
Query: 492 FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
R + ++DV+ +GI+L E + G P G N + + RM D+
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-NQQAREQVEKGYRMSCPQKCPDDV 223
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
V M R C D PE RPK SE+ + +
Sbjct: 224 YKV-----------MQR-------CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 51/296 (17%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
E LG+G G YK L S VA+K +K N ++EF Q+ +L+ L+H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLL-----------HESRGVGRIPLAWTTRLSII 424
++ ++ +++E+L +G L + L + L + L I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKA 480
Q A G+ + L SH H +L + N L+ + K+++FG + S R
Sbjct: 131 IQIAAGMEY----LSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 481 SENLAIGR--SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537
S++L R PE + T ++D++ FG++L E+ + G P G +N+ +
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--SNQ------EV 235
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
+ M I ++L E R+ L +EC + P +RP+ ++ R+
Sbjct: 236 IEM---------IRSRQLLPCPEDCPA--RVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 306 DKTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFV-QQ 363
D P LD+ ++ +G+G G AT +G VAVK++ ++ ++E + +
Sbjct: 13 DPGDPRSYLDNFVK-----IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNE 66
Query: 364 MQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI 423
+ ++ +H N+ ++ S Y +E ++ EFL G+L D++ +R + ++
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATV 120
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL----PSRK 479
K L+F LH+ V H ++KS +IL+ + R KL++FGF + P RK
Sbjct: 121 CLAVLKALSF----LHAQGVIHRDIKSDSILLTSDG---RVKLSDFGFCAQVSKEVPRRK 173
Query: 480 ---------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
A E I R P E D++ GI+++E++ G P
Sbjct: 174 SLVGTPYWMAPE--VISRLPYGTE-------VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/200 (26%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
E++G+G+ G+ + +G VAVK +K ++ + F+++ ++ KL H+NL +++
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
I+ E + G+L + L +RG + + + S+ A+G+ +L S K
Sbjct: 69 L-HNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSL--DVAEGMEYLE----SKK 120
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTHK 501
+ H +L + NIL+ + AK+++FG + + L + +PE + K+ + K
Sbjct: 121 LVHRDLAARNILVSEDG---VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSK 177
Query: 502 ADVYCFGIILLEVIT-GRIP 520
+DV+ +G++L EV + GR P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 59/240 (24%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQM---------QLLGKLK- 371
+++G+G + A E+ A+K L K++ +++ ++L +L
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI------LDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 372 HENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTA 428
H I+ YY+ EE L + E+ PNG L + + G + T +
Sbjct: 61 HPG---IIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTR--FYAAEIL 112
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK--------- 479
L +LH S + H +LK NIL+ + K+T+FG +L
Sbjct: 113 LALEYLH----SKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 480 --ASENLAIGR-------------SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524
+ R SPE K +D++ G I+ +++TG+ P GS
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 73/294 (24%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
++G+G G K E+G +VA+K+ + + KK ++++++L +L+HENL ++
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ K+ +++EF+ + L DL G L + + Q +G+ F H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEF----CH 117
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--PSRKASENLAIG--RSPEFPEG 495
SH + H ++K NIL+ + + KL +FGF L P ++ +A R+PE G
Sbjct: 118 SHNIIHRDIKPENILVSQSGVV---KLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 496 KRLTHKA-DVYCFGIILLEVITG-----------------RIPGNGSPGNNETSGDLSDW 537
+A D++ G ++ E++TG + GN P + E +
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
M + ++ ++E L R + L L +LA +C I P+ RP S++L
Sbjct: 235 AGMRL-----PEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 63/287 (21%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 314 LDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE 373
+D + LG G+ G + VA+K ++ A+S+ +F+++ +++ KL H
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHP 59
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
NL ++ + I+ E++ NG L + L E +G L + + + +
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVCEAMEY 115
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGR 488
L S+ H +L + N L+ +N + K+++FG + S + ++
Sbjct: 116 ----LESNGFIHRDLAARNCLVGEDNVV---KVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP-GNGSPGNNETSGDLSDWVRMVVDNDW 546
PE + R + K+DV+ FG+++ EV + G++P S N+E +S R
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGYR------- 219
Query: 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
L LA E + + C PE RP ++L ++
Sbjct: 220 ----LYRPKLAPTE-------VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E +GKG G YK + VVA+K + A + E +QQ + +L + + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
Y + II E+L GS DLL PL T +I+++ KGL +LH S
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLH----S 119
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
+ H ++K++N+L+ + D+ KL +FG L + N +G +PE +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDV---KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
KAD++ GI +E+ G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G +K E+G +VA+K+ + + KK ++++++L +LKH NL ++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ K + +++E+ + L +L RGV + II QT + + F H+ H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCHK----H 119
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--PSRKASENLAIG--RSPEFPEGK- 496
H ++K NILI ++ I KL +FGF +L P ++ +A R+PE G
Sbjct: 120 NCIHRDVKPENILITKQGQI---KLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 497 RLTHKADVYCFGIILLEVITG 517
+ DV+ G + E++TG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 53/176 (30%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 30 LLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSN-GHIVSLELEEIQLAGILPPGFL 88
LL + S+N S W +V W G++C+N +VS++L ++G +
Sbjct: 34 LLSFKSSINDPLKYLSNWNSS---ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 89 QNITFLNKLSLRNNLLSGSLP-------------NLTN-----------LVNLETVFLSQ 124
+ + ++ ++L NN LSG +P NL+N + NLET+ LS
Sbjct: 91 R-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSN 149
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIP 178
N S IP LK L+L N L G+IP N TSL ++ N L G IP
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 64/288 (22%), Positives = 133/288 (46%), Gaps = 49/288 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNM-NALSKKEFV-----QQMQLLGKLKHENL 375
+ LG G S Y+A +++G ++AVK+V + N S++E V ++++L+ +L H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+++ + E++ GS+ LL + ++ +Q +GL++LH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH 120
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------- 488
+ +++ H ++K +N+LI ++ R ++ +FG L ++ G+
Sbjct: 121 E----NQIIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547
+PE G++ DV+ G +++E+ T + P N + S L+
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN----AEKHSNHLA------------ 218
Query: 548 TDILDVEILAAREGQN--EMLR--LTELALECTDIAPEKRPKMSEVLR 591
L +I +A + E L L ++ L C ++ PE RP E+L+
Sbjct: 219 ---LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKI 378
E +G+G G YKA +G VVA+K+++ ++ ++ ++++ LL +L H N+ K+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +++ + +++EFL + L + S G IPL S + Q +GLAF H
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG-IPLPLIK--SYLFQLLQGLAFCH--- 117
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL--LPSRKASENLAI--GRSPEFPE 494
SH+V H +LK N+LI E I KL +FG +P R + + R+PE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAI---KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 495 GKRLTHKA-DVYCFGIILLEVITGR--IPGN 522
G + A D++ G I E++T R PG+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 58/288 (20%)
Query: 323 EVLGKGKVGSTYKATLES--GAV--VAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAK 377
+ LG G G + + G V VAVK +K+ +F+++ ++ L HENL +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + ++ E P GSL D L + +G ++ ++ Q A G+ +L
Sbjct: 61 LYGVVLTHPLMMV-TELAPLGSLLDRLRK-DALGHFLISTLCDYAV--QIANGMRYLESK 116
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK----ASENLAIGRS---P 490
+ H +L + NIL+ ++ + K+ +FG + LP + E+L + + P
Sbjct: 117 ----RFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E + +H +DV+ FG+ L E+ T G P G G
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----------------------- 206
Query: 550 ILDVEILAAREGQNEML--------RLTELALECTDIAPEKRPKMSEV 589
+IL + + E L + + L+C P RP + +
Sbjct: 207 ---SQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 325 LGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN--LAK---- 377
+ KG G + A +S G + A+K + K + +++ Q+ ++ E L++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK------VIKKADMIRKNQV-DQVLTERDILSQAQSP 53
Query: 378 -IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+V YYS ++ L ++ E+LP G L LL VG + I + L +
Sbjct: 54 YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVAR--IYIAEIVLALEY 108
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--------LPLLPSRKASENLA 485
LH + + H +LK NILI + KLT+FG L + +
Sbjct: 109 LHS----NGIIHRDLKPDNILIDSNGHL---KLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 486 IGR----SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
+G +PE G+ + D + G IL E + G P +G
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 32/281 (11%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+GKG+ YKA L G VVA+K+V+ M+A ++++ ++++ LL +L H N+ K ++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ E I+ E G L ++ + R + T Q L +HS
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEH----MHS 124
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
++ H ++K +N+ I + KL + G S+ + + +G SPE
Sbjct: 125 KRIMHRDIKPANVFITATGVV---KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
K+D++ G +L E+ + P G N L + + D+ L +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEKCDYPP--LPADHY 233
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ L +L C + PEKRP +S VL+ +E+
Sbjct: 234 SE--------ELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVS 380
EV+G+G G YKA ++G +VA+K + ++ ++E ++ +L K H N+A
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 381 FYYSK-----EEKL-IIYEFLPNGSLFDLLHESRGVG-RIPLAWTTRLSIIKQTAKGLAF 433
+ K +++L ++ E GS+ DL+ R G R+ W I+++T +GLA+
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAY 128
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS---- 489
LH+ +KV H ++K NIL+ + ++ KL +FG L S N IG
Sbjct: 129 LHE----NKVIHRDIKGQNILLTKNAEV---KLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 490 PEF------PEGKRLTHKADVYCFGIILLEVITGRIP 520
PE P+ ++DV+ GI +E+ G+ P
Sbjct: 182 PEVIACDEQPD-ASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-RVKNMNALS----KKEFVQQMQLLGKLKHENLA 376
+VLG G G+ YK + G V + +K +N + EF+ + ++ + H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESR-GVG-RIPLAWTTRLSIIKQTAKGLAFL 434
+++ S +L+ + +P+G L D +HE + +G ++ L W Q AKG+ +L
Sbjct: 73 RLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCV------QIAKGMMYL 125
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP---- 490
+ ++ H +L + N+L+ N + K+T+FG LL + N G+ P
Sbjct: 126 EE----RRLVHRDLAARNVLVKSPNHV---KITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 491 --EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSP 525
E ++ TH++DV+ +G+ + E++T G P +G P
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 52/206 (25%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 325 LGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
+G+G G AT++S G +VAVK++ ++ ++ ++ +HEN+ ++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+E ++ EFL G+L D++ +R + +A L+++K + LH+ V
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR-MNEEQIA-AVCLAVLKALS--------VLHAQGV 137
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPL----LPSRKASENLAIGRSPEFPEGKRLT 499
H ++KS +IL+ + R KL++FGF +P RK+ +PE
Sbjct: 138 IHRDIKSDSILLTHDG---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 500 HKADVYCFGIILLEVITGRIPGNGSP 525
+ D++ GI+++E++ G P P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 9e-12
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E +GKG G +K + VVA+K + A + E +QQ + +L + + K
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
Y + II E+L GS DLL PL T +I+++ KGL + LHS
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDY----LHS 119
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
K H ++K++N+L+ ++ KL +FG L + N +G +PE +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEV---KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
KAD++ GI +E+ G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 65/280 (23%), Positives = 124/280 (44%), Gaps = 47/280 (16%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G + + VA+K + N A+S+++F+++ +++ KL H L ++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
++ I+ EF+ NG L + L + +G L+ LS+ + +G+ +L + H+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNSFIHR-- 124
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------PEFPE 494
+L + N L+ + K+++FG +R ++ S PE
Sbjct: 125 --DLAARNCLV---SSTGVVKVSDFGM-----TRYVLDDEYTSSSGAKFPVKWSPPEVFN 174
Query: 495 GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553
+ + K+DV+ FG+++ EV T G++P E + + V M+ L
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMP-------FEKKSNY-EVVEMISRGFR----LYR 222
Query: 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
LA+ + E+ C PE RP +E+LR I
Sbjct: 223 PKLASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 49/205 (23%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNALSKK-EFVQQMQLLGKLKHENLAK 377
+V+G G+ G + L + VA+K +K ++ ++ +F+ + ++G+ H N+ +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ +II E++ NGSL L E+ G + +++ A G+ +L +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSE- 124
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP---EFPE 494
H +L + NIL+ N K+++FG L +A+ G+ P PE
Sbjct: 125 ---MNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 495 G---KRLTHKADVYCFGIILLEVIT 516
++ T +DV+ FGI++ EV++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG G G YKA E+GA+ A K ++ + ++++ ++++L H + K++ +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 384 SKEEKLIIYEFLPNGSLFDLLHE-SRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ I+ EF P G++ ++ E RG+ + I +Q + L + LHS K
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQY----LHSMK 130
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGF----LPLLPSRKASENLAIGRSPEFPEGKRL 498
+ H +LK+ N+L+ + DI KL +FG + L R + +PE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDI---KLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 499 T-----HKADVYCFGIILLEV 514
+KAD++ GI L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 51/238 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQ--QMQLLGKLK-HENLAKI 378
+ LG G GS Y A E+G +VA+K++K S +E + +++ L KL H N+ K+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +E ++E++ G+L+ L+ + +G P + + SII Q +GLA +H+
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK------------ASENLAI 486
H H +LK N+L+ + K+ +FG + SR A E L
Sbjct: 118 --HGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILL- 171
Query: 487 GRSPEFPEGKRLTHKADVYCFGIILLEVITGR--IPGN-------------GSPGNNE 529
RS + + D++ G I+ E+ T R PG+ G+P +
Sbjct: 172 -RSTSY------SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 325 LGKGKVGSTYKATLE------SGAV-VAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLA 376
LG G G Y+ T SG + VAVK ++ KKEF+++ L+ H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP---LAWTTRLSIIKQTAKGLAF 433
K++ E + II E + G L L ++R V R L L I AKG +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-VERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYR--AKLTNFGFLPLLPS----RKASENLAIG 487
L Q H + H +L + N L+ + K+ +FG + RK E L
Sbjct: 122 LEQM---HFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 488 R--SPEFPEGKRLTHKADVYCFGIILLEVIT 516
R +PE + T ++DV+ FG+++ E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
LG G+ G VA+K +K ++S+ EF+++ +++ KL HE L ++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
+ I+ E++ NG L + L E + L + K +G+A+ L S +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAY----LESKQFI 122
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKASENLAIGRSPEFPEGKRLT 499
H +L + N L+ +D K+++FG + S S+ PE + +
Sbjct: 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 500 HKADVYCFGIILLEVIT-GRIP 520
K+DV+ FG+++ EV + G++P
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
LG+G GS K L +G + A+K + N +K+ ++++++ K + K +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 383 YSKEEKLI--IYEFLPNGSLFDLLHE--SRGVGRI---PLAWTTRLSIIKQTAKGLAFLH 435
+ I E+ GSL + + RG GRI L I + KGL++LH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRG-GRIGEKVL-----GKIAESVLKGLSYLH 122
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA---IGRS--- 489
S K+ H ++K SNIL+ R+ + KL +FG S + +LA G S
Sbjct: 123 ----SRKIIHRDIKPSNILLTRKGQV---KLCDFGV-----SGELVNSLAGTFTGTSFYM 170
Query: 490 -PEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE +GK + +DV+ G+ LLEV R P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E +GKG G +K + VVA+K + A + E +QQ + +L + + K
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
Y + II E+L GS DLL P +++K+ KGL +LH S
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH----S 119
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
K H ++K++N+L+ + D+ KL +FG L + N +G +PE +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDV---KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 497 RLTHKADVYCFGIILLEVITGRIPGN 522
KAD++ GI +E+ G P +
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 325 LGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG G+ G Y+ + VAVK +K + + +EF+++ ++ ++KH NL +++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+ II EF+ G+L D L R R + L + Q + + +L
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLE----KKNF 125
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLLP----SRKASENLAIG-RSPEFPEGKRL 498
H +L + N L+ EN + K+ +FG L+ + A I +PE +
Sbjct: 126 IHRDLAARNCLV-GENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 499 THKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
+ K+DV+ FG++L E+ T G P PG DLS V +++ + +
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSP---YPGI-----DLSQ-VYELLEKGYRME-------- 225
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
EG ++ EL C P RP +E+ + E
Sbjct: 226 RPEGCPP--KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 44/223 (19%)
Query: 324 VLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALS------KKEFVQQMQ----LLGKLKH 372
++G G GS Y SG ++AVK+V+ + ++S K+ + + LL +L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVE-LPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
EN+ + + + I E++P GS+ LL+ G + ++Q KGL
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVR--NFVRQILKGLN 120
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---- 488
+ LH+ + H ++K +NIL+ + I K+++FG S+K N +
Sbjct: 121 Y----LHNRGIIHRDIKGANILVDNKGGI---KISDFGI-----SKKLEANSLSTKTNGA 168
Query: 489 -----------SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE + T KAD++ G +++E++TG+ P
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 42/245 (17%)
Query: 360 FVQQMQLLGKLKHENLAKIVSFYYSKEEKL----IIYEFLPNGSLFDLLHESRGVGRIPL 415
+++ L ++ N+ KI F + L +I E+ G L ++L + + L
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-----L 119
Query: 416 AWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475
++ T+L + KGL L++ P+ NL S + L+ EN Y+ K+ G +L
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLV-TEN--YKLKIICHGLEKIL 173
Query: 476 PSRKASE-NLAIGRSPE-----FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529
S N + S + F E T K D+Y G++L E+ TG+I P N
Sbjct: 174 SSPPFKNVNFMVYFSYKMLNDIFSE---YTIKDDIYSLGVVLWEIFTGKI-----PFENL 225
Query: 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589
T+ ++ D ++++ + S L + + E + + CT KRP + E+
Sbjct: 226 TTKEIYD---LIINKNNS---LKLPLDCPLEIKCIVEA-------CTSHDSIKRPNIKEI 272
Query: 590 LRRIE 594
L +
Sbjct: 273 LYNLS 277
|
Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
+G G G YKA L +G + AVK +K Q++ ++ + KH N+ Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
S+E+ I E+ GSL D+ H + + + +A+ R +T +GLA+LH H+
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKMHR- 130
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGKR-- 497
++K +NIL+ D+ KL +FG + + A IG +PE ++
Sbjct: 131 ---DIKGANILLTDNGDV---KLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 498 -LTHKADVYCFGIILLEV 514
D++ GI +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 36 SLNSTANLHSRWTG--PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITF 93
SLN +++ TG P + N+ N + L L + +L+G +PP ++
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKN----------LQYLFLYQNKLSGPIPPSIF-SLQK 285
Query: 94 LNKLSLRNNLLSGSLPNLT-NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLD 152
L L L +N LSG +P L L NLE + L N+F+ IP LP+L+ L+L N
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 153 GQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180
G+IP +L ++S NNL G IP+
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 46/229 (20%)
Query: 323 EVLGKGKVGSTYKATLESG------AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENL 375
LG+G G + +VAVK +K + ++K+F ++ +LL +HEN
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN- 69
Query: 376 AKIVSFY---YSKEEKLIIYEFLPNGSLFDLLH---------ESRGVGRIPLAWTTRLSI 423
IV FY + ++++E++ +G L L +S L + L I
Sbjct: 70 --IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILI----------F-RENDIYRAKLTNFGFL 472
Q A G+ + L S H +L + N L+ F D+Y G
Sbjct: 128 AVQIASGMVY----LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183
Query: 473 PLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
+LP R PE ++ T ++DV+ FG++L E+ T G+ P
Sbjct: 184 TMLPIR--------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 323 EVLGKGKVG--STYK---ATLESGAVVAVKRVKNMNALSKKE-FVQQMQLLGKLKHENLA 376
VLG+G G S Y A +G +VAVK +K + +++ +L L HEN+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 377 KIVSFYYSKEEK--LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
K + K +I E++P GSL D L + + L L +Q +G+A+
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAY- 122
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS-------RKASENLAIG 487
LHS H +L + N+L+ + + K+ +FG +P R+ ++
Sbjct: 123 ---LHSQHYIHRDLAARNVLLDNDRLV---KIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 488 RSPEFPEGKRLTHKADVYCFGIILLEVIT 516
+ E + + ++ +DV+ FG+ L E++T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK--HE-NLAKIV 379
LG G G K SG ++A K + L K ++ Q++ +LK HE N IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH----LEIKPAIRN-QIIRELKVLHECNSPYIV 62
Query: 380 SFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
FY YS E I E + GSL +L + GRIP ++SI +GL +L +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISI--AVLRGLTYLRE 117
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEF 492
HK+ H ++K SNIL+ +I KL +FG L A N +G SPE
Sbjct: 118 ---KHKIMHRDVKPSNILVNSRGEI---KLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 169
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
+G T ++D++ G+ L+E+ GR P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 325 LGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G + A + +VAVK +K + ++++F ++ +LL L+H+++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 379 VSFYYSKEEKLIIYEFLPNGSL----------FDLLHESRGVGRIPLAWTTRLSIIKQTA 428
L+++E++ +G L +L V L L+I Q A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRE-----------NDIYRAKLTNFGFLPLLPS 477
G+ +L +LH H +L + N L+ + DIY G +LP
Sbjct: 133 SGMVYL-ASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
R PE ++ T ++D++ FG++L E+ T G+ P
Sbjct: 189 R--------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 71/298 (23%), Positives = 120/298 (40%), Gaps = 60/298 (20%)
Query: 324 VLGKGKVGSTY----KATLESG--AVVAVK---RVKNMNALSKKEFVQQMQLLGKLKHEN 374
LG+G+ G + K E G +V VK + K+ N S EF +++ + KL H+N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRG----VGRIPLAWTTRLSIIKQTAKG 430
+ +++ E +I E+ G L L ++ + PL+ ++++ Q A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE-----NLA 485
+ L + + H +L + N L+ + K+ L L SE N
Sbjct: 130 M----DHLSNARFVHRDLAARNCLVSSQR---EVKV---SLLSLSKDVYNSEYYKLRNAL 179
Query: 486 IG---RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG----NNETSGDLSDW 537
I +PE + + K+DV+ FG+++ EV T G +P G N +G L
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-- 237
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
L EG RL +L C + P+ RP SE++ + E
Sbjct: 238 ------------------LPVPEGCPS--RLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 339 ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLI-IYEF 394
+G VA+K ++ + F ++ L +L H N+ ++ + L ++E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNIL 454
+P +L ++L G +P T RL + Q LA H+ + H +LK NI+
Sbjct: 61 VPGRTLREVLAAD---GALPAGETGRL--MLQVLDALA----CAHNQGIVHRDLKPQNIM 111
Query: 455 IFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-----------SPEFPEGKRLTHKAD 503
+ + AK+ +FG LLP + ++ + R +PE G+ +T +D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 504 VYCFGIILLEVITGR 518
+Y +G+I LE +TG+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKIV 379
V+G+G G + +V +K++ + ++K E + Q+L L H N+ +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ + +I+ E+ P G+L + + + L T L Q LA H +H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQIL--LALHH--VH 118
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEG 495
+ + H +LK+ NIL+ + + K+ +FG +L S+ + + +G SPE EG
Sbjct: 119 TKLILHRDLKTQNILLDKHKMV--VKIGDFGISKILSSKSKAYTV-VGTPCYISPELCEG 175
Query: 496 KRLTHKADVYCFGIILLEVIT 516
K K+D++ G +L E+ +
Sbjct: 176 KPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 34/203 (16%)
Query: 331 GSTYKATL----ESGAVVAVKRVKNMNALSKKEFVQ---QMQLLGKLKHENLAKIVSFYY 383
GS KA L E G +K + N++ +S KE + ++ +L +KH N IV +
Sbjct: 11 GSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPN---IVQYQE 66
Query: 384 SKEEK---LIIYEFLPNGSLFDLLHESRGV---GRIPLAWTTRLSIIKQTAKGLAFLHQT 437
S EE I+ ++ G L+ ++ RGV L W ++ LA H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC--------LALKH-- 116
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFP 493
+H K+ H ++KS NI + ++ I KL +FG +L S IG SPE
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTI---KLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
Query: 494 EGKRLTHKADVYCFGIILLEVIT 516
E + +K+D++ G +L E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
+G+G G AT + +G VAVK++ ++ ++ ++ HEN+ + + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+E ++ EFL G+L D++ +R + +A T LS++ + L++ LH+ V
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR-MNEEQIA-TVCLSVL----RALSY----LHNQGV 139
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPL----LPSRKASENLAIGRSPEFPEGKRLT 499
H ++KS +IL+ + R KL++FGF +P RK+ +PE
Sbjct: 140 IHRDIKSDSILLTSDG---RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 500 HKADVYCFGIILLEVITGRIPGNGSP 525
+ D++ GI+++E+I G P P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
E++G G G YK +++G + A+K V ++ ++E Q++ +L K H N+A
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 381 FYYSK------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ K ++ ++ EF GS+ DL+ ++G + W I ++ +GL+ L
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIA--YICREILRGLSHL 127
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SP 490
HQ HKV H ++K N+L+ ++ KL +FG L N IG +P
Sbjct: 128 HQ----HKVIHRDIKGQNVLLTENAEV---KLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 491 EF---PEGKRLTH--KADVYCFGIILLEVITGRIP 520
E E T+ K+D++ GI +E+ G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 67/310 (21%)
Query: 324 VLGKGKVGSTYKAT------LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
LG+G+ G KAT VAVK +K N ++ ++ + + LL ++ H ++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVG-------------------RIPLAW 417
K+ L+I E+ GSL L ESR VG L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 418 TTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477
+S Q ++G+ +L + K+ H +L + N+L+ + + K+++FG S
Sbjct: 127 GDLISFAWQISRGMQYLAEM----KLVHRDLAARNVLV---AEGRKMKISDFGL-----S 174
Query: 478 RKASENLA-IGRS----------PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG 526
R E + + RS E T ++DV+ FG++L E++T + GN PG
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--LGGNPYPG 232
Query: 527 NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586
+ + ++ + EM L L C P+KRP
Sbjct: 233 -------------IAPERLFNLLKTGYRMERPENCSEEMYNLM---LTCWKQEPDKRPTF 276
Query: 587 SEVLRRIEEI 596
+++ + +E++
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM----QLLGKLKHENLAKIV 379
LGKG G ++G + A+K +K + +KE V+ +L ++ H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPF---IV 56
Query: 380 SFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+Y+ EEKL ++ E+ P G LF L + GR + LA +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEERARF--YAAEIV--LALEY- 108
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEF 492
LHS + + +LK NIL+ + I KLT+FG L S + N G +PE
Sbjct: 109 -LHSLGIIYRDLKPENILLDADGHI---KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV 164
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
GK D + G++L E++TG+ P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 94 LNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG 153
L LSL N G LP+ LE + LS+N FS +P L +L +L+L EN L G
Sbjct: 454 LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513
Query: 154 QIPPFNQT--SLIDFNVSYNNLDGPIP 178
+IP + L+ ++S+N L G IP
Sbjct: 514 EIPDELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 315 DDLLRASAEVLGKGKVGSTYKATLE-SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKH 372
DD + S LG G G +K + + SG ++A K + + + + ++++Q+L H
Sbjct: 5 DDFEKISE--LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----H 58
Query: 373 E-NLAKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTA 428
E N IV FY YS E I E + GSL +L ++ GRIP ++SI
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSI--AVI 113
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR 488
KGL +L + HK+ H ++K SNIL+ +I KL +FG L A+ +
Sbjct: 114 KGLTYLRE---KHKIMHRDVKPSNILVNSRGEI---KLCDFGVSGQLIDSMANSFVGTRS 167
Query: 489 --SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
SPE +G + ++D++ G+ L+E+ GR P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHE-NLAKIVSF 381
LG G G K + SG ++A K + + + + ++++Q+L HE N IV F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL----HECNSPYIVGF 68
Query: 382 Y---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y YS E I E + GSL +L E++ RIP ++SI +GLA+L +
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSI--AVLRGLAYLRE-- 121
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--SPEFPEGK 496
H++ H ++K SNIL+ +I KL +FG L A+ + SPE +G
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
+ ++D++ G+ L+E+ GR P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKIV 379
+ +G+G G Y A +S + V + ++ + KE +++ LL K+KH N IV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN---IV 62
Query: 380 SFYYSKEEK---LIIYEFLPNGSLFDLLHESRGV----GRIPLAWTTRLSIIKQTAKGLA 432
+F+ S +E I+ E+ G L ++ RGV +I L+W ++S+ GL
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFVQISL------GL- 114
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---- 488
+ +H K+ H ++KS NI + + + AKL +FG L +G
Sbjct: 115 ---KHIHDRKILHRDIKSQNIFLSKNGMV--AKLGDFGIARQLNDSMELAYTCVGTPYYL 169
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524
SPE + + +K D++ G +L E+ T + P G+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 40/106 (37%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
P + +T LN L L N L+G +P +L NL NL+ +FL QN S IP L KL
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 144 LELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFP 187
L+L +N L G+IP +L ++ NN G IP + S P
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP--VALTSLP 332
|
Length = 968 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
+G+G G A + SG VAVK + ++ ++ ++ +H+N+ ++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
EE ++ EFL G+L D++ ++R L ++ + + L + LHS V
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCY----LHSQGV 138
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLL----PSRKASENLAIGRSPEFPEGKRLT 499
H ++KS +IL+ + R KL++FGF + P RK+ +PE
Sbjct: 139 IHRDIKSDSILLTLDG---RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 500 HKADVYCFGIILLEVITGRIP 520
+ D++ GI+++E++ G P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSK--KEFVQQMQLLGKLKHE-NLAKIVSF 381
LG G GS K V K+V ++ A S K+ ++++Q++ HE IVSF
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM----HECRSPYIVSF 68
Query: 382 Y--YSKEEKLII-YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + E + + EF+ GSL D +++ G P+ I +GL +L+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSL-DRIYKKGG----PIPVEILGKIAVAVVEGLTYLY--- 120
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----PEFPE 494
+ H++ H ++K SNIL+ I KL +FG L + A + +G S PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQI---KLCDFGVSGELINSIA--DTFVGTSTYMSPERIQ 175
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGD 533
G + T K+DV+ GI ++E+ G+ P S +++ D
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVK--NMNALSKKE---FVQQMQLLGKLKHENLAKI 378
LG+G G Y +++G +AVK+V + +KKE ++QLL L+HE +I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE---RI 66
Query: 379 VSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V +Y + + E++P GS+ D L + G L T +Q +G+ +LH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYG--ALTETVTRKYTRQILEGVEYLH 121
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGF---LPLLPSRKASENLAIGR--- 488
S+ + H ++K +NIL D KL +FG L + S G
Sbjct: 122 ----SNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
SPE G+ KADV+ G ++E++T + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 45/222 (20%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVK-----------NMNALSKKEFVQQMQLLGKLKH 372
LG+G YKA E+G +VA+K++K N AL ++++LL +LKH
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL------REIKLLQELKH 61
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
N+ ++ + K +++EF+ L ++ + I L S + T +GL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS----IVLTPADIKSYMLMTLRGLE 116
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL------PSRKASENLAI 486
+LH S+ + H +LK +N+LI KL +FG L P+RK + +
Sbjct: 117 YLH----SNWILHRDLKPNNLLI---ASDGVLKLADFG----LARSFGSPNRKMTHQVVT 165
Query: 487 G--RSPEFPEGKRL-THKADVYCFGIILLEVITGR--IPGNG 523
R+PE G R D++ G I E++ +PG+
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 8 KNVVLVASSVQIADYYPAERYDLLQ-IR--DSLNSTANLHSR--WTGPPCIDNVSNWFGV 62
K + +++++ + AE LL+ + +L S+ L R W G PC+ W G
Sbjct: 348 KGTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGA 407
Query: 63 SC------SNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLV 115
C I L L+ L G +P + + L ++L N + G++P +L ++
Sbjct: 408 DCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSIT 466
Query: 116 NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175
+LE + LS N F+ IP L L+ L L N L G++P +L G
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP----AAL-----------G 511
Query: 176 PIPQTRVVQSFPSSSFEHNSGLCGRP 201
R S +F N+GLCG P
Sbjct: 512 GRLLHRA-----SFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 45/206 (21%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 323 EVLGKGKVGSTYKATLE----SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
+V+G G+ G ++ L+ VA+K +K +++F+ + ++G+ H N+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + +II E++ NG+L L + G + + +++ A G+ +L
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-------RSP 490
+ H+ +L + NIL+ N K+++FG +L G +P
Sbjct: 127 NYVHR----DLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT 516
E ++ T +DV+ FGI++ EV++
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 38/231 (16%)
Query: 310 PVFDLDDLLRASAEVLGKGKVGSTYKATLESGAV---VAVKRVKNMNALSK-KEFVQQMQ 365
PV + +D+ +V+G+G G KA ++ + A+KR+K + ++F +++
Sbjct: 2 PVLEWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59
Query: 366 LLGKLKHENLAKIVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIP-------- 414
+L KL H I++ + E + +Y E+ P+G+L D L +SR + P
Sbjct: 60 VLCKLGHH--PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 415 ---LAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
L+ L A+G+ +L Q H+ +L + NIL+ EN Y AK+ +FG
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHR----DLAARNILV-GEN--YVAKIADFG- 169
Query: 472 LPLLPSRKASENLAIGRSP------EFPEGKRLTHKADVYCFGIILLEVIT 516
L ++ +GR P E T +DV+ +G++L E+++
Sbjct: 170 --LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLA 376
E LG+G + YK +G +VA+K + L +E ++++ L+ +LKHEN+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIH----LDAEEGTPSTAIREISLMKELKHENIV 61
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ +++ + ++++E++ DL ++ GV R L T S Q KG+AF
Sbjct: 62 RLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFC 116
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL--LPSRKASENLAI--GRSP 490
H+ ++V H +LK N+LI N KL +FG +P S + R+P
Sbjct: 117 HE----NRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169
Query: 491 EFPEGKRL-THKADVYCFGIILLEVITGR 518
+ G R + D++ G I+ E+ITGR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFV-----QQMQLLGKLKHENLA 376
E +G+G G YKA +G +VA+K+++ ++ E V +++ LL +L H N+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+++ +S+ + +++EFL DL L S + Q +G+A+ H
Sbjct: 62 RLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH- 116
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
SH+V H +LK N+LI RE + KL +FG
Sbjct: 117 ---SHRVLHRDLKPQNLLIDREGAL---KLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 325 LGKGKVGSTYKATL------ESGAVVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAK 377
+G+G G ++A E +VAVK +K +A + +F ++ L+ + H N+ K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHE-----------------SRGVGRIPLAWTTR 420
++ + +++E++ G L + L G+ +PL+ T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 421 LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478
L I KQ A G+A+L + K H +L + N L+ + K+ +FG + S
Sbjct: 133 LCIAKQVAAGMAYLSE----RKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADY 185
Query: 479 -KASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVIT 516
KASEN AI PE R T ++DV+ +G++L E+ +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG G G YKA E+G + A K + + ++++ ++ +L H N+ K++ +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+ I+ EF G++ ++ E PL + KQT + L +LH+ K+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHEN----KI 124
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--------PE- 494
H +LK+ NIL + DI KL +FG A I R F PE
Sbjct: 125 IHRDLKAGNILFTLDGDI---KLADFGV-------SAKNTRTIQRRDSFIGTPYWMAPEV 174
Query: 495 -------GKRLTHKADVYCFGIILLEV 514
+ +KADV+ GI L+E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKN---MNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+G+G+ Y+AT L G VA+K+V+ M+A ++ + ++++ LL +L H N+ K +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ E I+ E G L ++ + R+ + T Q L + +HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSAL----EHMHS 124
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
+V H ++K +N+ I + KL + G S+ + + +G SPE
Sbjct: 125 RRVMHRDIKPANVFITATGVV---KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
K+D++ G +L E+ + P G N L + + D+ L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPP-------L 228
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589
+ E+ +L + C + PEKRP ++ V
Sbjct: 229 PSDHYSEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 325 LGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G + A + +VAVK +K+ + ++K+F ++ +LL L+HE++ K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHE--------SRGVGRIPLAWTTRLSIIKQTAKG 430
+ ++++E++ +G L L + G L + L I +Q A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFREN------------DIYRAKLTNFGFLPLLPSR 478
+ + L S H +L + N L+ EN D+Y G +LP R
Sbjct: 133 MVY----LASQHFVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 479 KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
PE ++ T ++DV+ G++L E+ T G+ P
Sbjct: 188 --------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 49/229 (21%)
Query: 325 LGKGKVGSTYKAT------LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G + A + +VAVK +K+ ++K+F ++ +LL L+HE++ K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLH---------------ESRGVGRIPLAWTTRLSI 423
+ ++++E++ +G L L +++G L + L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG----ELGLSQMLHI 128
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR-----------ENDIYRAKLTNFGFL 472
Q A G+ + L S H +L + N L+ D+Y G
Sbjct: 129 ASQIASGMVY----LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 473 PLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
+LP R PE ++ T ++DV+ FG+IL E+ T G+ P
Sbjct: 185 TMLPIR--------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--NMNALSKKEFVQQMQ----LLGKLKHENLA 376
EVLGKG G+ Y G ++AVK+V+ N L+ ++ +++Q LL LKH N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ + I EF+P GS+ +L+ G +P + + KQ G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYT--KQILDGVAYLHN 120
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP----SRKASENLAIGR---- 488
+ V H ++K +N+++ I KL +FG L S L
Sbjct: 121 ----NCVVHRDIKGNNVMLMPNGII---KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 489 --SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE K+D++ G + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 41/222 (18%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVK-----NMNALSK-KEFV----QQMQLLGKLK 371
E++GKG G Y A + +G ++AVK+V+ S+ K+ V +++ L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 372 HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
H N+ + + F ++E I E++P GS+ L R GR + +Q +GL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFT--EQVLEGL 121
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLA 485
A+LH S + H +LK+ N+L+ + K+++FG S+K+ +N++
Sbjct: 122 AYLH----SKGILHRDLKADNLLVDADG---ICKISDFGI-----SKKSDDIYDNDQNMS 169
Query: 486 IGRS-----PEFPEGKRLTH--KADVYCFGIILLEVITGRIP 520
+ S PE + K D++ G ++LE+ GR P
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
EV+G G G YK +++G + A+K V ++ ++E ++ +L K H N+A
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 381 FYYSK------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ K ++ ++ EF GS+ DL+ ++G + W I ++ +GLA
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIA--YICREILRGLAH- 136
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SP 490
LH+HKV H ++K N+L+ ++ KL +FG L N IG +P
Sbjct: 137 ---LHAHKVIHRDIKGQNVLLTENAEV---KLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 491 EF------PEGKRLTHKADVYCFGIILLEVITGRIP 520
E P+ +++D++ GI +E+ G P
Sbjct: 191 EVIACDENPDAT-YDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E +G+G G+ +KA E+ +VA+KRV+ + + ++++ LL +LKH+N+ ++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 380 SFYYSKEEKLIIYEFLPNG--SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+S ++ +++E+ FD + G I S + Q KGLAF H
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCN-----GDIDPE--IVKSFMFQLLKGLAFCH-- 116
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
SH V H +LK N+LI + ++ KL +FG
Sbjct: 117 --SHNVLHRDLKPQNLLINKNGEL---KLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E+LG G G+ YKA L + ++AVK + ++ +K+ + ++++L K +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
++ + I EF+ GSL D+ +IP R+++ KGL +L S
Sbjct: 67 AFFVENRISICTEFMDGGSL-DVY------RKIPEHVLGRIAV--AVVKGLTYLW----S 113
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG--RSPEFPEGKRL 498
K+ H ++K SN+L+ N + KL +FG L + A + +PE G++
Sbjct: 114 LKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 499 THKADVYCFGIILLEVITGRIP 520
+DV+ GI +E+ GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 83/297 (27%), Positives = 124/297 (41%), Gaps = 55/297 (18%)
Query: 313 DLDDLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL- 370
DL DL +G+G G+ K SG ++AVKR+++ +KE Q +LL L
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKE---QKRLLMDLD 54
Query: 371 ---KHENLAKIVSFY---YSKEEKLIIYEFLPNGSL---FDLLHESRGVGRIPLAWTTRL 421
+ + IV FY + + + I E L + SL + ++E IP ++
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYE-VLKSVIPEEILGKI 112
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481
++ T K L +L + L K+ H ++K SNIL+ R +I KL +FG L A
Sbjct: 113 AV--ATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNI---KLCDFGISGQLVDSIAK 164
Query: 482 ENLAIGRSPEFPEGKRLTH--------KADVYCFGIILLEVITGRIPGNGSPGNNETSGD 533
A R PE R+ ++DV+ GI L EV TG+ P P N
Sbjct: 165 TRDAGCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEVATGKFP---YPKWNS---- 215
Query: 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
+ D + VV D IL+ E + C KRPK E+L
Sbjct: 216 VFDQLTQVVKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/218 (24%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 324 VLGKGKVGSTYKATL----ESGAV-VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
VLG G G+ YK E+ + VA+K ++ N + + KE + + ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRG-VG-RIPLAWTTRLSIIKQTAKGLAFLH 435
++ + +L+ + +P G L D + E++ +G + L W Q AKG+++L
Sbjct: 74 LLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCV------QIAKGMSYLE 126
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP----- 490
+ ++ H +L + N+L+ N + K+T+FG LL + + G+ P
Sbjct: 127 EV----RLVHRDLAARNVLVKSPNHV---KITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 491 -EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG 526
E +R TH++DV+ +G+ + E++T G P +G P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 58/297 (19%)
Query: 323 EVLGKGKVGSTYKAT---LESGAV-VAVKRVKNMNALSKKE-FVQQMQLLGKLKHENLAK 377
+G+G+ G Y+ E+ + VAVK KN + S +E F+Q+ ++ + H ++ K
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK---QTAKGLAFL 434
++ ++ I+ E P G L L ++ S+I Q + LA+L
Sbjct: 72 LIGVI-TENPVWIVMELAPLGELRSYLQVNK-------YSLDLASLILYSYQLSTALAYL 123
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--------KASE-NLA 485
S + H ++ + N+L+ + KL +FG SR KAS+ L
Sbjct: 124 E----SKRFVHRDIAARNVLV---SSPDCVKLGDFGL-----SRYLEDESYYKASKGKLP 171
Query: 486 IG-RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVD 543
I +PE +R T +DV+ FG+ + E++ G P G NN+ G + + R+ +
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-NNDVIGRIENGERLPMP 230
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600
N L L +C P KRP+ +E+ ++ +I
Sbjct: 231 ------------------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 43/222 (19%)
Query: 322 AEVLGKGKVGSTYKA-TLESGAVVAVKRV----------KNMNALSKKEFVQQMQLLGKL 370
++LG+G G Y ++G +AVK+V K +NAL ++QLL L
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE-----CEIQLLKNL 61
Query: 371 KHENLAKIVSFYY----SKEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
+H+ +IV +Y +E+KL I+ E++P GS+ D L + G + T R + +
Sbjct: 62 RHD---RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--R 113
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR------- 478
Q +G+++LH S+ + H ++K +NIL + KL +FG + +
Sbjct: 114 QILQGVSYLH----SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 479 KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
K+ SPE G+ KADV+ ++E++T + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 47/226 (20%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENL 375
E LG+ + G YK L E VA+K +K+ ++EF + + +L+H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLL-----HESRG------VGRIPLAWTTRLSII 424
++ ++ +I+ + + L + L H G + L + I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL------------ 472
Q A G+ F L SH V H +L + N+L+F D K+++ G
Sbjct: 131 TQIAAGMEF----LSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADYYKLM 183
Query: 473 --PLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT 516
LLP R SPE + + +D++ +G++L EV +
Sbjct: 184 GNSLLPIR--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 322 AEVLGKGKVGSTYKA-TLESGAVVAVKRV----------KNMNALSKKEFVQQMQLLGKL 370
++LG+G G Y ++G +AVK+V K +NAL ++QLL L
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALE-----CEIQLLKNL 61
Query: 371 KHENLAKIVSFYYSKEEKL--IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTA 428
HE + + E+ I E +P GS+ D L + G + T + + +Q
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYT--RQIL 116
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS-------RKAS 481
+G+++LH S+ + H ++K +NIL + + KL +FG L + K+
Sbjct: 117 EGVSYLH----SNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 482 ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
SPE G+ KAD++ G ++E++T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
EV+G G+ G + L+ VA+K +K +++F+ + ++G+ H N+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ +II EF+ NG+L L ++ G + +++ A G+ +L +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP--SRKASENLAIG-------R 488
+ H+ +L + NIL+ N K+++FG L + + ++G
Sbjct: 126 NYVHR----DLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVIT 516
+PE ++ T +DV+ +GI++ EV++
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 325 LGKGKVGSTYKATLES-GAVVAVKRVK--NMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
LG G G ++S A+K VK ++ ++E + ++L + H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPF---IVK 57
Query: 381 FYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFL 434
Y + ++K IY E+ G L+ +L + G +T R ++ LAF
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFD-EYTARFYIACVV------LAF- 106
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SP 490
+ LH+ + + +LK N+L+ + KL +FGF L S + + G +P
Sbjct: 107 -EYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAP 161
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524
E K D + GI+L E++TGR P
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 323 EVLGKGKVGSTYKATL--ESGAV---VAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLA 376
++LG G G+ +K E ++ VA+K +++ + + +E M +G L H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFL 434
+++ +L+ + P GSL D + + R + L W Q AKG+ +L
Sbjct: 73 RLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCV------QIAKGMYYL 125
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP---- 490
+ H++ H NL + NIL+ + ++ +FG LL + ++P
Sbjct: 126 EE----HRMVHRNLAARNILLKSD---SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 491 --EFPEGKRLTHKADVYCFGIILLEVIT 516
E R TH++DV+ +G+ + E+++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
+G G G YKA + +G + A+K +K Q++ ++ KH N+ Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+++ I EF GSL D+ H + + +A+ +R +T +GL +LH H+
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLHSKGKMHR- 130
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGKR-- 497
++K +NIL+ D KL +FG + + A IG +PE +R
Sbjct: 131 ---DIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 498 -LTHKADVYCFGIILLEV 514
D++ GI +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 41/215 (19%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQL---------LGKLKH 372
+ LG G G SG A+K LSK + V+ Q+ L ++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKI------LSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS--IIKQTAKG 430
L + + ++ E++P G LF L R GR P + ++
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVV------ 111
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS-----ENLA 485
LA + LHS + + +LK N+L+ + I K+T+FGF + R + E LA
Sbjct: 112 LAL--EYLHSLDIVYRDLKPENLLLDSDGYI---KITDFGFAKRVKGRTYTLCGTPEYLA 166
Query: 486 IGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE K D + GI++ E++ G P
Sbjct: 167 ----PEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G +KA E+G VA+K+V + + + +++++ L +H + K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ +++ E++P L ++L + PL S ++ KG+A++H ++
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMH----AN 118
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL---PSRKASENLAIG--RSPEFPEGK 496
+ H +LK +N+LI + + K+ +FG L R S +A R+PE G
Sbjct: 119 GIMHRDLKPANLLISADGVL---KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 497 R-LTHKADVYCFGIILLEVITGRIPGNGSP 525
R D++ G I E++ NGSP
Sbjct: 176 RKYDPGVDLWAVGCIFAELL------NGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 63/283 (22%), Positives = 125/283 (44%), Gaps = 48/283 (16%)
Query: 323 EVLGKGKVGSTYKATL--ESGAV---VAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLA 376
+VLG G G+ YK E V VA+K ++ + + KE + + ++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLL--HESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+++ + +LI + +P G L D + H+ + L W Q AKG+ +L
Sbjct: 73 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 125
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSP---- 490
+ ++ H +L + N+L+ + K+T+FG LL + + + G+ P
Sbjct: 126 EE----RRLVHRDLAARNVLVKTPQHV---KITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 491 --EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547
E + TH++DV+ +G+ + E++T G P +G P +E S L R+
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLP-----Q 232
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
I +++ + ++C I + RPK E++
Sbjct: 233 PPICTIDVYM-------------IMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 326 GKGKVGSTYKA---TLESGAVVAVKRVK----NMNALSKKEFVQQMQLLGKLKHENLAKI 378
G+G G YKA + G A+K+ K +S+ +++ LL +LKHEN+ +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELKHENVVSL 67
Query: 379 VSFYYSKEEKLI--IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
V + +K + ++++ + L+ ++ R R+ + + S++ Q G+ +LH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125
Query: 437 TLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGFL-----PLLPSRKASENLAI---- 486
S+ V H +LK +NIL+ E K+ + G PL P A + +
Sbjct: 126 ---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL--ADLDPVVVTIW 180
Query: 487 GRSPEFPEGKRLTHKA-DVYCFGIILLEVIT 516
R+PE G R KA D++ G I E++T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEF----VQQMQLLGKLKHENLAKIV 379
LG+G G YKA +++G VVA+K++ N K F ++++++L KLKH N+ ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLI 73
Query: 380 SFYY-----SKEEKLIIYEFLP--NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
SK ++ +Y P + L LL + L + + Q +G+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS----VKLTESQIKCYMLQLLEGIN 129
Query: 433 FLHQTLHSHKVPHANLKSSNILI----------FRENDIYRAKLTNFGFLPLLPSRKASE 482
+LH+ + + H ++K++NILI F Y N +
Sbjct: 130 YLHE----NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG-GGGGGTRKYT 184
Query: 483 NLAIG---RSPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
NL + R PE G +R T D++ G + E+ T R
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
P L N+T L L+L +N L G +P L + +L+ ++L N+ S IP+ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 144 LELQENYLDGQIPP-FNQTSLIDFNVSYNN-LDGPIPQT 180
L+L N L G IP + + Y N L GPIP +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
|
Length = 968 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+G+G+ Y+AT L VA+K+V+ M+A ++++ V+++ LL +L H N+ K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ E I+ E G L ++ + R+ + T Q + + +HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAV----EHMHS 124
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
+V H ++K +N+ I + KL + G S+ + + +G SPE
Sbjct: 125 RRVMHRDIKPANVFITATGVV---KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
K+D++ G +L E+ + P G N L + + D+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCDYPP-------- 227
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
E +E LR EL C P++RP + V + +++
Sbjct: 228 LPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 322 AEVLGKGKVGSTYKA-TLESGAVVAVKRV----------KNMNALSKKEFVQQMQLLGKL 370
++LG+G G Y +++G +A K+V K ++AL ++QLL L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE-----CEIQLLKNL 61
Query: 371 KHENLAKIVSFY-----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
+HE +IV +Y +++ I E++P GS+ D L + G + + T + + +
Sbjct: 62 QHE---RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYT--R 113
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS-------R 478
Q +G+++LH S+ + H ++K +NIL + KL +FG L +
Sbjct: 114 QILEGMSYLH----SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 479 KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
++ SPE G+ KADV+ G ++E++T + P
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 324 VLGKGKVGST---YKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
V+GKG G T V+ ++N + +K Q+ QLL +LKH N IV+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVA 63
Query: 381 FYYSKEEK----LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ S E + I+ F G L+ L E +G L + Q A L Q
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK---LLPENQVVEWFVQIAMAL----Q 116
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEF 492
LH + H +LK+ N+ + R N I K+ + G +L ++ + IG SPE
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNII---KVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 493 PEGKRLTHKADVYCFGIILLEVIT 516
K +K+DV+ G + E+ T
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 43/287 (14%)
Query: 324 VLGKGKVGSTYKATL----ESGAV--VAVKRVKNMNALSKKE-FVQQMQLLGKL-KHENL 375
LG G G +AT +S AV VAVK +K S++E + +++++ L HEN+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
++ L+I E+ G L + L R L LS Q AKG+AF
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAF-- 156
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-----KASENLAIG-RS 489
L S H +L + N+L+ I K+ +FG + + K + L + +
Sbjct: 157 --LASKNCIHRDLAARNVLL-THGKI--VKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548
PE T ++DV+ +GI+L E+ + G P G P +++ + + RM
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271
Query: 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
+I D+ M C D P KRP ++++ I +
Sbjct: 272 EIYDI-----------MKT-------CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 324 VLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
VLGKG G Y A L + +A+K + ++ + +++ L LKH N+ + +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAW--TTRLSIIKQTAKGLAFLHQTLHS 440
I E +P GSL LL G PL T + KQ +GL +LH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHD---- 126
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE-FPEG 495
+++ H ++K N+L+ + + K+++FG L G +PE +G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGV--VKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184
Query: 496 KR-LTHKADVYCFGIILLEVITGRIP 520
R AD++ G ++E+ TG+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 62/294 (21%), Positives = 113/294 (38%), Gaps = 46/294 (15%)
Query: 323 EVLGKGKVGSTYKATLESGAV----VAVKRVKNMNALSK--KEFVQQMQLLGKLKHENLA 376
++LG+G+ GS + L VAVK +K +EF+ + + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 377 KIVSFYYSKEEK------LIIYEFLPNGSLFDLLHESR-GVGRIPLAWTTRLSIIKQTAK 429
K++ + ++I F+ +G L L SR G L T L + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS 489
G+ + L + H +L + N ++ + + +FG + S I +
Sbjct: 125 GM----EYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 490 P------EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542
P E + T K+DV+ FG+ + E+ T G+ P G N+E L R+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL-- 234
Query: 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
++ ++ + L +L C P+ RP +++ +E I
Sbjct: 235 ----------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 71/275 (25%), Positives = 116/275 (42%), Gaps = 45/275 (16%)
Query: 292 SMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKA-TLESGAVVAVKRVK 350
S++DPE E F K P DL +G G G+ Y A + + VVA+K++
Sbjct: 8 SLKDPEIA---ELFFKEDPEKLFTDLRE-----IGHGSFGAVYFARDVRTNEVVAIKKMS 59
Query: 351 NMNALSK---KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHES 407
S ++ +++++ L ++KH N + Y + ++ E+ GS DLL
Sbjct: 60 YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE-- 116
Query: 408 RGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467
V + PL +I +GLA+LH SH + H ++K+ NIL+ + KL
Sbjct: 117 --VHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQV---KLA 167
Query: 468 NFGFLPLLPSRKASENLAIGRSPE----FPEGKRLTHKADVYCFGIILLEVITGRIP--- 520
+FG + + +PE EG+ K DV+ GI +E+ + P
Sbjct: 168 DFGSASIASPANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFN 226
Query: 521 -----------GNGSPGNNETSGDLSDWVRMVVDN 544
N SP S + SD+ R VD+
Sbjct: 227 MNAMSALYHIAQNESP--TLQSNEWSDYFRNFVDS 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 41/223 (18%)
Query: 323 EVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSK-KEFVQQMQLLGKLKHENLA 376
E LG+ G YK L + +VA+K +K++N + EF Q+ L+ +L H N+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLL------------HESRGVGRIPLAWTTRLSII 424
++ ++ +++E+L G L + L + G + L L I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-----------NDIYRAKLTNFGFLP 473
Q A G+ + L SH H +L + NILI + +IY A
Sbjct: 131 IQIAAGMEY----LSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 474 LLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT 516
LLP R PE + + +D++ FG++L E+ +
Sbjct: 187 LLPIR--------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY- 382
LGKG GS YK +G +A+K ++ L + +F Q + L L IV FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 383 --YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ + + E++ GSL L IP R I KGL FL +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKE---E 121
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPE----- 494
H + H ++K +N+L+ N + KL +FG L + A N IG +S PE
Sbjct: 122 HNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSG 176
Query: 495 --GKRLTH--KADVYCFGIILLEVITGRIP 520
+ T+ ++DV+ G+ +LE+ GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 57/295 (19%)
Query: 323 EVLGKGKVGSTYKATLESG-------AVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL 375
V+GKG G Y TL AV ++ R+ ++ + + F+++ ++ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNV 58
Query: 376 AKIVSFYYSKE-EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK---QTAKGL 431
++ E L++ ++ +G DL + R P T +I Q AKG+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNP----TVKDLIGFGLQVAKGM 111
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK--ASENLAIGRS 489
+L S K H +L + N ++ ++ + K+ +FG + ++ + N +
Sbjct: 112 EYLA----SKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 490 P------EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543
P E + ++ T K+DV+ FG++L E++T G+P + VD
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPD------------VD 207
Query: 544 NDWSTDILDVEILAAREGQNEML--RLTELALECTDIAPEKRPKMSEVLRRIEEI 596
S DI + R Q E L E+ L C PE RP SE++ RIE+I
Sbjct: 208 ---SFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 318 LRASAEVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHE 373
L + +G G G+ Y A + + VVA+K++ S ++ +++++ L KL+H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
N + Y + ++ E+ GS DLL V + PL ++ +GLA+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE-- 491
LH SH + H ++K+ NIL+ + KL +FG ++ +PE
Sbjct: 131 LH----SHNMIHRDVKAGNILLSEPGLV---KLGDFGSASIMAPANXFVGTPYWMAPEVI 183
Query: 492 --FPEGKRLTHKADVYCFGIILLEVITGRIP 520
EG+ K DV+ GI +E+ + P
Sbjct: 184 LAMDEGQ-YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
E LG G G A + +G A+K +K L K+ Q+ +L +L H + +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP--LAWTTRLSIIKQTAKGLAFLHQ 436
+ + + + EF+ G LF L R GR P +A ++ LAF +
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELV------LAF--E 132
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS-----ENLAIGRSPE 491
LHS + + +LK N+L+ + + K+T+FGF +P R + E LA PE
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHV---KVTDFGFAKKVPDRTFTLCGTPEYLA----PE 185
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIP 520
+ K D + G++L E I G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKN----MNALSKKEFVQQMQLLGKLKHENLAK 377
++LGKG G + A L+ + A+K +K M+ + V++ L +H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + +KE + E+L G DL+ + + L T + + GL FLH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYA--AEIICGLQFLH-- 113
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFP 493
S + + +LK NIL+ + I K+ +FG A G +PE
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHI---KIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIPGNG 523
G++ D + FG++L E++ G+ P +G
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRV----KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G G G+ Y AT + VVAVK++ K N ++ +++++ L +LKH N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
Y + ++ E+ GS DLL V + PL +I +GLA+LH
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLH---- 138
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE----FPEG 495
SH + H ++K+ NIL+ + KL +FG + +PE EG
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQV---KLADFGSASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
+ K DV+ GI +E+ + P
Sbjct: 196 Q-YDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 327 KGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFV----QQMQLLGKLKHENLAKIVSF 381
KG GS Y A +G A+K +K + ++K + ++ ++ + + +AK+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ SK+ ++ E+L G L+ + +G +P W + I + G+ LHQ
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLHQ----R 116
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--PE---GK 496
+ H ++K N+LI + + KLT+FG SR EN +P++ PE G
Sbjct: 117 GIIHRDIKPENLLIDQTGHL---KLTDFGL-----SRNGLENKKFVGTPDYLAPETILGV 168
Query: 497 RLTHKADVYCFGIILLEVITGRIPGN 522
+D + G ++ E + G P +
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E LG+G G K +G ++AVKR++ +N+ +K + M L ++ + V+
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLL--MDLDISMRSVDCPYTVT 64
Query: 381 FYYS--KEEKLIIYEFLPNGSLFDLLHESRGVG-RIP---LAWTTRLSIIKQTAKGLAFL 434
FY + +E + I + + SL + G IP L +SI+K L +L
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA-VSIVK----ALEYL 119
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPE 491
H L V H ++K SN+LI R + KL +FG L A A + +PE
Sbjct: 120 HSKL---SVIHRDVKPSNVLINRNGQV---KLCDFGISGYLVDSVAKTIDAGCKPYMAPE 173
Query: 492 F--PEGKRLTH--KADVYCFGIILLEVITGRIP 520
PE + + K+DV+ GI ++E+ TGR P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 65/305 (21%), Positives = 114/305 (37%), Gaps = 65/305 (21%)
Query: 317 LLRASAEVLGKGKVGSTYKATLESGAVVAVK---RVKNMNALSKKE----FVQQMQLLGK 369
LLRA LG G G Y+ AV+ VK + ++ F+ + ++ K
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 370 LKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRG--VGRIPLAWTTRLSIIKQT 427
H+N+ +++ + + + I+ E + G L L E+R L L +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRE--------------NDIYRAKLTNFGFLP 473
AKG + L + H ++ + N L+ + DIYRA G
Sbjct: 126 AKGCKY----LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 474 LLPSRKASENLAIGRSPE-FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETS 531
+LP + PE F +G T K DV+ FG++L E+ + G +P G
Sbjct: 182 MLPIKWM--------PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRT------ 226
Query: 532 GDLSDWVRMVVDNDWSTDILDVEILAAREG--QNEMLRLTELALECTDIAPEKRPKMSEV 589
+ ++++ R + + + +C PE RP + +
Sbjct: 227 ---------------NQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
Query: 590 LRRIE 594
L RI+
Sbjct: 272 LERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 47/269 (17%)
Query: 262 KKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRAS 321
KK+ E+E+S+ AGE E+KM D+ P + +L
Sbjct: 33 KKLDEEERSHNNNAGEDE---DEEKMIDNDINRSPNKSYKL------------------- 70
Query: 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
++G G G Y+A +++ VA+K+V +E + ++ L H N+ +
Sbjct: 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKD 126
Query: 381 FYYS----KEEKLI----IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+YY+ K EK I + EF+P + H +R +PL S Q + LA
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY--QLCRALA 184
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF 492
++H S + H +LK N+LI + + + KL +FG L + + S + R
Sbjct: 185 YIH----SKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238
Query: 493 PE----GKRLTHKADVYCFGIILLEVITG 517
PE T D++ G I+ E+I G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 49/281 (17%)
Query: 323 EVLGKGKVGSTYKATLES-GAVVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E +G+G G + L + VAVK + + K +F+Q+ ++L + H N+ +++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
K+ I+ E + G L + G L + +++ A G+ + L S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL-RTEGP---RLKVKELIQMVENAAAGMEY----LES 112
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL--AIG---------RS 489
H +L + N L+ +N + K+++FG SR+ + + + G +
Sbjct: 113 KHCIHRDLAARNCLVTEKNVL---KISDFGM-----SREEEDGVYASTGGMKQIPVKWTA 164
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548
PE R + ++DV+ FGI+L E + G +P + N +T + VR+
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVP-YANLSNQQTREAIEQGVRLPCPELCPD 223
Query: 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589
+ L C + P +RP S V
Sbjct: 224 AVY------------------RLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 19/155 (12%)
Query: 366 LLGKLKHENLAKIVSFYYSKEEKLIIYEFLP--NGSLFDLLHESRGVGRIPLAWTTRLSI 423
LL + H ++ ++ S ++ LP + L+ L ++ +P+ L I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL--TKRSRPLPID--QALII 162
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG---FLPLLPSRKA 480
KQ +GL +LH ++ H ++K+ NI I ND+ + + + G F + P+
Sbjct: 163 EKQILEGLRYLHA----QRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 481 SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515
+PE + KAD++ GI+L E++
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 324 VLGKGKVG----STYKATLESGAVVAVKR-VKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
VLGKG G + K T E A+ A+K+ V + + V++ L +H L +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +KE + E+L G DL+ + GR A + + GL FLH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYA--AEIICGLQFLH--- 113
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
+ + +LK N+L+ ++ I K+ +FG + + + G +PE +
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHI---KIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNG 523
G++ D + FG++L E++ G+ P +G
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKE------FVQQMQLLGKLKHENL 375
E +G+G G YK ++G +VA+K+++ L +E ++++ LL +L+H N+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIR----LESEEEGVPSTAIREISLLKELQHPNI 61
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ + +I+EFL DL + + +P ++K ++L+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLS----MDL---KKYLDSLPKGQYMDAELVK------SYLY 108
Query: 436 QTL------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL--LPSRKASENLAI- 486
Q L HS +V H +LK N+LI + I KL +FG +P R + +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVI---KLADFGLARAFGIPVRVYTHEVVTL 165
Query: 487 -GRSPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
R+PE G R + D++ G I E+ T +
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 66/268 (24%), Positives = 112/268 (41%), Gaps = 68/268 (25%)
Query: 267 KEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLG 326
KEK EGQ GE HL E + ME F DK F LD + VL
Sbjct: 10 KEKLGEGQFGE--VHLCEAE-----GMEK--------FMDKD---FSLDV--SGNQPVL- 48
Query: 327 KGKVGSTYKATLESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK 385
VAVK ++ + N ++ +F+++++++ +LK N+ ++++ +
Sbjct: 49 -----------------VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS 91
Query: 386 EEKLIIYEFLPNGSLFDLL--HESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKV 443
+ +I E++ NG L L HE + T S + A +A + L S
Sbjct: 92 DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF 151
Query: 444 PHANLKSSNILIFRENDIYRAKLTNFGF--------------LPLLPSRKAS-ENLAIGR 488
H +L + N L+ + I K+ +FG +LP R S E++ +G
Sbjct: 152 VHRDLATRNCLVGKNYTI---KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG- 207
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVIT 516
+ T +DV+ FG+ L E++T
Sbjct: 208 --------KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 23/188 (12%)
Query: 340 SGAVVAVKRVKNMNALSK-KEFVQQMQLLGKLKHENLAK---IVSFYYSKEEKLIIYEFL 395
+G VAVK +K + + + +++++L L HEN+ K I + KLI+ EFL
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EFL 90
Query: 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455
P+GSL + L R +I L + ++ Q KG+ + L S + H +L + N+L+
Sbjct: 91 PSGSLKEYL--PRNKNKINLKQQLKYAV--QICKGMDY----LGSRQYVHRDLAARNVLV 142
Query: 456 FRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-SPEF---PE---GKRLTHKADVYCFG 508
E+ + K+ +FG + + K + SP F PE + +DV+ FG
Sbjct: 143 ESEH---QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFG 199
Query: 509 IILLEVIT 516
+ L E++T
Sbjct: 200 VTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 339 ESGAVVAVKRVKNMNALSK--KEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFL 395
+ VAVK +K+ +A K + V +M+++ + KH+N+ ++ +I E+
Sbjct: 45 KEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 396 PNGSLFDLLHESRGVG--------RIP---LAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
G+L + L R G R+P + + +S Q A+G+ +L S K
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCI 159
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEFPEGKRL 498
H +L + N+L+ EN++ K+ +FG + + + GR +PE +
Sbjct: 160 HRDLAARNVLV-TENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 499 THKADVYCFGIILLEVIT-GRIPGNGSP 525
TH++DV+ FG+++ E+ T G P G P
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSPYPGIP 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 344 VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402
VAVK ++ + + ++++F++++++L +L N+A+++ +I E++ NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 403 LLHESRGV------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456
L + L+++T L + Q A G+ +L S H +L + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRNCLVG 164
Query: 457 RENDIYRAKLTNFGFLPLLPSRKASENLAI-------GRSP--------EFPEGKRLTHK 501
+ Y K+ +FG S NL GR+P E + T K
Sbjct: 165 KN---YTIKIADFGM---------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212
Query: 502 ADVYCFGIILLEVIT 516
+DV+ FG+ L E++T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE----FVQQMQLLGKLKHENLAK 377
+VLGKG G A L+ G AVK +K L + V++ L ++ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + +KE + EFL G DL+ + GR L T + + GL FLH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYA--AEIVCGLQFLH-- 113
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP--LLPSRKASENLAIGR--SPEFP 493
S + + +LK N+++ R+ I K+ +FG + +AS +PE
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHI---KIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIPGNG 523
+G + T D + FG++L E++ G+ P +G
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 37/230 (16%)
Query: 325 LGKGKVGSTYKATL--------ESGAVVAVKRVKNMNALSK--KEFVQQMQLLGKL-KHE 373
LG+G G +A + VAVK +K+ NA K + + +M+L+ + KH+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NATDKDLADLISEMELMKLIGKHK 78
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVG-----------RIPLAWTTRLS 422
N+ ++ + +I E+ G+L + L R G L++ +S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE 482
Q A+G+ +L S + H +L + N+L+ +N + K+ +FG + +
Sbjct: 139 CAYQVARGMEYLE----SRRCIHRDLAARNVLVTEDNVM---KIADFGLARGVHDIDYYK 191
Query: 483 NLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSP 525
+ GR +PE + TH++DV+ FGI++ E+ T G P G P
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEF----VQQMQLLGKLKHEN---L 375
+G+G G YKA ++G +VA+K+V+ N K+ F ++++++L +L H N L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 376 AKIVS-------FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTA 428
+IV+ F K +++E++ + L LL ES G + + S +KQ
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLL-ES---GLVHFSEDHIKSFMKQLL 126
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS--RKASENLAI 486
+GL + H+ H+ ++K SNIL+ N+ + KL +FG L S + N I
Sbjct: 127 EGLNYCHKKNFLHR----DIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 487 G---RSPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
R PE G +R DV+ G IL E+ T +
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 306 DKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLE-SGAVVAVKR-VKNMNALSKKEFVQQ 363
D DL+DL +G G G YK + +G V+AVK+ + N K +
Sbjct: 6 DGQKYPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63
Query: 364 MQLLGKLKHENLAKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR 420
+ ++ LK + IV Y + + I E + + D L R G IP +
Sbjct: 64 LDVV--LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKL-LKRIQGPIPEDILGK 118
Query: 421 LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480
+++ K L +L + H V H ++K SNIL+ ++ KL +FG L KA
Sbjct: 119 MTV--AIVKALHYLKEK---HGVIHRDVKPSNILLDASGNV---KLCDFGISGRLVDSKA 170
Query: 481 ---SENLAIGRSPEFPEGKRLTHK----ADVYCFGIILLEVITGRIP 520
S A +PE + K ADV+ GI L+E+ TG+ P
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 60/250 (24%)
Query: 312 FDLDDLLRASAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSK--KEFVQQ 363
D L + LG+G G KA + VAVK +K +A K + V +
Sbjct: 9 LPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSE 65
Query: 364 MQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVG----------- 411
M+++ + KH+N+ ++ + ++ E+ +G+L D L R G
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 412 RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI---------------- 455
L +S Q A+G+ FL S K H +L + N+L+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 456 FRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515
D YR K TN G LP+ + +A PE + TH++DV+ FG++L E+
Sbjct: 182 IHHIDYYR-KTTN-GRLPV-------KWMA----PEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 516 TGRIPGNGSP 525
T G GSP
Sbjct: 229 T---LG-GSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 323 EVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENL 375
+V+G+G G +A ++ + A+ +K + N ++F ++++L KL H N+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHHPNI 65
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP-------LAWTTRLSIIKQTA 428
++ ++ I E+ P G+L D L +SR + P A T + Q A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR 488
+A Q L + H +L + N+L+ + +K+ +FG L + +GR
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFG---LSRGEEVYVKKTMGR 179
Query: 489 SP------EFPEGKRLTHKADVYCFGIILLEVIT 516
P E T K+DV+ FG++L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/175 (29%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 356 SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK---LIIYEFLPNGSLFDLLHESRG--- 409
S+KE V LL K+KH N IV+F S E I+ E+ G L + RG
Sbjct: 45 SRKEAV----LLAKMKHPN---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97
Query: 410 VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469
L W ++ L H +H +V H ++KS NI + + + KL +F
Sbjct: 98 PEDTILQWFVQMC--------LGVQH--IHEKRVLHRDIKSKNIFLTQNGKV---KLGDF 144
Query: 470 GFLPLLPSRKASENLAIGR----SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
G LL S A +G PE E +K+D++ G IL E+ T + P
Sbjct: 145 GSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 316 DLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFV---QQMQLLGKLKH 372
+LL + + K + +VAVK++ N+++ SK++ Q++ +L+H
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQH 58
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLL--HESRGVGRIPLAWTTRLSIIKQTAKG 430
N+ V+ + E ++ + GS DLL H G+ + +A+ I+K
Sbjct: 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNA 113
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL-----------PLLPSRK 479
L ++H + H ++K+S+IL+ + + L+ + + K
Sbjct: 114 LDYIH---SKGFI-HRSVKASHILLSGDG---KVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 480 ASENLAIGRSPEFPEGKRL--THKADVYCFGIILLEVITGRIP 520
+S SPE + K+D+Y GI E+ G +P
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 26/218 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E +GKG G+ K G ++ K + NM K++ V ++ +L +LKH N IV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN---IV 62
Query: 380 SFYY-----SKEEKLIIYEFLPNGSLFDLLHESRGV-GRIP--LAWTTRLSIIKQTAKGL 431
+Y S + I+ E+ G L L+ + + I W I+ Q L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLAL 118
Query: 432 AFLHQTLH-SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-- 488
H + V H +LK +NI + N++ KL +FG +L + +G
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNV---KLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 489 --SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524
SPE K+D++ G ++ E+ P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE------FVQQMQLLGKLKHENL 375
E +G+G G YKA + +A+K+++ L +++ ++++ LL +++H N+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIR----LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL--SIIKQTAKGLAF 433
++ +S++ +++E+L DL + A RL + + Q +G+A+
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL--LPSRKASENLAI--GRS 489
H SH+V H +LK N+LI R + KL +FG +P R + + R+
Sbjct: 118 CH----SHRVLHRDLKPQNLLIDRRTNAL--KLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 490 PEFPEGKR-LTHKADVYCFGIILLEVITGR--IPGN 522
PE G R + D++ G I E++ + PG+
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 344 VAVKRVKNMNALSK--KEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400
VAVK +K+ +A K + V +M+++ + KH+N+ ++ ++ E+ G+L
Sbjct: 47 VAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 401 FDLLHESRGVG--------RIP---LAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLK 449
+ L R G ++P L + +S Q A+G+ +L S K H +L
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLA 161
Query: 450 SSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEFPEGKRLTHKAD 503
+ N+L+ +N + K+ +FG + + + GR +PE + TH++D
Sbjct: 162 ARNVLVTEDNVM---KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 504 VYCFGIILLEVIT-GRIPGNGSP 525
V+ FG++L E+ T G P G P
Sbjct: 219 VWSFGVLLWEIFTLGGSPYPGIP 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 360 FVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTT 419
F + ++ +L H++L +E +++ E++ GSL L +++ + I ++W
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISW-- 101
Query: 420 RLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA-----KLTNFGFLPL 474
+L + KQ A L FL + H N+ + N+L+ RE D KL++ G
Sbjct: 102 KLEVAKQLAWALHFLED----KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157
Query: 475 LPSRKASENLAIGRSPEFP-----EGKRLTHKADVYCFGIILLEVITG 517
+ ++ + + R P P + L+ AD + FG L E+ +G
Sbjct: 158 VLPKE----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 45/191 (23%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNA-----LSKKEFVQQMQLLGKLKHENLAKI 378
+G+G G+ YKA L +G VA+K+V+ + LS ++++ LL +L+ I
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEHPNI 63
Query: 379 VSFY-------YSKEEKL-IIYEFLPNGSLFDLL--HESRGVGRIPLAWTTRLSIIKQTA 428
V +E KL +++E + + L L G+ T + +++Q
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP----PETIK-DLMRQLL 117
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG- 487
+G+ FLH SH++ H +LK NIL+ + + K+ +FG +R S +A+
Sbjct: 118 RGVDFLH----SHRIVHRDLKPQNILVTSDG---QVKIADFGL-----ARIYSFEMALTS 165
Query: 488 -------RSPE 491
R+PE
Sbjct: 166 VVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 360 FVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTT 419
F + L+ ++ H +LA + E +++ EF+ +G L L + +G R+P+AW
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAW-- 118
Query: 420 RLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR----ENDIYRAKLTNFGFLPLL 475
++++ +Q A L++L + H N+ + NIL+ R E KL++ G
Sbjct: 119 KITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 476 PSRKASENLAIGRSPE-FPEGKRLTHKADVYCFGIILLEV 514
SR+ +PE P G L+ AD + FG LLE+
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 371 KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
+ N K+ + + ++I +++ +G LFDLL + G++ A + II+Q +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEA-EVKK-IIRQLVEA 121
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFREND-IY 462
L LH H + H ++K N+L R D IY
Sbjct: 122 L----NDLHKHNIIHNDIKLENVLYDRAKDRIY 150
|
Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 35/183 (19%)
Query: 363 QMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS 422
++ L H + K + S ++ L+I E+ G L + + R +P
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ-RLKEHLPF------- 166
Query: 423 IIKQTAKGLAFLHQTL-----HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477
++ GL F L HS K+ H +LKS+NI + I KL +FGF S
Sbjct: 167 --QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII---KLGDFGF-----S 216
Query: 478 RKASEN--LAIGRS---------PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG 526
++ S++ L + S PE E KR + KAD++ G+IL E++T P G P
Sbjct: 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PS 275
Query: 527 NNE 529
E
Sbjct: 276 QRE 278
|
Length = 478 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 54/261 (20%), Positives = 110/261 (42%), Gaps = 53/261 (20%)
Query: 344 VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402
VA+ ++ + ++ F+ + LG+ H N+ ++ +I+ E++ NG+L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL------HQTLHSHKVPHANLKSSNILIF 456
L + G L + ++ A G+ +L H+ L +HKV L +S+++
Sbjct: 96 FLRKHEG----QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV----LVNSDLV-- 145
Query: 457 RENDIYRAKLTNFGFLP-----LLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIIL 511
K++ F L + + + ++ + +PE + + +DV+ FGI++
Sbjct: 146 -------CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVM 198
Query: 512 LEVIT-GRIPGNGSPGNNETSGDLS--DWVRMVVDNDWSTDILDVEILAAREGQNEMLRL 568
EV++ G P D+S D ++ V D + A R N L
Sbjct: 199 WEVMSYGERP----------YWDMSGQDVIKAVEDG--------FRLPAPRNCPNL---L 237
Query: 569 TELALECTDIAPEKRPKMSEV 589
+L L+C +RP+ S++
Sbjct: 238 HQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVK--RVKNMNALSKKEFVQ-QMQLLGKLKHENLAKIVS 380
+G G G + S A+K + + L +++ V + ++L ++ H + ++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ + ++ E++P G LF L R GR + +T L + L +LH S
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL---RNSGR--FSNSTGLFYASEIVCALEYLH----S 119
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-----ASENLAIGRSPEFPEG 495
++ + +LK NIL+ +E I KLT+FGF L R E LA PE +
Sbjct: 120 KEIVYRDLKPENILLDKEGHI---KLTDFGFAKKLRDRTWTLCGTPEYLA----PEVIQS 172
Query: 496 KRLTHKADVYCFGIILLEVITGRIP 520
K D + GI++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 55/241 (22%), Positives = 93/241 (38%), Gaps = 54/241 (22%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLG--------------- 368
LG+G G KA +G +VA+K+VK + + + QL+G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEI--SNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 369 -KLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQT 427
++KHEN+ +V Y + ++ + + L ++ +I L + I+ Q
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR-----KIRLTESQVKCILLQI 128
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG------FLPLLPSRKAS 481
GL LH H +L +NI I N K+ +FG + P +
Sbjct: 129 LNGLN----VLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 482 ENLAIG------------RSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNN 528
E + R+PE G ++ D++ G I E++TG+ PG N
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL---FPGEN 238
Query: 529 E 529
E
Sbjct: 239 E 239
|
Length = 335 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 50/261 (19%)
Query: 323 EVLGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
E +GKG G +K ++G+ AVK + ++ + + E + +L L H N+ K
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYG 82
Query: 381 FYYSKEEK-----LIIYEFLPNGSLFDL----LHESRGVGRIPLAWTTRLSIIKQTAKGL 431
YY K+ K ++ E GS+ DL L + +A+ I+ + GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGL 137
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--- 488
Q LH +K H ++K +NIL+ E + KL +FG L S + N ++G
Sbjct: 138 ----QHLHVNKTIHRDVKGNNILLTTEGGV---KLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 489 -SPEFPEGKR-----LTHKADVYCFGIILLEVITG--------------RIPGNGSPGNN 528
+PE ++ + DV+ GI +E+ G +IP N P +
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 529 ET---SGDLSDWVRMVVDNDW 546
+ S + +D++R + D+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDY 271
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 15/196 (7%)
Query: 325 LGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS 384
G +V S V V +V + F + L+ +L H++L K+
Sbjct: 13 KGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV- 71
Query: 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVP 444
++E +++ E++ G L LH + + L W +L + KQ A L +L K+
Sbjct: 72 RDENIMVEEYVKFGPLDVFLHREKN--NVSLHW--KLDVAKQLASALHYLE----DKKLV 123
Query: 445 HANLKSSNILIFRENDIYR----AKLTNFGFLPLLPSRKASENLAIGRSPEFPEG--KRL 498
H N+ NIL+ R KL++ G + SR+ +PE L
Sbjct: 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASL 183
Query: 499 THKADVYCFGIILLEV 514
T AD + FG LLE+
Sbjct: 184 TIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 325 LGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSKK-EFVQQMQLLGKLKHENLAK 377
LG+G G Y+ E+ VAVK V +L ++ EF+ + ++ ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESR-----GVGRIPLAWTTRLSIIKQTAKGLA 432
++ + L++ E + +G L L R GR P + + + A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 433 FLHQTLHSHKVPHANLKSSNILIFREN-----------DIYRAKLTNFGFLPLLPSRKAS 481
+L+ + K H +L + N ++ + DIY G LLP R
Sbjct: 134 YLN----AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 482 ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRM 540
+PE + T +D++ FG++L E+ + P G +NE ++
Sbjct: 187 -----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQV------LKF 233
Query: 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI-EEIQPM 599
V+D + LD + N R+T+L C P+ RP E++ + +++ P
Sbjct: 234 VMDGGY----LD-------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
Query: 600 IEE 602
E
Sbjct: 283 FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRV-KNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+G G G+ YK +G + A+K + N +++ +++++L + H N+ K +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP-LAWTTRLSIIKQTAKGLAFLHQTLHSH 441
E ++ EF+ GSL E + LA R Q G+A+LH
Sbjct: 142 DHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR-----QILSGIAYLH----RR 187
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE-----F 492
+ H ++K SN+LI N K+ +FG +L N ++G SPE
Sbjct: 188 HIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
G + D++ G+ +LE GR P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 39/285 (13%)
Query: 325 LGKGKVGSTYKAT--LESGAVVAVKRVKNMNA-----LSKKEFVQQMQLLGKLKHENLAK 377
+G+G G +KA G VA+KRV+ LS V ++ L +H N+ +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 378 IVSF----YYSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ +E KL +++E + + L L + G T ++ Q +GL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---RS 489
FLH SH+V H +LK NIL+ I KL +FG + + A ++ + R+
Sbjct: 125 FLH----SHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
PE D++ G I E+ + GS ++ G + D + + + DW D
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDWPRD 236
Query: 550 I-LDVEILAAREGQ---------NEMLRLTELALECTDIAPEKRP 584
+ L + ++ Q +E+ + +L L+C P KR
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRI 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 325 LGKGKVGSTY-----KATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LGKG G+ Y KA E V+ V +N + Q+ QLL KL H + K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ + ++ II E+ L L E + G+ L+ Q G+ ++HQ
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-------RSPE 491
++ H +LK+ N IF +N++ K+ +FG LL S +LA SPE
Sbjct: 125 --RRILHRDLKAKN--IFLKNNL--LKIGDFGVSRLL---MGSCDLATTFTGTPYYMSPE 175
Query: 492 FPEGKRLTHKADVYCFGIILLEV 514
+ + K+D++ G IL E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 44/205 (21%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 324 VLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKI 378
V+G G+ G L+ VA+K +K +++F+ + ++G+ H N+ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +I+ E++ NGSL L + G + + +++ A G+ +L
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQLVGMLRGIASGMKYLSDMG 126
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-------RSPE 491
+ H+ +L + NIL+ N K+++FG +L + G +PE
Sbjct: 127 YVHR----DLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 492 FPEGKRLTHKADVYCFGIILLEVIT 516
++ T +DV+ +GI++ EV++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 50/225 (22%)
Query: 323 EVLGKGKVGSTY---KAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
+VLG+G G + K T ++G + A+K +K L ++ V+ L N I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFI 60
Query: 379 VSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI--------IKQT 427
V +Y+ E KL +I +FL G LF TRLS +K
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLF-----------------TRLSKEVMFTEEDVKFY 103
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG 487
LA LHS + + +LK NIL+ E I KLT+FG S+++ ++
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHI---KLTDFGL-----SKESIDHEKKA 155
Query: 488 RS---------PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
S PE + T AD + FG+++ E++TG +P G
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 323 EVLGKGKVGSTYKATLESGAV---VAVKRVKNMNALSK-KEFVQQMQLLGKLKHE-NLAK 377
+V+G+G G KA ++ + A+KR+K + ++F ++++L KL H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP-----------LAWTTRLSIIKQ 426
++ + + E+ P+G+L D L +SR + P L+ L
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
A+G+ +L Q H+ +L + NIL+ EN Y AK+ +FG L ++ +
Sbjct: 121 VARGMDYLSQKQFIHR----DLAARNILV-GEN--YVAKIADFG---LSRGQEVYVKKTM 170
Query: 487 GRSP------EFPEGKRLTHKADVYCFGIILLEVIT 516
GR P E T +DV+ +G++L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 48/236 (20%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE-------NLA 376
+G+G G + A ++G +VA+KR+K K + ++ + + E
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK-------KSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 377 KIVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+V Y+ ++ +Y E++P G LL+ + R + + +
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE----DHARFYMAEMFE-AVDA 116
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS---- 489
LH+ + H+ +LK N LI I KLT+FG + + S
Sbjct: 117 LHELGYIHR----DLKPENFLIDASGHI---KLTDFGL--------SKGIVTYANSVVGS 161
Query: 490 -----PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540
PE GK D + G +L E + G P +GS NET +L W
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS-TPNETWENLKYWKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 65/291 (22%), Positives = 123/291 (42%), Gaps = 47/291 (16%)
Query: 325 LGKGKVGSTYKATLESGAV-------VAVKRVKNMNALSKK-EFVQQMQLLGKLKHENLA 376
LG+G G Y+ + G V VA+K V ++ ++ EF+ + ++ + ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESR-----GVGRIPLAWTTRLSIIKQTAKGL 431
+++ + L+I E + G L L R + P + + + + A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKASENLAIG 487
A+L+ ++K H +L + N ++ + + K+ +FG + RK + L
Sbjct: 133 AYLN----ANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 488 R--SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544
R SPE + T +DV+ FG++L E+ T P G +NE +R V++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQV------LRFVMEG 237
Query: 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
+L + +M L EL C P+ RP E++ I+E
Sbjct: 238 G---------LLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 35/200 (17%)
Query: 411 GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
+ PL +S Q A+G+ FL S K H +L + NIL+ EN++ K+ +FG
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILL-SENNV--VKICDFG 218
Query: 471 FLPLL---PS--RKASENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNG 523
+ P RK L + +PE K T ++DV+ FG++L E+ + G P G
Sbjct: 219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
Query: 524 SPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR 583
+ E L + RM +++T E+ + L+C PE R
Sbjct: 279 VQIDEEFCRRLKEGTRMRAP-EYATP--------------EIYSIM---LDCWHNNPEDR 320
Query: 584 PKMSEVLRRIEEIQPMIEEN 603
P SE+ +E + +++EN
Sbjct: 321 PTFSEL---VEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 344 VAVKRVKNMNALSK--KEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400
VAVK +K+ +A K + + +M+++ + KH+N+ ++ +I E+ G+L
Sbjct: 53 VAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 401 FDLLHESRGVG--------RIP---LAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLK 449
+ L R G ++P L++ +S Q A+G+ +L S K H +L
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLA 167
Query: 450 SSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEFPEGKRLTHKAD 503
+ N+L+ +N + K+ +FG + + GR +PE + TH++D
Sbjct: 168 ARNVLVTEDNVM---KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 504 VYCFGIILLEVIT-GRIPGNGSP 525
V+ FG++L E+ T G P G P
Sbjct: 225 VWSFGVLLWEIFTLGGSPYPGVP 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKK------EFVQQMQLLGKLKHENLAK 377
+G G G+ Y A + + VVA+K+ M+ K+ + +++++ L +L+H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKK---MSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
Y + ++ E+ GS D+L V + PL +I +GLA+LH
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDILE----VHKKPLQEVEIAAICHGALQGLAYLH-- 132
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE-- 491
SH+ H ++K+ NIL+ E KL +FG S + N +G +PE
Sbjct: 133 --SHERIHRDIKAGNILL-TEPGT--VKLADFGS----ASLVSPANSFVGTPYWMAPEVI 183
Query: 492 --FPEGKRLTHKADVYCFGIILLEVITGRIP 520
EG+ K DV+ GI +E+ + P
Sbjct: 184 LAMDEGQ-YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLAKI 378
LG+G + YK + + +VA+K ++ L +E ++++ LL LKH N+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
++++ +++E+L DL G +L + Q +GL + H+
Sbjct: 70 HDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCHR-- 122
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAI--GRSPEFPE 494
KV H +LK N+LI N+ KL +FG +P++ S + R P+
Sbjct: 123 --RKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 495 GK-RLTHKADVYCFGIILLEVITGR--IPGN 522
G + + D++ G I E+ TGR PG+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 45/214 (21%)
Query: 325 LGKGKVGSTYKAT--LESGAV--VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
LG G GS K ++SG VAVK +K A KKEF+++ ++ +L H + +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 380 SFYYSKEEKLI-IYEFLPNGSLFDLLHESRGVGRIPLA-WTTRLSIIKQTAKGLAFLHQT 437
K E L+ + E P G L L + R + L Q A G+A+
Sbjct: 63 GV--CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH------QVAMGMAY---- 110
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR---------KASENLAIGR 488
L S H +L + N+L+ + +AK+++FG SR +A+ GR
Sbjct: 111 LESKHFVHRDLAARNVLLVNRH---QAKISDFGM-----SRALGAGSDYYRATTA---GR 159
Query: 489 ------SPEFPEGKRLTHKADVYCFGIILLEVIT 516
+PE + + K+DV+ +G+ L E +
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG G G + A + VAVK++ + S K +++++++ +L H+N+ K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 384 SKEEKL--------------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429
L I+ E++ L ++L + G + Q +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ----GPLSEEHARLFMY--QLLR 125
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-----SENL 484
GL ++H S V H +LK +N+ I E+ + K+ +FG ++ + SE L
Sbjct: 126 GLKYIH----SANVLHRDLKPANVFINTEDLVL--KIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 485 AIG--RSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGS 524
RSP T D++ G I E++TG+ G+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVS 380
E +GKG G YK T + G++ AVK + ++ + + E + +L L H N+ K
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYG 86
Query: 381 FYYSKEEKL-----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+Y ++ + ++ E GS+ +L+ G + ++I G
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVK-----GLLICGQRLDEAMISYILYGALLGL 141
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE 491
Q LH++++ H ++K +NIL+ E + KL +FG L S + N ++G +PE
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGV---KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 492 FPEGKR-----LTHKADVYCFGIILLEVITGRIP 520
++ + DV+ GI +E+ G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 39/124 (31%), Positives = 58/124 (46%), Gaps = 9/124 (7%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDG 130
L+L L G +P G L + L KL L +N L G +P +L +L V L N FS
Sbjct: 361 LDLSTNNLTGEIPEG-LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 131 IPFGYIDLPKLKKLELQENYLDGQI--PPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPS 188
+P + LP + L++ N L G+I ++ SL +++ N G +P SF S
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-----DSFGS 474
Query: 189 SSFE 192
E
Sbjct: 475 KRLE 478
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 320 ASAEVLGKGKVGSTYKATL---ESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHE 373
A + LG+G+ GS + L +S VAVK +K + ++ E F+ + + + H
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMK-IAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 374 NLAKIVSFYYSKEEK------LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI--IK 425
N+ +++ E ++I F+ +G L L SR +G P T++ + +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMT 119
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA 485
A G+ +L S H +L + N ++ N+ + +FG + +
Sbjct: 120 DIASGMEYLS----SKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 486 IGRSP------EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWV 538
I + P E + T K+DV+ FG+ + E+ T G+ P PG + ++ D++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPGVENS--EIYDYL 227
Query: 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
R D LD L L C + P+ RP + +E+
Sbjct: 228 RQGNRLKQPPDCLDG--------------LYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLAKI 378
LG+G + +K + + +VA+K ++ L +E ++++ LL LKH N+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+++ +++E+L + DL G + ++ + Q +GL++ H+
Sbjct: 69 HDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMF-QLLRGLSYCHK-- 121
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAI--GRSPEFPE 494
K+ H +LK N+LI N+ KL +FG +P++ S + R P+
Sbjct: 122 --RKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 495 GK-RLTHKADVYCFGIILLEVITGR--IPGN 522
G + D++ G IL E+ TGR PG+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVS 380
V+G+G G K E+ +VA+K+ K+ N K+ ++++++L LK EN+ ++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ + + +++E++ ++ +LL E G P S I Q K + + H+
Sbjct: 68 AFRRRGKLYLVFEYVEK-NMLELLEEMPN-GVPP---EKVRSYIYQLIKAIHWCHK---- 118
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP---SRKASENLAIG--RSPEFPEG 495
+ + H ++K N+LI ND+ KL +FGF L + +E +A RSPE G
Sbjct: 119 NDIVHRDIKPENLLI-SHNDVL--KLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 496 KRLTHKADVYCFGIILLEVITGR--IPG 521
D++ G IL E+ G+ PG
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 316 DLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL 375
L ++ E + V ST + + ++A KRVK + + + ++ LG+L HEN+
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSRAAI-QLENEILALGRLNHENI 225
Query: 376 AKIVSFYYSKEEKLII---YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
KI S+ +I Y+F ++D E+ PL TR +I+KQ +
Sbjct: 226 LKIEEILRSEANTYMITQKYDFDLYSFMYD---EAFDWKDRPLLKQTR-AIMKQLLCAVE 281
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG-FLPLLPSRKASENLAIG---- 487
++H K+ H ++K NI + + I L +FG +P R+A + +G
Sbjct: 282 YIH----DKKLIHRDIKLENIFLNCDGKIV---LGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 488 RSPEFPEGKRLTHKADVYCFGIILLEVITGRI-PGNGSPGN 527
SPE G D++ G+ILL++++ P G
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375
|
Length = 501 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 40/168 (23%), Positives = 79/168 (47%), Gaps = 45/168 (26%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEF----VQQMQLLGKLKHENLAKIV 379
+G+G G +KA ++ +VA+K+V N K+ F ++++++L LKHEN+ ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 77
Query: 380 SFYYSKEEK--------LIIYEF--------LPNGSL-FDLLHESRGVGRIPLAWTTRLS 422
+K +++EF L N ++ F L +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK-------------- 123
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
++K GL ++H +K+ H ++K++NILI ++ + KL +FG
Sbjct: 124 VMKMLLNGLYYIH----RNKILHRDMKAANILITKDGIL---KLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 3/98 (3%)
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
P L ++ L L L +N SG +P NL NL + LS N+ + IP G L K
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 144 LELQENYLDGQIPPFNQT--SLIDFNVSYNNLDGPIPQ 179
L L N L+G+IP SL + N+ G +P
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 21/189 (11%)
Query: 340 SGAVVAVKRVKN---MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396
+G VA+K++ L+K+ + ++++LL L+HEN+ + + S E + L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456
L LL SR PL + Q +GL ++H S V H +LK SNILI
Sbjct: 93 GTDLHRLL-TSR-----PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILIN 142
Query: 457 RENDIYRAKLTNFGFL-PLLPSRKASENLAIGRSPEFP-EGKRLTHKADVYCFGIILLEV 514
D+ K+ +FG P + R+PE ++ + D++ G I E+
Sbjct: 143 ENCDL---KICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 515 ITGR--IPG 521
+ G+ PG
Sbjct: 200 LEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 50/222 (22%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 325 LGKGKVGSTYKA---TLESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIV 379
LG G G+ K +S VAVK +KN + K E +++ ++ +L + + +++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
E +++ E G L L +++ V + ++ Q + G+ +L +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEE--- 113
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS---------- 489
H +L + N+L+ + + AK+++FG L + A EN ++
Sbjct: 114 -TNFVHRDLAARNVLLVTQ---HYAKISDFG---LSKALGADENYYKAKTHGKWPVKWYA 166
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNET 530
PE + + K+DV+ FG+++ E + G+ P G GN T
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL---PS--RKA 480
Q A+G+ FL S K H +L + NIL+ EN++ K+ +FG + P RK
Sbjct: 182 QVARGMEFLA----SRKCIHRDLAARNILL-SENNV--VKICDFGLARDIYKDPDYVRKG 234
Query: 481 SENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWV 538
S L + +PE K T ++DV+ FG++L E+ + G P G N E L D
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
RM R +N + + L C P++RP S + +E +
Sbjct: 295 RM------------------RAPENATPEIYRIMLACWQGDPKERPTFSAL---VEILGD 333
Query: 599 MIEEN 603
+++EN
Sbjct: 334 LLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 325 LGKGKVG----STYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLK-HENLAK 377
LG+G G + T E VA+K++ N+ + K +++++LL + H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 378 IVSF---YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ + +L +YE L L ++ + PL S I Q GL ++
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYI 121
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG------- 487
H S V H +LK N+L+ N K+ +FG +R SEN
Sbjct: 122 H----SANVLHRDLKPGNLLV---NADCELKICDFGL-----ARGFSENPGENAGFMTEY 169
Query: 488 ------RSPEFPEGKRLTHKA-DVYCFGIILLEVITGR 518
R+PE + KA DV+ G IL E++ +
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 44/218 (20%)
Query: 322 AEVLGKGKVGSTYKATLESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
AE LG+G + L VAVK ++ ++ ++ +F+++++++ +LK+ N+ +++
Sbjct: 30 AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESR------GVGRIP-LAWTTRLSIIKQTAKGLAF 433
S + +I E++ NG L L + IP ++ L + Q A G+ +
Sbjct: 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKY 144
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--------------LPLLPSR- 478
L S H +L + N L+ Y K+ +FG +LP R
Sbjct: 145 ----LASLNFVHRDLATRNCLVGNH---YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197
Query: 479 KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT 516
A E++ +G + T +DV+ FG+ L E+ T
Sbjct: 198 MAWESILLG---------KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 28/241 (11%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLK---HENLAK 377
+G G G+ YKA SG VA+K V+ N + L V+++ LL +L+ H N+ +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST-VREVALLKRLEAFDHPNIVR 66
Query: 378 IV----SFYYSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
++ + +E K+ +++E + DL V L T +++Q +GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---RS 489
FLH ++ + H +LK NIL+ + KL +FG + + A + + R+
Sbjct: 123 FLH----ANCIVHRDLKPENILVTSGGQV---KLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
PE D++ G I E+ R P + G + D + + ++DW D
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 550 I 550
+
Sbjct: 235 V 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 325 LGKGKVGSTYKATLESGA---VVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G YKA + G A+K+++ +++ LL +LKH N+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 382 YYSKEEKLIIYEF-LPNGSLFDLL--HESRGVGRIPLAWTTRL--SIIKQTAKGLAFLHQ 436
+ S ++ + F L+ ++ H + + P+ + S++ Q G+ +LH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 437 TLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL-----PLLPSRKASENLAI--GR 488
++ V H +LK +NIL+ E + R K+ + GF PL P + R
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 489 SPEFPEGKRLTHKA-DVYCFGIILLEVIT 516
+PE G R KA D++ G I E++T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLA 376
E LG+G + +K + + +VA+K ++ L +E ++++ LL LKH N+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ ++ + +++E+L DL G I ++ + Q +GLA+ H+
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKI-FLYQILRGLAYCHR 122
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAI--GRSPEF 492
KV H +LK N+LI N+ KL +FG +P++ S + R P+
Sbjct: 123 ----RKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 493 PEG-KRLTHKADVYCFGIILLEVITGR--IPGN 522
G + + D++ G I E+ +GR PG+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAKI 378
++LGKG G + SG A+K +K ++K E + ++L +H L +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +K+ + E++ G LF H SR R+ TR + L +LH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRE--RVFSEDRTRF-YGAEIVSALDYLH--- 112
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
S K+ + +LK N+++ ++ I K+T+FG + A+ G +PE E
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHI---KITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 495 GKRLTHKADVYCFGIILLEVITGRIP 520
D + G+++ E++ GR+P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 64/302 (21%)
Query: 324 VLGKGKVGSTYKATLE----SGAVVAVKRVK-NMNALSK-KEFVQQMQLLGKLKHENLAK 377
+LGKG+ GS +A L+ S VAVK +K ++ + S +EF+++ + + H N+ K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 378 IVSFYYSKEEK------LIIYEFLPNGSLFDLLHESR-GVGRIPLAWTTRLSIIKQTAKG 430
++ K ++I F+ +G L L SR G L T + + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFREN------------DIYRAKLTNFGFLPLLPSR 478
+ +L S H +L + N ++ EN IY G LP +
Sbjct: 126 MEYLS----SKNFIHRDLAARNCML-NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 479 -KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536
A E+LA T +DV+ FG+ + E++T G+ P G
Sbjct: 181 WLALESLA---------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAG------------- 218
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQ--NEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
V+N ++I + I R Q + + + EL +C P+ RP + ++E
Sbjct: 219 -----VEN---SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
Query: 595 EI 596
I
Sbjct: 271 LI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 325 LGKGKVGSTYKATLESGAV---VAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G YKA + G A+K+++ +++ LL +LKH N+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 382 YYSKEEKLIIYEF-LPNGSLFDLL--HESRGVGRIPLAWTTRL--SIIKQTAKGLAFLHQ 436
+ S ++ + F L+ ++ H + + P+ + S++ Q G+ +LH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 125
Query: 437 TLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL-----PLLPSRKASENLAI--GR 488
++ V H +LK +NIL+ E + R K+ + GF PL P + R
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 489 SPEFPEGKRLTHKA-DVYCFGIILLEVIT 516
+PE G R KA D++ G I E++T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 48/151 (31%), Positives = 69/151 (45%), Gaps = 27/151 (17%)
Query: 328 GKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK-----IVSFY 382
GKV K + + AVK VK + ++K V Q+Q + + LA IV Y
Sbjct: 18 GKVYLGRKKN--NSKLYAVKVVKKADMINKN-MVHQVQA----ERDALALSKSPFIVHLY 70
Query: 383 YSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
YS + +Y E+L G + LLH G +A + I + A L +LH+
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMA----VKYISEVALALDYLHR--- 122
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
H + H +LK N+LI E I KLT+FG
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHI---KLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 321 SAEVLGKGKVGSTYKATLESGAV-----VAVKRVKNMNALSKKE-FVQQMQLLGKLKHEN 374
+++L +G G + L V VK VK+ + + +Q+ LL L H+N
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 375 LAKIVSFYYSKEEK-LIIYEFLPNGSLFDLLHESR-GVGRIPLAWTTR--LSIIKQTAKG 430
+ I+ E ++Y ++ G+L L + R G P A +T+ + + Q A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF-LPLLPSRKAS----ENLA 485
+++LH V H ++ + N +I ++ + K+T+ L P EN
Sbjct: 130 MSYLH----KRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 486 IG-RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
+ + E K + +DV+ FG++L E++T G+ P
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 325 LGKGKVGSTYK---ATLESGAV---VAVKRVKNMNALSKK--EFVQQMQLLGKLKHENLA 376
LG+G G Y+ + G VA+K V N NA ++ EF+ + ++ K N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVM---KEFNCH 69
Query: 377 KIVSFY--YSKEEK-LIIYEFLPNGSLFDLLHESR------GVGRIPLAWTTRLSIIK-- 425
+V S + L++ E + G L L R P T I+
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP----TLQKFIQMA 125
Query: 426 -QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKA 480
+ A G+A+L K H +L + N ++ + K+ +FG + RK
Sbjct: 126 AEIADGMAYLAAK----KFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 481 SENLAIGR--SPEFPEGKRLTHKADVYCFGIILLEVIT 516
+ L R +PE + T K+DV+ FG++L E+ T
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGK--LKHENLAKIVSF 381
LGKG G ++ +G + A K++ KK+ ++M LL K L+ N IV+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 382 YYSKEEK--LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
Y+ E K L + L NG DL + VG L + Q G+ LH LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGG--DLKYHIYNVGERGLEMERVIHYSAQITCGI--LH--LH 112
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEFPEGK 496
S + + ++K N+L+ +D +L++ G L K A +PE + +
Sbjct: 113 SMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
++ D + G + E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 323 EVLGKGKVGSTYKA--TLESGAVVAVKRVKNMN---ALSKKE-------FVQQMQLLGK- 369
E LG G G YK ++A+K + N K+E V ++ ++ +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 370 LKHENLAKIVSFYYSKEEKLIIYEFL---PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQ 426
L+H N+ + + + I+ + + P G F+ L E + W +I Q
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFVQ 121
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
L +LH+ ++ H +L +NI++ E+D + +T+FG L ++ +
Sbjct: 122 MVLALRYLHK---EKRIVHRDLTPNNIML-GEDD--KVTITDFG-LAKQKQPESKLTSVV 174
Query: 487 G----RSPEFPEGKRLTHKADVYCFGIILLEVIT 516
G PE + + KADV+ FG IL ++ T
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE----FVQQMQLLGKLKHENLAK 377
+V+GKG G A + G AVK ++ L++KE ++ LL +KH L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + + E+ + +F+ G LF L R P A + A L +LH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-PRA----RFYAAEIASALGYLH-- 113
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--PEG 495
S + + +LK NIL+ + + LT+FG ++ + G +PE+ PE
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVV---LTDFGLCKEGIAQSDTTTTFCG-TPEYLAPEV 167
Query: 496 KR---LTHKADVYCFGIILLEVITGRIP 520
R + D +C G +L E++ G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 18/36 (50%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 94 LNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
L L L NN ++ LP L+NL NLET+ LS N +D
Sbjct: 3 LETLDLSNNQIT-DLPPLSNLPNLETLDLSGNKITD 37
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLA 376
E LG+G + YK + +G +VA+K ++ L ++E +++ LL LKH N+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIR----LQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ ++KE +++E++ + L + + G G P +L + Q +GL+++HQ
Sbjct: 67 LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPE--NVKLFLF-QLLRGLSYIHQ 121
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAI--GRSPEF 492
+ H +LK N+LI +D KL +FG +PS S + R P+
Sbjct: 122 ----RYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 493 PEGK-RLTHKADVYCFGIILLEVITG 517
G + D++ G I +E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 81/368 (22%), Positives = 138/368 (37%), Gaps = 112/368 (30%)
Query: 267 KEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEF---FDKTIPVFDLDDLLRASAE 323
KEK EGQ GE HL E + +P+ L+F K P+ +LR A
Sbjct: 10 KEKLGEGQFGE--VHLCE--------VVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA- 58
Query: 324 VLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
N NA + +F++++++L +LK N+ +++
Sbjct: 59 ---------------------------NKNA--RNDFLKEVKILSRLKDPNIIRLLGVCV 89
Query: 384 SKEEKLIIYEFLPNGSLFDLLH-------ESRGVGRIPLA-------WTTRLSIIKQTAK 429
++ +I E++ NG L L E G +P A +++ L + Q A
Sbjct: 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIAS 149
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--------------LPLL 475
G+ + L S H +L + N L+ I K+ +FG +L
Sbjct: 150 GMKY----LSSLNFVHRDLATRNCLVGENLTI---KIADFGMSRNLYAGDYYRIQGRAVL 202
Query: 476 PSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL 534
P R A E + +G + T +DV+ FG+ L E++ + G+L
Sbjct: 203 PIRWMAWECILMG---------KFTTASDVWAFGVTLWEIL--------MLCKEQPYGEL 245
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-------LTELALECTDIAPEKRPKMS 587
+D V++N E + Q + R L EL L+C +RP S
Sbjct: 246 TD--EQVIENAG-------EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296
Query: 588 EVLRRIEE 595
++ + E
Sbjct: 297 DIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 42/211 (19%)
Query: 328 GKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE-F----VQQMQLLGKLKHEN---LAKI 378
G G Y+A ++G +VA+K++K +KE F ++++ +L KL+H N + ++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 379 VSFYYSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
V S +K+ ++ E++ + L L+ + P + ++ Q G+A LH
Sbjct: 73 V--VGSNLDKIYMVMEYVEH-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHD- 124
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI---------GR 488
+ + H +LK+SN+L+ + K+ +FG +R+ L R
Sbjct: 125 ---NWILHRDLKTSNLLLNNRGIL---KICDFGL-----AREYGSPLKPYTQLVVTLWYR 173
Query: 489 SPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
+PE G K + D++ G I E++T +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 323 EVLGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKE----FVQQMQLLGKLKHENLAK 377
+V+GKG G A +S G+ AVK ++ L KKE ++ LL LKH L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + + E+ + +++ G LF L R P A + A +A
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCF-LEPRA--------RFYAAEVASAIGY 111
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP--LLPSRKAS------ENLAIGRS 489
LHS + + +LK NIL+ + + LT+FG + P S E LA
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVV---LTDFGLCKEGVEPEETTSTFCGTPEYLA---- 164
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE + D +C G +L E++ G P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 47/225 (20%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVS 380
+G G G A +G VA+K++ N+ + + K +++++LL L+HEN+ ++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 381 FYYSK-----EEKLIIYEFLPNGSLFDL---LHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ I+ E + DL + + PL + Q +GL
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLK 117
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----- 487
+LH S V H +LK SNIL+ D+ K+ +FG +R +
Sbjct: 118 YLH----SANVIHRDLKPSNILVNSNCDL---KICDFGL-----ARGVDPDEDEKGFLTE 165
Query: 488 -------RSPE-FPEGKRLTHKADVYCFGIILLEVITGRI--PGN 522
R+PE R T D++ G I E++T + PG
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 20/204 (9%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIV--SF 381
+GKG G + ++ + A+K ++ + +S+ E + L N IV F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 382 YYSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ EKL ++ F+ G LF H + GR +R TA+ L L + LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELF---HHLQREGRFD---LSRARFY--TAELLCAL-ENLHK 111
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGK 496
V + +LK NIL+ + I L +FG L N G +PE G
Sbjct: 112 FNVIYRDLKPENILLDYQGHI---ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
T D + G++L E++TG P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 325 LGKGKVGSTYKA-TLESGAVVAVKRVKNMNA-----LSKKEFVQQMQLLGKLKHENLAKI 378
+G+G G Y+A SG +VA+K+V+ N +S ++++ LL L+H N+ ++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIVEL 71
Query: 379 --VSFYYSKEEKLIIYEFLPN--GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
V + ++ E+ SL D + P + + ++ Q +GL +L
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-------PFSESQVKCLMLQLLRGLQYL 124
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL--LPSRKASENLAI--GRSP 490
H + + H +LK SN+L+ D K+ +FG LP++ + + R+P
Sbjct: 125 H----ENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
Query: 491 EFPEG-KRLTHKADVYCFGIILLEVITGR--IPGN 522
E G T D++ G IL E++ + +PG
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV----KNMNALSKKEFVQQMQLLGKLKHENLAK 377
+G+G G AT +G VA+K++ ++++++L + KHEN+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---LREIKILRRFKHENIIG 67
Query: 378 I-----VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQ 426
I + S + I+ E + L++ L T LS + Q
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMETD-----LYK--------LIKTQHLSNDHIQYFLYQ 114
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL-----PSRKAS 481
+GL + +HS V H +LK SN+L+ D+ K+ +FG + + +
Sbjct: 115 ILRGL----KYIHSANVLHRDLKPSNLLLNTNCDL---KICDFGLARIADPEHDHTGFLT 167
Query: 482 ENLAIG--RSPEFPEGKRLTHKA-DVYCFGIILLEVITGR--IPGN 522
E +A R+PE + KA D++ G IL E+++ R PG
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 32/175 (18%)
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL---PS--RKA 480
Q AKG+ FL S K H +L + NIL+ N + K+ +FG + P RK
Sbjct: 187 QVAKGMEFLA----SRKCIHRDLAARNILLSENNVV---KICDFGLARDIYKDPDYVRKG 239
Query: 481 SENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWV 538
L + +PE + T ++DV+ FG++L E+ + G P G + E L +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593
RM D++T + + L+C P +RP SE++ +
Sbjct: 300 RMRAP-DYTTP-----------------EMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 36/162 (22%)
Query: 323 EVLGKGKVGST-YKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLG-KLKHENLAK--- 377
+V+GKG G ++G + A M L K E ++ QL K + + LA+
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYA------MKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 378 --IVSFYYSKEEKLIIY---EFLPNGSLFDLLHE----SRGVGRIPLAWTTRLSIIKQTA 428
+VS YYS ++ +Y EFLP G L +L + S V R +A L+I +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV-LAI--EAV 117
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
L F+H+ ++K NILI R I KL++FG
Sbjct: 118 HKLGFIHR----------DIKPDNILIDRGGHI---KLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 324 VLGKGKVG----STYKATLESGAVVAVKR-VKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
VLGKG G + K T E AV +K+ V + + ++ L KH L ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
S + +K+ + E++ G DL+ + GR + + GL FLH+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAA--EIVLGLQFLHE-- 114
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP--LLPSRKAS------ENLAIGRSP 490
+ + +LK N+L+ E I K+ +FG +L S + +A P
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHI---KIADFGMCKEGILGGVTTSTFCGTPDYIA----P 165
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530
E + D + G++L E++ G+ P G++E
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSP---FEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 20/108 (18%)
Query: 430 GLAFLHQTL-----HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL 484
GL F+ L HS + H ++KS+NIL+ N + KL +FGF + + S++
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-SNGL--VKLGDFGFSKMY-AATVSDD- 200
Query: 485 AIGRS---------PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
+GR+ PE K + KAD++ G++L E++T + P +G
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.95 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.72 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.68 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.67 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.67 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.63 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.45 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.44 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.37 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.23 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.19 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.09 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.09 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.07 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.92 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.9 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-61 Score=561.76 Aligned_cols=472 Identities=30% Similarity=0.481 Sum_probs=348.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.++..|+|++|+++|.+|.. +.++++|+.|+|++|+++|.+| .++++++|++|+|++|+++|.+|..+.++++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRK-LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChh-hhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 46889999999999999987 8899999999999999999999 589999999999999999999999999999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPP 223 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~c~~~~~~~~~~~p~~s~~ 223 (604)
|++|+++|.+|.. .+.+|+.|++++|+++|.+|..+.+..+...++.+|+.+||.+.... . + +.
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~-----~----~c-- 619 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---L-----P----PC-- 619 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---C-----C----CC--
Confidence 9999999999983 68899999999999999999998888898999999999998642110 0 0 00
Q ss_pred CCCCcCCcCccchhhhhhhHHHHHHHHHHHHHHhhheeeccccccccCcCCCCCCCcccccccCCCCCCCCCCccceeee
Q 007427 224 PPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELE 303 (604)
Q Consensus 224 ~~~~~~~~~~~~~~~v~~i~~~~~lv~~~v~~~~~~~~rk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (604)
. . ..+.. ..+.+++++++++++++++++++++++++++.+.+..... ...+ ...
T Consensus 620 ~-~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~------------------~~~ 673 (968)
T PLN00113 620 K-R-VRKTP--SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE----DGTW------------------ELQ 673 (968)
T ss_pred c-c-ccccc--eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccc----cccc------------------ccc
Confidence 0 0 00111 1111222222222222222222222222221111100000 0000 001
Q ss_pred eecC-CCCccCHHHHHHHh--hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEE
Q 007427 304 FFDK-TIPVFDLDDLLRAS--AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIV 379 (604)
Q Consensus 304 ~~~~-~~~~~~~~~~~~~~--~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 379 (604)
+++. ....++++++.... .++||+|+||.||+|+. .+++.||||+++..... ..+|++.+++++|||||+++
T Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~ 749 (968)
T PLN00113 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLI 749 (968)
T ss_pred ccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEE
Confidence 1111 11224555554442 46899999999999986 57999999999754322 23568899999999999999
Q ss_pred EEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC
Q 007427 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459 (604)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 459 (604)
++|.+.+..++||||+++|+|.++++. ++|.++.+|+.|+++||+|||+.+ +++|+||||||+||++ +
T Consensus 750 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~---~ 817 (968)
T PLN00113 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIII---D 817 (968)
T ss_pred EEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEE---C
Confidence 999999999999999999999999962 889999999999999999999543 3699999999999999 4
Q ss_pred CcceEEEeeccCCCCCCCCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 460 DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 460 ~~~~~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
....+++. ||............++..|+|||+..+..++.++|||||||++|||+||+.||+... .....+.+|.+
T Consensus 818 ~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~ 893 (968)
T PLN00113 818 GKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWAR 893 (968)
T ss_pred CCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHH
Confidence 44555664 666554444444456789999999999999999999999999999999999986432 23445677776
Q ss_pred HHHhcCCccccccHHhhhc-ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 540 MVVDNDWSTDILDVEILAA-REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
............|+.+... ....++..++.+++.+||+.||++||+|.||+++|+++...
T Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 5544433333444333221 22345667889999999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=434.60 Aligned_cols=283 Identities=36% Similarity=0.660 Sum_probs=245.7
Q ss_pred CCCccCHHHHHHHh-----hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEE
Q 007427 308 TIPVFDLDDLLRAS-----AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382 (604)
Q Consensus 308 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 382 (604)
....|+++++..|+ .++||+|+||.||+|.+++|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999987 3689999999999999999999999988765432145699999999999999999999999
Q ss_pred ecCC-ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 383 YSKE-EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 383 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+. +.|+||||||+|||+ |++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILL---D~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILL---DED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeE---CCC
Confidence 9999 599999999999999999986532 68999999999999999999998754 589999999999999 888
Q ss_pred ceEEEeeccCCCCCCC-CCCC----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhH
Q 007427 462 YRAKLTNFGFLPLLPS-RKAS----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~-~~~~----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 536 (604)
+++||+|||+|+..+. .... .++.+|+|||+...+..++|+|||||||+|+||+||+.+.+.... .....+.+
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~ 291 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVE 291 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHH
Confidence 9999999999987765 3221 688999999999999999999999999999999999988875431 23345899
Q ss_pred HHHHHHhcCCccccccHHhhhcccCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 537 WVRMVVDNDWSTDILDVEILAAREGQ-NEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
|....+......+++|+.+....... .+..++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99988888888999999876444443 6788899999999999999999999999999776643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=369.88 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=212.4
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEe-cCCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc-e
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE-K 388 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~ 388 (604)
++++|+.+ .+.||+|..|+||++++ .+++.+|+|++.. .....++++.+|++++++.+||+||.+||.|+.... .
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 55666653 57899999999999986 4789999999953 344557889999999999999999999999999984 9
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
.++||||++|+|++++.... .+++...-+|+.++++||.|||+ .++||||||||+|||+ +..+++||||
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLv---NskGeVKicD 222 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLV---NSKGEVKICD 222 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeee---ccCCCEEecc
Confidence 99999999999999998753 38999999999999999999996 3799999999999999 6677899999
Q ss_pred ccCCCCCCCCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 469 FGFLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 469 FGla~~~~~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
||.++.+.... ...||..|||||.+.+..|+.++||||||++++|+++|+.||... ........+.+..+..+.-
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCC
Confidence 99998876553 457899999999999999999999999999999999999999764 2223344555544444321
Q ss_pred ccccccHHhhhcccCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 547 STDILDVEILAAREGQ-NEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.. .+. ...+++.+++..||++||.+||++.|+++.
T Consensus 300 P~-----------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 PR-----------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CC-----------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11 111 355679999999999999999999998763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=385.27 Aligned_cols=260 Identities=32% Similarity=0.465 Sum_probs=210.1
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccchh--hHHHHHHHHHHHccCCCCCcccEEEEEecCC-ce
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL--SKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-EK 388 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 388 (604)
++.+++. ..+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..
T Consensus 38 i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 4455543 34569999999999999985445999999754322 2568999999999999999999999999887 79
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCceEEeecCCcc-eEEE
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK-VPHANLKSSNILIFRENDIY-RAKL 466 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrDlkp~NILl~~~~~~~-~~kl 466 (604)
++|||||++|+|.++++... ...+++..+++|+.|||+||.|||+ ++ ||||||||+|||+ +... ++||
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~----~~~iIHrDLK~~NiLv---~~~~~~~KI 185 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHS----EGPIIHRDLKSDNILV---DLKGKTLKI 185 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc----CCCeeecccChhhEEE---cCCCCEEEE
Confidence 99999999999999998841 2369999999999999999999995 56 9999999999999 6665 9999
Q ss_pred eeccCCCCCCCC----CCCccccccCCCCCCC--CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 467 TNFGFLPLLPSR----KASENLAIGRSPEFPE--GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 467 ~DFGla~~~~~~----~~~~~~~~y~aPE~~~--~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
+|||+++..... ....+|..|||||++. ...|+.|+|||||||++|||+||+.||.+... ...+..
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~ 257 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASA 257 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 999999876542 2247889999999999 56999999999999999999999999986422 122222
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.........+ +..+...+..++.+||+.||++||++.+++..|+.+.....
T Consensus 258 v~~~~~Rp~~----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 258 VVVGGLRPPI----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHhcCCCCCC----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2222221111 11245578899999999999999999999999998876443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=379.40 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=213.9
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEE
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (604)
+..+++ ...+.||+|.||+||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..++..+||
T Consensus 203 i~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 203 IPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred ecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 344444 3567899999999999999988899999998753 4568899999999999999999999999998899999
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||||+.|+|.++|+... +..+...+.+.++.|||+||+||+ ++++|||||.++|||| +++..+||+|||+
T Consensus 280 tE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV---~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILV---DEDLVVKISDFGL 349 (468)
T ss_pred EEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheee---ccCceEEEccccc
Confidence 99999999999999733 234888999999999999999999 6899999999999999 7778999999999
Q ss_pred CCCCCCCCCC-----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 472 LPLLPSRKAS-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 472 a~~~~~~~~~-----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
|+...+.... .-...|.|||.+..++++.|||||||||+||||+| |+.||.+.. ..+.+..+- .+
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le-~G 420 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLE-RG 420 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHh-cc
Confidence 9965544322 22347889999999999999999999999999999 999987643 233333332 22
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
+.. ..+..++..+.+++..||+.+|++|||+..+...|+++....
T Consensus 421 yRl----------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 421 YRL----------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 221 123456678999999999999999999999999999886543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=359.96 Aligned_cols=193 Identities=25% Similarity=0.412 Sum_probs=174.4
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.||+|+||+||+|++ +++..||||.+... .....+.+..|+++|+.++|||||.++++++.++..|+|||||.|||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 4599999999999985 46899999999754 45556778999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc---ceEEEeeccCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI---YRAKLTNFGFLPLLP 476 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~---~~~kl~DFGla~~~~ 476 (604)
|.+|++... .+++.....++.|+|.||++|| +++||||||||+|||++..... ..+||+|||+|+.+.
T Consensus 96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999875 4899999999999999999999 5899999999999999775222 689999999999998
Q ss_pred CCCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 477 SRKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 477 ~~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.... ..|++.|||||++...+|+.|+|+||.|+|+||+++|+.||+..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7653 36899999999999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=362.17 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=201.4
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccchh-------hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNAL-------SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (604)
+.+.||+|+||.|-+|. .++|+.||||++++.... ......+|+++|++++|||||+++++|...+..||||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 35789999999999996 678999999999743211 1234579999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||++||+|.+.+-.+. .+.+..-..+++|++.|+.||| ++||+||||||+|||+..+.+...+||+|||+|
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999998765 3777778899999999999999 579999999999999988878899999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCC---CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRL---THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~---s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
+...... ...||+.|.|||++.+..+ ..|+|+||+||+||-+++|.+||.+.... ..+.+ .+..+.+
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl~e---QI~~G~y 399 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSLKE---QILKGRY 399 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccHHH---HHhcCcc
Confidence 9986443 3468999999999986553 34789999999999999999999864321 11222 2222222
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ........++..++|.+||..||++|||+.|+++
T Consensus 400 ~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 AFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 1123455668899999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=392.65 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=212.8
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
..+.||+|.||+||+|+.. +.+.||||.+++.... .+++|++|++++..++|||||+++|+|.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 3578999999999999843 4578999999976555 78999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 394 FLPNGSLFDLLHESRGVG---------RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
||..|||.++|+...... +.+++..+.+.||.|||.||+||- ++.+|||||..+|+|| ++.+.+
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLV---ge~l~V 642 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLV---GENLVV 642 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhcee---ccceEE
Confidence 999999999998654211 234899999999999999999998 5799999999999999 999999
Q ss_pred EEeeccCCCCCCCCCCCc------cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHH
Q 007427 465 KLTNFGFLPLLPSRKASE------NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 465 kl~DFGla~~~~~~~~~~------~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 537 (604)
||+|||+++.+-..+.+. -...|||||.+..++||++||||||||+|||++| |+.||.+... +...+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----QEVIEC 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----HHHHHH
Confidence 999999998876544332 2348999999999999999999999999999999 9999987532 122222
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
+..+.. -..+++++.++.+|+..||+.+|++||+++||-..|+......
T Consensus 718 ----i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 718 ----IRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ----HHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222211 1234567788999999999999999999999999999876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=371.45 Aligned_cols=238 Identities=25% Similarity=0.422 Sum_probs=205.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.++||+|+|+.||.++. .+|..||+|++.+. .....+...+|+++.++|+|||||+++++|++.+..|||.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 57899999999999996 88999999999752 334567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.++++..+ ++++.++..++.||+.||.||| +++|+|||||..|+++ ++++++||+|||+|..+..
T Consensus 103 ~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 103 GSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEY 170 (592)
T ss_pred ccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheee---cCcCcEEecccceeeeecC
Confidence 99999998433 6999999999999999999999 5799999999999999 8889999999999988874
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....||+.|.|||++.....+..+||||+|||||-|++|++||... .+.+....+...++..
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNEYSM----- 237 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcCccc-----
Confidence 3 2346899999999999999999999999999999999999999753 3444444444333321
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.....+..+||.++|+.||.+|||+++|+.
T Consensus 238 -------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 -------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123346789999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=341.91 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=206.7
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEE-EEecCCc-eEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVS-FYYSKEE-KLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e~~ 395 (604)
..++||+|+||+||++. ..+|..||.|.++- .+...+++...|+.+|++|+|||||++++ .+.++.+ .+||||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 45789999999999997 67899999999973 34455678999999999999999999998 4444444 89999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+|||.++++..+.. +..+++..+++++.|+++||.++|..++..-|+||||||.||++ +.++.+||+|||+++.+
T Consensus 103 ~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFL 178 (375)
T ss_pred cccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHh
Confidence 999999999876643 34599999999999999999999975554559999999999999 67779999999999999
Q ss_pred CCCCC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRKA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
..... ..||+.||+||.+.+..|+.||||||+||++|||..-++||.+. ++.+.-+.+-..++. .+.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qgd~~-~~p 249 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQGDYP-PLP 249 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcCCCC-CCc
Confidence 87643 47999999999999999999999999999999999999999874 344444443333221 111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
....+..+.+||..|+..||+.||+...++..+.
T Consensus 250 ---------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 ---------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1345567899999999999999998655555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=350.83 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=198.6
Q ss_pred HhhcccCcCCcceEEEEE-ecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCC-ceEEEEecC
Q 007427 320 ASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKE-EKLIIYEFL 395 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e~~ 395 (604)
...++||.|.||.||+|+ ..+|..||||++++.- ....-.-.||++.|++++ |||||++.+++.+.+ ..++|||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence 356789999999999997 6679999999997542 223334578999999998 999999999999888 899999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+. +|++++++.+ .++++.++..|+.||++||+|+| .+|+.|||+||+|||+ .....+||+|||+||.+
T Consensus 93 d~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 93 DC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILI---SGNDVIKIADFGLAREV 160 (538)
T ss_pred hh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEe---cccceeEeccccccccc
Confidence 65 9999998763 37999999999999999999999 5799999999999999 44568999999999998
Q ss_pred CCCC---CCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRK---ASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~---~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.... .+..|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+....+ .+.+.. .++.........
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D----qi~KIc-~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID----QIYKIC-EVLGTPDKDSWP 235 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH----HHHHHH-HHhCCCccccch
Confidence 7654 446889999999876 5678999999999999999999999998754211 111111 011100000000
Q ss_pred c------------HHhhh---cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 552 D------------VEILA---AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 552 ~------------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. +.... ..-......++.+++.+|+.+||++|||++|+++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 00000 00012355678999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.57 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=195.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.++|+|+||.||+++. ++|+.||||++.+. +...++-..+|+++|++++|+|+|.++++|......++|+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 5799999999999985 57999999999743 344567789999999999999999999999999999999999987 4
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC-C
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS-R 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~-~ 478 (604)
+.+-|..... .++...+.+++.|+++|+.|+| ++++|||||||+|||+ .....+||||||+|+.+.. .
T Consensus 87 vL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 87 VLHELERYPN----GVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 4444444331 3888999999999999999999 6899999999999999 5666889999999999873 3
Q ss_pred C---CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC------CchhHHHHHHHh-cCCc
Q 007427 479 K---ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS------GDLSDWVRMVVD-NDWS 547 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~-~~~~ 547 (604)
. ....|..|+|||.+.+ .+|...+||||.||++.||++|.+.|.+....+... +++.-....++. ..+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 2 3357889999999987 789999999999999999999999998754321110 011111111221 1111
Q ss_pred -----cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 -----TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
++.-+++...... +....-+.++++.|++.||++|++.+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111 223346889999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=339.50 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=197.6
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--ceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--EKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 397 (604)
..+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+++|.....+ .+++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4678999999999999854 59999999997543333567899999999999999999999865555 58999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-cceEEEeeccCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-IYRAKLTNFGFLPLLP 476 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~~~~kl~DFGla~~~~ 476 (604)
|+|.+++....+ .+++..+..++.||++||+||| ++||+||||||+|||+ +. .+.+||+|||+++...
T Consensus 101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEE---eCCCCeEEeccCccccccc
Confidence 999999998652 4999999999999999999999 6899999999999999 55 5789999999998766
Q ss_pred C-------CCCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 S-------RKASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~-------~~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
. .....+++.|||||++..+ ....++|||||||++.||+||+.||... .....++-.+......+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCCC
Confidence 3 1234789999999999953 3345999999999999999999999752 11222222222222111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.+ +...+.+..+++.+|+..||++|||+.++++.--.
T Consensus 243 ~i----------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EI----------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CC----------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11 11234468899999999999999999999986543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=377.58 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=209.9
Q ss_pred hhcccCcCCcceEEEEEecC--C----cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLES--G----AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
..+.||+|.||.||.|...+ | ..||||.+++. +.....+|.+|..+|+.++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35789999999999998642 3 35999999864 45567899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 394 FLPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||++|||..+|++.+.. ....++..+.+.++.|||+|+.||+ ++++|||||.++|+|| +....+||+|||+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL---~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLL---DERRVVKIADFGL 848 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheee---cccCcEEEcccch
Confidence 99999999999987421 2345899999999999999999999 5799999999999999 6668999999999
Q ss_pred CCCCCCCCCC------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 472 LPLLPSRKAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 472 a~~~~~~~~~------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
|+.+...... .-...|||||.+..+.++.|+|||||||++||++| |..||.+... .+.+......
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDVLEG 920 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHHHhC
Confidence 9965443322 12358999999999999999999999999999999 8899876432 1112222233
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
+.. ..+..++..+.++|..||+.+|++||++..+++++..+.+....
T Consensus 921 gRL-----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 921 GRL-----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred Ccc-----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 211 12345666789999999999999999999999999988765543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.87 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=207.1
Q ss_pred CccCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccchhh---HHHHHHHHHHHccCCCCCcccEEEEEec--
Q 007427 310 PVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS---KKEFVQQMQLLGKLKHENLAKIVSFYYS-- 384 (604)
Q Consensus 310 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 384 (604)
..++.+|+.......||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 44566666555557899999999999998 58999999997543322 4678899999999999999999999876
Q ss_pred --CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc
Q 007427 385 --KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462 (604)
Q Consensus 385 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~ 462 (604)
....++||||+++|+|.+++.... .+++....+++.|++.||+|||+. .+++||||||+||++ +++.
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~~~~Hrdlkp~nill---~~~~ 160 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLV---TENY 160 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc---CCCCCCcCChhhEEE---CCCC
Confidence 346789999999999999997643 488999999999999999999952 488899999999999 6667
Q ss_pred eEEEeeccCCCCCCCCC-CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 463 RAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 463 ~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+...
T Consensus 161 ~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~ 232 (283)
T PHA02988 161 KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYD 232 (283)
T ss_pred cEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 89999999988654432 3346788999999876 679999999999999999999999997532 122222
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
........... +......+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 233 ~i~~~~~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 LIINKNNSLKL----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHhcCCCCCC----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 22222211110 11234468899999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=357.85 Aligned_cols=247 Identities=22% Similarity=0.422 Sum_probs=209.0
Q ss_pred hhcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
++++||.|.||+||+|+++ ....||||.+|.. .+..+.+|..|+.||.++.||||++|.|+.......+||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 4689999999999999864 2467999999854 3445688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|+.+|+.+.+ .+++.+...++++||.||+||-+ .++|||||.++|||+ +.+..+|++|||+++.+
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd----m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD----MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh----cCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 99999999998764 48999999999999999999994 699999999999999 88899999999999988
Q ss_pred CCCCCC-cc------ccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSRKAS-EN------LAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~~~~-~~------~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
.+.... .. ...|.|||.+..+++|.+||||||||||||.++ |..||.+... + +.+..+.++...
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----Q---dVIkaIe~gyRL 853 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----Q---DVIKAIEQGYRL 853 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----H---HHHHHHHhccCC
Confidence 665422 11 247889999999999999999999999999988 9999986532 1 122222222211
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
+.+.+++..|.+|++.||++|-.+||.+.||+..|+++.
T Consensus 854 -----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 854 -----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 123457778999999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=341.48 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=197.3
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.++||+|.||.||+|+ ..+|+.||+|++.... ........+|+.+|++|+||||+++.+...+. ...|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 3689999999999998 6789999999997433 44567789999999999999999999998876 68999999998
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+ ||..++... ...++..++..+++|++.||+|+| ++||+|||||.+|||| |+.+.+||+|||+|+++.
T Consensus 202 h-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 202 H-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred c-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 8 999988764 235999999999999999999999 6899999999999999 888899999999999876
Q ss_pred CCCC-----CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hcCCc
Q 007427 477 SRKA-----SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DNDWS 547 (604)
Q Consensus 477 ~~~~-----~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 547 (604)
.... ..-|..|+|||.+.+ ..|+.+.|+||.||||.||++|++.|.+.... ..+....+..- ++.|.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv----eQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV----EQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH----HHHHHHHHHhCCCChhccc
Confidence 5442 245779999999886 56999999999999999999999999875321 11111111110 11111
Q ss_pred c-ccccHHhhh--ccc-------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 T-DILDVEILA--ARE-------GQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ~-~~~~~~~~~--~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .+....... ..+ ........++|+..+|..||++|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 000000000 000 1122346789999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=330.32 Aligned_cols=233 Identities=21% Similarity=0.336 Sum_probs=195.6
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
-++||+|+||+||.++ .++++.+|+|++++.... ..+...+|..+|.+++||.||+++-.|++.+..|+|+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 4789999999999997 457999999999864332 345678999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|.|..+|++.. .+++..+.-++..|+.||.||| ++|||||||||+|||+ |..++++|+|||+++..-.
T Consensus 110 GeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 110 GELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred ccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence 99999998765 4889999999999999999999 5799999999999999 7888999999999986533
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....||+.|||||++.+..|+..+|.||+||++|||++|.+||.+. +..++...+.......
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~~----- 244 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLPL----- 244 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCCC-----
Confidence 3 2236889999999999999999999999999999999999999863 3445555544443110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCC
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPK 585 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 585 (604)
.+.-...+..+++.+.+..||++|..
T Consensus 245 ------~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 245 ------PPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ------CCccCCHHHHHHHHHHhccCHHHhcC
Confidence 00112335789999999999999963
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=315.88 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=199.3
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..+++|+|.||.||+|+ .++|+.||||+++... ........+|++.|+.++|+||+.++++|-..+...+|+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 45789999999999998 5789999999997442 23356789999999999999999999999999999999999976
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
||+..+++.. ..++..++..++.++++||+||| ++.|+||||||.|+|+ +.++.+||+|||+|+.+..
T Consensus 86 -dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 86 -DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGS 153 (318)
T ss_pred -cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEE---cCCCcEEeecccchhccCC
Confidence 9999998764 36899999999999999999999 5799999999999999 6667899999999999875
Q ss_pred CCCC----ccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hcCCcc-
Q 007427 478 RKAS----ENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DNDWST- 548 (604)
Q Consensus 478 ~~~~----~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 548 (604)
.... ..+..|+|||.+.+ ..|+...||||.|||+.||+-|.+-|.+... .+.+....+..- ++.|..
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHHHHcCCCCcccCccc
Confidence 4322 46789999998876 5699999999999999999999988776432 111111111110 111110
Q ss_pred -ccccHHhhh-------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 -DILDVEILA-------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 -~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.+.|..... ..........+.+++.+|+..||.+|++++|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111110000 00112234467999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.23 Aligned_cols=238 Identities=27% Similarity=0.433 Sum_probs=198.2
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 402 (604)
+.||.|+-|.||+|+++ ++.||||+++...+ .+++-|++|+|+||+.+.|+|....-++||||||..|-|++
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 68999999999999998 78999999865432 56888999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC---
Q 007427 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK--- 479 (604)
Q Consensus 403 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~--- 479 (604)
+|+..+ +++......|..+||.||.||| .+.|||||||.-||||+.+ -.+||+|||-++......
T Consensus 202 VLka~~-----~itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~---d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 202 VLKAGR-----PITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYD---DVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred HHhccC-----ccCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeecc---ceEEeccccchHhhhhhhhhh
Confidence 999765 5888899999999999999999 4799999999999999554 468999999988775543
Q ss_pred CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcc
Q 007427 480 ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAR 559 (604)
Q Consensus 480 ~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (604)
...+|..|||||++.....++|+||||||||||||+||..||.+...... ++.- ....+...
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----------IwGV-------GsNsL~Lp 331 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----------IWGV-------GSNSLHLP 331 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----------EEec-------cCCccccc
Confidence 44789999999999999999999999999999999999999986432110 0000 00011112
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 560 EGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 560 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+..++..++-|+++||+..|..||++++++..|+-..+
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 234556678899999999999999999999999975543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=346.96 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=204.9
Q ss_pred ccCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce
Q 007427 311 VFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK 388 (604)
Q Consensus 311 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 388 (604)
.+.++++. ..+.||+|+||+||+|++. -.||||+++... ....+.|++|+..+++-+|.||+-+.|||..+..
T Consensus 388 eIp~~ev~--l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVL--LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhh--ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34555554 4689999999999999986 359999997443 3345789999999999999999999999998877
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
.||+.+|+|-+|+.+++..+ ..++..+.+.||.|||+|+.||| .++|||||||..||++ .++.++||+|
T Consensus 463 AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl---~~~~kVkIgD 531 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFL---HEDLKVKIGD 531 (678)
T ss_pred eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEE---ccCCcEEEec
Confidence 99999999999999999765 25899999999999999999999 6899999999999999 6668999999
Q ss_pred ccCCCCCCC------CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 469 FGFLPLLPS------RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 469 FGla~~~~~------~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
||++..-.. .....+...|||||++. ...|++.+||||||+|+|||+||..||.....+. .+.
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--------Iif 603 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--------IIF 603 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--------eEE
Confidence 999854321 12335677999999986 3568999999999999999999999998422111 011
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
++-.+....+... ...++..++.+|+..||..++++||.+.+|+.+|+++...
T Consensus 604 mVGrG~l~pd~s~-------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVGRGYLMPDLSK-------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EecccccCccchh-------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111111111111 1234566799999999999999999999999999888663
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=338.27 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=208.3
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccchhh-HHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..++||+|.||+|.++....+..||||+++...... +++|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 578999999999999999888999999998655443 5899999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..+... .+.-....+|+.||+.||+||. +-++|||||.++|+|+ |.++++||+|||+++.+-...
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH----hhchhhccccccceee---cCcccEEecCcccccccccCC
Confidence 99999987521 1345566789999999999999 5699999999999999 888999999999999765544
Q ss_pred CCc------cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh--CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 480 ASE------NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT--GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 480 ~~~------~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
... -...|||+|.+.-++++++||||+|||++||+++ ...||.... .+...+-...+++..-....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQVV- 765 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCccee-
Confidence 332 2358999999999999999999999999999987 778887532 22233333333332211111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
...+.-++..+.+++.+||..|-++||+++++...|++..
T Consensus 766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1123345667889999999999999999999999988753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.49 Aligned_cols=241 Identities=24% Similarity=0.417 Sum_probs=203.8
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
-.+||+|+.|.||.|+ ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...++.|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3689999999999997 667899999999877666677889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+.+.... +++.++..|++++++||+||| .+||+|||||.+|||+ +.++.+||+|||++..+....
T Consensus 358 TDvVt~~~------~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 358 TDVVTKTR------MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred hhhhhccc------ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEe---ccCCcEEEeeeeeeeccccccC
Confidence 99998764 899999999999999999999 5799999999999999 555678999999998776543
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...||++|||||+.....|.+|.||||||++++||+-|.+||....+ +.. +..+...+ ..++.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrA-lyLIa~ng-~P~lk----- 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA-LYLIATNG-TPKLK----- 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHH-HHHHhhcC-CCCcC-----
Confidence 44789999999999999999999999999999999999999974221 111 22222222 12221
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||+.|+++|+++.|+++.
T Consensus 491 ---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 ---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 223445579999999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.07 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=196.4
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCC-ceEEE
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKE-EKLII 391 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~lv 391 (604)
..+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||++++++|...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 357899999999999973 235789999997532 23346789999999999 8999999999987654 57899
Q ss_pred EecCCCCCHHHHhhcccCC---------------------------------------------------------CCCC
Q 007427 392 YEFLPNGSLFDLLHESRGV---------------------------------------------------------GRIP 414 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 414 (604)
|||+++|+|.+++...... ...+
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999999754210 0134
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC------CCccccccC
Q 007427 415 LAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGR 488 (604)
Q Consensus 415 l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~ 488 (604)
+++.++..++.|+++||+||| +++|+||||||+|||+ +.+..+||+|||+++...... ...++..|+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 888999999999999999999 5799999999999999 556689999999998654321 112346799
Q ss_pred CCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHH
Q 007427 489 SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR 567 (604)
Q Consensus 489 aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 567 (604)
|||++.+..++.++|||||||++|||++ |..||.+.... ........... ... ........
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~-~~~----------~~~~~~~~ 305 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGT-RMR----------APENATPE 305 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCC-CCC----------CCCCCCHH
Confidence 9999999999999999999999999997 99998753211 11111111111 100 01123346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 568 LTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 568 l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.85 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=205.4
Q ss_pred hcccCcCCcceEEEEEecC--C--cE-EEEEEecc---cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLES--G--AV-VAVKRVKN---MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.++||+|+||+||+|++.. + .. ||||..+. ......++|.+|++++++++|||||++||++......++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 3899999999999998542 2 23 89999984 234456889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
+|+||+|.++|+...+ .++..++..++.+.|+||+||| +++++||||.++|+|+ +....+||+|||+++
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLY---SKKGVVKISDFGLSR 310 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHhee---cCCCeEEeCcccccc
Confidence 9999999999998753 4899999999999999999999 5899999999999999 665678999999987
Q ss_pred CCCCCCCC----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 474 LLPSRKAS----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 474 ~~~~~~~~----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.-...... .-...|+|||.+....|++++|||||||++||+++ |..||.+... .+....+...++..
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVKAKIVKNGYRM 382 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHHHHHHhcCccC
Confidence 76422221 23468999999999999999999999999999999 8889986432 22222232333332
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
... ...+..+..++.+||..||++||+|.++.+.|+.+....+
T Consensus 383 ~~~----------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 PIP----------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCC----------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 221 1234457788999999999999999999999999876654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=335.26 Aligned_cols=239 Identities=21% Similarity=0.288 Sum_probs=196.6
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccch---hhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.++.||+|+|++||+|+ ..+++.||||++.+... ...+-..+|-.+|.+| .||.|++|+-.|++....|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 46789999999999997 56799999999964321 1224467888899999 8999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.++|+... .+++.....++.+|+.||+||| ++|||||||||+|||+ |.++++||+|||-|+.+
T Consensus 157 ~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH----~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILL---DKDGHIKITDFGSAKIL 224 (604)
T ss_pred CCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeE---cCCCcEEEeeccccccC
Confidence 9999999999875 4899999999999999999999 6899999999999999 88899999999999887
Q ss_pred CCCC-----------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 476 PSRK-----------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 476 ~~~~-----------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
.+.. ...||..|.+||++.....+..+|||+||||+|+|+.|++||.+... .. ..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yl-iF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YL-IF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HH-HH
Confidence 5321 23578899999999999999999999999999999999999986421 11 11
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.++.-.+ ..++..++.+.+|+.+.|..||.+|++..+|-+
T Consensus 297 qkI~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111111 111122346789999999999999999977755
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=336.88 Aligned_cols=238 Identities=21% Similarity=0.364 Sum_probs=204.9
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..+.||+|+||.||||+ ..+.+.||+|.+.+.. ....+.+.+|++++++++|||||.++++|+...+.++|.||+.|
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 35679999999999997 5578999999996533 33456789999999999999999999999999999999999966
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+|+.++.... .++++++..|+.++..||.||| +++|+|||+||.|||+ +..+.+|++|||+|+.+..
T Consensus 86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMST 152 (808)
T ss_pred -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeee---cCCCceeechhhhhhhccc
Confidence 9999998765 4999999999999999999999 6899999999999999 7888999999999999876
Q ss_pred CCC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RKA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... ..|++.|||||...+..|+..+|.||+||++||+++|++||.. ..+...++.+..+....
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~~d~v~~----- 219 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSILKDPVKP----- 219 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHhcCCCCC-----
Confidence 543 3689999999999999999999999999999999999999974 24555566655443211
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+......+..++...|.+||.+|.+-.+++.
T Consensus 220 -------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 -------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234456889999999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=318.87 Aligned_cols=262 Identities=28% Similarity=0.435 Sum_probs=200.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCcccEEEEEecCC----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGK--LKHENLAKIVSFYYSKE----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 395 (604)
.++||+|+||.||+|++. ++.||||++... .++.|..|-++.+. ++|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 367999999999999987 599999999743 45778888888765 58999999999876555 889999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL-----HSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
+.|+|.+||..+. ++|....+|+..+++||+|||+.. |.++|+|||||++|||+ .+++++.|+|||
T Consensus 291 ~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 291 PKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred cCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9999999999874 999999999999999999999874 45679999999999999 677899999999
Q ss_pred CCCCCCCCC------CCccccccCCCCCCCCCCC-C-----ccchhHhHHHHHHHHHhCCCCCC-CCCCCC--------C
Q 007427 471 FLPLLPSRK------ASENLAIGRSPEFPEGKRL-T-----HKADVYCFGIILLEVITGRIPGN-GSPGNN--------E 529 (604)
Q Consensus 471 la~~~~~~~------~~~~~~~y~aPE~~~~~~~-s-----~ksDVwSfGvvl~elltg~~p~~-~~~~~~--------~ 529 (604)
+|..+.... ...||..|||||++++..- . .+.||||+|.|||||+++-.-++ +..+.. .
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998876443 2368999999999986432 2 36899999999999999654432 111100 0
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
....+.+.......+.....+.+.-. ....+..+++.+..||+.||+.|.|+.-|.+++.++....+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~-----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR-----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh-----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11112222222222222222222111 11345578999999999999999999999999998876554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=321.55 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=198.6
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||.|..++||+|+ .+.+..||||++.-.... +.+.+++|+..++.++||||++++..|..+...|+||.||.+|+
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 4789999999999998 567899999999744332 35789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
+.++++..-..+ +++..+..|++++++||.||| .+|.||||||+.|||| +.++.+||+|||.+..+...
T Consensus 111 ~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 111 LLDIIKTYYPDG---LEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred HHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEE---cCCCcEEEcCceeeeeecccC
Confidence 999999876433 899999999999999999999 4799999999999999 77788999999976544322
Q ss_pred -------CCCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 479 -------KASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 479 -------~~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
....+++.|+|||++.. ..|+.|+||||||++..||.+|..||....+. +.....+.+....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLqn~pp~- 251 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQNDPPT- 251 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcCCCCC-
Confidence 23468899999999653 56999999999999999999999999865431 1111112221110
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+...............+.+++..||+.||++|||++++++
T Consensus 252 -~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 -LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000011111233447899999999999999999999885
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.63 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=198.5
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEeccc----ch-hhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM----NA-LSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+|+.|. ..+|..||+|++... .. ...+.+.+|+.++++++ ||||+++++++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 5689999999999997 457899999977643 11 23456778999999999 99999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc-ceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI-YRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~-~~~kl~DFGla~ 473 (604)
+.+|+|.+++.... ++.+..+..++.|++.|++|+| ++||+||||||+|||+ +.+ .++||+|||++.
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 99999999999833 4888999999999999999999 5799999999999999 555 789999999999
Q ss_pred CCC-C---CCCCccccccCCCCCCCCCC-CC-ccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 474 LLP-S---RKASENLAIGRSPEFPEGKR-LT-HKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 474 ~~~-~---~~~~~~~~~y~aPE~~~~~~-~s-~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
... . .....|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||++. +.....+.+....+.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------NVPNLYRKIRKGEFK 241 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------cHHHHHHHHhcCCcc
Confidence 883 2 23457899999999999977 85 6899999999999999999999862 223333333322211
Q ss_pred -cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 548 -TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 548 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
...+. ..++.+++.+|+..||.+|+++.||+ .-.-++
T Consensus 242 ~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 242 IPSYLL------------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred CCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 11110 44688999999999999999999998 444443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.80 Aligned_cols=239 Identities=23% Similarity=0.424 Sum_probs=202.4
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
++.||+|+.|.|-+|+ ..+|+.+|||++.+.. ......+.+|+.+|+-+.|||++++|+++++..++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 5679999999999998 5689999999997542 22346688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|.|++++..+. ++++.++.+++.||+.|+.|+| ..+|+||||||+|+|+ |...++||+|||+|..-..
T Consensus 97 GELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 97 GELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVP 164 (786)
T ss_pred chhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhh---hcccCEeeeccceeecccC
Confidence 99999998765 5999999999999999999999 4699999999999999 5556699999999987665
Q ss_pred CC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...|.+.|.+||++.+..| ..++||||+|||||.|+||+.||++. ++......+..+.+..
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~M----- 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEM----- 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccC-----
Confidence 53 4578899999999999998 46999999999999999999999853 3444444433332211
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+.....++.+|+.+|+..||++|.|++||++.
T Consensus 232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12344568899999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.30 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=194.4
Q ss_pred hcccCcCCcceEEEEEecC-----------------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLES-----------------GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
.+.||+|+||.||+|.+++ +..||+|.++... .....++.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4689999999999997532 3479999987542 333567999999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGV--------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLK 449 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlk 449 (604)
..+..++||||+++|+|.+++...... ....+++.++.+++.|++.||+||| +++|+|||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~ivH~dlk 165 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFVHRDLA 165 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCccccCcc
Confidence 999999999999999999998653210 1124788999999999999999999 4799999999
Q ss_pred CCceEEeecCCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh--CCCCC
Q 007427 450 SSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT--GRIPG 521 (604)
Q Consensus 450 p~NILl~~~~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt--g~~p~ 521 (604)
|+|||+ +....+||+|||+++.+..... ...+..|+|||++....++.++|||||||++|||++ +..||
T Consensus 166 p~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 166 TRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred hhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999 5667899999999976543321 123567999999988889999999999999999997 55677
Q ss_pred CCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 522 NGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
..... ......+............. .....++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 243 ~~~~~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTD-----EQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCH-----HHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 64321 11222222211111000000 0011233468999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.70 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=196.4
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
..+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 468999999999999963 246689999997432 23456788999999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCC--------------------------------------------------------------
Q 007427 393 EFLPNGSLFDLLHESRGV-------------------------------------------------------------- 410 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 410 (604)
||+++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999754210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC--
Q 007427 411 --------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-- 480 (604)
Q Consensus 411 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~-- 480 (604)
....+++..+.+++.||++||+||| +++|+||||||+|||+ +....+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEE---ECCCcEEEecCccceeccCccccc
Confidence 1124789999999999999999999 4799999999999999 5556799999999976643321
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...+..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+.+. .........
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~----~~~~~~~~~----- 338 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKM----IKEGYRMLS----- 338 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHH----HHhCccCCC-----
Confidence 122346999999999999999999999999999998 88888653211 111111 111111100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
+.....++.+++.+||+.||++||++.||+++|++.
T Consensus 339 -----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 -----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.99 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=191.5
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 578999999997532 223356788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++.++..++.||+.||+||| ++||+||||||+|||+ +....+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccC
Confidence 9999987643 4899999999999999999999 5799999999999999 56678999999998754222
Q ss_pred ----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 ----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... ..............
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~------- 213 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIR------- 213 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCC-------
Confidence 12347889999999999999999999999999999999999997531 11111212111110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.+......+.+++.+||+.||++|| ++.++++
T Consensus 214 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0112234688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=318.47 Aligned_cols=246 Identities=21% Similarity=0.377 Sum_probs=196.3
Q ss_pred hhcccCcCCcceEEEEEec----CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
..+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+++++||||+++++++...+..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 3578999999999999753 46789999997543 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++.+++.++.|++.||+||| +++++||||||+||++ +.+..+|++|||.+...
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 9999999997643 24899999999999999999999 4799999999999999 56678999999987654
Q ss_pred CCCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 476 PSRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 476 ~~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
.... ...++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .+...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~-~~~~~~ 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAVE-DGFRLP 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH-CCCCCC
Confidence 3221 1123457999999999999999999999999999875 9999875321 11222211 111110
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.....+..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 229 ----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122344688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=335.04 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=196.6
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
..+.||+|+||.||+|+. .++..||+|+++... ......+.+|+++++.+ +|+||++++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 467899999999999873 234589999997532 23346688999999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccC---------------------------------------------------------------
Q 007427 393 EFLPNGSLFDLLHESRG--------------------------------------------------------------- 409 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~--------------------------------------------------------------- 409 (604)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999865321
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC------C
Q 007427 410 --VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------S 481 (604)
Q Consensus 410 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~------~ 481 (604)
....++++.++.+++.|++.||+||| +++|+||||||+|||+ ++...+||+|||+++....... .
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01134788999999999999999999 5799999999999999 5566899999999876543321 1
Q ss_pred ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhccc
Q 007427 482 ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAARE 560 (604)
Q Consensus 482 ~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (604)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+. ...........
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~~~~----~~~~~~~~~~~---------- 336 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----SKFY----KMVKRGYQMSR---------- 336 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----HHHH----HHHHcccCccC----------
Confidence 23356999999998899999999999999999997 99998753211 1111 11111111100
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 561 GQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 561 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
....+.++.+++.+||+.||++||++.+|+++|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0012346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.23 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=201.7
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~ 395 (604)
.+.+|+|||+-||+++ ..++..||+|++.-....+.+..++|++..++++|||+++++++...+. +.|++++|.
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 4689999999999998 6789999999998666667788999999999999999999999875433 489999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
..|+|.+.+......+ ..+++.+.+.|+.++++||++||+. ...++||||||.|||+ .+...+++.|||.+...
T Consensus 106 ~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILl---s~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILL---SDSGLPVLMDLGSATQA 179 (302)
T ss_pred ccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEe---cCCCceEEEeccCcccc
Confidence 9999999998766433 3589999999999999999999975 3369999999999999 55678999999998765
Q ss_pred CCCC-------------CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 476 PSRK-------------ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 476 ~~~~-------------~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
+-.. ....+..|+|||.+. +...++++|||||||+||+|+.|..||+..... +..+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---GgSla---- 252 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---GGSLA---- 252 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---CCeEE----
Confidence 4221 124577999999886 456789999999999999999999999753221 11110
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
-.+....+... .....++.+.++++.|++.||.+||++.+++..++.+.
T Consensus 253 --------LAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111111111 11125567999999999999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=327.82 Aligned_cols=234 Identities=18% Similarity=0.254 Sum_probs=189.1
Q ss_pred cCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||.||+|+.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999854 6889999999643 222345678899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC
Confidence 99997643 4899999999999999999999 4799999999999999 666789999999987643222
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+...........
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~~--------- 211 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPLR--------- 211 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCC---------
Confidence 2347889999999999999999999999999999999999997531 22222222222110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCH---HHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKM---SEVL 590 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl 590 (604)
.+......+.+++.+||+.||++||++ .|++
T Consensus 212 ---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 212 ---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred ---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 011223467899999999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=322.55 Aligned_cols=244 Identities=17% Similarity=0.226 Sum_probs=193.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 36799999999999985 579999999986432 12234678999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+|||+ ++...+||+|||++.....
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCC
Confidence 99998886533 224899999999999999999999 5799999999999999 6667899999999977643
Q ss_pred CC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+........ .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-~------ 222 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ-E------ 222 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc-c------
Confidence 32 235688999999999999999999999999999999999999864321 11111111111100 0
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.........+.+|+.+||+.||++||+ ++++++
T Consensus 223 ----~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 ----EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ----cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011123346889999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.30 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=210.2
Q ss_pred hhcccCcCCcceEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
...+||.|.||.||.|.|+. .-.||||.++.+. ...++|.+|+.+|+.++|||+|+++|+|......|||+|||.+|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 45789999999999998764 5689999998654 457899999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+||++.. +..++.-..+.++.||+.||+||. .+++|||||.++|+|+ +++-.+|++|||+++++....
T Consensus 350 LLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 350 LLDYLRECN---RSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred HHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHH----Hhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc
Confidence 999999865 334777778899999999999999 5799999999999999 888899999999999997655
Q ss_pred CCc-----cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 480 ASE-----NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 480 ~~~-----~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... -...|.|||.+....++.|+|||+|||+|||+.| |..||.+.. +. .+..+++.++..+
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lS-qVY~LLEkgyRM~---- 486 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LS-QVYGLLEKGYRMD---- 486 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HH-HHHHHHhcccccc----
Confidence 332 2347889999999999999999999999999999 999998742 22 2334444444332
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.++.|++.+.+|++.||+++|.+||+++|+-+.++.+-
T Consensus 487 ------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 ------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 23457778999999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.35 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=197.6
Q ss_pred hcccCcCCcceEEEEEecC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLES------GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|.... ...||+|.++... ......+.+|++++.+++||||+++++++...+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 5789999999999998532 2579999987433 23356789999999999999999999999998999999999
Q ss_pred CCCCCHHHHhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 395 LPNGSLFDLLHESRGVG-----------RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
+++|+|.+++....... ...+++.++..++.|++.||+||| +++++||||||+||++ ++...
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~---~~~~~ 162 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLV---GEGLT 162 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEE---cCCCc
Confidence 99999999997643211 135889999999999999999999 4799999999999999 56678
Q ss_pred EEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhH
Q 007427 464 AKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 536 (604)
+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------QE 234 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 9999999987653322 1233567999999988899999999999999999998 9999875321 11
Q ss_pred HHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
....+.... ... .....+.++.+|+.+||+.||++||+++||++.|+++
T Consensus 235 ~~~~i~~~~-~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQ-LLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCC-cCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 122111111 111 1123445789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.31 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=195.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+++.+++..+|+|.++... ....++.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 46799999999999998888899999986432 33567899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
++++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||.++.......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee
Confidence 99875432 4889999999999999999999 4799999999999999 6667899999999876543221
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
......|+|||+..+..++.++||||||+++|||++ |+.||.... ..+............ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~~~---~--- 222 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFRLY---R--- 222 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCCC---C---
Confidence 123347999999998889999999999999999999 899986432 122222222211110 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
+......+.+++.+||+.+|++||++.|+++.|
T Consensus 223 -----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011223688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.04 Aligned_cols=191 Identities=26% Similarity=0.373 Sum_probs=166.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+++.. +|..||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 467999999999999854 6889999998753 23345679999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||+ +....+||+|||+++......
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEE---cCCCcEEEccCcccccccccc
Confidence 999997643 48899999999999999999995 2479999999999999 555679999999987664332
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
...++..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 23577899999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=315.34 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=190.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~ 395 (604)
.+++|.|+||.||+|.. .+++.||||++..... --.+|+++|+++.|||||++.-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 47899999999999985 4579999999965432 2347999999999999999999886533 235899999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+. +|.++++.... .+..++.-.+.-+..||.+||+||| +.||+||||||+|+|++.+ .+.+||||||.|+.+
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~--tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPD--TGVLKICDFGSAKVL 176 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCC--CCeEEeccCCcceee
Confidence 87 99999986321 1224777788899999999999999 4799999999999999533 478999999999998
Q ss_pred CCCCCC---ccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC-----
Q 007427 476 PSRKAS---ENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW----- 546 (604)
Q Consensus 476 ~~~~~~---~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 546 (604)
...... ..+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+... ...+...++.+-....
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHHHHhCCCCHHHHhh
Confidence 765543 45789999999886 5699999999999999999999999987532 2223322221111000
Q ss_pred --c--cccccHHhhhcc----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 --S--TDILDVEILAAR----EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 --~--~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .+...+.+.... .......+..+++.+++.++|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 011111111111 12234457899999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=302.80 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=193.1
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
-+.|++|+||.||+|+ .++++.||+|+++... ..-.-...+|+.+|.+++|||||.+-.+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 4789999999999998 4578999999997432 2223457899999999999999999988764 457999999998
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
. ||..++..-. .++...++..++.|+++|++||| .+.|+||||||+|+|+ .+.+.+||+|||+|+.+.
T Consensus 161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG 228 (419)
T ss_pred h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence 7 9999998754 36899999999999999999999 5799999999999999 677789999999999987
Q ss_pred CCC----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hcCCcc
Q 007427 477 SRK----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DNDWST 548 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 548 (604)
... ...-|..|+|||.+.+ ..|++..|+||+|||+.||+++++.|.+.... ..+....+..- +..|..
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~----dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI----DQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH----HHHHHHHHHhCCCccccCCC
Confidence 653 2245779999999886 45999999999999999999999999875321 11111111110 011110
Q ss_pred ccccH---HhhhcccC----------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDV---EILAAREG----------QNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~---~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...-+ .......+ ......-.+|+...+..||.+|.|+.|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 00000000 002245679999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=308.59 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=194.3
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEEEEec-----CCceEEEEec
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-----KEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~ 394 (604)
+.||+|+||.|+.+. ..+|+.||||++.. .+....++..+|+++|+.++|+||+.+.+++.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 679999999999997 46799999999973 345566888999999999999999999999865 3478999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
| ..||.+.++.+. .++......+++|+++||+|+| +.+|+||||||+|+++ +.+...||+|||+|+.
T Consensus 108 M-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLL---NADCDLKICDFGLARY 174 (359)
T ss_pred H-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhh----cccccccccchhheee---ccCCCEEeccccceee
Confidence 9 559999998765 4899999999999999999999 5799999999999999 6667789999999999
Q ss_pred CCCC------CCCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-----------CCchh-
Q 007427 475 LPSR------KASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET-----------SGDLS- 535 (604)
Q Consensus 475 ~~~~------~~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-----------~~~~~- 535 (604)
.... .....|..|+|||.+. ...|+.+.||||.|||+.||++|++.|.+....... ...+.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 8532 2235678999999876 467999999999999999999999999875421100 00000
Q ss_pred ---HHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 536 ---DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 536 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+.++..+........... ....+......++|+.+||..||.+|+|++|+++.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f----~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPF----SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCH----HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111111000000000 00011234568899999999999999999999863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.44 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=203.8
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEec--ccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..+.||+|.|+.||++. ..+|+.+|+|++. +....+.+++.+|+.+.+.|+||||+++.+.+.+....|+|+|+|+|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 34679999999999996 5689999999885 33444678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|..-+-... -+++..+-.++.||+.+|.|+| .++|||||+||+|+++.+.+..--+||+|||+|..+..
T Consensus 95 ~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 95 GELFEDIVARE-----FYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred hHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99977655432 3788888999999999999999 68999999999999998888778899999999988875
Q ss_pred CCCC---ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKAS---ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~---~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.... .++++|+|||+....+|+..+|||+.|||||-|+.|..||.+.. -......+....+...
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd~~----- 232 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYDYP----- 232 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccCCC-----
Confidence 5433 68999999999999999999999999999999999999998632 1222333333222111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+.....++..+|+.+||..||.+|.|+.|.++
T Consensus 233 ---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 ---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1123344557889999999999999999998875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.28 Aligned_cols=243 Identities=31% Similarity=0.525 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEec-----CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-----SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 367999999999999876 36789999997533 334688999999999999999999999999888899999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ...+++.++..|+.||++||+|||+ ++++|+||+++||++ +....+||+|||+++..
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~----~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS----NNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH----TTEEEST-SGGGEEE---ETTTEEEEESTTTGEET
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc----ccccccccccccccc---ccccccccccccccccc
Confidence 9999999999862 2258999999999999999999994 699999999999999 55678999999998776
Q ss_pred CCC------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSR------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
... ........|+|||.+....++.++||||||+++|||+| |+.||... ...+......+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~-~ 224 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQR-L 224 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEE-T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccccc-c
Confidence 321 12234568899999988889999999999999999999 77887642 12223333322211 1
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.. .......+.+++.+||+.||++||++.++++.|
T Consensus 225 ~~----------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PI----------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS----------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ee----------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 112234688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.16 Aligned_cols=237 Identities=19% Similarity=0.244 Sum_probs=190.6
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 578999999997532 223356778999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCC
Confidence 9999887643 4899999999999999999999 5799999999999999 56668999999998754222
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .............
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~~~------- 213 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIR------- 213 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCC-------
Confidence 1 23477899999999999999999999999999999999999975321 1111111111110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.+......+.+++.+||+.||++|| ++.++++
T Consensus 214 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0112234678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=310.63 Aligned_cols=239 Identities=23% Similarity=0.413 Sum_probs=203.6
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhH---HHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
..+.||+|.||.|-+|. ...|+.||||.+++....+. -.+++|+++|+.|+||||+.+|.+|+..+...|||||..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence 45789999999999997 57899999999986544433 457899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|.|++|+.+.+ .+++.+...++.||..|+.|+| .++++|||||.+|||+ |++.++||+|||++.++.
T Consensus 137 ~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILL---D~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 137 GGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYA 204 (668)
T ss_pred CccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh----hccceecccchhheee---cCCCCeeeeccchhhhhc
Confidence 999999999865 4999999999999999999999 5799999999999999 777889999999998887
Q ss_pred CCC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SRK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
... ...+.+.|.+||+..+..| .+.+|-||+||+||-|+.|..||++. +....++.+..+.+...
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~GaYrEP--- 273 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGAYREP--- 273 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcccccCC---
Confidence 664 3468899999999999888 56899999999999999999999874 34445555544433221
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+.+....-||.+||..+|++|-|+.+|...
T Consensus 274 ----------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ----------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 112245679999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=298.55 Aligned_cols=238 Identities=19% Similarity=0.287 Sum_probs=197.7
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEe-cCCcEEEEEEecccchhh---HHHHHHHHHHHccCCCCCcccEEEEEecCCc
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALS---KKEFVQQMQLLGKLKHENLAKIVSFYYSKEE 387 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 387 (604)
+.++|.. ....||.|+||.|.+++. .+|..+|+|++++..... .+...+|..+|+.+.||.++++++.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 4455553 347899999999999984 568999999997644332 3456789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.+|||||.+||.|+.+++..+ .+++..+.-+|.||+.||+||| +.+|++|||||+|||+ |..+.+||+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLl---D~~G~iKit 186 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLL---DQNGHIKIT 186 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeee---ccCCcEEEE
Confidence 999999999999999999865 4899999999999999999999 6899999999999999 777789999
Q ss_pred eccCCCCCCCCCC-CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 468 NFGFLPLLPSRKA-SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 468 DFGla~~~~~~~~-~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
|||+|+.+..... -.||+.|+|||++....++.++|.|||||++|||+.|.+||..... .+....+.....
T Consensus 187 DFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v 258 (355)
T KOG0616|consen 187 DFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKV 258 (355)
T ss_pred eccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcc
Confidence 9999999877643 3799999999999999999999999999999999999999986432 222333333321
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCC
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKR 583 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 583 (604)
. .+.-....+.+|+...++.|-.+|
T Consensus 259 ~------------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 K------------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c------------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 111223357899999999999988
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=323.13 Aligned_cols=239 Identities=20% Similarity=0.251 Sum_probs=193.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 468999999999999854 68999999986432 12345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +....+||+|||+++....
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccC
Confidence 99999997653 4889999999999999999999 5799999999999999 5566899999999987654
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..............
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~--------- 216 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGKLE--------- 216 (291)
T ss_pred CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcC---------
Confidence 32 2357889999999999889999999999999999999999997532 11222222221110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 592 (604)
.+......+.+++.+||+.||.+||+ +.|+++.
T Consensus 217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00112335789999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=339.66 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=202.4
Q ss_pred hhcccCcCCcceEEEEEecCC-cEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEE-ec------CCceEEE
Q 007427 321 SAEVLGKGKVGSTYKATLESG-AVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFY-YS------KEEKLII 391 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~~~~~lv 391 (604)
..+.|.+|||+.||+|+...+ ..||+|++-..++..-+...+|+++|++|+ |+|||.+++.. .. .-+.+|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 357899999999999997655 999999997667777888999999999996 99999999932 21 1257899
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||||.+|.|-++|...... .|++.++++|+.|+++|+++||.. ...|||||||-+|||| ..+...||||||.
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLl---s~~g~~KLCDFGS 192 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLL---SADGNYKLCDFGS 192 (738)
T ss_pred hhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEE---cCCCCEEeCcccc
Confidence 9999999999999865432 399999999999999999999976 5789999999999999 5556789999998
Q ss_pred CCCCCCCC-------------CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchh
Q 007427 472 LPLLPSRK-------------ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLS 535 (604)
Q Consensus 472 a~~~~~~~-------------~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~ 535 (604)
|....... ....|+.|+|||.+. +..+++|+||||+||+||-|+....||+......
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 75432211 124688999999764 6778999999999999999999999998642111
Q ss_pred HHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 536 DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
++...+.. +..+.....+.+||..||+.||++||++.+|+..+.++++..
T Consensus 266 -----Ilng~Y~~----------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 -----ILNGNYSF----------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----EEeccccC----------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11111111 112356668999999999999999999999999999987654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.72 Aligned_cols=238 Identities=21% Similarity=0.264 Sum_probs=191.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 568999999997532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||+ +....+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCc
Confidence 9999887643 4899999999999999999999 5799999999999999 66678999999998764322
Q ss_pred ----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 ----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~~~~------- 213 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEDIK------- 213 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccCCcc-------
Confidence 12347889999999999999999999999999999999999997531 11222221111100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 592 (604)
.+......+.+++.+||+.||++|| ++.|+++.
T Consensus 214 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 -----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0111234578999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.22 Aligned_cols=246 Identities=17% Similarity=0.238 Sum_probs=191.7
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
++||+|+||.||+|+. .+++.||+|+++... ....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999985 468999999997532 22335678899999888 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEE---CCCCCEEECcCcccccccc
Confidence 99999887543 4899999999999999999999 5799999999999999 6667899999999875321
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||+||+.||..............++...........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----
Confidence 1 1235678999999999999999999999999999999999999753322211222222322222211100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPK------MSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 591 (604)
.+......+.+++.+||+.||.+||+ +.|+++
T Consensus 224 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 ------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01112345889999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.59 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=202.0
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 468999999999999742 35679999998666555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 396 PNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 396 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
++++|.+++..... .....+++..++.++.|++.||+||| +++|+||||||+||++ +.+..+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~---~~~~~~ 162 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLV---GANLLV 162 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEE---ccCCcE
Confidence 99999999976431 11224899999999999999999999 5799999999999999 666789
Q ss_pred EEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHH
Q 007427 465 KLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 465 kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 537 (604)
||+|||+++...... ...++..|+|||+..+..++.++|||||||++|||+| |+.||..... .+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~ 234 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------TEV 234 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 999999987654322 1233567999999999999999999999999999999 9999865321 111
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........ .... ....+..+.+++.+||+.||++||++.+|+++|+++.+.
T Consensus 235 ~~~~~~~~-~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGR-VLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCC-CCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111111 1110 112234688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.66 Aligned_cols=238 Identities=21% Similarity=0.274 Sum_probs=192.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 478999999999999864 68999999997432 12345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence 99999998643 4788999999999999999999 5799999999999999 6667899999999987654
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...++..|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+............
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~~-------- 234 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILAGRLKF-------- 234 (329)
T ss_pred CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcCCcCC--------
Confidence 33 2357889999999999999999999999999999999999997532 112222222211100
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
+......+.+++.+||+.||.+||+ +.|+++
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0012235789999999999999997 566653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.52 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=198.3
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
..+.||+|+||.||+|+.. +++.||+|.++..... ..+.+.+|++++++++|+||+++++++......++|||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 3578999999999999853 3578999999764433 45789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 394 FLPNGSLFDLLHESRG---------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
|+++++|.+++..... .....+++.++..++.|++.||+||| +++++||||||+||++ +.+..+
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili---~~~~~~ 161 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLV---GYDLVV 161 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEE---cCCCeE
Confidence 9999999999976531 12234889999999999999999999 5799999999999999 666789
Q ss_pred EEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHH
Q 007427 465 KLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 465 kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 537 (604)
||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 999999987653322 1123457999999999999999999999999999999 9999865321 111
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
........ .... .......+.+++.+||+.||++||++.||++.|++
T Consensus 234 ~~~~~~~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGR-LLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCC-cCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22211111 1100 11233468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=316.26 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=201.6
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
..+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 357899999999999974 23567999999766555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 395 LPNGSLFDLLHESRG--------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
+++++|.+++..... .....+++.++..++.|++.||+||| ++|++||||||+||++ ++...+||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili---~~~~~~kl 161 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLV---GENLLVKI 161 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEE---ccCCcEEe
Confidence 999999999975431 11234899999999999999999999 4799999999999999 56678999
Q ss_pred eeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHH
Q 007427 467 TNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 467 ~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||..... .+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 9999987654322 1123457999999998899999999999999999999 8999865321 11112
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
....... ... .......+.+++.+||+.||.+|||+.|+.+.|+++...
T Consensus 234 ~i~~~~~-~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRV-LQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCc-CCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2211111 000 011234689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.93 Aligned_cols=241 Identities=17% Similarity=0.245 Sum_probs=188.0
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999985 46889999999753 222345577888888776 899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +.+..+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccC
Confidence 99999887543 4899999999999999999999 4799999999999999 6667899999999875422
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||+||+.||...............+.......... .
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~---- 223 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R---- 223 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C----
Confidence 1 123468899999999999999999999999999999999999964322222222222222222111110 0
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+......+.+++.+||+.||++||++
T Consensus 224 ------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 ------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 011223457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=311.81 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=198.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 47899999999999998888899999987533 23578899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
++++.... ..+++.++..++.|++.||+||| +++++||||||+||++ +....+||+|||+++.......
T Consensus 90 ~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 90 DFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEe---cCCCcEEECCCccceecCCCcee
Confidence 99976432 24888999999999999999999 4799999999999999 5667899999999987654321
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
..++..|+|||+.....++.++|||||||++|||+| |+.||..... .+..... .......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~-~~~~~~~------ 224 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSAL-QRGYRMP------ 224 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHH-HcCCCCC------
Confidence 123457999999988889999999999999999999 9999864311 1111111 1111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
........+.+++.+||+.+|++||+++++.+.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 ----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=314.62 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=188.5
Q ss_pred ccCcCCcceEEEEEecC-------------------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccE
Q 007427 324 VLGKGKVGSTYKATLES-------------------------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 378 (604)
.||+|+||.||+|.... ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999875544445678899999999999999999
Q ss_pred EEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 379 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
++++.+....++||||+++|+|..++.... ..+++..+..++.|+++||+||| +++|+||||||+|||++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEecc
Confidence 999999999999999999999999987543 24789999999999999999999 4799999999999999653
Q ss_pred C----CcceEEEeeccCCCCCCCCCCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHH-hCCCCCCCCCCCCCCCC
Q 007427 459 N----DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVI-TGRIPGNGSPGNNETSG 532 (604)
Q Consensus 459 ~----~~~~~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ell-tg~~p~~~~~~~~~~~~ 532 (604)
+ ....+|++|||.+..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS----- 228 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-----
Confidence 2 223589999999866554444456778999998865 56899999999999999994 699998753211
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
..... ....... .......+.+++.+||+.+|++||++.+|++.|
T Consensus 229 ~~~~~----~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKERF----YEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH----HHhccCC------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11111 1111000 001123588999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=310.32 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=202.5
Q ss_pred HhhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 320 ASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
...+.||+|+||.||+|...++..+|+|.++.........+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence 34678999999999999988899999999987655556789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... ..+++.++..++.|++.||+||| +++|+||||||+||++ +++..+||+|||.+.......
T Consensus 89 L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 89 LLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred HHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence 9999986532 34899999999999999999999 4799999999999999 666789999999987764332
Q ss_pred C----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 480 A----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 480 ~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+..|+|||......++.++||||||+++|||++ |+.||.... ..+....... .....
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~~~~----- 224 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITA-GYRMP----- 224 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHh-CCcCC-----
Confidence 1 123457999999988889999999999999999998 899986532 1111111111 11110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.....+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 -----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0112334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=322.60 Aligned_cols=192 Identities=26% Similarity=0.380 Sum_probs=166.5
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
..+.||+|+||.||++... ++..+|+|.++.. .......+.+|++++++++|+||++++++|...+..++||||+++|
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 3578999999999999864 6889999988753 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||.|||+ .++|+||||||+|||+ +....+||+|||++......
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 9999997643 47889999999999999999995 2579999999999999 55567999999998765432
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 223567899999999988899999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=310.63 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=198.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|.. +.++.||+|.++... ....++.+|++++++++|+||+++++++...+..+++|||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 46799999999999985 458899999987543 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ...+++..++.++.|++.||+||| +++++||||||+||++ ++...+||+|||+++.......
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEE---cCCCcEEeCCCcccccccccee
Confidence 99997643 224899999999999999999999 4799999999999999 5667899999999887654322
Q ss_pred C-----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 S-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 ~-----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ..+..|+|||...+..++.++|||||||++|||++ |..||.+.. ..+...... .......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~-~~~~~~~---- 226 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLE-KGYRMER---- 226 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHH-CCCCCCC----
Confidence 1 22457999999999999999999999999999998 899986531 122222211 1111110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
....+..+.+++.+||+.||++||++.+++++|+++
T Consensus 227 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 ------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=321.53 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=195.2
Q ss_pred ccCHHHHHHHhhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhh---HHHHHHHHHHHccCCCCCcccEEEEEecCC
Q 007427 311 VFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALS---KKEFVQQMQLLGKLKHENLAKIVSFYYSKE 386 (604)
Q Consensus 311 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 386 (604)
.+.++|.. +-..||+|+||+||+|+ ..+|..+|+|++++..... .+..+.|-.+|....+|.||+++-.|++.+
T Consensus 137 r~~~~DFe--~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFE--LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccch--hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 34444442 34789999999999997 5579999999998654333 345778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..||||||++|||+..+|.... .|++..+..++.+++.|+.-+|+ .|+|||||||+|+|| |..+++||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~----~gyIHRDIKPdNlLi---D~~GHiKL 282 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ----LGYIHRDIKPDNLLI---DAKGHIKL 282 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH----cCcccccCChhheee---cCCCCEee
Confidence 9999999999999999998765 59999999999999999999995 699999999999999 77789999
Q ss_pred eeccCCCCCCC-----------------------C-C---------------------------CCccccccCCCCCCCC
Q 007427 467 TNFGFLPLLPS-----------------------R-K---------------------------ASENLAIGRSPEFPEG 495 (604)
Q Consensus 467 ~DFGla~~~~~-----------------------~-~---------------------------~~~~~~~y~aPE~~~~ 495 (604)
+|||++.-+.. . . ...|++-|+|||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 99999843210 0 0 1146789999999999
Q ss_pred CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhc
Q 007427 496 KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALEC 575 (604)
Q Consensus 496 ~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 575 (604)
..|+..+|.||+|||+|||+.|.+||.+..+. .....+..|....... .......+..+||.+|
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRL 426 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHH
Confidence 99999999999999999999999999875431 2223333333222111 1112235688999999
Q ss_pred ccCCCCCCCC
Q 007427 576 TDIAPEKRPK 585 (604)
Q Consensus 576 l~~dP~~RPs 585 (604)
+. ||++|-.
T Consensus 427 l~-d~~~RLG 435 (550)
T KOG0605|consen 427 LC-DPENRLG 435 (550)
T ss_pred hc-CHHHhcC
Confidence 99 9999986
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.09 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=197.1
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 392 (604)
..++||+|+||.||+|+.. .+..||||+++... ....+.+.+|+++++++. ||||++++++|.+.+..++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 3578999999999999742 23479999997532 333567899999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCC--------------------------------------------------------------
Q 007427 393 EFLPNGSLFDLLHESRGV-------------------------------------------------------------- 410 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 410 (604)
||+++|+|.++++.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998754210
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 411 -----------------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 411 -----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
....+++.++..++.|+++||+||| +++|+||||||+|||+ +..
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill---~~~ 273 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLL---AQG 273 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEE---eCC
Confidence 0124788899999999999999999 4799999999999999 556
Q ss_pred ceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCch
Q 007427 462 YRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 534 (604)
..+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----~~~ 349 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----STF 349 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----HHH
Confidence 6899999999876543221 123457999999999899999999999999999997 99998753210 011
Q ss_pred hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
........... ........+.+++.+||+.||++||++.+|.++|+++.+
T Consensus 350 ----~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ----YNKIKSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ----HHHHhcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111110 011234468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=320.33 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=196.5
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+.||+|.||.||+|. ..+++.||+|++.-.. ....+++++|+.++.+++++||.++|+.+..+...+++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 689999999999998 4579999999997433 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+.++... .+++....-|++++..||.||| +++.+|||||+.|||+. ..+.+|++|||.+..+...
T Consensus 99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hhhhccCC-----CCccceeeeehHHHHHHhhhhh----hcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 99998654 3477778889999999999999 57999999999999994 4467899999998766543
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....+|+.|||||++....|+.|+||||+|++.+||.+|.+|+....+.. +...+.....+.
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------vlflIpk~~PP~------- 230 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------VLFLIPKSAPPR------- 230 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------EEEeccCCCCCc-------
Confidence 45579999999999999899999999999999999999999987643210 000111111111
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+++++..||+.||+.||++.++++.
T Consensus 231 ---L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 ---LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111344569999999999999999999999863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=290.04 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=202.5
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEE-ecCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE 387 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 387 (604)
.+++++ ..++.||+|.||.||.|+ .+++-.||+|++.+.. .....++.+|+++-+.|+||||+++|++|.+...
T Consensus 19 ~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 19 WTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 344444 247899999999999998 5578899999996532 2335789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.|+++||.+.|+++..|+..+. ..+++.....++.|+|.||.|+| .++|+||||||+|+|+ +.....||+
T Consensus 97 iyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLl---g~~~~lkiA 166 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLL---GSAGELKIA 166 (281)
T ss_pred eEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhcc---CCCCCeecc
Confidence 9999999999999999996553 24888888999999999999999 6899999999999999 666678999
Q ss_pred eccCCCCCCCC--CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 468 NFGFLPLLPSR--KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 468 DFGla~~~~~~--~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
|||.+..-+.. ....++..|.+||...+..++.++|+|++||+.||++.|.+||.... ..+-.+.+..-.
T Consensus 167 dfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~ 238 (281)
T KOG0580|consen 167 DFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVD 238 (281)
T ss_pred CCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHcc
Confidence 99998665433 34468899999999999999999999999999999999999998532 112222222211
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..+ +......+.++|.+|+..+|.+|.+..|+++.
T Consensus 239 ----~~~--------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 ----LKF--------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----ccC--------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 12233467899999999999999999998763
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.02 Aligned_cols=243 Identities=21% Similarity=0.374 Sum_probs=193.1
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 478999999886432 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||++ +....+||+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEE---cCCCcEEECccccCcccccccc
Confidence 99997532 24889999999999999999999 5799999999999999 5556799999999876543221
Q ss_pred C------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 481 S------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 481 ~------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. .....|+|||.+.+..++.++|||||||++|||++ |..||..... .. .............
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~~~~~~--- 217 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQGVRLPC--- 217 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcCCCCCC---
Confidence 1 11346999999998889999999999999999998 8888864211 11 1111111111110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
....+..+.+++.+||+.+|++||++.|++++|++
T Consensus 218 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 -------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.91 Aligned_cols=247 Identities=20% Similarity=0.231 Sum_probs=195.5
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++.+++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999865 58999999997432 12345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc
Confidence 99999997643 4889999999999999999999 4799999999999999 6667899999999987654
Q ss_pred C-CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 R-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~-~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+............. .+..
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~--~~~~- 222 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWKETLQ--RPVY- 222 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcccccc--CCCC-
Confidence 2 234578899999999999999999999999999999999999975321 111111111000000 0000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..........+.+++.+||..+|++||++.|+++.
T Consensus 223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=312.01 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=190.0
Q ss_pred cccCcCCcceEEEEEecC-------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceE
Q 007427 323 EVLGKGKVGSTYKATLES-------------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKL 389 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (604)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887654444567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC----cceEE
Q 007427 390 IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND----IYRAK 465 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~----~~~~k 465 (604)
+||||+++|+|..++.... ..+++..+..++.||++||+||| +++|+||||||+|||++.++. ...+|
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999887543 24899999999999999999999 579999999999999964332 12389
Q ss_pred EeeccCCCCCCCCCCCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHH-hCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 466 LTNFGFLPLLPSRKASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVI-TGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 466 l~DFGla~~~~~~~~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
++|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|+.||..... .+.. ....
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~-~~~~ 223 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEKE-RFYE 223 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHHH-HHHh
Confidence 99999987766555556777899999886 567899999999999999998 58888764211 1111 1111
Q ss_pred cCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.... .. ......+.+++.+||+.||++||++.+|++.+
T Consensus 224 ~~~~--~~----------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM--LV----------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc--CC----------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1100 00 01123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.27 Aligned_cols=237 Identities=19% Similarity=0.271 Sum_probs=189.9
Q ss_pred cccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 358899999997432 12235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++.... .+.+..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILL---DAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEE---CCCCCEEEeeCcCCee
Confidence 99999999997643 4788889999999999999999 5799999999999999 6667899999999875
Q ss_pred CCCCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 475 LPSRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 475 ~~~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||.... .............. +
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~~~--~ 219 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGKLN--L 219 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCC--C
Confidence 32221 2347789999999998889999999999999999999999997532 11222222222110 0
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.++++
T Consensus 220 ----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 ----------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011233578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.45 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=210.9
Q ss_pred CccCHHHHHHHhhcccCcCCcceEEEEEecC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 310 PVFDLDDLLRASAEVLGKGKVGSTYKATLES-----GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 310 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
+.+.+..-.....++||.|.||.||+|.+.+ .-.||||..+.. .....+.|..|..+|++++|||||+++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3455544444567899999999999997532 346899999864 3445688999999999999999999999997
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
+ ...|+|||.++-|.|..||+.++. .++......++.||+.||+||| ++.+|||||..+|||+. ..-.
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVs---Sp~C 529 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVS---SPQC 529 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeec---Ccce
Confidence 5 568999999999999999998653 4888999999999999999999 68999999999999994 4457
Q ss_pred EEEeeccCCCCCCCCCCCcc-----ccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHH
Q 007427 464 AKLTNFGFLPLLPSRKASEN-----LAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~~~~~-----~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 537 (604)
+||+|||+++.+.+...... ...|||||.+.-.+++.+||||-|||.+||++. |..||.+....+.. .
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~----- 603 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-G----- 603 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-E-----
Confidence 89999999999987665432 237899999999999999999999999999998 99999875432110 0
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.++.+. ..+.++.+++.+..|+.+||++||.+||.+.|+...|.++..
T Consensus 604 ---~iEnGe----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 ---HIENGE----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---EecCCC----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011110 112345677889999999999999999999999999998865
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.29 Aligned_cols=239 Identities=22% Similarity=0.349 Sum_probs=186.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 47899999999999985 468999999996432 2335678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+.. ...+..+..++.||+.||+||| +++|+||||||+|||+ +....+||+|||+++.+...
T Consensus 159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 159 LEGTH---------IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ccccc---------cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 86432 2566778899999999999999 4799999999999999 56678999999999876433
Q ss_pred ---CCCccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 ---KASENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
....++..|+|||++.. ...+.++|||||||++|||++|+.||.... ................ ..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~-~~- 295 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQP-PE- 295 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccCC-CC-
Confidence 23357889999998743 234568999999999999999999997321 1112211111111100 00
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......++.+++.+||+.||++||++.|+++.
T Consensus 296 ---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233468899999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=336.99 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=195.6
Q ss_pred hcccCcCCcceEEEEEec-C-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-S-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 478999999999999743 3 67889998765544445678889999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... ...++++..+..++.|++.||.||| +++|+||||||+|||+ +....+||+|||+++.+....
T Consensus 152 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 152 LNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred HHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCcc
Confidence 9998875421 2336889999999999999999999 4799999999999999 566789999999998764332
Q ss_pred ------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 480 ------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
...++..|+|||++.+..++.++|||||||++|||+||+.||.... ..+............
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~~----- 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKYDP----- 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC-----
Confidence 2247889999999999999999999999999999999999997531 122222222221110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++||++.+++.
T Consensus 291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00112346889999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.43 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=198.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 47899999999999998778899999997543 24577999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCCC
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~ 481 (604)
+++.... ...+++..+..++.|++.||.||| +++|+||||||+||++ +....+||+|||+++........
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCccc
Confidence 9997643 224899999999999999999999 4799999999999999 55667999999998776532211
Q ss_pred --c---cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 482 --E---NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 482 --~---~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ....|+|||+..+..++.++||||||+++|||+| |+.||.+... ...... ........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~-~~~~~~~~------ 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQ-VDQGYRMP------ 224 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcCCCCC------
Confidence 1 1246999999998899999999999999999999 9999865311 111111 11111100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
........+.+++.+||+.+|++||++.++++.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 ----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.28 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=198.1
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 468999999999999864 36789999887433 33346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 395 LPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+++++|.+++...... ....+++..+.+++.||+.||+||| +++++||||||+||+++.+++...+||+|||++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999765421 1225899999999999999999999 479999999999999976655567999999999
Q ss_pred CCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+.+..... ......|+|||++.+..++.++|||||||++|||++ |+.||..... .+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~~ 238 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEFVTGGG 238 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHcCC
Confidence 87643221 112357999999998899999999999999999997 9999875321 11222221111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.. . .....+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 239 ~~-~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 RL-D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC-C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 10 0 011223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.74 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=200.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||||.++.. .......+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999985 47899999988632 223345788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++..... ....+++..+..++.|++.||+||| +++++|+||||+||++ +....++|+|||++.....
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEE---cCCCCEEECccccceeccc
Confidence 999998865432 1234788999999999999999999 4799999999999999 5556799999999887654
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+............
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~---- 228 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYPPL---- 228 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCCCC----
Confidence 32 23466789999999888899999999999999999999999864211 12222222211111110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
........+.+++.+||+.+|++||++.+|++.++.++
T Consensus 229 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 ------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01123356889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.95 Aligned_cols=248 Identities=22% Similarity=0.399 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEec-CCc----EEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGA----VVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|++. ++. .||+|.++... ....+++.+|+.+++.++||||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 478999999999999853 343 48999987532 33457789999999999999999999998764 578999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++..... .+++..++.++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++..
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 91 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 99999999986532 4889999999999999999999 5799999999999999 56668999999999876
Q ss_pred CCCCCC------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~~------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...... ..+..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..+.. .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEIS-SILEKGERL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHH-HHHhCCCCC
Confidence 543221 22457999999999999999999999999999998 999987532 11111 111111110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. ....+...+.+++.+||+.||++||++.+++..|..+....
T Consensus 231 ~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 01112345789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=313.71 Aligned_cols=243 Identities=16% Similarity=0.230 Sum_probs=189.9
Q ss_pred cCcCCcceEEEEEe-cCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||+||++.. .+++.||+|.+...... ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 47899999998643221 235677899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++..... ....+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||++..+....
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc
Confidence 988864321 1235899999999999999999999 4799999999999999 556679999999987654432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~---------- 218 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILNDSV---------- 218 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcccCC----------
Confidence 235678999999999999999999999999999999999999753211 011111111111100
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.........+.+++.+||+.||++|| ++.++++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 --TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00112344688999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.84 Aligned_cols=251 Identities=18% Similarity=0.222 Sum_probs=188.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+||+. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 46899999999999985 578999999753 2456789999999999999999999999999999999994 699
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+++.... .+++..++.++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++.....
T Consensus 170 ~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 170 YCYLAAKR-----NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccccc
Confidence 99887643 4889999999999999999999 4799999999999999 56667999999999754321
Q ss_pred ---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC---CchhHHHHHHHh--cCCccc-
Q 007427 479 ---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS---GDLSDWVRMVVD--NDWSTD- 549 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~- 549 (604)
....++..|+|||++.+..++.++|||||||++|||+||+.||.......... ..+...+..... ..+...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 12357889999999999999999999999999999999998876432211110 011111110000 000000
Q ss_pred --cccHHh----h------h----cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 550 --ILDVEI----L------A----AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 550 --~~~~~~----~------~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+... . . ..........+.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0 0 0000123457889999999999999999999985
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=315.97 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=194.9
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||+||++.. .+++.||+|.++... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 36899999999988653 367899999997543 23456788999999999999999999988654 35789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++... .+++.++..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++
T Consensus 89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 99999999999754 3899999999999999999999 4799999999999999 556689999999998
Q ss_pred CCCCCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
....... ..+...|+|||......++.++||||||+++|||+||+.||........ ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~ 232 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMTVVR 232 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccchhh
Confidence 7654321 1234568999999888899999999999999999999999865321100 00000000000000
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
..+..+... ........+..+.+++.+||+.||++|||++++++.|+++++
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 233 LIELLERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhhhhhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 000000000 000112234578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.23 Aligned_cols=244 Identities=18% Similarity=0.243 Sum_probs=190.9
Q ss_pred cCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||.||+++. .+|+.||+|.+.... ....+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 469999999986421 11234566799999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +....+||+|||++.......
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce
Confidence 99886543 234889999999999999999999 4799999999999999 666789999999987665432
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... ....+............
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~--------- 217 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLEDEVKF--------- 217 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhcccccc---------
Confidence 235678999999999888999999999999999999999998753211 01111122211111000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.......++.+++.+||+.||++||+++|+++.+
T Consensus 218 --~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 --EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0012234688999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.80 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=204.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc-eEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE-KLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~~ 397 (604)
.+++|+|+||.++.++. .+++.|++|.+.-. ....++...+|+.++++++|||||.+.+.|.+++. .+|||+|++|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 47899999999999974 46889999999633 33445678999999999999999999999999998 8999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|++.+.+...++ ..++++++..++.|++.|+.||| ++.|+|||||++||+++++ ..+||+|||+|+.+..
T Consensus 89 g~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~---~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 89 GDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKD---KKVKLGDFGLAKILNP 158 (426)
T ss_pred CCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhcccc---CceeecchhhhhhcCC
Confidence 999999998762 35899999999999999999999 4799999999999999544 4569999999999877
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...+|+.|+.||.+.+..|..|+||||+||++|||++-+++|... ++...+..+......
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------~m~~Li~ki~~~~~~------ 224 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------NMSELILKINRGLYS------ 224 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------chHHHHHHHhhccCC------
Confidence 64 346899999999999999999999999999999999999999853 333444333333211
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..+.....++..++..|++.+|..||++.+++.+
T Consensus 225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123345578999999999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.77 Aligned_cols=245 Identities=24% Similarity=0.430 Sum_probs=196.8
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|++. +...||+|.++... .....++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 578999999999999864 24689999987533 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++....+ .+++.++.+++.|++.||+||| +++|+||||||+||++ +....+||+|||+++...
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 89 NGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999976542 5899999999999999999999 4799999999999999 566789999999998775
Q ss_pred CCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 477 SRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 477 ~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
.... ...+..|+|||...+..++.++||||||+++|||++ |..||.... ..+...... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~~ 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVE-DGYRLP 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHH-cCCCCC
Confidence 2111 123457999999998899999999999999999998 999986421 111111111 111110
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.....+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 229 ----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=306.64 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=196.7
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCC-cccEEEEEecCC------ceEEEE
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHEN-LAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv~ 392 (604)
++||+|+||+||+|+ ..+|+.||+|++.-.. +.......+|+.++++++|+| |+.+++++...+ ..++||
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 569999999999998 5679999999997433 234567889999999999999 999999998877 788999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||++. +|..++....... ..++...+..++.||++||+||| +++|+||||||+|||+ ++.+.+||+|||+|
T Consensus 97 e~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLI---SSSGVLKLADFGLA 167 (323)
T ss_pred Eeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEE---CCCCcEeeeccchH
Confidence 99955 9999998765321 23677889999999999999999 6899999999999999 56778899999999
Q ss_pred CCCCCCC----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hc
Q 007427 473 PLLPSRK----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DN 544 (604)
Q Consensus 473 ~~~~~~~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 544 (604)
+...-.. ....|..|+|||++.+. .|++..||||+|||+.||++++..|.+... ...+....+..- +.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCCcc
Confidence 8765222 23467789999999876 799999999999999999999999987532 111111111100 11
Q ss_pred CCccccc--cHH--hhhcc-------cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhh
Q 007427 545 DWSTDIL--DVE--ILAAR-------EGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEI 596 (604)
Q Consensus 545 ~~~~~~~--~~~--~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 596 (604)
.|..... +.. ..... ..+.......+++.+|++.+|.+|.|+..++++ +.++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1211110 000 00000 000111367899999999999999999999886 5544
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.02 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=190.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 578999999997532 223456778999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ .++|+||||||+|||+ +.+..+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCC
Confidence 9999887643 48999999999999999999994 1699999999999999 66678999999998753321
Q ss_pred ----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 ----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... ..............
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~~~~------- 214 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIR------- 214 (325)
T ss_pred CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcCCCC-------
Confidence 12347889999999999999999999999999999999999997532 11122221111100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.+......+.+++.+||+.||++|+ ++.++++
T Consensus 215 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 -----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0011234578999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.84 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=195.3
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 394 (604)
.+.||+|+||.||++.. .++..||+|+++.......+.+.+|++++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 46899999999999974 35889999999866555567899999999999999999999987543 467899999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++.... ..+++..+..++.|++.||+||| .+||+||||||+||++ +.+..+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 89 LPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILV---ESENRVKIGDFGLTKV 157 (284)
T ss_pred cCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEE---CCCCeEEECCCccccc
Confidence 99999999997543 24899999999999999999999 4799999999999999 5667899999999987
Q ss_pred CCCCCCC-------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCC-------CCCCchhHHHHH
Q 007427 475 LPSRKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN-------ETSGDLSDWVRM 540 (604)
Q Consensus 475 ~~~~~~~-------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~-------~~~~~~~~~~~~ 540 (604)
....... .....|+|||+..+..++.++|||||||++|||++|..|+....... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 6543221 12345899999998889999999999999999999887754321100 000000000011
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
........ .........+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 238 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNNGRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11110000 001123346889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=315.83 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=190.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999864 68899999997432 223467889999999999999999999999999999999999987
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
.+..+.... ..+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++.....
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 86 MLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccc
Confidence 776554322 24889999999999999999999 4799999999999999 55668999999999876432
Q ss_pred C-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC-------CchhHHHHHHHhcCC
Q 007427 479 K-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS-------GDLSDWVRMVVDNDW 546 (604)
Q Consensus 479 ~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 546 (604)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+........ ...............
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 2246778999999998889999999999999999999999997532110000 000000000000000
Q ss_pred ccccccHHh-----hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEI-----LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+.. ............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 000000113446899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.49 Aligned_cols=241 Identities=22% Similarity=0.370 Sum_probs=191.7
Q ss_pred ccCcCCcceEEEEEe---cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 324 VLGKGKVGSTYKATL---ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357899999986432 233567899999999999999999999875 45678999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++.+...
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEE---cCCCeEEECCCccccccCCC
Confidence 9999997543 4889999999999999999999 4799999999999999 55678999999999876543
Q ss_pred CC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 KA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.. ...+..|+|||......++.++|||||||++|||+| |+.||..... .+...... .......
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~-~~~~~~~ 219 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIE-SGERMEC 219 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-CCCCCCC
Confidence 21 112357999999988889999999999999999998 9999875311 12222221 1111111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
+...+.++.+++.+||+.||++||++++|.+.|++.
T Consensus 220 ----------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 ----------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112334688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.16 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 46899999999999985 468999999987432 2234567899999999999999999999999889999999997 49
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+|||+ +.+..+||+|||+++......
T Consensus 89 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 89 LKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999887543 24788999999999999999999 5799999999999999 666689999999987653222
Q ss_pred ----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC---ccccc
Q 007427 480 ----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW---STDIL 551 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 551 (604)
...++..|+|||.+.+ ..++.++||||+||++|||+||+.||.+.... ..+.... ....... ...+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLIF-RLLGTPTEETWPGIT 232 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-HHhCCCChHHhhccc
Confidence 2345778999998865 56899999999999999999999999754211 1111111 0000000 00000
Q ss_pred ---------cHHhhhc---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 ---------DVEILAA---REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ---------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+..... ........++.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.55 Aligned_cols=194 Identities=28% Similarity=0.435 Sum_probs=169.7
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-C-----CCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-H-----ENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.++||+|+||.|.+|. .++++.||||++++... ...+...|+.+|..++ | -|+|+++++|...++.|||+|.
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 4789999999999997 56799999999986543 3456678999999986 3 5899999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++. +|+++++.++-. .++...+..++.||+.||.+||+ .+|||+||||+||||...+.. .+||+|||.|..
T Consensus 270 L~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~----l~IIHcDLKPENILL~~~~r~-~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 270 LST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHE----LGIIHCDLKPENILLKDPKRS-RIKVIDFGSSCF 340 (586)
T ss_pred hhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCChhheeeccCCcC-ceeEEecccccc
Confidence 954 999999987633 48999999999999999999994 799999999999999766555 899999999988
Q ss_pred CCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 007427 475 LPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP 525 (604)
Q Consensus 475 ~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~ 525 (604)
..... ....+..|+|||++.+.+|+.+.||||||||+.||+||.+.|.+..
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 76554 3356789999999999999999999999999999999998888754
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.70 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=190.9
Q ss_pred cccCcCCcceEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLES--------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 235888888655444557788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-----cceEEEeec
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-----IYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-----~~~~kl~DF 469 (604)
+++|+|.++++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++. ...++++||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999986532 4889999999999999999999 479999999999999965432 134799999
Q ss_pred cCCCCCCCCCCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCC-CCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 470 GFLPLLPSRKASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGR-IPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 470 Gla~~~~~~~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
|++..........++..|+|||++.+ ..++.++|||||||++|||++|. .||..... ..... ......
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~-~~~~~~- 222 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQ-FYEDRH- 222 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHH-HHHccc-
Confidence 99887766555567788999999986 45799999999999999999985 55442111 11111 111110
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
. .+.....++.+++.+||+.||++|||++++++.|+
T Consensus 223 -~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -Q----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00112245889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.65 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=195.1
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecC-CceEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSK-EEKLII 391 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~lv 391 (604)
..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3578999999999999632 35789999987432 22345678899999999 899999999988754 567899
Q ss_pred EecCCCCCHHHHhhcccCC--------------------------------------------------------CCCCC
Q 007427 392 YEFLPNGSLFDLLHESRGV--------------------------------------------------------GRIPL 415 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l 415 (604)
|||+++++|.+++...... ...++
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998653210 01258
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC------CCccccccCC
Q 007427 416 AWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRS 489 (604)
Q Consensus 416 ~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~a 489 (604)
+|..+..++.||+.||+||| +++|+||||||+|||+ +....+||+|||+++.+.... ...++..|+|
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 99999999999999999999 5799999999999999 455679999999998764322 1223457999
Q ss_pred CCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHH
Q 007427 490 PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRL 568 (604)
Q Consensus 490 PE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 568 (604)
||++.+..++.++|||||||++|||++ |+.||.+.... ..+. ........... ......++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~----~~~~~~~~~~~----------~~~~~~~~ 305 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFC----RRLKEGTRMRA----------PEYATPEI 305 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHH----HHHhccCCCCC----------CccCCHHH
Confidence 999999999999999999999999998 99998753211 1111 11111111100 11223468
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 569 TELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 569 ~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=321.85 Aligned_cols=239 Identities=18% Similarity=0.204 Sum_probs=192.2
Q ss_pred hcccCcCCcceEEEEEecC--CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLES--GAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 4789999999999998543 3689999986432 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++...
T Consensus 115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecC
Confidence 999999997653 4889999999999999999999 5799999999999999 666789999999998765
Q ss_pred CCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 477 SRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 477 ~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+... ..............
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~------- 247 (340)
T PTZ00426 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGIIYF------- 247 (340)
T ss_pred CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCC-------
Confidence 432 33578899999999988899999999999999999999999975321 11112222211100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 592 (604)
+......+.+++.+|++.||++|+ +++|+++.
T Consensus 248 -----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 -----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011223578999999999999995 78887653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=303.50 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=194.7
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
++||+|+||.||+|...+++.+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999987543 223457889999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++.... ..+++..+..++.|++.||.|+| +++++||||||+||++ +....+||+|||++........
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEE---cCCCeEEECCCccceeccccccc
Confidence 9987543 24789999999999999999999 4799999999999999 5667899999999875443221
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
......|+|||+..+..++.++|||||||++||+++ |..||..... ...... .........
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~-~~~~~~~~~----- 215 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQ-VEKGYRMSC----- 215 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHH-HHcCCCCCC-----
Confidence 123456999999998899999999999999999999 9999865321 111111 111111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
....+..+.+++.+||+.+|++||++.|++++|.
T Consensus 216 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -----PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.86 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=188.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 468999999999999864 689999999974322 223567889999999999999999999999999999999995 68
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 89 LCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence 888887543 24888999999999999999999 5799999999999999 56678999999998754322
Q ss_pred ---CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hcC----Cc
Q 007427 479 ---KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DND----WS 547 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----~~ 547 (604)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.+... ..+...... ... +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-------IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHHhCCCChhhcc
Confidence 12345778999998865 4578899999999999999999999976321 111111110 000 00
Q ss_pred c----ccccHHhh---hccc------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 T----DILDVEIL---AARE------GQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ~----~~~~~~~~---~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ...++... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00000000 0000 0011235789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=319.92 Aligned_cols=233 Identities=20% Similarity=0.250 Sum_probs=186.7
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999985 468999999997432 22345677888888776 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCc
Confidence 99999987653 4889999999999999999999 4799999999999999 6667899999999875422
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~----- 215 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVY----- 215 (320)
T ss_pred CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCCCC-----
Confidence 1 12347889999999999999999999999999999999999997532 122222222211100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
+......+.+++.+||+.||++||++.
T Consensus 216 -------~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 216 -------PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred -------CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 011234578999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.60 Aligned_cols=256 Identities=22% Similarity=0.384 Sum_probs=201.1
Q ss_pred HhhcccCcCCcceEEEEEe--------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceE
Q 007427 320 ASAEVLGKGKVGSTYKATL--------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKL 389 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (604)
...+.||+|+||.||+|+. .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++......+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 3467899999999999973 134579999987432 33456789999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
+||||+++|+|.+++...... ....+++.++..++.|++.||+||| ++||+||||||+||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nili--- 170 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVLV--- 170 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEEE---
Confidence 999999999999999864321 1234788999999999999999999 4799999999999999
Q ss_pred CCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 007427 459 NDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETS 531 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~ 531 (604)
+....+||+|||+++....... ...+..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 5556899999999987643221 123457999999998889999999999999999999 788876421
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
..+......... .... .......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 245 --~~~~~~~~~~~~-~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 245 --VEELFKLLKEGH-RMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --HHHHHHHHHcCC-cCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 222222222111 1110 11234468899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.83 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=194.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+++..++..+|+|.++... .....+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 46799999999999998777789999987543 33567999999999999999999999999888999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++..... .+++.+++.++.|++.||+||| +++++|+||||+||++ +.+..+||+|||.++.......
T Consensus 88 ~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 88 NYLREHGK----RFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee
Confidence 99976432 4899999999999999999999 4799999999999999 5566899999999876543321
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
..++..|+|||...+..++.++|||||||++|||+| |+.||..... .+............ .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~-~----- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLY-R----- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCC-C-----
Confidence 123457999999988889999999999999999999 9999864321 11111221111110 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.......+.+++.+||+.||.+||++.++++.|+
T Consensus 223 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.39 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=194.7
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|.. .++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 46899999999999974 356889999997433 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 396 PNGSLFDLLHESRG------------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 396 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
++++|.+++..... .....+++.+...++.|++.||+||| +++|+||||||+||++ ++...
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili---~~~~~ 162 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILI---GEQLH 162 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEE---cCCCc
Confidence 99999999864321 11234789999999999999999999 4799999999999999 55667
Q ss_pred EEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhH
Q 007427 464 AKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 536 (604)
+||+|||+++...... ...++..|+|||+..+..++.++|||||||++|||++ |..||.+... ..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------QE 234 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 9999999997654322 1223456999999988889999999999999999999 9989865321 11
Q ss_pred HHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.......... .. ........+.+++.+||+.||++||++.+|.++|..
T Consensus 235 ~~~~~~~~~~-~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL-LP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc-CC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 00 011223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=305.97 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=194.1
Q ss_pred cccCcCCcceEEEEEec-CCc--EEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGA--VVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999864 343 57889887532 33456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 398 GSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 398 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
|+|.+++...... ....+++.++..++.|++.||+||| +++++||||||+||++ +....+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili---~~~~~~kl 153 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILV---GENYVAKI 153 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEE---cCCCeEEE
Confidence 9999999764311 1124789999999999999999999 4799999999999999 66678999
Q ss_pred eeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 467 TNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 467 ~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
+|||+++...... ....+..|+|||+.....++.++|||||||++|||++ |+.||.+.. ..+......
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~ 225 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLP 225 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHh
Confidence 9999986433211 1122456999999988889999999999999999997 999986532 112222211
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.....+. .......+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 226 -~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 -QGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCCCCCC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111110 1112346889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.75 Aligned_cols=237 Identities=21% Similarity=0.250 Sum_probs=188.6
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999854 58899999997532 22335577888888866 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEE---CCCCCEEEeecccceeccc
Confidence 99999987653 4889999999999999999999 4799999999999999 6667899999999875432
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||++.+..++.++|||||||++|||+||+.||.... ..+............
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~~----- 215 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVLY----- 215 (321)
T ss_pred CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCC-----
Confidence 21 2246789999999999899999999999999999999999997532 112222222221110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRP-------KMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.++++
T Consensus 216 -------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 -------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 011223578999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=307.53 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=192.6
Q ss_pred hcccCcCCcceEEEEEecC-Cc--EEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEE
Q 007427 322 AEVLGKGKVGSTYKATLES-GA--VVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 390 (604)
.+.||+|+||.||+|+..+ +. .||+|.++.. .....+.+.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 5689999999999998654 33 6899988643 233456788999999999999999999987532 24689
Q ss_pred EEecCCCCCHHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 391 IYEFLPNGSLFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+|||+++|+|.+++...+. .....+++.....++.|++.||+|||+ ++|+||||||+|||+ +....+||+||
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~Nil~---~~~~~~kl~Df 156 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS----KSFIHRDLAARNCML---NENMNVCVADF 156 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH----CCeeccccchhheEE---cCCCCEEECCC
Confidence 9999999999998854321 122358999999999999999999994 799999999999999 66678999999
Q ss_pred cCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+++.+.... ....+..|++||+..+..++.++|||||||++|||++ |+.||.+... .+......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence 9998764332 1134457999999999899999999999999999999 7888864211 11111111
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
...... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLK-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111100 0112234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.59 Aligned_cols=236 Identities=20% Similarity=0.280 Sum_probs=185.0
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGK-LKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|+. .+++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999985 468899999997432 1223445667777664 4899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCC
Confidence 99999987643 4889999999999999999999 4799999999999999 5667899999999875432
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+... .+....+......
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~------ 214 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILNDRPH------ 214 (316)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCC------
Confidence 21 23468899999999998999999999999999999999999975321 1122222111100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS-EVL 590 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 590 (604)
.+......+.+++.+||+.||++||++. +++
T Consensus 215 ------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 ------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111233578999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=305.47 Aligned_cols=242 Identities=20% Similarity=0.358 Sum_probs=191.1
Q ss_pred ccCcCCcceEEEEEec---CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLE---SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||.||+|.+. .+..||+|+++.... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 456799999975432 23467899999999999999999999875 457899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++.++.+++.|++.||+||| +++++||||||+||++ +....+||+|||+++......
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEE---cCCCcEEeccCCccccccCCc
Confidence 999987543 24899999999999999999999 4799999999999999 566789999999987654322
Q ss_pred C-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 480 A-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 480 ~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
. ...+..|+|||......++.++|||||||++||+++ |+.||..... .+..... .......
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~~~~~-- 218 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFI-EQGKRLD-- 218 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH-HCCCCCC--
Confidence 1 112357999999988889999999999999999996 9999875321 1111111 1111111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.+.....++.+++.+||..||++||++.+|.+.|+.+
T Consensus 219 --------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 --------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=307.08 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=195.4
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc------eE
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE------KL 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 389 (604)
.+.||+|+||.||+|... .+..||+|+++... ......+.+|++.++.++|+||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 468999999999999854 24789999987432 2334678999999999999999999999876554 78
Q ss_pred EEEecCCCCCHHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 390 IIYEFLPNGSLFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
++|||+++|+|..++..... .....+++..+..++.|++.||+||| +++|+||||||+||++ ++...+||+|
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~---~~~~~~kl~d 156 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCML---REDMTVCVAD 156 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEE---CCCCeEEECC
Confidence 99999999999999865432 12235899999999999999999999 4799999999999999 6667899999
Q ss_pred ccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 469 FGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 469 FGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+++....... ...+..|+|||+..+..++.++|||||||++|||++ |..||.+... .+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 999987643321 123457999999988899999999999999999999 8888865321 1122222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
..... .. ........+.+++.+||+.||++||++.|+++.|+++
T Consensus 229 ~~~~~-~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNR-LK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCC-CC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21111 10 1112344689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=308.93 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=194.6
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|... .+..||+|+++... .....++.+|+.+++.++|+||+++++++......++||||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 468999999999999753 35689999986432 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 395 LPNGSLFDLLHESRGV-----GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+++|+|.+++...... ....+++..+..++.|++.||+||| +++++||||||+||++ +.+..+||+||
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~---~~~~~~~l~df 163 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMV---AEDFTVKIGDF 163 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEE---cCCCCEEECCC
Confidence 9999999999764321 1224688899999999999999999 4799999999999999 56678999999
Q ss_pred cCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+++....... ...+..|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~~~~~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVLRFVM 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHH
Confidence 99876543221 123457999999998899999999999999999999 788886432 112222222
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.... ... .......+.+++.+||+.||++||++.|+++.|++
T Consensus 236 ~~~~-~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGL-LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCc-CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2111 110 11223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.68 Aligned_cols=242 Identities=22% Similarity=0.403 Sum_probs=194.6
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
..+.||+|+||.||++..+++..+|+|.+.... .....+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 457899999999999998777899999986432 2346788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||++ +....+||+|||+++.......
T Consensus 87 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 87 LNYLRERKG----KLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEE---CCCCcEEECCcccceecccccc
Confidence 999976432 4899999999999999999999 4799999999999999 5667899999999876643321
Q ss_pred C-----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 S-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 ~-----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. .....|+|||...+..++.++|||||||++|||+| |+.||..... .+...... ......
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~-~~~~~~----- 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVS-AGYRLY----- 221 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHH-cCCcCC-----
Confidence 1 12346999999998999999999999999999999 8999864321 11111111 111000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.....+..+.+++.+||..+|++||++.|+++.|
T Consensus 222 -----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0112344688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=322.63 Aligned_cols=234 Identities=22% Similarity=0.306 Sum_probs=188.5
Q ss_pred cccCcCCcceEEEEEe----cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999974 3689999999975322 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccC
Confidence 999999997543 4899999999999999999999 4799999999999999 566689999999987654
Q ss_pred CCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.||.... ..+...........
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~~~----- 216 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAKLG----- 216 (318)
T ss_pred CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCCCC-----
Confidence 331 2246788999999998889999999999999999999999997531 11222222221110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSE 588 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 588 (604)
.+......+.+++.+||+.||++||++.+
T Consensus 217 -------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 -------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01112345789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=310.85 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=195.9
Q ss_pred hcccCcCCcceEEEEEec-CC--cEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SG--AVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++|||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 468999999999999864 33 35788888743 233456789999999999 79999999999999999999999999
Q ss_pred CCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 397 NGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 397 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
+|+|.++++..... ....+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+|
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill---~~~~~~k 159 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLV---GENLASK 159 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEE---CCCCeEE
Confidence 99999999764311 1124889999999999999999999 4799999999999999 5667899
Q ss_pred EeeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 466 LTNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 466 l~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
|+|||++....... .......|+|||+..+..++.++|||||||++|||+| |..||..... .+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~~~~ 231 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELYEKL 231 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH
Confidence 99999986543221 1122346999999998889999999999999999998 9999875321 1222221
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.. ..... ........+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 232 ~~-~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 232 PQ-GYRME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred hc-CCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11110 0112234688999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=306.03 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++. .+++.+|||.+... ......++.+|+.+++.++|+||+++++++...+..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 46799999999999984 57999999988642 222346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++..... ....+++.++..++.|++.||+||| +++++|+||||+||++ +....++|+|||++.....
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 87 GDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---cCCCCEEECcchhhhcccc
Confidence 999999875332 1235899999999999999999999 4799999999999999 5556799999999877654
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||+..+..++.++||||||+++|||++|..||.+... .................
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~---- 228 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDYPPL---- 228 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhhcCCCCCC----
Confidence 32 23466789999999888899999999999999999999999864321 11122222111111000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
........+.+++.+||+.||++||||.+|++.++++.
T Consensus 229 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01123446889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.66 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=187.6
Q ss_pred ccCcCCcceEEEEEec---CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLE---SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||.||+|... ++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999854 34679999987543 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++...........++..+..++.|++.||+||| +.+++||||||+||++ +....+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 999998654322334678888899999999999999 4799999999999999 556789999999987654322
Q ss_pred ------CCccccccCCCCCCCCC-------CCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 480 ------ASENLAIGRSPEFPEGK-------RLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~~~-------~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
...++..|+|||++... .++.++|||||||++|||++ |+.||..... ...... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~~---~~~~~ 226 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLTY---TVREQ 226 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH---Hhhcc
Confidence 12245679999988642 35789999999999999996 9999964321 111111 11110
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.....++.. .......+.+++.+|| .+|++|||+.||++.|+
T Consensus 227 -~~~~~~~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 -QLKLPKPRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -cCCCCCCcc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111110 0112235778999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=304.24 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=202.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999865 7999999988632 222356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++..... ....+++.++..++.|++.||+||| +.||+||||||+||++ +.+..++|+|||+++....
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEE---CCCCcEEEeccceeeeccC
Confidence 999999875432 2235899999999999999999999 4799999999999999 5566789999999876644
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|.|||...+..++.++|||||||++|||++|+.||.... ....+.......... ....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~-~~~~-- 229 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKCDY-PPLP-- 229 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcCCC-CCCC--
Confidence 32 2245678999999998889999999999999999999999986432 122222222211111 1100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.......+.+++.+||..+|++||++.+|+++|+++++
T Consensus 230 -------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 230 -------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred -------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 11233468899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.38 Aligned_cols=233 Identities=21% Similarity=0.272 Sum_probs=184.5
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHH-HHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQ-LLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999999986 4789999999964321 12234455544 56789999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+||| ++||+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEE---CCCCcEEEeccCCCccccc
Confidence 99999987643 4889999999999999999999 4799999999999999 6667899999999875432
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+............
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~----- 215 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKPLRL----- 215 (323)
T ss_pred CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCC-----
Confidence 21 2246789999999999999999999999999999999999997531 222222222211100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
.......+.+++.+||+.||++||++.
T Consensus 216 -------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 -------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011234688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.07 Aligned_cols=236 Identities=20% Similarity=0.281 Sum_probs=186.2
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGK-LKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+.. +++.||+|+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999864 58899999997532 1223456677778775 4899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCC
Confidence 99999997643 4889999999999999999999 4799999999999999 5566899999999875322
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~~------ 214 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMDNPC------ 214 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC------
Confidence 1 12346789999999999999999999999999999999999997532 11111111111100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS-EVL 590 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 590 (604)
.+......+.+++.+||+.||++||++. ++.
T Consensus 215 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 ------YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0011233578999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.20 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=199.8
Q ss_pred hcccCcCCcceEEEEEecC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLES-----GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 5789999999999998765 788999998753 33345678899999999999999999998876 4678999999
Q ss_pred CCCCCHHHHhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 395 LPNGSLFDLLHESRGV---GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
+++|+|.+++...... ....+++.++..++.|++.||+||| +++++||||||+||++ ++...+||+|||+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~---~~~~~~kl~d~g~ 163 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVI---DEELQVKITDNAL 163 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEE---cCCCcEEECCCCC
Confidence 9999999998765321 1135899999999999999999999 4799999999999999 5667899999999
Q ss_pred CCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 472 LPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 472 a~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
++.+.... ...++..|+|||++.+..++.++|||||||++||+++ |+.||..... .++..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~ 234 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLK-D 234 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH-c
Confidence 98664322 1234557999999998889999999999999999999 9999875321 11211111 1
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
..... .....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11100 0111234688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.92 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=196.9
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 392 (604)
..+.||+|+||.||+|++. .++.||+|+++... ....+.+.+|++++.++. ||||++++++|...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4689999999999999853 34689999997542 223457889999999997 999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCC--------------------------------------------------------------
Q 007427 393 EFLPNGSLFDLLHESRGV-------------------------------------------------------------- 410 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 410 (604)
||+++|+|.++++..+..
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 999999999999764310
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC
Q 007427 411 -------------------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459 (604)
Q Consensus 411 -------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 459 (604)
....+++.++..++.|++.||+||| +++|+||||||+|||+ +
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~NiLl---~ 273 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNVLI---C 273 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceEEE---e
Confidence 1124678889999999999999999 5799999999999999 5
Q ss_pred CcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 007427 460 DIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSG 532 (604)
Q Consensus 460 ~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~ 532 (604)
+...+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------ 347 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------ 347 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------
Confidence 56689999999997653221 1234567999999998889999999999999999998 8889865321
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.+............. .+......+.+++.+||..+|.+||+++||++.|+++.
T Consensus 348 --~~~~~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 --NEQFYNAIKRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --hHHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111111111110 01112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.36 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=195.7
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
..+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++.+++||||+++++++...+..++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 3578999999999999853 357899999975432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc
Q 007427 394 FLPNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~ 462 (604)
|+++++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+||++ ++..
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~---~~~~ 161 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLV---FDKL 161 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEe---cCCC
Confidence 9999999999863210 11234888999999999999999999 4799999999999999 5566
Q ss_pred eEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchh
Q 007427 463 RAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLS 535 (604)
Q Consensus 463 ~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 535 (604)
.+||+|||+++...... ....+..|+|||...+..++.++|||||||++|||++ |..||.+.. ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 79999999987654322 1123568999999988889999999999999999998 888876421 12
Q ss_pred HHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 536 DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
++.......... . ........+.+++.+||+.+|++||++++|++.|+.
T Consensus 234 ~~~~~i~~~~~~-~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQVL-P----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCcC-C----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 223322222211 0 011234458899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.59 Aligned_cols=241 Identities=18% Similarity=0.293 Sum_probs=187.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---------h-----hHHHHHHHHHHHccCCCCCcccEEEEEecC-
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---------L-----SKKEFVQQMQLLGKLKHENLAKIVSFYYSK- 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 385 (604)
...||+|.||.|-+|+. .+++.||||++.+... . ..+...+|+.+|++++|||||+++++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 46799999999999984 5799999999964211 1 125789999999999999999999998764
Q ss_pred -CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 386 -EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 386 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
+..|||+|||..|.+...=.. ...+++.++++++.++..||+||| .+|||||||||+|+|+ +.++++
T Consensus 182 s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl---~~~g~V 249 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLL---SSDGTV 249 (576)
T ss_pred cCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEE---cCCCcE
Confidence 578999999998877543211 112899999999999999999999 5799999999999999 666899
Q ss_pred EEeeccCCCCCCCCC---------CCccccccCCCCCCCCCC----CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 007427 465 KLTNFGFLPLLPSRK---------ASENLAIGRSPEFPEGKR----LTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531 (604)
Q Consensus 465 kl~DFGla~~~~~~~---------~~~~~~~y~aPE~~~~~~----~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 531 (604)
||+|||.+....... ...||+.++|||...++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------ 323 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------ 323 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch------
Confidence 999999987663221 246899999999987632 3568899999999999999999997531
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..+....+...... .+..++..+.+.+||+++|.+||++|.+..+|...
T Consensus 324 --~~~l~~KIvn~pL~----------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 324 --ELELFDKIVNDPLE----------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred --HHHHHHHHhcCccc----------CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 12222222222111 11122455678999999999999999999888654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=303.91 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=190.3
Q ss_pred cccCcCCcceEEEEEecC-C----------cEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEE
Q 007427 323 EVLGKGKVGSTYKATLES-G----------AVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (604)
+.||+|+||.||+|...+ + ..+++|.++..... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998653 3 25788887654332 6788999999999999999999999988 778999
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC----CcceEEEe
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN----DIYRAKLT 467 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~~~~kl~ 467 (604)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+||+++.++ ....+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999986542 4889999999999999999999 57999999999999995543 22369999
Q ss_pred eccCCCCCCCCCCCccccccCCCCCCCCC--CCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 468 NFGFLPLLPSRKASENLAIGRSPEFPEGK--RLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 468 DFGla~~~~~~~~~~~~~~y~aPE~~~~~--~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
|||++..........+...|+|||++.+. .++.++|||||||++|||++ |..||..... ..+.......
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~~~~~ 222 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERFYQDQ 222 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHHHhcC
Confidence 99999887665455566789999998876 78999999999999999999 5777654321 1111111111
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.. ... .....+.+++.+||..+|++||++.||++.|+
T Consensus 223 ~~-~~~------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR-LPM------------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-CCC------------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 10 000 00146889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=303.09 Aligned_cols=246 Identities=23% Similarity=0.385 Sum_probs=190.0
Q ss_pred cccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 396 (604)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2467999998643 23345678899999999999999999998764 456789999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++..... ..++..+..++.|++.||+||| ..+++||||||+|||+ ++...+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCML---DESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEE---cCCCcEEECCcccccccc
Confidence 9999999976432 3677888999999999999999 4699999999999999 566789999999987653
Q ss_pred CCC--------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC-CCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 477 SRK--------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR-IPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 477 ~~~--------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
... ...++..|+|||+..+..++.++|||||||++|||++|. .||... ...+...........
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 221 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLLQGRRL 221 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhcCCCC
Confidence 321 122345799999998889999999999999999999964 455432 112222222211110
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.. ....+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ~~-----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 LQ-----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CC-----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00 01123468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.03 Aligned_cols=237 Identities=20% Similarity=0.257 Sum_probs=189.4
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+.. +++.||+|+++... ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999864 58899999997532 22345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCc
Confidence 99999987653 4899999999999999999999 5799999999999999 6667899999999865322
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..............
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~~~------ 214 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDEVR------ 214 (318)
T ss_pred CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCC------
Confidence 11 2246789999999999999999999999999999999999997532 11222222211110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKM-----SEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 591 (604)
.+......+.+++.+||+.||++||++ .++++
T Consensus 215 ------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 ------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011123468899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.19 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=197.3
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
..+.||+|+||.||++... ....+|+|.++.. ......++.+|++++.++ +|+||+++++++...+..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 3468999999999999853 2368999998753 223345688999999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 393 EFLPNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
||+++|+|.++++.... .....+++..++.++.|++.||+||| +++|+||||||+||++ +++
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~---~~~ 168 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLV---TED 168 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEE---cCC
Confidence 99999999999975321 12235899999999999999999999 4799999999999999 556
Q ss_pred ceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCch
Q 007427 462 YRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 534 (604)
..+||+|||+++.+..... ...+..|+|||...+..++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~ 240 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------V 240 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--------H
Confidence 6899999999987654321 123457999999988899999999999999999998 999986432 1
Q ss_pred hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.+..... ....... ........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 ~~~~~~~-~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELFKLL-KEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHH-HcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 1111100 01122346889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=322.88 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=187.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+|+.||||+++.. .......+.+|++++++++||||+++++++.... ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46899999999999985 57899999998742 2223456889999999999999999999886432 4799999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+. ++|.+++.... .+++..+..++.|+++||+||| +++|+||||||+|||+ +....+||+|||+++
T Consensus 85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILA---NADCKLKICDFGLAR 151 (338)
T ss_pred cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEE---CCCCcEEEccCcccc
Confidence 995 69999987543 4899999999999999999999 5799999999999999 666789999999997
Q ss_pred CCCCCC-------CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.+.... .....+......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~ 226 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGT 226 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCC
Confidence 653221 2346788999999865 67899999999999999999999999753210 000000000000
Q ss_pred CC-----------ccccccHHhhh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 545 DW-----------STDILDVEILA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 545 ~~-----------~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.. ...... .+.. ..........+.+++.+||+.||++||++.|+++.
T Consensus 227 ~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHH-hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000000 0000 00001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=309.84 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=197.2
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. ....+|+|.+.... .....++.+|+.++++++||||+++++.+...+..++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 468999999999999743 23578999887543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 395 LPNGSLFDLLHESRG-------------------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
+++|+|.+++..... ....++++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~nill 160 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAARNVLV 160 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhheEEE
Confidence 999999999875321 11235889999999999999999999 4799999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNN 528 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~ 528 (604)
++...+||+|||+++...... ....+..|+|||...+..++.++||||||+++|||+| |+.||.+...
T Consensus 161 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 161 ---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred ---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 556689999999987653322 1133457999999988889999999999999999999 9999865321
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
..+.+ ......... ........+.+++.+||+.+|++||++.|+++.|+++-.
T Consensus 236 ---~~~~~----~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ---ERLFN----LLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHH----HHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 111111111 011223468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.72 Aligned_cols=237 Identities=18% Similarity=0.269 Sum_probs=185.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHH---ccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLL---GKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|.+++ ++++||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 36799999999999985 468999999997432 12234566666554 567899999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|..+++.. .+++..+..++.|++.||+||| +++|+||||||+||++ +.+..+||+|||+++.
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKE 150 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEE---CCCCcEEeCcccCCcc
Confidence 9999999888643 3899999999999999999999 4799999999999999 5667899999999875
Q ss_pred CCCC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 475 LPSR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 475 ~~~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.+.. ..+...........
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~~--- 219 (324)
T cd05589 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDEVR--- 219 (324)
T ss_pred CCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC---
Confidence 4322 12346789999999999999999999999999999999999997532 11222222221110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.+......+.+++.+||+.||.+||+ +.++++
T Consensus 220 ---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01112345789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.76 Aligned_cols=240 Identities=17% Similarity=0.227 Sum_probs=187.2
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999985 468899999997532 22345678899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEE---eCCCCEEEeccccceeccC
Confidence 99999887543 4899999999999999999999 4799999999999999 5566799999999875322
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||........ ....++......... ..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~-~~---- 221 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKP-IR---- 221 (327)
T ss_pred CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCC-CC----
Confidence 1 123578899999999999999999999999999999999999975322111 111122221111110 00
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
.+......+.+++.+||+.||++|+++.
T Consensus 222 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 ------IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ------CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0111233578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.26 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=197.0
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||++... ++..+|+|.++.......+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 578999999999999642 46789999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 396 PNGSLFDLLHESRGV----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
++|+|.+++...... ....+++.+++.++.|++.||+||| +++++||||||+||++ ++...+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~---~~~~~~k 162 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLV---GQGLVVK 162 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEE---cCCCCEE
Confidence 999999999764310 1124889999999999999999999 4799999999999999 5667899
Q ss_pred EeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHH
Q 007427 466 LTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 466 l~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 538 (604)
|+|||+++...... ....+..|+|||...+..++.++|||||||++|||++ |+.||..... .+..
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~ 234 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEAI 234 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHHH
Confidence 99999987553322 1123467999999999999999999999999999999 8999864211 1111
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
....... ... .....+..+.+++.+||+.||.+||++.||++.|++
T Consensus 235 ~~~~~~~-~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGR-ELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCc-cCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111 000 011223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.37 Aligned_cols=236 Identities=20% Similarity=0.271 Sum_probs=185.9
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999864 68999999997532 12334566777777654 899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEE---CCCCCEEeCccCCCeeccc
Confidence 99999987643 4889999999999999999999 4799999999999999 5666899999999875321
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.+... .+.......... .
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~~--~---- 214 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDTP--H---- 214 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--C----
Confidence 1 223468899999999999999999999999999999999999975321 111111111110 0
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS-EVL 590 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 590 (604)
.+.....++.+++.+||+.||++||++. ++.
T Consensus 215 ------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 ------YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0011233578999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.37 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=195.1
Q ss_pred hhcccCcCCcceEEEEEec-CCc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGA--VVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
..+.||+|+||.||+|... ++. .+|+|.++.. .......+.+|++++.++ +|+||+++++++...+..++||||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 3578999999999999854 454 4688877643 233456788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 396 PNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
++|+|.++++..... ....+++.+++.++.|++.||+||| ++||+||||||+|||+ +....+
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili---~~~~~~ 163 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILV---GENYVA 163 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEe---cCCCcE
Confidence 999999999765311 1224789999999999999999999 5799999999999999 566689
Q ss_pred EEeeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHH
Q 007427 465 KLTNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 465 kl~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
||+|||+++...... ....+..|+|||+..+..++.++|||||||++|||+| |..||..... .+....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEK 235 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHHHH
Confidence 999999986432211 1122456999999988889999999999999999998 9999865321 111111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
. ....... ........+.+++.+||+.+|++||++.++++.|+++..
T Consensus 236 ~-~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 236 L-PQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred H-hcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1111000 001123457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=312.14 Aligned_cols=196 Identities=24% Similarity=0.393 Sum_probs=159.8
Q ss_pred hcccCcCCcceEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE---SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
+.+||+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56889999987542 23567889999999999999999999864 346789999995
Q ss_pred CCCHHHHhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec-CCcceEEEeeccC
Q 007427 397 NGSLFDLLHESRG----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGF 471 (604)
Q Consensus 397 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~~~~kl~DFGl 471 (604)
++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+..+ +....+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 589888764321 11235889999999999999999999 5799999999999999543 3446799999999
Q ss_pred CCCCCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 472 LPLLPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 472 a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
++...... ...++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 98764321 2345778999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=305.11 Aligned_cols=245 Identities=21% Similarity=0.416 Sum_probs=196.1
Q ss_pred hcccCcCCcceEEEEEec-CC---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SG---AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. ++ ..+|+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 578999999999999864 33 37999998754 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++ +.+..+||+|||++....
T Consensus 90 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 90 NGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence 999999997643 24899999999999999999999 4699999999999999 566789999999987664
Q ss_pred CCCCC-------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 SRKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~~~~~-------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... .....|+|||++....++.++|||||||++|||++ |+.||.... ..+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~~~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFRLP 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCCCC
Confidence 32211 12346999999988889999999999999999998 999986431 122222222111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~-----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 A-----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 112334688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.42 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=198.7
Q ss_pred hhcccCcCCcceEEEEEec--------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEE
Q 007427 321 SAEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (604)
..+.||+|+||.||+++.. ++..+|+|.++... .....++.+|+++++++ +|+||+++++++...+..++
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578999999999999742 23579999997532 33456788899999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC
Q 007427 391 IYEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 459 (604)
||||+++|+|.+++...... ....+++.++++++.|++.||+||| ++|++||||||+||++ +
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill---~ 174 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLV---T 174 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheEE---c
Confidence 99999999999999865321 1124899999999999999999999 4799999999999999 5
Q ss_pred CcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 007427 460 DIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSG 532 (604)
Q Consensus 460 ~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~ 532 (604)
.+..+||+|||.++....... ......|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence 566899999999876643211 122357999999998889999999999999999998 888886421
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
..+..... ........ .......+.+++.+||+.+|++||++.||++.|+++.+.
T Consensus 248 -~~~~~~~~-~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 -VEELFKLL-KEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHHHHHH-HcCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 12222221 11111110 112334688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=307.46 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=195.6
Q ss_pred hhcccCcCCcceEEEEEe-----cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 392 (604)
..+.||+|+||.||+++. .++..||+|.++... ......+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05079 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87 (284)
T ss_pred hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence 457899999999999974 357899999997543 33346789999999999999999999998775 5678999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++++|.+++.... ..+++.++..++.|++.||+||| ++||+||||||+||++ +.+..+||+|||++
T Consensus 88 e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~ 156 (284)
T cd05079 88 EFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLV---ESEHQVKIGDFGLT 156 (284)
T ss_pred EccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEE---cCCCCEEECCCccc
Confidence 9999999999997543 24899999999999999999999 4799999999999999 55567999999999
Q ss_pred CCCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCC-------CCCCCchhHHH
Q 007427 473 PLLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGN-------NETSGDLSDWV 538 (604)
Q Consensus 473 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~-------~~~~~~~~~~~ 538 (604)
+.+.... ...+...|+|||+..+..++.++|||||||++|||+|++.|+...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 8764432 123445799999998888999999999999999999988765321100 00011111111
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.......... .....+..+.+++.+||+.||++||++.++++.|+++
T Consensus 237 ~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP-----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC-----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111000 0112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.06 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=194.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..+...||+|+++.... ..+.+.+|++++++++|+||+++++++. .+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 568999999999999987777899999975332 3567899999999999999999999875 45679999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++..... ..+++..+..++.|++.||+||| +++|+||||||+||++ +++..+||+|||.++.+.....
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 89 DFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred HHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEE---cCCCcEEeccCCceeeccccccc
Confidence 99976431 24789999999999999999999 4799999999999999 5566799999999976643321
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
..++..|+|||+..+..++.++|||||||++|||+| |+.||..... .+..... .......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~-~~~~~~~------ 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERGYRMP------ 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHH-hcCCCCC------
Confidence 123457999999988889999999999999999999 8888864321 1111111 1111000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.....+..+.+++.+|++.||++||++.++++.|++.
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1123345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=302.05 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=195.0
Q ss_pred cccCcCCcceEEEEEecC--C--cEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLES--G--AVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999986554 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++..... ..+++..+..++.|++.||+||| +++++||||||+||++ +.+..+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEE---ecCCEEEeccccccccccc
Confidence 999999987542 35899999999999999999999 5799999999999999 5557899999999987654
Q ss_pred CC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 478 RK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 478 ~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
.. ...++..|+|||+..+..++.++|||||||++|||+| |+.||..... .+.............
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 221 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGERLE 221 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCcCC
Confidence 21 1234568999999998899999999999999999999 9999864311 112222111111100
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ----------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=302.88 Aligned_cols=243 Identities=23% Similarity=0.378 Sum_probs=193.0
Q ss_pred cccCcCCcceEEEEEec----CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE----SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|... .+..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999742 237899999975433 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ..+++||||||+||++ +....+||+|||+++....
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEE---cCCCcEEeccccccceeec
Confidence 99999998653 4899999999999999999999 4699999999999999 5667899999999886643
Q ss_pred CCCC-------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 478 RKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 478 ~~~~-------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
.... .++..|+|||...+..++.++|||||||++|||++ |+.||.... ...+...+ .. .....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~---~~-~~~~~ 218 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAML---ES-GERLP 218 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHH---Hc-CCcCC
Confidence 3221 12346999999998899999999999999999998 999986432 11122221 11 11111
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.....+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 219 ----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 ----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01123346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.37 Aligned_cols=238 Identities=21% Similarity=0.272 Sum_probs=186.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHH-HHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQ-LLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+. .+|+.||+|++.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999985 578999999996432 222344555554 46779999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... .+++..+..++.||+.||+||| ++||+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCC
Confidence 99999887543 4899999999999999999999 4799999999999999 6667899999999875422
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+............
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~~~~----- 215 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKPLVL----- 215 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCCccC-----
Confidence 1 12347789999999999999999999999999999999999997532 122222222211100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+|++.||.+||++++.++.
T Consensus 216 -------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 -------RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 01123357899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=302.37 Aligned_cols=244 Identities=24% Similarity=0.457 Sum_probs=198.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 578999999999999876 88999999976544 4678999999999999999999999999889999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCCC
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~ 481 (604)
+++..... ..+++..+..++.|++.||.||| +++++||||||+||++ +....+||+|||.++........
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 89 DYLRSRGR---AVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEE---eCCCCEEEccccccccccccccc
Confidence 99976532 24899999999999999999999 4799999999999999 66678999999999877443322
Q ss_pred -ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcc
Q 007427 482 -ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAR 559 (604)
Q Consensus 482 -~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (604)
.....|+|||++....++.++||||||+++|||++ |+.||.... ..+... ..........
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~-~~~~~~~~~~--------- 220 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVP-HVEKGYRMEA--------- 220 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHH-HHhcCCCCCC---------
Confidence 23457999999998889999999999999999998 999986431 111111 1111111110
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 560 EGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 560 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
....+..+.+++.+||..+|++||++.|++++|+.+
T Consensus 221 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=302.90 Aligned_cols=244 Identities=29% Similarity=0.471 Sum_probs=195.3
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
..+.||+|+||.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 3578999999999999988888999999975432 3567999999999999999999999875 4568999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.++++... ...+++.++..++.|++.||+|||+ ++|+||||||+||++ ++...+||+|||++..+.....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER----MNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCccceEEE---eCCceEEeCCceeeeeccCccc
Confidence 99997643 2248999999999999999999994 799999999999999 5567899999999976643321
Q ss_pred -----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 -----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 -----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
..+...|+|||+..+..++.++||||||+++|||++ |+.||.+.. ..+....... .....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~~~~----- 223 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVER-GYRMP----- 223 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHc-CCCCC-----
Confidence 123346999999988889999999999999999999 888986531 1112221111 11110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
........+.+++.+||..+|++|||+.++.+.|++
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 -----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.52 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=192.7
Q ss_pred hcccCcCCcceEEEEEec-CCc----EEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGA----VVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 478999999999999853 444 478888754322 23456788888999999999999999875 45578999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++..... .+++..+..++.|++.||+||| +++++||||||+||++ +.+..+||+|||+++..
T Consensus 91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 99999999976432 4899999999999999999999 4799999999999999 66678999999999765
Q ss_pred CCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ...++..|+|||+..+..++.++|||||||++||++| |+.||.+... ..+.+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~----~~~~~~~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPD----LLEKGERL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH----HHHCCCcC
Confidence 4322 1234557999999998899999999999999999998 9999875321 11111 11211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. . ...+...+.+++.+||..||++|||+.|+++.|+.+....
T Consensus 231 ~--~--------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 231 A--Q--------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C--C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1 0 0012235788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=306.07 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=195.8
Q ss_pred hcccCcCCcceEEEEEe-cCCc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGA----VVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.++||+|+||+||+|++ .+|+ .||+|.++.. .....+.+.+|+.+++.++|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46899999999999984 3454 4899998743 33345678899999999999999999999875 4578999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+|||+ ++...+||+|||+++..
T Consensus 91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 91 PYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (279)
T ss_pred CCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence 9999999997643 24899999999999999999999 5799999999999999 55567999999999876
Q ss_pred CCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... ......|+|||...+..++.++|||||||++|||+| |..||.... ...+..++ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~----~~~~~~ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLL----EKGERL 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCCcC
Confidence 53221 123457999999998899999999999999999998 889986432 11122211 111111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
. ........+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 231 ~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 231 P----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred C----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 0 011233468899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=288.85 Aligned_cols=242 Identities=22% Similarity=0.367 Sum_probs=199.9
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccch-----h---hHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNA-----L---SKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
.+.||.|..+.|-++. ..+|+.+|+|++..... . -.+.-.+|+.+|+++ .||+|+.+.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4679999999999886 56789999999853211 1 124567899999998 699999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
+|.|+.|.|+++|...- .+++....+|+.|+..|++||| .++||||||||+|||+ ++++++||+|||+
T Consensus 102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILl---ddn~~i~isDFGF 169 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILL---DDNMNIKISDFGF 169 (411)
T ss_pred hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheee---ccccceEEeccce
Confidence 99999999999998754 5999999999999999999999 5799999999999999 8889999999999
Q ss_pred CCCCCCCCC---CccccccCCCCCCCC------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 472 LPLLPSRKA---SENLAIGRSPEFPEG------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 472 a~~~~~~~~---~~~~~~y~aPE~~~~------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|..++.... ..|+++|.|||.+.- ..|+...|+||+|||+|-|+.|.+||.... -.-..+.+.
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~Im 241 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIM 241 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHH
Confidence 999887653 368999999998763 457889999999999999999999998521 112234444
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
++.+.-. .++..+......+||.+||+.||.+|.|+.|+++
T Consensus 242 eGkyqF~--------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQFR--------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccccC--------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 4443211 1233455667899999999999999999999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.02 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=194.3
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--------ceEE
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--------EKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~l 390 (604)
.+.||+|+||+||+|+ ..+|+.||||++... .......+.+|+..+..++|+||+++++.+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 4689999999999997 457999999998643 2334567889999999999999999988775432 2679
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+++|+|.+++...... ..++++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl---~~~~~vkL~DFG 188 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILL---CSNGLVKLGDFG 188 (496)
T ss_pred EEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEE---eCCCCEEEEecc
Confidence 99999999999999764422 235899999999999999999999 5799999999999999 556789999999
Q ss_pred CCCCCCCC------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 471 FLPLLPSR------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 471 la~~~~~~------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
+++.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||.+. ...+.+......
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKTLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHhcC
Confidence 98765432 1234778999999999999999999999999999999999999753 222333333222
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.... .+......+.+++.+||+.||.+||++.++++.
T Consensus 261 ~~~~-----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDP-----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC-----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 011233468899999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=300.99 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=199.3
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCcccEEEEEecCC----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGK--LKHENLAKIVSFYYSKE----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 395 (604)
.+.||+|.||+||+|+++ |..||||++...+ ++.+.+|.++++. |+|+||+.+++.-..++ +.+||.+|.
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 478999999999999998 8999999997543 4678888888876 49999999998865543 579999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL----HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
+.|||+|||... .++....++++..+|.||++||.+. ..+.|.|||||+.|||+ ..+..+.|+|+|+
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGL 362 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGL 362 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeecee
Confidence 999999999875 4899999999999999999999763 35679999999999999 6667889999999
Q ss_pred CCCCCCC--------CCCccccccCCCCCCCCCCC------CccchhHhHHHHHHHHHhC----------CCCCCCCCCC
Q 007427 472 LPLLPSR--------KASENLAIGRSPEFPEGKRL------THKADVYCFGIILLEVITG----------RIPGNGSPGN 527 (604)
Q Consensus 472 a~~~~~~--------~~~~~~~~y~aPE~~~~~~~------s~ksDVwSfGvvl~elltg----------~~p~~~~~~~ 527 (604)
|-..... ....||..|||||++....- -..+||||||.|+||+.-. +.||++..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9665443 23368899999999875321 2368999999999999862 4788776554
Q ss_pred CCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
+...+++.+.+ . .+.+.+.+...-...+.+..+.++++.||..+|..|-|+-.+-+.|.++.+.
T Consensus 443 DPs~eeMrkVV---C-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKVV---C-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcce---e-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 44333333221 0 0111111111112235666789999999999999999999999999988753
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=309.50 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=196.6
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
..+.||+|+||.||++.. .++..||+|.++... ....+.+.+|+++++++ +|+||+++++++...+..++||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 457899999999999974 235689999987543 23346789999999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++|+|.++++.... ..+++.++..++.|++.||+||| +++|+|+||||+||++ +....+|++|||++
T Consensus 119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 99999999999976432 23899999999999999999999 4799999999999999 56668999999999
Q ss_pred CCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~~ 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKEG 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHcC
Confidence 86643321 123457999999998899999999999999999998 9999875321 11111111111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.... .......++.+++.+||+.+|++||++.|+++.|+++
T Consensus 261 ~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA----------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1110 0011234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.67 Aligned_cols=242 Identities=19% Similarity=0.235 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|+.++.++ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46899999999999974 368999999996422 22345678899999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||++
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~ 152 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILL---DSEGHVVLTDFGLS 152 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEE---CCCCCEEEeeCcCC
Confidence 9999999999997643 4889999999999999999999 4799999999999999 55668999999998
Q ss_pred CCCCCCC-----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 473 PLLPSRK-----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 473 ~~~~~~~-----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
+...... ...++..|+|||++.+. .++.++|||||||++|||+||+.||...... ...............
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~ 228 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILKCDP 228 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhcCCC
Confidence 7653322 23478899999998865 4788999999999999999999999753211 111122222211110
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
. ........+.+++.+||+.||++|| +++++++
T Consensus 229 --~----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 --P----------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --C----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 0011233578999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=303.04 Aligned_cols=243 Identities=28% Similarity=0.457 Sum_probs=195.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||+++++|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 578999999999999988899999999975432 3567899999999999999999999874 56789999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++ ++...++|+|||++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEE---cCCCCEEEccCcceeecCCCCcc
Confidence 9987643 235899999999999999999999 4799999999999999 666789999999987665222
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.......|+|||+..+..++.++||||||+++|||++ |+.||.+... .+...... .......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~----- 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLE-RGYRMPR----- 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHH-cCCCCCC-----
Confidence 1123457999999988889999999999999999999 9999875321 11111111 1111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
......++.+++.+||+.+|++||+++++++.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=310.16 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=185.3
Q ss_pred hcccCcCCcceEEEEEe--cCCcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCcccEEEEEec-----CCceE
Q 007427 322 AEVLGKGKVGSTYKATL--ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL---KHENLAKIVSFYYS-----KEEKL 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~~~ 389 (604)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++++ +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 46799999999999985 347889999986432 22234566777776655 69999999999853 34689
Q ss_pred EEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+||||++ ++|.+++..... ..+++.++..++.|++.||+||| +++|+||||||+|||+ +....+||+||
T Consensus 86 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~---~~~~~~kl~Df 154 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILV---TSSGQIKLADF 154 (290)
T ss_pred EEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEE---cCCCCEEEccc
Confidence 9999996 699999876432 24899999999999999999999 4799999999999999 56678999999
Q ss_pred cCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---h
Q 007427 470 GFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---D 543 (604)
Q Consensus 470 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 543 (604)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..+........ .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~----~~~~~i~~~~~~~~~ 230 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVIGLPGE 230 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCCCCh
Confidence 9987664332 234678899999998889999999999999999999999999864221 11111111000 0
Q ss_pred cCCccccc-cHHhhh--cc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 NDWSTDIL-DVEILA--AR-----EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ~~~~~~~~-~~~~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+..... ...... .. ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 000000 00 00122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=302.15 Aligned_cols=243 Identities=25% Similarity=0.417 Sum_probs=194.8
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEe-cCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY-SKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..+++|||+++++|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 478999999999999875 7889999987543 3467899999999999999999999765 45678999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.++++.... ..+++..+..++.|++.||+||| +++|+||||||+||++ +++..+||+|||+++.......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 88 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEE---cCCCcEEecCCccceeccccCC
Confidence 999976432 24889999999999999999999 5799999999999999 5667899999999876544322
Q ss_pred -CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 481 -SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 481 -~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
......|+|||+..+..++.++|||||||++|||++ |+.||... ...+...... .......
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~~~-------- 220 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVE-KGYKMDA-------- 220 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHh-cCCCCCC--------
Confidence 234457999999998889999999999999999998 99998642 1222222221 1111111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 --PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112344688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.22 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=188.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 36799999999999974 568999999996532 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+ +...++||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccc
Confidence 99999997643 4888999999999999999999 4799999999999999 5566899999999754310
Q ss_pred C---------------------------------------------------CCCccccccCCCCCCCCCCCCccchhHh
Q 007427 478 R---------------------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYC 506 (604)
Q Consensus 478 ~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwS 506 (604)
. ....++..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0 0124678999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHh--cccCCCCCCC
Q 007427 507 FGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALE--CTDIAPEKRP 584 (604)
Q Consensus 507 fGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RP 584 (604)
|||++|||+||+.||..... .+.............. ........++.+++.+ |+..+|..||
T Consensus 234 lG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~--------~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHI--------PPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCC--------CCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999999999975321 1111111110000000 0001123357788877 5566777799
Q ss_pred CHHHHHHH
Q 007427 585 KMSEVLRR 592 (604)
Q Consensus 585 s~~evl~~ 592 (604)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (381)
T cd05626 298 GADDIKAH 305 (381)
T ss_pred CHHHHhcC
Confidence 99999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=309.07 Aligned_cols=244 Identities=18% Similarity=0.240 Sum_probs=192.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.++||+|+||+||++.. .+++.||+|++..... .....+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46899999999999985 4689999999964321 1234577899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+||++ ++...++|+|||++.....
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence 99999886532 224899999999999999999999 4799999999999999 6667899999999887643
Q ss_pred CCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
... ..++..|+|||++.+..++.++|||||||++|||++|+.||.+.... ...+.+........ .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-~------ 222 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKEDQ-E------ 222 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhcc-c------
Confidence 322 25678999999999888999999999999999999999999753211 11111111111110 0
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.........+.+++.+||+.||++|| ++.++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 ----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 01112344688999999999999999 7778755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=304.43 Aligned_cols=245 Identities=23% Similarity=0.452 Sum_probs=195.2
Q ss_pred hcccCcCCcceEEEEEec-CC---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SG---AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. ++ ..||+|.++.. .....++|..|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 578999999999999854 33 36999998754 33345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++....+ .+++.+++.++.|++.||+||| ++|++||||||+||++ +.+..+||+|||+++...
T Consensus 89 ~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 89 NGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 9999999976432 4899999999999999999999 4799999999999999 666789999999987654
Q ss_pred CCCCC------c---cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 477 SRKAS------E---NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 477 ~~~~~------~---~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... . ....|+|||++.+..++.++|||||||++||+++ |..||..... ....+++ . ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i---~-~~~ 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAI---E-QDY 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHH---H-cCC
Confidence 32211 1 1236999999999999999999999999999987 9999875321 1122221 1 111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
... ...+.+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 229 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0112334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.14 Aligned_cols=238 Identities=20% Similarity=0.245 Sum_probs=185.3
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHH-HHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQM-QLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999854 678999999964321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+.+.....++.|++.||+||| ++||+||||||+|||+ +.+..+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEE---CCCCCEEEccCCCCccccc
Confidence 99999997643 3778888899999999999999 5799999999999999 5566899999999875432
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~------ 214 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKPLQ------ 214 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCcC------
Confidence 2 12347889999999999999999999999999999999999997532 11222222221110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+|++.||.+||++.+.+..
T Consensus 215 ------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 ------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 011223457899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=309.65 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=192.3
Q ss_pred hcccCcCCcceEEEEEecC---------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLES---------------GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 385 (604)
.+.||+|+||.||+++... ...||+|.++.. .......+.+|++++++++|+||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4679999999999987532 235899998754 233346789999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 386 EEKLIIYEFLPNGSLFDLLHESRGV-------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 386 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
+..++||||+++++|.+++...... ....+++..++.++.|++.||+||| +++++||||||+||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nill--- 162 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNCLV--- 162 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhEEE---
Confidence 9999999999999999998653210 1123788999999999999999999 4799999999999999
Q ss_pred CCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh--CCCCCCCCCCCCCC
Q 007427 459 NDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT--GRIPGNGSPGNNET 530 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~~ 530 (604)
+++..+||+|||++........ ..++..|+|||+..+..++.++|||||||++|||++ +..||.....
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---- 238 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---- 238 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh----
Confidence 5566799999999876543221 122457999999988889999999999999999998 5667654211
Q ss_pred CCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.................... ......+..+.+++.+||+.||++||++.+|++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 -EQVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111110000000 0011123468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.22 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=198.3
Q ss_pred hhcccCcCCcceEEEEEec--------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEE
Q 007427 321 SAEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (604)
..+.||+|+||.||+|+.. ....+|+|.++... ......+.+|+++++++ +||||+++++++...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4678999999999999742 24579999987532 23346788999999999 69999999999999889999
Q ss_pred EEecCCCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC
Q 007427 391 IYEFLPNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 459 (604)
+|||+++|+|.+++..... .....+++.++..++.|++.||+||| ++||+||||||+||++ +
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill---~ 168 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVLV---T 168 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEEE---c
Confidence 9999999999999976431 11235899999999999999999999 4799999999999999 5
Q ss_pred CcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 007427 460 DIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSG 532 (604)
Q Consensus 460 ~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~ 532 (604)
.+..+||+|||+++....... ......|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------- 241 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------- 241 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-------
Confidence 556799999999987643221 122346999999998889999999999999999999 888886432
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
..+...... ....... .......+.+++.+||+.||++||++.|+++.|+++....
T Consensus 242 -~~~~~~~~~-~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 242 -VEELFKLLR-EGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -HHHHHHHHH-cCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111111111 1111110 1122346889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.50 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=194.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 46799999999999998777789999886543 23567899999999999999999999875 45688999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
++++... ...+++..+..++.|++.||+|||+ .+++||||||+||++ ++...+||+|||+++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~----~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER----MNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh----CCEeecccCcceEEE---cCCCeEEECCCccceEccCCccc
Confidence 9997643 2247899999999999999999994 699999999999999 6667899999999976543221
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...+..|+|||+..+..++.++|||||||++|||+| |+.||.+... .+..... .......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~-~~~~~~~------ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQV-ERGYRMP------ 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcCCCCC------
Confidence 123457999999988889999999999999999999 8999875321 1111111 1111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.....+..+.+++.+||+.||++||++++|++.|++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=304.28 Aligned_cols=249 Identities=21% Similarity=0.271 Sum_probs=185.7
Q ss_pred ccCcCCcceEEEEEecC---CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLES---GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578888876432 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++...........++.....++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 999998765332233567888999999999999999 4799999999999999 666789999999987543221
Q ss_pred ------CCccccccCCCCCCC-------CCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 480 ------ASENLAIGRSPEFPE-------GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~-------~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
....+..|+|||+.. ...++.++|||||||++|||++ |..||..... .+.........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~ 226 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQ 226 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhcc
Confidence 122345699999864 3456889999999999999999 7788764311 11111111111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
. .....+. ........+.+++..|| .||++||++.||++.|.
T Consensus 227 ~-~~~~~~~-----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 D-IKLPKPQ-----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C-ccCCCCc-----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0111110 11123345678889998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.08 Aligned_cols=241 Identities=17% Similarity=0.258 Sum_probs=190.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 46899999999999985 468999999997432 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEE---CCCCCEEEeecccceeccc
Confidence 99999997643 4899999999999999999999 4799999999999999 6667899999999865432
Q ss_pred CC------------------------------------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHH
Q 007427 478 RK------------------------------------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515 (604)
Q Consensus 478 ~~------------------------------------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ell 515 (604)
.. ...+++.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11 123678999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 007427 516 TGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK---MSEVLR 591 (604)
Q Consensus 516 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 591 (604)
+|+.||..... .+............... ........+.+++.+|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNP--------QETYRKIINWKETLQFP--------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCH--------HHHHHHHHcCCCccCCC--------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999975321 11112221111000000 001123457889999996 9999998 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.98 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=198.3
Q ss_pred cccCcCCcceEEEEEecC----CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLES----GAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|.... +..||+|.++..... ..+.+.+|++.+++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 889999999764433 367889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 398 GSLFDLLHESRGV----GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 398 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
++|.+++...... ....+++.++..++.|++.||+||| +++++||||||+||++ +.+..+||+|||.+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili---~~~~~~~l~dfg~~~ 153 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLV---GEDLVVKISDFGLSR 153 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEE---CCCCcEEEccccccc
Confidence 9999999875211 0135899999999999999999999 5799999999999999 666789999999998
Q ss_pred CCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
...... ...++..|+|||......++.++||||+||++|||++ |..||.... ..+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGY- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-
Confidence 776532 2345678999999988889999999999999999999 699987531 112222221111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
... .....+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLP----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 100 01122456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.63 Aligned_cols=243 Identities=26% Similarity=0.430 Sum_probs=195.0
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
++||+|+||.||++...+++.||+|.++..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999777999999998754332 4568999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++..... .+++..+..++.+++.||+||| +++++||||||+||++ +....+||+|||+++.......
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcce
Confidence 99976431 4789999999999999999999 4799999999999999 5566899999999876542221
Q ss_pred -----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 -----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 -----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
......|+|||...+..++.++|||||||++|||+| |..||..... ...... ........
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~-~~~~~~~~----- 215 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRER-IESGYRMP----- 215 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHH-HhcCCCCC-----
Confidence 122346999999988899999999999999999999 8888865321 111111 11111000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.....+..+.+++.+||..+|++||++.|+++.|++
T Consensus 216 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 -----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 011233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.12 Aligned_cols=242 Identities=20% Similarity=0.269 Sum_probs=194.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 468999999999999864 78999999997432 12346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +.+..+||+|||+++....
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 86 GDLMNLLIRKD-----VFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcc
Confidence 99999998653 4889999999999999999999 4799999999999999 6667899999999977654
Q ss_pred CC---------------------------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 478 RK---------------------------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 478 ~~---------------------------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 224678999999999999999999999999999999999999753
Q ss_pred CCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 007427 525 PGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK-MSEVLRR 592 (604)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 592 (604)
.. ......+......... .........+.+++.+|+. ||.+||+ +.|+++.
T Consensus 234 ~~--------~~~~~~i~~~~~~~~~--------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TL--------QETYNKIINWKESLRF--------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CH--------HHHHHHHhccCCcccC--------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21 1111111110000000 0001124468899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.32 Aligned_cols=242 Identities=17% Similarity=0.240 Sum_probs=191.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++. .+++.||+|.++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 47899999999999985 468999999996421 22335578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++... .++...+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 9999998753 3788889999999999999999 5799999999999999 6667899999999876643
Q ss_pred CC-----CCccccccCCCCCCCCC----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 478 RK-----ASENLAIGRSPEFPEGK----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.. ...++..|+|||++.+. .++.++|||||||++|||++|+.||.+.. .......+.......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHKNSL 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCcC
Confidence 22 23578899999988653 47899999999999999999999997532 112222222211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 592 (604)
... ........+.+++.+||+.+|++ ||++.|+++.
T Consensus 267 ~~~--------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFP--------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC--------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 01123346889999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.77 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=198.9
Q ss_pred HhhcccCcCCcceEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceE
Q 007427 320 ASAEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKL 389 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (604)
...+.||+|+||.||+|+.. .+..||+|.++.. .....+++.+|+++++++ +|+||++++++|...+..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 34678999999999999742 1237899988743 233456789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
++|||+++|+|.+++..... .....+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill--- 167 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLV--- 167 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEE---
Confidence 99999999999999976431 11235889999999999999999999 4799999999999999
Q ss_pred CCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 007427 459 NDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETS 531 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~ 531 (604)
+....+||+|||+++....... ...+..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------
Confidence 5556899999999876643221 122356999999999999999999999999999999 888886431
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
..+......... .... .......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 242 --~~~~~~~~~~~~-~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 --VEELFKLLKEGH-RMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --HHHHHHHHHcCC-CCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222322222211 1111 11223468899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=308.84 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=195.1
Q ss_pred hcccCcCCcceEEEEEecC-----------------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLES-----------------GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
.+.||+|+||.||+|+... +..||+|.+.... ....+.+.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4789999999999987542 3568999987543 334567899999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGV------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR 457 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~ 457 (604)
.++..+++|||+++++|.+++...... ....+++..++.++.|++.||+||| +++|+||||||+||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~Nili-- 163 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRNCLV-- 163 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchhceee--
Confidence 999999999999999999999765421 1225899999999999999999999 4799999999999999
Q ss_pred cCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh--CCCCCCCCCCCCC
Q 007427 458 ENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT--GRIPGNGSPGNNE 529 (604)
Q Consensus 458 ~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~ 529 (604)
+....++|+|||+++...... ....+..|+|||+..+..++.++|||||||++|||++ +..||.....
T Consensus 164 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05051 164 -GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--- 239 (296)
T ss_pred -cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence 666789999999987654322 1123457999999988889999999999999999998 6777754211
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.................... ......+.++.+++.+||+.||++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111110000000 0111223568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.23 Aligned_cols=191 Identities=21% Similarity=0.302 Sum_probs=165.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 46899999999999975 468999999997532 22235678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +....+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccc
Confidence 99999997643 4899999999999999999999 5799999999999999 5667899999999875432
Q ss_pred C---------------------------------------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC
Q 007427 478 R---------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR 518 (604)
Q Consensus 478 ~---------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~ 518 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1 1124678999999999999999999999999999999999
Q ss_pred CCCCCC
Q 007427 519 IPGNGS 524 (604)
Q Consensus 519 ~p~~~~ 524 (604)
.||.+.
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.84 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=191.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 47899999999999985 57899999999754444456788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.++++... ++++.++..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++......
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEE---CCCCCEEECcCccceeeccccc
Confidence 99987543 4889999999999999999999 4799999999999999 566679999999987654322
Q ss_pred ---CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 480 ---ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
...++..|+|||.+. ...++.++|||||||++|||++|+.||........ ... ...........
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~----~~~~~~~~~~~-- 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFL----MSKSNFQPPKL-- 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----hee----eecCCCCCCCC--
Confidence 234567899999874 44578899999999999999999999864321100 000 00000000000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.........+.+++.+||+.||++||+++++++.
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0011223468899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.47 Aligned_cols=248 Identities=22% Similarity=0.393 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 578999999999999753 24789999987443 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 395 LPNGSLFDLLHESRGV-----GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+++|+|.+++...... ....+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+||
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill---~~~~~~kl~df 163 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMV---AEDLTVKIGDF 163 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEE---cCCCCEEECCc
Confidence 9999999999754321 1224789999999999999999999 4799999999999999 66678999999
Q ss_pred cCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+++.+.... ...++..|+|||...+..++.++|||||||++||++| |+.||..... .+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~ 235 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKFVI 235 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHHHh
Confidence 9987654322 1233567999999988889999999999999999998 8999864211 11112221
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
... .... +......+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGG-HLDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCC-CCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 1110 11124468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.39 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=193.7
Q ss_pred hcccCcCCcceEEEEEec-----------------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-----------------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
.+.||+|+||.||+++.. ++..||+|+++.. ......++.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 467999999999998532 2457999999753 2334568999999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGVG------RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR 457 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~ 457 (604)
..+..++||||+++|+|.+++....... ...+++.++..++.|++.||+||| +++|+||||||+||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~Nili-- 163 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRNCLV-- 163 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChheEEE--
Confidence 9999999999999999999997643211 124788899999999999999999 4799999999999999
Q ss_pred cCCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh--CCCCCCCCCCCCC
Q 007427 458 ENDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT--GRIPGNGSPGNNE 529 (604)
Q Consensus 458 ~~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt--g~~p~~~~~~~~~ 529 (604)
+....+||+|||+++.+..... ......|++||...+..++.++|||||||++|||+| |..||.....
T Consensus 164 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05095 164 -GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--- 239 (296)
T ss_pred -cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---
Confidence 5566899999999876543221 122457899998888889999999999999999998 7788764321
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.................... .....+...+.+++.+||+.||++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111000000 0011233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=312.90 Aligned_cols=233 Identities=18% Similarity=0.237 Sum_probs=184.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC-CCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..++| ++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 468999999999999854 57899999997432 2234567889999999976 468889999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++...
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENI 152 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEE---cCCCCEEEeecCcceecC
Confidence 999999987643 4889999999999999999999 4799999999999999 556689999999986532
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+...........
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~~~----- 219 (324)
T cd05587 153 FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEHNVS----- 219 (324)
T ss_pred CCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC-----
Confidence 21 12246889999999999999999999999999999999999997532 11122222211110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+......+.+++.+||+.||.+|++.
T Consensus 220 -------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 -------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 001123357899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.28 Aligned_cols=245 Identities=21% Similarity=0.412 Sum_probs=195.2
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 478999999999999753 23479999987532 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++.... ..+++.++..++.|++.||+||| +++++||||||+||++ +.+..+||+|||+++.+.
T Consensus 89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 999999997643 24899999999999999999999 4799999999999999 566789999999998765
Q ss_pred CCCCC-------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 SRKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~~~~~-------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... ..+..|+|||++.+..++.++|||||||++||+++ |+.||..... .+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~-~~~~ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEE-GYRL 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhC-CCcC
Confidence 43211 11346999999998899999999999999999887 9999875321 111111111 1110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
. .....+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 229 ~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 P----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.03 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=195.4
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 468999999999999743 25589999986443 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 395 LPNGSLFDLLHESRG-----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+++|+|.+++..... .+....++..+..++.|++.||+||| +++|+||||||+||++ +.+..+||+||
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili---~~~~~~~L~Df 163 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMV---AHDFTVKIGDF 163 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEE---cCCCcEEECcC
Confidence 999999999975431 11234677889999999999999999 5799999999999999 56678999999
Q ss_pred cCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+++....... ..++..|+|||...+..++.++|||||||++|||++ |..||.+.. ..+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~ 235 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVLKFVM 235 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH
Confidence 99876543221 122456999999998899999999999999999999 788886421 122222222
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
....... .......+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 ~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLDQ-----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCCC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2211110 1112346899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.97 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=194.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 36799999999999984 57899999999765554567789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.|++.||+||| +.+|+||||||+||++ +.+..+||+|||++.......
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc
Confidence 9998653 3789999999999999999999 4799999999999999 556689999999987654322
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.. ..... .....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~-~~~~~----- 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNG-TPELQ----- 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCC-CCCCC-----
Confidence 23566789999999988899999999999999999999999975321 111111 11111 00000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||..||++||++.|+++.
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011233468899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.55 Aligned_cols=242 Identities=17% Similarity=0.227 Sum_probs=188.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 36899999999999974 578999999986432 22235678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+ +....+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 99999997643 4888999999999999999999 5799999999999999 5667899999999863321
Q ss_pred C---------------------------------------------------CCCccccccCCCCCCCCCCCCccchhHh
Q 007427 478 R---------------------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYC 506 (604)
Q Consensus 478 ~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwS 506 (604)
. ....++..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0 0123678899999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCC---
Q 007427 507 FGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR--- 583 (604)
Q Consensus 507 fGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--- 583 (604)
|||++|||+||+.||.+... .+............... ........+.+++.+|+. +|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p--------~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFP--------DDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCC--------CCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 99999999999999975321 11111111111000000 001123457899999997 77765
Q ss_pred CCHHHHHHH
Q 007427 584 PKMSEVLRR 592 (604)
Q Consensus 584 Ps~~evl~~ 592 (604)
+++.|+++.
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 599888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.67 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 468999999999999853 46889999987542 33356799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee
Q 007427 395 LPNGSLFDLLHESRG-----------------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR 457 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~ 457 (604)
+++|+|.+++..... .....+++.+++.++.|++.||+||| .++++||||||+||++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~nil~-- 163 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATRNCLV-- 163 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHhheEe--
Confidence 999999999975321 11234788999999999999999999 4799999999999999
Q ss_pred cCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 007427 458 ENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNET 530 (604)
Q Consensus 458 ~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~ 530 (604)
+....+||+|||+++.+.... .......|+|||...+..++.++|||||||++|||++ |..||.+..
T Consensus 164 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~----- 237 (288)
T cd05050 164 -GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA----- 237 (288)
T ss_pred -cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 566789999999987653221 1123456999999988899999999999999999998 888886431
Q ss_pred CCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
..+........... . .......++.+++.+||+.||++||++.|+++.|++
T Consensus 238 ---~~~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ---HEEVIYYVRDGNVL-S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHHHhcCCCC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222222222111 0 011223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.24 Aligned_cols=233 Identities=20% Similarity=0.279 Sum_probs=183.2
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHH-HHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQ-LLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
++||+|+||.||+|+. .+++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999986 468999999986432 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... .+++..+..++.||+.||+||| +++|+||||||+||++ +.+..+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCC
Confidence 99998887543 4788899999999999999999 4799999999999999 5666899999999875322
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ............. .
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~--~---- 214 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKPL--Q---- 214 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCC--C----
Confidence 11 2246789999999998899999999999999999999999997531 2222222222110 0
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
........+.+++.+||+.||.+||++.
T Consensus 215 ------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 ------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0111233588999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.59 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=198.3
Q ss_pred hcccCcCCcceEEEEEec-----CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-----SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 393 (604)
.+.||+|+||.||+|+.. ++..||+|.++..... ..+.+.+|++++++++|+||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 368999999999999853 4789999999755432 46789999999999999999999999877 557899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++..... .+++..+..++.|++.||+||| +++++||||||+||++ +.+..+||+|||.+.
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 9999999999976542 4899999999999999999999 4799999999999999 556789999999998
Q ss_pred CCCCCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-------CCchhHHHH
Q 007427 474 LLPSRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET-------SGDLSDWVR 539 (604)
Q Consensus 474 ~~~~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 539 (604)
....... ......|++||...+..++.++||||||+++|||+||+.|+......... ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7763221 12345689999998889999999999999999999999998653221100 001111111
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.. ...... ........++.+++.+||+.+|++||++.||+++|++++
T Consensus 238 ~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LL-KEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HH-HcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11 111000 001123356889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.92 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+|.. .+++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 36799999999999985 46899999998632 3345678899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.++++... ...+++.++..++.|++.||.||| +.+++||||||+||++ +....+||+|||+++.....
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCc
Confidence 9999998753 225899999999999999999999 4799999999999999 55567899999998876543
Q ss_pred CC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 KA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ..+...|+|||+..+..++.++|||||||++|||++|+.||.... -........... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~---- 221 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGV-FPPV---- 221 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-CCCC----
Confidence 22 245678999999999999999999999999999999999997532 111112221111 1110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.15 Aligned_cols=245 Identities=21% Similarity=0.368 Sum_probs=203.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchh---hHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|.||.||+++.+ +|+.+|+|.+++.... ....+.+|+++|+++. |||||.++++|++....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 368999999999999855 5999999999754332 3468999999999998 9999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-cceEEEeeccCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-IYRAKLTNFGFLPLL 475 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~~~~kl~DFGla~~~ 475 (604)
||.|.+.+... .+++..+..++.|++.+++||| +.||+||||||+|+|+...+. ...+|++|||++...
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999875 1899999999999999999999 579999999999999976654 458999999999988
Q ss_pred CCC---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 476 PSR---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 476 ~~~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
... ....+++.|+|||++....|+..+||||+||++|.|++|..||.+.... ... ..+....+ ++
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~~----~~i~~~~~--~f-- 257 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EIF----LAILRGDF--DF-- 257 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HHH----HHHHcCCC--CC--
Confidence 763 2346899999999999999999999999999999999999999874321 111 12222222 00
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...........+.+++..|+..||.+|+|+.++++.
T Consensus 258 ----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 ----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 011223445678999999999999999999999883
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.02 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=191.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.++||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 36899999999999984 57899999998643 23334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|..+. .+++..+..++.|++.||+||| +++|+|+||||+||++ +.+..+||+|||++.......
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc
Confidence 97542 2678889999999999999999 4799999999999999 666789999999987654332
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||.......... .............. ...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~-~~~------- 220 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDP-PVL------- 220 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCC-CCC-------
Confidence 2356779999999999899999999999999999999999997532211111 11111111111110 000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......++.+++.+||+.||++||++.|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=315.60 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=193.9
Q ss_pred hhcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecC-CceEEE
Q 007427 321 SAEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSK-EEKLII 391 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~~lv 391 (604)
..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 467899999999999973 357899999997533 22345688999999999 689999999988654 457899
Q ss_pred EecCCCCCHHHHhhcccCC-------------------------------------------------------------
Q 007427 392 YEFLPNGSLFDLLHESRGV------------------------------------------------------------- 410 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 410 (604)
|||+++|+|.++++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999998753210
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC------Ccc
Q 007427 411 -GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SEN 483 (604)
Q Consensus 411 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~------~~~ 483 (604)
....+++.++..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++....... ...
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0123788899999999999999999 5799999999999999 5566899999999876533211 123
Q ss_pred ccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCH
Q 007427 484 LAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQ 562 (604)
Q Consensus 484 ~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (604)
+..|+|||...+..++.++|||||||++|||++ |..||...... ...... ......... +.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~~----------~~ 305 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRR-LKEGTRMRA----------PD 305 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHH-HhccCCCCC----------CC
Confidence 456999999988899999999999999999997 89998653210 111111 111111100 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 563 NEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.....+.+++.+||+.||++||++.||++.|+.+.+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112358899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.27 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=195.6
Q ss_pred hhcccCcCCcceEEEEEecC----CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATLES----GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
..+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 35789999999999998543 3579999887544 3445689999999999999999999998875 5678999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++.++..++.|++.||+||| +++++||||||+||++ +....+||+|||+++..
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 9999999997643 24899999999999999999999 4799999999999999 55567999999998766
Q ss_pred CCCCC-----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 476 PSRKA-----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 476 ~~~~~-----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
..... ......|+|||......++.++|||||||++||+++ |+.||..... . +........... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~---~~~~~~~~~~~~-~ 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----N---DVIGRIENGERL-P 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----H---HHHHHHHcCCcC-C
Confidence 44321 122347999999988889999999999999999996 9999875321 1 111111111110 0
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.....+..+.+++.+|+..+|++|||+.++++.|+++++.
T Consensus 229 ----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 ----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112334688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.81 Aligned_cols=254 Identities=16% Similarity=0.217 Sum_probs=188.0
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..+.||+|+||.||++... .++.||||... ...+.+|++++++++|+||+++++++...+..++||||+ .++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence 3468999999999999864 58899999643 234578999999999999999999999999999999999 479
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++.+++.|+.|+++||+||| ++||+||||||+|||+ +....+||+|||+++......
T Consensus 246 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 246 LYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccc
Confidence 999887543 25899999999999999999999 4799999999999999 666789999999997654322
Q ss_pred ------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc----cc
Q 007427 480 ------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS----TD 549 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 549 (604)
...++..|+|||++.+..++.++|||||||++|||++|..|+.................+.+...... ..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 12478899999999999999999999999999999998876654321111111111111111111100 00
Q ss_pred cccHHh----hh-------c----ccCH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 550 ILDVEI----LA-------A----REGQ---NEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 550 ~~~~~~----~~-------~----~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.....+ .. . .... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00 0 0000 112357899999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.91 Aligned_cols=233 Identities=19% Similarity=0.243 Sum_probs=185.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 468999999999999854 67899999997532 12234566788888777 58999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++...
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENM 152 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEE---CCCCcEEEccCCCceecC
Confidence 999999987643 4889999999999999999999 4799999999999999 666789999999987543
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||.+.. .......+......
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~~~~----- 219 (323)
T cd05616 153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVA----- 219 (323)
T ss_pred CCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC-----
Confidence 21 12346789999999999999999999999999999999999997532 11222222221110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+.....++.+++.+|++.||++|++.
T Consensus 220 -------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 -------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.90 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=198.1
Q ss_pred ccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHH
Q 007427 324 VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 402 (604)
+||+|.||+||.|+. .+...+|||.+........+-+..|+.+.++++|.|||+++|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999985 4567899999987766667788999999999999999999999999999999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC----C
Q 007427 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----R 478 (604)
Q Consensus 403 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~----~ 478 (604)
+++..-+ ...=++.+.-.+.+||++||.|||+ +.|||||||-+|||+. ...+.+||+|||-++.+.. .
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHe----n~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHE----NKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhh----cceeeccccCCcEEEe--eccceEEecccccchhhccCCccc
Confidence 9987653 2222778888999999999999994 7999999999999994 4457899999998877643 3
Q ss_pred CCCccccccCCCCCCCCC--CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 KASENLAIGRSPEFPEGK--RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 ~~~~~~~~y~aPE~~~~~--~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....|+..|||||++..+ .|..++|||||||++.||.||++||....... .. .+.-+..+ .
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------AA-MFkVGmyK-------v 796 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------AA-MFKVGMYK-------V 796 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------Hh-hhhhccee-------c
Confidence 455789999999999854 58999999999999999999999997543211 00 11111000 0
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...-+.+...+...+|.+|+.+||.+||++.++++
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11223456667899999999999999999999875
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.22 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=199.8
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
..+.||+|+||+||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 457899999999999985 468999999886432 334578899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ++++..+..++.+++.||.|||+ .++++||||||+||++ ++...++|+|||++......
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9999987643 48999999999999999999995 3589999999999999 66678999999998765322
Q ss_pred C--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC---CCchhHHHHHHHhcCCccccccH
Q 007427 479 K--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET---SGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 479 ~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ...++..|+|||++.+..++.++|||||||++|||+||+.||......... ...+.++......... ...
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 233 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRL--- 233 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-CCC---
Confidence 2 235678899999998888999999999999999999999999864322111 1112222222221110 000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
........+.+++.+||+.||++||++.|++++.--+
T Consensus 234 ------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 234 ------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0012344688999999999999999999999874333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=316.20 Aligned_cols=233 Identities=21% Similarity=0.297 Sum_probs=189.7
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEecccchh---hHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
...+||+|.||+|+++.. .+++.+|||.+++.... +.+..+.|.+++... +||.++.++..|+..++.|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 357899999999999985 46889999999875433 345667788887766 5999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.|||+..+.+.. .+++..+.-++..|+.||+||| .+|||+||||.+|||+ |..+.+||+|||+++..
T Consensus 452 ~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 452 AGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEG 518 (694)
T ss_pred CCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEE---cccCcEEeccccccccc
Confidence 999955444433 3999999999999999999999 5899999999999999 77778999999999875
Q ss_pred CCC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
... ...-||+.|+|||++.+..|+.++|.|||||+||||+.|..||.+... .+....+...+.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~FdsI~~d~~----- 585 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFDSIVNDEV----- 585 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCC-----
Confidence 422 234689999999999999999999999999999999999999986421 111222222111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.++.....+..+++.+++..+|++|-.+
T Consensus 586 -------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1223345578899999999999999876
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.42 Aligned_cols=242 Identities=17% Similarity=0.222 Sum_probs=192.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+++. .+|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 46899999999999985 478999999997532 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||++..+..
T Consensus 86 ~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 86 GDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEE---CCCCCEEeccCCCCeECCC
Confidence 99999998653 24899999999999999999999 5799999999999999 6667899999999977653
Q ss_pred CC-----CCccccccCCCCCCC------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 478 RK-----ASENLAIGRSPEFPE------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.. ...++..|+|||++. ...++.++|||||||++|||++|+.||..... ......+.....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 32 224678999999986 45678999999999999999999999975321 112222221111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ........+.+++.+|++ +|++||++.++++
T Consensus 227 ~~~~~--------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFP--------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCC--------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 011223467899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.44 Aligned_cols=196 Identities=24% Similarity=0.396 Sum_probs=159.0
Q ss_pred hcccCcCCcceEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE---SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
+.+||+|+||+||+|+.. ++..||+|.++... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 45789999987543 23467899999999999999999999854 456789999996
Q ss_pred CCCHHHHhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec-CCcceEEEeeccC
Q 007427 397 NGSLFDLLHESRG----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGF 471 (604)
Q Consensus 397 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~~~~kl~DFGl 471 (604)
++|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+|||+..+ +....+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 588888754321 12235889999999999999999999 5799999999999999543 3456899999999
Q ss_pred CCCCCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 472 LPLLPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 472 a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 98764322 1245778999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.11 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=193.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+++. .++..+|+|.++.. ......++.+|++++++++||||+++++++..++..++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 46799999999999985 46889999998743 22334668899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.++++... .+++..+..++.|+++||.|||+ ..+++||||||+||++ +.+..+||+|||++......
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 86 LDQVLKKAG-----RIPENILGKISIAVLRGLTYLRE---KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---hCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc
Confidence 999997653 48899999999999999999995 2589999999999999 55567899999998765432
Q ss_pred -CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc---------
Q 007427 479 -KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST--------- 548 (604)
Q Consensus 479 -~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 548 (604)
....++..|+|||...+..++.++|||||||++|||++|+.||..... .....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-----hhHHHhhcCccccccccCCcccccCC
Confidence 223467789999999888899999999999999999999999864321 01111100000000000
Q ss_pred -----------ccccHHhhh---cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 -----------DILDVEILA---AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 -----------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+..+..... ..........+.+++.+||..||++||++.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000123468899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.07 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=199.3
Q ss_pred hhcccCcCCcceEEEEEec--CC--cEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 321 SAEVLGKGKVGSTYKATLE--SG--AVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
..++||+|.||.|++|.|. +| ..||||.++..... ...+|.+|+.+|.+|+|+|++++||+..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999875 34 46899999865443 56899999999999999999999999887 7789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+.|+|.+.|++.. +..+-......++.|||.||.||. ++++|||||..+|+|+. ..-.+||+|||+.+-+
T Consensus 193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNllla---sprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLA---SPRTVKICDFGLMRAL 262 (1039)
T ss_pred ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheec---ccceeeeecccceecc
Confidence 9999999999832 235778888999999999999999 68999999999999994 4457899999999988
Q ss_pred CCCCCCc-------cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSRKASE-------NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~~~~~-------~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
....... -...|.|||.+....++.+||||+|||++|||+| |..||.+.... +..+.+-+...
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~er- 333 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGER- 333 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhcccccc-
Confidence 7654332 2346889999999999999999999999999999 88999875431 11111111111
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
-..++.+.+++.++++.||..+|.+||++..|.+.+-
T Consensus 334 ----------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 334 ----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1223467788999999999999999999999985543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.73 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=194.5
Q ss_pred cccCcCCcceEEEEEecC-------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLES-------GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 3579999886432 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC--CcceEEEeecc
Q 007427 395 LPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--DIYRAKLTNFG 470 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--~~~~~kl~DFG 470 (604)
+++++|.+++...... ....+++.+++.++.|++.||+||| +.+++|+||||+||+++.++ ....+|++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999764321 1234789999999999999999999 47999999999999996543 23479999999
Q ss_pred CCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 471 FLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 471 la~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
+++...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||..... .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~ 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTA 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhc
Confidence 987654321 1123467999999999999999999999999999998 9999864211 111111111
Q ss_pred cCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.. ... .....+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 229 ~~-~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GG-RLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CC-ccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 000 111234568899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.92 Aligned_cols=241 Identities=19% Similarity=0.239 Sum_probs=185.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999985 568999999997432 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccc
Confidence 99999997643 4788899999999999999999 4799999999999999 6667899999999753210
Q ss_pred C---------------------------------------------------CCCccccccCCCCCCCCCCCCccchhHh
Q 007427 478 R---------------------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYC 506 (604)
Q Consensus 478 ~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwS 506 (604)
. ....++..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0 0123677899999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-
Q 007427 507 FGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK- 585 (604)
Q Consensus 507 fGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 585 (604)
|||++|||++|+.||.+... .+............... .......++.+++.+|+ .+|.+|++
T Consensus 234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p--------~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTP--------LETQMKVINWQTSLHIP--------PQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred chHHHHHHHhCCCCCCCCCH--------HHHHHHHHccCCCcCCC--------CcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 99999999999999975321 11111111111000000 00112335677777765 49999997
Q ss_pred --HHHHHH
Q 007427 586 --MSEVLR 591 (604)
Q Consensus 586 --~~evl~ 591 (604)
+.|+++
T Consensus 297 ~~~~ei~~ 304 (382)
T cd05625 297 NGADEIKA 304 (382)
T ss_pred CCHHHHhc
Confidence 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=320.21 Aligned_cols=242 Identities=18% Similarity=0.242 Sum_probs=187.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999985 4689999999964321 2245678999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+ +....+||+|||+|..+..
T Consensus 86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccc
Confidence 99999997643 4788889999999999999999 4799999999999999 5666899999999753210
Q ss_pred C-----------------------------------------------CCCccccccCCCCCCCCCCCCccchhHhHHHH
Q 007427 478 R-----------------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYCFGII 510 (604)
Q Consensus 478 ~-----------------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvv 510 (604)
. ....++..|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 01246788999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC---CHH
Q 007427 511 LLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP---KMS 587 (604)
Q Consensus 511 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ 587 (604)
+|||++|+.||.+... .+.............. .........+.+++.+|+ .+|.+|+ ++.
T Consensus 234 lyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~--------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 234 LYEMLVGQPPFLADTP--------AETQLKVINWETTLHI--------PSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eeehhhCCCCCCCCCH--------HHHHHHHhccCccccC--------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 9999999999975321 1111111111000000 000112335677888876 4999999 888
Q ss_pred HHHHH
Q 007427 588 EVLRR 592 (604)
Q Consensus 588 evl~~ 592 (604)
|+++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.72 Aligned_cols=242 Identities=17% Similarity=0.240 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++.. +++.||+|.+.+.. ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999864 68899999986421 22345678999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence 9999999753 3788899999999999999999 5799999999999999 6667899999999987643
Q ss_pred CC-----CCccccccCCCCCCCCC----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 478 RK-----ASENLAIGRSPEFPEGK----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.. ...++..|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.......
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~ 266 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKNSL 266 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCccc
Confidence 22 23578899999998654 37889999999999999999999997532 112222222211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 592 (604)
... ........+.+++.+|+..++.+ ||++.|+++.
T Consensus 267 ~~p--------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFP--------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCC--------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100 01122345778999999865543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.41 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=183.8
Q ss_pred ccCcCCcceEEEEEecCC---cEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLESG---AVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||.||+++..++ ..+++|.++... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 356677765432 3345789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.++++..... ....++.....++.|+++||+||| +.+++||||||+|||+ +....+||+|||++......
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEE---cCCccEEecccccccccCcch
Confidence 99999865321 224677788899999999999999 4699999999999999 66678999999998643211
Q ss_pred -----CCCccccccCCCCCCCC-------CCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 479 -----KASENLAIGRSPEFPEG-------KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 479 -----~~~~~~~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
....++..|+|||+... ..++.++|||||||++|||++ |..||.... ..+.........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~ 225 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQ 225 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhc
Confidence 12245678999998753 345789999999999999997 566775321 112222222211
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
. ....++... ......+.+++..|| .+|++||+++||++.|.
T Consensus 226 ~-~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 Q-VKLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred c-cccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 111111111 112345778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=297.68 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=191.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch-----hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA-----LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|++|.||++.. .+++.||+|.++.... ...+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 57899999999999985 5689999999864321 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++ +.+..++|+|||+++..
T Consensus 87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL 154 (263)
T ss_pred CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---cCCCCEEEeecccceec
Confidence 9999999987643 4888999999999999999999 4799999999999999 55567999999998765
Q ss_pred CCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ...+...|+|||...+..++.++||||||+++|||++|+.||..... ... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~~~~~ 226 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAA-IFKIATQPTNP 226 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHH-HHHHhccCCCC
Confidence 4321 22355689999999998899999999999999999999999864211 111 11111111111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. ........+.+++.+||..+|++||++.|+++.
T Consensus 227 ~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 Q----------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C----------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 011233468899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=298.57 Aligned_cols=244 Identities=30% Similarity=0.496 Sum_probs=197.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 46899999999999998888899999987543 34578999999999999999999999999888999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++..... ..+++.++..++.|++.||+||| +++++|+||||+||++ +++..+||+|||.++......
T Consensus 90 ~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 90 DFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred HHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEE---cCCCCEEECccccceeccchhhh
Confidence 99976431 24899999999999999999999 4799999999999999 666789999999987765321
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.......|+|||...+..++.++|||||||++||++| |+.||.+... .......... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~-~~~~------ 224 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERG-YRMP------ 224 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC-CCCC------
Confidence 1123457999999998889999999999999999999 9999864311 1111111111 1000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 ----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.21 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=183.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC--------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 57899999999999985 468999999885432 2345799999999999999999987432 1356899
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+++..... ....+++..+..++.|++.||+||| +++|+||||||+|||++.+ ...+||+|||+|
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~--~~~vkL~DFGla 218 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPN--THTLKLCDFGSA 218 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCC--CCceeeeccccc
Confidence 99975 78887764321 1235899999999999999999999 5799999999999999432 246899999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH------
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV------ 542 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 542 (604)
+.+.... ...++..|+|||++.+ ..++.++|||||||++|||+||++||.+.... ..+...+....
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHH
Confidence 8764332 2356788999998865 46899999999999999999999999764221 11111111100
Q ss_pred ----hcCCc----cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 ----DNDWS----TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 ----~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+. .......+ ....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l-~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDL-KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhH-HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 00000000 00001112356889999999999999999999984
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.77 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=186.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 47899999999999985 46899999999642 2233567889999999999999999999986543 469999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+.++. .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||++
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a 170 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 170 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEE---CCCCCEEEecCCCc
Confidence 99965 67776643 3788899999999999999999 5799999999999999 66678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCC----------CCCchhH---
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE----------TSGDLSD--- 536 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~----------~~~~~~~--- 536 (604)
+...... ...++..|+|||.+.+..++.++|||||||++|||+||+.||.+...... ....+.+
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 7654322 23567889999999999999999999999999999999999975421100 0000000
Q ss_pred -HHHHHHhcC-Ccccc-ccHHhhh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 537 -WVRMVVDND-WSTDI-LDVEILA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 537 -~~~~~~~~~-~~~~~-~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.+....... ..... ....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 00000 0000000 00001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.78 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=192.2
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3467999999999999865 578899999876555556778999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|..++.... .++++..+..++.|++.||+||| +.+|+||||||+||++ +....+||+|||++......
T Consensus 89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999886532 25899999999999999999999 4799999999999999 55567999999998765332
Q ss_pred ---CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 ---KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... .+.+......... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~-~~ 228 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPP-TL 228 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCCC-CC
Confidence 2234677899999874 45578899999999999999999999864321 1111111111110 00
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ........+.+++.+||+.||.+||++.++++
T Consensus 229 ~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 A--------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01122346889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.88 Aligned_cols=193 Identities=21% Similarity=0.257 Sum_probs=159.7
Q ss_pred hcccCcC--CcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKG--KVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.++||+| +|++||+++. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 7899999974 679999999997432 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +....++++||+.+....
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMI 152 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEE---ecCCcEEEcccchhhccc
Confidence 9999999975432 24899999999999999999999 4799999999999999 555678999998654332
Q ss_pred CC-----------CCCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 477 SR-----------KASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 477 ~~-----------~~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 11 11234567999999876 45899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.58 Aligned_cols=255 Identities=21% Similarity=0.335 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 393 (604)
.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46899999999999985 57999999998643 2234467889999999999999999999998776 7899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+. ++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLV---NSNCVLKICDFGLAR 151 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEE---CCCCCEEecccccee
Confidence 996 58888876533 4899999999999999999999 5799999999999999 666789999999987
Q ss_pred CCCCCC-----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC--------CCchhHH--
Q 007427 474 LLPSRK-----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNET--------SGDLSDW-- 537 (604)
Q Consensus 474 ~~~~~~-----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~-- 537 (604)
...... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....... .....++
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 654322 12356789999998764 4789999999999999999999999764321000 0000000
Q ss_pred ----HHH-HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 538 ----VRM-VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 538 ----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
... ........... ... .........++.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSL-PVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCch-HHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 00000000000 000 00001123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.42 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=195.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.++||+|+||.||+|+. .+|+.||+|+++... ....+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 46899999999999985 468999999997432 22356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 398 GSLFDLLHESRGV------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 398 gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
|+|.+++...... ....+++..+++++.||++||+||| ++||+||||||+||++ +....+||+|||+
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILL---d~dg~vKLiDFGL 159 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILL---GLFGEVVILDWGA 159 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEE---cCCCCEEEEecCc
Confidence 9999998753211 1124677888999999999999999 4799999999999999 5666789999999
Q ss_pred CCCCCCC----------------------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCC
Q 007427 472 LPLLPSR----------------------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529 (604)
Q Consensus 472 a~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~ 529 (604)
++..... ....++..|+|||+..+..++.++|||||||++|||+||+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 9765210 0124678999999999999999999999999999999999999753211
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcc
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-KMSEVLRRIEEIQP 598 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 598 (604)
.... ... ..++... ......+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus 238 ---ki~~--~~~--------i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 ---KISY--RDV--------ILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hhhh--hhh--------ccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 000 0000000 00112334688999999999999996 67778787877643
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=296.55 Aligned_cols=243 Identities=27% Similarity=0.451 Sum_probs=195.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||++...++..+|+|.++... ...+.+.+|++++++++|+||+++++++.. ...+++|||+++++|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 47899999999999998778889999887543 245678999999999999999999999887 7789999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++ +....+||+|||.+........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~----~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ----RNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh----CCccccccCcceEEE---cCCCcEEECCCcceeeccCCCcc
Confidence 9997643 2247899999999999999999994 699999999999999 6667899999999876543221
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
..+...|+|||++....++.++|||||||++||++| |+.||..... ..+... .........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~----~~~~~~~~~----- 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRA----LERGYRMPR----- 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH----HhCCCCCCC-----
Confidence 123456999999998889999999999999999999 8999875311 111111 111111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=296.12 Aligned_cols=241 Identities=24% Similarity=0.426 Sum_probs=193.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||++...++..+|+|.++... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 46899999999999988778899999987433 23567899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++..... .+++..+..++.|++.||+|||+ .+++||||||+||++ +....+||+|||+++.......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~----~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 88 DYLRAQRG----KFSQETLLGMCLDVCEGMAYLES----SNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH----CCccccccccceEEE---cCCCeEEECCCcceeecccCccc
Confidence 99976432 47899999999999999999994 699999999999999 5566899999999876543221
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...+..|+|||...+..++.++|||||||++|||++ |+.||.... ........... ... ..+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~-~~~--~~~-- 223 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAG-FRL--YKP-- 223 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCC-CCC--CCC--
Confidence 123457999999998899999999999999999998 999986421 11222222111 100 000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
......+.+++.+||+.+|++||++.|++++|
T Consensus 224 ------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 ------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 01234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.11 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=191.5
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 457899999999999985 5689999999875544445668899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... .+++.++..++.|++.||+||| +.|++|+||||+||++ +....+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 93 LQDIYHVTG-----PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 999987543 4899999999999999999999 4699999999999999 55667999999998655332
Q ss_pred ---CCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 479 ---KASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... . ................
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~-~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------R-ALFLMTKSNFQPPKLK 232 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------h-hHHhhhccCCCCCccc
Confidence 2235678899999874 456889999999999999999999998643211 0 0011111111111000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|++||++.++++
T Consensus 233 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 -------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00112235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.39 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=197.0
Q ss_pred hcccCcCCcceEEEEEec-CCc----EEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGA----VVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|... +|. .+|+|.++.... .....+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 478999999999999853 333 689998875432 345678899999999999999999999987 7889999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||.++..
T Consensus 91 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 91 PLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (279)
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence 99999999986532 4899999999999999999999 4799999999999999 55668999999999876
Q ss_pred CCCCCC------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~~------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...... ..+..|+|||......++.++|||||||++||+++ |+.||.+.. ..++...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 231 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGERLP 231 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCCCC
Confidence 543221 12356999999988889999999999999999999 999987532 122222222111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. +......+.+++.+||..||++||++.++++.|+++....
T Consensus 232 ~-----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 232 Q-----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred C-----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0 1112235789999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.62 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 468999999999999854 68899999987432 22345678899999999999999999999999999999999975 8
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++......
T Consensus 90 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 90 LKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 988886543 24788999999999999999999 4799999999999999 566689999999987653322
Q ss_pred ----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC----Cc---
Q 007427 480 ----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND----WS--- 547 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~--- 547 (604)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+.... ..+....+ ..... +.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE----DELHLIFR-LLGTPTEETWPGIS 233 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH-HhCCCCHHHHhhhc
Confidence 2245778999998765 46889999999999999999999999754221 11111110 00000 00
Q ss_pred --cccccHHhhhc------ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 --TDILDVEILAA------REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 --~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+...... .........+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 000122346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.41 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=190.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++|+||+.+.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 36799999999999985 5789999999864321 2234578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ...+++..+..++.|++.||.||| +++|+||||||+||++ ++...+||+|||++.....
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCC
Confidence 99999887543 225899999999999999999999 4799999999999999 5566899999999876543
Q ss_pred CC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~~~-------- 222 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLETEE-------- 222 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhcccc--------
Confidence 22 235678999999999889999999999999999999999999753210 001111111111100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.........+.+++.+||+.||++||+ +.++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001122335789999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=297.70 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=190.3
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
..||+|+||.||+|+. .++..||+|.+........+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 4799999999999984 467899999987665556678999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 402 DLLHESRGVGRIPL--AWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
+++..... ++ ++..+..++.|++.||+||| +++|+||||||+||+++.+ ...+||+|||.+.......
T Consensus 94 ~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 94 ALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred HHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCC
Confidence 99986431 24 78888999999999999999 4799999999999999432 3478999999987654321
Q ss_pred ----CCccccccCCCCCCCCCC--CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 480 ----ASENLAIGRSPEFPEGKR--LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~--~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
...++..|+|||++.... ++.++|||||||++|||++|+.||...... ....+....... ...
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--~~~---- 232 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFKI--HPE---- 232 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhcc--CCC----
Confidence 224677899999986543 788999999999999999999998642110 011110000000 000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 233 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 ------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01123346889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.60 Aligned_cols=234 Identities=17% Similarity=0.233 Sum_probs=185.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+..|..++..+. |++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 36899999999999985 468999999997432 223356778888888885 5778889999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||+++...
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEE---CCCCCEEEeccccccccC
Confidence 999999987643 4899999999999999999999 4799999999999999 566689999999987643
Q ss_pred CCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
... ...++..|+|||++.+..++.++|||||||++|||+||+.||.+... .............
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~----- 219 (323)
T cd05615 153 VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVS----- 219 (323)
T ss_pred CCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-----
Confidence 221 23477899999999998999999999999999999999999975321 1122222221110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
.+......+.+++.+||+.||.+|++..
T Consensus 220 -------~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 -------YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0111234578999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=318.07 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=206.1
Q ss_pred HHHHHHhhcccCcCCcceEEEEEe-cCC----cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce
Q 007427 315 DDLLRASAEVLGKGKVGSTYKATL-ESG----AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK 388 (604)
Q Consensus 315 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 388 (604)
+|.+....++||+|+||+||+|.+ ..| .+||+|++... .....+++.+|+-+|.+++|||+++++++|.... .
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 344444568999999999999974 443 47899988654 3344688999999999999999999999998766 8
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
.||++||+.|+|.+|++.+++ ++..+..+.|..|||+||.|||+ ++++||||.++|||+. ..-.+||.|
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~----qrlVHrdLaaRNVLVk---sP~hvkitd 841 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE----QRLVHRDLAARNVLVK---SPNHVKITD 841 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh----cchhhhhhhhhheeec---CCCeEEEEe
Confidence 899999999999999998764 58889999999999999999994 7999999999999994 445789999
Q ss_pred ccCCCCCCCCCCCcc------ccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 469 FGFLPLLPSRKASEN------LAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 469 FGla~~~~~~~~~~~------~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+++.+........ ...|+|-|.+....|+.++|||||||++||++| |..||++.+.. . +...
T Consensus 842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----e----I~dl 912 (1177)
T KOG1025|consen 842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----E----IPDL 912 (1177)
T ss_pred cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----H----hhHH
Confidence 999999876654322 235677888888999999999999999999999 99999875421 1 2222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
++.+.. -..++.+...+..++.+||..|+..||+++++.+.+.++....+
T Consensus 913 le~geR----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 913 LEKGER----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred Hhcccc----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 222211 11234566678899999999999999999999999998765543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=301.72 Aligned_cols=240 Identities=23% Similarity=0.411 Sum_probs=194.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 35799999999999974 57899999999755444567789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.|++.||+||| +++++||||||+||++ +....+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc
Confidence 9998653 3899999999999999999999 5799999999999999 556689999999987654332
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..... . .......... .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~-~~~~~~~~~~-~~~~~----- 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------L-RALYLIATNG-TPELQ----- 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHhcC-CcccC-----
Confidence 22466789999999988899999999999999999999999975321 1 1111111111 10000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||..||++||++.++++
T Consensus 237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11123346889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.03 Aligned_cols=240 Identities=23% Similarity=0.399 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46899999999999985 57999999999765555567788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.|++.||.||| +.+|+||||||+||++ +....+||+|||++.......
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 104 TDVVTET------CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc
Confidence 9998653 3788999999999999999999 4699999999999999 556689999999987654332
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||...+..++.++|||||||++|+|++|+.||........ .. ...... .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~----~~~~~~-~~~~~----- 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY----LIATNG-TPELQ----- 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----ee----eeccCC-CCCCC-----
Confidence 23466789999999988899999999999999999999999975322110 00 000000 00000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++||++.++++
T Consensus 237 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=296.17 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=194.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||++.. .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++++...+..+++|||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 46899999999999985 46899999998642 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... ..+++.....++.|++.||+||| +++|+|+||||+||++ ++...++++|||.+.......
T Consensus 85 l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 85 LMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 9999875432 24788999999999999999999 4799999999999999 556689999999987664332
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||+..+..++.++||||||+++|+|++|+.||.... .............. ..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~----- 220 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQGSYK-PL----- 220 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhcCCCC-CC-----
Confidence 2346678999999998889999999999999999999999997421 12222222211111 00
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++||++.|++..
T Consensus 221 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.19 Aligned_cols=244 Identities=19% Similarity=0.246 Sum_probs=191.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 36799999999999985 4689999999864321 2234577899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ...+++.++..++.|++.||.||| +++|+||||||+||++ +....++|+|||++.....
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCC
Confidence 99999986543 224889999999999999999999 4799999999999999 5666799999999876543
Q ss_pred CCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
... ..++..|+|||++.+..++.++|||||||++|||++|+.||...... ............. ..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~-~~------ 222 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEV-QE------ 222 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhh-hh------
Confidence 322 35678999999999999999999999999999999999999753211 0001111111100 00
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.........+.+++.+||+.||++||| +.|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 001122345789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=299.97 Aligned_cols=238 Identities=25% Similarity=0.389 Sum_probs=192.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 46799999999999985 468899999987432 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++... .+++..+..++.|+++||.||| .++++|+||+|+||++ ++...+|++|||++..+....
T Consensus 89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 89 ALDLLKPG------PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence 99998643 4889999999999999999999 4799999999999999 555679999999987765432
Q ss_pred C----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 A----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ..++..|+|||++.+..++.++|||||||++|||+||+.||...... . .... ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~---~~~~-~~~~~~~~------ 220 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----R---VLFL-IPKNSPPT------ 220 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----h---HHhh-hhcCCCCC------
Confidence 2 23567899999999988999999999999999999999998643211 0 1111 11111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|++||++.|+++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 ----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01123346889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.59 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=183.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC------CCcccEEEEEecC-CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH------ENLAKIVSFYYSK-EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~lv~e 393 (604)
.++||+|+||+||+|.. .+++.||||+++.... ....+..|++++.+++| .+++++++++... .+.++|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 46899999999999985 4688999999965322 23455667777766654 5588999988764 46889999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-------------
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND------------- 460 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~------------- 460 (604)
++ +++|.+++.... .+++..+..|+.||+.||+|||+ ..||+||||||+|||++.++.
T Consensus 213 ~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 213 KY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHT---ELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred cc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 98 779999887643 48999999999999999999994 149999999999999965432
Q ss_pred cceEEEeeccCCCCCCCC-CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC------C-
Q 007427 461 IYRAKLTNFGFLPLLPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS------G- 532 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~-~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~------~- 532 (604)
...+||+|||.+...... ....++..|+|||++.+..++.++|||||||++|||+||+.||.+........ .
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 235899999987654332 23467889999999999999999999999999999999999997643110000 0
Q ss_pred chhHHHH--------HHHhc-CCccccccHHhh----hcc--cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 533 DLSDWVR--------MVVDN-DWSTDILDVEIL----AAR--EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 533 ~~~~~~~--------~~~~~-~~~~~~~~~~~~----~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.-..|.. ..... .......++... ... ........+.+|+.+||+.||++|||+.|+++
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000100 00000 000000000000 000 00011345789999999999999999999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.07 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=191.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||+++++++..+...++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 467999999999999864 5899999999766555567889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
..++.... ..+++..+..++.|++.||+||| +++++||||||+||++ +....+||+|||++......
T Consensus 97 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 97 DAIMLELD----RGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEE---cCCCCEEEccCccceecccccc
Confidence 98876543 24899999999999999999999 4799999999999999 55567999999998654322
Q ss_pred --CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 479 --KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ............. ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~-~~~ 236 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPP-TLS 236 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCc-cCC
Confidence 1224567899999884 34568899999999999999999999864321 1111111111110 000
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++||++.|+++
T Consensus 237 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 --------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01122346889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.50 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE---SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++||||+. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 468999999999999743 4678999988643 345689999999999999999999999999999999995 6
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++.....
T Consensus 171 ~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 171 DLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEE---cCCCCEEEccCccccccCcc
Confidence 8999884332 5899999999999999999999 4799999999999999 66678999999998766433
Q ss_pred C------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC--Ccc--
Q 007427 479 K------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND--WST-- 548 (604)
Q Consensus 479 ~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 548 (604)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+..... ....+...++...... +..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCcc
Confidence 2 2357889999999999999999999999999999999999997654321 1111111111110000 000
Q ss_pred -----------------ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 -----------------DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
....+... ........+.+++.+||..||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVI---RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchh---hccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000123467889999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.79 Aligned_cols=232 Identities=15% Similarity=0.205 Sum_probs=179.2
Q ss_pred cCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccC---CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKL---KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 325 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
||+|+||+||+|+. .+++.||+|++..... .....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 4689999999864321 1223445566666655 699999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||++||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILL---DATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCC
Confidence 99999987543 4889999999999999999999 5799999999999999 5666899999999876432
Q ss_pred CC----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 478 RK----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ...++..|+|||++.+. .++.++|||||||++|||+||+.||.... ..+........... ...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~--~~~ 218 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGKVR--FPK 218 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCCCC--CCC
Confidence 21 23478899999998754 48999999999999999999999997531 12222222211110 000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
......+.+++.+||+.||++||++.
T Consensus 219 ---------~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 ---------NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ---------ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 01233578999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.90 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=195.4
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCce
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEK 388 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 388 (604)
+.+..-++...++||+||.+.||++...+.+.||+|++.. .+......|.+|+..|.+| .|.+||.+++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3344444555689999999999999998889999998863 3444567899999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
||||||-+ .||..+|+.... ....| .++.+..|++.++.+.|+ +||||.||||.|+|+.+ +.+||+|
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~----~gIVHSDLKPANFLlVk----G~LKLID 502 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQ----HGIVHSDLKPANFLLVK----GRLKLID 502 (677)
T ss_pred EEEeeccc-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHH----hceeecCCCcccEEEEe----eeEEeee
Confidence 99999984 499999987653 23445 778899999999999996 69999999999999943 4789999
Q ss_pred ccCCCCCCCCCC------CccccccCCCCCCCCC-----------CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 007427 469 FGFLPLLPSRKA------SENLAIGRSPEFPEGK-----------RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531 (604)
Q Consensus 469 FGla~~~~~~~~------~~~~~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 531 (604)
||+|..+..... ..||..||+||.+... +.++++||||+|||||+|+.|+.||....
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------ 576 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------ 576 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------
Confidence 999999876543 3689999999988632 25689999999999999999999987421
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.....+..+.+.+...++.+ . ....++.++++.||.+||++||++.|+++
T Consensus 577 -n~~aKl~aI~~P~~~Iefp~--~-------~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 -NQIAKLHAITDPNHEIEFPD--I-------PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHHHHhhcCCCccccccC--C-------CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11111222222221111111 0 01123899999999999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.33 Aligned_cols=248 Identities=23% Similarity=0.436 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEe-cCCc----EEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGA----VVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|.. .+|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 46899999999999985 3444 578998875432 2345788999999999999999999998754 467999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||++ ++...+||+|||+++..
T Consensus 91 ~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 91 PHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (303)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeee---cCCCceEEccccccccc
Confidence 9999999987643 24889999999999999999999 4799999999999999 55567999999999876
Q ss_pred CCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... ...+..|+|||++.+..++.++|||||||++|||++ |+.||.+.. .....++ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~----~~~~~~~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDL----LEKGERL 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH----HHCCCCC
Confidence 53221 123457999999998899999999999999999998 899986531 1111221 1111110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. ........+.+++.+||..+|++||++.++++.|+++....
T Consensus 231 ~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 00112346789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.18 Aligned_cols=239 Identities=25% Similarity=0.411 Sum_probs=191.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh---------hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL---------SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (604)
...||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 46899999999999985 46899999988643221 125688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
|||+++++|.+++.... .+++..+..++.|++.||+||| +++++||||||+||++ ++...+||+|||.
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~---~~~~~~~l~dfg~ 152 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILV---DNKGGIKISDFGI 152 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEE---cCCCCEEecccCC
Confidence 99999999999997643 4888999999999999999999 4799999999999999 6667899999999
Q ss_pred CCCCCCCC----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 472 LPLLPSRK----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 472 a~~~~~~~----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..... .. .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~ 224 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQ-AIFKI 224 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HH-HHHHH
Confidence 87765221 12356789999999988899999999999999999999999975311 11 11111
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ..... ........+.+++.+||+.||.+||++.|+++
T Consensus 225 ~~-~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GE-NASPE----------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hc-cCCCc----------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 00000 01123346889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=296.20 Aligned_cols=240 Identities=27% Similarity=0.410 Sum_probs=193.7
Q ss_pred hcccCcCCcceEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4679999999999998654 89999999975433 67899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++ +....+||+|||++.......
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~----~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS----NKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc
Confidence 99987543 258999999999999999999994 699999999999999 556679999999988765432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ........
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~~~~-~~~~~~~~------ 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AIFMI-PNKPPPTL------ 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hhhhh-ccCCCCCC------
Confidence 2235678999999998899999999999999999999999987532110 00000 00000000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++||++.||++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011123346889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.44 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=193.6
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
..+.||+|+||.||++... +++.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 3468999999999999865 7899999988643 3333467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ...+++..+..++.|++.||.|||+ +.+|+||||||+||++ +....+||+|||++..+...
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 85 SLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred CHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence 99999876421 2258999999999999999999995 3589999999999999 55667999999998765433
Q ss_pred C--CCccccccCCCCCCCCC------CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 K--ASENLAIGRSPEFPEGK------RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ~--~~~~~~~y~aPE~~~~~------~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
. ...++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ............... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~-~~- 229 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDGDP-PT- 229 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhcCC-CC-
Confidence 2 22456689999998654 358899999999999999999999964211 111111111111110 00
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||+.+|++||++.++++.
T Consensus 230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 112244568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.52 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||++.. ..++.||+|++... .......+.+|+.+++.++||||+++++++... ...++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 46899999999999985 46899999999743 223346788999999999999999999988643 2469999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+.+.. .+++..+..++.|++.||+||| ++||+||||||+|||+ +.+..+||+|||++
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill---~~~~~~kl~Dfg~~ 166 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEE---CCCCCEEEeeCccc
Confidence 99965 77777653 3788999999999999999999 5799999999999999 56678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH------------
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW------------ 537 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~------------ 537 (604)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+...
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHH
Confidence 8765432 235678999999999989999999999999999999999999753210 000000
Q ss_pred ------HHHHHhcCCc-cccccHHhh------h-cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 538 ------VRMVVDNDWS-TDILDVEIL------A-AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 538 ------~~~~~~~~~~-~~~~~~~~~------~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+......... .....+... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000000000 0 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.21 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN------ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|...+++.+|+|.++... ......+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999998889999999886321 112356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++++|.+++.... ++++..+..++.|++.||+||| +.+|+|+||||+||++ +....+||+|||++...
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRL 152 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEE---CCCCeEEeccchhhHhh
Confidence 9999999997643 4789999999999999999999 4699999999999999 56678999999998754
Q ss_pred CCC----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 476 PSR----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 476 ~~~----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
... ....++..|+|||+..+..++.++|||||||++|||++|+.||..... ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~ 225 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRG 225 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccC
Confidence 211 122456789999999988899999999999999999999999974311 111111000000
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... .......+.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRL----------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00110 1122346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=311.56 Aligned_cols=242 Identities=16% Similarity=0.232 Sum_probs=187.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 578999999999999854 68899999986422 22345578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++... .++...+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCc
Confidence 9999998754 3788889999999999999999 5799999999999999 5667899999999977643
Q ss_pred CC-----CCccccccCCCCCCCCC----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 478 RK-----ASENLAIGRSPEFPEGK----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.. ...++..|+|||++... .++.++|||||||++|||++|+.||.... .......+.......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~ 266 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMNHKNSL 266 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCcc
Confidence 22 23478899999998753 37899999999999999999999997532 122222222211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 592 (604)
... ........+.+++..|+..++.+ ||++.|+++.
T Consensus 267 ~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 110 01123446789999999844433 7788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.61 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=192.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
...||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35799999999999985 46899999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.|++.||+||| +++|+||||||+||++ +++..+||+|||++.......
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc
Confidence 9988643 3889999999999999999999 4799999999999999 555689999999987653322
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||...+..++.++|||||||++|||++|+.||..... ........ ........+
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~~~---- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRIR-DNLPPRVKD---- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hcCCCcccc----
Confidence 22456789999999888899999999999999999999999874321 11111111 110011000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||..||.+|||+.|+++.
T Consensus 241 ----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 ----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11223357899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=291.24 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=194.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 36799999999999985 46789999999765444567899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++.++..++.|++.||+||| +++|+|+||||+||++ ++...+||+|||.+.......
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh
Confidence 99987652 24889999999999999999999 4799999999999999 556678999999987665322
Q ss_pred ---CCccccccCCCCCCCCC---CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 480 ---ASENLAIGRSPEFPEGK---RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~---~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
...++..|+|||...+. .++.++|||||||++|||+||+.||..... .+...............
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKSNFPPPKL-- 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCCccc--
Confidence 22456689999998876 889999999999999999999999875321 01111111111000000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||..+|.+||++.+|+.
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011233456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.34 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=196.3
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||.++ ..+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 3689999999999997 456899999998643 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++ ++...+||+|||++......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 85 TLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccc
Confidence 9999998653 224899999999999999999999 4699999999999999 55567999999998766443
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...++..|.|||...+..++.++||||||+++|||++|+.||.... ..+.............
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~----- 221 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGNYTPV----- 221 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCC-----
Confidence 3 2346778999999988889999999999999999999999986421 2222222222221111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.27 Aligned_cols=239 Identities=24% Similarity=0.371 Sum_probs=193.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++|+||+++++++.+....++||||+++|+
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 467999999999999864 68899999987432 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++... ++++.+...++.|++.||+||| +.+++|+||+|+||++ +....++|+|||++.......
T Consensus 89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence 99998753 3888999999999999999999 5799999999999999 555678999999987665432
Q ss_pred C----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 A----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ..++..|+|||++.+..++.++|||||||++|||+||+.||...... .... ........
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~-~~~~~~~~------- 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLF-LIPKNNPP------- 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhh-hhhcCCCC-------
Confidence 1 23566899999999888999999999999999999999998753211 1111 11111111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122345578899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=300.62 Aligned_cols=241 Identities=22% Similarity=0.374 Sum_probs=187.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecC------CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSK------EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~e 393 (604)
.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... ...++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 46799999999999985 468899999986543 3346788999999998 799999999998753 35789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+||++ ++...+||+|||++.
T Consensus 90 ~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 90 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 159 (272)
T ss_pred cCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEE---CCCCCEEEccCCCce
Confidence 999999999998643 225889999999999999999999 4799999999999999 566679999999987
Q ss_pred CCCCC----CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSR----KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
..... ....++..|+|||++. ...++.++|||||||++|||++|+.||..... ..... ... .
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-~~~-~ 230 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-LIP-R 230 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH-HHh-c
Confidence 65432 1234677899999986 34578899999999999999999999864321 11111 111 1
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....... .......+.+++.+||..||.+|||+.|+++
T Consensus 231 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLK---------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCC---------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1001100 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.18 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=192.5
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceE
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKL 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 389 (604)
.+.||+|+||.||+|... +++.||+|+++.. .....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999753 4689999998743 2334567889999999999999999999886532 237
Q ss_pred EEEecCCCCCHHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 390 IIYEFLPNGSLFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
+++||+++|+|.+++..... .....+++.....++.|++.||+||| +++|+||||||+||++ +.+..+||+|
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili---~~~~~~kl~d 156 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCML---NENMTVCVAD 156 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEE---cCCCCEEECc
Confidence 89999999999988764321 12234788999999999999999999 4799999999999999 6667899999
Q ss_pred ccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 469 FGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 469 FGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+++...... .......|++||......++.++|||||||++|||++ |+.||..... .+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHH
Confidence 99988664322 1123457899999988889999999999999999999 8888764311 1111111
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
........ .......+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 229 ~~~~~~~~-----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 229 IKGNRLKQ-----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred HcCCcCCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111100 0122346889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.17 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=192.4
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
..+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||+++++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 357899999999999975 57889999986532 346789999999999999999999998654 57999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ...+++..+..++.|++.||+||| ++|++||||||+||++ +.+..+||+|||+++......
T Consensus 86 ~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 86 VNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC
Confidence 99997643 224789999999999999999999 4799999999999999 556689999999987654322
Q ss_pred CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 ~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
.......|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..... ........
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~-------- 218 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECV-EKGYRMEP-------- 218 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHH-hCCCCCCC--------
Confidence 2223457999999988899999999999999999998 999986432 11222211 11111110
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
....+..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.32 Aligned_cols=241 Identities=19% Similarity=0.265 Sum_probs=187.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999985 468999999997432 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +....+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccc
Confidence 99999997643 4889999999999999999999 5799999999999999 6667899999999875432
Q ss_pred CC---------------------------------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC
Q 007427 478 RK---------------------------------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR 518 (604)
Q Consensus 478 ~~---------------------------------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~ 518 (604)
.. ...++..|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 10 124678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 007427 519 IPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK---MSEVLR 591 (604)
Q Consensus 519 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 591 (604)
.||.+... ......+......... .+ ......++.+++.+|+. ||.+|++ +.|+++
T Consensus 234 ~Pf~~~~~--------~~~~~~i~~~~~~~~~-p~-------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETP--------QETYRKVMNWKETLVF-PP-------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCH--------HHHHHHHHcCCCceec-CC-------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99975321 1111222111000000 00 00123357788888764 9999996 455543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=330.55 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=193.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+. .++..||+|.+... .......+.+|+.++++++||||++++++|... ...++||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 46899999999999985 46788999988643 233456789999999999999999999988643 46899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCCCceecCCCCCceEEeec--------------C
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL---HSHKVPHANLKSSNILIFRE--------------N 459 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~~~ivHrDlkp~NILl~~~--------------~ 459 (604)
+|+|.++|...... ...+++..++.|+.||+.||+|||+.. +.++|+||||||+|||++.+ +
T Consensus 98 gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 99999999764321 225899999999999999999999631 11469999999999999542 1
Q ss_pred CcceEEEeeccCCCCCCCCC---CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCch
Q 007427 460 DIYRAKLTNFGFLPLLPSRK---ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 460 ~~~~~kl~DFGla~~~~~~~---~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~ 534 (604)
....+||+|||+++.+.... ...+++.|+|||++.+ ..++.++|||||||++|||+||+.||.... ..
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-------~~ 249 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-------NF 249 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-------cH
Confidence 23458999999998764332 2357889999999854 458899999999999999999999997432 12
Q ss_pred hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHHhh
Q 007427 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR--RIEEI 596 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 596 (604)
...+....... ... .......+.+||..||+.+|.+||++.|++. .+..+
T Consensus 250 ~qli~~lk~~p-~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 250 SQLISELKRGP-DLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHhcCC-CCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 22222221111 000 0112346889999999999999999999983 44444
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.59 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 46899999999999985 46889999999743 223346788999999999999999999987643 3579999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+++.. .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||++
T Consensus 109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a 173 (364)
T cd07875 109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 173 (364)
T ss_pred eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEE---CCCCcEEEEeCCCc
Confidence 99965 78877753 3788999999999999999999 5799999999999999 66678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH----------
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR---------- 539 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 539 (604)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+...+.
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCHHHH
Confidence 8765432 235678999999999999999999999999999999999999754211 00111000
Q ss_pred --------HHHhcCC-ccccccHHhhh-------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 540 --------MVVDNDW-STDILDVEILA-------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 540 --------~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
....... ........... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000000000 00001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=293.73 Aligned_cols=249 Identities=19% Similarity=0.343 Sum_probs=194.7
Q ss_pred hcccCcCCcceEEEEEecC--CcEEEEEEeccc----------chhhHHHHHHHHHHHcc-CCCCCcccEEEEEecCCce
Q 007427 322 AEVLGKGKVGSTYKATLES--GAVVAVKRVKNM----------NALSKKEFVQQMQLLGK-LKHENLAKIVSFYYSKEEK 388 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~ 388 (604)
.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999998654 788999988532 12223557788888865 7999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ ..+++|+||||+||++ +....+||+|
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEE---CCCCcEEEec
Confidence 999999999999998865321 12358999999999999999999994 2589999999999999 6667899999
Q ss_pred ccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 469 FGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 469 FGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
||.+....... ...++..|++||...+..++.++||||||+++|||++|+.||.... ............
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~~~ 229 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEAV 229 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhhcc
Confidence 99987765442 2346678999999998889999999999999999999999986421 122222222211
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
... . ........+.+++.+||+.||++||++.|+.+++++
T Consensus 230 ~~~-~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YEP-L---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCc-C---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 110 0 001123468899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.30 Aligned_cols=240 Identities=24% Similarity=0.391 Sum_probs=199.5
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
..||.|+||.||-|+ ..+...||||++.... .....++.+|+..|++++|||+|.+.|+|......|+||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 569999999999998 4578899999996432 233478899999999999999999999999999999999999 56
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+-.|++.-.+ .++.+..+..|+.+.+.||+||| +++.||||||+.|||+ .+.+.+||+|||.|....+.
T Consensus 111 SAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 111 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred cHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEe---cCCCeeeeccccchhhcCch
Confidence 8888887654 36889999999999999999999 6799999999999999 77789999999999999999
Q ss_pred CCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 KASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
....||++|||||++. .+.|+-|+||||+|++..||...++|+..... +... ..+-.+. .+-.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSAL-YHIAQNe-sPtL----- 245 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSAL-YHIAQNE-SPTL----- 245 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHH-HHHHhcC-CCCC-----
Confidence 9999999999999986 57899999999999999999999999775421 1111 1111111 1110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...+....+.+++..||+.-|.+|||..++++.
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 123445578999999999999999999988764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.57 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=185.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCcccEEEEEecC-----CceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL---KHENLAKIVSFYYSK-----EEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~~~l 390 (604)
.+.||+|+||+||+|+. .+++.||+|.++... ......+.+|+++++++ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 36799999999999985 468999999986432 11234556777777665 799999999988642 35789
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||++ ++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||
T Consensus 85 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili---~~~~~~kl~dfg 153 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILV---TSGGQVKLADFG 153 (288)
T ss_pred EEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCCCCEEECccC
Confidence 999997 489998876432 24899999999999999999999 5799999999999999 566679999999
Q ss_pred CCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hc
Q 007427 471 FLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DN 544 (604)
Q Consensus 471 la~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 544 (604)
+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHHHhCCCChh
Confidence 998765432 23457789999999988999999999999999999999999865321 111111111100 00
Q ss_pred CCcccc------ccHHhh--hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDI------LDVEIL--AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~------~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.... ...... ...........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000 00000123346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.88 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=193.6
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..+.||+|+||.||++.. .++..||+|.++.......+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 346799999999999986 4689999999976555556789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .++++..+..++.|++.||.||| +.+|+|+||||+||++ +....++|+|||++.......
T Consensus 89 L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 89 LDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEE---CCCCCEEEccCccchhhcccc
Confidence 999987643 25899999999999999999999 4799999999999999 666789999999886654322
Q ss_pred ----CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 ----ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...++..|+|||.+. ...++.++|||||||++|||++|+.||..... ............ ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-~~~ 228 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEP-PTL 228 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCCC-CCc
Confidence 224677899999874 34578899999999999999999999875311 111111111110 000
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. .+......+.+++.+||+.+|++||++.++++.
T Consensus 229 -~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -D-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -C-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 011223468899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.43 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=192.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
..||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999985 468999999987544445677889999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++... .+++..+..++.|++.||+||| +++++||||||+||++ +.+..+||+|||++.......
T Consensus 107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 107 DIVSQT------RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccccc
Confidence 987643 3889999999999999999999 4799999999999999 666789999999987654322
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~------- 237 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDSP-PPKL------- 237 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhccC-CCCc-------
Confidence 23467789999999988899999999999999999999999874211 11111111110 0000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.........+.+++.+||+.+|++||++.++++.
T Consensus 238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011123357899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.06 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=186.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46899999999999984 578899999987432 22345677899999999999999999987543 3568999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
|++ +++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++ +.+..+||+|||++
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~ 165 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAV---NEDCELRILDFGLA 165 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEE---CCCCCEEEcCCccc
Confidence 998 78999887643 3899999999999999999999 4799999999999999 66678999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
+...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+... .... ..+.
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~-~~~~-~~~~ 239 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEV-VGTP-SPEV 239 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHH-hCCC-CHHH
Confidence 8765432 2356789999999876 56899999999999999999999999753210 011111100 0000 0000
Q ss_pred c--------cHH---hhhcc------cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 551 L--------DVE---ILAAR------EGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 551 ~--------~~~---~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. ... +.... ........+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 00000 000112347899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.19 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=190.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 357999999999999865 68999999986432 223456889999999999999999999999999999999999998
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|..++.... .+++..+..++.|++.||+|||+ ++++||||||+||++ +....+||+|||++......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~----~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK----HNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCChhhEEE---cCCCcEEECccccceecCCC
Confidence 8888765432 48999999999999999999994 799999999999999 55568999999999876544
Q ss_pred C----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH----------HHh
Q 007427 479 K----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM----------VVD 543 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~ 543 (604)
. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ......... ...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChHHhhhcc
Confidence 3 2345678999999876 55789999999999999999999999754221 011111000 000
Q ss_pred -cCCccccccHHhhhc----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 -NDWSTDILDVEILAA----REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 -~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+......+..... .........+.+++.+||+.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000000 000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.63 Aligned_cols=245 Identities=15% Similarity=0.206 Sum_probs=187.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+++. .+++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 46899999999999985 46899999999642 122345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||+ +....+||+|||++..+..
T Consensus 86 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCC
Confidence 99999997532 14889999999999999999999 5799999999999999 6667899999999876543
Q ss_pred CCC-----CccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 478 RKA-----SENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 478 ~~~-----~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
... ..++..|+|||++.. ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCc
Confidence 221 247889999999863 457889999999999999999999997531 12222222211110
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCC--CCCCCHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAP--EKRPKMSEVLRR 592 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~ 592 (604)
.... .........+.+++.+|+..++ ..||++.++++.
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFP-------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCC-------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0100 0011133457788888775533 347898888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.22 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=200.3
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.++||+|+||.||+|. ..+|+.+|||.+.-.. +.+++.+|+.+++++..|++|++||.|......++|||||-.|+.
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 4689999999999997 5679999999997543 467899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+.++..+ .++++.++..++...++||+|||. ..-+|||||+.|||+ +..+.+||+|||.|..+.+.
T Consensus 116 SDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~----~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 116 SDIMRARR----KPLSEQEISAVLRDTLKGLQYLHD----LKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred HHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHH----HHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH
Confidence 99998754 479999999999999999999995 477899999999999 66778999999999776543
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....+++.|||||+++.-.|+.++||||+|++..||..|++||.+..+..... .++-.-. .
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PP--------P 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPP--------P 247 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCC--------C
Confidence 34468999999999999999999999999999999999999998643211000 0000000 1
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.-..++....++.+++++||-..|++|-|+.++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111233455679999999999999999999888763
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=297.15 Aligned_cols=245 Identities=29% Similarity=0.486 Sum_probs=191.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhH--HHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSK--KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+++.. +++.||+|.+........ ....+|+.++++++||||+++++++......++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 468999999999999865 567899999986543332 23456999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC---
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--- 475 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~--- 475 (604)
+|.+++.... .+++..+..++.|+++||+|||+ .+|+|+||||+||++ +....++|+|||.+...
T Consensus 84 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~----~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 84 SLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHS----KGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp BHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHH----TTEEESSBSGGGEEE---STTSEEEESSGTTTEESTST
T ss_pred cccccccccc-----ccccccccccccccccccccccc----ccccccccccccccc---cccccccccccccccccccc
Confidence 9999998433 48999999999999999999995 699999999999999 66678899999998643
Q ss_pred -CCCCCCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 476 -PSRKASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 476 -~~~~~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.......++..|+|||... +..++.++||||+|+++|+|++|+.||.... ................ ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~-----~~ 221 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPL-----PS 221 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHH-----HH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhcccccc-----cc
Confidence 1122345677899999998 8889999999999999999999999987530 0011111111111000 00
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .........+.+++.+||+.||++||++.++++
T Consensus 222 ~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000001257899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=295.62 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 367999999999999864 68999999986432 2234678899999999999999999999999999999999997 6
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ...+++..+..++.|++.||+||| +++|+||||||+||++ +.+..+||+|||++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 99998875432 235899999999999999999999 5799999999999999 56678999999998765332
Q ss_pred C----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---cCCc--c
Q 007427 479 K----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---NDWS--T 548 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~ 548 (604)
. ...++..|+|||.+.+. .++.++|||||||++|||+||+.||.+.... ............ ..+. .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcch
Confidence 1 12346789999987654 5788999999999999999999999753211 000000000000 0000 0
Q ss_pred ccccHHhh--h------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVEIL--A------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~~~--~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+.... . .........++.+++.+||+.||++|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0 0000113446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.47 Aligned_cols=184 Identities=22% Similarity=0.312 Sum_probs=156.5
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++...+..++||||+ .++
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 142 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCc
Confidence 3578999999999999864 5788999975432 2356899999999999999999999999999999999 469
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... .++++..+..|+.|++.||+||| +++|+||||||+|||+ +....+||+|||+++.....
T Consensus 143 l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 143 LYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence 999887543 25899999999999999999999 4799999999999999 66668999999998754322
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCC
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGN 522 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~ 522 (604)
....++..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 22357789999999999999999999999999999999665553
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=293.68 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 467999999999999854 68999999987443 3334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++... ++++..+..++.|++.||.||| +++++||||+|+||++ ++...++|+|||+++.+....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEE---CCCCCEEEcccccceeecccc
Confidence 99998754 4899999999999999999999 4799999999999999 666789999999987765432
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||+..+..++.++|||||||++|||+||+.||..... ...... ...........
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~-~~~~~~~~~~~--- 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFL-IPKNNPPSLEG--- 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHH-hhhcCCCCCcc---
Confidence 23456689999999988899999999999999999999999975321 111111 11111111100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+.+++.+||..||++||+++++++
T Consensus 221 ------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 ------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 013346889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=293.35 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
...||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 357999999999999853 3567999988654333 356799999999999999999999999998999999999
Q ss_pred CCCCCHHHHhhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 395 LPNGSLFDLLHESRGVG----RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
+++|+|.+++....... ...+++..+..++.|++.||+||| +++|+||||||+||++ +....++++|||
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili---~~~~~~~l~~~~ 162 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLV---SSQREVKVSLLS 162 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEE---eCCCcEEEcccc
Confidence 99999999997654211 125899999999999999999999 4799999999999999 555678999999
Q ss_pred CCCCCCCCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 471 FLPLLPSRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 471 la~~~~~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
+++...... ...++..|+|||...+..++.++||||||+++|||++ |..||..... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~~~~ 234 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRLQAG 234 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHHHcC
Confidence 986543221 1223456999999988888999999999999999999 7888864321 1111111111
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
...... ....+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 235 ~~~~~~----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLELPV----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcCCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111000 01223468899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=289.40 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=191.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-ceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-EKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 397 (604)
.+.||+|++|.||++.. .+++.||+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..+++|||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 46899999999999985 457899999986432 234467889999999999999999999876444 57899999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ...+++.++..++.|++.|++||| +++|+||||||+||++ +....++|+|||++.....
T Consensus 85 ~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 85 GDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEE---ecCCcEEEecccceEEecc
Confidence 99999998643 225899999999999999999999 4799999999999999 5667899999999876643
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||+..+..++.++||||||+++|||++|+.||.... ............ ...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~-~~~---- 221 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEGK-LPP---- 221 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcC-CCC----
Confidence 21 2245678999999999999999999999999999999999987421 222222222211 111
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++||++.++++
T Consensus 222 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 ------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01123346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=294.84 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=193.2
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~g 398 (604)
+.||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||++++++|... ...++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 6799999999999986 4689999999874322 3456789999999999999999999998654 3689999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++ +....++|+|||++......
T Consensus 87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---ecCCeEEEeecccccccccc
Confidence 99998765332 1234888999999999999999999 4799999999999999 55567999999998765433
Q ss_pred C--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 K--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 ~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
. ...++..|+|||...+..++.++|||||||++|||++|+.||......... ..+.......... ... ...
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~-~~~-~~~-- 231 (287)
T cd06621 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPN-PEL-KDE-- 231 (287)
T ss_pred ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC---hHHHHHHHhcCCc-hhh-ccC--
Confidence 2 234567899999999889999999999999999999999999864321111 1122211111110 000 000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..........+.+++.+||+.+|++|||+.|+++
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.33 Aligned_cols=241 Identities=20% Similarity=0.356 Sum_probs=194.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+++. .+|+.||+|.+... .....+++.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46899999999999984 56899999998642 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ..+++.++..++.|++.||+||| +++++|+||+|+||++ +....++|+|||++......
T Consensus 85 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 85 DLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcc
Confidence 99999876432 24789999999999999999999 4799999999999999 55567999999998766443
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...++..|+|||+..+..++.++|||||||++|||++|+.||... ...+.+..........
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~~~~------ 220 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGSYPP------ 220 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCCCCC------
Confidence 2 123567899999999888999999999999999999999998642 1222222222221110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|++||++.||++
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 -----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.16 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=188.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 367999999999999854 68899999986432 2234567889999999999999999999999999999999996 59
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|+++||+||| +++|+||||||+||++ +.+..+||+|||++.......
T Consensus 90 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 90 LKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence 999887643 24789999999999999999999 5799999999999999 566689999999987653222
Q ss_pred ----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---Cccccc
Q 007427 480 ----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND---WSTDIL 551 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 551 (604)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+....... ......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCChhhchhhh
Confidence 2245678999998765 45788999999999999999999999754211 1111111110000 000000
Q ss_pred cH------Hhhh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DV------EILA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~------~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000 0000122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=295.82 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=191.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|.+.... ....+++.+|+++++.++||||++++++|...+..++||||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 46899999999999985 468999999986432 2233568899999999999999999999999999999999996
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|++.+++.... .++++..+..++.|++.||.||| +.+|+||||+|+||++ +++..+||+|||++.....
T Consensus 99 g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 99 GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 58877776433 24899999999999999999999 4799999999999999 6667899999999987766
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....++..|+|||++. ...++.++||||||+++|||+||+.||..... ........... ....
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~~-~~~~---- 234 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQND-SPTL---- 234 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcCC-CCCC----
Confidence 65556778899999874 45688999999999999999999999864311 11111111111 0000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||+.||++||++.+++..
T Consensus 235 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 -----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011234568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=289.09 Aligned_cols=243 Identities=28% Similarity=0.453 Sum_probs=194.6
Q ss_pred hcccCcCCcceEEEEEecC-----CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLES-----GAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||.|+||.||+++..+ +..||+|.++..... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999998653 488999999755433 4678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++++|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+||++ +....++|+|||+++..
T Consensus 84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLV---GENLVVKISDFGLSRDL 153 (258)
T ss_pred CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEE---ccCCeEEEcccCCceec
Confidence 99999999986542 12899999999999999999999 5799999999999999 55668999999998776
Q ss_pred CCCCC-----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 476 PSRKA-----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 476 ~~~~~-----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
..... ...+..|+|||...+..++.++||||+|+++|||++ |+.||... ...+.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~-~~ 224 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKKGYR-LP 224 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCC-CC
Confidence 54321 124568999999988889999999999999999999 78887642 11222222211111 10
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.......++.+++.+|+..||++|||+.|+++.|
T Consensus 225 ----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ----------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111344688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=288.06 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=194.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 46899999999999985 57899999998643 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++..+..++.|++.||+||| +++++|+||||+||+++.+ ...+||+|||.+......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 85 TLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSK 155 (256)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCC--CCEEEEccCCCceecCCC
Confidence 9999997643 224899999999999999999999 4799999999999999432 346899999998876543
Q ss_pred CC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 KA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ..++..|+|||...+..++.++||||||+++|||++|+.||.... .............. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~----- 221 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSGTFA-PI----- 221 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHhcCCC-CC-----
Confidence 22 345678999999998889999999999999999999999986532 11222222211111 10
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 222 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 -----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0113346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=290.13 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=185.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++... ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 46899999999999985 468999999886321 12235688999999999999999999988753 56789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.... .+++.....++.|++.||+||| +.+|+||||||+||++ +.+..+||+|||+++
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~ 154 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILR---DSAGNVKLGDFGASK 154 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEE---CCCCCEEEccCCCcc
Confidence 999999999997643 4789999999999999999999 4799999999999999 566789999999987
Q ss_pred CCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... . ..+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~-~~~~~~~~~~~ 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------M-AAIFKIATQPT 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------H-HHHHHHhcCCC
Confidence 653211 12356789999999998899999999999999999999999874311 1 11111111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... .+......+.+++ +||..+|++||+++||++
T Consensus 227 ~~~----------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----------LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 010 0112223456666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=289.25 Aligned_cols=240 Identities=26% Similarity=0.367 Sum_probs=191.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|++++++++|+||+++++++......++++||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 367999999999999865 78999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++++|.+++.... ++++..+..++.|++.||+||| +.+|+|+||||+||++ +....+||+|||++...
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV 152 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999997643 4889999999999999999999 4799999999999999 56678999999998765
Q ss_pred CCCC---CCccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRK---ASENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~---~~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.... ...++..|++||.+.... ++.++|+|||||++|||++|+.||..... .+.............+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~- 223 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKELPPI- 223 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccCCCc-
Confidence 4432 234667899999987766 89999999999999999999999875321 1111111110000000
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.+|++||++.+++.
T Consensus 224 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ---------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122346789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.62 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=189.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch----------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA----------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (604)
.+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|+.++++++|+||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46899999999999974 4689999998853211 012457889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+++++|.++++... .+++..+..++.|++.||.||| +++++||||||+||++ +....++++|||
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~---~~~~~~~l~d~~ 153 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLV---DADGICKISDFG 153 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEE---cCCCeEEEeecc
Confidence 999999999999997652 4889999999999999999999 4799999999999999 666789999999
Q ss_pred CCCCCCCCC------CCccccccCCCCCCCCCC--CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 471 FLPLLPSRK------ASENLAIGRSPEFPEGKR--LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 471 la~~~~~~~------~~~~~~~y~aPE~~~~~~--~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
+++...... ...++..|+|||...... ++.++||||||+++||+++|+.||..... .... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~-~~~~ 225 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAM-FKLG 225 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHH-HHhh
Confidence 987654321 124567899999987654 88999999999999999999999864211 1111 1111
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........ .. .........+.+++.+||+.||++||++.||++
T Consensus 226 ~~~~~~~~-~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 NKRSAPPI-PP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCcC-Cc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11100110 00 011123457889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=280.51 Aligned_cols=262 Identities=18% Similarity=0.329 Sum_probs=210.5
Q ss_pred CHHHHHHHhhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEE
Q 007427 313 DLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 313 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (604)
+++|+-+-+.++||+|+|+.|--+. ..+|..||||++.+.....+.+..+|++++.+. .|+||+.++++|+++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3567766788999999999999986 788999999999887777788999999999998 59999999999999999999
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
|||-|.||.|..+|++.+ -+++.++.++.++|+.||.||| .+||.||||||+|||....+...-+||+||.
T Consensus 154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999998865 4899999999999999999999 5799999999999999888777889999998
Q ss_pred CCCCCCCC-----------CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCC---CCC
Q 007427 471 FLPLLPSR-----------KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN---ETS 531 (604)
Q Consensus 471 la~~~~~~-----------~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~---~~~ 531 (604)
+..-+.-. ....+...|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.-..+ ...
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 87544211 1224667899999764 3468999999999999999999999998764321 111
Q ss_pred CchhHH----HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 532 GDLSDW----VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 532 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.-... ...+.++.+ ++.| ........+..+++...+..|+.+|-++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkY--eFPd------kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKY--EFPD------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCC--cCCh------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122211 222222221 1111 223455667889999999999999999998876
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.59 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=191.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 36799999999999985 4678999999875432 2345678999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++..+..++.|++.||+||| +++++||||||+||++ +....+||+|||+++....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEE---CCCCCEEEeeCCCccccCc
Confidence 99999997643 4899999999999999999999 4799999999999999 6667899999999864210
Q ss_pred C-------------------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 478 R-------------------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 478 ~-------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
. ....++..|+|||++....++.++|||||||++|||++|+.||.+.. ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 0 01234567999999988889999999999999999999999997532 11222
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
............ ........+.+++.+||+.||++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDDIEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcccCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 222211110000 001223457899999999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=292.83 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=193.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|++|.||++.. .+++.+++|+++.......+.+.+|+.++++++|+||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999985 57899999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++..+..++.|++.||+||| +++|+||||||+||++ +.+..++|+|||.+.......
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 9998762 3889999999999999999999 4799999999999999 566789999999876554322
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||...+..++.++|||||||++|||++|+.||.... ............ .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~~-~~~~~----- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDNL-PPKLK----- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhcC-CCCCc-----
Confidence 2246678999999988889999999999999999999999986421 112222221111 00000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|++||++.++++
T Consensus 237 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 ---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01113346899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.85 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=193.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++. .++..||+|.+.... ......+.+|++++++++|+|++++++++...+..++||||++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 46799999999999985 468999999986432 2233578899999999999999999999999999999999996
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .++++.++..++.|++.||.||| +++|+||||+|+||++ +....+||+|||++.....
T Consensus 109 g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 109 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence 58888776433 25899999999999999999999 4799999999999999 5566899999999887766
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....++..|+|||++. ...++.++|||||||++|||++|+.||.... ................
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~~----- 244 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPTL----- 244 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccCCCC-----
Confidence 65667788999999974 4568899999999999999999999986421 1111111111111100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
........+.+++.+||+.+|.+||++.++++..-
T Consensus 245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 01123346889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.71 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=194.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEec--c--cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc--eEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVK--N--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE--KLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 394 (604)
.++||+|+|-+||+|.. .+|..||=-.++ + ......++|..|+.+|+.|+|+|||++|.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46799999999999985 357777733222 2 223334789999999999999999999999987665 6789999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
|..|+|..|+++.+ .++.....+|++||++||.|||.. .++|+|||||-+||+|+ +..+.+||+|.|+|..
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 99999999999876 378889999999999999999986 67999999999999995 6678999999999988
Q ss_pred CCCCCC--CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 475 LPSRKA--SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 475 ~~~~~~--~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
+..... ..||+.+||||.++ ..|++.+||||||+.++||+|+..||..... -.+.++.+..+..+.. +
T Consensus 196 ~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~s-l- 265 (632)
T KOG0584|consen 196 LRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAA-L- 265 (632)
T ss_pred hhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHH-h-
Confidence 876544 36999999999987 7899999999999999999999999986432 2333333333222111 0
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ..+++.++|.+|+.. .++|||+.|+++
T Consensus 266 ----~kV----~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 ----SKV----KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----hcc----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 000 123588999999999 999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=292.12 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=199.1
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
++.||+|.|+.|-+|+ .-+|..||||++.+ .+......+.+|++.|+-++|||||++|++.......|||+|.-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 4679999999999997 45799999999975 34455677889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|++||-.+.. .+.+....+++.||..|+.|+|+ ..+|||||||+||.+... .+-+||.|||++..+.+.
T Consensus 103 Dl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq----LHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 103 DLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ----LHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred hHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh----hhhhcccCCcceeEEeee--cCceEeeeccccccCCCc
Confidence 99999987653 48999999999999999999996 479999999999998643 457899999999877665
Q ss_pred C---CCccccccCCCCCCCCCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K---ASENLAIGRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s-~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+...|.|||++.+..|+ +++||||+|||||-|+.|+.||...... +-..++++-.+.
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------ETLTmImDCKYt------- 237 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------ETLTMIMDCKYT------- 237 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------hhhhhhhccccc-------
Confidence 4 34577889999999999886 5789999999999999999999865321 222333332221
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
-+.....++.+||..||..||.+|-+.+||+.
T Consensus 238 -----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 -----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 12334557899999999999999999888864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=289.67 Aligned_cols=244 Identities=21% Similarity=0.392 Sum_probs=192.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN------ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46899999999999984 678999999986432 11246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++++|.+++.... ++++..+..++.|++.||+||| +++++|+||||+||+++.++ ..+||+|||.+..
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~ 153 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTG--QRLRIADFGAAAR 153 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCC--CEEEEcccccccc
Confidence 99999999997643 5889999999999999999999 47999999999999994332 3589999999876
Q ss_pred CCCCC--------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSRK--------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~~--------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... ...++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~ 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATT 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCC
Confidence 64321 12346689999999888899999999999999999999999864321 111111111111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ........+.+++.+||+.+|++||++.|+++
T Consensus 229 ~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APS----------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCC----------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111 11223456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.41 Aligned_cols=245 Identities=14% Similarity=0.197 Sum_probs=187.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 468999999999999864 57889999986422 12234578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||+ +.+..+||+|||++.....
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 86 GDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME 154 (332)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEE---CCCCCEEEeecchheeccc
Confidence 999999976431 4889999999999999999999 4799999999999999 6667899999999876533
Q ss_pred CC-----CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 478 RK-----ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
.. ...++..|+|||++. ...++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCcc
Confidence 21 235788999999886 3468899999999999999999999997531 22222222221110
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCC--CCCCHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPE--KRPKMSEVLRR 592 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 592 (604)
.... .........+.+++.+|+..+++ .|+++.|+++.
T Consensus 227 ~~~p-------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFP-------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCC-------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 00112344678899998865444 46889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.68 Aligned_cols=245 Identities=13% Similarity=0.196 Sum_probs=187.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999854 68899999986421 22235578899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+|||+ +....+||+|||+++....
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 86 GDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEE---cCCCCEEEEeccceeeccC
Confidence 99999998643 14889999999999999999999 5799999999999999 5666899999999876643
Q ss_pred CCC-----CccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 478 RKA-----SENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 478 ~~~-----~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCc
Confidence 321 247889999998875 467889999999999999999999997532 11222222211100
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLRR 592 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 592 (604)
... .........++.+++.+|+..++++ |++++++++.
T Consensus 227 ~~~-------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQF-------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccC-------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 0001122346889999999866544 4578777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.03 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=189.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 368999999999999865 589999999864322 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.++..... .+++.++..++.|++.||+||| +.+++||||+|+||++ +++..+||+|||++......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCC
Confidence 9988776432 3899999999999999999999 4799999999999999 56678999999998765433
Q ss_pred CC----CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH----------HHHh
Q 007427 479 KA----SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR----------MVVD 543 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~~ 543 (604)
.. ..++..|+|||+..+ ..++.++|||||||++|||++|+.||...... ........ ....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHHHhCCCchhhHHHhc
Confidence 21 235678999999875 45788999999999999999999998643210 00000000 0000
Q ss_pred cCC-ccccccHHhh----hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 NDW-STDILDVEIL----AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ~~~-~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ......+... ...........+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0000000000 00001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=291.49 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=196.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++++||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 467999999999999865 68999999987543 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .++++..+..++.|++.||+|||+ ..+++|+||||+||++ ++...+||+|||.+.......
T Consensus 86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE---KHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC---CCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHH
Confidence 999998653 258899999999999999999994 1799999999999999 556689999999987653221
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||+..+..++.++||||||+++|||++|+.||..... ......+............ ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-~~------ 225 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPPPR-LP------ 225 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCCCC-CC------
Confidence 24566789999999999999999999999999999999999875321 1122223333322221110 00
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||..||++||++.|++.
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 ---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0013446889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=288.20 Aligned_cols=243 Identities=19% Similarity=0.199 Sum_probs=187.3
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchh---hHHHHHHHHHH-HccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL---SKKEFVQQMQL-LGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|.. .+|+.||+|.++..... ....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 46899999998653221 12234455444 4455899999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ++++..+..++.|++.||.||| +.+++||||+|+||++ +....+||+|||+++....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc
Confidence 99999997643 4889999999999999999999 4799999999999999 5566899999999887655
Q ss_pred CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
.....++..|+|||...+..++.++||||||+++|||+||..||..... ...............
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~-------- 213 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINWP-------- 213 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCCC--------
Confidence 5455677889999999888899999999999999999999999964321 111111111110000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
..........+.+++.+||+.||++||++.++.+.|
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000012345688999999999999999876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.98 Aligned_cols=254 Identities=23% Similarity=0.260 Sum_probs=187.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++|+||+++++++.+....++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 36799999999999985 468999999986432 2223567889999999999999999999999999999999996 5
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ..+++..+..++.||++||+||| +++|+||||||+||++ +....+||+|||+++.....
T Consensus 84 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 84 DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCC
Confidence 8888876543 24899999999999999999999 4799999999999999 55668999999998765432
Q ss_pred C----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC--------
Q 007427 479 K----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND-------- 545 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 545 (604)
. ...++..|+|||.+.+. .++.++|||||||++|||+||+.|+...... ...+.. +.......
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKR-IFRLLGTPTEESWPGV 228 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH---HHHHHH-HHHHhCCCChHHhHHh
Confidence 2 22356789999988764 4789999999999999999999986542211 001110 00000000
Q ss_pred ----Ccccc--ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 ----WSTDI--LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 ----~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... .................+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00000000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.81 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=193.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 46799999999999974 46889999998754444557789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++... .+++.++..++.|++.||.||| +++++||||||+||++ +....+||+|||++........
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 104 TDVVTET------CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc
Confidence 9998754 3788999999999999999999 5799999999999999 5556799999998866543322
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
..++..|+|||......++.++|||||||++||+++|+.||........ +. ...... ....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~----~~~~~~-~~~~------ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY----LIATNG-TPEL------ 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----ee----ehhcCC-CCCC------
Confidence 2456679999999888899999999999999999999999975322110 00 000000 0000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=285.46 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=195.1
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEec-CCcEEEEEEecccchhh---HHHHHHHHHHHccCCCCCcccEEEEEecCCc
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALS---KKEFVQQMQLLGKLKHENLAKIVSFYYSKEE 387 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 387 (604)
+.++.+. .-+.||.|.-|+||+++.. ++..+|+|++.+..... ..+...|-+||+.+.||.++.+|+.++.++.
T Consensus 74 l~l~~f~--llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 74 LGLRHFR--LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred cCHHHHH--HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 3444442 3468999999999999965 46899999997654332 3456779999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.|++||||+||+|..+.+.+.+ ..+++..+.-++.+++-||+|||- .|||.|||||+|||| .+++++-|+
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHm----lGivYRDLKPENILv---redGHIMLs 221 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHM----LGIVYRDLKPENILV---REDGHIMLS 221 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHh----hceeeccCCcceeEE---ecCCcEEee
Confidence 9999999999999999987763 348999999999999999999994 699999999999999 666778999
Q ss_pred eccCCCCCCC---------------------------------C-C--------------------------CCcccccc
Q 007427 468 NFGFLPLLPS---------------------------------R-K--------------------------ASENLAIG 487 (604)
Q Consensus 468 DFGla~~~~~---------------------------------~-~--------------------------~~~~~~~y 487 (604)
||.++..... . . ...||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9987632110 0 0 01245578
Q ss_pred CCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHH
Q 007427 488 RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR 567 (604)
Q Consensus 488 ~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 567 (604)
.|||++.+...+.++|.|+|||++|||+.|+.||.+.... +.+.+.+ .... .+ ...+..+..
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----~Tl~NIv----~~~l--~F--------p~~~~vs~~ 363 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----ETLRNIV----GQPL--KF--------PEEPEVSSA 363 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----hhHHHHh----cCCC--cC--------CCCCcchhH
Confidence 9999999999999999999999999999999999986432 2222222 1110 00 111234457
Q ss_pred HHHHHHhcccCCCCCCCC----HHHHH
Q 007427 568 LTELALECTDIAPEKRPK----MSEVL 590 (604)
Q Consensus 568 l~~li~~cl~~dP~~RPs----~~evl 590 (604)
+.+||++.|.+||.+|.. +.||-
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhh
Confidence 899999999999999998 66654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=287.00 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=198.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 468999999999999865 599999999875433 346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS-HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
|.+++.... ++++..+..++.|+++||+||| + .+++||||+|+||++ +....++|+|||.+......
T Consensus 86 L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 86 LADLLKKVG-----KIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENT 153 (264)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccC
Confidence 999997642 5899999999999999999999 5 799999999999999 66678999999998876543
Q ss_pred CC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 KA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ..+...|+|||...+..++.++||||||+++|||+||+.||..... ....+.......... ..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~-~~----- 222 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPP-PS----- 222 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCC-CC-----
Confidence 32 2456789999999998999999999999999999999999875421 122222222221111 00
Q ss_pred hhhcccCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQN-EMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 223 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111 34568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.07 Aligned_cols=240 Identities=18% Similarity=0.242 Sum_probs=182.9
Q ss_pred ccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHH---ccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 324 VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLL---GKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
+||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 4689999998864321 1123344444333 34479999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||++....
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEE---CCCCCEEEccCCcceecc
Confidence 999999987643 4899999999999999999999 5799999999999999 566689999999987554
Q ss_pred CCC--CCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 477 SRK--ASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 477 ~~~--~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... ...++..|+|||... +..++.++|||||||++|||++|+.||...... ............ ...
T Consensus 149 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~--~~~---- 217 (279)
T cd05633 149 KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTV--NVE---- 217 (279)
T ss_pred ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHHHHHHhhcC--CcC----
Confidence 322 235778999999886 456899999999999999999999999753221 111111111000 000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 592 (604)
.......++.+++.+||+.||++|| +++|+++.
T Consensus 218 ------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 ------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112344688999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=293.27 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=188.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||++ +
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence 46899999999999985 468999999986432 234567889999999996 9999999999999999999999985 4
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
++.++...........+++..+..++.|++.||+|||+ ..+|+||||||+||++ +....+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccC
Confidence 66554332111112358999999999999999999995 3589999999999999 55567999999998765432
Q ss_pred C---CCccccccCCCCCCCCC---CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 479 K---ASENLAIGRSPEFPEGK---RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~---~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
. ...++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+.+........ ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~-~~~-- 231 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGDP-PIL-- 231 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCCC-CcC--
Confidence 2 23467789999998766 68999999999999999999999987431 11111111111110 000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...........+.+++.+||+.||++||++.||++.
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 ----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112244568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.88 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=186.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHH-HccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQL-LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++||||+++++++..++..+++|||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 367999999999999854 69999999987532 2234456666665 566789999999999999999999999996 6
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++...... ...+++..+..++.|++.||+|||+. .+++||||||+||++ +.+..+||+|||+++.....
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSK---LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 998888764322 23589999999999999999999941 389999999999999 66678999999998876433
Q ss_pred CC---CccccccCCCCCCCC----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 479 KA---SENLAIGRSPEFPEG----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 479 ~~---~~~~~~y~aPE~~~~----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.. ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .. +.......... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~-~~~~ 229 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PF-QQLKQVVEEPS-PQLP 229 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CH-HHHHHHHhcCC-CCCC
Confidence 21 245678999998865 4568899999999999999999999864211 11 11111111111 1100
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+..+.+++.+||..+|++||++.++++
T Consensus 230 ---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=292.71 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEe-----cCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYY-----SKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~e~ 394 (604)
.+.||+|+||.||++.. .+++.+|+|+++.... ....+.+|+.+++++ +|+||+++++++. ..+..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 36799999999999985 4688999998865322 246688899999999 6999999999884 33468999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++++|.+++...... ...+++..+..++.|++.||.||| +++|+||||||+||++ +....+||+|||+++.
T Consensus 102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 102 CNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 173 (286)
T ss_pred cCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEE---CCCCCEEEccCCceee
Confidence 9999999988643211 235889999999999999999999 4799999999999999 5556799999999876
Q ss_pred CCCCC----CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 475 LPSRK----ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 475 ~~~~~----~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+.... ...++..|+|||++. +..++.++|||||||++|||++|+.||..... ..... ... ..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~~~~-~~~-~~ 244 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALF-KIP-RN 244 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hHHHh-hcc-cc
Confidence 54322 234678899999875 34578899999999999999999999875321 01110 000 00
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
......+ .......+.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 245 PPPTLHQ--------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCcccC--------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0001000 01122358899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.86 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=191.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 46799999999999985 468999999997543 333567899999999999999999999999999999999999 99
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .++++.++..++.|+++||+||| +++++|+||||+||++ +....++|+|||++......
T Consensus 84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEE 152 (286)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCC
Confidence 9999987643 25899999999999999999999 4799999999999999 55667999999998876543
Q ss_pred C-----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC----Cc-
Q 007427 479 K-----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND----WS- 547 (604)
Q Consensus 479 ~-----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~- 547 (604)
. ...++..|+|||.+.+. .++.++||||+||++|||+||+.||.+... ...+. ......... +.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLA-IVFRTLGTPNEETWPG 227 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHH-HHHHHcCCCChHHHhh
Confidence 2 23466789999998654 468999999999999999999887764321 00011 110000000 00
Q ss_pred -cccccH---------HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 -TDILDV---------EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 -~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+..+. .........+....+.+++.+||+.||++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 00000000122367899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=278.50 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=199.7
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEec----CCceEEEEec
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS----KEEKLIIYEF 394 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~ 394 (604)
..++||-|-.|.|..+. ..+|+.+|+|++.+ ....++|+++.-+. .|||||.++++|.+ .....+|||.
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 45799999999999997 45799999999854 34567888876555 69999999999864 3356799999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
|+||.|+..++++. ...+++.++-.|+.||+.|+.||| +.+|.||||||+|+|.+....+..+||+|||+|+.
T Consensus 141 meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 141 MEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred ccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 99999999998865 346999999999999999999999 57999999999999999888888999999999988
Q ss_pred CCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 475 LPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 475 ~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
..... ...-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||+.... ..+...++..+..+.. ++.
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~~gqy-~FP 287 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIRTGQY-EFP 287 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhhccCc-cCC
Confidence 76432 23457899999999999999999999999999999999999987543 2222233332222211 111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+ .+....++..+++|+.+|..+|.+|.|+.|+++
T Consensus 288 ~------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 E------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred C------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 223455678899999999999999999999875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.67 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=186.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 46899999999999985 468999999885321 12235788899999999999999999988764 45789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.... .+++....+++.|++.||+||| +.+|+|+||||+||++ +....+||+|||+++
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILR---DSVGNVKLGDFGASK 154 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEe---cCCCCEEECcCcccc
Confidence 999999999987543 4788899999999999999999 4799999999999999 566789999999987
Q ss_pred CCCCC-------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSR-------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~-------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~~~~~ 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAI-FKIATQPT 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHH-HHHhcCCC
Confidence 65321 12246678999999988889999999999999999999999986421 11111 11111110
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ..+......+.+++.+|+. +|++||+++|+++
T Consensus 227 ~~----------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 NP----------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC----------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 0112333467889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=288.22 Aligned_cols=239 Identities=26% Similarity=0.396 Sum_probs=192.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 46799999999999985 468999999886432 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++... .+++..+..++.|++.|+.||| +++++|+||||+||++ +....++|+|||++..+....
T Consensus 89 l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 89 ALDLLEPG------PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEE---CCCCCEEEeecccceecccch
Confidence 99998643 3889999999999999999999 4799999999999999 556679999999987664432
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||...+..++.++|||||||++|||++|..||..... ....... .......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~~~------ 220 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLI-PKNNPPT------ 220 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHH-hcCCCCC------
Confidence 12456789999999888899999999999999999999999864211 1111111 1111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011233468899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.71 Aligned_cols=248 Identities=21% Similarity=0.301 Sum_probs=194.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||++.. .+++.||+|.++.. .....+.+.+|++++++++|+||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 36799999999999974 57899999998642 23345678899999999999999999998764 345789999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL-HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+++|.+++..... ...++++..++.++.|++.||+|||... .+.+++|+||||+||++ +....+||+|||++...
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKIL 160 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccc
Confidence 9999999976532 1235899999999999999999999321 13689999999999999 55678999999999877
Q ss_pred CCCCC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRKA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
..... ..++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ............ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~-- 229 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKEGK-FRR-- 229 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhcCC-CCC--
Confidence 65432 346778999999998889999999999999999999999987532 112222211111 111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+|++.+|++||++.+|++.
T Consensus 230 --------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 --------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.14 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=189.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL-----SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 35799999999999985 46899999999754322 2356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+|+|.+++.... ..+++..+..++.|+++||+||| +++|+|+||||+||++ +.+..+||+|||+++..
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLI---ASDGVLKLADFGLARSF 152 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEE---cCCCCEEEccceeeeec
Confidence 899999997643 25899999999999999999999 5799999999999999 55567999999998776
Q ss_pred CCCCC----CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---cCC-
Q 007427 476 PSRKA----SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---NDW- 546 (604)
Q Consensus 476 ~~~~~----~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~- 546 (604)
..... ...+..|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+......... ..+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFEALGTPTEENWP 228 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHHHcCCCchhhhh
Confidence 54321 234567999998864 45789999999999999999998777643210 111111110000 000
Q ss_pred ----ccccccHH----hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 547 ----STDILDVE----ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 547 ----~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........ .............+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 00000011234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=296.19 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 368999999999999864 68999999986432 2223457789999999999999999999999999999999997 49
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... .+++.....++.|++.||.||| +++|+||||||+||++ +....+||+|||+++......
T Consensus 89 L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 89 LKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence 9998876432 4889999999999999999999 4799999999999999 666689999999986543211
Q ss_pred ----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---------
Q 007427 480 ----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND--------- 545 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 545 (604)
....+..|+|||...+ ..++.++|||||||++|||++|+.||...... ...+. .........
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLH-KIFRVLGTPTEETWPGVS 233 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHH-HHHHhcCCCChhhhhhhh
Confidence 1234667999998875 45789999999999999999999999753210 00000 000000000
Q ss_pred -------Cccccc-cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 -------WSTDIL-DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 -------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... ................+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000000000011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.85 Aligned_cols=242 Identities=20% Similarity=0.298 Sum_probs=190.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 367999999999999865 5899999999754322 346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||++ +.+..++|+|||++.....
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEE---cCCCCEEEeecchhhcccc
Confidence 99999987543 235899999999999999999999 4799999999999999 5556789999999865432
Q ss_pred CC---------------------------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 478 RK---------------------------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 478 ~~---------------------------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.. ...++..|+|||+..+..++.++||||||+++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 11 113456799999999888999999999999999999999999753
Q ss_pred CCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 007427 525 PGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK----MSEVLR 591 (604)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 591 (604)
.. ............... ........+.+++.+||+.||++||+ +.|+++
T Consensus 236 ~~--------~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NR--------DETFSNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ch--------HHHHHHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 111111111111000 00113456899999999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.53 Aligned_cols=242 Identities=27% Similarity=0.400 Sum_probs=192.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 46899999999999985 4789999999875433 24678899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+||| +.+|+|+||||+||++ ++...+||+|||.+......
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCC
Confidence 9999997643 3788999999999999999999 4799999999999999 55678999999998776543
Q ss_pred CC--------CccccccCCCCCCCCCC---CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 479 KA--------SENLAIGRSPEFPEGKR---LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 479 ~~--------~~~~~~y~aPE~~~~~~---~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
.. ..+...|+|||++.+.. ++.++||||||+++||+++|+.||..... . ......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~------~-~~~~~~~~~-~~~ 224 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------E-FQIMFHVGA-GHK 224 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc------h-HHHHHHHhc-CCC
Confidence 22 23567899999988766 88999999999999999999999974321 0 111111111 100
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.... ........+.+++.+||+.+|++||++.|++.
T Consensus 225 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIP--------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC--------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100 01112346789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.36 Aligned_cols=234 Identities=20% Similarity=0.260 Sum_probs=182.6
Q ss_pred cCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCCHHH
Q 007427 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402 (604)
Q Consensus 325 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 402 (604)
||+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||+++++++...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999984 5688999999864322111 22222212 79999999999999999999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc-eEEEeeccCCCCCCCCCCC
Q 007427 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGFLPLLPSRKAS 481 (604)
Q Consensus 403 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~-~~kl~DFGla~~~~~~~~~ 481 (604)
++.... ++++.++..++.|+++||+||| +.+++||||||+||+++ ... .++|+|||+++........
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~~~~ 166 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTPSCY 166 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCCccC
Confidence 997653 5899999999999999999999 47999999999999994 444 7899999999887766666
Q ss_pred ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccC
Q 007427 482 ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREG 561 (604)
Q Consensus 482 ~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (604)
.++..|+|||++.+..++.++|||||||++|||++|+.||...... ......+.... ... .. ..
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~~--~~----------~~ 230 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQ-QKK--LP----------FI 230 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhh-ccc--CC----------cc
Confidence 7788999999999989999999999999999999999999743211 11122222211 100 00 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 007427 562 QNEMLRLTELALECTDIAPEKRPK-MSEVLR 591 (604)
Q Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 591 (604)
......+.+++.+||+.+|.+||+ ++|+++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 123446889999999999999996 588874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.44 Aligned_cols=239 Identities=22% Similarity=0.366 Sum_probs=192.0
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+||+|+||.||++.. .+++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999986544445677899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++... .+++.....++.|++.||+||| ++|++||||||+||++ +.+..++|+|||++.......
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccccc
Confidence 987543 3789999999999999999999 4799999999999999 555679999999887654322
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||+..+..++.++|||||||++|||++|+.||.+... .+...... ........
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~-~~~~~~~~------ 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIR-DNLPPKLK------ 237 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hhCCcccC------
Confidence 22456789999999888899999999999999999999999874211 11111111 11111000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||.+||++.++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00112335789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=296.83 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=190.9
Q ss_pred hcccCcCCcceEEEEEec---CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE---SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 357999999999999864 48999999997632 23346678899999999999999999999988 78999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL 472 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla 472 (604)
|+++ +|.+++..........+++..+..++.|++.||+||| +++|+||||||+||+++.++ ....+||+|||++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9965 7888776554333336889999999999999999999 57999999999999995411 2678999999998
Q ss_pred CCCCCCCC-------CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCC-----chhHHHH
Q 007427 473 PLLPSRKA-------SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSG-----DLSDWVR 539 (604)
Q Consensus 473 ~~~~~~~~-------~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~-----~~~~~~~ 539 (604)
+....... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+......... .+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643221 234667999998766 4578999999999999999999999986543220000 0111111
Q ss_pred HHHhc------------CCcc-------cccc-HHhhh-cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 540 MVVDN------------DWST-------DILD-VEILA-AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 540 ~~~~~------------~~~~-------~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... .+.. .... ..... .........++.+++.+||+.||++|||+.|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000 0000 00000 0000022346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=294.55 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=185.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++|+||+++++++...+..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 36799999999999975 568999999986432 2223467889999999999999999999999999999999995 68
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+.+..+..++.|++.||+||| +.+|+||||||+||++ +....+||+|||+++......
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence 887775432 24788889999999999999999 4799999999999999 556689999999987643221
Q ss_pred ----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH-----------Hh
Q 007427 480 ----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV-----------VD 543 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 543 (604)
...++..|+|||.+.+. .++.++|||||||++|||+||+.||...... ...+.+..... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhhhh
Confidence 22356789999998754 5788999999999999999999999753211 00011000000 00
Q ss_pred -cCCccccc----cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 -NDWSTDIL----DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 -~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+..... ................+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000000000011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.85 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=188.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 36799999999999985 468999999986432 2223578899999999999999999999999999999999995 6
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++..+..++.|++.||+||| +++++||||+|+||++ +.+..+||+|||+++.....
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccC
Confidence 8999887643 225899999999999999999999 4799999999999999 56678999999998765432
Q ss_pred CC----CccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---C----
Q 007427 479 KA----SENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND---W---- 546 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 546 (604)
.. ..++..|+|||...+.. ++.++|||||||++|||+||+.||.+... ...+........... +
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhhhh
Confidence 21 23466799999887644 58899999999999999999999975321 111111111000000 0
Q ss_pred --------ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 --------STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......... .........+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.55 Aligned_cols=239 Identities=20% Similarity=0.271 Sum_probs=191.6
Q ss_pred cCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||.|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999864 58999999986432 22346789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++..+..++.|++.||+||| +++++|+||||+||++ +....+||+|||+++......
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc
Confidence 99997653 4889999999999999999999 4799999999999999 556689999999998775532
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|++||.+.+..++.++||||||+++|||++|+.||..... +..+.............
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~-------- 214 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLE-------- 214 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCC--------
Confidence 23457789999999888899999999999999999999999975421 11222222221111000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.+......+.+++.+||+.+|++||+ +.|+++
T Consensus 215 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 --FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01112346899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.59 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=191.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 467999999999999865 6889999998643 2223467899999999999999999999999999999999999987
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
.+..+..... .+++.++..++.|++.||+|||+ ++++||||||+||++ ++...+||+|||++......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 86 LLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHS----HNIIHRDIKPENILV---SESGVLKLCDFGFARALRAR 153 (288)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCC
Confidence 7766554322 48999999999999999999994 699999999999999 66778999999998876544
Q ss_pred C-----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---------
Q 007427 479 K-----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD--------- 543 (604)
Q Consensus 479 ~-----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 543 (604)
. ...++..|+|||++.+. .++.++||||||+++|||++|+.||.+.... +..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhh
Confidence 3 22456779999999887 8899999999999999999999998753210 00000000000
Q ss_pred ---cC-----CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 ---ND-----WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ---~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ......+..............++.+++.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0000000000011111123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.75 Aligned_cols=256 Identities=21% Similarity=0.242 Sum_probs=185.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.+|.|+++.||++.. +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 6999999998743 33345689999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... ..+++.....++.|++.||+||| +++|+||||||+||++ +.+..+||+|||.+.......
T Consensus 86 l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 86 CEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEE---ecCCceEEecCccceeecccc
Confidence 9999986532 24788999999999999999999 4799999999999999 555678999999886543211
Q ss_pred -----------CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH----
Q 007427 480 -----------ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---- 542 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 542 (604)
...++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 231 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCcccc
Confidence 1234567999999875 358899999999999999999999997532110 0001000000
Q ss_pred hcCC-------ccc----cccHHh---hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 543 DNDW-------STD----ILDVEI---LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 543 ~~~~-------~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.... ... ..+... ............+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000 000000 0011112334578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=293.34 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEec------CCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS------KEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. .+..+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 46899999999999985 568999999986543 2345688899999998 69999999999853 456799999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+||++ ++...++|+|||++.
T Consensus 100 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~ 169 (282)
T cd06636 100 FCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 169 (282)
T ss_pred eCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEeeCcchh
Confidence 9999999999976442 24788889999999999999999 4799999999999999 566679999999987
Q ss_pred CCCCC----CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSR----KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
..... ....++..|+|||.+. ...++.++|||||||++|||++|+.||...... .. ......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~-~~~~~~- 240 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RA-LFLIPR- 240 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hh-hhhHhh-
Confidence 65422 2234677899999875 346788999999999999999999999653211 00 000000
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... ........+.+++.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NPPPKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 01123446899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.03 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=187.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecC-----CceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSK-----EEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e~ 394 (604)
.+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|||++++++++... +..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 35799999999999985 5789999999865322 346678899999998 899999999998754 357999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.++++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +....+||+|||+++.
T Consensus 106 ~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~----~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 106 CNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN----NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177 (291)
T ss_pred CCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHEEE---cCCCCEEEeecccchh
Confidence 999999999875321 12258999999999999999999994 699999999999999 5556789999999876
Q ss_pred CCCCC----CCccccccCCCCCCCCC-----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 475 LPSRK----ASENLAIGRSPEFPEGK-----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 475 ~~~~~----~~~~~~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
..... ...++..|+|||.+... .++.++|||||||++|||++|+.||..... . ..+..... .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~-~~~~~~~~-~ 248 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------V-KTLFKIPR-N 248 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------H-HHHHHHhc-C
Confidence 54322 23456789999987643 368899999999999999999999875321 0 11111111 1
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+ .......+.+++.+||+.+|++||++.|+++
T Consensus 249 ~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 PPPTLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 1122346889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.96 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=196.6
Q ss_pred ccCHHHHHHHhhcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCc
Q 007427 311 VFDLDDLLRASAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEE 387 (604)
Q Consensus 311 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 387 (604)
..++.|+.. ...||.|..|.|++++.. +|...|||.+... +....+++...+.++.+-+ .|.||+.+|||..+..
T Consensus 88 ~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 345666643 467999999999999854 6899999999754 3444567777888776664 8999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.++.||.| ..-++.+++...+ ++++...-++...+.+||.||-+ .++|+|||+||+|||+ |+.+++|++
T Consensus 166 V~IcMelM-s~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILl---De~GniKlC 234 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILL---DERGNIKLC 234 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEE---ccCCCEEee
Confidence 99999999 4466777765542 58888888999999999999987 5899999999999999 777889999
Q ss_pred eccCCCCCCCCC---CCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 468 NFGFLPLLPSRK---ASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 468 DFGla~~~~~~~---~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
|||++..+-+.. ...+.+.|||||.+.- ..|+.++||||||+.++||.||+.||.+.... +. .+..+
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------Fe-~ltkv 307 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------FE-VLTKV 307 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------HH-HHHHH
Confidence 999997775543 3468889999999864 46888999999999999999999999874321 11 12222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..+. . ..++. .......+.+++..||+.|+.+||...++++.
T Consensus 308 ln~e-P-P~L~~-------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 308 LNEE-P-PLLPG-------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HhcC-C-CCCCc-------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2211 1 11111 11245578999999999999999999988763
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=284.72 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||++... +|..||+|.+... .....+.+.+|++++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999854 6889999998643 1233467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.+ ...+||+|||.+......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 85 DLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCC--CCeEEecccccchhccCC
Confidence 99999976432 24799999999999999999999 4799999999999999433 245799999998776543
Q ss_pred CC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 KA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ..++..|+|||+..+..++.++|||||||++|||++|+.||.... ..+........... ..
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~---- 222 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGYFA-PI---- 222 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcccCC-CC----
Confidence 22 245678999999988889999999999999999999999986421 22333322222111 10
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112336889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=288.77 Aligned_cols=238 Identities=18% Similarity=0.263 Sum_probs=185.4
Q ss_pred cCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||+||++.. .+|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999974 468999999986422 12244567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++..... ..+++..+..++.|++.||.||| +.+++||||||+||++ +++..+||+|||.+.......
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc
Confidence 999976542 24899999999999999999999 4799999999999999 666689999999987654322
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...+...|+|||+..+..++.++|||||||++|||++|+.||...... .............. .
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~--~--------- 215 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRTLEMA--V--------- 215 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhcccccc--c---------
Confidence 224566899999998888999999999999999999999999753221 01111111110000 0
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSE 588 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 588 (604)
.........+.+++.+||+.||++||+.+|
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 216 -EYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred -cCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 001122346889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=288.84 Aligned_cols=237 Identities=19% Similarity=0.268 Sum_probs=190.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 468999999999999854 68999999986432 22346688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++..+..++.|++.||+||| +++|+||||+|+||++ +.+..+||+|||+++....
T Consensus 86 ~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 86 GELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCC
Confidence 99999997653 4889999999999999999999 4799999999999999 5566899999999987654
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...++..|+|||.+.+...+.++||||||+++|||++|+.||.... ............. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~--~------- 216 (290)
T cd05580 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEGKV--R------- 216 (290)
T ss_pred CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCc--c-------
Confidence 42 2346778999999988888999999999999999999999987532 1111111111110 0
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVL 590 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl 590 (604)
.+......+.+++.+||+.||.+|| +++|++
T Consensus 217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0011234688999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=287.52 Aligned_cols=241 Identities=25% Similarity=0.425 Sum_probs=194.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 367999999999999865 689999999975543 457788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++..+..++.|++.||+||| +.||+|+||||+||++ +.+..++|+|||++.......
T Consensus 103 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 103 TDIITQNF----VRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh
Confidence 99998753 25899999999999999999999 4799999999999999 555679999999876654332
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|++||...+..++.++|||||||++|||++|+.||..... ........... .....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~~----- 237 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITTKG-IPPLK----- 237 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-CCCCc-----
Confidence 22356789999999888899999999999999999999999864211 11111111111 11110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|.+||++.++++
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11113346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.56 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||.|+||+||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 46799999999999985 468899999986432 2245788999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.++++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +++..+||+|||++..+....
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 9999976432 124899999999999999999999 4799999999999999 555679999999987665432
Q ss_pred CC--------ccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 AS--------ENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ~~--------~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.. .++..|+|||++... .++.++|||||||++|||++|+.||...... ..+.+. ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~----~~~~~~-~- 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLT----LQNDPP-S- 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHH----hcCCCC-C-
Confidence 22 356789999998876 7899999999999999999999999753221 111111 111100 0
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ............+.+++.+||+.||++||++.|+++
T Consensus 227 ~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 L----ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred c----CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000001133456889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.52 Aligned_cols=239 Identities=25% Similarity=0.387 Sum_probs=189.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCC---CCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLK---HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|.. .+++.||+|.++.. ......++.+|++++++++ |||++++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 36799999999999985 57899999998643 2333467889999999986 9999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++... ++++..+..++.|++.||.||| +.+|+|+||+|+||++ +....++|+|||++....
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLN 152 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecC
Confidence 99999998653 4899999999999999999999 4799999999999999 556689999999987765
Q ss_pred CCCC----CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 477 SRKA----SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 477 ~~~~----~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.... ..++..|+|||...+ ..++.++|||||||++|||++|+.||..... ...... ..........
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~~~~~~~ 223 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKSKPPRLE 223 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccCCCCCCC
Confidence 4322 245668999998865 4468999999999999999999999975321 111110 0010001100
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++||++.|+++
T Consensus 224 ---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 ---------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0013346889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.20 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=202.2
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 393 (604)
.+.||+|+||.||+++ ..+|+.||||.++... ....+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 6789999999998643 334577889999999999999999999865433 5689999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL 472 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla 472 (604)
||.+|||+..|..-.. ...+++.+.+.+..+++.||.|||+ +||+||||||.||++.... ....-||+|||.|
T Consensus 98 yC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrE----n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRE----NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHH----cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999987553 3459999999999999999999994 7999999999999996543 3446799999999
Q ss_pred CCCCCCCC---CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC--
Q 007427 473 PLLPSRKA---SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW-- 546 (604)
Q Consensus 473 ~~~~~~~~---~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 546 (604)
+.+++... ..||..|.+||.++. ..|+..+|.|||||++||.+||..||-........ .+.+........
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~----~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN----KEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc----chhhhhhhccCCCc
Confidence 99987763 368999999999994 88999999999999999999999999764332111 111111111110
Q ss_pred ccccccHHhh-----------hcccCHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHHhhc
Q 007427 547 STDILDVEIL-----------AAREGQNEMLRLTELALECTDIAPEKRP--KMSEVLRRIEEIQ 597 (604)
Q Consensus 547 ~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~ 597 (604)
..-...++.. ...........+..++..++..+|++|. ...+....+..|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 0000000000 0011123345677888999999999999 7777777776664
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.16 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=186.3
Q ss_pred cccCcC--CcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKG--KVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..||+| +||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999985 579999999986432 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+||++ +....+|++||+.+.....
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhc
Confidence 999999886532 24889999999999999999999 4799999999999999 5556789999985433211
Q ss_pred CC-----------CCccccccCCCCCCCCC--CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH----
Q 007427 478 RK-----------ASENLAIGRSPEFPEGK--RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM---- 540 (604)
Q Consensus 478 ~~-----------~~~~~~~y~aPE~~~~~--~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 540 (604)
.. ...+...|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~ 229 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGPPYS 229 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHhcCCCCC
Confidence 10 11234569999998763 47899999999999999999999997532100 00000000
Q ss_pred ----------------------------HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 541 ----------------------------VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 541 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...........+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER-LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred Cccccccchhhhhhccchhhhhcccccchhcccccccccccc-ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000000000 001112234567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=289.68 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=187.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCc-----eEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEE-----KLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~ 392 (604)
.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++ |+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 46799999999999985 468999999886432 122357888999999995 6999999999887665 79999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+++..........+++..+..++.||+.||+||| +++|+||||||+||+++.+ ...+||+|||++
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~--~~~~kl~dfg~~ 158 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQ--KGLLKIADLGLG 158 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecC--CCeEEEeecccc
Confidence 99975 8999887654332346899999999999999999999 4799999999999999431 567999999998
Q ss_pred CCCCCCC----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC--
Q 007427 473 PLLPSRK----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND-- 545 (604)
Q Consensus 473 ~~~~~~~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 545 (604)
+...... ...++..|+|||++.+ ..++.++|||||||++|||++|..||.+.... ..+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL----QQLLHIFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHHhCCCChh
Confidence 7653321 1234667999998765 45789999999999999999999999753211 01111111000000
Q ss_pred -Cc-----------cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 -WS-----------TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 -~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+. ........ ....+....++.+++.+||+.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDL--SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhH--HHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=276.28 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEe-c--C--CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-E--S--GAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 393 (604)
...||+|.||.||+|.. + + .+.+|+|+++... ........+|+.+++.++|||++.+..++.+ +...++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 46799999999999953 2 2 3479999997542 2234667899999999999999999999987 678899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL 472 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla 472 (604)
|.+. ||.+.++.++......++...+..|+.||+.|+.||| ++=|+||||||.|||+..++ +.+++||+|||++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9988 9999998877655567899999999999999999999 57899999999999997653 3478999999999
Q ss_pred CCCCCCC-------CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC-CchhHHHHHHHh
Q 007427 473 PLLPSRK-------ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS-GDLSDWVRMVVD 543 (604)
Q Consensus 473 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 543 (604)
+.+...- ...-|..|+|||.+.+. .||.+.||||.|||+.||+|-++.|.+........ ..-.+.+..+++
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 9876432 22456799999998874 58999999999999999999998887643221111 111111111111
Q ss_pred -------cCCc---------cccccHHhhhccc--CH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 544 -------NDWS---------TDILDVEILAARE--GQ-------NEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 544 -------~~~~---------~~~~~~~~~~~~~--~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..|. ..+.+.+...... .. .......+|+.++|..||.+|.|+.+.++.
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111 0000100000000 00 011236799999999999999999998764
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=285.63 Aligned_cols=240 Identities=18% Similarity=0.245 Sum_probs=192.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 468999999999999865 68999999997432 23357889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ++++..+..++.|+++||.||| .++++|+||||+||++ ++...++|+|||.+.....
T Consensus 85 ~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 85 GDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEE---cCCCCEEEeecccccccCC
Confidence 99999997652 5889999999999999999999 4799999999999999 5666889999999877654
Q ss_pred C---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 R---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ....+...|+|||...+..++.++||||||+++|+|++|+.||...... ............ ..
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--~~----- 219 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQETA--DV----- 219 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhccc--cc-----
Confidence 4 2234667899999999888999999999999999999999999754321 111111111110 00
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKM--SEVL 590 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 590 (604)
..+......+.+++.+||+.||.+||++ +|++
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 ----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111223568899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=286.21 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=186.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 36799999999999985 468999999987532 222334567888898885 99999999999987 88999999996
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
|+|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||++ +. ..+||+|||+++...
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~----~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR----NGIFHRDIKPENILI---KD-DILKLADFGSCRGIY 150 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCceecccCHHHEEE---cC-CCeEEEecccccccc
Confidence 58888887543 258999999999999999999994 699999999999999 44 789999999998764
Q ss_pred CCCC---CccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---------
Q 007427 477 SRKA---SENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD--------- 543 (604)
Q Consensus 477 ~~~~---~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 543 (604)
.... ..++..|+|||... +..++.++|||||||++|||++|+.||.+.... ...........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHh
Confidence 4322 24567899999765 455788999999999999999999999753211 11111111100
Q ss_pred --cCCccccccHHhhh---cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 --NDWSTDILDVEILA---AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 --~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.... .......+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 0001123567999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=279.17 Aligned_cols=242 Identities=30% Similarity=0.453 Sum_probs=196.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 367999999999999865 7899999999765544567899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++..+..++.|++.||+||| .++++||||+|+||++ ++...++|+|||.+.......
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence 99987653 25899999999999999999999 4799999999999999 556789999999988776543
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...+...|++||...+..++.++||||||+++|||++|+.||.... .......... ........
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~----- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLRN----- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcCc-----
Confidence 3456778999999988889999999999999999999999987431 1111111111 11111100
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.73 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=190.4
Q ss_pred cCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 599999999975432 3356788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++..+..++.|++.||+||| ..+++||||+|+||++ +....+||+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcc
Confidence 99997643 4899999999999999999999 4799999999999999 556689999999987653321
Q ss_pred -----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 480 -----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...+...|++||.......+.++||||||+++||+++|+.||.... ..+............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 220 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILNGKIEW 220 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCcCC
Confidence 1235568999999988889999999999999999999999987432 112222221111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
. ........+.+++.+||+.+|++||++.++.+.|+
T Consensus 221 ~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 P----------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C----------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 00012446889999999999999999966655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.20 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=188.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... +..++||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 478999999999999865 689999999974322 2234577899999999999999999998877 78999999997
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
++|.+++..... .+++..+..++.|++.||+||| +++++||||||+||++ +....+||+|||+++...
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLL---NNRGILKICDFGLAREYG 157 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEE---CCCCcEEEeecCceeecc
Confidence 599998876432 4899999999999999999999 4799999999999999 666789999999988765
Q ss_pred CCC----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---------
Q 007427 477 SRK----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV--------- 542 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 542 (604)
... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchHHHHH
Confidence 431 22456789999988754 4689999999999999999999998753211 00110000000
Q ss_pred ----h--c-CCccccccHHhhhcccCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 ----D--N-DWSTDILDVEILAAREGQN-EMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 ----~--~-~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. . ........... ....... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 00000000000 0000001 2456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.11 Aligned_cols=246 Identities=15% Similarity=0.228 Sum_probs=175.8
Q ss_pred hcccCcCCcceEEEEEecC----CcEEEEEEecccchhh-----------HHHHHHHHHHHccCCCCCcccEEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLES----GAVVAVKRVKNMNALS-----------KKEFVQQMQLLGKLKHENLAKIVSFYYSKE 386 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 386 (604)
.++||+|+||.||+|...+ +..+|+|......... ......+...+..+.|+|++++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 4689999999999998654 4566666543221110 011233445567789999999999765543
Q ss_pred ----ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc
Q 007427 387 ----EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462 (604)
Q Consensus 387 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~ 462 (604)
..++++|++. .++.+.+.... ..++..+..|+.|++.||+||| +++|+||||||+|||+ +...
T Consensus 97 ~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill---~~~~ 163 (294)
T PHA02882 97 CRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMV---DGNN 163 (294)
T ss_pred CCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---cCCC
Confidence 3467888874 47777665432 2567888999999999999999 4799999999999999 5567
Q ss_pred eEEEeeccCCCCCCCC-----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 007427 463 RAKLTNFGFLPLLPSR-----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531 (604)
Q Consensus 463 ~~kl~DFGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 531 (604)
.+||+|||+|+.+... ....++..|+|||+..+..++.++|||||||++|||++|+.||.+........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 8999999999765321 12257889999999999999999999999999999999999998642211000
Q ss_pred -CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 532 -GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 532 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
....++......... ........+.+++..|++.+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000111111111100 0112245688999999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=285.09 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=189.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+|.. .+|+.||+|++.... ......+.+|++++++++|+|++++++++.+.+..+++|||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 36799999999999985 479999999986432 2234678899999999999999999999999999999999995 6
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ..+++..+..++.|+++||+||| +++++||||+|+||++ +....++|+|||+++.....
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVP 152 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCC
Confidence 99999876542 24899999999999999999999 4799999999999999 55668999999998765432
Q ss_pred C----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---Cc--c
Q 007427 479 K----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND---WS--T 548 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~ 548 (604)
. ...++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+..+...... +. .
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhh
Confidence 2 12346789999987654 578899999999999999999999875321 011111111000000 00 0
Q ss_pred ccccHH--h------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVE--I------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~--~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+.. . ............+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0 000001122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.95 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=202.3
Q ss_pred HhhcccCcCCcceEEEEEec--------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceE
Q 007427 320 ASAEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKL 389 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (604)
...+.+|+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34559999999999999742 14579999998543 34567899999999999 5999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccc---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESR---------GVGR--IPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
+|+||++.|+|.++++..+ .... ..++..+.+.++.|||.|++||+ +.++|||||.++|||+
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi--- 451 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLI--- 451 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEe---
Confidence 9999999999999999877 1111 13889999999999999999999 5789999999999999
Q ss_pred CCcceEEEeeccCCCCCCCCCCCc-------cccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 007427 459 NDIYRAKLTNFGFLPLLPSRKASE-------NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNET 530 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~~~~~~~~-------~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~ 530 (604)
..+..+||+|||+|+......... -...|||||.+....|+.|||||||||+||||+| |..||.+...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~---- 527 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP---- 527 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc----
Confidence 666789999999999765443221 1235999999999999999999999999999999 8899876221
Q ss_pred CCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
..+... .+..+...+ .+..+..++.++++.||+.+|++||++.|+.+.++..
T Consensus 528 ---~~~l~~-~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ---TEELLE-FLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHHHHH-HHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 112222 222222211 1233455788999999999999999999999999984
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=287.00 Aligned_cols=244 Identities=26% Similarity=0.387 Sum_probs=189.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCC------ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKE------EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~e 393 (604)
.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 468999999999999864 678999999875433 346789999999999 7999999999997654 4899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++ +.+..+||+|||++.
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~ 161 (275)
T cd06608 90 LCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA 161 (275)
T ss_pred cCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEE---ccCCeEEECCCccce
Confidence 9999999999876431 1235899999999999999999999 5799999999999999 556789999999987
Q ss_pred CCCCCC----CCccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSRK----ASENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~~----~~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
...... ...++..|+|||++.. ..++.++|||||||++|||++|+.||..... ... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~-~~~~~~- 232 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRA-LFKIPR- 232 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHH-HHHhhc-
Confidence 654322 2345678999998753 3467899999999999999999999864211 111 111111
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....... ........+.+++.+||..||++|||+.|+++
T Consensus 233 ~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTLK--------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCCC--------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111110 11123456889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.16 Aligned_cols=241 Identities=25% Similarity=0.368 Sum_probs=189.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+++.||+|.+.... ....+.+.+|++++++++|+|++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 46799999999999985 468999999986432 2233568889999999999999999999999999999999995
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .++++.++..++.|++.||+||| ++|++||||||+||++ +....+||+|||++.....
T Consensus 105 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 105 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP 173 (313)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence 58888876533 25899999999999999999999 4799999999999999 5556799999999876655
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....++..|+|||++. ...++.++|||||||++|||++|..||..... ............. ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~-~~~--- 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNDSP-TLQ--- 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCCC-CCC---
Confidence 55556778899999974 45688899999999999999999999875321 1111111111111 000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122357899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=283.91 Aligned_cols=239 Identities=17% Similarity=0.224 Sum_probs=182.2
Q ss_pred ccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHH---HHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 324 VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQM---QLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
+||+|+||.||+|.. .+++.||+|.+..... .....+..|. +.++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4689999999864321 1112233343 34455689999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|+++||+||| +++|+||||||+||++ +.+..+||+|||++....
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccC
Confidence 999999886543 5899999999999999999999 4799999999999999 556679999999987654
Q ss_pred CCC--CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 477 SRK--ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 477 ~~~--~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ............ ..
T Consensus 149 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~--~~---- 217 (278)
T cd05606 149 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMA--VE---- 217 (278)
T ss_pred ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHHHHHhhccC--CC----
Confidence 322 23567889999998754 68999999999999999999999997542211 111111110000 00
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
........+.+++.+|+..+|.+|| ++.++++
T Consensus 218 ------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0111234688999999999999999 8889875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.50 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=190.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 46799999999999985 46889999998632 22234568899999999999999999999999999999999996
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .++++.++..++.|++.||.||| +.+++||||||+||++ +....+||+|||++.....
T Consensus 99 ~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 99 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 68888776433 24889999999999999999999 4799999999999999 5566899999999887766
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||..... ............ ...
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~-~~~---- 234 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES-PAL---- 234 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHHhhcCC-CCc----
Confidence 55556778999999874 35678899999999999999999999864211 111111111111 000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
........+.+++.+||+.+|++||++.++++.-
T Consensus 235 -----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0112334688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=287.45 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +++.+|+|+++... ......+.+|++++++++|+|++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 367999999999999865 58999999997542 33346788999999999999999999999888 78999999997
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+ +|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++ +++..+||+|||++....
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~----~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS----NGILHRDIKGSNILI---NNDGVLKLADFGLARPYT 151 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH----CCceeccCcHHHeEE---cCCCCEEEccccceeecc
Confidence 5 9998887542 258999999999999999999994 699999999999999 666789999999987765
Q ss_pred CCC-----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc----CC
Q 007427 477 SRK-----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN----DW 546 (604)
Q Consensus 477 ~~~-----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 546 (604)
... ....+..|+|||.+.+ ..++.++||||||+++|||+||+.||...... .....+...... .+
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENW 226 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhc
Confidence 432 1234567999997764 45789999999999999999999998753211 111111100000 00
Q ss_pred c------------cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 S------------TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ....................+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000000000112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.16 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... +..++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 367999999999999865 789999999875432 3457889999999999999999999999988 88999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||++ +....+||+|||.+....
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~----~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS----NGIVHRDIKGANILV---DSDGVVKLADFGCAKRLG 152 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEE---cCCCCEEEcccccEEecc
Confidence 999999998653 58999999999999999999994 799999999999999 556688999999987765
Q ss_pred CCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 477 SRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 477 ~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
... ...+...|+|||...+..++.++||||||+++|+|++|+.||.... .................
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~- 224 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPPE- 224 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCcC-
Confidence 543 2356778999999988889999999999999999999999987532 11111111111011111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+|++.||++||++.|+++
T Consensus 225 ---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ---------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.52 Aligned_cols=241 Identities=22% Similarity=0.344 Sum_probs=193.9
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
..||.|+||.||+|..+ .+-..|.|++...+....++|.-|++||..+.||+||++++.|+..+..+++.|||.||-..
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 46899999999999855 45566788887666667789999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC----C
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP----S 477 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~----~ 477 (604)
.++-.-. .++++.++.-+++|++.||.||| +++|||||||+.|||++-+ +.++|+|||.+.... .
T Consensus 118 aimlEL~----r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~Tld---GdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 118 AIMLELG----RVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLD---GDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred HHHHHhc----cccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEec---CcEeeecccccccchhHHhh
Confidence 9887654 25999999999999999999999 6899999999999999555 457999999875432 3
Q ss_pred CCCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 478 RKASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.....|+++|||||+.. ...|+.++||||||++|.||..+.+|-..... +.-.+. +.. ..++-.+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllK-iaK-SePPTLl- 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK-IAK-SEPPTLL- 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHH-Hhh-cCCCccc-
Confidence 45668999999999865 56799999999999999999999999653211 111111 111 1111111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+......+.+++.+||..||+.||++.++++
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12234456899999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=294.72 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=186.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+|+.||+|.+... .......+.+|+.++++++|+||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46899999999999985 47899999998642 223345678899999999999999999998644 3569999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+. ++|.+.+... +++..+..++.|++.||+||| ++||+||||||+||++ +.+..+||+|||++
T Consensus 101 e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~ 165 (353)
T cd07850 101 ELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 165 (353)
T ss_pred eccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEE---CCCCCEEEccCccc
Confidence 9995 5888887532 788899999999999999999 4799999999999999 56668999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCC----------CCCchhHH--
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE----------TSGDLSDW-- 537 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~----------~~~~~~~~-- 537 (604)
+...... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 8765432 22456789999999999999999999999999999999999975321000 00000000
Q ss_pred --HHHHHhcCCc--cccccHHhh---h----cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 538 --VRMVVDNDWS--TDILDVEIL---A----AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 538 --~~~~~~~~~~--~~~~~~~~~---~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......... ...+..... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000000 0 00011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=285.03 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=190.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|++|.||+|+.. +|+.||+|.++... ......+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 367999999999999864 68999999987542 22346678899999999999999999999999999999999975 8
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++..... ...+++..+..++.|++.||+||| +++++||||||+||++ ++...+||+|||+++......
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCc
Confidence 9998876442 235899999999999999999999 4699999999999999 566689999999987654321
Q ss_pred ----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH-----------Hh
Q 007427 480 ----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV-----------VD 543 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 543 (604)
...++..|++||.+.+. .++.++|||||||++|||++|+.||.+.... .......... ..
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhc
Confidence 22346789999987654 5688999999999999999999999754321 1111111000 00
Q ss_pred -cCCccc---cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 -NDWSTD---ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 -~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+... ..+... ....+.....+.+++.+|++.||.+||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDL--QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHH--HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000000 0001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.89 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=178.8
Q ss_pred hcccCcCCcceEEEEEecC--CcEEEEE------------------EecccchhhHHHHHHHHHHHccCCCCCcccEEEE
Q 007427 322 AEVLGKGKVGSTYKATLES--GAVVAVK------------------RVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 381 (604)
.+.||+|+||+||++..+. +..++.| .++. .......+.+|+.++++++|+||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 4789999999999987432 2222222 1111 11234568899999999999999999999
Q ss_pred EecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 382 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
+...+..++|+|++. ++|.+++..............+...|+.|++.||+||| +++|+||||||+|||+ +..
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl---~~~ 303 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFL---NCD 303 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCC
Confidence 999999999999994 58888876543211112345667889999999999999 5799999999999999 666
Q ss_pred ceEEEeeccCCCCCCCCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhH
Q 007427 462 YRAKLTNFGFLPLLPSRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 536 (604)
..+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|..++....... ....+.+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHHHHH
Confidence 789999999998765432 2357889999999999999999999999999999999886543221100 0011111
Q ss_pred HHHHHH--hcCCccc---cccH---H-hhhcc-c------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 537 WVRMVV--DNDWSTD---ILDV---E-ILAAR-E------GQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 537 ~~~~~~--~~~~~~~---~~~~---~-~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.+.... ...+... ..+. . ..... . .......+.+++.+||+.||++|||+.|+++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111000 0000000 0000 0 00000 0 00112356788999999999999999999863
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.44 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=193.5
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.+||.|.||.||-|. .++|...|+|-++-. .....+...+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 5689999999999997 678999999988632 2233466889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+.+...+ ..++.....+..|++.|++|||+ +|||||||||.||++ +..+.+|++|||.|..+...
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~----~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE----HGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh----cCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence 9999998754 25666777889999999999995 699999999999999 66678999999999887654
Q ss_pred C--------CCccccccCCCCCCCCCC---CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh-cCC
Q 007427 479 K--------ASENLAIGRSPEFPEGKR---LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD-NDW 546 (604)
Q Consensus 479 ~--------~~~~~~~y~aPE~~~~~~---~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 546 (604)
. ...||+.|||||++.+.. ...+.||||+|||++||+||+.||..... +|.-++.- .+.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAGH 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhccC
Confidence 3 236899999999998643 56689999999999999999999975422 23322211 111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.+++ +.....+-.+++..||+.||++|.++.|+++.
T Consensus 1459 ~Pq~----------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQI----------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCC----------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111 12244456799999999999999999887653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=275.30 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=194.2
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..||.|.||+|++-. .++|+..|||+++... ..+.++++.|.+...+- +.||||++||.+..++..|+.||.|. .+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 579999999999987 5679999999998543 35677888888866554 78999999999999999999999994 47
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|..+...-.......+++...-.|+.....||.||-+. ..|||||+||+|||+ +..+.+||||||++..+..+.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~---lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE---LKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH---hhhhhccCChhheEE---ecCCCEeeecccchHhHHHHH
Confidence 77654432222233588888889999999999999874 689999999999999 666778999999987765543
Q ss_pred ---CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 480 ---ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
...|...|+|||.+.. ..|+-+|||||+|++|||+.||+.||.... .+.+.+..+..+....-..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~--- 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLF--- 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecC---
Confidence 3367889999999874 358999999999999999999999987532 2344444444433222111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.....+....+.+++..|+..|-++||...++.+
T Consensus 293 ---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 ---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1222345567999999999999999999998765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.14 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=185.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 394 (604)
.+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++|+||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 46899999999999974 578999999986432 223466888999999999999999999876443 57999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++ ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||+++.
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLL---NTNCDLKICDFGLARI 155 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEE---CCCCCEEECcccceee
Confidence 96 4898888643 4899999999999999999999 4799999999999999 6667899999999876
Q ss_pred CCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... .....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCC
Confidence 54322 1235678999998654 56889999999999999999999999753210 00000000000000
Q ss_pred ccc---ccc-------------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 547 STD---ILD-------------VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 547 ~~~---~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
... +.+ ..............++.+++.+||+.||++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000 0000000001124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.32 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhh--------------HHHHHHHHHHHccCCCCCcccEEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALS--------------KKEFVQQMQLLGKLKHENLAKIVSFYYSKE 386 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 386 (604)
.+.||+|+||+||+|.. .+++.||+|.++...... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 46799999999999985 468999999986432211 125778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..++||||++ |+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+||++ +....+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill---~~~~~~kl 160 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFI---NSKGICKI 160 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEE---CCCCCEEE
Confidence 9999999996 69999987543 4889999999999999999999 4799999999999999 55668999
Q ss_pred eeccCCCCCCCCC------------------CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCC
Q 007427 467 TNFGFLPLLPSRK------------------ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGN 527 (604)
Q Consensus 467 ~DFGla~~~~~~~------------------~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~ 527 (604)
+|||+++...... ...++..|+|||.+.+. .++.++|||||||++|||+||+.||.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654110 11245679999998764 4689999999999999999999999754211
Q ss_pred CCCCCchhHHHHHHHhcC----Ccccc-----------ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 528 NETSGDLSDWVRMVVDND----WSTDI-----------LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~----~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+. .+....... +.... ...... .........+.+++.+||+.+|++||++.|++.
T Consensus 241 ----~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 ----DQLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK--TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ----HHHH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHH--HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111 111111000 00000 000000 001122356889999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.71 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=185.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++||||++
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 46799999999999985 4689999999864321 1234567899999999999999999998765 46899999996
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++ +....+||+|||++....
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 48988887543 25899999999999999999999 4799999999999999 566689999999988765
Q ss_pred CCC----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---Ccc
Q 007427 477 SRK----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND---WST 548 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 548 (604)
... ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+....... ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhhch
Confidence 432 1223567999999865 45789999999999999999999999753211 0111010000000 000
Q ss_pred ccc------cHHhhhc------ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DIL------DVEILAA------REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~------~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..- ....... .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 000112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.17 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=186.3
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCC--ceEEEEec
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKE--EKLIIYEF 394 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~~lv~e~ 394 (604)
..+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +|+||+++++++...+ ..++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3578999999999999864 6889999988542 222345677899999999 9999999999986543 57999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++ ++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+++.
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILL---NSDCRVKLADFGLARS 156 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence 96 5999988753 3789999999999999999999 4799999999999999 6667899999999876
Q ss_pred CCCCCC---------CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh-
Q 007427 475 LPSRKA---------SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD- 543 (604)
Q Consensus 475 ~~~~~~---------~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 543 (604)
...... ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+..... ....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-----~~~~~~~~~~~ 231 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-----QLEKIIEVIGP 231 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCC
Confidence 643321 235667999998764 457889999999999999999999997532110 0000000000
Q ss_pred ----------cCCccccccH----Hh-hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 544 ----------NDWSTDILDV----EI-LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 544 ----------~~~~~~~~~~----~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
......+.+. .. ............+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 00 0000001134568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.94 Aligned_cols=243 Identities=23% Similarity=0.317 Sum_probs=195.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+++. .+++.+|+|.+... .......+.+|++++++++|+||+++++++......++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999974 47889999998743 2334567789999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ....+++..+..++.|++.||+||| +.|++|+||+|+||++ ++...+||+|||+++.....
T Consensus 85 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 85 DLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred CHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC
Confidence 99999876432 2235899999999999999999999 5799999999999999 44567899999998776544
Q ss_pred C--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 K--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 ~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
. ...+...|++||...+..++.++|+||||+++|||++|+.||.... ............ ...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~------- 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYKVQRGK-YPP------- 220 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-CCC-------
Confidence 2 2245678999999999889999999999999999999999987532 111111111111 111
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+|++.+|++||++.|+++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11133456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=284.33 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=187.0
Q ss_pred hhcccCcCCcceEEEEEecC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKATLES-GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..+.||+|+||.||+|...+ ++.||||.++... ......+.+|+.++.+.. |+||+++++++......+++|||++
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 35789999999999999764 8999999997532 223455677777776664 9999999999999999999999985
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .++++..+..++.|++.||+|||+ .++|+||||+|+||++ +.+..+||+|||++..+..
T Consensus 98 ~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 98 TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD 167 (296)
T ss_pred cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEE---cCCCCEEECccccchhccC
Confidence 57877776533 258999999999999999999995 2589999999999999 5667899999999876643
Q ss_pred CC---CCccccccCCCCCCCCCC----CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 478 RK---ASENLAIGRSPEFPEGKR----LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~----~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.. ...++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... -.+........... ..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~ 239 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEEPP-SL 239 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCCCC-CC
Confidence 32 223556899999987554 78899999999999999999999864211 01112222221110 00
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. .......++.+++.+||+.||++||++.++++.
T Consensus 240 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P--------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C--------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 001123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.99 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=183.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc--------eEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE--------KLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------~~l 390 (604)
.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+. .++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 46899999999999985 468999999886432 2223456789999999999999999999876543 499
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+. ++|.+++.... ..+++.++..++.|++.||+||| +++++|+||||+||++ +....+||+|||
T Consensus 97 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~---~~~~~~kl~dfg 164 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILI---TKDGILKLADFG 164 (310)
T ss_pred EEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEE---CCCCcEEECcCC
Confidence 999996 58888886542 24899999999999999999999 4699999999999999 666789999999
Q ss_pred CCCCCCCCCC--------CccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSRKA--------SENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~~~--------~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
++........ ..++..|+|||.+.+. .++.++||||||+++|||+||+.||.+... ......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~ 239 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQL 239 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHH
Confidence 9876643221 1345679999987664 478899999999999999999999875321 0111111111
Q ss_pred Hhc---CCcccc-----cc---------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDN---DWSTDI-----LD---------VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~---~~~~~~-----~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ...... .+ ...............+.+++.+||..||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 000000 00 000000000011235679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.00 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=191.1
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.||+|++|.||++.. .+++.+++|.++.... .....+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 5799999999999985 4789999999875322 2456788999999999999999999999999999999999975 8
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .++++..+..++.|++.||+||| +++|+|+||||+||++ +.+..+||+|||.+.......
T Consensus 84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCc
Confidence 988887643 25899999999999999999999 4799999999999999 556689999999987665433
Q ss_pred ----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC---ccccc
Q 007427 480 ----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW---STDIL 551 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 551 (604)
...++..|+|||...+. .++.++||||||+++|+|+||+.||...... ..+..... ...... .....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFR-TLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHH-HcCCCchHhcccch
Confidence 23456679999998876 7899999999999999999999998753211 00000000 000000 00000
Q ss_pred c-----------HH-hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 D-----------VE-ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~-----------~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+ .. ............++.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00 0000011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=275.97 Aligned_cols=239 Identities=26% Similarity=0.415 Sum_probs=193.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+++.. +++.||+|.+..... .....+.+|++++++++|+|++++++++.+.+..+++|||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 468999999999999854 688999999976543 34567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||.||| +.||+||||||+||++ +....++|+|||.+......
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCC
Confidence 9999987653 5899999999999999999999 5799999999999999 55568999999998876544
Q ss_pred CC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 KA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ..++..|+|||...+..++.++||||+|+++|||++|+.||.... ........ .... ...
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~~-~~~~-~~~----- 218 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFRI-VQDD-HPP----- 218 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH-hccC-CCC-----
Confidence 32 346778999999988888999999999999999999999987431 11111111 1110 000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||..+|++||++.|++.
T Consensus 219 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 -----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01122346889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=282.29 Aligned_cols=242 Identities=18% Similarity=0.249 Sum_probs=187.9
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccch----hhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNA----LSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+++. .+|+.||+|+++.... ...+.+.+|++++.++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999985 3689999999975321 2346678899999999 5999999999999988999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++++|.+++.... ++++..+..++.|++.||+||| +.+++||||||+||++ +.+..+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~ 152 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILL---DSNGHVVLTDFGLS 152 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEE---CCCCCEEEeeCccc
Confidence 9999999999997643 4788999999999999999999 4799999999999999 56678999999998
Q ss_pred CCCCCCC-----CCccccccCCCCCCCCC--CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRK-----ASENLAIGRSPEFPEGK--RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~-----~~~~~~~y~aPE~~~~~--~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+...... ...++..|+|||..... .++.++||||||+++|||++|+.||..... ...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~ 228 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE 228 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC
Confidence 7764322 22356789999998753 467899999999999999999999864211 112222222222111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
.. ........+.+++.+||+.||++|| ++.++++
T Consensus 229 ~~------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 PP------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CC------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 10 0111234578999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.29 Aligned_cols=246 Identities=18% Similarity=0.232 Sum_probs=191.3
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +|+||+++++.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999974 357899999987432 22345688999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++|+|.+++.... .+++..+..++.|+++||+||| +.+++||||||+||++ +.+..++|+|||++
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~ 152 (288)
T cd05583 85 DYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILL---DSEGHVVLTDFGLS 152 (288)
T ss_pred ecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEE---CCCCCEEEEECccc
Confidence 9999999999987543 4889999999999999999999 4799999999999999 55667999999998
Q ss_pred CCCCCCCC-----CccccccCCCCCCCCCC--CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRKA-----SENLAIGRSPEFPEGKR--LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~~-----~~~~~~y~aPE~~~~~~--~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+....... ..+...|+|||...+.. .+.++||||||+++|||++|..||..... .....+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~ 228 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKSK 228 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHccC
Confidence 76543321 23567899999987655 78899999999999999999999864211 111122222221111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
.. ........+.+++.+||+.||++|||+.++.+.|+.
T Consensus 229 ~~------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 PP------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CC------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 011123457899999999999999999988777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=279.92 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccC---CCCCcccEEEEEecCCc-----eEE
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKL---KHENLAKIVSFYYSKEE-----KLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~~l 390 (604)
.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 367999999999999975 589999999974321 2234566787776655 69999999999988776 899
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
+|||++ ++|.+++..... ..+++..+..++.|+++||+||| +++++|+||||+||++ +.+..+||+|||
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili---~~~~~~~l~dfg 152 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILV---TSDGQVKIADFG 152 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEE---ccCCCEEEeccC
Confidence 999996 489998876432 24899999999999999999999 4699999999999999 555789999999
Q ss_pred CCCCCCCCCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---c
Q 007427 471 FLPLLPSRKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---N 544 (604)
Q Consensus 471 la~~~~~~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 544 (604)
++........ ..++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChH
Confidence 9877644322 2356679999999998999999999999999999999999875321 1111111111000 0
Q ss_pred CCcccc------ccHHhh--hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDI------LDVEIL--AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~------~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.... ...... ...........+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 000000 00001223456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=283.13 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=186.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|++|.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 367999999999999854 78999999986432 2234678899999999999999999999999999999999995 5
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++.....++.||+.||+||| +++++||||||+||+++.+ ...+||+|||++......
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~--~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIP 156 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECC--CCEEEEcccccccccCCC
Confidence 8888876543 223678888899999999999999 4799999999999999533 346899999998765432
Q ss_pred C----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---cCCc--c
Q 007427 479 K----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---NDWS--T 548 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~ 548 (604)
. ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+......... ..+. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChhhccccc
Confidence 1 2234678999998866 45789999999999999999999999753211 111111000000 0000 0
Q ss_pred ccccHHhh--------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVEIL--------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+.... .....+.....+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 00001122346889999999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=291.25 Aligned_cols=238 Identities=20% Similarity=0.371 Sum_probs=195.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
...||+|.|++|.+|+. .++..||+|.+.+.. ....+.+.+|+++|..++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 46899999999999984 579999999997542 333355899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
.+++++..+.. +....+..++.|+.+|++||| ++.|+|||||++|||| +.++++||+|||++..+...
T Consensus 141 e~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 141 ELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred hhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhccc---ccccceeeeccccceeeccc
Confidence 99999998753 555888899999999999999 5799999999999999 88889999999999888754
Q ss_pred C---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-. ..-...+...+...
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr~rvl~gk~rIp----- 275 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELRPRVLRGKYRIP----- 275 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cccchheeeeeccc-----
Confidence 3 4568899999999998876 56899999999999999999999974321 11111111111100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.-...++.+++++++..+|.+|++++++.+
T Consensus 276 -------~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 -------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -------ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 011225779999999999999999999865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=292.87 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=186.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 46799999999999984 569999999987532 2234667889999999999999999998763 3467999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+. ++|.+++.... .+++..+..++.|++.||+||| .++|+||||||+||++ +.+..+||+|||+++.
T Consensus 90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLV---NEDCELRIGDFGMARG 156 (334)
T ss_pred hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence 95 69999886543 4899999999999999999999 4799999999999999 6667899999999876
Q ss_pred CCCCC--------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH--------
Q 007427 475 LPSRK--------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW-------- 537 (604)
Q Consensus 475 ~~~~~--------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------- 537 (604)
..... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..... .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~----~~~~~~~~~g~~~ 232 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH----QLKLILSVLGSPS 232 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH----HHHHHHHHhCCCh
Confidence 54322 1245678999998765 458899999999999999999999997532110 00000
Q ss_pred -----------HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 538 -----------VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 538 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
............... ...........+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVP----WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCC----HHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000000 00001123457899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=276.97 Aligned_cols=239 Identities=22% Similarity=0.320 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-----NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46899999999999985 56899999987532 122345788999999999999999999998764 35789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.... .+++.....++.|++.||.||| +.+++|+||||+||++ +.+..++|+|||+++
T Consensus 87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~ 154 (264)
T cd06653 87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILR---DSAGNVKLGDFGASK 154 (264)
T ss_pred eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEE---cCCCCEEECcccccc
Confidence 999999999987543 4788999999999999999999 4799999999999999 556679999999987
Q ss_pred CCCCC-------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSR-------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~-------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... ....++..|+|||+..+..++.++|||||||++|||++|+.||..... ... +........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~-~~~~~~~~~ 226 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAA-IFKIATQPT 226 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHH-HHHHHcCCC
Confidence 65321 112466789999999988899999999999999999999999874311 111 111111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... .+......+.+++.+||. +|.+||++.+++.
T Consensus 227 ~~~----------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPM----------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCC----------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 112233468899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=274.15 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=196.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 367999999999999854 68999999997543 245677899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ....+++.++..++.+++.||.||| +.+++|+||+|+||++ ++...++|+|||.+......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 99999987531 1235899999999999999999999 4699999999999999 55567999999998776544
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..+.......... ...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-~~~---- 223 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQY-PPI---- 223 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCCC-CCC----
Confidence 2 2245678999999988889999999999999999999999986431 2222222222111 110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||..+|++||++.|+++
T Consensus 224 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=292.10 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=190.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 393 (604)
.+.||+|+||+||+|+. .+++.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 46899999999999984 57899999998642 222345677899999999999999999988654 34799999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+. ++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||++ +....+||+|||+++
T Consensus 90 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 90 LMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred CCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 995 69999887543 4899999999999999999999 4799999999999999 556689999999998
Q ss_pred CCCCCC----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC--
Q 007427 474 LLPSRK----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW-- 546 (604)
Q Consensus 474 ~~~~~~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 546 (604)
...... ...++..|+|||.+.. ..++.++|||||||++|||++|+.||.+.... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCChH
Confidence 765431 2245678999998764 46889999999999999999999999753210 00000000000000
Q ss_pred ---------cc-------ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhcc
Q 007427 547 ---------ST-------DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQP 598 (604)
Q Consensus 547 ---------~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 598 (604)
.. ...+... ..........+.+++.+||+.||++|||+.|+++. ++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00 0000000 00011234568899999999999999999999976 655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=280.40 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch-hhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+.. +++.||+|++..... .......+|+..+.+++ |+||+++++++...+..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999865 588999999865322 22334567999999999 999999999999999999999999 88
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++.++..++.|++.+|.||| +++++|+||||+||++ ++...++|+|||++......
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEE---cCCCCEEEeecccceeccCC
Confidence 9999987654 124899999999999999999999 4799999999999999 66778999999998776543
Q ss_pred C---CCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC--------CchhHHHHHHHhcCC
Q 007427 479 K---ASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS--------GDLSDWVRMVVDNDW 546 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 546 (604)
. ...++..|+|||.+. ...++.++||||||+++|||++|+.||.......... ..-..|.........
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 234567899999875 4557899999999999999999999987542110000 000000000000000
Q ss_pred cccc----ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDI----LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.... ..... . .........+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSL-H-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccH-H-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00000 0 000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=308.52 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=176.1
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecC---------------
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------------- 385 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------- 385 (604)
++||+||||.||+++.+ ||+.||||++.-. +......+.+|+..+++|+|||||+++..+.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 68999999999999954 8999999999743 333446788999999999999999987654110
Q ss_pred --------------------------------------------------------------------------------
Q 007427 386 -------------------------------------------------------------------------------- 385 (604)
Q Consensus 386 -------------------------------------------------------------------------------- 385 (604)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ------------------------CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007427 386 ------------------------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441 (604)
Q Consensus 386 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 441 (604)
...||-||||+...|.++++.+.-. -.....++++.+|+.||+|+| +.
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH----~~ 716 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIH----DQ 716 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHH----hC
Confidence 0036778999987777777765411 035678899999999999999 46
Q ss_pred CceecCCCCCceEEeecCCcceEEEeeccCCCCCC----------------------CCCCCccccccCCCCCCCCC---
Q 007427 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP----------------------SRKASENLAIGRSPEFPEGK--- 496 (604)
Q Consensus 442 ~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~----------------------~~~~~~~~~~y~aPE~~~~~--- 496 (604)
|||||||||.||++ +....+||+|||+|.... ......||..|+|||.+.+.
T Consensus 717 giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999 566678999999998721 01122578899999998864
Q ss_pred CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcc
Q 007427 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECT 576 (604)
Q Consensus 497 ~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 576 (604)
.|+.|+|+||+|||++||+. ||... ..-...+........+.+ . ....+....-.++|.+++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts-------MERa~iL~~LR~g~iP~~-~-------~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTS-------MERASILTNLRKGSIPEP-A-------DFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCch-------HHHHHHHHhcccCCCCCC-c-------ccccccchHHHHHHHHHh
Confidence 49999999999999999995 45432 111111222211111111 0 001122334468999999
Q ss_pred cCCCCCCCCHHHHHH
Q 007427 577 DIAPEKRPKMSEVLR 591 (604)
Q Consensus 577 ~~dP~~RPs~~evl~ 591 (604)
++||.+|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.39 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=196.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 393 (604)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 468999999999999864 58999999997543 334567899999999999999999999988765 7899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|++ ++|.+++.... ++++..+..++.|++.||+||| ++||+||||||+||++ +.+..++|+|||++.
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~ 151 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILV---NSNCDLKICDFGLAR 151 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---cCCCCEEEcccCceE
Confidence 997 58999887543 5899999999999999999999 5799999999999999 556789999999988
Q ss_pred CCCCCC-------CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
...... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.... .....+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~ 226 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTP 226 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCC
Confidence 765442 22356679999999887 7899999999999999999999999764311 0001110000000
Q ss_pred C-----------ccccccH-----HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhccc
Q 007427 546 W-----------STDILDV-----EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQPM 599 (604)
Q Consensus 546 ~-----------~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~ 599 (604)
. ....+.. ..............+.+++.+||+.+|++||++.++++. ++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0 0000000 000000011134568899999999999999999999984 6665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=285.53 Aligned_cols=259 Identities=19% Similarity=0.305 Sum_probs=188.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+|+.||+|+++.. .......+.+|++++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999985 57899999998642 2223456889999999999999999999987543 468999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+.. +|.+++.. .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||++
T Consensus 100 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~ 164 (342)
T cd07879 100 PYMQT-DLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAV---NEDCELKILDFGLA 164 (342)
T ss_pred ccccc-CHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEE---CCCCCEEEeeCCCC
Confidence 99964 77776531 3889999999999999999999 4799999999999999 56678999999998
Q ss_pred CCCCCCCC-CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH-----------
Q 007427 473 PLLPSRKA-SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR----------- 539 (604)
Q Consensus 473 ~~~~~~~~-~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----------- 539 (604)
+....... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+.....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCHHHHH
Confidence 87643322 245678999999876 46889999999999999999999999753210 00110000
Q ss_pred HHHhcC---C---ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhccccc
Q 007427 540 MVVDND---W---STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQPMIE 601 (604)
Q Consensus 540 ~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~~~ 601 (604)
...... + .......... ...+.....+.+++.+||+.||++||++.|++.. ++.+++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFS--TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HhcccchHHHHhhcCCcccchHH--HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 000000 0 0000000000 0001123457899999999999999999999954 777766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=282.63 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=186.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC----------ce
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE----------EK 388 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------~~ 388 (604)
.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 478999999999999864 68999999996432 223456788999999999999999999987654 78
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
++|+||+++ ++.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+||++ ++...+||+|
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili---~~~~~~kl~d 159 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILL---NNKGQIKLAD 159 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCCCcEEeCc
Confidence 999999976 7877776532 24899999999999999999999 4799999999999999 6667899999
Q ss_pred ccCCCCCCCCCC-----CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 469 FGFLPLLPSRKA-----SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 469 FGla~~~~~~~~-----~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
||++........ ......|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~----~~~~~~~~~-~~ 234 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE----LAQLELISR-LC 234 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH-Hh
Confidence 999887654321 133567999998764 4578899999999999999999999874221 111111111 10
Q ss_pred hcCCc---cccc--------cHHhh----hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 DNDWS---TDIL--------DVEIL----AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 ~~~~~---~~~~--------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ..+. +.... ........+..+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 0000 00000 00000112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=287.26 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=183.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC--------------C
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------------E 386 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------~ 386 (604)
.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46799999999999985 56899999999765555567788999999999999999999876543 3
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..++||||++ ++|.+++... .+++..+..++.|++.||.|||+ .||+||||||+||+++. +...+|+
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~----~givH~dikp~Nili~~--~~~~~kl 156 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS----ANVLHRDLKPANVFINT--EDLVLKI 156 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEEcC--CCceEEE
Confidence 5789999996 5999888643 38899999999999999999994 69999999999999953 3346899
Q ss_pred eeccCCCCCCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 467 TNFGFLPLLPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 467 ~DFGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
+|||.++...... ...++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~~~ 232 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQLIL 232 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH
Confidence 9999987653221 1235668999997654 567889999999999999999999997542110 000000
Q ss_pred HH-------------------HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 539 RM-------------------VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 539 ~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .............. .......++.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD-----LLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH-----HccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 00000000000000 00112346889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=283.84 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=182.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--------ceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--------EKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~l 390 (604)
.+.||+|+||.||+|+. .+++.+|+|++.... ......+.+|++++++++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 46799999999999985 468999999986432 222356788999999999999999999875443 4699
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
|+||+.+ +|.+.+.... ..+++.++..++.|+++||+||| +++|+||||||+||++ +++..+||+|||
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 9999965 7877776532 24899999999999999999999 5799999999999999 666789999999
Q ss_pred CCCCCCCCCC---------------CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCch
Q 007427 471 FLPLLPSRKA---------------SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 471 la~~~~~~~~---------------~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~ 534 (604)
+++....... ..++..|+|||...+ ..++.++|||||||++|||++|+.||.+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~----~~ 236 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID----QL 236 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence 9876543221 123566999998765 457899999999999999999999987532210 00
Q ss_pred hHHHHHHHhcC----C-----cccc--------ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 535 SDWVRMVVDND----W-----STDI--------LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 535 ~~~~~~~~~~~----~-----~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ..... + .... ....... ........+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFK-LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHH-HhCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 00000 0 0000 0000000 00112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.75 Aligned_cols=232 Identities=22% Similarity=0.299 Sum_probs=187.8
Q ss_pred cCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999864 589999999875332 2345788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||++ +....++|+|||.+......
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC
Confidence 99997653 4899999999999999999999 4799999999999999 55667999999998776543
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....++..|++||...+...+.++|+||||+++||+++|+.||..... .............
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~--------- 211 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLR--------- 211 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCC---------
Confidence 223456789999999888899999999999999999999999964311 1222222221110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSE 588 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 588 (604)
........+.+++.+||..||++||++.+
T Consensus 212 ---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 ---FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00111346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.75 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=188.6
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||.||++. ..+|+.||||+++.. .....+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 3679999999999997 457999999998642 2223456889999999999999999999987653 358999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++ +....+||+|||++
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~ 165 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAV---NEDCELKILDFGLA 165 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE---cCCCCEEEeecccc
Confidence 999 77999888643 3899999999999999999999 4799999999999999 55668999999999
Q ss_pred CCCCCCCC-CccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH-----------HH
Q 007427 473 PLLPSRKA-SENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW-----------VR 539 (604)
Q Consensus 473 ~~~~~~~~-~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~ 539 (604)
........ ..++..|+|||.+.+ ..++.++|||||||++|++++|+.||...... ....+. ..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL----DQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCHHHHH
Confidence 87654332 345778999998875 45889999999999999999999999753210 000000 00
Q ss_pred HHHhcCCc------cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH--HHHHhhc
Q 007427 540 MVVDNDWS------TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL--RRIEEIQ 597 (604)
Q Consensus 540 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~i~ 597 (604)
........ ......... .........+.+++.+|++.||++|||+.+++ ..++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFR--SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhcchhHHHHHHhccccCcchHH--HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00000000 000000000 00012234588999999999999999999998 4454443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=274.75 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=187.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-----NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+++.. .+..+++|.++.. .......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 467999999999999854 3455666665532 1223345778999999999999999999999889999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++++|.+++...... ...+++.+++.++.|++.||.||| +++++|+||||+||+++ +. .+||+|||.++..
T Consensus 85 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~---~~-~~~l~d~g~~~~~ 155 (260)
T cd08222 85 EGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLK---NN-LLKIGDFGVSRLL 155 (260)
T ss_pred CCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEee---cC-CEeecccCceeec
Confidence 999999998754322 235899999999999999999999 47999999999999994 32 4899999998766
Q ss_pred CCCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.... ...++..|+|||...+..++.++||||||+++|+|++|..||.... ............. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~~-~~-- 224 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGPT-PS-- 224 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCCC-CC--
Confidence 4332 2245678999999988888999999999999999999999986421 1222222211110 00
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.+|++||++.|+++
T Consensus 225 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.66 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=190.1
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 57999999999999865 59999999997542 2334678889999999999999999999999999999999997 59
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||+|+||++ ++...+||+|||.++......
T Consensus 84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~----~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS----HRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChheEEE---cCCCCEEEecCCcccccCCCc
Confidence 999998653 248999999999999999999994 699999999999999 666789999999987764432
Q ss_pred ----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc------c
Q 007427 480 ----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS------T 548 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 548 (604)
.......|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.... ........ .
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~ 227 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI----DQLFKIF-QILGTPTEESWPGVT 227 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH-HHhCCCcHHHHHhhc
Confidence 12345679999998766 7899999999999999999999998653210 0000000 00000000 0
Q ss_pred cc--ccHHhhh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DI--LDVEILA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~--~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .+..... ....+.....+.+++.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000 0000112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=284.47 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=186.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++++||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 46899999999999984 47999999988542 22234678899999999999999999999876 45789999999 5
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++... ++++.....++.|++.||+||| +++|+||||||+||++ +....+||+|||.+.....
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP 160 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence 6999888643 3788888999999999999999 4799999999999999 6667899999999876544
Q ss_pred CC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-------CCchhHHHHHHHhcCCcc
Q 007427 478 RK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET-------SGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 548 (604)
.. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||......... .....++......... .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT-L 239 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh-H
Confidence 32 2345678999998765 56899999999999999999999999753210000 0000011110000000 0
Q ss_pred ccccHHhhhcc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 DILDVEILAAR-----EGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+.......... ........+.+++.+||+.+|++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 001123578899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=270.67 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=203.1
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecC-CceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-EEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 392 (604)
...++-+|.||.||+|.+. +.+.|-+|.++.. +......+..|...+..+.|||+..+.+++.++ ...+.+|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3467889999999999653 3456778888743 344456788999999999999999999998654 5678999
Q ss_pred ecCCCCCHHHHhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 393 EFLPNGSLFDLLHESRG---VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
.++.-|+|..++...++ .....++..+...++.|++.|++||| +++|||.||.++|+++ ++..++||+|=
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvI---dd~LqVkltDs 440 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVI---DDQLQVKLTDS 440 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhccee---hhheeEEeccc
Confidence 99999999999984432 12345777888999999999999999 5799999999999999 88899999999
Q ss_pred cCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
.+++.+-+... ......||+||.+....|+.++|||||||+||||+| |+.||...++ .+ +...+
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------fE-m~~yl 511 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------FE-MEHYL 511 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------HH-HHHHH
Confidence 99988765432 234568999999999999999999999999999999 9999875432 22 22223
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
.+++.. ..+.+++.++..++..||..+|++||+++|++.-|.+....+
T Consensus 512 kdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 KDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred hcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 332211 123456778999999999999999999999999998876443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=279.82 Aligned_cols=238 Identities=18% Similarity=0.244 Sum_probs=193.1
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
++||+|+||.||-++. .+|+.||.|.+.+.. ........+|-.+|.+++.+.||.+--.|.+.+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 6899999999999974 579999999885432 122345788999999999999999998899999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
||.-+|.+... ..+++..++-++.+|+.||++||+ .+||.||+||+|||+ |+.++++|+|.|+|..++..
T Consensus 271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~----~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR----RRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh----cceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence 99999887653 349999999999999999999994 699999999999999 88889999999999988766
Q ss_pred CCC---ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchh-HHHHHHHhcCCccccccHH
Q 007427 479 KAS---ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLS-DWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~~~---~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 554 (604)
... .||.+|||||++....|+...|.||+||++|||+.|+.||..... ..-. +.-++.....
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~eEvdrr~~~~~--------- 406 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKREEVDRRTLEDP--------- 406 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhHHHHHHHHhcch---------
Confidence 533 689999999999999999999999999999999999999975321 1111 1111111110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
........++..++....|+.||.+|-..+
T Consensus 407 ---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 407 ---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 112233455788999999999999997543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=285.06 Aligned_cols=243 Identities=21% Similarity=0.378 Sum_probs=198.2
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.++||.|.||+||-|+ .++|+.||||++.+.. .....++++|+.+|++++||.||.+-..|+..+..+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 5899999999999997 4689999999997543 233467899999999999999999999999999999999999 55
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
|..+++-.... + .+++....-++.||+.||.||| -++|+|+||||+|||+.+.+..-++||+|||+|+.+...
T Consensus 648 DMLEMILSsEk-g--RL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK-G--RLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc-c--cchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 76666654432 2 4888888899999999999999 479999999999999988877889999999999999876
Q ss_pred CC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 KA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ..+++.|.|||++..+.|+..-|+||.|||+|--++|..||... +++.+.++.. .+.-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNA-------aFMy--- 783 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNA-------AFMY--- 783 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhcc-------cccc---
Confidence 53 46899999999999999999999999999999999999999753 2233222210 0000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
......+.....+++|...|+..-++|.|....+
T Consensus 784 -Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 784 -PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 0112234555688999999999999999987654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=277.34 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=190.5
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||++... +|+.||+|++... .....+.+.+|++++++++ |+||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999854 7999999998642 2233467889999999998 9999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++.... .+++..+..++.|++.||+||| +.+++|+||||+||++ +....++++|||++....
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEE---CCCCCEEecCCccccccC
Confidence 999999998653 5899999999999999999999 4799999999999999 556678999999987654
Q ss_pred CCCC------------------------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 007427 477 SRKA------------------------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSG 532 (604)
Q Consensus 477 ~~~~------------------------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~ 532 (604)
.... ..++..|+|||......++.++||||||++++|+++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------ 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence 3321 1245689999999888899999999999999999999999875320
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKM----SEVLR 591 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 591 (604)
...........+. ........+.+++.+||+.+|++||++ .|+++
T Consensus 228 --~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --YLTFQKILKLEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHHhcCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111111110 011123468899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.77 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=182.1
Q ss_pred hcccCcCCcceEEEEEec-C--CcEEEEEEecccc--hhhHHHHHHHHHHHccC-CCCCcccEEEEEecC----CceEEE
Q 007427 322 AEVLGKGKVGSTYKATLE-S--GAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSK----EEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~lv 391 (604)
.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999854 4 7899999986421 22346688899999999 599999999875432 457888
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
+||+. ++|.+++.... .+++..+..++.|++.||+||| .+||+||||||+||++ +....+||+|||+
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili---~~~~~~kl~Dfg~ 151 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLV---NADCELKICDFGL 151 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEE---cCCCCEEeCcCCC
Confidence 99985 69999986543 4899999999999999999999 4799999999999999 5566899999999
Q ss_pred CCCCCCCC--------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC-------Cchh
Q 007427 472 LPLLPSRK--------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS-------GDLS 535 (604)
Q Consensus 472 a~~~~~~~--------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~-------~~~~ 535 (604)
++...... ...++..|+|||+..+ ..++.++|||||||++|||++|+.||.......... ....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 97654321 1245678999998765 468999999999999999999999987532100000 0000
Q ss_pred HHHHHHHhcC--------CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 536 DWVRMVVDND--------WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 536 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+......... ......... .........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFE----SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchH----hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000000000 000112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=270.17 Aligned_cols=220 Identities=15% Similarity=0.166 Sum_probs=173.5
Q ss_pred CCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHHHhhc
Q 007427 328 GKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHE 406 (604)
Q Consensus 328 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 406 (604)
|.||.||+++. .+++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 578999999997543 233455555566799999999999999999999999999999999876
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-CCcccc
Q 007427 407 SRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-ASENLA 485 (604)
Q Consensus 407 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-~~~~~~ 485 (604)
.. .+++..+..++.|++.||+||| +++|+||||||+||++ +....++++|||.+....... ....+.
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~ 146 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCDGEAVEN 146 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEE---cCCCCEEEecccchhccccccccCCcCc
Confidence 43 4899999999999999999999 4799999999999999 555678999999876654432 223456
Q ss_pred ccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHH
Q 007427 486 IGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEM 565 (604)
Q Consensus 486 ~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (604)
.|+|||...+..++.++||||+||++|||++|+.|+....... ....... .+....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~~~~~~----------~~~~~~ 202 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NTHTTLN----------IPEWVS 202 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------ccccccC----------CcccCC
Confidence 7999999988889999999999999999999998875421100 0000000 001123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHH
Q 007427 566 LRLTELALECTDIAPEKRPKMSE 588 (604)
Q Consensus 566 ~~l~~li~~cl~~dP~~RPs~~e 588 (604)
..+.+++.+|++.||++||++.+
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCc
Confidence 45789999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=281.97 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=184.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++++++|+||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 35799999999999974 578999999997432 22346688899999999999999999988643 3467888
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++ +....+||+|||++
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~ 167 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAV---NEDCELKILDFGLA 167 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEE---cCCCCEEEeccccc
Confidence 887 78999888643 3899999999999999999999 4799999999999999 55668999999998
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc--CCcc
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN--DWST 548 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 548 (604)
+...... ...++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+.......... ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 168 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHHh
Confidence 8764432 2346778999998765 56888999999999999999999998643210 1111111000000 0000
Q ss_pred ccccH---Hhhh------c----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 DILDV---EILA------A----REGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~---~~~~------~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...+. .... . .........+.+++.+|++.||.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000 0 0000123467899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.96 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=191.0
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.++||+|.||+||+|+ .++++.||+|+++- .++.......+|+.+++.++|+|||+++++...+...-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 3689999999999998 56789999999873 3344567889999999999999999999999999999999999955
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|..+...-.+ .++.+....++.|+++||.|+| ++++.|||+||.|.|+ +.+++.|++|||+++.+.-.
T Consensus 86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnlli---n~ngelkladfglarafgip 154 (292)
T KOG0662|consen 86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCc
Confidence 99988876543 4889999999999999999999 6799999999999999 77788999999999887543
Q ss_pred C----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH---HhcCCcc-
Q 007427 479 K----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV---VDNDWST- 548 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 548 (604)
. ....+..|++|.++.+. -|++..|+||.||++.|+.. |++.|.+... ...+....+.. .++.|..
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv----ddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH----HHHHHHHHHHhCCCccccCCcc
Confidence 2 33457789999998875 48999999999999999998 6666665321 11122211111 1122211
Q ss_pred -ccccHHh----hhcccCHHHH----HHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 -DILDVEI----LAAREGQNEM----LRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 -~~~~~~~----~~~~~~~~~~----~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...|... .......... ..=.+++.+.+.-+|.+|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111100 0000111111 23457888888889999999998765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=274.16 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--C----CcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH--E----NLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~~lv~e~ 394 (604)
...+|+|.||.|-.+.. ..+..||||+++.... ..+..+-|+++++++.+ | -+|.+.++|.-.++.++|+|.
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 46799999999999974 4579999999986543 35667889999999942 2 267788889999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC---------------
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--------------- 459 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--------------- 459 (604)
+ |-|++++|..+. -.+++...+..++.|++++++||| +.+++|-||||+|||+.+.+
T Consensus 173 l-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 173 L-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred c-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 9 669999998764 346889999999999999999999 57999999999999995421
Q ss_pred --CcceEEEeeccCCCCCCCCCC-CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhH
Q 007427 460 --DIYRAKLTNFGFLPLLPSRKA-SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 460 --~~~~~kl~DFGla~~~~~~~~-~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 536 (604)
....+|++|||.|........ ...|..|+|||++.+-.++.++||||+||||+|+.||...|+..... +.+ .
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~----EHL-a 319 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL----EHL-A 319 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH----HHH-H
Confidence 245789999999988765543 36789999999999999999999999999999999999999865321 111 1
Q ss_pred HHHHHHhcCCccccc--------------c------------------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCC
Q 007427 537 WVRMVVDNDWSTDIL--------------D------------------VEILAAREGQNEMLRLTELALECTDIAPEKRP 584 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~--------------~------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 584 (604)
.+..++. ..+..+. | +.-........+..++.+|+.+||..||.+|+
T Consensus 320 MMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 320 MMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 1211111 0000000 0 00000011224456799999999999999999
Q ss_pred CHHHHHH
Q 007427 585 KMSEVLR 591 (604)
Q Consensus 585 s~~evl~ 591 (604)
|+.|++.
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=281.48 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=185.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc------eEEEE
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE------KLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 392 (604)
...||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 468999999999999864 6889999998642 22234567789999999999999999998876554 89999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+ +++|.+++... .+++..+..++.|+++||+||| +.||+||||||+||++ +....+||+|||++
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~ 165 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAV---NEDCELKILDFGLA 165 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEE---CCCCCEEEcccccc
Confidence 999 67999998753 4899999999999999999999 4799999999999999 55668999999998
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC-Ccc-
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND-WST- 548 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~- 548 (604)
....... ...++..|+|||...+ ..++.++|||||||++|||+||+.||..... .+......... ...
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--------IDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCCH
Confidence 8764432 2345678999998765 4678999999999999999999999975321 11111111000 000
Q ss_pred c----cccHH----hh---h------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 D----ILDVE----IL---A------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~----~~~~~----~~---~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. +.... .. . ..........+.+++.+||+.||++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 00000 00 0 0000112457889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=272.69 Aligned_cols=247 Identities=19% Similarity=0.281 Sum_probs=192.3
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEeccc---c----hhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEe
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNM---N----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 393 (604)
.+||+|+|++||+|. +...+.||||+-.-. . ....+...+|.++.+.|.||.||++|+||.- .+..|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 579999999999997 567899999976421 1 1112456789999999999999999999964 557889999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
||+|.+|.-||+.++ .+++.++..|+.||+.||.||.+. +.+|||-||||.|||+......+.+||.|||+++
T Consensus 549 YceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 999999999999876 489999999999999999999987 6799999999999999888888999999999999
Q ss_pred CCCCCCC-----------CccccccCCCCCCCC----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 474 LLPSRKA-----------SENLAIGRSPEFPEG----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 474 ~~~~~~~-----------~~~~~~y~aPE~~~~----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
.+.+... ..++..|.+||.+.- -+++.|+||||.|||+|..+.|+.||.... ...++.+.-
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq----sQQdILqeN 697 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ----SQQDILQEN 697 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch----hHHHHHhhh
Confidence 9876532 246788999998763 357889999999999999999999997532 112222111
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
. ++... ++. -+..+....+...+|.+||++.-++|....++.
T Consensus 698 T-IlkAt---EVq------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 T-ILKAT---EVQ------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred c-hhcce---ecc------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 11110 000 001122334578999999999999998877664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.21 Aligned_cols=233 Identities=20% Similarity=0.251 Sum_probs=187.2
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
...+|.|+|+.|-.+. ..+++..++|++.+. ..+..+|+.++.+. +||||+++.+.+.+..+.|+|||++.++-
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 3459999999999987 567899999999754 23344677666555 79999999999999999999999999998
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
+.+.+...+ .....+..|+.+|+.|+.||| ++|||||||||+|||+. ++..+++|+|||.++......
T Consensus 403 ll~ri~~~~------~~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 403 LLRRIRSKP------EFCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred HHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh
Confidence 888877654 233677789999999999999 57999999999999995 355679999999999887763
Q ss_pred CC-ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 AS-ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 ~~-~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
.. .-+..|.|||+.....|++++||||||++||||++|+.||...+.. .+....+.....
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~------------ 531 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKF------------ 531 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCcc------------
Confidence 33 4567899999999999999999999999999999999999865432 122222211111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+...++|+.+||+.||.+||+|.++..
T Consensus 532 --s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 --SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1234456889999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=299.05 Aligned_cols=140 Identities=24% Similarity=0.339 Sum_probs=123.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|... +++.||||+++... ......+.+|+.++..++|+||+++++++...+..++||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999865 78999999997432 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
++|.+++.... .+++..++.|+.||+.||+||| .++|+||||||+|||+ +....+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 99999997643 4788999999999999999999 4699999999999999 555689999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=260.38 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=191.9
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHH---HHHHHHHHccCCCCCcccEEEEEecCCc
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKIVSFYYSKEE 387 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~ 387 (604)
++.+|.. .-++||+|.||+|.+++ ..+|+.+|+|++++.-...+++ -..|-++|+..+||.+..+.-.|+..+.
T Consensus 165 vTm~dFd--fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDFD--FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchhh--HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 3444443 24789999999999997 5689999999998754444433 4568899999999999999989999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.|+||||..||.|+-+|...+ .+++....-+...|+.||.||| +++||.||||.+|.|+ |.++++||+
T Consensus 243 lCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlL---DkDGHIKit 310 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLL---DKDGHIKIT 310 (516)
T ss_pred EEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhhee---ccCCceEee
Confidence 999999999999999998755 4888888889999999999999 6899999999999999 666788999
Q ss_pred eccCCCCCCCC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 468 NFGFLPLLPSR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 468 DFGla~~~~~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
|||+++.--.. ....+++.|.|||++....|..++|.|.+|||+|||+.|+.||+... ...+.+.+ .-
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kLFeLI---l~ 382 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKLFELI---LM 382 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHHHHHH---Hh
Confidence 99999764322 34478999999999999999999999999999999999999998542 12222222 11
Q ss_pred cCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC
Q 007427 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP 584 (604)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 584 (604)
... ..+.....+...|+...|..||.+|.
T Consensus 383 ed~------------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 EDL------------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhc------------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 110 11122334577899999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=255.78 Aligned_cols=253 Identities=21% Similarity=0.366 Sum_probs=187.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEec--ccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC--------CceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------EEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~l 390 (604)
..+||+|.||+||+|+. ++|+.||+|++- ...........+|+++|..++|+|++.++++|... ...|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 36899999999999984 568889998763 23333456788999999999999999999988643 24799
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||.+|+. ||..++.... ..++..++.+++.++..||.|+| +..|+|||+||+|+|+ +.+..+||+|||
T Consensus 102 Vf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLI---t~dgilklADFG 169 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLI---TKDGILKLADFG 169 (376)
T ss_pred eHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEE---cCCceEEeeccc
Confidence 9999977 9999987643 35889999999999999999999 5799999999999999 666789999999
Q ss_pred CCCCCCCCCCC--------ccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSRKAS--------ENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~~~~--------~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
+++.+...... ..+..|++||.+.+ ..|+++.|||..|||+.||+|+.+.+.+... ..-...+...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-----qqql~~Is~L 244 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-----QQQLHLISQL 244 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-----HHHHHHHHHH
Confidence 99776543322 23678999999886 4689999999999999999999988876421 1111111111
Q ss_pred H----hcCCccccccHHhhh---------cc--cCHHHH------HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 542 V----DNDWSTDILDVEILA---------AR--EGQNEM------LRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 542 ~----~~~~~~~~~~~~~~~---------~~--~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. .+-|+ .+..-++.. .. ..++.. ....+|+..++..||.+|+++++++..
T Consensus 245 cGs~tkevWP-~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 245 CGSITKEVWP-NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCCcccCC-CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 11111 110000000 00 001111 257899999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=256.68 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=189.7
Q ss_pred CcceEEEEEec-CCcEEEEEEecccchhh-HHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHHHhhc
Q 007427 329 KVGSTYKATLE-SGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHE 406 (604)
Q Consensus 329 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 406 (604)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 58999999997654433 67899999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC---CCCcc
Q 007427 407 SRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR---KASEN 483 (604)
Q Consensus 407 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~---~~~~~ 483 (604)
.. .+++..+..++.++++++.|||+ .+++|+||+|+||++ +....++|+|||.+...... ....+
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 148 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS----NGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVG 148 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH----cCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccC
Confidence 43 28899999999999999999994 699999999999999 55578999999998877653 33456
Q ss_pred ccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHH
Q 007427 484 LAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQN 563 (604)
Q Consensus 484 ~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (604)
...|++||......++.++||||||+++|||++|..||.... ................... ...
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---------~~~ 212 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFPPP---------EWK 212 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCccc---------ccc
Confidence 778999999988889999999999999999999999986421 1122222221111111000 000
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 564 EMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...++.+++.+|+..+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 3346889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=292.94 Aligned_cols=241 Identities=17% Similarity=0.228 Sum_probs=193.6
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
..++||+|+||.|..++. .+++.||+|++.+. ......-|..|-.+|..-+.+-|+.++-.|++.++.|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 457899999999999985 57899999999763 22344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
||||-.++.... ++++..+..++..|..||.-+| +.|+|||||||+|||+ |..+++||+|||.+-.+.
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEe---cccCcEeeccchhHHhcC
Confidence 999999998764 4888888999999999999999 4799999999999999 777899999999887766
Q ss_pred CC-----CCCccccccCCCCCCC----C-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 477 SR-----KASENLAIGRSPEFPE----G-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 477 ~~-----~~~~~~~~y~aPE~~~----~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.. ....||+-|.+||++. + +.|++.+|.||+||++|||+.|..||+.. .+++-+..+.....
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETYGKIMNHKE 298 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHHHHHhchhh
Confidence 33 2447999999999986 3 67899999999999999999999999852 34444443333311
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC---HHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK---MSEVL 590 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 590 (604)
...+. ...+.++...+||.+.+. +|+.|-. +.++-
T Consensus 299 ~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 299 SLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 11111 112345567888888776 7888877 66654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=284.02 Aligned_cols=242 Identities=27% Similarity=0.353 Sum_probs=185.8
Q ss_pred hhcccCcCCcce-EEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 321 SAEVLGKGKVGS-TYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 321 ~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
..+++|.|+.|+ ||+|.++ |+.||||++-.. ......+|+..|+.- .|||||++++.-.++...||..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 356789999876 6999987 899999998543 235678999999887 699999999998999999999999955
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec--CCcceEEEeeccCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE--NDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--~~~~~~kl~DFGla~~~~ 476 (604)
+|.+++..... ......-...+.+..|++.||++|| +-+||||||||.||||+.. +...+++|+|||+++.+.
T Consensus 588 sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 588 SLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999987411 1101111345678899999999999 5699999999999999774 234689999999999887
Q ss_pred CCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhC-CCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 SRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITG-RIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ..|+.+|+|||.+....-+.++||||+|||+|..++| ++||.+.-.. -..++......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----------~~NIl~~~~~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----------QANILTGNYTL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----------hhhhhcCccce
Confidence 5542 3578899999999998888999999999999999995 9999753211 11122222111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+. ...++ +..+||.+|++.||..||++.+|+.
T Consensus 733 ~~L~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHLE-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeec-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 11112 6789999999999999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=235.30 Aligned_cols=196 Identities=24% Similarity=0.321 Sum_probs=164.4
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKN-MNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
....||+|++|.|-+-+ ..+|+..|+|+++. ...+..++..+|+.+..+. ..|.+|.+||.+......++.||.|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 34679999999998887 46899999999974 3445567788888876665 79999999999999999999999994
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
.+|..+..+--.. ...+++...-+|+..+.+||.|||+. ..++|||+||+|||+ +..+++|+||||++..+.+
T Consensus 129 tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~k---L~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 129 TSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSK---LSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVD 201 (282)
T ss_pred hhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHH---hhhhhccCCcceEEE---ccCCcEEEcccccceeehh
Confidence 4888776553322 23588888999999999999999984 689999999999999 7778999999999988876
Q ss_pred CCC---CccccccCCCCCCCC----CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 478 RKA---SENLAIGRSPEFPEG----KRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 478 ~~~---~~~~~~y~aPE~~~~----~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
+.. ..+...|+|||.+.. ..|+-||||||+|+.+.||.+++.||+..
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 543 357889999998763 46899999999999999999999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=273.71 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=172.5
Q ss_pred hcccCcCCcceEEEEEe-----------------cCCcEEEEEEecccchhhHHHH--------------HHHHHHHccC
Q 007427 322 AEVLGKGKVGSTYKATL-----------------ESGAVVAVKRVKNMNALSKKEF--------------VQQMQLLGKL 370 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~~~l~~l 370 (604)
.++||+|+||.||+|.. .+++.||||+++.......++| ..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 57899999999999963 2457899999975433323333 3466677777
Q ss_pred CCCCc-----ccEEEEEec--------CCceEEEEecCCCCCHHHHhhcccCC-------------------CCCCCCHH
Q 007427 371 KHENL-----AKIVSFYYS--------KEEKLIIYEFLPNGSLFDLLHESRGV-------------------GRIPLAWT 418 (604)
Q Consensus 371 ~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~ 418 (604)
+|.++ ++++++|.. .+..++||||+++|+|.++++...+. ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66554 677787753 35689999999999999999753210 11235778
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-----CccccccCCCCCC
Q 007427 419 TRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-----SENLAIGRSPEFP 493 (604)
Q Consensus 419 ~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~-----~~~~~~y~aPE~~ 493 (604)
.+..++.|++.||.||| +.+|+||||||+|||+ +....+||+|||+++.+..... ...++.|+|||.+
T Consensus 310 ~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred HHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 89999999999999999 4699999999999999 5556899999999976543221 1235789999987
Q ss_pred CCCC--------------------C--CccchhHhHHHHHHHHHhCCC-CCCCCCCCCC----CCCchhHHHHHHHhcCC
Q 007427 494 EGKR--------------------L--THKADVYCFGIILLEVITGRI-PGNGSPGNNE----TSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 494 ~~~~--------------------~--s~ksDVwSfGvvl~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 546 (604)
.... + ..+.||||+||++|||++|.. ||........ ...++..|.. ......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~~~~ 461 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKGQKY 461 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcccCC
Confidence 5322 1 235799999999999999875 6653211110 0111222211 111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAP---EKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 591 (604)
.... .........+++.+++..+| .+|+|++|+++
T Consensus 462 ~~~~----------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DFSL----------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred Cccc----------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 11223467899999999766 78999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=281.16 Aligned_cols=255 Identities=18% Similarity=0.180 Sum_probs=159.4
Q ss_pred hcccCcCCcceEEEEEec-C----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEE------EecCCceEE
Q 007427 322 AEVLGKGKVGSTYKATLE-S----GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF------YYSKEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~~l 390 (604)
.+.||+|+||.||+|+.. + +..||+|++..... .+....| .+....+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 578999999999999864 4 68999999864322 1111111 1122222222222211 245567899
Q ss_pred EEecCCCCCHHHHhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 391 IYEFLPNGSLFDLLHESRGV---------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
||||+++++|.+++...... .........+..++.|++.||+||| +++|+||||||+|||+
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDLKP~NILl 288 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDVKPQNIIF 288 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcCCHHHEEE
Confidence 99999999999998754210 0001123345689999999999999 4799999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCC-----CCCccccccCCCCCCCCC----------------------CCCccchhHhHH
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSR-----KASENLAIGRSPEFPEGK----------------------RLTHKADVYCFG 508 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~s~ksDVwSfG 508 (604)
+. +...+||+|||+|+.+... ....+++.|+|||.+... .++.++||||||
T Consensus 289 ~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 289 SE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred eC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 43 2457999999999865432 223467799999965321 234567999999
Q ss_pred HHHHHHHhCCCCCCCCCC-----CCCCCCchhHHHHHHHhcCCccccccHHhhhc-ccCHHHHHHHHHHHHhcccCCCCC
Q 007427 509 IILLEVITGRIPGNGSPG-----NNETSGDLSDWVRMVVDNDWSTDILDVEILAA-REGQNEMLRLTELALECTDIAPEK 582 (604)
Q Consensus 509 vvl~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~ 582 (604)
|++|||+++..+++.... ......++..|....... .. ...... ...........+|+.+||+.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-AS-----PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cc-----hhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766442100 000001112221111100 00 000000 000001123558999999999999
Q ss_pred CCCHHHHHHH
Q 007427 583 RPKMSEVLRR 592 (604)
Q Consensus 583 RPs~~evl~~ 592 (604)
|||+.|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999873
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=253.88 Aligned_cols=232 Identities=19% Similarity=0.251 Sum_probs=183.2
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhh---HHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALS---KKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
..+||+|+||.|.+|. ..+.+.+|||++++.-... .+--..|-++|..- +-|.++.++.+|+.-+..|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 4689999999999997 4567889999998643221 22234566666655 56889999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
||+|--++++-. .+.+..+.-+|..||-||-||| ++||+.||||.+|||+ +..+++||+|||+++.--
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 501 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEe---ccCCceEeeecccccccc
Confidence 999998888754 3777888999999999999999 6899999999999999 666789999999987643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
-. ....+++.|+|||++....|+.++|.|||||+||||+.|+.||++.. -.+..+.+.+.+..
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--------E~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQAIMEHNVS----- 568 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHHccCc-----
Confidence 22 23468999999999999999999999999999999999999998742 12223333332211
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPK 585 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 585 (604)
++...+.+...+....+...|.+|..
T Consensus 569 -------yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 -------YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------CcccccHHHHHHHHHHhhcCCccccC
Confidence 12233446778888889999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=268.89 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=195.1
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEec-----CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS-----KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~ 394 (604)
.+.||+|.+|.||+++ .++++.+|+|+...... ..++...|.++++.. .|||++.++|+|.. ++..||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 4689999999999998 56799999998865443 346788899999887 69999999999864 5689999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
|.+|+..|+++... ...+.|..+..|++.+++||.+|| .+.++|||||-.|||+ ..+..+|+.|||.+..
T Consensus 103 C~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 172 (953)
T ss_pred cCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEE---eccCcEEEeeeeeeee
Confidence 99999999998766 235999999999999999999999 4799999999999999 6667899999999877
Q ss_pred CCC----CCCCccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 475 LPS----RKASENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 475 ~~~----~~~~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+.. .....+++.|||||++.. ..|+..+|+||+|++..||.-|.+|+.+..+ ++.++.-.
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~Ip 241 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIP 241 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhccCC
Confidence 654 345578999999999863 3477799999999999999999999876432 11111111
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... . .....+..-..++.++|..||..|-.+||++.++++
T Consensus 242 RNP---P---PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNP---P---PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCC---C---ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 100 0 111223456678999999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=248.01 Aligned_cols=262 Identities=20% Similarity=0.330 Sum_probs=196.9
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-----C---CCcccEEEEEec----CCce
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-----H---ENLAKIVSFYYS----KEEK 388 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~----~~~~ 388 (604)
.++||-|.|++||++. ....+.||+|+.+... ...+....|+++|++++ | .+||+++++|.. +.+.
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 4789999999999997 4567899999997543 34567889999999884 2 469999999975 4589
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec----------
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE---------- 458 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---------- 458 (604)
+||+|++ |-+|..+|....-. .++...+.+|++||+.||.|||+. -||||-||||+|||+...
T Consensus 162 CMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~e---cgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHRE---CGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHh---cCccccCCCcceeeeeccccchhhhhhh
Confidence 9999999 77999999876532 388899999999999999999986 489999999999998100
Q ss_pred --------------------------------------------------------------------------------
Q 007427 459 -------------------------------------------------------------------------------- 458 (604)
Q Consensus 459 -------------------------------------------------------------------------------- 458 (604)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred -------------------------------------------------------------------------CCcceEE
Q 007427 459 -------------------------------------------------------------------------NDIYRAK 465 (604)
Q Consensus 459 -------------------------------------------------------------------------~~~~~~k 465 (604)
....++|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0013578
Q ss_pred EeeccCCCCCCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCC--CCCchhHHHHH--
Q 007427 466 LTNFGFLPLLPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE--TSGDLSDWVRM-- 540 (604)
Q Consensus 466 l~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~-- 540 (604)
|+|||-|....... ....|..|+|||++.+..|++.+|||||+|++|||+||...|+....... ++..+...+..
T Consensus 395 IaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG 474 (590)
T KOG1290|consen 395 IADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLG 474 (590)
T ss_pred EeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHh
Confidence 88888877654432 33567899999999999999999999999999999999999986554331 22223322211
Q ss_pred ------HHhcCCccccccH----------------Hhh--hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 541 ------VVDNDWSTDILDV----------------EIL--AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 541 ------~~~~~~~~~~~~~----------------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+.+..++++. .++ ......+...++.+++.-||+.+|++|||+.+.++
T Consensus 475 ~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 475 KIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred hccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111222222211 111 12234567788999999999999999999999884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=264.08 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=194.0
Q ss_pred ccCHHHHHHHhhcccCcCCcceEEEEEecCCc-EEEEEEecccchh---hHHHHHHHHHHHccCCCCCcccEEEEEecCC
Q 007427 311 VFDLDDLLRASAEVLGKGKVGSTYKATLESGA-VVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAKIVSFYYSKE 386 (604)
Q Consensus 311 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 386 (604)
...++++.+ ...||-|+||.|=+++.+... .+|+|.+++.... ..+....|-.+|...+.|.||++|..|.+..
T Consensus 416 ~v~l~dl~~--iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKR--IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhh--hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 344455533 346999999999999866433 4899988764433 3455778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..|++||-|-||.|...|++.. .++..+..-++..+.+|++||| ++|||.|||||+|.++ +..+-+||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllL---d~~Gy~KL 561 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLL---DNRGYLKL 561 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH----hcCceeccCChhheee---ccCCceEE
Confidence 9999999999999999998765 4888888999999999999999 6899999999999999 77778999
Q ss_pred eeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 467 TNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 467 ~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
.|||+|+.+.... ...+|+.|.|||++.....+.++|.||+|+++|||+||++||.+..+. .-...++.
T Consensus 562 VDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILk 633 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILK 633 (732)
T ss_pred eehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHh
Confidence 9999999987654 347999999999999999999999999999999999999999875331 11111111
Q ss_pred cCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC
Q 007427 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK 585 (604)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 585 (604)
+-...+ .+........+++++....+|.+|-.
T Consensus 634 Gid~i~----------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 GIDKIE----------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhhh----------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 110000 11223335678999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=246.03 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=189.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-----ceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-----EKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 393 (604)
.+.||-|+||.||.++. ++|+.||+|++... +-.+.+.+.+|+++|..++|.|++..+++..-.. +.|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999985 57999999999753 2334678899999999999999999998876443 5688999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
.|. .||...+-.- .+++...+.-+.+||++||+||| +.+|.||||||.|.|+ +.+...||+|||+++
T Consensus 138 LmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 994 4888887653 35888888999999999999999 5799999999999999 888899999999999
Q ss_pred CCCCCCCC-----ccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCC-------chhHHHHH
Q 007427 474 LLPSRKAS-----ENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSG-------DLSDWVRM 540 (604)
Q Consensus 474 ~~~~~~~~-----~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~ 540 (604)
..+..... .-+.+|+|||.+++. .|+.+.||||.|||+.|++..+..|....+.+.... --.+-++.
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 87655433 245689999999974 689999999999999999999999876433211000 00011111
Q ss_pred HHhcCCc------cccccHHhh-hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 541 VVDNDWS------TDILDVEIL-AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 541 ~~~~~~~------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
..++... ....+...+ ..........+...+...++..||++|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111000 000000000 0001112223466888999999999999988877644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=230.08 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=188.1
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCC--ceEEEEecCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKE--EKLIIYEFLP 396 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~~ 396 (604)
..+++|+|.|++||.|. ..+.+.++||+++... .+.+.+|+.+|..++ ||||++++++..+.. ...+|+||+.
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 35789999999999997 5678999999998643 578899999999997 999999999987754 4679999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+.+...+.. .++...+..++.+++.||.|+| |.||+|||+||.|++++.. .-..+|+|+|+|.+..
T Consensus 119 n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~--~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 119 NTDFKQLYP--------TLTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYH 184 (338)
T ss_pred cccHHHHhh--------hhchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechh--hceeeeeecchHhhcC
Confidence 988877654 2677788899999999999999 6899999999999999543 3468999999999887
Q ss_pred CCCCC---ccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC------
Q 007427 477 SRKAS---ENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW------ 546 (604)
Q Consensus 477 ~~~~~---~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 546 (604)
+.... .....+..||.+.. ..|+.+-|+|||||++.+|+..+.||...... ...++..++-.-....
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN---~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC---HHHHHHHHHHhChHHHHHHHHH
Confidence 66543 34557779998875 55788999999999999999999998754321 2222222211100000
Q ss_pred ccccccHHhhh---------------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILA---------------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..-.+|++... .....-..++..+++.+.|..|-.+|+|+.|..+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00001111110 0011112357889999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=230.76 Aligned_cols=207 Identities=33% Similarity=0.519 Sum_probs=179.0
Q ss_pred cCcCCcceEEEEEec-CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHH
Q 007427 325 LGKGKVGSTYKATLE-SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402 (604)
Q Consensus 325 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 402 (604)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999875 4899999999754332 34679999999999999999999999999899999999999999999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC----
Q 007427 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR---- 478 (604)
Q Consensus 403 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~---- 478 (604)
++.... ..+++..+..++.+++++++||| +.+++|+||+|.||+++.. ...++|+|||.+......
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchh
Confidence 987652 24889999999999999999999 4699999999999999431 467999999998776543
Q ss_pred CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 479 KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 479 ~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
........|.+||..... .++.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 234567789999998877 788999999999999999
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
..+.+++..|++.||++||++.++++.
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 247799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=252.63 Aligned_cols=203 Identities=20% Similarity=0.321 Sum_probs=168.1
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccchhhH---HHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||-|+||+|.+++ .++...||.|.+++.+...+ .....|..||.....+-||+||-.|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 569999999999997 55678899999976543333 34577999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC--
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP-- 476 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~-- 476 (604)
|+-.+|.... -+.+..+..++..+..|+++.| ..|+|||||||+|||| |.++++||.|||++.-+.
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEE---ccCCceeeeeccccccceec
Confidence 9999987654 3788888889999999999999 5799999999999999 666788999999975431
Q ss_pred -------CC-------------------------------------CCCccccccCCCCCCCCCCCCccchhHhHHHHHH
Q 007427 477 -------SR-------------------------------------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILL 512 (604)
Q Consensus 477 -------~~-------------------------------------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ 512 (604)
.. ....++..|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 0013577899999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 513 EVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 513 elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
||+.|+.||...... +....+.+|.
T Consensus 863 em~~g~~pf~~~tp~-~tq~kv~nw~ 887 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPG-ETQYKVINWR 887 (1034)
T ss_pred HHhhCCCCccCCCCC-cceeeeeehh
Confidence 999999999865442 2333444553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=230.89 Aligned_cols=261 Identities=20% Similarity=0.315 Sum_probs=192.7
Q ss_pred CCccCHHHHHHHhhcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEE-EecC
Q 007427 309 IPVFDLDDLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSF-YYSK 385 (604)
Q Consensus 309 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~ 385 (604)
++.+++.|.- .+.+.+|+|.||.+-++++ .+.+.+++|.+.... ...++|.+|...--.| .|.||+.-|++ |+..
T Consensus 17 l~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 17 LKKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred ccccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 3455565543 4567899999999999985 467889999987543 3468899999776666 58999998875 5667
Q ss_pred CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 386 EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
+.+.+++||++.|||.+-+.... +.+....+++.|++.|+.||| ++++||||||.+|||+...|.. ++|
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~-rvK 163 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFY-RVK 163 (378)
T ss_pred ceEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCcc-EEE
Confidence 78889999999999998887643 778888999999999999999 6899999999999999766544 999
Q ss_pred EeeccCCCCCCCCCCC-ccccccCCCCCCCCC-----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 466 LTNFGFLPLLPSRKAS-ENLAIGRSPEFPEGK-----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 466 l~DFGla~~~~~~~~~-~~~~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
|+|||..+........ ..+..|.+||..... ...+.+|||.||+++|.++||+.||......+ ....+|..
T Consensus 164 lcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~ 240 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQ 240 (378)
T ss_pred eeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHH
Confidence 9999998766543322 345577888876532 34678999999999999999999998543222 22333332
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.. ........+ ......+.+.++.++-+..+|++|-...++.++-.
T Consensus 241 w~--~rk~~~~P~-------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 241 WL--KRKNPALPK-------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred Hh--cccCccCch-------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 22 211111111 01123346788999999999999977777666554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=238.21 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=183.6
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEEe
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 393 (604)
..+|.|.- .|..+.. -.++.||+|++.. ......++..+|...+..+.|+||++++.+|.-.. +.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45677776 5555542 2588999998853 23345678889999999999999999999986443 5799999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|| ..+|.+.++. .++-.+...|..|++.|++||| +.||+||||||+||++ .....+||.|||+|+
T Consensus 102 ~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv---~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 102 LM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVV---NSDCTLKILDFGLAR 166 (369)
T ss_pred hh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH----hcceeecccCccccee---cchhheeeccchhhc
Confidence 99 4599999883 2777889999999999999999 6799999999999999 777889999999998
Q ss_pred CCCCC---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC--------------CCchhH
Q 007427 474 LLPSR---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET--------------SGDLSD 536 (604)
Q Consensus 474 ~~~~~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--------------~~~~~~ 536 (604)
.-... .....+..|+|||++.+..+.+.+||||.||++.||++|+..|.+....+.. ...+..
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 76544 2335677999999999988999999999999999999999998864311100 000111
Q ss_pred HHHHHHhcCC-------ccccccHHhhhcc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 537 WVRMVVDNDW-------STDILDVEILAAR-EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 537 ~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.++....... ...+.|....... ..+-....+.+++.+||-.||++|.+++++++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111111000 0000010000000 01122335789999999999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=232.86 Aligned_cols=240 Identities=17% Similarity=0.226 Sum_probs=184.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
-.+||+|+|++|..+++ ++.+.||+|++++.-. .+.+=.+.|-.+..+. +||.+|.+..+|+.....++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 46899999999999984 5688999999975321 1222344565566555 79999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
||+|--+++.++ .++++.+.-+...|.-||.||| ++||+.||||.+|||+ |..+.+|+.|+|+++.--
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh----~rgiiyrdlkldnvll---daeghikltdygmcke~l 402 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence 999988888766 4899999999999999999999 4799999999999999 667789999999987643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....+++.|.|||++.+..|....|.|++||+++||+.|+.||+-... +...++-.++.-.++-+....
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekqir---- 477 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIR---- 477 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhccc----
Confidence 22 234689999999999999999999999999999999999999974321 222223333332222111000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPK 585 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 585 (604)
-+.....+...+++.-|..||.+|..
T Consensus 478 -------iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 -------IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 01112234567888999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=250.44 Aligned_cols=194 Identities=24% Similarity=0.299 Sum_probs=164.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC------CCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK------HENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
....|+|-|++|.+|.. ..|..||||++..... -.+.=++|+++|++|+ .-|+++++..|...+++|||||-
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~ 515 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEP 515 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehh
Confidence 34679999999999984 3578999999986533 3355678999999995 35889999999999999999998
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+ ..+|.++|+.... ...|....+..++.|+.-||..|-. -||+|.||||+|||+... ...+||||||.|..
T Consensus 516 L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~----c~vlHaDIKPDNiLVNE~--k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 516 L-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK----CGVLHADIKPDNILVNES--KNILKLCDFGSASF 586 (752)
T ss_pred h-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh----cCeeecccCccceEeccC--cceeeeccCccccc
Confidence 8 5599999987653 3358888999999999999999995 499999999999999533 34689999999988
Q ss_pred CCCCCCC--ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 007427 475 LPSRKAS--ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP 525 (604)
Q Consensus 475 ~~~~~~~--~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~ 525 (604)
....... .....|+|||++.+..|+...|+||.||.||||.||+..|.+..
T Consensus 587 ~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 587 ASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 7665543 34568999999999999999999999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=225.77 Aligned_cols=191 Identities=30% Similarity=0.503 Sum_probs=166.1
Q ss_pred hcccCcCCcceEEEEEecC-CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLES-GAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999998764 899999999765443 56789999999999999999999999999899999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++..... .+++.....++.+++.++.|||+ .+++|+||+|+||++ +....++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~----~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS----LGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcc
Confidence 9999986541 17899999999999999999994 699999999999999 55578999999998877554
Q ss_pred ----CCCccccccCCCCCC-CCCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 479 ----KASENLAIGRSPEFP-EGKRLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~-~~~~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
....+...|++||.. ....++.++||||||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 233456679999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=240.92 Aligned_cols=191 Identities=22% Similarity=0.329 Sum_probs=163.2
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccchhh--------HHHHHHHHHHHccCC---CCCcccEEEEEecCCce
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALS--------KKEFVQQMQLLGKLK---HENLAKIVSFYYSKEEK 388 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 388 (604)
+-+.+|+|+||.|+.|.++ +...|+||.+.+..... -...-.|++||..++ |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 4578999999999999854 46789999986532211 123456999999997 99999999999999999
Q ss_pred EEEEecC-CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 389 LIIYEFL-PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 389 ~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
||+||-. ++-+|++++..+. .+++.++..|++|++.|+++|| +.||||||||-+||.+ +.++-+||+
T Consensus 645 yl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenviv---d~~g~~kli 712 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIV---DSNGFVKLI 712 (772)
T ss_pred EEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccc----ccCceecccccccEEE---ecCCeEEEe
Confidence 9999974 5679999998765 4899999999999999999999 5799999999999999 677789999
Q ss_pred eccCCCCCCCC--CCCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCC
Q 007427 468 NFGFLPLLPSR--KASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 468 DFGla~~~~~~--~~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
|||.|...... ....+|..|.|||++.+.+| ...-|||++|++||.++...-||+.
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998877654 35579999999999999887 4568999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=246.11 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=192.6
Q ss_pred cccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
..+|.|.||.|||++ ..+++..|+|.++-.........++|+-+++..+|+|||.++|.+...+..++.||||.+|+|.
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 679999999999998 5679999999998665556677889999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC----C
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP----S 477 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~----~ 477 (604)
+..+... ++++.++...++...+||+||| +.|-+|||||-.|||+ .+...+|++|||.+..+. .
T Consensus 101 diy~~Tg-----plselqiayvcRetl~gl~ylh----s~gk~hRdiKGanill---td~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 101 DIYHVTG-----PLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred ceeeecc-----cchhHHHHHHHhhhhccchhhh----cCCcccccccccceee---cccCceeecccCchhhhhhhhhh
Confidence 9877543 6999999999999999999999 6799999999999999 556678999999876654 3
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
+....|++.|||||+.. .+.|..++|||+.|+...|+-.-+.|-.+..+ +....- .-... +++.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~L-mTkS~-----~qpp 235 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFL-MTKSG-----FQPP 235 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHH-hhccC-----CCCC
Confidence 45668999999999864 56799999999999999999887777443211 111111 11111 1111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
-+ .......+.+.++++.|+..+|++||++..++.
T Consensus 236 ~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00 111233446889999999999999999887654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=228.16 Aligned_cols=188 Identities=25% Similarity=0.383 Sum_probs=158.2
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.++||+|.|++||++... ..+.||+|.+...+ ......+|+++|..+ .+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 579999999999999743 47899999997654 356789999999999 58999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
..+..++... ++..++..+++.+..||+++| .+|||||||||+|+|.+.... .-.|.|||+|....
T Consensus 119 H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 119 HDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQRYD 184 (418)
T ss_pred ccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccC--CceEEechhHHHHH
Confidence 9999888864 678899999999999999999 689999999999999965443 45899999986110
Q ss_pred -----------------C-------------------------------CCCCccccccCCCCCCCC-CCCCccchhHhH
Q 007427 477 -----------------S-------------------------------RKASENLAIGRSPEFPEG-KRLTHKADVYCF 507 (604)
Q Consensus 477 -----------------~-------------------------------~~~~~~~~~y~aPE~~~~-~~~s~ksDVwSf 507 (604)
. .....||++|+|||++.. ...++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 001146789999999875 456889999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 007427 508 GIILLEVITGRIPGNGSP 525 (604)
Q Consensus 508 Gvvl~elltg~~p~~~~~ 525 (604)
|||++-+++++.||....
T Consensus 265 GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAK 282 (418)
T ss_pred cceeehhhccccccccCc
Confidence 999999999999997654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=265.55 Aligned_cols=193 Identities=18% Similarity=0.188 Sum_probs=139.8
Q ss_pred cCCC-CCcccEEEEE-------ecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 007427 369 KLKH-ENLAKIVSFY-------YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440 (604)
Q Consensus 369 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 440 (604)
.++| +||++++++| ...+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+||| +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH----~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH----S 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH----h
Confidence 4455 6888888887 2334567888988 569999997532 25899999999999999999999 5
Q ss_pred CCceecCCCCCceEEeec----------------CCcceEEEeeccCCCCCCCCC--------------------CCccc
Q 007427 441 HKVPHANLKSSNILIFRE----------------NDIYRAKLTNFGFLPLLPSRK--------------------ASENL 484 (604)
Q Consensus 441 ~~ivHrDlkp~NILl~~~----------------~~~~~~kl~DFGla~~~~~~~--------------------~~~~~ 484 (604)
+||+||||||+|||++.. +....+|++|||+++...... ...++
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 799999999999999531 234567888888886532100 01356
Q ss_pred cccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHH
Q 007427 485 AIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNE 564 (604)
Q Consensus 485 ~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (604)
..|+|||++.+..++.++|||||||+||||++|..|+.... ..+....... ..+.. ...
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~---------~~~~~------~~~ 237 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRV---------LPPQI------LLN 237 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhh---------cChhh------hhc
Confidence 67999999999999999999999999999999888764210 0111111100 00000 011
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 565 MLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.....+++.+||+.||.+||+|.|+++
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 234568889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=204.05 Aligned_cols=169 Identities=24% Similarity=0.246 Sum_probs=125.2
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.++++... .++++.++..|+.|+++||+|||+ ++ ||+|||+ +.+..+|+ ||+++....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~----~~------kp~Nil~---~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHR----QA------KSGNILL---TWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh----cC------CcccEeE---cCccceee--ccceEeecc
Confidence 68999998643 259999999999999999999995 34 9999999 66677888 999887654
Q ss_pred CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
.. ..++..|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+...... ......
T Consensus 62 ~~-~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~------- 129 (176)
T smart00750 62 EQ-SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPA-DDPRDR------- 129 (176)
T ss_pred cc-CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhcc-CCcccc-------
Confidence 33 3567999999999999999999999999999999999999864321 11111111111111 000000
Q ss_pred cccCHHHH--HHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 558 AREGQNEM--LRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 558 ~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
....... ..+.+++.+||+.||++||++.|+++.+..+..
T Consensus 130 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 -SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred -ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0011122 258999999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=207.56 Aligned_cols=256 Identities=20% Similarity=0.328 Sum_probs=190.5
Q ss_pred cCHHHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceE
Q 007427 312 FDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKL 389 (604)
Q Consensus 312 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (604)
++..++.. ..+|.+...|+.|+|+++ |..+++|+++- ......++|..|.-.|+.+.||||..+++.|....+..
T Consensus 187 id~~~lnl--~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNL--ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhh--hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34444432 346888999999999998 55566777753 33334578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
++..||+.|+|+..+++... ...+..++.+++.++|+|++|||+. .+-|..--|.+..+++ |++++++|+ .
T Consensus 264 ~isq~mp~gslynvlhe~t~---vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmi---dedltaris-m 334 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMI---DEDLTARIS-M 334 (448)
T ss_pred EeeeeccchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEe---cchhhhhee-c
Confidence 99999999999999998652 3477889999999999999999976 3344455789999999 777777764 2
Q ss_pred cCCCCCCCCCCCccccccCCCCCCCCCCC---CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 470 GFLPLLPSRKASENLAIGRSPEFPEGKRL---THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 470 Gla~~~~~~~~~~~~~~y~aPE~~~~~~~---s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
+-+++.-........+.|++||.++..+- -.++|+|||++++||+.|...||.+..+.+ -.++..+++-.
T Consensus 335 ad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------cgmkialeglr 407 (448)
T KOG0195|consen 335 ADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------CGMKIALEGLR 407 (448)
T ss_pred ccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------hhhhhhhcccc
Confidence 22222222233344678999999886543 357999999999999999999998654311 11111111110
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
..-++.....+.+++.-|+..||.+||.+..|+-.|++++
T Consensus 408 -----------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 -----------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0112234456889999999999999999999999999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=231.56 Aligned_cols=136 Identities=29% Similarity=0.527 Sum_probs=123.7
Q ss_pred cCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCeeeEEecC------CcEeEEEeCCCCceecCChhhhcCCcc
Q 007427 20 ADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSN------GHIVSLELEEIQLAGILPPGFLQNITF 93 (604)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~c~~~~~~w~gv~c~~------~~~~~l~l~~~~l~g~~p~~~~~~l~~ 93 (604)
..+.+.|+.||+.+|..+..+.. .+|+++||.+..+.|.||.|.. ..|+.|+|++|+|+|.+|++ ++.|++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCCC
Confidence 56788999999999999976532 4899999987777899999952 24899999999999999998 899999
Q ss_pred CCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC
Q 007427 94 LNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF 158 (604)
Q Consensus 94 L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~ 158 (604)
|+.|+|++|+|+|.+| .+++|++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 9999999999999999 5999999999999999999999999999999999999999999999974
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=203.57 Aligned_cols=152 Identities=14% Similarity=0.171 Sum_probs=116.4
Q ss_pred hcccCcCCcceEEEEEec--CCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE--SGAVVAVKRVKNM-----NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|+|++..+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 468999999999999864 5788899987532 12235679999999999999999863322 2467999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCceEEeecCCcceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL-KSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl-kp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
+++++|... .. .. ...++.|+++||+||| ++||+|||| ||+|||+ +....+||+|||+|+
T Consensus 100 ~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv---~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 100 TEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLM---GPDGEAAVIDFQLAS 160 (365)
T ss_pred cCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEE---cCCCCEEEEECccce
Confidence 999999632 11 11 1467889999999999 479999999 9999999 555679999999998
Q ss_pred CCCCCCC------------CccccccCCCCCCCC
Q 007427 474 LLPSRKA------------SENLAIGRSPEFPEG 495 (604)
Q Consensus 474 ~~~~~~~------------~~~~~~y~aPE~~~~ 495 (604)
.+..... ..++..|.|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7654321 124556889998763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=199.49 Aligned_cols=255 Identities=18% Similarity=0.204 Sum_probs=186.7
Q ss_pred hhcccCcCCcceEEEEEecCC--cEEEEEEecccchhhHHHHHHHHHHHccCCC----CCcccEEEEE-ecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLESG--AVVAVKRVKNMNALSKKEFVQQMQLLGKLKH----ENLAKIVSFY-YSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~e 393 (604)
..+.||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 357899999999999986543 5788888765433222367888888888863 6899999988 47778899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC--CcceEEEeeccC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--DIYRAKLTNFGF 471 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--~~~~~kl~DFGl 471 (604)
.+ |.+|.++..... ...++..+..+|+.|++.+|+++| +.|++||||||+|+++...+ +...+.|.|||+
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 98 889999876554 235899999999999999999999 57999999999999995443 125799999999
Q ss_pred CCCCC-----------CC---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH
Q 007427 472 LPLLP-----------SR---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 472 a~~~~-----------~~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 537 (604)
++... .. ....+|..|.++....+...+.+.|+||++.++.|++.|..||........ ..+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KSKF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HHHH
Confidence 98221 11 123478899999999999999999999999999999999999965432111 1111
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
........... ........+.++...+-..+..++|....+...|+....
T Consensus 250 -~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 250 -EKDPRKLLTDR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred -HHHhhhhcccc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11111100000 001122345566666666899999999999998876643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-20 Score=190.44 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=188.2
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCC-CcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHE-NLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 357899999999999877 88999999754332 367899999999999988 799999999777778999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc-eEEEeeccCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGFLPLLP 476 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~-~~kl~DFGla~~~~ 476 (604)
+++.+++...... ..+.......++.|++.++.|+| +.+++|||+||+||++ +... .++++|||.++...
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeee---cCCCCeEEEeccCcceecC
Confidence 9999777654311 24888999999999999999999 4689999999999999 4444 68999999987554
Q ss_pred CC----------CCCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 477 SR----------KASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 477 ~~----------~~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
.. ....++..|++||...+ ..++...|+||+|++++++++|..||...... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~ 229 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILE 229 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHh
Confidence 32 23467789999999987 57889999999999999999999996643211 001111111111
Q ss_pred cCCc--cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 544 NDWS--TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 544 ~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.... ........ .......+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSN-----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccc-----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1110 00000000 01122457899999999999999998887664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-22 Score=216.82 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=177.9
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEec----c-cchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVK----N-MNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
...++|.|++|.|+.+.. .....++.|... . .... ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 357899999998887753 334444444332 1 1111 11225667888888999999888887777766666699
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
||++ ||+.++.... .++..++-.++.|+..|++|+| +.||.|||+|++|+++ ...+.+||+|||.+.
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~---~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLV---TENGILKIIDFGAAS 468 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEE---ecCCceEEeecCcce
Confidence 9999 9999998752 3788889999999999999999 5799999999999999 555689999999986
Q ss_pred CCCCCC--------CCccccccCCCCCCCCCCCCc-cchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSRK--------ASENLAIGRSPEFPEGKRLTH-KADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~~--------~~~~~~~y~aPE~~~~~~~s~-ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
...... ...+...|.|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... ......
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~ 541 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYS 541 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccc
Confidence 654332 224677999999999998876 5899999999999999999997643322111 000000
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+......+. .-....+.+...++.++|+.||.+|.|+.+|++
T Consensus 542 ~~~~~~~~~~----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQRNIFEGPN----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccChH----HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000000 001123345778999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=173.28 Aligned_cols=251 Identities=18% Similarity=0.247 Sum_probs=182.4
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.++||.|+||.+|.|. ..+|..||||.-..... ..++..|.++...++| ..|..+..|..+.+.-.+||+.. |.+
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 4689999999999997 67899999998754322 2457788888888875 66777777888888889999999 889
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|+++..-... .++..+++-++-|++.-++|+|. ++++||||||+|+|..-+...-.+.++|||+|+.+.+..
T Consensus 97 LEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~----r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 97 LEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHL----RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred HHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHh----hccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9998876532 48999999999999999999994 799999999999999555555678999999998764432
Q ss_pred -----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 480 -----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...+|..|.+-....+...+.+-|+-|+|.+|...--|..||.+..... -.+....+.+.....
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-----k~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-----KKQKYEKISEKKMST 243 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-----HHHHHHHHHHhhcCC
Confidence 2356777776666666667888999999999999999999999864321 111122222211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 595 (604)
..+.+.. ..+.++.-.+.-|-..--++-|...-+.+.+.-
T Consensus 244 ---~ie~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 244 ---PIEVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred ---CHHHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 0111111 223345666667766666777766655555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=179.49 Aligned_cols=139 Identities=18% Similarity=0.210 Sum_probs=106.1
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchh--h------------------------HHHHHHHHHHHccCCCCCcc
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL--S------------------------KKEFVQQMQLLGKLKHENLA 376 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~niv 376 (604)
..||+|+||.||+|...+|+.||||+++..... . .....+|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999878999999999743211 0 11223599999999888764
Q ss_pred cEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEe
Q 007427 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456 (604)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 456 (604)
....+.. ...++||||++++++........ +++..+...++.|++.+|.|+|+ +.||+||||||+|||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE
Confidence 4333322 23489999999887765432221 48889999999999999999942 46999999999999995
Q ss_pred ecCCcceEEEeeccCCCCC
Q 007427 457 RENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 457 ~~~~~~~~kl~DFGla~~~ 475 (604)
+ ..++|+|||+|...
T Consensus 153 ---~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 ---D-GKLYIIDVSQSVEH 167 (190)
T ss_pred ---C-CcEEEEEccccccC
Confidence 2 36899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=197.12 Aligned_cols=214 Identities=30% Similarity=0.453 Sum_probs=163.0
Q ss_pred HccCCCCCcccEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceec
Q 007427 367 LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHA 446 (604)
Q Consensus 367 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHr 446 (604)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+.... ..++|.....++++|+.||+|+|. +....|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 467899999999999999999999999999999999998743 358999999999999999999996 3444999
Q ss_pred CCCCCceEEeecCCcceEEEeeccCCCCCCC------CCCCccccccCCCCCCCCC-------CCCccchhHhHHHHHHH
Q 007427 447 NLKSSNILIFRENDIYRAKLTNFGFLPLLPS------RKASENLAIGRSPEFPEGK-------RLTHKADVYCFGIILLE 513 (604)
Q Consensus 447 Dlkp~NILl~~~~~~~~~kl~DFGla~~~~~------~~~~~~~~~y~aPE~~~~~-------~~s~ksDVwSfGvvl~e 513 (604)
.++++|+++ +..+.+||+|||+...... .........|.|||.+... ..+.++||||||++++|
T Consensus 74 ~l~s~nClv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eecccccee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999 8889999999999877743 1112234578899988753 14678999999999999
Q ss_pred HHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 514 VITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 514 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
+++.+.||+........ .+.+..+.... ...+.+.+.... +....+..++..||..+|.+||++.+|-..+
T Consensus 151 i~~r~~~~~~~~~~~~~----~eii~~~~~~~--~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDP----DEIILRVKKGG--SNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HHhccCccccccccCCh----HHHHHHHHhcC--CCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 99999999864332221 22222222211 111111111110 2333688999999999999999999999999
Q ss_pred Hhhccc
Q 007427 594 EEIQPM 599 (604)
Q Consensus 594 ~~i~~~ 599 (604)
+.+...
T Consensus 222 ~~~~~~ 227 (484)
T KOG1023|consen 222 LTINKG 227 (484)
T ss_pred hhhccc
Confidence 887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-21 Score=181.39 Aligned_cols=164 Identities=13% Similarity=0.156 Sum_probs=124.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHH---------HHHHHHHHccCCCCCcccEEEEEecC-------
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKE---------FVQQMQLLGKLKHENLAKIVSFYYSK------- 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~------- 385 (604)
.+++|+|+||.||++.. ++..+|+|.+.......... +.+|+..+.++.|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 57899999999999766 57789999997543222222 68999999999999999999886643
Q ss_pred -CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 386 -EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 386 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
...++||||++|.+|.++.. ++. ....+++.+|..+| ..|++|||+||+||+++. .. +
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~---~g-i 173 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSK---NG-L 173 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeC---CC-E
Confidence 35789999999999988732 222 34569999999999 479999999999999954 33 8
Q ss_pred EEeeccCCCCCCCCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHH
Q 007427 465 KLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515 (604)
Q Consensus 465 kl~DFGla~~~~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ell 515 (604)
+|+|||............ .+.....+..++||||||+.+.-..
T Consensus 174 ~liDfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 999999876653322211 1333445667999999999987554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.4e-20 Score=174.61 Aligned_cols=258 Identities=16% Similarity=0.218 Sum_probs=190.3
Q ss_pred hhcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+++||+|.||.++.|+ +-+++.||||.-...+. .-++..|.+..+.| ..+.|..+|-|-.++.+-.||+|.+ |.
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 47899999999999997 56799999997754332 34677788888877 4689999888888888889999999 88
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC--cceEEEeeccCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND--IYRAKLTNFGFLPLLP 476 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--~~~~kl~DFGla~~~~ 476 (604)
+|+|+..-... .++..++..+|.|++.-++|+| ++.+|.|||||+|+||...+. .-.+.++|||+|+.+.
T Consensus 109 SLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 109 SLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998765532 4899999999999999999999 579999999999999955332 2368999999998875
Q ss_pred CCC-----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 477 SRK-----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 477 ~~~-----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+.. .-.+|..||+-....+..-+.+-|.-|+|-|+...+-|..||.+.... ...+....+-+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-----tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-----TNKEKYEKIGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-----chHHHHHHhcccc
Confidence 432 236788999888888888899999999999999999999999986432 1222222222211
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.... .+.+.. ..+.++..-+.-.-..+-.+-|..+-+...+.++.....
T Consensus 256 r~T~---i~~Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 256 RSTP---IEVLCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred ccCC---HHHHHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1111 111111 123334444444445677788888777777766654443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=207.90 Aligned_cols=240 Identities=23% Similarity=0.257 Sum_probs=171.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc-hhhHHHHHHHHHH--HccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN-ALSKKEFVQQMQL--LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||.+.|=+|.+|+.+.|. |+||++-+.. ...-+.|.++++- ...++|||.+++..+-..+.-.|||-+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 467999999999999998888 8899885432 3333444433332 4556899999988887777778899999966
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC--C
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--P 476 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~--~ 476 (604)
+|+|.+.... -+...+.+.|+.|++.||.-+|+ .||+|||||.+|||+++- .-+.|+||.--+.. +
T Consensus 106 nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~----~gVcHGDIKsENILiTSW---NW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 106 NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK----LGVCHGDIKSENILITSW---NWLYLTDFASFKPTYLP 173 (1431)
T ss_pred hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH----cCccccccccceEEEeee---chhhhhcccccCCccCC
Confidence 9999987643 47778889999999999999994 799999999999999543 34689999765432 1
Q ss_pred CCC---------CCccccccCCCCCCCCC----------C-CCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchh
Q 007427 477 SRK---------ASENLAIGRSPEFPEGK----------R-LTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLS 535 (604)
Q Consensus 477 ~~~---------~~~~~~~y~aPE~~~~~----------~-~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 535 (604)
.+. ....-..|.|||.+... . .+++-||||+||++.||++ |++||.- .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------S 242 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------S 242 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------H
Confidence 111 12334588999987531 1 5778999999999999999 6888752 1
Q ss_pred HHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 536 DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
+.....-. ...+++..-.. -+...+.+++..|++.||++|.++++.++.-.
T Consensus 243 QL~aYr~~-----~~~~~e~~Le~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 QLLAYRSG-----NADDPEQLLEK---IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHhHhcc-----CccCHHHHHHh---CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111100 01111111000 01125789999999999999999999988743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=172.82 Aligned_cols=140 Identities=18% Similarity=0.185 Sum_probs=108.9
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHccCCCCCcc
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL--------------------------SKKEFVQQMQLLGKLKHENLA 376 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~niv 376 (604)
..||+|+||.||+|+..+|+.||||+++..... ....+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999778999999998753210 012246789999999999885
Q ss_pred cEEEEEecCCceEEEEecCCCCCHHHH-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 377 KIVSFYYSKEEKLIIYEFLPNGSLFDL-LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
....+... ..++||||++++++... +... .++..+...++.|++.++.++|+ ..||+||||||+||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEE
Confidence 55444333 34899999988765433 3321 37788899999999999999994 1699999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+ ...++|+|||++..+..
T Consensus 152 ~----~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H----DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E----CCCEEEEEcccceecCC
Confidence 4 35789999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=170.52 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=106.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-----CCCCcccEEEEEecCC---c-eEEEE
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-----KHENLAKIVSFYYSKE---E-KLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv~ 392 (604)
.++||+|+||.||. ...++.. +||++........+.+.+|+.+++++ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 3334444 79988754444567899999999999 5799999999998864 3 33789
Q ss_pred ec--CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEee
Q 007427 393 EF--LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL-AFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTN 468 (604)
Q Consensus 393 e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~D 468 (604)
|| +++|+|.+++.+.. +++. ..++.+++.++ +||| +++|+||||||+|||++..+ ...+++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 66799999996532 4444 35678888888 9999 57999999999999997543 345899999
Q ss_pred ccCC
Q 007427 469 FGFL 472 (604)
Q Consensus 469 FGla 472 (604)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=164.10 Aligned_cols=179 Identities=13% Similarity=0.112 Sum_probs=130.8
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhh----HHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS----KKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
...|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|+++. |+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999998776 57888888776543311 235889999999995 5889999886 45799999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCceEEeecCCcceEEEeeccCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL-KSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl-kp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
|.+|.+.+.. ....++.|++++|+++| ++||+|||| ||+|||+ +.+..++|+|||+|...
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRG 142 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEE---cCCCCEEEEECCCceec
Confidence 9998754321 11357789999999999 479999999 7999999 45567999999999865
Q ss_pred CCCCCC-----------------ccccccCCCCCCCC-CCCC-ccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 476 PSRKAS-----------------ENLAIGRSPEFPEG-KRLT-HKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 476 ~~~~~~-----------------~~~~~y~aPE~~~~-~~~s-~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
...... ..++.|.+|+...- ...+ ...+.++-|..+|.++|++.+..+.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 543311 01223333332111 1222 4568889999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=210.33 Aligned_cols=151 Identities=31% Similarity=0.567 Sum_probs=110.4
Q ss_pred CHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCeeeEEecC-CcEeEEEeCCCCceecCChhhhcCCccCCeeeCcc
Q 007427 23 YPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSN-GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRN 101 (604)
Q Consensus 23 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~c~~~~~~w~gv~c~~-~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~ 101 (604)
.+.|+.||++||+++.+|.....+|+.. .++|.|.||+|.. ++|+.|+|++|+++|.+|+. +..+++|+.|+|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~---~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~-~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS---ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA-IFRLPYIQTINLSN 102 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC---CCCCcCcceecCCCCcEEEEEecCCCccccCChH-HhCCCCCCEEECCC
Confidence 6789999999999998777667889631 2356899999974 78999999999999998887 78899999999999
Q ss_pred CCCcccCCC--CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccC
Q 007427 102 NLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 102 n~l~g~~p~--~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~ 177 (604)
|+++|.+|. +.++++|++|||++|+++|.+|. +.+++|++|+|++|.++|.+|. ..+++|+.|+|++|.+.|.+
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 999988884 34677777777777777666663 3455555555555555555554 23455555555555555555
Q ss_pred CC
Q 007427 178 PQ 179 (604)
Q Consensus 178 p~ 179 (604)
|.
T Consensus 181 p~ 182 (968)
T PLN00113 181 PN 182 (968)
T ss_pred Ch
Confidence 43
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-20 Score=191.49 Aligned_cols=225 Identities=22% Similarity=0.286 Sum_probs=179.7
Q ss_pred ccCcCCcceEEEEE----ecCCcEEEEEEecccchhh--HHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCC
Q 007427 324 VLGKGKVGSTYKAT----LESGAVVAVKRVKNMNALS--KKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+|+|.||.|++++ .+.|..+|+|..++..... ......|..++...+ ||.++++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999885 3457889999887543221 124556778888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|...+.... .+++.....+...++-+++++| +.+|+|||+|++||++ +.++.+|+.|||+++..-
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceee---cccCccccCCchhhhHhH
Confidence 999999887654 3677777888889999999999 4699999999999999 777788999999998877
Q ss_pred CCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 477 SRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 477 ~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
......++..|||||+.. .....+|.||||++++||+||..||.. +.++.+....
T Consensus 149 ~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~----------- 203 (612)
T KOG0603|consen 149 KEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE----------- 203 (612)
T ss_pred hhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-----------
Confidence 666668899999999987 567899999999999999999999874 2222222211
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
...+......+.+++..++..+|.+|--.
T Consensus 204 -~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 -LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11233445567788888888899888754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-19 Score=174.47 Aligned_cols=229 Identities=22% Similarity=0.241 Sum_probs=145.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCC----------CCcccEEEEEec---
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKH----------ENLAKIVSFYYS--- 384 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~--- 384 (604)
++.||.|+++.||.++.. +|+.+|+|++... .....+++++|.-....+.+ -.++..++...-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999864 6999999988522 22234667777655555432 122222222211
Q ss_pred ------C---C-----ceEEEEecCCCCCHHHHhhc---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 007427 385 ------K---E-----EKLIIYEFLPNGSLFDLLHE---SRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHAN 447 (604)
Q Consensus 385 ------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrD 447 (604)
. . ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++|| +.|++|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH----SYGLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH----HTTEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh----hcceEecc
Confidence 1 1 236788888 5699888553 2211 123455667788899999999999 47999999
Q ss_pred CCCCceEEeecCCcceEEEeeccCCCCCCCCCC-CccccccCCCCCCCC--------CCCCccchhHhHHHHHHHHHhCC
Q 007427 448 LKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-SENLAIGRSPEFPEG--------KRLTHKADVYCFGIILLEVITGR 518 (604)
Q Consensus 448 lkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~elltg~ 518 (604)
|||+|+++ +.++.++|+||+.......... ...+..|.+||.... -.++.+.|.|++|+++|.|..++
T Consensus 171 i~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLL---DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE----TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEE---cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999 6678899999987665544333 334466788886533 24788999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCC
Q 007427 519 IPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR 583 (604)
Q Consensus 519 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 583 (604)
.||........... . ..... +.++.+..||..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~~---------------------~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------------D--FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------------G--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------------c--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986422111100 0 01122 566678999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=168.46 Aligned_cols=195 Identities=19% Similarity=0.215 Sum_probs=139.0
Q ss_pred CCCCcccEEEEEecC---------------------------CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHH
Q 007427 371 KHENLAKIVSFYYSK---------------------------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI 423 (604)
Q Consensus 371 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 423 (604)
+|||||++.++|.+. ...|+||.-++. +|.+++..+. .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 599999999887532 246899998866 9999998654 566677788
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCCCCCCC----------CCCCccccccCCCCC
Q 007427 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFLPLLPS----------RKASENLAIGRSPEF 492 (604)
Q Consensus 424 ~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla~~~~~----------~~~~~~~~~y~aPE~ 492 (604)
+.|+++|+.||| .+||.|||+|++|||+.-++ ..-...|+|||++---.. .....+...-||||+
T Consensus 347 laQlLEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 999999999999 47999999999999996544 345688999998633221 112345667789998
Q ss_pred CCCCC------CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHH
Q 007427 493 PEGKR------LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEML 566 (604)
Q Consensus 493 ~~~~~------~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (604)
..... --.|+|.|+.|.+.||+++..-||+.... ..-+...+ .+.. .. ..+..++.
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~r~Y----qe~q-LP----------alp~~vpp 484 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDTRTY----QESQ-LP----------ALPSRVPP 484 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heechhhh----hhhh-CC----------CCcccCCh
Confidence 76432 23589999999999999999999986211 11111111 1111 01 11223444
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 567 RLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 567 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
.+.+++...|+.||++|++..-....|.
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 6789999999999999999876665553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=161.44 Aligned_cols=139 Identities=16% Similarity=0.162 Sum_probs=105.8
Q ss_pred hhcccCcCCcceEEEEE--ecCCcEEEEEEecccchh------------------------hHHHHHHHHHHHccCCCCC
Q 007427 321 SAEVLGKGKVGSTYKAT--LESGAVVAVKRVKNMNAL------------------------SKKEFVQQMQLLGKLKHEN 374 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~n 374 (604)
..+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 568999999998743210 1123578999999997533
Q ss_pred --cccEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCC
Q 007427 375 --LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK-VPHANLKSS 451 (604)
Q Consensus 375 --iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrDlkp~ 451 (604)
+.+++++ ...++||||+++++|........ ++...+...++.|++.+++|||+ .| |+||||||+
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~----~g~iiH~Dikp~ 178 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYK----EGELVHGDLSEY 178 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHh----cCCEEeCCCChh
Confidence 3444443 23589999999988876543221 35566678999999999999994 68 999999999
Q ss_pred ceEEeecCCcceEEEeeccCCCCCC
Q 007427 452 NILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 452 NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
||+++ ...++|+|||.+....
T Consensus 179 NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE----CCCEEEEEChhhhccC
Confidence 99995 4578999999976543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=156.83 Aligned_cols=134 Identities=16% Similarity=0.331 Sum_probs=111.5
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|++++..++|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 577899998653221 1124678899999999999998888787777888999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++|++|.+++.... + .+..++.+++.+|.++| ..+++|||++|+||+++ ...++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999986432 2 78899999999999999 47999999999999995 34689999998755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=184.38 Aligned_cols=187 Identities=24% Similarity=0.327 Sum_probs=145.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK---HENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
...||+|+||+||+|...+|+.||+|+-+..... +|.--.+++.||+ -+-|+.+...+.-.+..++|+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 5689999999999999888999999998764432 2222233444444 234555555556677789999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee----cCCcceEEEeeccCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR----ENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~----~~~~~~~kl~DFGla~~ 474 (604)
+|.+++...+ .++|...+.++.|+++-+++|| ..+|||+||||+|+||.. +.+..-++|+|||.+-.
T Consensus 780 tlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 780 TLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred cHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999998443 4899999999999999999999 469999999999999943 23356789999998754
Q ss_pred CC---CCCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCC
Q 007427 475 LP---SRKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520 (604)
Q Consensus 475 ~~---~~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p 520 (604)
+. +... ...+-.+--+|...++.++...|-|.++-+++-|+.|+.-
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 42 3211 1344456678999999999999999999999999999743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.1e-17 Score=153.25 Aligned_cols=130 Identities=18% Similarity=0.332 Sum_probs=105.3
Q ss_pred ccCcCCcceEEEEEecCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 324 VLGKGKVGSTYKATLESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.||+|+||.||+|.+ +|..+++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 478899998653211 12356788999999999887766666666677789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++++|.+++.... . .++.+++.+|.+|| +.+++|||++|+||+++ ...++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 9999999875421 0 78999999999999 47999999999999995 35789999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=150.62 Aligned_cols=135 Identities=18% Similarity=0.245 Sum_probs=104.3
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccch----------------------hhHHHHHHHHHHHccCCCC--Ccc
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA----------------------LSKKEFVQQMQLLGKLKHE--NLA 376 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--niv 376 (604)
..+.||+|+||.||++...+|+.||||+++.... .....+.+|+.++..+.|+ .+.
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~ 98 (198)
T cd05144 19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP 98 (198)
T ss_pred cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence 4578999999999999988899999998753210 0112367888999998877 445
Q ss_pred cEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEe
Q 007427 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456 (604)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 456 (604)
..++. ...++||||+++++|.+.... .....++.+++.++.++|+ .||+||||||+||++
T Consensus 99 ~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~----~gi~H~Dl~p~Nill- 158 (198)
T cd05144 99 KPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK----HGIIHGDLSEFNILV- 158 (198)
T ss_pred ceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH----CCCCcCCCCcccEEE-
Confidence 55442 345899999999998765421 2345788999999999994 699999999999999
Q ss_pred ecCCcceEEEeeccCCCCCCC
Q 007427 457 RENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 457 ~~~~~~~~kl~DFGla~~~~~ 477 (604)
+.+..++|+|||++.....
T Consensus 159 --~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --cCCCcEEEEECCccccCCC
Confidence 5566899999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=173.69 Aligned_cols=132 Identities=22% Similarity=0.330 Sum_probs=106.2
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEE-eccc-c------hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKR-VKNM-N------ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||+||++.+.... +++|+ +.+. . ....+.+.+|++++.+++|++++..+.++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999876444 34433 2211 1 1123568899999999999999988888887778899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++. ....++.+++++|.||| +.+++||||||+|||+ + ...++|+|||+++
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl---~-~~~~~liDFGla~ 475 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV---R-DDRLYLIDFGLGK 475 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE---E-CCcEEEEeCcccc
Confidence 999999999875 23578999999999999 4799999999999999 2 2368999999986
Q ss_pred CC
Q 007427 474 LL 475 (604)
Q Consensus 474 ~~ 475 (604)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 63
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.3e-17 Score=163.50 Aligned_cols=169 Identities=24% Similarity=0.290 Sum_probs=122.7
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..|+.|++|...+|.+||...+. ....++...+.++.|++.|++| ++.+|||+||.||+.. .+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~---~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFS---DDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh-------ccchhhhccccccccc---cchhhhh
Confidence 46899999999999999986553 2346788899999999999998 3899999999999994 4447899
Q ss_pred eeccCCCCCCCCC----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchh
Q 007427 467 TNFGFLPLLPSRK----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLS 535 (604)
Q Consensus 467 ~DFGla~~~~~~~----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 535 (604)
.|||+........ ...++..||+||.+.+..|+.|+||||+|++|+|+++ -..++...
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------- 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------- 466 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------
Confidence 9999976654332 3357889999999999999999999999999999998 33332210
Q ss_pred HHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 007427 536 DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589 (604)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 589 (604)
.....+.+..+.+.... ..+.=..++.+++...|.+||++.++
T Consensus 467 ~t~~d~r~g~ip~~~~~-----------d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEFLQ-----------DYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCCChHHhh-----------cCcHHHHHHHHhcCCCcccCchHHHH
Confidence 00111111111111110 01123479999999999999954443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=171.17 Aligned_cols=199 Identities=22% Similarity=0.256 Sum_probs=132.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.++|..|+||.||.++++ ..+.+|+|+-++ .. +.+- ++.....|.+| ||-
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq-~l-----ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-----ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccccc-ch-----hhhc--cccccCCccee---------------------chh
Confidence 478999999999999865 467888843322 11 1110 22223333333 444
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC---
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS--- 477 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~--- 477 (604)
...++... . ++. +.+.+++||| +.||+|||+||+|.++ ...+++|+.|||+++..--
T Consensus 139 ~tllk~~g---~--lPv--------dmvla~Eylh----~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 139 ATLLKNIG---P--LPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred hhhcccCC---C--Ccc--------hhhHHhHhhc----cCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence 44444322 1 221 2278899999 4699999999999999 5556789999998765310
Q ss_pred ----------------CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 478 ----------------RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 478 ----------------~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
.....+++.|+|||++....|...+|.|++|+|+||.+.|..||.+...++ .+..+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--------lfg~v 270 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LFGQV 270 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--------HHhhh
Confidence 112257899999999999999999999999999999999999999754321 11111
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
+.... ...+.......++.+++.+.|+.+|..|--.
T Consensus 271 isd~i---------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 271 ISDDI---------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhc---------cccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11110 0001112233467899999999999999643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=135.67 Aligned_cols=134 Identities=18% Similarity=0.163 Sum_probs=110.4
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--CCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH--ENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .+++++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 568999999999999864 7899999865433 5678899999999976 5899999988888889999999988776
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
..+ +......++.+++++++++|.. +..+++|+|++|+||+++ ....+++.|||.++..
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~-~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQL-PLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCC-CceEEEecCCCcceEEEE---CCcEEEEEecccccCC
Confidence 543 3456678899999999999954 124799999999999994 4457899999987653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.1e-15 Score=142.32 Aligned_cols=138 Identities=22% Similarity=0.266 Sum_probs=105.1
Q ss_pred HhhcccC-cCCcceEEEEEecCCcEEEEEEecccc-------------hhhHHHHHHHHHHHccCCCCCc--ccEEEEEe
Q 007427 320 ASAEVLG-KGKVGSTYKATLESGAVVAVKRVKNMN-------------ALSKKEFVQQMQLLGKLKHENL--AKIVSFYY 383 (604)
Q Consensus 320 ~~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~ 383 (604)
.....|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|++| +..+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3456898 8999999999886 7789999885311 1223567889999999998875 67777654
Q ss_pred cCC----ceEEEEecCCC-CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 384 SKE----EKLIIYEFLPN-GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 384 ~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
... ..++||||+++ .+|.+++... +++.. .+.+++.+|.+|| ..||+||||||+|||++.
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~- 177 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDP- 177 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcC-
Confidence 332 22599999997 6999988642 24433 3678999999999 479999999999999943
Q ss_pred CCcceEEEeeccCCCCC
Q 007427 459 NDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~ 475 (604)
+..++|+|||.+...
T Consensus 178 --~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 --DGKFWLIDFDRGELR 192 (239)
T ss_pred --CCCEEEEECCCcccC
Confidence 447899999987653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=139.44 Aligned_cols=137 Identities=19% Similarity=0.225 Sum_probs=96.1
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchh--hHHH----------------------HHHHHHHHccCCCC--Ccc
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL--SKKE----------------------FVQQMQLLGKLKHE--NLA 376 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--niv 376 (604)
+.||+|+||+||+|...+|+.||||+++..... .... ...|.+.+.++.+. .+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999888999999998643211 1111 13455566665443 244
Q ss_pred cEEEEEecCCceEEEEecCCCCCHHH-HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 377 KIVSFYYSKEEKLIIYEFLPNGSLFD-LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. +.+|+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~---~~~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR---EAGLVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh---ccCcCcCCCChhhEEE
Confidence 44443 24689999999854422 111110 11 5567899999999999994 2799999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+ ...++++|||.+.....
T Consensus 149 ~----~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D----DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E----CCcEEEEECcccccccC
Confidence 5 45789999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.8e-15 Score=161.90 Aligned_cols=244 Identities=22% Similarity=0.288 Sum_probs=177.3
Q ss_pred cccCcCCcceEEEEEe--cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL--ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+|+.|-.... .....+|+|.+.... .........|..+-..+. |+|++++++.....+..+++++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 4589999999988865 335567777765432 222344556777777776 99999999999999999999999999
Q ss_pred CCHHHHh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 398 GSLFDLL-HESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 398 gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++.+.+ +... ...+......+..|+..++.|+|. ..++.||||||+|.+++..+. ..|++|||+|..+.
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYR 176 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCC--cccCCCchhhcccc
Confidence 9999988 3322 125556677899999999999993 269999999999999954432 78999999998776
Q ss_pred C-CC------CCcc-ccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 477 S-RK------ASEN-LAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 477 ~-~~------~~~~-~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
. .. ...+ +..|.|||...+. ...+..|+||.|+++.-+++|..|+....... .....|...... .
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~---~ 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGR---F 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccc---c
Confidence 5 22 1245 8899999999884 45678999999999999999999987653322 122222211100 0
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
. ............+++.+++..+|..|.+.+++.
T Consensus 251 ~---------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 T---------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c---------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 0 000112223467888999999999999987764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-13 Score=143.00 Aligned_cols=141 Identities=18% Similarity=0.239 Sum_probs=97.7
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhh----------------------------------------HHHHHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS----------------------------------------KKEFVQ 362 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 362 (604)
+.||.|++|.||+|++.+|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986431100 012445
Q ss_pred HHHHHccCC----CCCcccEEEEEe-cCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 007427 363 QMQLLGKLK----HENLAKIVSFYY-SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK-GLAFLHQ 436 (604)
Q Consensus 363 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 436 (604)
|++.+.+++ |.+-+.+-.++. .....++||||++|++|.++...... .. .+..++.+++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH-
Confidence 665555542 333233333332 23457999999999999887654321 12 23456666666 367777
Q ss_pred cCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 437 ~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
..|++|+|+||.||++ +.+.+++++|||++..+..
T Consensus 275 ---~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 4699999999999999 5556899999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=131.80 Aligned_cols=201 Identities=21% Similarity=0.286 Sum_probs=139.0
Q ss_pred HHHHccCCCCCcccEEEEEecCC-----ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 007427 364 MQLLGKLKHENLAKIVSFYYSKE-----EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438 (604)
Q Consensus 364 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 438 (604)
..-+-++.|.|||+++.|+.+.. ...++.|||+.|++.++|++.+.. ...+......+|+-||..||.|||..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34455667999999999986543 467999999999999999886643 23477778889999999999999987
Q ss_pred CCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC--------CCCCCCccccccCCCCCCCCCCCCccchhHhHHHH
Q 007427 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL--------PSRKASENLAIGRSPEFPEGKRLTHKADVYCFGII 510 (604)
Q Consensus 439 ~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~--------~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvv 510 (604)
++.|+|+++..+-|++ ..+.-+|+.--.-.... .......+.++|.+||+-.....+..+|||+||..
T Consensus 196 -~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred -CCccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 6799999999999999 45555555321111000 01112245678999999888888899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 511 LLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 511 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
.+||..+..--............+...+. ..+++ .=.+++..|++..|..||+|++++
T Consensus 272 AlemailEiq~tnseS~~~~ee~ia~~i~-~len~---------------------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSESKVEVEENIANVII-GLENG---------------------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHHheeccCCCcceeehhhhhhhhee-eccCc---------------------cccCcCcccccCCCCCCcchhhhh
Confidence 99999887542221111011111100000 00000 123678899999999999999886
Q ss_pred HH
Q 007427 591 RR 592 (604)
Q Consensus 591 ~~ 592 (604)
..
T Consensus 330 fH 331 (458)
T KOG1266|consen 330 FH 331 (458)
T ss_pred cC
Confidence 54
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=145.07 Aligned_cols=114 Identities=33% Similarity=0.523 Sum_probs=100.5
Q ss_pred cCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEcc
Q 007427 93 FLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVS 169 (604)
Q Consensus 93 ~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls 169 (604)
.++.|+|++|.|+|.+| ++++|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|. ..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 57899999999999999 599999999999999999999999999999999999999999999998 369999999999
Q ss_pred CCcccccCCCCcc--ccCCCCCccCCCCCCcCCCCCCCC
Q 007427 170 YNNLDGPIPQTRV--VQSFPSSSFEHNSGLCGRPLEKLC 206 (604)
Q Consensus 170 ~n~l~g~~p~~~~--~~~~~~~~~~~n~~lcg~~~~~~c 206 (604)
+|+|+|.+|.... ........+.+|+.+||.|....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 9999999997632 123345678899999987654555
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=136.05 Aligned_cols=239 Identities=23% Similarity=0.264 Sum_probs=171.5
Q ss_pred hhcccCc--CCcceEEEEEe---cCCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGK--GKVGSTYKATL---ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
...-+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....++ .|+|.++.+..+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 4567899 99999999976 46889999985422 222334445677666666 4999999888889999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCceecCCCCCceEEeecCCc-ceEEEe
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK----GLAFLHQTLHSHKVPHANLKSSNILIFRENDI-YRAKLT 467 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~-~~~kl~ 467 (604)
|++ +.+|.++.+.... .++....+.+..+..+ ||.++| +.+++|-|+||.||+. ..+ ...+++
T Consensus 198 E~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~---~~~~~s~~~~ 265 (524)
T KOG0601|consen 198 ELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFT---TSDWTSCKLT 265 (524)
T ss_pred ccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheec---ccccceeecC
Confidence 999 5688888876542 2555666777777777 999999 6899999999999999 444 678999
Q ss_pred eccCCCCCCCCCC---------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 468 NFGFLPLLPSRKA---------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 468 DFGla~~~~~~~~---------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
|||+...+..... ..+...|++||...+ .++.++||||+|.++.|..++..+..... ...|.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------~~~W~ 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK--------NSSWS 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC--------CCCcc
Confidence 9998877655431 156778999998754 57889999999999999999877654321 11111
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .+..+ +.+. .......++...+.++++.+|..|++.+++.+
T Consensus 337 ~--~r~~~---ip~e------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 Q--LRQGY---IPLE------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--ccccc---Cchh------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 01110 1111 11112224556899999999999998776654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.5e-11 Score=127.01 Aligned_cols=143 Identities=17% Similarity=0.185 Sum_probs=89.3
Q ss_pred cccCcCCcceEEEEEecC-CcEEEEEEecccchh----------------------------------hH------HHHH
Q 007427 323 EVLGKGKVGSTYKATLES-GAVVAVKRVKNMNAL----------------------------------SK------KEFV 361 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~------~~~~ 361 (604)
+.||.|++|.||+|++++ |+.||||+.+..-.. .. -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999877 999999999743100 00 1244
Q ss_pred HHHHHHccCC----CCCcccEEEEEec-CCceEEEEecCCCCCHHHHhhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007427 362 QQMQLLGKLK----HENLAKIVSFYYS-KEEKLIIYEFLPNGSLFDLLHES-RGVGRIPLAWTTRLSIIKQTAKGLAFLH 435 (604)
Q Consensus 362 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH 435 (604)
+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.+.++-.-. .+.....+.......++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555554442 4444444444433 34678999999999998753211 110001122222222333332
Q ss_pred hcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCCCCCC
Q 007427 436 QTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 436 ~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla~~~~ 476 (604)
..|++|+|+||.||+++.++ ...++++.|||++..++
T Consensus 278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 35999999999999995442 22378999999976653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-13 Score=120.46 Aligned_cols=128 Identities=24% Similarity=0.397 Sum_probs=113.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
++++.|.|++|.++ .+||. +..|.+|+.|+|++|++....++++.|++|+.|+++-|+|.- +|..+|+++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhc-CccccCCCchhhhhhc
Confidence 57999999999999 78998 899999999999999999988899999999999999999987 9999999999999999
Q ss_pred cCCcccc-cCCC--CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCC
Q 007427 147 QENYLDG-QIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197 (604)
Q Consensus 147 ~~N~l~g-~ip~--~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~l 197 (604)
..|+|+- .+|. +.+..|+.|.|+.|.|.=-.|+.+.+.++.-++...|.-+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence 9999974 5565 3578899999999999887787777777777777666533
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=113.41 Aligned_cols=131 Identities=18% Similarity=0.169 Sum_probs=94.1
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcc-cEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLA-KIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
+.++.|.++.||+++.. +..|++|....... ....+.+|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999876 78899998765432 223567899999988665544 455443 33458999999998875
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL-HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+. . . ....++.+++++|+.||... ...+++|+|++|.||+++ ...++++|||.+..
T Consensus 80 ~~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 43 0 0 11245679999999999531 012369999999999995 23689999998643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-10 Score=103.61 Aligned_cols=144 Identities=17% Similarity=0.267 Sum_probs=110.1
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEec-c-------cchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVK-N-------MNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.++-+|+-+.|+++.+. |+...||.-. + ......++..+|++++.+++--.|.--.=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 57889999999999987 7777777432 1 1223456788999999998765655555556666777899999
Q ss_pred CCC-CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 395 LPN-GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
+++ .++.+++...-.. +........++.+|-+.+.-|| .++|+|+||..+||++.+++....+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 4788888765422 1222333678889999999999 6899999999999999998888889999999975
Q ss_pred C
Q 007427 474 L 474 (604)
Q Consensus 474 ~ 474 (604)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-10 Score=118.04 Aligned_cols=164 Identities=18% Similarity=0.175 Sum_probs=125.3
Q ss_pred EecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCC
Q 007427 337 TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLA 416 (604)
Q Consensus 337 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 416 (604)
+..++.+|.|...+...........+-++.|+.++||||+++++.+...+..|+|+|-+. -|..++.+. .
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------G 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------H
Confidence 456788999988876554334557788899999999999999999999999999999873 677777653 3
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC----CccccccCCCCC
Q 007427 417 WTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA----SENLAIGRSPEF 492 (604)
Q Consensus 417 ~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~----~~~~~~y~aPE~ 492 (604)
.....-.+.||+.||.|||+. .+++|++|.-+.|++ +..++-||++|-++........ ......|..|+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d---~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD---CNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc---CCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 455667789999999999974 689999999999999 6666789999987655433221 112234456665
Q ss_pred CCCCCCCccchhHhHHHHHHHHHhCC
Q 007427 493 PEGKRLTHKADVYCFGIILLEVITGR 518 (604)
Q Consensus 493 ~~~~~~s~ksDVwSfGvvl~elltg~ 518 (604)
..... -..|.|-|||+++|++.|.
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCcc
Confidence 43222 3569999999999999994
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=106.02 Aligned_cols=135 Identities=16% Similarity=0.164 Sum_probs=96.5
Q ss_pred cccCcCCcceEEEEEecC-------CcEEEEEEeccc-------------c---------hhhHHHH----HHHHHHHcc
Q 007427 323 EVLGKGKVGSTYKATLES-------GAVVAVKRVKNM-------------N---------ALSKKEF----VQQMQLLGK 369 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 369 (604)
..||.|.-+.||.|...+ +..+|||+.+.. . ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 579999987421 0 0012223 389999999
Q ss_pred CCC--CCcccEEEEEecCCceEEEEecCCCCCHHH-HhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCcee
Q 007427 370 LKH--ENLAKIVSFYYSKEEKLIIYEFLPNGSLFD-LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL-HQTLHSHKVPH 445 (604)
Q Consensus 370 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivH 445 (604)
+.. -++...+++ ...++||||+.+..+.. .+++. .++..+...+..+++.+|.+| | ..|++|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H----~~glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYK----ECNLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHH----hCCeec
Confidence 853 566667764 46789999997644422 22221 245556678889999999999 6 469999
Q ss_pred cCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 446 ANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 446 rDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+||++.||++.. ..++|+|||.+-..
T Consensus 149 GDLs~~NIL~~~----~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD----GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC----CcEEEEECCCceeC
Confidence 999999999942 35899999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=109.66 Aligned_cols=145 Identities=18% Similarity=0.216 Sum_probs=109.6
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccch-hhHHHHHHHHHHHccCCC--CCcccEEEEEecCC---ceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKH--ENLAKIVSFYYSKE---EKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 396 (604)
+.|+.|.++.||+++..+|+.+++|....... .....+.+|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999998764322 134578899999999976 44677888776543 5689999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH------------------------------------- 439 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~------------------------------------- 439 (604)
+.++.+.+.. ..++..++..++.+++++|.+||+...
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888775532 136777888889999999999985310
Q ss_pred ---------------CCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 440 ---------------SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 440 ---------------~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
...++|+|++|.||+++.++ ...+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-CcEEEEEecccccc
Confidence 24579999999999995421 34578999998654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.7e-11 Score=125.06 Aligned_cols=241 Identities=22% Similarity=0.181 Sum_probs=169.5
Q ss_pred cccCcCCcceEEEEEe--cCCcEEEEEEecccchhhHH--HHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL--ESGAVVAVKRVKNMNALSKK--EFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
..||.|.|+.|+.... .++..|++|.+.+....... .-..|+-+...+ .|.+++..+..+...+..++=-||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 5799999999999864 46889999988754333222 224555555555 588899988888888888899999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+++...+.-. ..++...++++..|++.++.++| ++.++|+|+||+||++..++ +..++.|||.+..+.-
T Consensus 351 ~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 351 GSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAF 419 (524)
T ss_pred cchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccch--hhhhccccccccccce
Confidence 9887665322 13777888999999999999999 57999999999999996544 6779999999864332
Q ss_pred CC-CC-cccccc-CCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK-AS-ENLAIG-RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~-~~-~~~~~y-~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. .. .....| .+++..+...+..+.|+||||.-+.|.+++..--... ..|... . .+...
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------~~~~~i-~-~~~~p------ 481 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------VQSLTI-R-SGDTP------ 481 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCcccCccc----------ccceee-e-ccccc------
Confidence 22 22 233344 3566666777889999999999999999987542211 111110 0 00000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
........+..+.+.+...++..||.+.+.....+.++
T Consensus 482 -----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 482 -----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00111135667888899999999999988776655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6e-10 Score=99.69 Aligned_cols=131 Identities=20% Similarity=0.360 Sum_probs=98.7
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEeccc--------chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNM--------NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
..+++|+-+.+|.+.+. |..+++|.-... ......+..+|+.++.+++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999875 444666643211 111235678899999998765655555566677888999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
.+|..|.+.+... ...++..+-.-+.-|| ..||+|+||.++||++..+ .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~----~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGG----RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCC----cEEEEECCcccc
Confidence 9998999888754 2356777778888899 5799999999999999533 379999999764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.6e-11 Score=123.91 Aligned_cols=106 Identities=31% Similarity=0.426 Sum_probs=85.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCccc-------------------
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS------------------- 128 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~------------------- 128 (604)
+...|+|++|++. +||.+++.+|+.|-+||||+|+|...+|.+-+|..|++|+||+|.|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 5667777777776 78888888999999999999999988888888888888888888763
Q ss_pred ------ccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccc
Q 007427 129 ------DGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 129 ------g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g 175 (604)
-.||.++-.|.+|..+|||.|+|. .+|. +.+.+|+.||||+|.++.
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 358888888888888999999887 6676 357777777777777654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-08 Score=100.66 Aligned_cols=152 Identities=15% Similarity=0.104 Sum_probs=105.5
Q ss_pred HHHHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccchh-----------hHHHHHHHHHHHccCCCCC--cccEEEE
Q 007427 315 DDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL-----------SKKEFVQQMQLLGKLKHEN--LAKIVSF 381 (604)
Q Consensus 315 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~ 381 (604)
+.+.....+.+-.-....|+++.+. |+.|.||+....... ....+.+|...+.++...+ ....+++
T Consensus 20 ~~~~~~~~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 20 EEVKTLQGEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred HHHHhcCCcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 3333333455555555567787764 788999977533211 1124789999988885433 3445556
Q ss_pred Eec-----CCceEEEEecCCCC-CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 382 YYS-----KEEKLIIYEFLPNG-SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 382 ~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
... ....++|+|++++. +|.+++..... .+.+...+..++.+++..+.-|| ..||+|+|++++|||+
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl 171 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLL 171 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEE
Confidence 543 23468999999876 89999864321 13556777899999999999999 4799999999999999
Q ss_pred eec----CCcceEEEeeccCCCC
Q 007427 456 FRE----NDIYRAKLTNFGFLPL 474 (604)
Q Consensus 456 ~~~----~~~~~~kl~DFGla~~ 474 (604)
+.+ ++...+.++||+.+..
T Consensus 172 ~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 172 HLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eccccCCCCCceEEEEECCcccc
Confidence 642 3356899999998753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-11 Score=123.00 Aligned_cols=122 Identities=25% Similarity=0.319 Sum_probs=63.0
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCc--ccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLS--GSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~--g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+..|.+++|+|. ++--+ ++.|+.|+.+++..|+|. |.+|+|-+|..|++||||+|+|.- .|..+.+-+++-.|+|
T Consensus 57 LEHLs~~HN~L~-~vhGE-Ls~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 57 LEHLSMAHNQLI-SVHGE-LSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhH-hhhhh-hccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEc
Confidence 444455555554 23223 444555555555555552 223345556666666666666654 5655555555666666
Q ss_pred cCCcccccCCCC---CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~---~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
|+|++. +||.. ++..|-+||||+|+|.--.|+..-+..+..+.+++|
T Consensus 134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred ccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCC
Confidence 666655 55542 345555566666666555554433333333333333
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.6e-11 Score=116.75 Aligned_cols=121 Identities=24% Similarity=0.316 Sum_probs=88.1
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCC-CCCCCCEEecc
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKLELQ 147 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~-~l~~l~~l~l~ 147 (604)
+..||...|-| +.||++ +|.|.+|..|+|..|++.- +|+|++|+.|..|.++.|++.- +|.+.+ +|++|..|||.
T Consensus 185 L~~ld~~~N~L-~tlP~~-lg~l~~L~~LyL~~Nki~~-lPef~gcs~L~Elh~g~N~i~~-lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 185 LKHLDCNSNLL-ETLPPE-LGGLESLELLYLRRNKIRF-LPEFPGCSLLKELHVGENQIEM-LPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred HHhcccchhhh-hcCChh-hcchhhhHHHHhhhccccc-CCCCCccHHHHHHHhcccHHHh-hHHHHhcccccceeeecc
Confidence 33444444444 367777 6777777777777777763 5677777777777777777765 787776 88899999999
Q ss_pred CCcccccCCCC--CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 148 ENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 148 ~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
+|+++ +.|.. .+.+|..||+|+|.+++-.+.-+.+ .+......||+
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 99998 78874 5788999999999999877765544 55555666664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=7e-09 Score=115.60 Aligned_cols=147 Identities=20% Similarity=0.270 Sum_probs=85.7
Q ss_pred cccCCCHhHHHHHHHHHHhcCCCCCCC---CCCCC--CCCCCCC-----------CCeeeEEecCC--------------
Q 007427 18 QIADYYPAERYDLLQIRDSLNSTANLH---SRWTG--PPCIDNV-----------SNWFGVSCSNG-------------- 67 (604)
Q Consensus 18 ~~~~~~~~~~~~l~~~~~~~~~~~~~~---~~w~~--~~c~~~~-----------~~w~gv~c~~~-------------- 67 (604)
+..++.++|.+.++++.+.+.+|.... ..|++ +.|..+. .+=.-|.|..+
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQAS 135 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccc
Confidence 357888999999999999998776432 24864 6777554 22233555321
Q ss_pred -------------------------------------------cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCC
Q 007427 68 -------------------------------------------HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLL 104 (604)
Q Consensus 68 -------------------------------------------~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l 104 (604)
+.+.|+|++++++ .+|.. +. ++|+.|+|++|+|
T Consensus 136 ~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~-Ip--~~L~~L~Ls~N~L 211 (754)
T PRK15370 136 SASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPAC-IP--EQITTLILDNNEL 211 (754)
T ss_pred cCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcc-cc--cCCcEEEecCCCC
Confidence 2347777777777 46765 32 4677777777777
Q ss_pred cccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCCccc
Q 007427 105 SGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 105 ~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~ 174 (604)
+...+.+. .+|+.|+|++|+|+. ||..+. .+|+.|+|++|+++ .||.....+|+.|++++|+|+
T Consensus 212 tsLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 212 KSLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFHNKIS 275 (754)
T ss_pred CcCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcCCccC
Confidence 74322232 356666666666663 555432 24555555555554 444433334444555554444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.8e-10 Score=100.63 Aligned_cols=101 Identities=28% Similarity=0.356 Sum_probs=39.3
Q ss_pred cEeEEEeCCCCceecCChhhhc-CCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccC-CCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQ-NITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGY-IDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~-~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~-~~l~~l~~l~ 145 (604)
++..|+|.+|+++ .|. . ++ .+++|+.||||+|.++. ++.+..|++|+.|+|++|+++. |+..+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~-L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-N-LGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S---TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc-c-hhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 5788999999997 454 3 55 58899999999999985 6778889999999999999986 76555 3689999999
Q ss_pred ccCCcccccCCC----CCCCCCcEEEccCCccc
Q 007427 146 LQENYLDGQIPP----FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 146 l~~N~l~g~ip~----~~~~~l~~l~ls~n~l~ 174 (604)
|++|++.. +-. ..+++|+.|++.+|.++
T Consensus 95 L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCC-hHHhHHHHcCCCcceeeccCCccc
Confidence 99999873 333 25788889999888776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.1e-09 Score=95.95 Aligned_cols=126 Identities=19% Similarity=0.222 Sum_probs=81.5
Q ss_pred eEEEEEecCCcEEEEEEecccc--------------------------hhhHHHHHHHHHHHccCCCC--CcccEEEEEe
Q 007427 332 STYKATLESGAVVAVKRVKNMN--------------------------ALSKKEFVQQMQLLGKLKHE--NLAKIVSFYY 383 (604)
Q Consensus 332 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 383 (604)
.||.|...+|..+|+|+.+... ........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999874210 00123467899999999765 566676552
Q ss_pred cCCceEEEEecCC--CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 384 SKEEKLIIYEFLP--NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 384 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
...+||||++ |..+..+.... ++......++.+++..+..+++ ..||+|+||.+.||+++ +.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~---~~ 143 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVD---DG 143 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEE---TT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEee---cc
Confidence 4579999998 54454433221 1233456778888886666532 57999999999999994 33
Q ss_pred ceEEEeeccCCCCC
Q 007427 462 YRAKLTNFGFLPLL 475 (604)
Q Consensus 462 ~~~kl~DFGla~~~ 475 (604)
.+.++|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 7899999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.8e-08 Score=99.34 Aligned_cols=171 Identities=22% Similarity=0.328 Sum_probs=127.4
Q ss_pred CcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEecCCC-CCHHH
Q 007427 329 KVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEFLPN-GSLFD 402 (604)
Q Consensus 329 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~ 402 (604)
.-.+.|++. ..||..|++|+++............-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789997 56899999999964433333334456788999999999999998863 3467899999986 57887
Q ss_pred HhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 403 LLHESRGV----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 403 ~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+-...... .....++...+.++.|+..||.++| +.|..-+-|.+.+|++ ...++++|+-.|+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv---~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILV---TGKMRIRISGCGIM 440 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEe---eCcceEEEecccce
Confidence 65433211 1234678899999999999999999 5699999999999999 66668899888876
Q ss_pred CCCCCCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCC
Q 007427 473 PLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519 (604)
Q Consensus 473 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~ 519 (604)
..+..... |-++. -.+-|.=.||.+++.|.||..
T Consensus 441 Dvl~~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 441 DVLQEDPT----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eeecCCCC----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 55544320 11111 246788899999999999963
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.5e-10 Score=98.74 Aligned_cols=88 Identities=33% Similarity=0.497 Sum_probs=80.1
Q ss_pred hcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcE
Q 007427 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLID 165 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~ 165 (604)
+.+++..+.|-||+|+++-..|.+..|.+|++|++++|++.. +|.++++|++|+.|+++-|+|. .+|.. .++.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 456788889999999999999999999999999999999997 9999999999999999999998 67763 5899999
Q ss_pred EEccCCcccccC
Q 007427 166 FNVSYNNLDGPI 177 (604)
Q Consensus 166 l~ls~n~l~g~~ 177 (604)
|||++|+|+...
T Consensus 107 ldltynnl~e~~ 118 (264)
T KOG0617|consen 107 LDLTYNNLNENS 118 (264)
T ss_pred hhcccccccccc
Confidence 999999998543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.3e-10 Score=122.49 Aligned_cols=236 Identities=21% Similarity=0.212 Sum_probs=154.4
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+-+-+|.++.++.++- ..|...+.|..+..... ..+....+-.++-..+||-++...--+......+++++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 3677899999988863 34555555544322111 1122223333333334455554443344567789999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC-
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS- 477 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~- 477 (604)
+|...++... ..+..-.......+..+++|||. ..+.|||++|.|++. ......+++|||......-
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s----~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS----SLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhcccc----chhhcccccccchhh---cccCCcccCccccccccccc
Confidence 9999998765 24444455667788899999993 458999999999999 5566779999984322100
Q ss_pred ----------------------------------CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 478 ----------------------------------RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 478 ----------------------------------~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
.....+++.|.+||...+......+|.|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0112356788999999999999999999999999999999999986
Q ss_pred CCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 524 SPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
...... .+.+.. .++. .............+++...+..+|.+|-.|.
T Consensus 1038 ~tpq~~--------f~ni~~----~~~~-----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI--------FENILN----RDIP-----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh--------hhcccc----CCCC-----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 433211 111111 1111 1111223334567888888899999998765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-10 Score=116.19 Aligned_cols=127 Identities=22% Similarity=0.233 Sum_probs=100.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.++..|+|..|+++ .+...++.+|+.|+.|+||+|.+...-+ ++..+++|+.||||+|+++--=|.++.-|..|+.|+
T Consensus 269 ~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred cccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 36889999999998 5666667889999999999999998766 588899999999999999985567788889999999
Q ss_pred ccCCcccccCCCC---CCCCCcEEEccCCcccccCCCCc----cccCCCCCccCCCC
Q 007427 146 LQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTR----VVQSFPSSSFEHNS 195 (604)
Q Consensus 146 l~~N~l~g~ip~~---~~~~l~~l~ls~n~l~g~~p~~~----~~~~~~~~~~~~n~ 195 (604)
|++|.++ .|-.+ .+++|+.|||++|.+++.|-+.. .+..+..+.+.||.
T Consensus 348 Ls~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 348 LSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 9999887 45443 47889999999999998886532 12333445555553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.8e-09 Score=77.26 Aligned_cols=59 Identities=41% Similarity=0.558 Sum_probs=32.0
Q ss_pred cCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcc
Q 007427 93 FLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYL 151 (604)
Q Consensus 93 ~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l 151 (604)
+|++|+|++|+++...+ .|.++++|++|++++|+++.--|..+..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45555555555554333 355555555556665555553334455566666666665553
|
... |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-09 Score=106.72 Aligned_cols=123 Identities=24% Similarity=0.286 Sum_probs=82.5
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
|+.++++.|++. .+|.. +..+..|+..-+.+|+.-+.+| .++.+++|+.|+|++|-|.. +|.+++.+..|+.||+|
T Consensus 390 Vt~VnfskNqL~-elPk~-L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS 466 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKR-LVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLS 466 (565)
T ss_pred eEEEecccchHh-hhhhh-hHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheeccc
Confidence 788899998887 67776 5555555554444444445555 46777777777777776665 77777777777777777
Q ss_pred CCcccccCCC-----------------------C---CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 148 ENYLDGQIPP-----------------------F---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 148 ~N~l~g~ip~-----------------------~---~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
+|+|- .+|. . ++.+|..|||.+|.+.--.|.-+...++..+...||+
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCc
Confidence 77765 5553 1 3567778888888887665555555666666666664
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.3e-09 Score=115.99 Aligned_cols=102 Identities=28% Similarity=0.367 Sum_probs=78.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
|+..|+|+.|+|. .+|++.+.+|..|+.|+||+|+|+-..-.+.++..|++|...+|++.- +| ++.+++.|+.+|||
T Consensus 384 hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS 460 (1081)
T KOG0618|consen 384 HLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLS 460 (1081)
T ss_pred ceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecc
Confidence 6788888888885 788887888888888888888887544357788888888888888875 77 78888888888888
Q ss_pred CCccc-ccCCCC-CCCCCcEEEccCCc
Q 007427 148 ENYLD-GQIPPF-NQTSLIDFNVSYNN 172 (604)
Q Consensus 148 ~N~l~-g~ip~~-~~~~l~~l~ls~n~ 172 (604)
.|+|+ +.+|.. ..++|++|||++|.
T Consensus 461 ~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 461 CNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cchhhhhhhhhhCCCcccceeeccCCc
Confidence 88886 445543 23788888888875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9e-08 Score=91.03 Aligned_cols=135 Identities=19% Similarity=0.252 Sum_probs=96.0
Q ss_pred HHHHhhcccCcCCcceEEEEEecCCcEEEEEEecccc----------------------hhhHHHHHHHHHHHccCCCC-
Q 007427 317 LLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMN----------------------ALSKKEFVQQMQLLGKLKHE- 373 (604)
Q Consensus 317 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~- 373 (604)
...+.++.||-|.-+.||.|..+.|.++|||.-+... ..++....+|.++|.+|.-.
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3445689999999999999999999999999643110 11234568899999999654
Q ss_pred -CcccEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 007427 374 -NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSN 452 (604)
Q Consensus 374 -niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~N 452 (604)
.+.+.+++ +...+||||.+|--|...- ++....-.++..|++-+..+- ..||||+|+.+-|
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSEFN 232 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH----HcCccccCCchhe
Confidence 67776654 4568999999886665432 122233345555555554444 2699999999999
Q ss_pred eEEeecCCcceEEEeeccCC
Q 007427 453 ILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 453 ILl~~~~~~~~~kl~DFGla 472 (604)
|++ ++++.+.++||--+
T Consensus 233 IlV---~~dg~~~vIDwPQ~ 249 (304)
T COG0478 233 ILV---TEDGDIVVIDWPQA 249 (304)
T ss_pred EEE---ecCCCEEEEeCccc
Confidence 999 55566799999754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-09 Score=118.06 Aligned_cols=125 Identities=26% Similarity=0.345 Sum_probs=105.3
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.|..|.|.+|.|+...-|- +-++.+|++|+|++|+|+. +| .+.+|..|+.|+||+|.|+- ||..+.++..|++|.
T Consensus 360 ~Lq~LylanN~Ltd~c~p~-l~~~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPV-LVNFKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHhcCcccccchhh-hccccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHh
Confidence 6889999999999877554 7889999999999999974 56 38899999999999999997 999999999999999
Q ss_pred ccCCcccccCCCC-CCCCCcEEEccCCcccc-cCCCCccccCCCCCccCCCCC
Q 007427 146 LQENYLDGQIPPF-NQTSLIDFNVSYNNLDG-PIPQTRVVQSFPSSSFEHNSG 196 (604)
Q Consensus 146 l~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g-~~p~~~~~~~~~~~~~~~n~~ 196 (604)
..+|++. ..|.. .++.|+.+|||.|+|+- .+|....-.++..+.+.||..
T Consensus 437 ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 77875 68999999999999984 444332224556677888874
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-08 Score=75.30 Aligned_cols=59 Identities=36% Similarity=0.519 Sum_probs=54.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHF 127 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l 127 (604)
+++.|+|++|+++ .||+..+..+++|++|+|++|+++...| .|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 6899999999999 6887778999999999999999998777 589999999999999986
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.9e-08 Score=107.74 Aligned_cols=94 Identities=29% Similarity=0.340 Sum_probs=55.5
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|+|+ .||.. +++|++|+|++|+|+. +|.+ ..+|+.|+|++|+|+. +|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lts-LP~l--p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTS-LPVL--PPGLLELSIFSNPLTH-LPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCc-ccCc--ccccceeeccCCchhh-hhhch---hhcCEEECc
Confidence 6788888888887 47752 5788888888888885 4532 3455666666666553 44321 334455555
Q ss_pred CCcccccCCCCCCCCCcEEEccCCcccc
Q 007427 148 ENYLDGQIPPFNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 148 ~N~l~g~ip~~~~~~l~~l~ls~n~l~g 175 (604)
+|+++ .+|.. .++|+.|+|++|+|++
T Consensus 291 ~N~Lt-~LP~~-p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 291 GNQLT-SLPVL-PPGLQELSVSDNQLAS 316 (788)
T ss_pred CCccc-ccccc-ccccceeECCCCcccc
Confidence 55554 33431 2445555555555554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.8e-09 Score=108.69 Aligned_cols=110 Identities=25% Similarity=0.342 Sum_probs=68.8
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCcc---CCCCCCCCE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFG---YIDLPKLKK 143 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~---~~~l~~l~~ 143 (604)
++..|+|++|+++ .++++.+..|..|+.|+|++|+++-.-. .|-.+++|+.|||++|.+++.|-.. +..|++|+.
T Consensus 318 kL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 318 KLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred cceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 4556666666665 4444445556666666666666553322 2556777777777777777765532 445777777
Q ss_pred EeccCCcccccCCC---CCCCCCcEEEccCCcccccCCC
Q 007427 144 LELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 144 l~l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|+|.+|++. .||. ..+..|+.|||.+|-+..--|.
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCcceeeccc
Confidence 777777776 6775 2577777777777776554443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.2e-08 Score=111.06 Aligned_cols=75 Identities=29% Similarity=0.402 Sum_probs=44.2
Q ss_pred ccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCC
Q 007427 92 TFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYN 171 (604)
Q Consensus 92 ~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n 171 (604)
.+|+.|+|++|+|++ +|.+ ..+|+.|++++|+|++ ||... ++|+.|+|++|+|++ +|.. .++|+.|++|+|
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~l--p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP~l-~s~L~~LdLS~N 412 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LPVL-PSELKELMVSGN 412 (788)
T ss_pred cccceEecCCCccCC-CCCC--Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CCCc-ccCCCEEEccCC
Confidence 367888888888886 4432 2355566666666664 56432 345666666666663 4432 245566666666
Q ss_pred cccc
Q 007427 172 NLDG 175 (604)
Q Consensus 172 ~l~g 175 (604)
+|++
T Consensus 413 ~Lss 416 (788)
T PRK15387 413 RLTS 416 (788)
T ss_pred cCCC
Confidence 6653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.3e-07 Score=88.21 Aligned_cols=110 Identities=24% Similarity=0.333 Sum_probs=85.9
Q ss_pred HHHHHHHHHHHccCCC--CCcccEEEEEecCC----ceEEEEecCCCC-CHHHHhhcccCCCCCCCCHHHHHHHHHHHHH
Q 007427 357 KKEFVQQMQLLGKLKH--ENLAKIVSFYYSKE----EKLIIYEFLPNG-SLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429 (604)
Q Consensus 357 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 429 (604)
.....+|...+.++.. =...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 4567888888887753 33466677665532 348999999874 89999886431 455677899999999
Q ss_pred HHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 430 gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.++-|| ..||+|+|+++.|||++.++....+.++||+-++..
T Consensus 130 ~i~~lH----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLH----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHH----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 479999999999999987766678999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.63 E-value=9e-08 Score=113.78 Aligned_cols=111 Identities=26% Similarity=0.276 Sum_probs=95.3
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|.+|++. .+|.. +..+++|+.|+|++|+.-+.+|+++.+++|+.|+|++|.....+|.++.+|++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~-~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDG-VHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccc-cccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 46888999998887 67777 68899999999999887788999999999999999998888889999999999999999
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccccCCC
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
++|..-+.+|.. .+++|+.|++++|...+.+|.
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~ 722 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSRLKSFPD 722 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCCcccccc
Confidence 998766688874 688899999998877666664
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.9e-08 Score=107.75 Aligned_cols=98 Identities=26% Similarity=0.333 Sum_probs=74.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .+|.. +. ++|+.|+|++|+|++ +|. +. .+|+.|+|++|+++ .||..+. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~-l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPEN-LQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChh-hc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 36889999999998 68876 33 589999999999984 553 32 46888888888887 5887664 4788888
Q ss_pred ccCCcccccCCCCCCCCCcEEEccCCcccc
Q 007427 146 LQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 146 l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g 175 (604)
|++|+|+ .||..-..+|+.|+|++|+|++
T Consensus 269 Ls~N~L~-~LP~~l~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 269 LFHNKIS-CLPENLPEELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccC-ccccccCCCCcEEECCCCcccc
Confidence 8888888 5776444678888888888875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=3e-07 Score=97.93 Aligned_cols=142 Identities=16% Similarity=0.240 Sum_probs=90.7
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchh----------------------------------------hHHHHHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL----------------------------------------SKKEFVQ 362 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 362 (604)
+.|+.++-|.||+|++++|+.||||+.+..-.. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 567789999999999999999999988532100 0012345
Q ss_pred HHHHHccCC----CCCcccEEEEEec-CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHh
Q 007427 363 QMQLLGKLK----HENLAKIVSFYYS-KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL-AFLHQ 436 (604)
Q Consensus 363 E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~ 436 (604)
|...+.+++ +..=+.+=.+|++ .....|+|||++|-.+.+...-... ..+. ..++..++++. ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~---k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDR---KELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCH---HHHHHHHHHHHHHHHH-
Confidence 555555542 2222333333433 4567899999999888887432221 1332 23333333321 1111
Q ss_pred cCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 437 ~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
..|++|.|..|.||++ ..++++.+.|||+...+++.
T Consensus 283 ---~dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ---RDGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---hcCccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence 2599999999999999 55577899999998777644
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.7e-08 Score=89.69 Aligned_cols=84 Identities=33% Similarity=0.500 Sum_probs=28.5
Q ss_pred hcCCccCCeeeCccCCCcccCCCCC-CCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC-C--CCCCC
Q 007427 88 LQNITFLNKLSLRNNLLSGSLPNLT-NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-F--NQTSL 163 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n~l~g~~p~~~-~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~-~--~~~~l 163 (604)
+.+...++.|+|++|+++- |..++ .+.+|+.||||+|.++. |+ .+..|++|+.|+|++|+++ .|+. . .+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred ccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 4567789999999999985 66777 58999999999999996 65 5788999999999999999 4653 2 47999
Q ss_pred cEEEccCCcccc
Q 007427 164 IDFNVSYNNLDG 175 (604)
Q Consensus 164 ~~l~ls~n~l~g 175 (604)
+.|++++|++..
T Consensus 91 ~~L~L~~N~I~~ 102 (175)
T PF14580_consen 91 QELYLSNNKISD 102 (175)
T ss_dssp -EEE-TTS---S
T ss_pred CEEECcCCcCCC
Confidence 999999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1e-06 Score=88.17 Aligned_cols=262 Identities=13% Similarity=0.152 Sum_probs=151.5
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEE----e--cCC-ceEEEE
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFY----Y--SKE-EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~----~--~~~-~~~lv~ 392 (604)
+..||+|+-+.+|-.- ..+ -+.|++.........+. ++.|... .||-+-.-+.+= . +.. ..-++|
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4679999999999753 221 24566654322222222 2223332 455433211111 1 111 245777
Q ss_pred ecCCCC-CHHHHhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 393 EFLPNG-SLFDLLHESR-GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 393 e~~~~g-sL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
+.+++. -...++.... ...-...+|...++.+..+|.+.+-||+ .|.+-+|+.++|+|+ ++...+.|.|-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~----~Gh~vGDVn~~~~lV---sd~~~V~LVdsD 162 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE----HGHVVGDVNQNSFLV---SDDSKVVLVDSD 162 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh----cCCcccccCccceee---ecCceEEEEccc
Confidence 777654 2223332211 1112247899999999999999999995 588999999999999 555667777744
Q ss_pred CCCCCCCCC---CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhC-CCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSRK---ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITG-RIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~~---~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
.-..-.... ...+...|.+||.-. +-.-+...|-|.+||++++++.| ++||.+.........-...-+..
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~- 241 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH- 241 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence 322222221 224667889999654 33446789999999999999986 99999865332222222211100
Q ss_pred HhcCCccccccHH---hhhcccC--HHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHHhhcccc
Q 007427 542 VDNDWSTDILDVE---ILAAREG--QNEMLRLTELALECTDI--APEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 542 ~~~~~~~~~~~~~---~~~~~~~--~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~~ 600 (604)
+...+..+.. ....... ......+.-+..+|+.. .+.-|||++..+..|.++++.+
T Consensus 242 ---g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 ---GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ---ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0000000000 0000011 11233566788888875 3678999999999998887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.9e-08 Score=105.15 Aligned_cols=145 Identities=24% Similarity=0.282 Sum_probs=98.4
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCCC-------------ccccccCCC
Q 007427 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS-------------ENLAIGRSP 490 (604)
Q Consensus 424 ~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~-------------~~~~~y~aP 490 (604)
+.+++.||.|+|+ +.++||++|.|++|.+ +.....||+.|+++......... .....|.||
T Consensus 105 l~~v~dgl~flh~---sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 105 LGNVADGLAFLHR---SAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhcccchhhhhcc---Ccceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3455699999997 5899999999999999 66667799999987554431111 233478899
Q ss_pred CCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHH
Q 007427 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLT 569 (604)
Q Consensus 491 E~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 569 (604)
|++.+...+.++|+||+||++|.+.. |+.-+...... ..........+. .......+.+.++.
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~~~~~-----------~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRNLLNA-----------GAFGYSNNLPSELR 242 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhccccc-----------ccccccccCcHHHH
Confidence 99999888999999999999999994 55444332110 000000000000 00111233455788
Q ss_pred HHHHhcccCCCCCCCCHHHHH
Q 007427 570 ELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 570 ~li~~cl~~dP~~RPs~~evl 590 (604)
+=+.+++..++..||++.++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHhcCCcccCcchhhhh
Confidence 889999999999999877664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=3e-06 Score=78.97 Aligned_cols=139 Identities=18% Similarity=0.195 Sum_probs=101.9
Q ss_pred CcCCcceEEEEEecCCcEEEEEEeccc-----c-hhhHHHHHHHHHHHccCCCC--CcccEEEEEe-cC----CceEEEE
Q 007427 326 GKGKVGSTYKATLESGAVVAVKRVKNM-----N-ALSKKEFVQQMQLLGKLKHE--NLAKIVSFYY-SK----EEKLIIY 392 (604)
Q Consensus 326 g~G~~g~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv~ 392 (604)
|+||.+-|++..++ |+.+-+|+-... . ......|.+|+..+.++... .+.+.+ ++. .. ..-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67999999998876 446888876421 1 23467899999999998532 244444 332 11 1357999
Q ss_pred ecCCC-CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 393 EFLPN-GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 393 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
|-+++ -||.+++.+.. ..+.+...+..++.++++.++-|| ..|+.|+|+-+.||+++.++ ...++++||--
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk 176 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEK 176 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCC-CeeEEEEEhhc
Confidence 97753 58999886543 124677888899999999999999 47999999999999996544 45799999976
Q ss_pred CCC
Q 007427 472 LPL 474 (604)
Q Consensus 472 a~~ 474 (604)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.2e-07 Score=106.75 Aligned_cols=78 Identities=24% Similarity=0.290 Sum_probs=37.4
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++++..+.+|. ++.+++|+.|+|++|..-..+| ++++|++|+.|++++|..-+.+|..+ ++++|+.|+|
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~L 711 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNL 711 (1153)
T ss_pred CCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeC
Confidence 455566655544344543 4455555555555554444444 34555555555555544334444433 3334443333
Q ss_pred cC
Q 007427 147 QE 148 (604)
Q Consensus 147 ~~ 148 (604)
++
T Consensus 712 sg 713 (1153)
T PLN03210 712 SG 713 (1153)
T ss_pred CC
Confidence 33
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.4e-08 Score=93.89 Aligned_cols=102 Identities=22% Similarity=0.308 Sum_probs=83.2
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
-++.|||++|.++ .|..+ ..-++.++.|+||+|.++- +-++..|.+|+.||||+|.|+. +-.+=..|.++++|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhh-hhhccceeEEeccccceee-ehhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence 4789999999998 78777 7888999999999999874 4458889999999999999986 55555678889999999
Q ss_pred CCcccccCCC-CCCCCCcEEEccCCccc
Q 007427 148 ENYLDGQIPP-FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 148 ~N~l~g~ip~-~~~~~l~~l~ls~n~l~ 174 (604)
.|.+. .+.. ..+=+|.+||++.|++.
T Consensus 361 ~N~iE-~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 361 QNKIE-TLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhHh-hhhhhHhhhhheeccccccchh
Confidence 99876 2222 23668889999999875
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.1e-07 Score=97.02 Aligned_cols=109 Identities=23% Similarity=0.259 Sum_probs=82.1
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCcc---CCeeeCccCCCccc----CC-CCCCC-CCccEEeCCCCccccc----CCc
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITF---LNKLSLRNNLLSGS----LP-NLTNL-VNLETVFLSQNHFSDG----IPF 133 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~---L~~l~l~~n~l~g~----~p-~~~~l-~~L~~l~l~~N~l~g~----iP~ 133 (604)
.+++.|+|++|.+.+..+.. +..+.+ |+.|+|++|++++. +. .+..+ ++|+.|+|++|++++. ++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~-~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGV-LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHHH-HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 48999999999998766655 555555 99999999999842 21 25566 8899999999999853 444
Q ss_pred cCCCCCCCCEEeccCCccccc----CCC--CCCCCCcEEEccCCccccc
Q 007427 134 GYIDLPKLKKLELQENYLDGQ----IPP--FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 134 ~~~~l~~l~~l~l~~N~l~g~----ip~--~~~~~l~~l~ls~n~l~g~ 176 (604)
.+..+.+|+.|+|++|++++. ++. ...++|+.|++++|.+++.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 566778899999999999853 221 1356899999999988744
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.4e-07 Score=62.12 Aligned_cols=41 Identities=29% Similarity=0.631 Sum_probs=28.6
Q ss_pred HhHHHHHHHHHHhcCC-CCCCCCCCCCCCCCCCCCCeeeEEec
Q 007427 24 PAERYDLLQIRDSLNS-TANLHSRWTGPPCIDNVSNWFGVSCS 65 (604)
Q Consensus 24 ~~~~~~l~~~~~~~~~-~~~~~~~w~~~~c~~~~~~w~gv~c~ 65 (604)
+.|++||++||+++.+ +...+.+|+... ..++|+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence 6799999999999984 667889997542 2456789999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.2e-05 Score=77.53 Aligned_cols=72 Identities=14% Similarity=0.124 Sum_probs=54.6
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--cccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN--LAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 25567888876532 3456788999998886433 4677888777777889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.6e-05 Score=74.22 Aligned_cols=135 Identities=15% Similarity=0.245 Sum_probs=95.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc----------------hhhHHHHHHHHHHHccCC------CCCcccEE
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN----------------ALSKKEFVQQMQLLGKLK------HENLAKIV 379 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 379 (604)
...||+|+.=.||.- ++.....||+.+... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 357999999888864 445567788886544 123466777777666665 88999999
Q ss_pred EEEecCCceEEEEecCCC------CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 007427 380 SFYYSKEEKLIIYEFLPN------GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453 (604)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NI 453 (604)
|+.+++....+|+|.+.+ -+|.+++.... ++. ...+.+.+. .+||- .++|+.+|++|+||
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~-~~~~~L~~f---~~~l~----~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE-ELRQALDEF---KRYLL----DHHIVIRDLNPHNI 149 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH-HHHHHHHHH---HHHHH----HcCCeecCCCcccE
Confidence 999999888999987533 37888885542 444 333333333 34554 46899999999999
Q ss_pred EEeecCCcc-eEEEee-ccCC
Q 007427 454 LIFRENDIY-RAKLTN-FGFL 472 (604)
Q Consensus 454 Ll~~~~~~~-~~kl~D-FGla 472 (604)
++...++.. .+.|+| ||..
T Consensus 150 v~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEEecCCCceEEEEEeCCCCc
Confidence 998776665 788888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.3e-08 Score=100.31 Aligned_cols=101 Identities=23% Similarity=0.332 Sum_probs=48.6
Q ss_pred EEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCc
Q 007427 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENY 150 (604)
Q Consensus 71 ~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~ 150 (604)
.|-+++|+++ .+|++ ++.+..|..||.|.|++....+.+++|.+|+.|++..|++.- +|+++..| .|..||+|.|+
T Consensus 147 vli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred eEEEecCccc-cCCcc-cccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCc
Confidence 3334444443 34444 344444444444444444433344444444445555555443 55555433 35555555555
Q ss_pred ccccCCCC--CCCCCcEEEccCCccccc
Q 007427 151 LDGQIPPF--NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 151 l~g~ip~~--~~~~l~~l~ls~n~l~g~ 176 (604)
++ .||.. .|..|++|-|-+|-|..+
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 55 55542 355555555555555543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.9e-06 Score=87.80 Aligned_cols=145 Identities=17% Similarity=0.287 Sum_probs=90.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhh-------------------------------------HHHHHHHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-------------------------------------KKEFVQQM 364 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~ 364 (604)
.+.||.-+.|.||+|++++|+.||||+-+..-... +-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36788899999999999999999999875421100 01234444
Q ss_pred HHHccC----CCCCc---ccEEEEEec-CCceEEEEecCCCCCHHHH--hhcccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007427 365 QLLGKL----KHENL---AKIVSFYYS-KEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434 (604)
Q Consensus 365 ~~l~~l----~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 434 (604)
+-..++ .|-+. |.+=.++++ ...+.|+||||+|..+.+. |.+.. ++... ++..+.++ |+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~---i~~~l~~~--~~ 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHD---ILNKLVEA--YL 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC------CCHHH---HHHHHHHH--HH
Confidence 433332 34441 112223332 3467999999999866654 33322 44443 33333332 22
Q ss_pred HhcCCCCCceecCCCCCceEEeec-CCcceEEEeeccCCCCCCCC
Q 007427 435 HQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 435 H~~~~~~~ivHrDlkp~NILl~~~-~~~~~~kl~DFGla~~~~~~ 478 (604)
++.. ..|++|+|-.|.||++.++ ....++.+-|||+...+...
T Consensus 315 ~qIf-~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 EQIF-KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHH-hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2211 2589999999999999754 24578999999998776544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.7e-07 Score=94.28 Aligned_cols=108 Identities=28% Similarity=0.308 Sum_probs=77.3
Q ss_pred CcEeEEEeCCCCcee------cCChhhhcCCccCCeeeCccCCCcccCC-CCCCCC---CccEEeCCCCcccc----cCC
Q 007427 67 GHIVSLELEEIQLAG------ILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLV---NLETVFLSQNHFSD----GIP 132 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g------~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~---~L~~l~l~~N~l~g----~iP 132 (604)
..++.|+++++.+.+ .++.. +..+++|+.|+|++|.+++..+ .+..+. +|+.|++++|++++ .+.
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~-l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQG-LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHH-HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 357888888887763 23333 6778889999999998887555 243444 48999999998883 344
Q ss_pred ccCCCC-CCCCEEeccCCcccccCCC------CCCCCCcEEEccCCcccc
Q 007427 133 FGYIDL-PKLKKLELQENYLDGQIPP------FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 133 ~~~~~l-~~l~~l~l~~N~l~g~ip~------~~~~~l~~l~ls~n~l~g 175 (604)
..+..+ ++|+.|+|++|++++..+. ..+.+|+.|++++|.+++
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 455666 8889999999988854332 135678889999988885
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-07 Score=95.44 Aligned_cols=123 Identities=26% Similarity=0.396 Sum_probs=101.3
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
..++.|||+.|+++ .+|.. +..|+ |+.|-+++|+++-..++++.+..|..||.|.|++.. +|+.++.|.+|+.|.+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~-lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDG-LCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChh-hhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHH
Confidence 46889999999998 78887 66555 999999999999877789999999999999999987 9999999999999999
Q ss_pred cCCcccccCCC-CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPP-FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~-~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~ 195 (604)
..|++. .+|. ...-.|..||+|+|+++ .||.. ..+..+..+.+..|+
T Consensus 197 rRn~l~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hhhhhh-hCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 999999 5554 44667899999999997 45543 333444445555554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=7.8e-08 Score=101.60 Aligned_cols=126 Identities=25% Similarity=0.254 Sum_probs=74.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l~l 146 (604)
.+...+.+.|+|. .+-.+ +.-++.|+.||||+|+|+..- .+..|..|+.|||++|.|+- +|.- ...+. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~S-Lqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDES-LQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHH-HHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhcc-ccccchhhhh-heeeee
Confidence 3455555666665 34444 666777777777777777543 56677777777777777775 6632 22333 777777
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccC--CCCccccCCCCCccCCCCCCc
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPI--PQTRVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~--p~~~~~~~~~~~~~~~n~~lc 198 (604)
+||.++--.--.++.+|+.||||+|-|.|-- -.-..+..+..+.+.||+--|
T Consensus 240 rnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 7777763222245677777777777776532 111122233344556665433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.5e-05 Score=71.66 Aligned_cols=138 Identities=15% Similarity=0.224 Sum_probs=92.0
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhh-------------------HHH-----HHHHHHHHccCC--CCCcc
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-------------------KKE-----FVQQMQLLGKLK--HENLA 376 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~-----~~~E~~~l~~l~--h~niv 376 (604)
..|+.|.-+.||+|...++..+|||+++...... .++ ..+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4688899999999998889999999986321110 011 245777777663 44445
Q ss_pred cEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEe
Q 007427 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456 (604)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 456 (604)
+-+++. +-.|||||+... - ...+.-...++...+...+..++++.+.-|-. ..++||+||..-|||+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~-g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~---~a~LVHgDLSEyNiL~- 200 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDD-G----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK---EAGLVHGDLSEYNILV- 200 (268)
T ss_pred Cceeec----CCeEEEEeccCC-C----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH---hcCcccccchhhheEE-
Confidence 555543 347999998542 1 01111111223333567778888888888874 3689999999999999
Q ss_pred ecCCcceEEEeeccCCCCCC
Q 007427 457 RENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 457 ~~~~~~~~kl~DFGla~~~~ 476 (604)
+ ...+.|+|||-|....
T Consensus 201 --~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 --H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --E-CCeEEEEECccccccC
Confidence 4 3478999999876554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.5e-07 Score=78.19 Aligned_cols=83 Identities=23% Similarity=0.251 Sum_probs=38.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.++|++|.|. .+|+.|-...+.++.|+|++|.++..+-++..++.|+.|++++|.|.- .|.-+..|.+|..||..
T Consensus 54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNA-EPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCcccc-chHHHHHHHhHHHhcCC
Confidence 4444555555554 344443333344444455554444322234444444444444444443 44444444444444444
Q ss_pred CCccc
Q 007427 148 ENYLD 152 (604)
Q Consensus 148 ~N~l~ 152 (604)
+|...
T Consensus 132 ~na~~ 136 (177)
T KOG4579|consen 132 ENARA 136 (177)
T ss_pred CCccc
Confidence 44443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.1e-06 Score=58.88 Aligned_cols=36 Identities=39% Similarity=0.608 Sum_probs=21.6
Q ss_pred CccEEeCCCCcccccCCccCCCCCCCCEEeccCCccc
Q 007427 116 NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 116 ~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~ 152 (604)
+|++|+|++|+++. ||+.+++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 56666666666663 6666666666666666666665
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=5e-07 Score=89.34 Aligned_cols=127 Identities=24% Similarity=0.383 Sum_probs=96.2
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC-CcccccCCc-cCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ-NHFSDGIPF-GYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~-N~l~g~iP~-~~~~l~~l~~l 144 (604)
..+.|+|..|+++ .||+..++.+.+|+.||||+|+++-.-| .|..|.+|..|-+.+ |+++- ||. .++.|.+|+.|
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~-l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD-LPKGAFGGLSSLQRL 145 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh-hhhhHhhhHHHHHHH
Confidence 5689999999999 8999889999999999999999998888 588888877765555 99987 885 57899999999
Q ss_pred eccCCcccccCCC---CCCCCCcEEEccCCcccccCCCCc--cccCCCCCccCCCCCCc
Q 007427 145 ELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQTR--VVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 145 ~l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~g~~p~~~--~~~~~~~~~~~~n~~lc 198 (604)
.+.-|+++ -++. ..+++|..|.+-.|.+. .|+... .+......-...|++.|
T Consensus 146 llNan~i~-Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic 202 (498)
T KOG4237|consen 146 LLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC 202 (498)
T ss_pred hcChhhhc-chhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc
Confidence 99999998 4444 35778888888888765 333321 11222334445566555
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2e-06 Score=90.66 Aligned_cols=100 Identities=30% Similarity=0.456 Sum_probs=49.3
Q ss_pred EeEEEeCCCCceecCChhhhcCCc-cCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 69 IVSLELEEIQLAGILPPGFLQNIT-FLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~-~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
++.|++.+|+++ .||+. .+.++ +|+.|++++|++.-....++++++|+.|++++|+++- +|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~-~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPL-IGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccc-cccchhhcccccccccchhhhhhhhhccccccccccCCchhhh-hhhhhhhhhhhhheecc
Confidence 455555555554 44443 34342 5555555555554332244555555555555555554 45444455555555555
Q ss_pred CCcccccCCCC--CCCCCcEEEccCCc
Q 007427 148 ENYLDGQIPPF--NQTSLIDFNVSYNN 172 (604)
Q Consensus 148 ~N~l~g~ip~~--~~~~l~~l~ls~n~ 172 (604)
+|+++ .||.. ....|..|.+++|.
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 55555 44443 23335555555553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.0001 Score=72.19 Aligned_cols=75 Identities=11% Similarity=0.152 Sum_probs=53.7
Q ss_pred cCcCCc-ceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCCCHHH
Q 007427 325 LGKGKV-GSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFD 402 (604)
Q Consensus 325 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 402 (604)
|..|.. ..||+.... +..+.+|+..... .....+|+++++.+. +--+.+++++....+..++||||++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 889999865 4788888876543 345677888887773 3446677877776667899999999887764
Q ss_pred H
Q 007427 403 L 403 (604)
Q Consensus 403 ~ 403 (604)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.4e-05 Score=66.55 Aligned_cols=127 Identities=19% Similarity=0.278 Sum_probs=87.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccc-EEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK-IVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.|++|.+|.||++.+. |..+|+|+-+..+ .+..+..|+++|..+.-.++.+ ++.|- .-++.|||..|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 468999999999999987 6689999876544 3678999999999998766654 44332 23455999988888
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC--CceEEeecCCcceEEEeeccCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKS--SNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp--~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+.-... +-.+. ..+++. +|.-+ ..||-|+.|.- .||++ ++. .+.|+||.-|...
T Consensus 100 ~~~~~~~--------~rk~l----~~vlE~-a~~LD---~~GI~H~El~~~~k~vlv---~~~-~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG--------DRKHL----LRVLEK-AYKLD---RLGIEHGELSRPWKNVLV---NDR-DVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc--------cHHHH----HHHHHH-HHHHH---HhccchhhhcCCceeEEe---cCC-cEEEEEccchhhc
Confidence 7765421 12222 333444 44444 36888888864 56666 332 6899999987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-05 Score=86.14 Aligned_cols=152 Identities=14% Similarity=0.246 Sum_probs=93.0
Q ss_pred cccCcCCcceEEEEEecCC---cEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCCc--ccEEEEEecC---CceEEEE
Q 007427 323 EVLGKGKVGSTYKATLESG---AVVAVKRVKNMN-ALSKKEFVQQMQLLGKLK-HENL--AKIVSFYYSK---EEKLIIY 392 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 392 (604)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4678999999999887654 467888765422 123457889999999995 6665 7788887664 4678999
Q ss_pred ecCCCCCHHH--------------------H---hhcccCC--C----CCCCCH--HHHHHHH---------------HH
Q 007427 393 EFLPNGSLFD--------------------L---LHESRGV--G----RIPLAW--TTRLSII---------------KQ 426 (604)
Q Consensus 393 e~~~~gsL~~--------------------~---l~~~~~~--~----~~~l~~--~~~~~i~---------------~~ 426 (604)
||+++..+.+ . ||..... + ..+..+ .+...+. -.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998754321 1 2221100 0 001111 1111111 11
Q ss_pred HHHHHHHHHhcCCC-------CCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 427 TAKGLAFLHQTLHS-------HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 427 ia~gL~yLH~~~~~-------~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+...+++|....+. ..++|+|+++.||+++.++. ...-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~-~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTED-RVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCC-eEEEEEeeeccccC
Confidence 23345667544332 35999999999999964332 24578999887553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.5e-05 Score=71.46 Aligned_cols=129 Identities=12% Similarity=0.186 Sum_probs=78.3
Q ss_pred ccCcCCcceEEEEEecCCcEEEEEEecccchhhHHH---------HHHHHHHHccCCC---CCcccEEEEEec-----CC
Q 007427 324 VLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKE---------FVQQMQLLGKLKH---ENLAKIVSFYYS-----KE 386 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~~~-----~~ 386 (604)
++-......|.+...+ |+.+++|..+.......+. ..+++..+.+++. .....++.+... ..
T Consensus 38 v~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 38 VFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred eecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 3444444445555544 7889999886543222222 2334444444432 222232222221 23
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..+++|||++|..|.++.. ++. .++..+.+++.-+|+ .|++|+|..|.|++++.+ .+++
T Consensus 117 ~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~----~G~~HGD~hpgNFlv~~~----~i~i 175 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK----HGFYHGDPHPGNFLVSNN----GIRI 175 (229)
T ss_pred EEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH----cCCccCCCCcCcEEEECC----cEEE
Confidence 4568999999988766532 222 355667788999994 699999999999999532 4799
Q ss_pred eeccCCCC
Q 007427 467 TNFGFLPL 474 (604)
Q Consensus 467 ~DFGla~~ 474 (604)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.1e-05 Score=72.47 Aligned_cols=77 Identities=17% Similarity=0.290 Sum_probs=56.7
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CcccEEEEEec---CCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE--NLAKIVSFYYS---KEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~ 397 (604)
+.++.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|+|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468899999999999886 68999998654 3456788888888888533 35667765433 2346899999999
Q ss_pred CCHHH
Q 007427 398 GSLFD 402 (604)
Q Consensus 398 gsL~~ 402 (604)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 88777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.8e-06 Score=56.68 Aligned_cols=37 Identities=51% Similarity=0.668 Sum_probs=24.9
Q ss_pred ccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccc
Q 007427 92 TFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSD 129 (604)
Q Consensus 92 ~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g 129 (604)
++|++|+|++|+++. +|. +++|++|++|+|++|+++.
T Consensus 1 ~~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCCC
Confidence 467777777777774 444 7777777777777777763
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.4e-07 Score=76.78 Aligned_cols=126 Identities=25% Similarity=0.226 Sum_probs=92.3
Q ss_pred cEeEEEeCCCCceecCChhh--hcCCccCCeeeCccCCCcccCCCCCC-CCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGF--LQNITFLNKLSLRNNLLSGSLPNLTN-LVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~--~~~l~~L~~l~l~~n~l~g~~p~~~~-l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+-.++|+++.+- .|+... +.....|...+|++|.|....|.|.. .+.++.|+|++|.++. +|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhc
Confidence 3457888888884 676641 44556777789999999987777655 5589999999999997 99999999999999
Q ss_pred eccCCcccccCCC--CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCC
Q 007427 145 ELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197 (604)
Q Consensus 145 ~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~l 197 (604)
+++.|.|+ ..|. ..+.+|..|+..+|... +||......+.+.+--.||..+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl 158 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPL 158 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcc
Confidence 99999998 4454 35777778888777653 5665433333443333455544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 604 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-31 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-64
Identities = 88/292 (30%), Positives = 155/292 (53%), Gaps = 17/292 (5%)
Query: 311 VFDLDDLLRA-----SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNAL-SKKEFVQQM 364
F L +L A + +LG+G G YK L G +VAVKR+K + +F ++
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 365 QLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSII 424
+++ H NL ++ F + E+L++Y ++ NGS+ L E + PL W R I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIA 137
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA--SE 482
+A+GLA+LH + H ++K++NIL+ ++ + A + +FG L+ + +
Sbjct: 138 LGSARGLAYLHDHCDPKII-HRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 483 NLA--IG-RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539
+ IG +PE+ + + K DV+ +G++LLE+ITG+ + + N+ L DWV+
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
++ ++DV+ L E+ +L ++AL CT +P +RPKMSEV+R
Sbjct: 254 GLLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-61
Identities = 82/311 (26%), Positives = 145/311 (46%), Gaps = 46/311 (14%)
Query: 312 FDLDDLLRA-----SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQL 366
L DL A ++G G G YK L GA VA+KR ++ +EF +++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 367 LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQ 426
L +H +L ++ F + E ++IY+++ NG+L L+ S + + ++W RL I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIG 147
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN--- 483
A+GL + LH+ + H ++KS NIL+ ++ + K+T+FG S+K +E
Sbjct: 148 AARGLHY----LHTRAIIHRDVKSINILL---DENFVPKITDFGI-----SKKGTELDQT 195
Query: 484 ------------LAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531
+ PE+ RLT K+DVY FG++L EV+ R S +
Sbjct: 196 HLSTVVKGTLGYID----PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQ---NEMLRLTELALECTDIAPEKRPKMSE 588
L++W +N I+D + + + + + A++C ++ E RP M +
Sbjct: 252 --LAEWAVESHNNGQLEQIVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 589 VLRRIEEIQPM 599
VL ++E +
Sbjct: 306 VLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-58
Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 47/323 (14%)
Query: 301 ELEFFDKTIPVFDLDDLLRA-----------SAEVLGKGKVGSTYKATLESGAVVAVKRV 349
LE D F +L +G+G G YK + VAVK++
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKL 62
Query: 350 KNMNALS----KKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLH 405
M ++ K++F Q+++++ K +HENL +++ F ++ ++Y ++PNGSL D L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 406 ESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465
G PL+W R I + A G+ FLH+ + H ++KS+NIL+ + + AK
Sbjct: 123 CLD--GTPPLSWHMRCKIAQGAANGINFLHE----NHHIHRDIKSANILL--DEA-FTAK 173
Query: 466 LTNFGFLPLLPSRKASEN----------LAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515
+++FG + +A PE G+ +T K+D+Y FG++LLE+I
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMA----PEALRGE-ITPKSDIYSFGVVLLEII 228
Query: 516 TGRIPGNGSPGNNETSGDLSDWVR-MVVDNDWSTDILDVEILAAREGQNEMLRLTELALE 574
TG + + L D + + D +D ++ + + +A +
Sbjct: 229 TGLPAVD----EHREPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQ 282
Query: 575 CTDIAPEKRPKMSEVLRRIEEIQ 597
C KRP + +V + ++E+
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 77/333 (23%), Positives = 128/333 (38%), Gaps = 72/333 (21%)
Query: 312 FDLDDLLRAS-----AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQL 366
++L S EV +G+ G +KA L VAVK + S + ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 367 LGKLKHENLAKIVSFY-------YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTT 419
L +KHEN I+ F + +I F GSL D L + ++W
Sbjct: 72 LPGMKHEN---ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122
Query: 420 RLSIIKQTAKGLAFLHQTLHSHKVP------HANLKSSNILIFRENDIYRAKLTNFGFLP 473
I + A+GLA+LH+ + K H ++KS N+L+ + N A + +FG
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-KNN--LTACIADFGLAL 179
Query: 474 LLPSRKASE--NLAIG--R--SPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGN 522
+ K++ + +G R +PE EG + + D+Y G++L E+ + +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 523 GSP-----------GNNETSGDLSDWV-----RMVVDNDWSTDILDVEILAAREGQNEML 566
G G + + D+ + V R V+ + W M
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG-------------MA 286
Query: 567 RLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599
L E EC D E R V RI ++Q +
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 312 FDLDDLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL 370
F DL+ EVLGKG G K T E+G V+ +K + + +++ F+++++++ L
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 371 KHENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQT 427
+H N ++ F K+++L I E++ G+L ++ W+ R+S K
Sbjct: 65 EHPN---VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDI 117
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF------LPLLPSRKAS 481
A G+A+LH S + H +L S N L+ REN + +FG P S
Sbjct: 118 ASGMAYLH----SMNIIHRDLNSHNCLV-REN--KNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 482 ENLAIGRS------------PEFPEGKRLTHKADVYCFGIILLEVITGRIP-GNGSPGNN 528
+ PE G+ K DV+ FGI+L E+I + P
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSE 588
+ ++ ++ + + + C D+ PEKRP +
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFF------------------PITVRCCDLDPEKRPSFVK 272
Query: 589 VLRRIEEIQ 597
+ +E ++
Sbjct: 273 LEHWLETLR 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-43
Identities = 70/313 (22%), Positives = 129/313 (41%), Gaps = 51/313 (16%)
Query: 303 EFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLES-GAVVAVKRVK-------NMNA 354
EF +P +++ + +GKG G +K L +VVA+K +
Sbjct: 7 EFPKSRLPTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 355 LSKKEFVQQMQLLGKLKHENLAKIVSFY-YSKEEKLIIYEFLPNGSLFDLLHESRGVGRI 413
+EF +++ ++ L H N IV Y ++ EF+P G L+ L +
Sbjct: 65 EKFQEFQREVFIMSNLNHPN---IVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKA----H 117
Query: 414 PLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI--FRENDIYRAKLTNFGF 471
P+ W+ +L ++ A G+ ++ + + H +L+S NI + EN AK+ +FG
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 472 LPLLPSRKASENLAIGR------SPE--FPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
S+++ +++ +PE E + T KAD Y F +IL ++TG P +
Sbjct: 176 -----SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 524 SPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR 583
++ M+ + I E LR + C P+KR
Sbjct: 231 YSYGK------IKFINMIREEGLRPTI--------PEDCPPRLR--NVIELCWSGDPKKR 274
Query: 584 PKMSEVLRRIEEI 596
P S +++ + E+
Sbjct: 275 PHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 68/309 (22%), Positives = 123/309 (39%), Gaps = 62/309 (20%)
Query: 313 DLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH 372
D ++ EV+G+G G KA VA+K++++ + +K F+ +++ L ++ H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNH 60
Query: 373 ENLAKIVSFY-YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
N IV Y ++ E+ GSL+++LH + + +S Q ++G+
Sbjct: 61 PN---IVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYT--AAHAMSWCLQCSQGV 115
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL--AIG-- 487
A+LH + + H +LK N+L+ + K+ +FG + ++ G
Sbjct: 116 AYLHS-MQPKALIHRDLKPPNLLLVAGGTV--LKICDFGT-----ACDIQTHMTNNKGSA 167
Query: 488 --RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545
+PE EG + K DV+ +GIIL EVIT R P ++ ++
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----------FDEIGGPAFRIMW-- 215
Query: 546 WSTDILDVEILAAREGQNEMLRLT----------ELALECTDIAPEKRPKMSEVLRRIEE 595
A G R L C P +RP M E+++ +
Sbjct: 216 -----------AVHNG----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 596 IQPMIEEND 604
+ D
Sbjct: 261 LMRYFPGAD 269
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 84/333 (25%), Positives = 136/333 (40%), Gaps = 55/333 (16%)
Query: 281 HLSEKKMPDSWSMEDPERRVE--LEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATL 338
H M D + ++ D IP DL+ E +G G G+ ++A
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIK-----EKIGAGSFGTVHRAEW 58
Query: 339 ESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEEKL-IIYE 393
G+ VAVK + + +A EF++++ ++ +L+H N IV F ++ L I+ E
Sbjct: 59 H-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN---IVLFMGAVTQPPNLSIVTE 114
Query: 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453
+L GSL+ LLH+S R L RLS+ AKG+ +LH + + H NLKS N+
Sbjct: 115 YLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNL 170
Query: 454 LIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS---------PEFPEGKRLTHKADV 504
L+ + Y K+ +FG SR + +S PE + K+DV
Sbjct: 171 LV---DKKYTVKVCDFGL-----SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 505 YCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNE 564
Y FG+IL E+ T + P + V V +I N
Sbjct: 223 YSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCKRLEI--------PRNLNP 266
Query: 565 MLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ + C P KRP + ++ + +
Sbjct: 267 QVA--AIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-41
Identities = 54/290 (18%), Positives = 107/290 (36%), Gaps = 51/290 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
L + G +K G + VK +K + + ++F ++ L H N ++
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN---VLP 71
Query: 381 FY-YSKEEKL----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ +I ++P GSL+++LHE + + + A+G+AFLH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH 128
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPE 491
+P L S +++I ++ A+++ + +PE
Sbjct: 129 T--LEPLIPRHALNSRSVMI---DEDMTARISMADV-----KFSFQSPGRMYAPAWVAPE 178
Query: 492 FPEGKRL---THKADVYCFGIILLEVITGRIPGNG-SPGNNETSGDLSDWVRMVVDNDWS 547
+ K AD++ F ++L E++T +P S + V
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVALEG-- 227
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
L I G + + +L C + P KRPK ++ +E++Q
Sbjct: 228 ---LRPTI---PPGISPHVS--KLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-39
Identities = 75/356 (21%), Positives = 128/356 (35%), Gaps = 85/356 (23%)
Query: 300 VELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKE 359
+E + ++ + +L L E++G+G+ G+ YK +L+ VAVK + +++
Sbjct: 1 MEAAASEPSLDLDNLKLL-----ELIGRGRYGAVYKGSLD-ERPVAVKV---FSFANRQN 51
Query: 360 FVQ--QMQLLGKLKHENLAKIVSFY--------YSKEEKLIIYEFLPNGSLFDLLHESRG 409
F+ + + ++H+N I F + E L++ E+ PNGSL L
Sbjct: 52 FINEKNIYRVPLMEHDN---IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-- 106
Query: 410 VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH-----KVPHANLKSSNILIFRENDIYRA 464
W + + +GLA+LH L + H +L S N+L+ +
Sbjct: 107 ----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC 159
Query: 465 KLTNFGFLPLLPSRKASENLAIGR------------SPEFPEG-------KRLTHKADVY 505
+++FG L + +PE EG + + D+Y
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 506 CFGIILLEVI---TGRIPGNGSP----------GNNETSGDLSDWV-----RMVVDNDWS 547
G+I E+ T PG P GN+ T D+ V R W
Sbjct: 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
+ L V L E +C D E R R+ E+ + E N
Sbjct: 280 ENSLAVRSLK------------ETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 53/293 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK----NMNALSKKEFVQQMQLLGKLKHENLAKI 378
E++G G G Y+A G VAVK + + + + Q+ +L LKH N I
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN---I 68
Query: 379 VSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
++ KE L ++ EF G L +L R + ++ Q A+G+ +LH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLH 122
Query: 436 QTLHSHKVPHANLKSSNILI-----FRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-- 488
+ H +LKSSNILI + K+T+FG +R+ +
Sbjct: 123 D-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL-----AREWHRTTKMSAAG 176
Query: 489 -----SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543
+PE + +DV+ +G++L E++TG +P G G V
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAM 228
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
N + I +L +C + P RP + +L ++ I
Sbjct: 229 NKLALPIPS----------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ +G G G+ YK VAVK + + F ++ +L K +H N I+
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN---ILL 84
Query: 381 FY-YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
F YS +L I+ ++ SL+ LH S + I +QTA+G+ +LH
Sbjct: 85 FMGYSTAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH--- 137
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAIG----RSPE- 491
+ + H +LKS+NI + ++ K+ +FG S G +PE
Sbjct: 138 -AKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 492 --FPEGKRLTHKADVYCFGIILLEVITGRIPGNG-SPGNNETSGDLSDWVRMVVDNDWST 548
+ + ++DVY FGI+L E++TG++P + + + MV
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGS--- 242
Query: 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
L ++ R + ++ L EC ++RP +L IEE+
Sbjct: 243 --LSPDLSKVRSNCPKRMK--RLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 60/340 (17%), Positives = 121/340 (35%), Gaps = 65/340 (19%)
Query: 283 SEKKMPDSWSMEDPERRVELEFFDK--TIPVFDLDDLLRASAEVLGKGKVGSTYKATLES 340
E + + P + + F + IP L+ E++GKG+ G Y
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIG-----ELIGKGRFGQVYHGRW-H 55
Query: 341 GAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEEKL-IIYEFL 395
G V A++ + N K F +++ + +HEN +V F L II
Sbjct: 56 GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN---VVLFMGACMSPPHLAIITSLC 111
Query: 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455
+L+ ++ +I L I ++ KG+ +LH + + H +LKS N+
Sbjct: 112 KGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFY 163
Query: 456 FRENDIYRAKLTNFG----FLPLLPSRK--------------ASENLAIGRSPEFPEGKR 497
D + +T+FG L R+ A E + +
Sbjct: 164 ----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
+ +DV+ G I E+ P P ++ + + ++ + +
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQP---------AEAIIWQMGTGMKPNLSQIGMGK 270
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
++++ L C E+RP ++++ +E++
Sbjct: 271 E---------ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 65/320 (20%), Positives = 110/320 (34%), Gaps = 69/320 (21%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAKIVSF 381
+ +GKG+ G + G VAVK S +E ++ ++HEN I+ F
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHEN---ILGF 96
Query: 382 Y-------YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
S + +I ++ NGSL+D L L + L + + GL L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHL 150
Query: 435 H----QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-- 488
H T + H +LKS NIL+ + + G S ++
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 489 ------SPEFPEGKRL------THKADVYCFGIILLEVITG----------RIPGNGSPG 526
PE + AD+Y FG+IL EV ++P +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 527 NNETSGDLSDWV-----RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPE 581
++ + D+ + V R N WS+D + + +L EC P
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ-------------MGKLMTECWAHNPA 314
Query: 582 KRPKMSEVLRRIEEIQPMIE 601
R V + + ++ +
Sbjct: 315 SRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 68/315 (21%), Positives = 116/315 (36%), Gaps = 69/315 (21%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAKIVSF 381
E +GKG+ G ++ + + G VAVK + + S +E ++ L+HEN I+ F
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHEN---ILGF 67
Query: 382 Y-------YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+S + +I + GSL+D L L + L I+ A GLA L
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHL 121
Query: 435 H----QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF----LPLLPSRKASENLAI 486
H T + H +LKS NIL+ ++N + + + G N +
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILV-KKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 487 G----RSPEFPEGK------RLTHKADVYCFGIILLEVITGRIPGNGSP----------G 526
G +PE + + D++ FG++L EV +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 527 NNETSGDLSDWV-----RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPE 581
N+ + D+ V R + N W +D + L +L EC P
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSD-------------PTLTSLAKLMKECWYQNPS 285
Query: 582 KRPKMSEVLRRIEEI 596
R + + + +I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 58/317 (18%), Positives = 110/317 (34%), Gaps = 71/317 (22%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFV--QQMQLLGKLKHENLAKIVS 380
E +GKG+ G ++ G VAVK + ++ + ++ L+HEN I+
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHEN---ILG 100
Query: 381 FYYSKEEK-------LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
F + + ++ ++ +GSLFD L+ R + + + TA GLA
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 154
Query: 434 LHQ----TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR- 488
LH T + H +LKS NIL+ + + G S + ++A
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 489 -------SPEFPEGKRL------THKADVYCFGIILLEVITGRIPGNGSP---------- 525
+PE + +AD+Y G++ E+ G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 526 GNNETSGDLSDWV-----RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAP 580
++ + ++ V R + N W + E M ++ EC
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSC----------EALRVMAKIMR---ECWYANG 318
Query: 581 EKRPKMSEVLRRIEEIQ 597
R + + + ++
Sbjct: 319 AARLTALRIKKTLSQLS 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-32
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 14/204 (6%)
Query: 15 SSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLEL 74
++ IA + ++ + L + ++ +S +
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST----------RNPCNI 615
Query: 75 EEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPF 133
G P N + L + N+LSG +P + ++ L + L N S IP
Sbjct: 616 TSRVYGGHTSP-TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 134 GYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSF 191
DL L L+L N LDG+IP T L + ++S NNL GPIP+ ++FP + F
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 192 EHNSGLCGRPLEKLCPISPPPPSP 215
+N GLCG PL + P + +
Sbjct: 735 LNNPGLCGYPLPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-27
Identities = 38/164 (23%), Positives = 64/164 (39%), Gaps = 15/164 (9%)
Query: 24 PAERYDLLQIRDSLNSTANLHSRWTG--PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAG 81
E + L+ +D L L W+ PC + GV+C + + S++L L
Sbjct: 11 YREIHQLISFKDVLPDKNLLPD-WSSNKNPC-----TFDGVTCRDDKVTSIDLSSKPLNV 64
Query: 82 ILP--PGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI--D 137
L ++T L L L N+ ++GS+ +L ++ LS+N S +
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124
Query: 138 LPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIP 178
LK L + N LD SL ++S N++ G
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-21
Identities = 29/120 (24%), Positives = 51/120 (42%), Gaps = 3/120 (2%)
Query: 59 WFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLE 118
+ +S G + L + +++G + N+ FL+ + +N S +P L + L+
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD---VSSNNFSTGIPFLGDCSALQ 226
Query: 119 TVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
+ +S N S +LK L + N G IPP SL +++ N G IP
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIP 286
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-19
Identities = 39/121 (32%), Positives = 56/121 (46%), Gaps = 4/121 (3%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVF 121
+ L L+ G +PP L N + L L L N LSG++P+ L +L L +
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPP-TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 122 LSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQ 179
L N IP + + L+ L L N L G+IP N T+L ++S N L G IP+
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 180 T 180
Sbjct: 509 W 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-19
Identities = 31/118 (26%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
+ L + Q G +PP L++ L LSL N +G +P+ L + LS N
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKS---LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQT 180
HF +P + L+ L L N G++P L ++S+N G +P++
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-19
Identities = 36/119 (30%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 68 HIVSLELEEIQLAGILPPGF--LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQN 125
+ L+L ++G G+ L L++ N +SG + ++ VNLE + +S N
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSN 210
Query: 126 HFSDGIP-FGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTR 181
+FS GIP G D L+ L++ N L G T L N+S N GPIP
Sbjct: 211 NFSTGIPFLG--DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP 267
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-19
Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 54 DNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNI-TFLNKLSLRNNLLSGSLPN-L 111
+ ++ +++L+L +G + P QN L +L L+NN +G +P L
Sbjct: 357 GELPESLTNLSAS--LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 112 TNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVS 169
+N L ++ LS N+ S IP L KL+ L+L N L+G+IP +L +
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 170 YNNLDGPIPQT 180
+N+L G IP
Sbjct: 475 FNDLTGEIPSG 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-19
Identities = 39/132 (29%), Positives = 58/132 (43%), Gaps = 14/132 (10%)
Query: 50 PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP 109
P + ++S + L+L L G +P L + L L L N L+G +P
Sbjct: 435 PSSLGSLSK----------LRDLKLWLNMLEGEIPQ-ELMYVKTLETLILDFNDLTGEIP 483
Query: 110 N-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDF 166
+ L+N NL + LS N + IP L L L+L N G IP + SLI
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543
Query: 167 NVSYNNLDGPIP 178
+++ N +G IP
Sbjct: 544 DLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-17
Identities = 34/128 (26%), Positives = 51/128 (39%), Gaps = 8/128 (6%)
Query: 58 NWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNL 114
+ + L+L + +G LP L L L +N SG +
Sbjct: 337 DTLL-KMRG--LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 115 VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNN 172
L+ ++L N F+ IP + +L L L NYL G IP + + L D + N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 173 LDGPIPQT 180
L+G IPQ
Sbjct: 454 LEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-17
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 4/106 (3%)
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYI 136
L+G +P L +++ L L L N+L G +P L + LET+ L N + IP G
Sbjct: 429 YLSGTIPS-SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 137 DLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180
+ L + L N L G+IP + +L +S N+ G IP
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-15
Identities = 41/118 (34%), Positives = 55/118 (46%), Gaps = 8/118 (6%)
Query: 64 CSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFL 122
+ +L L+ L G +P G L N T LN +SL NN L+G +P + L NL + L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSG-LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL 521
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIP 178
S N FS IP D L L+L N +G IP F Q+ I + N + G
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKRY 575
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-13
Identities = 26/134 (19%), Positives = 48/134 (35%), Gaps = 20/134 (14%)
Query: 50 PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP 109
P + N C+N + + L +L G +P ++ + L L L NN SG++P
Sbjct: 483 PSGLSN--------CTN--LNWISLSNNRLTGEIPK-WIGRLENLAILKLSNNSFSGNIP 531
Query: 110 -NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF----NQTSLI 164
L + +L + L+ N F+ IP + N++ G+ +
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKEC 587
Query: 165 DFNVSYNNLDGPIP 178
+ G
Sbjct: 588 HGAGNLLEFQGIRS 601
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
+G+G + YK E+ VA +++ L+K E F ++ ++L L+H N I
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPN---I 87
Query: 379 VSFYYS------KEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
V FY S ++ +++ E + +G+L L + + S +Q KGL
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGL 142
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE 491
FLH + + H +LK NI I K+ + G L + A + +PE
Sbjct: 143 QFLHT--RTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRASFAKAVI---GTPE 195
Query: 492 F--PE--GKRLTHKADVYCFGIILLEVITGRIP 520
F PE ++ DVY FG+ +LE+ T P
Sbjct: 196 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 65/308 (21%), Positives = 111/308 (36%), Gaps = 75/308 (24%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E++G G G +KA G +KRVK + ++ ++++ L KL H N IV +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVN---IVHY 69
Query: 382 YYSKEEKL-------------------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS 422
+ I EF G+L + + RG L L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALE 126
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE 482
+ +Q KG+ ++H S K+ + +LK SNI + + K+ +FG
Sbjct: 127 LFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQV---KIGDFGL-----VTSLKN 174
Query: 483 NLAIGR--------SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL 534
+ R SPE + + D+Y G+IL E++ ETS
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA------FETSKFF 228
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
+D ++ + + + + ++L PE RP SE+LR
Sbjct: 229 TDLRDGIISDIFDKKEKTL-L-------QKLLSKK----------PEDRPNTSEILRT-L 269
Query: 595 EIQPMIEE 602
+ E
Sbjct: 270 TVWKKSPE 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/317 (21%), Positives = 120/317 (37%), Gaps = 50/317 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ +G+G G E G +K + M++ ++E +++ +L +KH N IV
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN---IV 86
Query: 380 SFYYSKEEK---LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ S EE I+ ++ G LF ++ +GV L Q L
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKH--- 140
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEF 492
+H K+ H ++KS NI + ++ + +L +FG +L S IG SPE
Sbjct: 141 -VHDRKILHRDIKSQNIFLTKDGTV---QLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP---------------GNGSPGNNETSGDLSDW 537
E K +K+D++ G +L E+ T + G+ P + S DL
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256
Query: 538 VRMVVDNDWS-----TDILDVEILAAR-------EGQNEMLRLTELALECTDIAPEKRPK 585
V + + IL+ +A R + E L + + P KRP
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316
Query: 586 MSEVLRRIEEIQPMIEE 602
+ + Q + +
Sbjct: 317 SGQNSISVMPAQKITKP 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 56/298 (18%), Positives = 113/298 (37%), Gaps = 64/298 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKL-KHENLAKI 378
E +G G+ GS +K G + A+KR K ++ ++ ++++ L +H + +
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH---V 73
Query: 379 VSFY--YSKEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V ++ +++++ ++I E+ GSL D + E+ + ++ Q +GL ++H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYIH 132
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYR----------------AKLTNFGFLPLLPSRK 479
S + H ++K SNI I R + K+ + G + + S +
Sbjct: 133 ----SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 480 ASENLAIGR----SPE-FPEGKRLTHKADVYCFGIILLEVITGR-IPGNGSPGNNETSGD 533
E G + E E KAD++ + ++ +P NG + G
Sbjct: 189 VEE----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 244
Query: 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
L + S + TEL PE+RP +++
Sbjct: 245 LPR-----IPQVLSQE------------------FTELLKVMIHPDPERRPSAMALVK 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/292 (21%), Positives = 120/292 (41%), Gaps = 38/292 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLKHENLAKI 378
+ +G+G+ Y+A L G VA+K+V+ M+A ++ + ++++ LL +L H N +
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---V 94
Query: 379 VSFYYS--KEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ +Y S ++ +L I E G L ++ + R + T Q L
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTVWKYFVQLCSALEH-- 151
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPE 491
+HS +V H ++K +N+ I + KL + G S+ + + +G SPE
Sbjct: 152 --MHSRRVMHRDIKPANVFITATGVV---KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
K+D++ G +L E+ + P G N L + + D+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYP---- 256
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
+ + + L +L C + PEKRP ++ V + + +
Sbjct: 257 --PLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 46/191 (24%), Positives = 72/191 (37%), Gaps = 36/191 (18%)
Query: 24 PAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSN----GHIVSLELEEIQL 79
P ++ LLQI+ L + L S C + W GV C + +L+L + L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNR--TWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 80 AGILP--------------------------PGFLQNITFLNKLSLRNNLLSGSLP-NLT 112
P P + +T L+ L + + +SG++P L+
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 113 NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDF-NVS 169
+ L T+ S N S +P LP L + N + G IP + + L +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 170 YNNLDGPIPQT 180
N L G IP T
Sbjct: 183 RNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 36/140 (25%), Positives = 52/140 (37%), Gaps = 27/140 (19%)
Query: 65 SNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQ 124
+N ++ ++L L G F + K+ L N L+ L + NL + L
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN 253
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRV 182
N G +P L NVS+NNL G IPQ
Sbjct: 254 NRIY------------------------GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 183 VQSFPSSSFEHNSGLCGRPL 202
+Q F S++ +N LCG PL
Sbjct: 290 LQRFDVSAYANNKCLCGSPL 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/312 (23%), Positives = 122/312 (39%), Gaps = 81/312 (25%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E +GKG G +K + VVA+K + A + E +QQ + +L + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTK 84
Query: 381 FY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+Y Y K+ KL II E+L GS DLL PL T +I+++ KGL +
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDY---- 134
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFP 493
LHS K H ++K++N+L+ ++ KL +FG L + N +G +PE
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEV---KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 494 EGKRLTHKADVYCFGIILLEVITGR--------------IPGNGSPGNNETSGDLSDWVR 539
+ KAD++ GI +E+ G IP N P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-------------- 237
Query: 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL--------- 590
++ ++S + E + C + P RP E+L
Sbjct: 238 -TLEGNYSKPL------------KEFVEA------CLNKEPSFRPTAKELLKHKFILRNA 278
Query: 591 RRIEEIQPMIEE 602
++ + +I+
Sbjct: 279 KKTSYLTELIDR 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 63/344 (18%), Positives = 126/344 (36%), Gaps = 59/344 (17%)
Query: 286 KMPDSWSMEDPERR--VELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATL-ESGA 342
K + +++ +R+ + + DD + LG G G +K + SG
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGL 59
Query: 343 VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEEKL-IIYEFLPNG 398
V+A K + + + + ++++Q+L + IV FY + + ++ I E + G
Sbjct: 60 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPY---IVGFYGAFYSDGEISICMEHMDGG 116
Query: 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458
SL +L ++ + L + KGL +L + HK+ H ++K SNIL+
Sbjct: 117 SLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSR 168
Query: 459 NDIYRAKLTNFGFLPLLPSRKASENLA---IGR----SPEFPEGKRLTHKADVYCFGIIL 511
+I KL +FG S + +++A +G SPE +G + ++D++ G+ L
Sbjct: 169 GEI---KLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220
Query: 512 LEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTEL 571
+E+ GR P + + + + EL
Sbjct: 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
Query: 572 ALE------------------------CTDIAPEKRPKMSEVLR 591
C P +R + +++
Sbjct: 281 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 59/297 (19%)
Query: 274 QAGEGSAHLSEKKMPDSWSMEDPERRVEL-EFFDKTIPVFDLDDLLRASAEVLGKGKVGS 332
G +E S + + + L D+ P LD +G+G G
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSY-----VKIGEGSTGI 60
Query: 333 TYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEEKL 389
A SG VAVK + ++ ++ ++ +H N +V Y Y E+L
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN---VVEMYKSYLVGEEL 117
Query: 390 -IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLHQTLHSHK 442
++ EFL G+L D++ + RL+ + + + LA+ LH+
Sbjct: 118 WVLMEFLQGGALTDIVSQ------------VRLNEEQIATVCEAVLQALAY----LHAQG 161
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGKRL 498
V H ++KS +IL+ + + KL++FGF + +G +PE
Sbjct: 162 VIHRDIKSDSILLTLDGRV---KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 499 THKADVYCFGIILLEVITG--------------RIPGNGSP---GNNETSGDLSDWV 538
+ D++ GI+++E++ G R+ + P +++ S L D++
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 54/295 (18%), Positives = 104/295 (35%), Gaps = 63/295 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G G G K G ++ K + +M K+ V ++ LL +LKH N IV
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IV 68
Query: 380 SFYYSKEEKL-----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+Y ++ I+ E+ G L ++ + + L L ++ Q L
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKEC 127
Query: 435 H-QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
H ++ H V H +LK +N+ + + ++ KL +FG +R + + + +
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNV---KLGDFGL-----ARILNHDTSFAKTFVGT 179
Query: 489 ----SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD- 543
SPE K+D++ G +L E+ P + + +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKIREG 231
Query: 544 ------NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592
+S + L E+ ++ RP + E+L
Sbjct: 232 KFRRIPYRYSDE------------------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 38/225 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +G+G G+ Y A + +G VA++++ K+ + ++ ++ + K+ N IV++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN---IVNY 82
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y ++L ++ E+L GSL D++ E+ + ++ ++ + L F L
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEF----L 132
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPE 494
HS++V H ++KS NIL+ + + KLT+FGF + ++ + +G +PE
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 495 GKRLTHKADVYCFGIILLEVITG--------------RIPGNGSP 525
K K D++ GI+ +E+I G I NG+P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
VLGKG G Y L + +A+K + ++ + +++ L LKH+N IV +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN---IVQY 84
Query: 382 Y--YSKEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+S+ + I+ E +P GSL LL G + T KQ +GL + L
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKY----L 138
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS--------- 489
H +++ H ++K N+LI + + K+++FG S++ + +
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGV--LKISDFGT-----SKRLAGINPCTETFTGTLQYMA 191
Query: 490 PE--FPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE + AD++ G ++E+ TG+ P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 75/295 (25%), Positives = 120/295 (40%), Gaps = 51/295 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
LG+G G + T VA+K +K +S + F+Q+ Q++ KL+HE +V Y
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEK---LVQLY 245
Query: 383 --YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
S+E I+ E++ GSL D L G L + + Q A G+A++
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVE----R 298
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------P 490
H +L+++NIL+ + K+ +FG +R +N R P
Sbjct: 299 MNYVHRDLRAANILV---GENLVCKVADFGL-----ARLIEDNEYTARQGAKFPIKWTAP 350
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E R T K+DV+ FGI+L E+ T GR+P G N E + RM +
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPES 409
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
+ D+ M + C PE+RP + +E+ E
Sbjct: 410 LHDL-----------MCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G ++ ++G AVK+V+ + +E + L IV
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEE----LVACAGLSSPR---IVPL 115
Query: 382 Y--YSKEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + + I+ E L GSL L+ + L L + Q +GL + L
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEY----L 166
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS--------- 489
H+ ++ H ++K+ N+L+ +D RA L +FG L ++L G
Sbjct: 167 HTRRILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE GK K D++ ++L ++ G P
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ LG+G G ++A A+KR++ L++++ +++++ L KL+H IV
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG---IVR 67
Query: 381 FYYSKEEKL---------------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
++ + EK I + +L D ++ + + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFL 125
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF------------LP 473
Q A+ + FLH S + H +LK SNI ++ + K+ +FG +
Sbjct: 126 QIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVV---KVGDFGLVTAMDQDEEEQTVL 178
Query: 474 LLPSRKASENLAIG----RSPEFPEGKRLTHKADVYCFGIILLEVIT 516
A +G SPE G +HK D++ G+IL E++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 51/285 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +GKG+ G G VAVK +KN + + F+ + ++ +L+H N +V
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSN---LVQLL 252
Query: 383 ----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
K I+ E++ GSL D L R GR L L + + +L
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEF 492
+ H +L + N+L+ ++ AK+++FG +++AS G+ +PE
Sbjct: 307 -GNNFVHRDLAARNVLV---SEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEA 357
Query: 493 PEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
K+ + K+DV+ FGI+L E+ + GR+P P + + +M + +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAVY 416
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
DV M C + RP ++ ++E I
Sbjct: 417 DV-----------M-------KNCWHLDAATRPTFLQLREQLEHI 443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/265 (24%), Positives = 110/265 (41%), Gaps = 57/265 (21%)
Query: 283 SEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESG 341
KK+ + + PE ++ E LG+G GS YKA E+G
Sbjct: 14 QLKKLDEDSLTKQPEEVFDVL-------------------EKLGEGSYGSVYKAIHKETG 54
Query: 342 AVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEEKL-IIYEFLPNG 398
+VA+K+V + L +E ++++ ++ + + +V +Y Y K L I+ E+ G
Sbjct: 55 QIVAIKQVPVESDL--QEIIKEISIMQQCDSPH---VVKYYGSYFKNTDLWIVMEYCGAG 109
Query: 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458
S+ D++ L +I++ T KGL + LH + H ++K+ NIL+ E
Sbjct: 110 SVSDIIRLRNK----TLTEDEIATILQSTLKGLEY----LHFMRKIHRDIKAGNILLNTE 161
Query: 459 NDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPEFPEGKRLTHKADVYCFGIILLEV 514
KL +FG L A N IG +PE + AD++ GI +E+
Sbjct: 162 GHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
Query: 515 ITGR--------------IPGNGSP 525
G+ IP N P
Sbjct: 219 AEGKPPYADIHPMRAIFMIPTNPPP 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 75/302 (24%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 323 EVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK 377
LGKG GS +GA+VAVK++++ +++F +++Q+L L + + K
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 378 I--VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
VS+ ++ ++ E+LP+G L D L R R+ + L Q KG+ +
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDAS--RLLLYSSQICKGMEY-- 142
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR----KASENLAIGRSPE 491
L S + H +L + NIL+ K+ +FG LLP E G+SP
Sbjct: 143 --LGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREP---GQSPI 194
Query: 492 F---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544
F PE + ++DV+ FG++L E+ T + S G D
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA----- 249
Query: 545 DWSTDILDVEILAAREGQNEMLRLT----------ELALECTDIAPEKRPKMSEVLRRIE 594
+ +L+ EGQ RL EL C +P+ RP S + +++
Sbjct: 250 --LSRLLE----LLEEGQ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 595 EI 596
+
Sbjct: 300 ML 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 55/308 (17%), Positives = 108/308 (35%), Gaps = 68/308 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+ LG+G L G A+KR+ ++E ++ + H N I+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN---ILRL 91
Query: 382 YYS-------KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
K E ++ F G+L++ + E L L ++ +GL
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEA- 149
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAIG----- 487
+H+ H +LK +NIL+ E L + G + + + L +
Sbjct: 150 ---IHAKGYAHRDLKPTNILLGDEGQP---VLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 488 ------RSPEFPEGKR---LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538
R+PE + + + DV+ G +L ++ G P + ++ V
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-------V 256
Query: 539 RMVVDNDW--------STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
+ V N S+ + + + N M+ + P +RP + +L
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQL-L-------NSMMTVD----------PHQRPHIPLLL 298
Query: 591 RRIEEIQP 598
++E +QP
Sbjct: 299 SQLEALQP 306
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 53/289 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAV-VAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G+ G Y+ + ++ VAVK +K + + +EF+++ ++ ++KH N +V
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPN---LVQL 281
Query: 382 Y---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ II EF+ G+L D L R R ++ L + Q + + +L
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---------- 488
H NL + N L+ + + K+ +FG SR + +
Sbjct: 336 -KKNFIHRNLAARNCLV---GENHLVKVADFGL-----SRLMTGDTYTAHAGAKFPIKWT 386
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547
+PE + + K+DV+ FG++L E+ T G P G ++ L RM
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCP 445
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++ M C P RP +E+ + E +
Sbjct: 446 EKVYEL-----------MRA-------CWQWNPSDRPSFAEIHQAFETM 476
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 61/301 (20%), Positives = 112/301 (37%), Gaps = 66/301 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
EV+G G A VA+KR+ + + + + +Q + + H N IVS
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN---IVS 77
Query: 381 FY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFL 434
+Y + +++L ++ + L GS+ D++ G +I+++ +GL +
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY- 136
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF-----LPLLPSRKASENLAIGR- 488
LH + H ++K+ NIL+ + + ++ +FG +R +G
Sbjct: 137 ---LHKNGQIHRDVKAGNILLGEDGSV---QIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 489 ---SPE-FPEGKRLTHKADVYCFGIILLEVITGR--------------IPGNGSPGNNET 530
+PE + + KAD++ FGI +E+ TG N P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
D + +M+ L C PEKRP +E+L
Sbjct: 251 VQDKEM------LKKYGKSF------------RKMISL------CLQKDPEKRPTAAELL 286
Query: 591 R 591
R
Sbjct: 287 R 287
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 75/295 (25%), Positives = 120/295 (40%), Gaps = 51/295 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
LG+G G + T VA+K +K +S + F+Q+ Q++ KL+HE +V Y
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEK---LVQLY 328
Query: 383 --YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
S+E I+ E++ GSL D L G L + + Q A G+A++
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVE----R 381
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------P 490
H +L+++NIL+ + K+ +FG +R +N R P
Sbjct: 382 MNYVHRDLRAANILV---GENLVCKVADFGL-----ARLIEDNEYTARQGAKFPIKWTAP 433
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E R T K+DV+ FGI+L E+ T GR+P G N E + RM +
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPES 492
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
+ D+ M + C PE+RP + +E+ E
Sbjct: 493 LHDL-----------MCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 51/287 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ LG G+ G + AT VAVK +K ++S + F+ + ++ L+H+ +V +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDK---LVKLH 249
Query: 383 --YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+KE II EF+ GSL D L G + Q A+G+AF+
Sbjct: 250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIE----Q 302
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------P 490
H +L+++NIL+ + K+ +FG +R +N R P
Sbjct: 303 RNYIHRDLRAANILV---SASLVCKIADFGL-----ARVIEDNEYTAREGAKFPIKWTAP 354
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E T K+DV+ FGI+L+E++T GRIP G N E L RM + +
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEE 413
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++ M+R C PE+RP + +++
Sbjct: 414 LYNI-----------MMR-------CWKNRPEERPTFEYIQSVLDDF 442
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 41/230 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G G YKA E+GA+ A K ++ + ++++ ++++L H IV
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY---IVKL 81
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + KL I+ EF P G++ ++ E L + +Q + L F L
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNF----L 133
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE--- 491
HS ++ H +LK+ N+L+ E DI +L +FG + IG +PE
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDI---RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 492 --FPEGKRLTHKADVYCFGIILLEVITGR--------------IPGNGSP 525
+ +KAD++ GI L+E+ I + P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 59/294 (20%)
Query: 323 EVLGKGKVGSTYKATLESGAV-VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E +G+G G + L + VAVK + + K +F+Q+ ++L + H N IV
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN---IVR 176
Query: 381 FY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
K+ I+ E + G L L T L ++ A G+ +L
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--------- 488
S H +L + N L+ + K+++FG SR+ ++ +
Sbjct: 231 --SKCCIHRDLAARNCLV---TEKNVLKISDFG-----MSREEADGVYAASGGLRQVPVK 280
Query: 489 --SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDLSDWVRMVVD 543
+PE R + ++DV+ FGI+L E + G P P N +T + R+
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPCP 337
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ + M + C P +RP S + + ++ I+
Sbjct: 338 ELCPDAVFRL-----------MEQ-------CWAYEPGQRPSFSTIYQELQSIR 373
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 51/287 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
E LG G+ G + VAVK +K ++S F+ + L+ +L+H+ +V Y
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR---LVRLY 74
Query: 383 --YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
++E II E++ NGSL D L G+ L L + Q A+G+AF +
Sbjct: 75 AVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAF----IEE 127
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------P 490
H +L+++NIL+ +D K+ +FG +R +N R P
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGL-----ARLIEDNEYTAREGAKFPIKWTAP 179
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E T K+DV+ FGI+L E++T GRIP G N E +L RMV ++ +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEE 238
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ + M C PE RP + +E+
Sbjct: 239 LYQL-----------MRL-------CWKERPEDRPTFDYLRSVLEDF 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 69/285 (24%), Positives = 126/285 (44%), Gaps = 47/285 (16%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +G G+ G + + VA+K ++ A+S+++F+++ +++ KL H L ++
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ ++ EF+ +G L D L RG+ A T L + +G+A+ L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAY----LEEAC 124
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------PEF 492
V H +L + N L+ EN + K+++FG +R ++ + PE
Sbjct: 125 VIHRDLAARNCLVG-ENQV--IKVSDFGM-----TRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 493 PEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
R + K+DV+ FG+++ EV + G+IP N+E D+S R+ ST +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVY 235
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ M C PE RP S +LR++ EI
Sbjct: 236 QI-----------MNH-------CWRERPEDRPAFSRLLRQLAEI 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 51/285 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +GKG+ G G VAVK +KN + + F+ + ++ +L+H N +V
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSN---LVQLL 80
Query: 383 ----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
K I+ E++ GSL D L R GR L L + + + L
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEY----L 133
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEF 492
+ H +L + N+L+ ++ AK+++FG +++AS G+ +PE
Sbjct: 134 EGNNFVHRDLAARNVLV---SEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEA 185
Query: 493 PEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
K+ + K+DV+ FGI+L E+ + GR+P P + + +M + +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAVY 244
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+V M C + RP ++ ++E I
Sbjct: 245 EV-----------M-------KNCWHLDAAMRPSFLQLREQLEHI 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 71/303 (23%), Positives = 129/303 (42%), Gaps = 48/303 (15%)
Query: 323 EVLGKGKVGSTYKATLE-----SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK 377
+ LGKG GS + +G VVAVK++++ ++F +++++L L+H+N+ K
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 378 I--VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V + + +I E+LP GSL D L + + RI L Q KG+ +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHI--KLLQYTSQICKGMEY-- 160
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR----KASENLAIGRSPE 491
L + + H +L + NIL+ + R K+ +FG +LP K E G SP
Sbjct: 161 --LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEP---GESPI 212
Query: 492 F---PEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545
F PE + + +DV+ FG++L E+ T P +M+V
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--- 269
Query: 546 WSTDILDVEILAAREGQNEMLR-------LTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
++ + + R + + EC + +RP ++ R+++I+
Sbjct: 270 -------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
Query: 599 MIE 601
+
Sbjct: 323 QMA 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 68/299 (22%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 323 EVLGKGKVGSTYKATLE-----SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK 377
+ LGKG GS + +G VVAVK++++ ++F +++++L L+H+N+ K
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 378 I--VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V + + +I E+LP GSL D L + + + L Q KG+ +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEY-- 129
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR----KASENLAIGRSPE 491
L + + H +L + NIL+ + R K+ +FG +LP K E G SP
Sbjct: 130 --LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEP---GESPI 181
Query: 492 F---PEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545
F PE + + +DV+ FG++L E+ T P +M+V
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--- 238
Query: 546 WSTDILDVEILAAREGQNEM-------LRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
++ + + + + EC + +RP ++ R+++I+
Sbjct: 239 -------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 53/289 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAV-VAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G+ G Y+ + ++ VAVK +K + + +EF+++ ++ ++KH N +V
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPN---LVQL 74
Query: 382 Y--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
++E II EF+ G+L D L R R ++ L + Q + + + L
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEY----L 127
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS--------- 489
H +L + N L+ EN + K+ +FG SR + + +
Sbjct: 128 EKKNFIHRDLAARNCLV-GENHL--VKVADFGL-----SRLMTGDTYTAHAGAKFPIKWT 179
Query: 490 -PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547
PE + + K+DV+ FG++L E+ T G P G ++ L RM
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCP 238
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++ M C P RP +E+ + E +
Sbjct: 239 EKVYEL-----------M-------RACWQWNPSDRPSFAEIHQAFETM 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/301 (20%), Positives = 105/301 (34%), Gaps = 66/301 (21%)
Query: 323 EVLGKGKVGSTYKATLESGAV--------VAVKRVKNMNALSKKEFVQQMQLLGKLKHEN 374
E LG+G +K V +K + + + F + ++ KL H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 375 LAKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
+V Y +E +++ EF+ GSL L +++ I + W +L + KQ A +
Sbjct: 74 ---LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILW--KLEVAKQLAAAM 126
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYR-----AKLTNFGFLPLLPSRKASENLAI 486
F L + + H N+ + NIL+ RE D KL++ G S I
Sbjct: 127 HF----LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-----SITVLPK-DI 176
Query: 487 GR------SPE-FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDLSD 536
+ PE K L D + FG L E+ + G P + D
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQRKLQFYED 233
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
++ + L L C D P+ RP ++R + +
Sbjct: 234 RHQL--------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 597 Q 597
Sbjct: 274 F 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 60/319 (18%)
Query: 294 EDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGA-----VVAVKR 348
E P + + L +T +VLG G G+ YK VA+K
Sbjct: 2 EAPNQAL-LRILKETEFKKI---------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 349 VK-NMNALSKKEFVQQMQLLGKLKHENLAK---IVSFYYSKEEKLIIYEFLPNGSLFDLL 404
++ + + KE + + ++ + + ++ + I +I + +P G L D +
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICL----TSTVQLITQLMPFGCLLDYV 107
Query: 405 HESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464
E + I L+ Q AKG+ + L ++ H +L + N+L+
Sbjct: 108 REHK--DNIGS--QYLLNWCVQIAKGMNY----LEDRRLVHRDLAARNVLV---KTPQHV 156
Query: 465 KLTNFGFLPLLPSRKASENLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-G 517
K+T+FG LL + + + G+ + E + TH++DV+ +G+ + E++T G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 518 RIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTD 577
P +G P +E S L R+ + D+ + M + C
Sbjct: 217 SKPYDGIP-ASEISSILEKGERLPQPPICTIDVYMI-----------MRK-------CWM 257
Query: 578 IAPEKRPKMSEVLRRIEEI 596
I + RPK E++ ++
Sbjct: 258 IDADSRPKFRELIIEFSKM 276
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 53/288 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ LG G+ G + VAVK +K ++S+ EF Q+ Q + KL H +V FY
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPK---LVKFY 69
Query: 383 --YSKEE-KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
SKE I+ E++ NG L + L L + L + +G+AF L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAF----LE 121
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS---------- 489
SH+ H +L + N L+ + K+++FG +R ++ +
Sbjct: 122 SHQFIHRDLAARNCLVD-RDLC--VKVSDFGM-----TRYVLDDQYVSSVGTKFPVKWSA 173
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548
PE + + K+DV+ FGI++ EV + G++P + N+E +S R+ + S
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASD 232
Query: 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
I + M C PEKRP ++L IE +
Sbjct: 233 TIYQI-----------MYS-------CWHELPEKRPTFQQLLSSIEPL 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQ----LLGKLKHENLAKI 378
LGKGK G+ Y A +S ++A+K V L K Q++ + L+H N+ ++
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+++ +I E+ P G+++ L + + + T + I + A L++ H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCH--- 126
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS------ENLAIGRSPEF 492
S +V H ++K N+L+ ++ K+ +FG+ PS + + + L PE
Sbjct: 127 -SKRVIHRDIKPENLLLGSAGEL---KIADFGWSVHAPSSRRTDLCGTLDYLP----PEM 178
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
EG+ K D++ G++ E + G+ P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 57/285 (20%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ LG G+ G VA+K +K ++S+ EF+++ +++ L HE L ++
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ II E++ NG L + L E R L + K + + + L S +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEY----LESKQ 140
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS----------PEF 492
H +L + N L+ + + K+++FG SR ++ PE
Sbjct: 141 FLHRDLAARNCLVN-DQGV--VKVSDFGL-----SRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 493 PEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
+ + K+D++ FG+++ E+ + G++P N+ET+ ++ +R+ + S +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY 251
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ M C ++RP +L I ++
Sbjct: 252 TI-----------MYS-------CWHEKADERPTFKILLSNILDV 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 59/308 (19%), Positives = 115/308 (37%), Gaps = 60/308 (19%)
Query: 323 EVLGKGKVGSTYKATLE-----SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
LG+G G + +G +VAVK +K + + + Q++ +L L HE++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 377 KI--VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
K ++ E++P GSL D L + L +Q +G+A+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY- 149
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR----KASENLAIGRSP 490
LH+ H +L + N+L+ + K+ +FG +P + E+ G SP
Sbjct: 150 ---LHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVRED---GDSP 200
Query: 491 EF---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVD 543
F PE + + +DV+ FG+ L E++T + + ++ ++
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP----------TKFLELIGI 250
Query: 544 NDWSTDILDVEILAAREGQNEMLRLT----------ELALECTDIAPEKRPKMSEVLRRI 593
+L + G+ RL L C + RP ++ +
Sbjct: 251 AQGQMTVLRL-TELLERGE----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 594 EEIQPMIE 601
+ + +
Sbjct: 306 KTVHEKYQ 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 46/209 (22%), Positives = 71/209 (33%), Gaps = 28/209 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKL-KHENLAKI 378
LG G G +K E G + AVKR + + ++ K+ +H
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC---C 119
Query: 379 VSFYYS--KEEKLIIY-EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V + + L + E SL W ++ T LA LH
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLH 174
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--P 493
S + H ++K +NI + KL +FG L L + + G P + P
Sbjct: 175 ----SQGLVHLDVKPANIFLGPRGRC---KLGDFGLLVEL-GTAGAGEVQEG-DPRYMAP 225
Query: 494 E--GKRLTHKADVYCFGIILLEVITGRIP 520
E ADV+ G+ +LEV
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 66/280 (23%)
Query: 274 QAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGST 333
AG + L + + + + +DPE+ +G G G+
Sbjct: 30 PAGGRAGSLKDPDVAELFFKDDPEKLFSDL-------------------REIGHGSFGAV 70
Query: 334 YKAT-LESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKIVSFY--YSKEE 387
Y A + + VVA+K++ S ++ +++++ L KL+H N + + Y +E
Sbjct: 71 YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN---TIQYRGCYLREH 127
Query: 388 KL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHA 446
++ E+ GS DLL + PL ++ +GLA+LH SH + H
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH----SHNMIHR 178
Query: 447 NLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE---FPEGKRLT 499
++K+ NIL+ + KL +FG ++ N +G +PE + +
Sbjct: 179 DVKAGNILLSEPGLV---KLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYD 231
Query: 500 HKADVYCFGIILLEVITGR--------------IPGNGSP 525
K DV+ GI +E+ + I N SP
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 9e-21
Identities = 58/359 (16%), Positives = 108/359 (30%), Gaps = 81/359 (22%)
Query: 281 HLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKG--KVGSTYKAT- 337
H+ S EL V+GKG + + A
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELL-------------------TVIGKGFEDLMTVNLARY 48
Query: 338 LESGAVVAVKRVKNMNALSKKEF---VQQMQLLGKLKHENLAKIVSFY--YSKEEKL-II 391
+G V V+R+ N+ A S + ++ + H N IV + + + +L ++
Sbjct: 49 KPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPN---IVPYRATFIADNELWVV 104
Query: 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSS 451
F+ GS DL+ + I++ K L + +H H ++K+S
Sbjct: 105 TSFMAYGSAKDLICTHFM-DGMNELAIA--YILQGVLKALDY----IHHMGYVHRSVKAS 157
Query: 452 NILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--------PE-----GKRL 498
+ILI + + L+ + S + + PE +
Sbjct: 158 HILISVDGKV---YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 214
Query: 499 THKADVYCFGIILLEVITGR--------------IPGNGSPGNNETSGDLSDWVRMVVDN 544
K+D+Y GI E+ G P +TS ++ + M
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274
Query: 545 DWSTDILDVEILAAREGQNEMLRLTELALE------------CTDIAPEKRPKMSEVLR 591
+ L + + + + C P+ RP S +L
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 44/219 (20%), Positives = 79/219 (36%), Gaps = 35/219 (15%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ +G G ++ E + A+K V + + + + ++ L KL+ + KI+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 92
Query: 381 FYYSKEEKLIIYEFL--PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + IY + N L L + I K + + T+
Sbjct: 93 LYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKS--YWKNMLEAV----HTI 143
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA--IG----RSPE- 491
H H + H++LK +N LI KL +FG + S +G PE
Sbjct: 144 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 492 ----------FPEGKRLTHKADVYCFGIILLEVITGRIP 520
+++ K+DV+ G IL + G+ P
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 56/300 (18%), Positives = 111/300 (37%), Gaps = 52/300 (17%)
Query: 323 EVLGKGKVGSTYKATLE-----SGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
LG+G G + +G VAVK +K + +++++L L HEN+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 377 KI--VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
K + +I EFLP+GSL + L +++ + +L Q KG+ +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY- 141
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR----KASENLAIGRSP 490
L S + H +L + N+L+ ++ K+ +FG + + ++ SP
Sbjct: 142 ---LGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDD---RDSP 192
Query: 491 EF---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVD 543
F PE + +DV+ FG+ L E++T + + G
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG----------- 241
Query: 544 NDWSTDILDVEILAAREGQNEMLR-------LTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++ + + + +L +C + P R ++ E +
Sbjct: 242 -PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 42/224 (18%), Positives = 78/224 (34%), Gaps = 45/224 (20%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ +G G ++ E + A+K V + + + + ++ L KL+ + KI+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 73
Query: 381 FYYSKEEKLIIYEFL--PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + IY + N L L + I K + + T+
Sbjct: 74 LYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKS--YWKNMLEAV----HTI 124
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---------- 488
H H + H++LK +N LI KL +FG + + +
Sbjct: 125 HQHGIVHSDLKPANFLIVDGM----LKLIDFGI-----ANQMQPDTTSVVKDSQVGTVNY 175
Query: 489 -SPE-----------FPEGKRLTHKADVYCFGIILLEVITGRIP 520
PE +++ K+DV+ G IL + G+ P
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 64/310 (20%), Positives = 121/310 (39%), Gaps = 49/310 (15%)
Query: 299 RVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRV-KNMNALSK 357
+E + D+ V + + +VLG G G+ + VAVKR+ + +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65
Query: 358 KEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRI 413
+E +QLL + +H N ++ ++ +++++ Y E +L + + E + +
Sbjct: 66 RE----VQLLRESDEHPN---VIRYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHL 116
Query: 414 PLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF--RENDIYRAKLTNFGF 471
L +++++QT GLA LHS + H +LK NILI + +A +++FG
Sbjct: 117 GLE---PITLLQQTTSGLAH----LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 472 LPLLPSRKASENLAIG-------RSPE---FPEGKRLTHKADVYCFGIILLEVITGRIPG 521
L + S + G +PE + T+ D++ G + VI+
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH- 228
Query: 522 NGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPE 581
P ++ S D L E + L + + P+
Sbjct: 229 ---PFGKSLQRQA-----NILLGACSLDCLHPEKHEDVIARE-------LIEKMIAMDPQ 273
Query: 582 KRPKMSEVLR 591
KRP VL+
Sbjct: 274 KRPSAKHVLK 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 44/219 (20%), Positives = 79/219 (36%), Gaps = 35/219 (15%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ +G G ++ E + A+K V + + + + ++ L KL+ + KI+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 120
Query: 381 FYYSKEEKLIIYEFL--PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
Y + IY + N L L + I K + + T+
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKS--YWKNMLEAV----HTI 171
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA--IGR----SPE- 491
H H + H++LK +N LI KL +FG + S +G PE
Sbjct: 172 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 492 ----------FPEGKRLTHKADVYCFGIILLEVITGRIP 520
+++ K+DV+ G IL + G+ P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 45/219 (20%), Positives = 89/219 (40%), Gaps = 32/219 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
++LG+G + ++ ++G + A+K N++ L + + ++L KL H+N+ K+ +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 381 FYYSKEEKLI--IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ I EF P GSL+ +L E +P + L +++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLR--- 129
Query: 439 HSHKVPHANLKSSNILIFRENDI-YRAKLTNFGFLPLLPSRKASEN-------------- 483
+ + H N+K NI+ D KLT+FG +R+ ++
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA-----ARELEDDEQFVSLYGTEEYLH 183
Query: 484 --LAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+ K+ D++ G+ TG +P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 58/238 (24%), Positives = 111/238 (46%), Gaps = 42/238 (17%)
Query: 294 EDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKA-TLESGAVVAVKRVKNM 352
E P+R+ ++ FD + R LGKGK G+ Y A ++ ++A+K V
Sbjct: 5 EMPKRKFTIDDFD----------IGR----PLGKGKFGNVYLAREKQNKFIMALK-VLFK 49
Query: 353 NALSKKEFVQQM----QLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESR 408
+ L K+ Q+ ++ L+H N+ ++ ++++ ++ ++ EF P G L+ L +
Sbjct: 50 SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---Q 106
Query: 409 GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468
GR + + +++ A L + H KV H ++K N+L+ + ++ K+ +
Sbjct: 107 KHGRFD-EQRSA-TFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGEL---KIAD 157
Query: 469 FGFLPLLPSRKAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
FG+ PS + + L PE EGK K D++C G++ E + G P
Sbjct: 158 FGWSVHAPSLRRRTMCGTLDYLP----PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 50/236 (21%), Positives = 85/236 (36%), Gaps = 51/236 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
VLG+G G KA A+K+++ + ++ LL L H+ +V +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY---VVRY 67
Query: 382 YYSKEEKL----------------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
Y + E+ I E+ NG+L+DL+H + W + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFR 123
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA 485
Q + L+++H S + H +LK NI I ++ K+ +FG + L
Sbjct: 124 QILEALSYIH----SQGIIHRDLKPMNIFIDESRNV---KIGDFGLAKNVHRSLDILKLD 176
Query: 486 IGR------------------SPEFPEGKRL-THKADVYCFGIILLEVITGRIPGN 522
+ E +G K D+Y GII E+I G
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 50/290 (17%)
Query: 323 EVLGKGKVGSTYKATLESGA-----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+VLG G G+ +K V +K ++ S + M +G L H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 377 K---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+ + ++ ++LP GSL D + + RG L L+ Q AKG+ +
Sbjct: 79 RLLGLCP----GSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYY 130
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
L H + H NL + N+L+ + ++ +FG LLP + +
Sbjct: 131 ----LEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
+ E + TH++DV+ +G+ + E++T G P G E L R+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQIC 242
Query: 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ D+ V M ++C I RP E+ +
Sbjct: 243 TIDVYMV-----------M-------VKCWMIDENIRPTFKELANEFTRM 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 53/255 (20%)
Query: 286 KMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVV 344
D ++ DP EL E++G G G YK +++G +
Sbjct: 12 DEIDLSALRDPAGIFELV-------------------ELVGNGTYGQVYKGRHVKTGQLA 52
Query: 345 AVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFY--------YSKEEKL-IIYEF 394
A+K + ++ ++E Q++ +L K H N I ++Y +++L ++ EF
Sbjct: 53 AIKVM-DVTGDEEEEIKQEINMLKKYSHHRN---IATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNIL 454
GS+ DL+ ++G + W I ++ +GL+ LH HKV H ++K N+L
Sbjct: 109 CGAGSVTDLIKNTKG-NTLKEEWIA--YICREILRGLSHLH----QHKVIHRDIKGQNVL 161
Query: 455 IFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE-----FPEGKRLTHKADVY 505
+ ++ KL +FG L N IG +PE K+D++
Sbjct: 162 LTENAEV---KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218
Query: 506 CFGIILLEVITGRIP 520
GI +E+ G P
Sbjct: 219 SLGITAIEMAEGAPP 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 2e-19
Identities = 51/291 (17%), Positives = 105/291 (36%), Gaps = 35/291 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
E LG G G + ++G VA+K+ + + +E +Q++ KL H N+
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 381 FYYSKEE------KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ L+ E+ G L L++ L +++ + L +L
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG--LKEGPIRTLLSDISSALRYL 137
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF---LP---LLPSRKASENLAIGR 488
H+ +++ H +LK NI++ K+ + G+ L L +
Sbjct: 138 HE----NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL--- 190
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG--------NNETSGDLSDWVRM 540
+PE E K+ T D + FG + E ITG P + +++ + + +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+S+ + L+ ++ R + L +R +
Sbjct: 251 TGAVKFSSVLPTPNHLSGIL-AGKLERWLQCMLMWH---QRQRGTDPQNPN 297
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 28/218 (12%), Positives = 66/218 (30%), Gaps = 24/218 (11%)
Query: 323 EVLGKGKVGSTYKAT------LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLA 376
+LG+G Y+AT ++ +K K N Q M+ L
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
K S + + +++ E G+L + ++ + + +S + + +
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI----E 186
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRA--------KLTNFGFLPLLPSRKASENL--AI 486
+H ++ H ++K N ++ L + G +
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 487 G----RSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+ E K ++ D + + ++ G
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 40/312 (12%), Positives = 73/312 (23%), Gaps = 70/312 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV---KNMNALSKKEFVQQMQLLGKLKHENLA-- 376
E L G + +E A+K + + + +L E+
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 377 -------------------KIVSFYYSKEEKLIIYEFL----PNGSLFDLLHE--SRGVG 411
+++ + L + L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 412 RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
R + Q + A L S + H + N+ I + + L +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRL---MLGDVSA 240
Query: 472 LPLLPSRKASENLAIG------RSPEF--PEGKRLTHKADVYCFGIILLEVITGRIP-GN 522
K EF TH + + G+ + V +P G
Sbjct: 241 -----LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 523 GSPGNNETSGDLSDWVRMVVDNDWSTDIL---DVEILAAREGQNEMLRLTELALECTDIA 579
+PG + S V + + V+ L R L
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR-----FLNFD---------- 340
Query: 580 PEKRPKMSEVLR 591
+R E +
Sbjct: 341 RRRRLLPLEAME 352
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 50/290 (17%)
Query: 323 EVLGKGKVGSTYKATLESGA-----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+VLG G G+ YK VA+K ++ + + KE + + ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 377 K---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+ I +I + +P G L D + E + + L+ Q AKG+ +
Sbjct: 81 RLLGICL----TSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNY 132
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
L ++ H +L + N+L+ K+T+FG LL + + + G+
Sbjct: 133 ----LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 489 -SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
+ E + TH++DV+ +G+ + E++T G P +G P +E S L R+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPIC 244
Query: 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ D+ + M ++C I + RPK E++ ++
Sbjct: 245 TIDVYMI-----------M-------VKCWMIDADSRPKFRELIIEFSKM 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 67/303 (22%)
Query: 323 EVLGKGKVGSTYKATLESGAV----VAVKRVKN---MNALSKKEFVQQMQLLGKLKHENL 375
E LG G G + ++ + VAVK +K + +F++++ + L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 376 AK---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ +V ++ E P GSL D L + + G L T Q A+G+
Sbjct: 84 IRLYGVVL----TPPMKMVTELAPLGSLLDRLRKHQ--GHFLL--GTLSRYAVQVAEGMG 135
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---- 488
+ L S + H +L + N+L+ D+ K+ +FG + LP + R
Sbjct: 136 Y----LESKRFIHRDLAARNLLLA-TRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 489 ---SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544
+PE + + +H +D + FG+ L E+ T G+ P G G+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------- 231
Query: 545 DWSTDILDVEILAAREGQNEML--------RLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+IL + + E L + + ++C PE RP + + E
Sbjct: 232 ---------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
Query: 597 QPM 599
QP
Sbjct: 283 QPT 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM----QLLGKLKHENLAKIV 379
LGKG Y+A + +G VA+K + + A+ K VQ++ ++ +LKH ++ ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+++ ++ E NG + L A + Q G+ + LH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH----FMHQIITGMLY----LH 129
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRK-----ASENLAIGRSPEF 492
SH + H +L SN+L+ R +I K+ +FG +P K + N SPE
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNI---KIADFGLATQLKMPHEKHYTLCGTPNYI---SPEI 183
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
++DV+ G + ++ GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 63/302 (20%), Positives = 115/302 (38%), Gaps = 61/302 (20%)
Query: 316 DLLRASAEVLGKGKVGSTYKATLESGAV---VAVKRVKN--MNALSKKEFVQQMQLLGKL 370
LL + LG G G+ K + V VAVK +KN + K E + + ++ +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 371 KHENLAK---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQT 427
+ + + I E +++ E G L L ++R V + + ++ Q
Sbjct: 76 DNPYIVRMIGICE----AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQV 126
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--KASENLA 485
+ G+ + L H +L + N+L+ AK+++FG S+ +A EN
Sbjct: 127 SMGMKY----LEESNFVHRDLAARNVLLV-TQHY--AKISDFGL-----SKALRADENYY 174
Query: 486 IGRS----------PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534
++ PE + + K+DV+ FG+++ E + G+ P G +E + L
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML 233
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
RM ++ D+ M C E RP + V R+
Sbjct: 234 EKGERMGCPAGCPREMYDL-----------M-------NLCWTYDVENRPGFAAVELRLR 275
Query: 595 EI 596
Sbjct: 276 NY 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 34/230 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-MQLLGKLKHENLAKIVS 380
++LG+G + ++ ++G + A+K N++ L + + ++L KL H+N+ K+ +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 381 FYYSKEEKLI--IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ I EF P GSL+ +L E +P + L +++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLR--- 129
Query: 439 HSHKVPHANLKSSNILIFRENDI-YRAKLTNFGFLPLLPSRKASEN-------------- 483
+ + H N+K NI+ D KLT+FG +R+ ++
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA-----ARELEDDEQFVSLYGTEEYLH 183
Query: 484 --LAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP--GNGSPGNNE 529
+ K+ D++ G+ TG +P P N+
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 42/246 (17%), Positives = 79/246 (32%), Gaps = 60/246 (24%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK------RVKNMNALSKKEFVQQMQLLGKLKHENL 375
VLG+ + +AT E+G V R + KE V +++LL +K++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 376 A-------------------KIVSFYYSKEEKLIIYEFL----PNGSLFDLLHE--SRGV 410
A K++ + + ++ F +L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 411 GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
L RL + Q + LA LH + + H L+ +I++ + + LT F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGV---FLTGFE 251
Query: 471 FLPLLPSRKASENLAIGRSPEF--PE--------------GKRLTHKADVYCFGIILLEV 514
+ + S F PE +T D + G+++ +
Sbjct: 252 H-----LVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 515 ITGRIP 520
+P
Sbjct: 307 WCADLP 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 62/245 (25%), Positives = 100/245 (40%), Gaps = 41/245 (16%)
Query: 297 ERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNA 354
E +L+ + F +DL +G+G GS K SG ++AVKR++ ++
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 355 LSKKEFVQQMQ-LLGKLKHENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGV 410
+K+ + + ++ IV FY +E I E + + S V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPY---IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 411 --GRIPLAWTTRLSII-KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467
IP L I T K L L + K+ H ++K SNIL+ R +I KL
Sbjct: 118 LDDVIPEEI---LGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNI---KLC 168
Query: 468 NFGFLPLLPSRKASENLA----IGR----SPE----FPEGKRLTHKADVYCFGIILLEVI 515
+FG S + +++A G +PE + ++DV+ GI L E+
Sbjct: 169 DFGI-----SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 516 TGRIP 520
TGR P
Sbjct: 224 TGRFP 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 65/306 (21%), Positives = 107/306 (34%), Gaps = 71/306 (23%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
LG G G Y+ + S VAVK + + + +F+ + ++ K H+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN- 135
Query: 376 AKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--LSIIKQTAKG 430
IV + I+ E + G L L E+R P + L + + A G
Sbjct: 136 --IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN------- 483
+ L + H ++ + N L+ AK+ +FG +R
Sbjct: 194 CQY----LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRAGYYRKGG 244
Query: 484 ---LAIGR--SPE-FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536
L + + PE F EG T K D + FG++L E+ + G +P N E
Sbjct: 245 CAMLPV-KWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV------ 295
Query: 537 WVRMVVDNDWSTDILDVEILAAREG------QNEMLRLTELALECTDIAPEKRPKMSEVL 590
+ V G +N + + +C PE RP + +L
Sbjct: 296 -LEFV-----------------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 591 RRIEEI 596
RIE
Sbjct: 338 ERIEYC 343
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 64/299 (21%), Positives = 114/299 (38%), Gaps = 56/299 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAV----VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
+LG+G G Y+ + VAVK K + +K++F+ + ++ L H +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH--- 74
Query: 378 IVSFY--YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
IV +E II E P G L L ++ + + T + Q K +A+
Sbjct: 75 IVKLIGIIEEEPTWIIMELYPYGELGHYLERNK--NSLKV--LTLVLYSLQICKAMAY-- 128
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS------ 489
L S H ++ NIL+ + KL +FG SR + S
Sbjct: 129 --LESINCVHRDIAVRNILVA-SPEC--VKLGDFGL-----SRYIEDEDYYKASVTRLPI 178
Query: 490 ----PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544
PE +R T +DV+ F + + E+++ G+ P N + G L R+ +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRLPKPD 237
Query: 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
+ + M R C D P RP+ +E++ + ++ M ++
Sbjct: 238 LCPPVLYTL-----------MTR-------CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 62/341 (18%), Positives = 118/341 (34%), Gaps = 78/341 (22%)
Query: 294 EDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGA----VVAVKRV 349
D + + E D IP + ++ S V+GKG G Y A A+K +
Sbjct: 1 RDLDSALLAEVKDVLIP---HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 350 K-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY----YSKEEKLIIYEFLPNGSLFDLL 404
+ F+++ L+ L H N +++ + ++ ++ +G L +
Sbjct: 58 SRITEMQQVEAFLREGLLMRGLNHPN---VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 405 HESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI--------- 455
+ +S Q A+G+ +L K H +L + N ++
Sbjct: 115 RSPQR----NPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVA 166
Query: 456 -F------RENDIYRAKLTNFGFLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYC 506
F + + Y + LP+ K A E+L R F T K+DV+
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPV----KWTALESLQTYR---F------TTKSDVWS 213
Query: 507 FGIILLEVIT-GRIPGNGSPG--NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQN 563
FG++L E++T G P + + L+ R+ + V
Sbjct: 214 FGVLLWELLTRGAPP---YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV---------- 260
Query: 564 EMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604
M + C + P RP ++ +E+I + +
Sbjct: 261 -MQQ-------CWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 66/316 (20%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLA 376
++LG+G+ GS + L + VAVK +K N + +EF+ + + H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN-- 97
Query: 377 KIVSFY--------YSKEEKLIIYEFLPNGSLFDLLHESR-GVGRIPLAWTTRLSIIKQT 427
++ + ++I F+ G L L SR G + T L +
Sbjct: 98 -VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILI----------F------RENDIYRAKLTNFGF 471
A G+ +L + H +L + N ++ F D YR
Sbjct: 157 ALGMEYLS----NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ--GRIAK 210
Query: 472 LPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG-- 526
+P+ K A E+LA + T K+DV+ FG+ + E+ T G P PG
Sbjct: 211 MPV----KWIAIESLADRV---Y------TSKSDVWAFGVTMWEIATRGMTP---YPGVQ 254
Query: 527 NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586
N+E L R+ D ++ ++ M C P RP
Sbjct: 255 NHEMYDYLLHGHRLKQPEDCLDELYEI-----------M-------YSCWRTDPLDRPTF 296
Query: 587 SEVLRRIEEIQPMIEE 602
S + ++E++ + +
Sbjct: 297 SVLRLQLEKLLESLPD 312
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 63/302 (20%), Positives = 109/302 (36%), Gaps = 71/302 (23%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
EV+G+G G Y TL AVK + + +F+ + ++ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN--- 87
Query: 378 IVSFY----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
++S S+ L++ ++ +G L + + + Q AKG+ +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKY 143
Query: 434 LHQTLHSHKVPHANLKSSNILI----------F------RENDIYRAKLTNFGFLPLLPS 477
L S K H +L + N ++ F + + Y LP+
Sbjct: 144 LA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV--- 196
Query: 478 RK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534
K A E+L + F T K+DV+ FG++L E++T G P + + L
Sbjct: 197 -KWMALESLQTQK---F------TTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYL 245
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
R++ + +V M L+C E RP SE++ RI
Sbjct: 246 LQGRRLLQPEYCPDPLYEV-----------M-------LKCWHPKAEMRPSFSELVSRIS 287
Query: 595 EI 596
I
Sbjct: 288 AI 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 61/320 (19%), Positives = 109/320 (34%), Gaps = 87/320 (27%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
VL +G Y+A + SG A+KR+ + + +Q++ + KL H N IV
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN---IVQ 90
Query: 381 FYYS----------KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
F + + + ++ L G L + L + G + T L I QT +
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD--TVLKIFYQTCRA 148
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF-----LPLLPSRKASENLA 485
+ +H+ + H +LK N+L+ + I KL +FG S A
Sbjct: 149 VQHMHR--QKPPIIHRDLKVENLLLSNQGTI---KLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 486 IG-----------RSPE---FPEGKRLTHKADVYCFGIILLEVITGRIPGNGS------- 524
+ R+PE + K D++ G IL + + P
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
Query: 525 -----PGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIA 579
P ++ +R ML+ +
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRA------------------------MLQ----------VN 289
Query: 580 PEKRPKMSEVLRRIEEIQPM 599
PE+R ++EV+ +++EI
Sbjct: 290 PEERLSIAEVVHQLQEIAAA 309
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 313 DLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNALSKKEFVQQMQ-LLGK 369
DL+ + LG+G G K + SG ++AVKR++ +N+ +K + + +
Sbjct: 8 DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62
Query: 370 LKHENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLL-HESRGVGRIPLAWTTRLSIIK 425
+ V+FY +E + I E + + SL IP + I
Sbjct: 63 VDCPF---TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAV 116
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA 485
K L LH V H ++K SN+LI + K+ +FG S +++A
Sbjct: 117 SIVKALEHLH---SKLSVIHRDVKPSNVLINALGQV---KMCDFGI-----SGYLVDDVA 165
Query: 486 ----IGR----SPE----FPEGKRLTHKADVYCFGIILLEVITGRIP 520
G +PE K + K+D++ GI ++E+ R P
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 55/268 (20%), Positives = 104/268 (38%), Gaps = 45/268 (16%)
Query: 262 KKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRAS 321
++ + + Q + D++ + ++ K V D D+
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH--- 162
Query: 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E LG G G ++ T +G A K V + K+ +++Q + L+H L +
Sbjct: 163 -EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFL 434
+ E ++IYEF+ G LF+ + + ++S ++Q KGL
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHN----------KMSEDEAVEYMRQVCKGLCH- 270
Query: 435 HQTLHSHKVPHANLKSSNILIF--RENDIYRAKLTNFGFLPLLPSRKASEN----LAIGR 488
+H + H +LK NI+ R N++ KL +FG + + G
Sbjct: 271 ---MHENNYVHLDLKPENIMFTTKRSNEL---KLIDFGL-----TAHLDPKQSVKVTTG- 318
Query: 489 SPEF--PE---GKRLTHKADVYCFGIIL 511
+ EF PE GK + + D++ G++
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 32/224 (14%)
Query: 312 FDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGK 369
+++DL +G G G +K ++G V+AVK+++ + N K + + ++ K
Sbjct: 22 AEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK 79
Query: 370 L-KHENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIK 425
IV + + + I E + + + L +
Sbjct: 80 SHDCPY---IVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTV 131
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA 485
K L +L H V H ++K SNIL+ I KL +FG L KA ++ +
Sbjct: 132 AIVKALYYLK---EKHGVIHRDVKPSNILLDERGQI---KLCDFGISGRLVDDKA-KDRS 184
Query: 486 IGR----SPE-----FPEGKRLTHKADVYCFGIILLEVITGRIP 520
G +PE P +ADV+ GI L+E+ TG+ P
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 59/266 (22%), Positives = 103/266 (38%), Gaps = 46/266 (17%)
Query: 262 KKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRAS 321
H G+ + +K D W P + VE+ K V+D D+L
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVP-QPVEV----KQGSVYDYYDIL--- 56
Query: 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E LG G G ++ +G V K + L K ++ ++ +L H L +
Sbjct: 57 -EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFL 434
+ K E ++I EFL G LFD RI A ++S ++Q +GL
Sbjct: 116 AFEDKYEMVLILEFLSGGELFD---------RI-AAEDYKMSEAEVINYMRQACEGLKH- 164
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN----LAIGRSP 490
+H H + H ++K NI+ + K+ +FG + K + + + +
Sbjct: 165 ---MHEHSIVHLDIKPENIMCETKKA-SSVKIIDFGL-----ATKLNPDEIVKVTTA-TA 214
Query: 491 EF--PE---GKRLTHKADVYCFGIIL 511
EF PE + + D++ G++
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 56/292 (19%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
+G+G+ G ++ S VA+K K + +++F+Q+ + + H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH--- 77
Query: 378 IVSFY--YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
IV ++ II E G L L + L + + Q + LA+L
Sbjct: 78 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLE 133
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS------ 489
S + H ++ + N+L+ + KL +FG SR ++ S
Sbjct: 134 ----SKRFVHRDIAARNVLV---SSNDCVKLGDFGL-----SRYMEDSTYYKASKGKLPI 181
Query: 490 ----PEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDN 544
PE +R T +DV+ FG+ + E++ G P G NN+ G + + R+ +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPP 240
Query: 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ + + M + C P +RP+ +E+ ++ I
Sbjct: 241 NCPPTLYSL-----------MTK-------CWAYDPSRRPRFTELKAQLSTI 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 65/310 (20%), Positives = 106/310 (34%), Gaps = 79/310 (25%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
LG G G Y+ + S VAVK + + + +F+ + ++ K H+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN- 94
Query: 376 AKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--LSIIKQTAKG 430
IV + I+ E + G L L E+R P + L + + A G
Sbjct: 95 --IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN------- 483
+ L + H ++ + N L+ AK+ +FG +R
Sbjct: 153 CQY----LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRASYYRKGG 203
Query: 484 ---LAIGR--SPE-FPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536
L + + PE F EG T K D + FG++L E+ + G +P N E
Sbjct: 204 CAMLPV-KWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV------ 254
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLT----------ELALECTDIAPEKRPKM 586
+ V G R+ + +C PE RP
Sbjct: 255 -LEFV-----------------TSGG----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292
Query: 587 SEVLRRIEEI 596
+ +L RIE
Sbjct: 293 AIILERIEYC 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 50/298 (16%), Positives = 105/298 (35%), Gaps = 57/298 (19%)
Query: 325 LGKGKVGSTYKATLESGAV---VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
LG G GS + VA+K +K +E +++ Q++ +L + IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY---IVR 74
Query: 381 FY--YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
E +++ E G L L R + + ++ Q + G+ +L
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLE--- 127
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF------ 492
H +L + N+L+ + + AK+++FG S+ + + +
Sbjct: 128 -EKNFVHRDLAARNVLL---VNRHYAKISDFGL-----SKALGADDSYYTARSAGKWPLK 178
Query: 493 ---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545
PE ++ + ++DV+ +G+ + E ++ G+ P E + RM +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPE 237
Query: 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
++ + M +C E RP V +R+ +
Sbjct: 238 CPPELYAL-----------M-------SDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 58/293 (19%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
+G+G+ G ++ S VA+K K + +++F+Q+ + + H ++ K
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 378 ---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+++ + II E G L L + L + + Q + LA+L
Sbjct: 456 LIGVIT----ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYL 507
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI----GRSP 490
S + H ++ + N+L+ ND KL +FG SR ++ G+ P
Sbjct: 508 E----SKRFVHRDIAARNVLVS-SNDC--VKLGDFGL-----SRYMEDSTYYKASKGKLP 555
Query: 491 EF---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVD 543
PE +R T +DV+ FG+ + E++ G P G NN+ G + + R+ +
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMP 614
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ L L +C P +RP+ +E+ ++ I
Sbjct: 615 PNCPPT------------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 6e-17
Identities = 66/426 (15%), Positives = 139/426 (32%), Gaps = 88/426 (20%)
Query: 191 FEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSALVP 250
+ + L++ CP S + P+ P P +I ++ P
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLN----SDGYTP 294
Query: 251 FLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIP 310
+ + + E D E ++++ L+
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPF------------SDPE--ELKDKKLFLK------- 333
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKATLESGAV---VAVKRVK-NMNALSKKEFVQQMQL 366
D L + LG G GS + VA+K +K +E +++ Q+
Sbjct: 334 ----RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 389
Query: 367 LGKLKHENLAK---IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI 423
+ +L + + + + E +++ E G L L R + + +
Sbjct: 390 MHQLDNPYIVRLIGVCQ----AEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAEL 441
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN 483
+ Q + G+ + L H NL + N+L+ + AK+++FG S+ +
Sbjct: 442 LHQVSMGMKY----LEEKNFVHRNLAARNVLLVNRH---YAKISDFGL-----SKALGAD 489
Query: 484 ------LAIGRSPEF---PEG---KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNET 530
+ G+ P PE ++ + ++DV+ +G+ + E ++ G+ P E
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEV 548
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
+ RM + ++ + M +C E RP V
Sbjct: 549 MAFIEQGKRMECPPECPPELYAL-----------M-------SDCWIYKWEDRPDFLTVE 590
Query: 591 RRIEEI 596
+R+
Sbjct: 591 QRMRAC 596
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 82/314 (26%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLA 376
LG+G G + A + +VAVK +K+ ++K+F ++ +LL L+HE+
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH-- 78
Query: 377 KIVSFY--YSKEE-KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-----------LS 422
IV FY + ++++E++ +G L L I + R L
Sbjct: 79 -IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-----------DIYRAKLTNFGF 471
I Q A G+ + L S H +L + N L+ D+Y G
Sbjct: 138 IASQIASGMVY----LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 472 LPLLPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNE 529
+LP R E++ + F T ++DV+ FG+IL E+ T G+ P N E
Sbjct: 194 HTMLPIRWMPPESIMYRK---F------TTESDVWSFGVILWEIFTYGKQPWFQLS-NTE 243
Query: 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-------LTELALECTDIAPEK 582
+ + +G + R + ++ L C P++
Sbjct: 244 V-------IECI-----------------TQG-RVLERPRVCPKEVYDVMLGCWQREPQQ 278
Query: 583 RPKMSEVLRRIEEI 596
R + E+ + + +
Sbjct: 279 RLNIKEIYKILHAL 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 41/240 (17%), Positives = 75/240 (31%), Gaps = 49/240 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK------RVKNMNALSKKEFVQQMQLLGKLKHENL 375
VLG+ + +AT E+G V R + KE V +++LL +K++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 376 A-------------------KIVSFYYSKEEKLIIYEFL----PNGSLFDLLHESRGVGR 412
A K++ + + ++ F +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 413 I--PLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
L RL + Q + LA LH + + H L+ +I++ + LT F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRG---GVFLTGFE 256
Query: 471 FLPLLPSRKASENLAIGRSPEF----------PEGKRLTHKADVYCFGIILLEVITGRIP 520
L + S PE +T D + G+ + + +P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 70/308 (22%), Positives = 118/308 (38%), Gaps = 74/308 (24%)
Query: 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLA 376
+LGKG+ GS +A L S VAVK +K + + +EF+++ + + H ++A
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 377 KI--VSF----YYSKEEKLIIYEFLPNGSLFDLLHESRGVGR-IPLAWTTRLSIIKQTAK 429
K+ VS ++I F+ +G L L SR L T + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILI----------F------RENDIYRAKLTNFGFLP 473
G+ +L S H +L + N ++ F D YR LP
Sbjct: 149 GMEYLS----SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ--GCASKLP 202
Query: 474 LLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NN 528
+ K A E+LA + T +DV+ FG+ + E++T G+ P G N
Sbjct: 203 V----KWLALESLADNL---Y------TVHSDVWAFGVTMWEIMTRGQTP---YAGIENA 246
Query: 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSE 588
E L R+ + ++ D+ M + C P++RP +
Sbjct: 247 EIYNYLIGGNRLKQPPECMEEVYDL-----------MYQ-------CWSADPKQRPSFTC 288
Query: 589 VLRRIEEI 596
+ +E I
Sbjct: 289 LRMELENI 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/333 (16%), Positives = 121/333 (36%), Gaps = 66/333 (19%)
Query: 285 KKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGA-- 342
+ + + E+P R F + I + +++G G G L
Sbjct: 24 QFYAEPHTYEEPGRAGRS--FTREIEASRI-----HIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 343 --VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY--YSKEE-KLIIYEFLP 396
VA+K +K +++F+ + ++G+ H N I+ ++ +I+ E++
Sbjct: 77 DVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN---IIRLEGVVTRGRLAMIVTEYME 133
Query: 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456
NGSL L G + +++ G+ + L H +L + N+L+
Sbjct: 134 NGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRY----LSDLGYVHRDLAARNVLV- 184
Query: 457 RENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE---F------PEG---KRLTHKADV 504
+ K+++FG SR ++ + PE + + +DV
Sbjct: 185 --DSNLVCKVSDFGL-----SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237
Query: 505 YCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQN 563
+ FG+++ EV+ G P N + + + R+ + +
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGCPHALHQL---------- 286
Query: 564 EMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
M L+C +RP+ S+++ ++ +
Sbjct: 287 -M-------LDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLKHENLAKI 378
+ LG G + + Y A VA+K + + K F +++ +L H+N I
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN---I 73
Query: 379 VSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
VS EE Y E++ +L + + PL+ T ++ Q G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAH 128
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE------NLAIGR- 488
++ H ++K NILI K+ +FG ++ SE N +G
Sbjct: 129 D----MRIVHRDIKPQNILIDSNK---TLKIFDFGI-----AKALSETSLTQTNHVLGTV 176
Query: 489 ---SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
SPE +G+ D+Y GI+L E++ G P NG
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 70/365 (19%), Positives = 134/365 (36%), Gaps = 89/365 (24%)
Query: 273 GQAGEGSAHLSEKKMP---DSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGK 329
G G GS+ + +E+P+ D + D+ LG+G
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFS-----DACVHHIKRRDI--VLKWELGEGA 53
Query: 330 VGSTYKATLESGA------VVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY- 382
G + A + +VAVK +K + ++++F ++ +LL L+H++ IV F+
Sbjct: 54 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH---IVRFFG 110
Query: 383 -YSKEE-KLIIYEFLPNGSLFDLLHESR----------GVGRIPLAWTTRLSIIKQTAKG 430
++ L+++E++ +G L L V PL L++ Q A G
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFREN-----------DIYRAKLTNFGFLPLLPSR- 478
+ + L H +L + N L+ + DIY G +LP R
Sbjct: 171 MVY----LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 479 KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537
E++ + F T ++DV+ FG++L E+ T G+ P N E
Sbjct: 227 MPPESILYRK---F------TTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEA------- 269
Query: 538 VRMVVDNDWSTDILDVEILAAREG------QNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ + +G + + + C P++R + +V
Sbjct: 270 IDCI-----------------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 592 RIEEI 596
R++ +
Sbjct: 313 RLQAL 317
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 65/317 (20%), Positives = 117/317 (36%), Gaps = 68/317 (21%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHEN 374
+ LG+G G +A + VAVK +K + + ++++L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 375 LAKIVSFY--YSKEEK--LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR---------- 420
+V+ +K ++I EF G+L L R
Sbjct: 93 ---VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 421 -LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479
+ Q AKG+ FL S K H +L + NIL+ ++ K+ +FG +R
Sbjct: 150 LICYSFQVAKGMEFLA----SRKCIHRDLAARNILL---SEKNVVKICDFGL-----ARD 197
Query: 480 ASENL-----AIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGN 527
++ R +PE + T ++DV+ FG++L E+ + G P G +
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMS 587
E L + RM + + ++ M L+C P +RP S
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQT-----------M-------LDCWHGEPSQRPTFS 299
Query: 588 EVLRRIEEIQPMIEEND 604
E++ + + + D
Sbjct: 300 ELVEHLGNLLQANAQQD 316
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRV-KNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
++LG G G+ G VAVKR+ + ++ E ++LL + H N+ +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESDDHPNVIRYYC 76
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFLHQT 437
+ I E L N +L DL+ ES+ V L S+++Q A G+A
Sbjct: 77 SETTDRFLYIALE-LCNLNLQDLV-ESKNVSDENLKLQKEYNPISLLRQIASGVAH---- 130
Query: 438 LHSHKVPHANLKSSNILI----------FRENDIYRAKLTNFG----FLPLLPSRKASEN 483
LHS K+ H +LK NIL+ + R +++FG S + + N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 484 LAIG----RSPE-------FPEGKRLTHKADVYCFGIILLEVITG 517
G R+PE +RLT D++ G + +++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 64/291 (21%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAV-----VAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+V+G G+ G YK L++ + VA+K +K + +F+ + ++G+ H N
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN-- 107
Query: 377 KIVSFY--YSKEE-KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
I+ SK + +II E++ NG+L L E G + + +++ A G+ +
Sbjct: 108 -IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKY 162
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
L + H +L + NIL+ N K+++FG +L + G
Sbjct: 163 LA----NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 489 --SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545
+PE ++ T +DV+ FGI++ EV+T G P N+E ++D R+ D
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPMD 274
Query: 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ + +L ++C +RPK ++++ ++++
Sbjct: 275 CPSA------------------IYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 56/267 (20%), Positives = 109/267 (40%), Gaps = 38/267 (14%)
Query: 262 KKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLR-A 320
+ H + K A + K + +++ P + T ++ +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 321 SAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E+LG G+ G +K +G +A K +K K+E ++ ++ +L H NL ++
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAF 433
+ SK + +++ E++ G LFD RI + + L+ +KQ +G+
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFD---------RI-IDESYNLTELDTILFMKQICEGIRH 202
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN----LAIGRS 489
+H + H +LK NIL D + K+ +FG +R+ + G +
Sbjct: 203 ----MHQMYILHLDLKPENIL-CVNRDAKQIKIIDFGL-----ARRYKPREKLKVNFG-T 251
Query: 490 PEF--PE---GKRLTHKADVYCFGIIL 511
PEF PE ++ D++ G+I
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 42/213 (19%), Positives = 84/213 (39%), Gaps = 34/213 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM----QLLGKLKHENLAK 377
LGKG ++ + ++ V A K + + L K ++M + L H++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH--- 76
Query: 378 IVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+V F+ E+ ++ E SL +L + R ++Q G +
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEP-EAR-YYLRQIVLGCQY- 130
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRK-----ASENLAIG 487
LH ++V H +LK N+ + + ++ K+ +FG + + N
Sbjct: 131 ---LHRNRVIHRDLKLGNLFLNEDLEV---KIGDFGLATKVEYDGERKKVLCGTPNYI-- 182
Query: 488 RSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE K + + DV+ G I+ ++ G+ P
Sbjct: 183 -APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 39/221 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM----QLLGKLKHENLAK 377
++G+G +G Y+A +VA+K + + S F +M + G+L+ +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH--- 95
Query: 378 IVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+V + E +Y + L +L G + ++I++Q L
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRA--VAIVRQIGSALDAA 150
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE------NLAIG- 487
H H ++K NIL+ ++ A L +FG + ++ +G
Sbjct: 151 HA----AGATHRDVKPENILVSADD---FAYLVDFGI-----ASATTDEKLTQLGNTVGT 198
Query: 488 ---RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSP 525
+PE T++AD+Y +L E +TG P G
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 75/362 (20%), Positives = 127/362 (35%), Gaps = 98/362 (27%)
Query: 276 GEGSAHLSEKKMP--DSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGST 333
G ++ ++P W E P R+ + LG G G
Sbjct: 1 GNNYVYIDPTQLPYDHKW--EFPRNRLSFG-------------------KTLGAGAFGKV 39
Query: 334 YKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHENLAKIVSFY--Y 383
+AT ++ VAVK +K + + ++ + ++++L L H N IV+
Sbjct: 40 VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN---IVNLLGAC 96
Query: 384 SKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-------------LSIIKQTAK 429
+ +I E+ G L + L R LS Q AK
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--------KAS 481
G+AFL S H +L + NIL+ K+ +FG +R
Sbjct: 157 GMAFLA----SKNCIHRDLAARNILL---THGRITKICDFGL-----ARDIKNDSNYVVK 204
Query: 482 ENLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534
N R +PE T ++DV+ +GI L E+ + G P G P +++ +
Sbjct: 205 GN---ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
+ RM+ ++ D+ M C D P KRP ++++ IE
Sbjct: 262 KEGFRMLSPEHAPAEMYDI-----------M-------KTCWDADPLKRPTFKQIVQLIE 303
Query: 595 EI 596
+
Sbjct: 304 KQ 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 42/213 (19%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM----QLLGKLKHENLAK 377
LGKG ++ + ++ V A K + + L K ++M + L H++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQH--- 102
Query: 378 IVSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+V F+ E+ ++ E SL +L + + R ++Q G +
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTE-PEAR-YYLRQIVLGCQY- 156
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRK-----ASENLAIG 487
LH ++V H +LK N+ + + ++ K+ +FG + + N
Sbjct: 157 ---LHRNRVIHRDLKLGNLFLNEDLEV---KIGDFGLATKVEYDGERKKVLCGTPNYI-- 208
Query: 488 RSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+PE K + + DV+ G I+ ++ G+ P
Sbjct: 209 -APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 63/311 (20%), Positives = 120/311 (38%), Gaps = 80/311 (25%)
Query: 323 EVLGKGKVGSTYKATLESGAV---VAVKRVK-NMNALSKKEFVQQMQLLGKL-KHENLAK 377
+V+G+G G KA ++ + A+KR+K + ++F ++++L KL H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN--- 87
Query: 378 IVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-----------LSI 423
I++ + + E+ P+G+L D L +SR + P L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILI----------F---RENDIYRAKLTNFG 470
A+G+ + L + H +L + NIL+ F R ++Y G
Sbjct: 148 AADVARGMDY----LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMG 201
Query: 471 FLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG- 526
LP+ + A E+L + T +DV+ +G++L E+++ G P G
Sbjct: 202 RLPV----RWMAIESLNYSV---Y------TTNSDVWSYGVLLWEIVSLGGTP---YCGM 245
Query: 527 -NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK 585
E L R+ + ++ D+ M +C P +RP
Sbjct: 246 TCAELYEKLPQGYRLEKPLNCDDEVYDL-----------M-------RQCWREKPYERPS 287
Query: 586 MSEVLRRIEEI 596
+++L + +
Sbjct: 288 FAQILVSLNRM 298
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/287 (20%), Positives = 116/287 (40%), Gaps = 43/287 (14%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAK 377
+V+G G+ G L+ + VA+K +K +++F+ + ++G+ H N+ +
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + +I+ E++ NGSL L + + +++ A G+ +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKY---- 162
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-------SP 490
L H +L + NILI N K+++FG +L + G SP
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 491 EFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
E ++ T +DV+ +GI+L EV++ G P N + + + R+ D
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDCPAA 278
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
L +L L+C RPK +++ ++++
Sbjct: 279 ------------------LYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 72/379 (18%), Positives = 134/379 (35%), Gaps = 108/379 (28%)
Query: 262 KKVHEKEKSNEGQAGEGSAHLSEKKMP--DSWSMEDPERRVELEFFDKTIPVFDLDDLLR 319
K + K E G + ++P + W E P ++
Sbjct: 10 PKYQVRWKIIESYEGNSYTFIDPTQLPYNEKW--EFPRNNLQFG---------------- 51
Query: 320 ASAEVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-K 371
+ LG G G +AT ++ VAVK +K +A K+ + +++++ L +
Sbjct: 52 ---KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 372 HENLAKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESR---------GVGRIPLAWTT 419
HEN IV+ L+I E+ G L + L + +
Sbjct: 109 HEN---IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 420 RLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478
L Q A+G+AFL S H ++ + N+L+ + + AK+ +FG +R
Sbjct: 166 LLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLL---TNGHVAKIGDFGL-----ARD 213
Query: 479 -------KASENLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGS 524
N R +PE T ++DV+ +GI+L E+ + G P G
Sbjct: 214 IMNDSNYIVKGN---ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 525 PGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-------LTELALECTD 577
N++ ++V ++G +M + + + C
Sbjct: 271 LVNSKF-------YKLV-----------------KDG-YQMAQPAFAPKNIYSIMQACWA 305
Query: 578 IAPEKRPKMSEVLRRIEEI 596
+ P RP ++ ++E
Sbjct: 306 LEPTHRPTFQQICSFLQEQ 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 66/325 (20%), Positives = 115/325 (35%), Gaps = 92/325 (28%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
LG+G G Y+ E VA+K V + + EF+ + ++ + +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH- 89
Query: 376 AKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESR-----GVGRIPLAWTTRLSIIKQT 427
+V + L+I E + G L L R P + + + + +
Sbjct: 90 --VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILI----------F------RENDIYRAKLTNFGF 471
A G+A+L+ ++K H +L + N ++ F E D YR G
Sbjct: 148 ADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--GKGL 201
Query: 472 LPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG-N 527
LP+ + + E+L G F T +DV+ FG++L E+ T P G +
Sbjct: 202 LPV----RWMSPESLKDGV---F------TTYSDVWSFGVVLWEIATLAEQP---YQGLS 245
Query: 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-------LTELALECTDIAP 580
NE ++L + + L EL C P
Sbjct: 246 NE------------------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNP 281
Query: 581 EKRPKMSEVLRRIEE-IQPMIEEND 604
+ RP E++ I+E ++P E
Sbjct: 282 KMRPSFLEIISSIKEEMEPGFREVS 306
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ-MQLLGKLKHENL 375
E LG G+ K +G A K + + +E +++ + +L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAK 429
+ Y ++ + ++I E + G LFD L + LS IKQ
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQK-----------ESLSEEEATSFIKQILD 126
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIF-RENDIYRAKLTNFGFLPLLPSRKASEN----L 484
G+ + LH+ K+ H +LK NI++ + I KL +FG + + +
Sbjct: 127 GVNY----LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL-----AHEIEDGVEFKN 177
Query: 485 AIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
G +PEF PE + L +AD++ G+I
Sbjct: 178 IFG-TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 24/208 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ LG G G + A+K + +++ S + ++++ +L L H N+ K+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
F+ K ++ E G LFD + R+ IIKQ G+ + LH
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFD-----EIIHRMKFNEVDAAVIIKQVLSGVTY----LH 153
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEF--PE 494
H + H +LK N+L+ + K+ +FG S + + + PE
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGL-----SAVFENQKKMKERLGTAYYIAPE 208
Query: 495 --GKRLTHKADVYCFGIILLEVITGRIP 520
K+ K DV+ G+IL ++ G P
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 71/302 (23%)
Query: 323 EVLGKGKVGSTYKATLESGA----VVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAK 377
EV+G+G G Y TL AVK + + + +F+ + ++ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN--- 151
Query: 378 IVSFY----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
++S S+ L++ ++ +G L + + + Q AKG+ F
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKF 207
Query: 434 LHQTLHSHKVPHANLKSSNILI----------------FRENDIYRAKLTNFGFLPLLPS 477
L S K H +L + N ++ + + LP+
Sbjct: 208 LA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV--- 260
Query: 478 RK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534
K A E+L + F T K+DV+ FG++L E++T G P + + L
Sbjct: 261 -KWMALESLQTQK---F------TTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYL 309
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
R++ + +V M L+C E RP SE++ RI
Sbjct: 310 LQGRRLLQPEYCPDPLYEV-----------M-------LKCWHPKAEMRPSFSELVSRIS 351
Query: 595 EI 596
I
Sbjct: 352 AI 353
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 64/322 (19%), Positives = 119/322 (36%), Gaps = 95/322 (29%)
Query: 323 EVLGKGKVGSTYKATLESGA------VVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
E LG+ + G YK L A VA+K +K ++EF + L +L+H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN- 73
Query: 376 AKIVSFY--YSKEE-KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-----------L 421
+V +K++ +I+ + +G L + L + R +
Sbjct: 74 --VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI-------------FR---ENDIYRAK 465
++ Q A G+ + L SH V H +L + N+L+ FR D Y+
Sbjct: 132 HLVAQIAAGMEY----LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 466 LTNFGFLPLLPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNG 523
+ LLP R A E + G+ F + +D++ +G++L EV + G P
Sbjct: 188 GNS-----LLPIRWMAPEAIMYGK---F------SIDSDIWSYGVVLWEVFSYGLQP--- 230
Query: 524 SPG-NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLR-------LTELALEC 575
G +N+ +++ + + + L +EC
Sbjct: 231 YCGYSNQ------------------------DVVEMIRNRQVLPCPDDCPAWVYALMIEC 266
Query: 576 TDIAPEKRPKMSEVLRRIEEIQ 597
+ P +RP+ ++ R+
Sbjct: 267 WNEFPSRRPRFKDIHSRLRAWG 288
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 38/218 (17%)
Query: 313 DLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVK--RVKNMNALSKKEFVQQMQLLGK 369
+ ++ +++ LG+GK + +G A K + + + E + ++ +L
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 370 LKH-ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------ 422
K + + Y + E ++I E+ G +F +S
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFS---------LCLPELAEMVSENDVIR 135
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE 482
+IKQ +G+ +LH + + H +LK NIL+ + K+ +FG SRK
Sbjct: 136 LIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM-----SRKIGH 186
Query: 483 N----LAIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
+G +PE+ PE +T D++ GII
Sbjct: 187 ACELREIMG-TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 26/197 (13%), Positives = 56/197 (28%), Gaps = 38/197 (19%)
Query: 40 TANLHSRWTGPPCIDNVSNWFGVSCSN-GHIVSLELEEIQLAGILPPGFLQNITFLNKLS 98
+ W +D GVS ++ G + L LE +G +P +T L L+
Sbjct: 53 GTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAI-GQLTELEVLA 111
Query: 99 LRNNLLSGS-----LPNLTNLVNLETVFLSQNHFSDGIP--FGYIDLPKLKKLELQENYL 151
L ++ + ++ ++ E + H+ D L K + +
Sbjct: 112 LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171
Query: 152 DGQIPPFNQ-------------------------TSLIDFNVSYNNLDGPIPQTRVVQSF 186
I ++ T L F + + ++
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICE----AW 227
Query: 187 PSSSFEHNSGLCGRPLE 203
+ + E+ L+
Sbjct: 228 ENENSEYAQQYKTEDLK 244
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 25/138 (18%), Positives = 45/138 (32%), Gaps = 11/138 (7%)
Query: 48 TGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS 107
+ + + I + + L LQ + L L N L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 108 LPNLTNLVNLETVFLSQNHFSDGIP---FGYIDLPKLKKLELQENYLDGQIPPF----NQ 160
LP + + L ++ L+ N + IP G +++ L N L IP +
Sbjct: 346 LPAFGSEIKLASLNLAYNQIT-EIPANFCG--FTEQVENLSFAHNKL-KYIPNIFDAKSV 401
Query: 161 TSLIDFNVSYNNLDGPIP 178
+ + + SYN +
Sbjct: 402 SVMSAIDFSYNEIGSVDG 419
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 23/156 (14%), Positives = 54/156 (34%), Gaps = 22/156 (14%)
Query: 36 SLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLN 95
++ T DN+ + + +E+ LP L+ + +
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKD----------LTDVEVYNCPNLTKLPTF-LKALPEMQ 276
Query: 96 KLSLRNNLLSG---------SLPNLTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKLE 145
+++ N +L + ++ +++ N+ + + KL LE
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 146 LQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQT 180
N L+G++P F ++ L N++YN +
Sbjct: 337 CLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 25/135 (18%), Positives = 46/135 (34%), Gaps = 21/135 (15%)
Query: 64 CSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG--------SLPNLTNLV 115
++ S+ L Q++ P + L+ ++L N+L+ N N
Sbjct: 430 FKGINVSSINLSNNQISKF-PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 116 NLETVFLSQNHFSDGIP--FGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDF----- 166
L ++ L N + + F LP L ++L N P N ++L F
Sbjct: 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 167 -NVSYNNLDGPIPQT 180
+ N P+
Sbjct: 547 RDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 14/107 (13%), Positives = 29/107 (27%), Gaps = 7/107 (6%)
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLS------GSLPNLTNLVNLETVFLSQNHFSDGI 131
+L + + +L + L N S + L N
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
Query: 132 PFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
P G P L +L++ N + + ++ ++ N
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 19/129 (14%), Positives = 39/129 (30%), Gaps = 20/129 (15%)
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--------LTNLVNLETVFLSQNHFSD 129
+L I ++++ ++ + N + +N+ ++ LS N S
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK 447
Query: 130 GIPFGYIDLPKLKKLELQENYLDGQIPP----------FNQTSLIDFNVSYNNLDGPIPQ 179
+ L + L N L IP N L ++ +N L +
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
Query: 180 TRVVQSFPS 188
+ P
Sbjct: 506 DFRATTLPY 514
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 12/148 (8%), Positives = 34/148 (22%), Gaps = 22/148 (14%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
++ + + ++ +N ++ + L L ++ + F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRIT-LKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPF 218
Query: 128 SDGIPFGYI-------------------DLPKLKKLELQENYLDGQIPP--FNQTSLIDF 166
+L L +E+ ++P +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 167 NVSYNNLDGPIPQTRVVQSFPSSSFEHN 194
NV+ N Q+ +
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 15/115 (13%), Positives = 35/115 (30%), Gaps = 14/115 (12%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL------LSGSLPN-LTNLVNLETV 120
++V ++L + P N + L +RN P +T +L +
Sbjct: 514 YLVGIDLSYNSFSKF--PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 121 FLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNL 173
+ N + P + L++++N + + Y+
Sbjct: 572 QIGSNDIR-KVNEK--ITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 47/229 (20%)
Query: 324 VLGKGKVGSTYKATLESGAVVAVKRVK-------------NMNALSKKEFVQQM----QL 366
L +GK + A+K+ + N + +S K Q+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 367 LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS---- 422
+ +K+E + +E IIYE++ N S+ + +T +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF---FVLDKNYTCFIPIQVI 153
Query: 423 --IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480
IIK +++H + + H ++K SNIL+ + + KL++FG S
Sbjct: 154 KCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRV---KLSDFGE-----SEYM 202
Query: 481 SENLAIGR-------SPEFPEGKRLTH--KADVYCFGIILLEVITGRIP 520
+ G PEF + + K D++ GI L + +P
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 79/378 (20%), Positives = 136/378 (35%), Gaps = 107/378 (28%)
Query: 264 VHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAE 323
V + + A +SE ++P+ E P ++ L +
Sbjct: 47 VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLG-------------------K 87
Query: 324 VLGKGKVGSTYKATL--------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHE 373
LG+G G A + VAVK +K + + V +M+++ + KH+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 374 NLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTR---------- 420
N I++ +++ L +I E+ G+L + L R G R
Sbjct: 148 N---IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 421 -LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI----------F------RENDIYR 463
+S Q A+G+ +L S K H +L + N+L+ F D Y+
Sbjct: 205 LVSCTYQLARGMEYLA----SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 464 AKLTNFGFLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIP 520
TN G LP+ K A E L + TH++DV+ FG+++ E+ T G P
Sbjct: 261 KT-TN-GRLPV----KWMAPEALFDRV---Y------THQSDVWSFGVLMWEIFTLGGSP 305
Query: 521 GNGSPG--NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDI 578
PG E L + RM + N L + +C
Sbjct: 306 ---YPGIPVEELFKLLKEGHRM------------------DKPANCTNELYMMMRDCWHA 344
Query: 579 APEKRPKMSEVLRRIEEI 596
P +RP +++ ++ I
Sbjct: 345 VPSQRPTFKQLVEDLDRI 362
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQ-MQLLGKLKHENLAKI 378
VLGKG G +G AVK + + + + KE + + +QLL +L H N+ K+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
F+ K ++ E G LFD + R + II+Q G+ + +
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFD-----EIISRKRFSEVDAARIIRQVLSGITY----M 142
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEF--P 493
H +K+ H +LK N+L+ ++ ++ +FG S + + + + P
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIAP 197
Query: 494 E--GKRLTHKADVYCFGIILLEVITGRIP 520
E K DV+ G+IL +++G P
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ-MQLLGKLKHENL 375
E LG G+ K +G A K + + +E +++ + +L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAK 429
+ Y ++ + ++I E + G LFD L + LS IKQ
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQK-----------ESLSEEEATSFIKQILD 126
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIF-RENDIYRAKLTNFGFLPLLPSRKASEN----L 484
G+ + LH+ K+ H +LK NI++ + I KL +FG + + +
Sbjct: 127 GVNY----LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL-----AHEIEDGVEFKN 177
Query: 485 AIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
G +PEF PE + L +AD++ G+I
Sbjct: 178 IFG-TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 38/205 (18%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E LG+G+ G ++ S K VK + + +++ +L +H N+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLH 435
+ S EE ++I+EF+ +F+ RI L+ + Q + L F
Sbjct: 70 FESMEELVMIFEFISGLDIFE---------RI-NTSAFELNEREIVSYVHQVCEALQF-- 117
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN----LAIGRSPE 491
LHSH + H +++ NI+ K+ FG +R+ L +PE
Sbjct: 118 --LHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQ-----ARQLKPGDNFRLLFT-APE 168
Query: 492 F--PE---GKRLTHKADVYCFGIIL 511
+ PE ++ D++ G ++
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 4/115 (3%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNH 126
+ L++ P + L L L L P +L +L+ + +S N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIP 178
F F Y L L+ L+ N++ +SL N++ N+
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 23/117 (19%), Positives = 49/117 (41%), Gaps = 5/117 (4%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNH 126
+ L+L ++ I G Q+++ L+ L L N + + L +L+ + + +
Sbjct: 53 ELQVLDLSRCEIQTI-EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDG-QIPPF--NQTSLIDFNVSYNNLDGPIPQT 180
+ F L LK+L + N + ++P + N T+L ++S N +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 21/118 (17%), Positives = 40/118 (33%), Gaps = 7/118 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
+ L+L + + FL + L L +++ L +L NL + +S
Sbjct: 374 SLKYLDLSFNGVITM-SSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQT 180
H + L L+ L++ N P +L ++S L+ P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 25/125 (20%), Positives = 41/125 (32%), Gaps = 5/125 (4%)
Query: 60 FGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNL 117
F V S +++ L++ G ++ L L + N + T L NL
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVA-FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 118 ETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDG 175
+ LSQ P + L L+ L + N SL + S N++
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
Query: 176 PIPQT 180
Q
Sbjct: 533 SKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 30/148 (20%), Positives = 50/148 (33%), Gaps = 9/148 (6%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSL-RNNLLSGSLPN-LTNLVNLETVFLSQNHFS 128
L E LA + + ++ L +L++ N + S LP +NL NLE + LS N
Sbjct: 104 KLVAVETNLASL-ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 129 DGIPFGYIDLPKLK----KLELQENYLDGQIP-PFNQTSLIDFNVSYNNLDGPIPQTRVV 183
L ++ L+L N ++ P F + L + N + +T +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT-CI 221
Query: 184 QSFPSSSFEHNSGLCGRPLEKLCPISPP 211
Q R L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 23/133 (17%), Positives = 35/133 (26%), Gaps = 18/133 (13%)
Query: 51 PCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN 110
PC++ V N C + + P + L+ L N L
Sbjct: 2 PCVEVVPNIT-YQCMELNFYKI-----------PDNLPFSTKNLD---LSFNPLRHLGSY 46
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFN 167
+ L+ + LS+ Y L L L L N + +SL
Sbjct: 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 168 VSYNNLDGPIPQT 180
NL
Sbjct: 107 AVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 21/124 (16%), Positives = 43/124 (34%), Gaps = 10/124 (8%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLS--GSLPN-LTNLVNLET 119
+ + L + L ++ FL+ L N LS G +L+
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD---LSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 120 VFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGP 176
+ LS N + ++ L +L+ L+ Q + L + +LI ++S+ +
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 177 IPQT 180
Sbjct: 437 FNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 19/120 (15%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 62 VSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVF 121
V + + L + G T L L L N + N L LE +
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDF-GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLD 402
Query: 122 LSQNHFSDGIPFGYI-DLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIP 178
++ F L L L++ + +SL ++ N+
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 21/120 (17%), Positives = 37/120 (30%), Gaps = 6/120 (5%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFL 122
N I L + +T ++ SL + + + + + + + L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLEL 311
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD--GPIPQT 180
F P L LK+L N + SL ++S N L G Q+
Sbjct: 312 VNCKFG-QFPTLK--LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 19/148 (12%), Positives = 36/148 (24%), Gaps = 12/148 (8%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG----------SLPNLTNLVNL 117
+ L L + + +Q + L L +L L NL
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 118 ETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPI 177
E +++ D I + L + L ++ +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 178 PQTRVVQSFPSSSFEHNSGLCGRPLEKL 205
++S +F N G L
Sbjct: 321 TLK--LKSLKRLTFTSNKGGNAFSEVDL 346
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 20/115 (17%), Positives = 35/115 (30%), Gaps = 9/115 (7%)
Query: 68 HIVSLELEEIQLAGILPPGF--LQNITFLN-KLSLRNNLLSGSLPNLTNLVNLETVFLSQ 124
++ L+L ++ I L + LN L L N ++ P + L + L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 125 NHFSDGIPFGYI-DLPKLKKLELQENYLDGQ-----IPPFNQTSLIDFNVSYNNL 173
N S + I L L+ L + L + + L
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 44/212 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ-MQLLGKLKHENL 375
E LG G+ K +G A K R K+ +E +++ + +L +++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAK 429
+ Y +K + ++I E + G LFD L E L+ +KQ
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEK-----------ESLTEEEATEFLKQILN 125
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIF-RENDIYRAKLTNFGFLPLLPSRKASEN----L 484
G+ + LHS ++ H +LK NI++ R R K+ +FG + K
Sbjct: 126 GVYY----LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL-----AHKIDFGNEFKN 176
Query: 485 AIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
G +PEF PE + L +AD++ G+I
Sbjct: 177 IFG-TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 65/320 (20%), Positives = 123/320 (38%), Gaps = 74/320 (23%)
Query: 323 EVLGKGKVGSTYKATL--------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KH 372
+ LG+G G A VAVK +K + + + +M+++ + KH
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 373 ENLAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--------- 420
+N I++ +++ L +I E+ G+L + L R G +
Sbjct: 135 KN---IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 421 --LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478
+S Q A+G+ +L S K H +L + N+L+ + K+ +FG +R
Sbjct: 192 DLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLV---TEDNVMKIADFGL-----AR 239
Query: 479 KASENL-----AIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG 526
GR +PE + TH++DV+ FG++L E+ T G P PG
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPG 296
Query: 527 --NNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP 584
E L + RM ++ + ++ + M +C P +RP
Sbjct: 297 VPVEELFKLLKEGHRMDKPSNCTNELYMM-----------M-------RDCWHAVPSQRP 338
Query: 585 KMSEVLRRIEEIQPMIEEND 604
+++ ++ I + +
Sbjct: 339 TFKQLVEDLDRIVALTSNQE 358
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 47/249 (18%), Positives = 89/249 (35%), Gaps = 56/249 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQMQLLGKLKHENLA 376
+G+G G A ++ A+ A+K +++ +N + +++L+ KL H N+A
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL--------------- 421
++ Y ++ ++ E G L D L+ A
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 422 --------------------SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461
+I++Q L + LH+ + H ++K N L F N
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHY----LHNQGICHRDIKPENFL-FSTNKS 206
Query: 462 YRAKLTNFGFLPLLPSRKASENLAIGR---SPEF--PE-----GKRLTHKADVYCFGIIL 511
+ KL +FG E + +P F PE + K D + G++L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 512 LEVITGRIP 520
++ G +P
Sbjct: 267 HLLLMGAVP 275
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 76/370 (20%), Positives = 133/370 (35%), Gaps = 107/370 (28%)
Query: 280 AHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATL- 338
A +SE ++P+ E P ++ L + LG+G G A
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLG-------------------KPLGEGAFGQVVMAEAV 57
Query: 339 -------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHENLAKIVSFY---YSKE 386
+ VAVK +K + + V +M+++ + KH+N I++
Sbjct: 58 GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN---IINLLGACTQDG 114
Query: 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-----------LSIIKQTAKGLAFLH 435
+I E+ G+L + L R G R +S Q A+G+ +L
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 174
Query: 436 QTLHSHKVPHANLKSSNILI----------F------RENDIYRAKLTNFGFLPLLPSRK 479
S K H +L + N+L+ F D Y+ TN G LP+ K
Sbjct: 175 ----SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-TN-GRLPV----K 224
Query: 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSGDL 534
A E L + TH++DV+ FG+++ E+ T G P PG E L
Sbjct: 225 WMAPEALFDRV---Y------THQSDVWSFGVLMWEIFTLGGSP---YPGIPVEELFKLL 272
Query: 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594
+ RM + + ++ + M +C P +RP +++ ++
Sbjct: 273 KEGHRMDKPANCTNELYMM-----------M-------RDCWHAVPSQRPTFKQLVEDLD 314
Query: 595 EIQPMIEEND 604
I + +
Sbjct: 315 RILTLTTNEE 324
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK-----NMNALSKKEFVQQMQLLGKLKHENLA 376
E+LG G + + A L VAVK ++ + + + F ++ Q L H
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR--FRREAQNAAALNHPA-- 73
Query: 377 KIVSFYYSKEEKL-------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429
IV+ Y + E + I+ E++ +L D++H G P+ + +I +
Sbjct: 74 -IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG----PMTPKRAIEVIADACQ 127
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS---ENLAI 486
L F HQ + + H ++K +NI+I N K+ +FG + S I
Sbjct: 128 ALNFSHQ----NGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 487 GR----SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
G SPE G + ++DVY G +L EV+TG P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 9e-14
Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 32/213 (15%)
Query: 323 EVLGKGKVGSTYKA--TLESGAVVAVKRVKN-MNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ G +G Y A +G V +K + + +A ++ + + Q L ++ H ++ +I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 380 SF--YYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+F + + + Y E++ SL ++P+A ++ + + L++L
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEA--IAYLLEILPALSYL 198
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSP 490
H S + + +LK NI++ E + KL + G SR S G ++P
Sbjct: 199 H----SIGLVYNDLKPENIMLTEE----QLKLIDLG----AVSRINSFGYLYGTPGFQAP 246
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523
E T D+Y G L + NG
Sbjct: 247 EIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/315 (19%), Positives = 106/315 (33%), Gaps = 74/315 (23%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHEN 374
+VLG G G AT VAVK +K ++ ++ + +++++ +L HEN
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 375 LAKIVSFY--YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTR----------- 420
IV+ + + +I+E+ G L + L R
Sbjct: 111 ---IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 421 -------LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473
L Q AKG+ F L H +L + N+L+ K+ +FG
Sbjct: 168 VLTFEDLLCFAYQVAKGMEF----LEFKSCVHRDLAARNVLV---THGKVVKICDFGL-- 218
Query: 474 LLPSRKASENLA-----IGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPG 521
+R + R +PE T K+DV+ +GI+L E+ + G P
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 522 NGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPE 581
G P + + + +M + +I + M C
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYII-----------M-------QSCWAFDSR 317
Query: 582 KRPKMSEVLRRIEEI 596
KRP + +
Sbjct: 318 KRPSFPNLTSFLGCQ 332
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ-MQLLGKLKHENL 375
E LG G+ K +G A K R+ + +E +++ + +L +++H N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAK 429
+ + +K + ++I E + G LFD L E + L+ +KQ
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAE-KE----------SLTEDEATQFLKQILD 119
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIF-RENDIYRAKLTNFGFLPLLPSRKASEN----L 484
G+ + LHS ++ H +LK NI++ + R KL +FG + K
Sbjct: 120 GVHY----LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI-----AHKIEAGNEFKN 170
Query: 485 AIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
G +PEF PE + L +AD++ G+I
Sbjct: 171 IFG-TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 33/205 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV-KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
LG G G + SG +K + K+ + + ++ ++++L L H N+ KI
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFL 434
+ I+ E G L + + ++ G+ LS ++KQ LA+
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGK-------ALSEGYVAELMKQMMNALAY- 139
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL----AIGRSP 490
HS V H +LK NIL + K+ +FG + + A G +
Sbjct: 140 ---FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL-----AELFKSDEHSTNAAG-TA 190
Query: 491 EF--PE--GKRLTHKADVYCFGIIL 511
+ PE + +T K D++ G+++
Sbjct: 191 LYMAPEVFKRDVTFKCDIWSAGVVM 215
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 78/364 (21%), Positives = 137/364 (37%), Gaps = 98/364 (26%)
Query: 276 GEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYK 335
G S + K+ + E P + + L + LG+G+ G K
Sbjct: 1 GPLSLSVDAFKILEDPKWEFPRKNLVLG-------------------KTLGEGEFGKVVK 41
Query: 336 ATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFY---YSK 385
AT VAVK +K N + ++ + + +L ++ H + ++ Y
Sbjct: 42 ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH---VIKLYGACSQD 98
Query: 386 EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR-------------------LSIIKQ 426
L+I E+ GSL L ESR VG L +S Q
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL-- 484
++G+ +L K+ H +L + NIL+ + + K+++FG SR E
Sbjct: 159 ISQGMQYLA----EMKLVHRDLAARNILV---AEGRKMKISDFGL-----SRDVYEEDSY 206
Query: 485 ---AIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPG--NNETSG 532
+ GR + E T ++DV+ FG++L E++T G P PG
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPPERLFN 263
Query: 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592
L RM ++ S ++ + M L+C P+KRP +++ +
Sbjct: 264 LLKTGHRMERPDNCSEEMYRL-----------M-------LQCWKQEPDKRPVFADISKD 305
Query: 593 IEEI 596
+E++
Sbjct: 306 LEKM 309
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 49/226 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK---------NMNALSKKEFVQQM----QLLG 368
LG G G + A+K +K + + + ++F +++ LL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 369 KLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------ 422
L H N+ K+ + K+ ++ EF G LF+ + R +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RH----------KFDECDAAN 150
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE 482
I+KQ G+ + LH H + H ++K NIL+ +N + K+ +FG S S+
Sbjct: 151 IMKQILSGICY----LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL-----SSFFSK 201
Query: 483 NL----AIGRSPEF--PE--GKRLTHKADVYCFGIILLEVITGRIP 520
+ +G + + PE K+ K DV+ G+I+ ++ G P
Sbjct: 202 DYKLRDRLG-TAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 36/204 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
EVLG G + +G + A+K +K A ++ +L K+KHEN+ +
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLH 435
Y S ++ + + G LFD + E RG + +I+Q + +
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILE-RG----------VYTEKDASLVIQQVLSAVKY-- 121
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL---AIGRSPEF 492
LH + + H +LK N+L + + +T+FG S+ + A G +P +
Sbjct: 122 --LHENGIVHRDLKPENLLYLTPEENSKIMITDFGL-----SKMEQNGIMSTACG-TPGY 173
Query: 493 --PE---GKRLTHKADVYCFGIIL 511
PE K + D + G+I
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 63/328 (19%), Positives = 115/328 (35%), Gaps = 101/328 (30%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
+G+G G ++A E +VAVK +K +A + +F ++ L+ + + N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN- 111
Query: 376 AKIVSFY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR------------ 420
IV + +++E++ G L + L L+ +
Sbjct: 112 --IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 421 -------LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI----------F------R 457
L I +Q A G+A+ L K H +L + N L+ F
Sbjct: 170 PLSCAEQLCIARQVAAGMAY----LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 458 ENDIYRAKLTNFGFLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVI 515
D Y+A N +P+ + E++ R + T ++DV+ +G++L E+
Sbjct: 226 SADYYKAD-GN-DAIPI----RWMPPESIFYNR---Y------TTESDVWAYGVVLWEIF 270
Query: 516 T-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREG------QNEMLRL 568
+ G P G + E + V R+G +N L L
Sbjct: 271 SYGLQPYYGMA-HEEV-------IYYV-----------------RDGNILACPENCPLEL 305
Query: 569 TELALECTDIAPEKRPKMSEVLRRIEEI 596
L C P RP + R ++ +
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 38/215 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+LGKG G K + AVK + + +++++LL KL H N+ K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAF 433
I+ E G LFD + + R R S IIKQ G+ +
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIK-RK----------RFSEHDAARIIKQVFSGITY 136
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL----AIGRS 489
+H H + H +LK NIL+ + K+ +FG S +N IG +
Sbjct: 137 MH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGL-----STCFQQNTKMKDRIG-T 186
Query: 490 PEF--PE--GKRLTHKADVYCFGIILLEVITGRIP 520
+ PE K DV+ G+IL +++G P
Sbjct: 187 AYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 41/265 (15%), Positives = 87/265 (32%), Gaps = 49/265 (18%)
Query: 346 VKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY---EFLPNGSLFD 402
+ S + ++ + V K+ +Y + +L D
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 403 LLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462
++ + L I Q A+ + FLH S + H +LK SNI ++ +
Sbjct: 151 WMNRRCSLEDRE--HGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVV- 203
Query: 463 RAKLTNFG------------FLPLLPSRKASENLAIG----RSPEFPEGKRLTHKADVYC 506
K+ +FG + A+ +G SPE G +HK D++
Sbjct: 204 --KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 507 FGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEML 566
G+IL E++ E ++D + ++ +
Sbjct: 262 LGLILFELLYSFSTQ------MERVRIITDVRNLKFPLLFT---------------QKYP 300
Query: 567 RLTELALECTDIAPEKRPKMSEVLR 591
+ + + +P +RP+ ++++
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 43/220 (19%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEF----VQQMQLLGKLKHENLAK 377
+ G+G G+ +G VA+K+V + F +Q MQ L L H N+ +
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 378 IVSFYYSKEEK-------LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL--SIIKQTA 428
+ S++Y+ E+ ++ E++P+ L R R +A L + Q
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPD----TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG- 487
+ + LH S V H ++K N+L+ + KL +FG S K
Sbjct: 140 RSIGCLHL--PSVNVCHRDIKPHNVLVNEAD--GTLKLCDFG------SAKKLSPSEPNV 189
Query: 488 --------RSPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
R+PE G + T D++ G I E++ G
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM-----QLLGKLKHENLA 376
+G+G G +K ++G +VA+K+ ++++ ++L +LKH NL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIALREIRMLKQLKHPNLV 65
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
++ + K +++E+ + +LHE R + SI QT + + F H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCH- 119
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
H H ++K NILI + + I KL +FGF
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVI---KLCDFGF 148
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 307 KTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQ 365
K V D L + +VLG G G + +G A+K + + + +++E V
Sbjct: 22 KKYAVTDDYQLSK---QVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQE-VDHHW 76
Query: 366 LLGKLKHENLAKIVSFY----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR- 420
++ I+ Y + K LII E + G LF R R A+T R
Sbjct: 77 QA--SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS-----RIQERGDQAFTERE 129
Query: 421 -LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479
I++ + FLH SH + H ++K N+L + KLT+FGF +++
Sbjct: 130 AAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF-----AKE 180
Query: 480 ASENL---AIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
++N +P + PE ++ D++ G+I+
Sbjct: 181 TTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 42/200 (21%), Positives = 81/200 (40%), Gaps = 17/200 (8%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQMQLLGKLKHENLA 376
EV+GKG + E+G AVK + + LS ++ ++ + LKH ++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+++ Y S +++EF+ L + + R + ++Q + L +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRY--- 145
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF--PE 494
H + + H ++K +L+ + + KL FG L +G +P F PE
Sbjct: 146 -CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG-TPHFMAPE 203
Query: 495 ---GKRLTHKADVYCFGIIL 511
+ DV+ G+IL
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 38/206 (18%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+LGKG G K + AVK + + +++++LL KL H N+ K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAF 433
I+ E G LFD + + R R S IIKQ G+ +
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIK-RK----------RFSEHDAARIIKQVFSGITY 136
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL----AIGRS 489
+H H + H +LK NIL+ + K+ +FG S +N IG +
Sbjct: 137 ----MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL-----STCFQQNTKMKDRIG-T 186
Query: 490 PEF--PE--GKRLTHKADVYCFGIIL 511
+ PE K DV+ G+IL
Sbjct: 187 AYYIAPEVLRGTYDEKCDVWSAGVIL 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+V+G G G Y+A L +SG +VA+K+V K+ +++Q++ KL H N+ ++ F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 382 YYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL--SIIKQTAKGLAF 433
+YS EK ++ +++P + +R R + Q + LA+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
+H S + H ++K N+L+ + + KL +FG
Sbjct: 172 IH----SFGICHRDIKPQNLLLDPDTAV--LKLCDFG 202
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 29/112 (25%), Positives = 51/112 (45%), Gaps = 7/112 (6%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
++ L L Q+ I P L N+ L L + N ++ + L NL NL ++L++++
Sbjct: 67 NLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNI 122
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
SD P +L K+ L L N+ + P + T L V+ + + P
Sbjct: 123 SDISPLA--NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 8/112 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L++ + ++ L++IT KL + ++ S+ + L NLE + L+ N
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESIT---KLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQI 78
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
+D P +L KL L + N + I T+L + ++ +N+ P
Sbjct: 79 TDISPLS--NLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
++ L L E ++ I P L + L+L N L L+N+ L + ++++
Sbjct: 111 NLRELYLNEDNISDISPLANLTK---MYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
D P +L L L L N ++ I P TSL F N + P
Sbjct: 168 KDVTPIA--NLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 28/111 (25%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
Q+ I P + LN L + NN ++ L L NL L + + N SD
Sbjct: 203 YFTAYVNQITDITPVANMTR---LNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQISDI 258
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIPQT 180
DL KLK L + N + I N + L ++ N L +
Sbjct: 259 NAVK--DLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 8/107 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L + E ++ + P + N+T L LSL N + + L +L +L N
Sbjct: 156 GLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIE-DISPLASLTSLHYFTAYVNQI 211
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
+D P ++ +L L++ N + + P + L + N +
Sbjct: 212 TDITPVA--NMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 7/109 (6%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
SL L L P L N+T LN L++ + + + + NL +L ++ L+ N D
Sbjct: 136 SLNLGANHNLSDLSP--LSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDI 192
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
P L L N + I P T L + N + P
Sbjct: 193 SPLA--SLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 19/87 (21%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
++++T L L++ +N +S + L NL L ++FL+ N + L L L L
Sbjct: 261 VKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 148 ENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
+N++ I P + + + + +
Sbjct: 320 QNHITD-IRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 15/109 (13%), Positives = 36/109 (33%), Gaps = 8/109 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
+L + I P ++ + L+ ++ + L ++ + ++ +
Sbjct: 4 TLATLPAPINQIFP---DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASI 59
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
Y L L+ L L N + I P + L + + N +
Sbjct: 60 QGIEY--LTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 5/86 (5%)
Query: 94 LNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG 153
L+ ++ + +L L + +D + +L + KL + +
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA- 57
Query: 154 QIPPFNQ-TSLIDFNVSYNNLDGPIP 178
I T+L N++ N + P
Sbjct: 58 SIQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 38/159 (23%), Positives = 79/159 (49%), Gaps = 28/159 (17%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+V+G G G ++A L VA+K+V K+ +++Q++ +KH N+ + +F+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 383 YSKEEKL------IIYEFLPNGSLFDLL-HESRGVGRIPLAWTTRLSIIK----QTAKGL 431
YS +K ++ E++P +++ H ++ +P+ +IK Q + L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM------LLIKLYMYQLLRSL 154
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
A++H S + H ++K N+L+ + + KL +FG
Sbjct: 155 AYIH----SIGICHRDIKPQNLLLDPPSGV--LKLIDFG 187
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 24/111 (21%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ +L+ + + + I ++ + L +++ NN L+ + L NL L + ++ N
Sbjct: 47 QVTTLQADRLGIKSIDG---VEYLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNNNQI 102
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
+D P +L L L L N + P N T+L +S N +
Sbjct: 103 ADITPLA--NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 8/109 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
SL Q++ I P G L N L++LSL N L + L +L NL + L+ N S+
Sbjct: 203 SLIATNNQISDITPLGILTN---LDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNL 258
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
P L KL +L+L N + I P T+L + ++ N L+ P
Sbjct: 259 APLS--GLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 22/111 (19%), Positives = 39/111 (35%), Gaps = 6/111 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L + + + L +T L + S+ + L NL + S N
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVT---TLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 80
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
+D P +L KL + + N + P N T+L + N + P
Sbjct: 81 TDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L++ +++ I L +T L L NN +S + L L NL+ + L+ N D
Sbjct: 181 RLDISSNKVSDISV---LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKDI 236
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
L L L+L N + P T L + + N + P
Sbjct: 237 GTLA--SLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 6/127 (4%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
+LEL E QL I P + N+ L L+L N +S + +++L L+ +F N SD
Sbjct: 291 NLELNENQLEDISP---ISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSDV 346
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSS 190
+L + L N + P N T + ++ + S P++
Sbjct: 347 SSLA--NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 191 FEHNSGL 197
L
Sbjct: 405 KNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 6/111 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
++ L+L Q++ + P L +T L +L L N +S ++ L L L + L++N
Sbjct: 244 NLTDLDLANNQISNLAP---LSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQL 299
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
D P +L L L L N + P + T L N +
Sbjct: 300 EDISPIS--NLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSS 348
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+V + + Q+A I P L N+T L L NN ++ + L NL NL + LS N
Sbjct: 91 KLVDILMNNNQIADITPLANLTNLTGLT---LFNNQIT-DIDPLKNLTNLNRLELSSNTI 146
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIP 178
SD L L++L D + P N T+L ++S N +
Sbjct: 147 SDISALS--GLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 3/91 (3%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
+ K L ++ + T+L + T+ + Y L L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDGVEY--LNNLTQINFS 76
Query: 148 ENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
N L P N T L+D ++ N + P
Sbjct: 77 NNQLTDITPLKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 20/109 (18%), Positives = 41/109 (37%), Gaps = 10/109 (9%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L +++ + L N +N LS +N +S L L NL + + L+ +++
Sbjct: 335 RLFFYNNKVSDVSSLANLTN---INWLSAGHNQIS-DLTPLANLTRITQLGLNDQAWTN- 389
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGP 176
P Y + +N I P + S + ++++N
Sbjct: 390 APVNY--KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 4/86 (4%)
Query: 94 LNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG 153
L ++ + + T L L + + +D + DL ++ L+ +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS 60
Query: 154 QIPPFNQ-TSLIDFNVSYNNLDGPIP 178
I +L N S N L P
Sbjct: 61 -IDGVEYLNNLTQINFSNNQLTDITP 85
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 25/157 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM-----QLLGKLKHENLA 376
++G+G G K ++G +VA+K+ + + V+++ +LL +L+HENL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLV 87
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLH--ESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ K+ +++EF+ + +L E G L + + Q G+ F
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNG---LDYQVVQKYLFQIINGIGFC 140
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
H SH + H ++K NIL+ + + KL +FGF
Sbjct: 141 H----SHNIIHRDIKPENILVSQSGVV---KLCDFGF 170
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 42/207 (20%), Positives = 86/207 (41%), Gaps = 39/207 (18%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E LGKG + +G A K + K ++A ++ ++ ++ KL+H N+ ++
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAF 433
+ ++++ + G LF+ + R S I+Q + +A+
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVA-RE----------FYSEADASHCIQQILESIAY 120
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL----AIGRS 489
HS+ + H NLK N+L+ + KL +FG + + +++ G +
Sbjct: 121 ----CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEVNDSEAWHGFAG-T 170
Query: 490 PEF--PE---GKRLTHKADVYCFGIIL 511
P + PE + D++ G+IL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 34/204 (16%), Positives = 72/204 (35%), Gaps = 36/204 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G A + A K++ F Q+++++ L H N+ ++
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLH 435
+ + ++ E G LF+ + + I+K +A+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVH-KR----------VFRESDAARIMKDVLSAVAY-- 121
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL----AIGRSPE 491
H V H +LK N L ++ KL +FG + + +G +P
Sbjct: 122 --CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL-----AARFKPGKMMRTKVG-TPY 173
Query: 492 F--PE--GKRLTHKADVYCFGIIL 511
+ P+ + D + G+++
Sbjct: 174 YVSPQVLEGLYGPECDEWSAGVMM 197
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 24/161 (14%), Positives = 42/161 (26%), Gaps = 18/161 (11%)
Query: 50 PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP 109
+ + + I + L LQ + L L +N + L
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE 589
Query: 110 NLTNLVNLETVFLSQNHFSDGIPFGY-IDLPKLKKLELQENYLDGQIPPF----NQTSLI 164
V L + L N IP + +++ L N L IP + +
Sbjct: 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMG 647
Query: 165 DFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKL 205
+ SYN + S + G +
Sbjct: 648 SVDFSYNKI----------GSEGRNISCSMDDYKGINASTV 678
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 15/137 (10%), Positives = 36/137 (26%), Gaps = 10/137 (7%)
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLS------GSLPNLTNLVNLETVFLSQNHFSDGI 131
+L + + +L+ + + N S + L N
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 132 PFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL-DGPIPQTRVVQSFPSSS 190
P G P L +L++ N + + L +++ N +
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
Query: 191 FEHN--SGLCGRPLEKL 205
++ + G +
Sbjct: 858 LLYDKTQDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 22/163 (13%), Positives = 45/163 (27%), Gaps = 11/163 (6%)
Query: 29 DLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFL 88
L LN + L P + + +S + + ++ I +
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD---TQIGNLTNRITFI--SKAI 444
Query: 89 QNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQE 148
Q +T L + N+ + V+ E + + +L L +EL
Sbjct: 445 QRLTKLQIIYFANSPFTY----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 149 NYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSS 189
Q+P ++ L N++ N
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 22/152 (14%), Positives = 44/152 (28%), Gaps = 20/152 (13%)
Query: 53 IDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLT 112
I+ + F + L +L I +++ + + N + N++
Sbjct: 607 IEEIPEDFCAFTDQ--VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
Query: 113 ------NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--------- 157
+N TV LS N + + + L N + IP
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPKDGN 723
Query: 158 -FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPS 188
N L ++ +N L + + P
Sbjct: 724 YKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/162 (14%), Positives = 49/162 (30%), Gaps = 22/162 (13%)
Query: 26 ERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPP 85
+ L I ++L+ N + NW +E+ + G P
Sbjct: 270 DYKALKAIWEALDG-KNWRYYSGTINNTIHSLNW------------NFNKELDMWGDQPG 316
Query: 86 GFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144
L N + LSL G +P+ + L L+ + + + +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 145 ELQENYLDGQIPP--------FNQTSLIDFNVSYNNLDGPIP 178
E +++ + N + L+ ++ N PI
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 45/228 (19%), Positives = 89/228 (39%), Gaps = 50/228 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLK------ 371
LG G + + A + + VA+K V+ K + + ++LL ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 372 --HENLAKIV----SFYYSKEEKL---IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS 422
I+ F + + +++E L +L L+ + G IPL + +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVKQ-- 135
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF---RENDIYRAKLTNFG--------F 471
I KQ GL ++H+ + H ++K N+L+ ++ + K+ + G +
Sbjct: 136 ISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 472 LPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
+ +R RSPE G AD++ ++ E+ITG
Sbjct: 193 TNSIQTR-------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 27/215 (12%)
Query: 307 KTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-M 364
K P + DL + LG+G K +S AVK + + Q+ +
Sbjct: 2 KDSPFYQHYDL-DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEI 56
Query: 365 QLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--L 421
L + H N+ K+ ++ + ++ E L G LF+ + + + ++
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KK------HFSETEAS 109
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481
I+++ ++ +H V H +LK N+L END K+ +FGF L P
Sbjct: 110 YIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 482 ENLAIGRSPEF--PE---GKRLTHKADVYCFGIIL 511
+ + PE D++ G+IL
Sbjct: 166 LKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 31/153 (20%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
+VLG+G L + AVK ++ + +++++L + + H N+ +++
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--LSIIKQTAKGLAFLHQTL 438
F+ ++ +++E + GS+ +H+ R + +++ A L FLH
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHK-RR------HFNELEASVVVQDVASALDFLH--- 128
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
+ + H +LK NIL N + K+ +F
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 42/206 (20%), Positives = 85/206 (41%), Gaps = 37/206 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E LGKG + +G A K + K ++A ++ ++ ++ KL+H N+ ++
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAF 433
+ ++++ + G LF+ + R S I+Q + +A+
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVA-RE----------FYSEADASHCIQQILESIAY 143
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----- 488
HS+ + H NLK N+L+ + KL +FG + + +++ A
Sbjct: 144 ----CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEVNDSEAWHGFAGTP 194
Query: 489 ---SPEFPEGKRLTHKADVYCFGIIL 511
SPE + + D++ G+IL
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 34/205 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK--RVKNMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E LGKG + + +G A K ++A ++ ++ ++ LKH N+ ++
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS--------IIKQTAKGL 431
+ +I++ + G LF+ I R I+Q + +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFE---------DI----VAREYYSEADASHCIQQILEAV 123
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPE 491
H V H NLK N+L+ + KL +FG + + + G +P
Sbjct: 124 LH----CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG-TPG 178
Query: 492 F--PE---GKRLTHKADVYCFGIIL 511
+ PE D++ G+IL
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 25/129 (19%), Positives = 47/129 (36%), Gaps = 6/129 (4%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNH 126
+ SL++ ++ + P Q + L L+L++N LS NL + L N
Sbjct: 50 QLTSLDVGFNTISKL-EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQ 184
++ L L+L N L +L + +S N + + +
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE--LD 166
Query: 185 SFPSSSFEH 193
F +SS +
Sbjct: 167 IFANSSLKK 175
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 26/134 (19%), Positives = 51/134 (38%), Gaps = 7/134 (5%)
Query: 53 IDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-- 110
+ ++N VS ++ + L L + +++ I + L L L N + L
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKI-ESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 111 LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG--QIPPF--NQTSLIDF 166
L N+ ++LS N + + +P L++L L+ L P +L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 167 NVSYNNLDGPIPQT 180
++S NN+
Sbjct: 486 DLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 13/139 (9%)
Query: 55 NVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQ-NITFLNKLSLRNNLLSGSLPN-LT 112
+++ + +N I +L L QL+ FL T L L L N L+ +
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269
Query: 113 NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG--------QIPPF---NQT 161
L LE FL N+ L ++ L L+ ++ +I F
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 162 SLIDFNVSYNNLDGPIPQT 180
L N+ N++ G
Sbjct: 330 CLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 20/100 (20%), Positives = 40/100 (40%), Gaps = 4/100 (4%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKL 141
P FL+ ++ L+ L+L +N +L L+ + L N+ + + + L
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
Query: 142 KKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIP 178
K L LQ+N + +L + ++ +N D
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 18/129 (13%), Positives = 37/129 (28%), Gaps = 17/129 (13%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN----------LTNLVNL 117
+ LE + + L + + L+L+ + S+ L L
Sbjct: 273 QLEYFFLEYNNIQHL-FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 118 ETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFN------QTSLIDFNVSYN 171
E + + N + L LK L L ++ + + L N++ N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 172 NLDGPIPQT 180
+
Sbjct: 392 KISKIESDA 400
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 11/109 (10%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLS---------GSLPNLTNLVNLETVFLSQNHFSDGIPF 133
+ L+ + L L L++N L+ G + L L +L + L N F +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 134 GYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180
+ DL +LK ++L N L+ NQ SL N+ N + +
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 28/122 (22%), Positives = 41/122 (33%), Gaps = 17/122 (13%)
Query: 62 VSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETV 120
CS+ + + P NIT LN L +N L T L ++
Sbjct: 9 ADCSHLKLTQV-----------PDDLPTNITVLN---LTHNQLRRLPAANFTRYSQLTSL 54
Query: 121 FLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIP 178
+ N S P LP LK L LQ N L T+L + ++ N++
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 179 QT 180
Sbjct: 115 NP 116
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 23/121 (19%), Positives = 46/121 (38%), Gaps = 9/121 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQ 124
++++L+L L+ G + L +L L NN + + +L+ + LS
Sbjct: 122 NLITLDLSHNGLSST-KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-----FNQTSLIDFNVSYNNLDGPIPQ 179
N + P + + +L L L L + TS+ + ++S + L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 180 T 180
T
Sbjct: 241 T 241
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 39/262 (14%)
Query: 265 HEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEV 324
H S+ G + + + + V + D + L D
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGS-NRDALSDFFEVE-SE 60
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY 383
LG+G Y+ + A+K +K + KK ++ +L +L H N+ K+ +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLHQT 437
+ E ++ E + G LFD + E +G S +KQ + +A+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVE-KG----------YYSERDAADAVKQILEAVAY---- 163
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--------S 489
LH + + H +LK N+L K+ +FG S+ + + +
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGL-----SKIVEHQVLMKTVCGTPGYCA 218
Query: 490 PEFPEGKRLTHKADVYCFGIIL 511
PE G + D++ GII
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 25/158 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFV-----QQMQLLGKLKHENLA 376
E LG G + YK +G VA+K VK L +E +++ L+ +LKHEN+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLMKELKHENIV 66
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRL--SIIKQTAKGLA 432
++ +++ + +++EF+ N DL +SR VG P L Q +GLA
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
F H +K+ H +LK N+LI + + KL +FG
Sbjct: 123 FCH----ENKILHRDLKPQNLLINKRGQL---KLGDFG 153
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-------MQLLGKLKHEN 374
+V+GKG G KA + VA+K V+N +K F +Q ++ L K +N
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 375 LAKIV----SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
++ +F + + + +E L + +L++L+ +++ G L R +
Sbjct: 158 TMNVIHMLENFTF-RNHICMTFELL-SMNLYELIKKNKFQG-FSLP-LVR-KFAHSILQC 212
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG--------FLPLLPSRKASE 482
L LH +++ H +LK NIL ++ K+ +FG + SR
Sbjct: 213 LDALH----KNRIIHCDLKPENIL-LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFY-- 265
Query: 483 NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529
R+PE G R D++ G IL E++TG PG +E
Sbjct: 266 -----RAPEVILGARYGMPIDMWSLGCILAELLTGYPL---LPGEDE 304
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV-------KNMNALSKKEFVQQ-MQLLGKLKHE 373
+ LG G G A ++ VA++ + + V+ +++L KL H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 374 NLAKIVSFY--YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
I+ + E+ I+ E + G LFD + VG L T Q +
Sbjct: 201 C---IIKIKNFFDAEDYYIVLELMEGGELFD-----KVVGNKRLKEATCKLYFYQMLLAV 252
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
+LH + + H +LK N+L+ + + K+T+FG
Sbjct: 253 QYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 36/202 (17%), Positives = 71/202 (35%), Gaps = 32/202 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +G G + + AVK + + + E ++ + +H N+ +
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTEEIEILLRY--GQHPNIITLKDV 84
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAKGLAFLH 435
Y + ++ E + G L D + + S ++ K + +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILR-QK----------FFSEREASAVLFTITKTVEY-- 131
Query: 436 QTLHSHKVPHANLKSSNILIF-RENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEF-- 492
LH+ V H +LK SNIL + ++ +FGF L + + F
Sbjct: 132 --LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVA 188
Query: 493 PE---GKRLTHKADVYCFGIIL 511
PE + D++ G++L
Sbjct: 189 PEVLERQGYDAACDIWSLGVLL 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 26/133 (19%), Positives = 49/133 (36%), Gaps = 18/133 (13%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L+ + L + ++ L L + + N L +LE + ++ N F
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQTRVVQ 184
+ L L L+L + L+ Q+ P + +SL N++ N L +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL----------K 507
Query: 185 SFPSSSFEHNSGL 197
S P F+ + L
Sbjct: 508 SVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 26/138 (18%), Positives = 51/138 (36%), Gaps = 18/138 (13%)
Query: 51 PCIDNVSNWFGVSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLR 100
PC++ V N C + + + + L+ L + L L L
Sbjct: 2 PCVEVVPNIT-YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 101 NNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF 158
+ ++ + +L +L T+ L+ N + L L+KL E L + F
Sbjct: 61 RCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENF 118
Query: 159 ---NQTSLIDFNVSYNNL 173
+ +L + NV++N +
Sbjct: 119 PIGHLKTLKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 22/98 (22%), Positives = 33/98 (33%), Gaps = 8/98 (8%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LP 139
G ++ L L + N + T L NL + LSQ + + L
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 494
Query: 140 KLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLD 174
L+ L + N L +P TSL + N D
Sbjct: 495 SLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 11/151 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLL-SGSLPN-LTNLVNLETVFLSQN 125
+ L E LA L + ++ L +L++ +NL+ S LP +NL NLE + LS N
Sbjct: 101 SLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 126 HFSDGIPFGYIDLPKLK----KLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQ 179
L ++ L+L N ++ I P F + L + N + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 180 TRVVQSFPSSSFEHNSGLCGRPLEKLCPISP 210
T +Q R L
Sbjct: 219 T-CIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 6/112 (5%)
Query: 72 LELEEIQLAGI-LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L+L L+ T L L L N + N L LE + ++
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 131 IPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIP 178
F L L L++ + FN +SL ++ N+
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 5/84 (5%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L++ P + L L L L L +L +L+ + ++ N
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK- 507
Query: 130 GIPFGYID-LPKLKKLELQENYLD 152
+P G D L L+K+ L N D
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 22/135 (16%), Positives = 40/135 (29%), Gaps = 12/135 (8%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFL 122
N I L + +T ++ SL + + + + + + + L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL 311
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRV 182
F F + L LK+L N + SL ++S N L
Sbjct: 312 VNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS-------- 360
Query: 183 VQSFPSSSFEHNSGL 197
+ S S + L
Sbjct: 361 FKGCCSQSDFGTTSL 375
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 23/205 (11%)
Query: 274 QAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGST 333
Q + + P + P+ V+ K + D + +VLG G G
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTS---QVLGLGINGKV 78
Query: 334 YKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY----YSKEEK 388
+ + A+K +++ ++E V+ + ++ +IV Y ++
Sbjct: 79 LQIFNKRTQEKFALKMLQDCPKA-RRE-VELHWRA--SQCPHIVRIVDVYENLYAGRKCL 134
Query: 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--LSIIKQTAKGLAFLHQTLHSHKVPHA 446
LI+ E L G LF R R A+T R I+K + + +LH S + H
Sbjct: 135 LIVMECLDGGELFS-----RIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHR 185
Query: 447 NLKSSNILIFRENDIYRAKLTNFGF 471
++K N+L + KLT+FGF
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGF 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 20/158 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+VLG G G + + A+K +++ ++E V+ + ++ +IV
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RRE-VELHWRA--SQCPHIVRIVDV 79
Query: 382 Y----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR--LSIIKQTAKGLAFLH 435
Y ++ LI+ E L G LF R R A+T R I+K + + +LH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473
S + H ++K N+L + KLT+FGF
Sbjct: 135 ----SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 3/110 (2%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNH 126
+ +L++ N T L L L L L L+ + +S N+
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLD 174
Y L L L+ N ++ SL FN++ N++
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 18/121 (14%), Positives = 37/121 (30%), Gaps = 7/121 (5%)
Query: 65 SNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFL 122
+ L+L I+ + L L +++ L +L L + +
Sbjct: 374 GTNSLRHLDLSFNGA--IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQ 179
S + ++ L L L++ N N T+L ++S L+
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 180 T 180
Sbjct: 492 V 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 24/118 (20%), Positives = 42/118 (35%), Gaps = 7/118 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
++ L++ G +T LN L + N + + N NL + LS+
Sbjct: 425 KLLYLDISYTNTKID-FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 126 HFSDGIPFGYID-LPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180
I +G D L +L+ L + N L SL + S+N ++
Sbjct: 484 QLE-QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 21/145 (14%), Positives = 42/145 (28%), Gaps = 5/145 (3%)
Query: 36 SLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLN 95
L+ + + ++ + I L F + ++
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF-HCLANVS 288
Query: 96 KLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQI 155
+SL + L ++ +++ + + P DLP LK L L N
Sbjct: 289 AMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISF 344
Query: 156 PPFNQTSLIDFNVSYNNLDGPIPQT 180
SL ++S N L +
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCS 369
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 28/151 (18%), Positives = 43/151 (28%), Gaps = 28/151 (18%)
Query: 50 PPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP 109
PCI+ V N C + + + P + ++ L N L
Sbjct: 5 NPCIEVVPN-ITYQCMDQKLSKV-----------PDDIPSSTKNID---LSFNPLKILKS 49
Query: 110 N-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-FNQ-TSLIDF 166
+N L+ + LS+ + L L L L N + P F+ TSL +
Sbjct: 50 YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
Query: 167 NVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
L S S L
Sbjct: 110 VAVETKL----------ASLESFPIGQLITL 130
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 29/153 (18%), Positives = 51/153 (33%), Gaps = 16/153 (10%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
+L E +LA + + + L KL++ +N + +NL NL V LS N+
Sbjct: 108 NLVAVETKLASL-ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 129 DGIPFGYIDL-----PKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTR 181
I + L++ N + I F L + + N I +T
Sbjct: 167 -TITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKT- 223
Query: 182 VVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPS 214
+ + H L + + PS
Sbjct: 224 ---CLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 24/112 (21%), Positives = 36/112 (32%), Gaps = 8/112 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS-- 128
SL + QL P L L L+L N S L +L + LS+N S
Sbjct: 311 SLSIIRCQLKQF-PTLDLPF---LKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFS 365
Query: 129 DGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQ 179
+ + L+ L+L N F L + ++ L
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEF 417
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 12/116 (10%), Positives = 30/116 (25%), Gaps = 11/116 (9%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG----------SLPNLTNLVNL 117
+ L L + + LQN+ L+ L + L ++ +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TI 263
Query: 118 ETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ L+ + + L + + L + ++ L
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 30/158 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKHEN 374
E +G+G G YKA G A+K+++ + +++ +L +LKH N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI------REISILKELKHSN 61
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ K+ ++K+ ++++E L DL L + L T S + Q G+A
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
+ H +V H +LK N+LI RE ++ K+ +FG
Sbjct: 115 YCH----DRRVLHRDLKPQNLLINREGEL---KIADFG 145
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 30/159 (18%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKHE 373
E +G+G G YKA +G VVA+K+++ A+ +++ LL +L H
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLLKELNHP 62
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGL 431
N+ K++ +++ + +++EFL DL ++ + IPL S + Q +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASALTGIPLP--LIKSYLFQLLQGL 116
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
AF H SH+V H +LK N+LI E I KL +FG
Sbjct: 117 AFCH----SHRVLHRDLKPQNLLINTEGAI---KLADFG 148
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 23/124 (18%), Positives = 48/124 (38%), Gaps = 4/124 (3%)
Query: 53 IDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLT 112
+++S + S+ L++ I + L +L L LS L
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNI-SSNTFHCFSGLQELDLTATHLSELPSGLV 298
Query: 113 NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVS 169
L L+ + LS N F + + P L L ++ N ++ N +L + ++S
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 170 YNNL 173
++++
Sbjct: 359 HDDI 362
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 22/117 (18%), Positives = 44/117 (37%), Gaps = 9/117 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLN--KLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124
+ E++ I P + + ++ ++L+ + N L+ + L+
Sbjct: 229 SLWLGTFEDMDDEDI-SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIP 178
H S+ +P G + L LKKL L N + + N SL ++ N +
Sbjct: 288 THLSE-LPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 23/116 (19%), Positives = 39/116 (33%), Gaps = 4/116 (3%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNH 126
++ L+L Q+ I Q+ L+ L L N L L+ L+ +F Q
Sbjct: 58 NLTFLDLTRCQIYWI-HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180
S + L+ L L N++ P F L + N + +
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 6/117 (5%)
Query: 70 VSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQNH 126
L ++ L G L+N+ L +L L ++ + S L NL +L+++ LS N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQT 180
+ + P+L+ L+L L + N L N+S++ LD Q
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/134 (14%), Positives = 35/134 (26%), Gaps = 20/134 (14%)
Query: 51 PCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN 110
CI+ N +C N + + P + L N+L
Sbjct: 7 KCIEKEVNKT-YNCENLGLNEI-----------PGTLPNSTECLE---FSFNVLPTIQNT 51
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDF 166
+ L+NL + L++ + +L L L N L + +L
Sbjct: 52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHL 110
Query: 167 NVSYNNLDGPIPQT 180
+
Sbjct: 111 FFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 25/132 (18%), Positives = 40/132 (30%), Gaps = 12/132 (9%)
Query: 61 GVSCSNGHIVSLE-LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTN 113
C N + +L L+ + L+ L + L L L L N
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 114 LVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF-----NQTSLIDFNV 168
L L+ + LS + + LP L+ L LQ N+ L +
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 169 SYNNLDGPIPQT 180
S+ +L
Sbjct: 484 SFCDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 22/116 (18%), Positives = 40/116 (34%), Gaps = 9/116 (7%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSG----SLPNLTNLVNLETVFLSQN 125
L+ + L+ I + L L+L+ N +L L LE + LS
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIP-PFNQTSLIDFNVSYNNLDGPIPQT 180
S + L + ++L N L + I N++ N++ +P
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/120 (15%), Positives = 44/120 (36%), Gaps = 9/120 (7%)
Query: 68 HIVSLELEEIQLAGILPPGF-LQNITFLNKLSLRNN----LLSGSLPNLTNLVNLETVFL 122
SL Q ++ G I L + + + L + ++E++ L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINL 261
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180
+++F + + L++L+L +L ++P ++L +S N + +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQIS 320
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 15/121 (12%), Positives = 34/121 (28%), Gaps = 9/121 (7%)
Query: 68 HIVSLELEEIQLAGILPPGF--LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQN 125
+ L+ + + + LQ T L L+L N ++G P + +++
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 126 HFSDGIP--FGYIDLPKLKKLELQENYL----DGQIPPFNQTSLIDFNVSYNNLDGPIPQ 179
I + L ++ + S+ N+ +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 180 T 180
T
Sbjct: 273 T 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/71 (21%), Positives = 32/71 (45%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLK 142
+ ++ +N + L +N L+ S + + + L+ NH S +P L + +
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQR 550
Query: 143 KLELQENYLDG 153
+ L++N LD
Sbjct: 551 TINLRQNPLDC 561
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 325 LGKGKVGSTYKA---TLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G YKA + A+K+++ +++ LL +LKH N+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--SACREIALLRELKHPNVISLQKV 86
Query: 382 YYSKEEKLI--IYEFLPNGSLFDLLH-------ESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ S ++ + ++++ + DL H + L S++ Q G+
Sbjct: 87 FLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGF 471
+LH ++ V H +LK +NIL+ E R K+ + GF
Sbjct: 143 YLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 39/158 (24%), Positives = 73/158 (46%), Gaps = 30/158 (18%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKHEN 374
E +G+G G YKA G +VA+KR++ A+ +++ LL +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI------REISLLKELHHPN 80
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
+ ++ +S+ +++EF+ DL + + + L + + Q +G+A
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVA 133
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
H H++ H +LK N+LI + + KL +FG
Sbjct: 134 HCH----QHRILHRDLKPQNLLINSDGAL---KLADFG 164
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 24/208 (11%), Positives = 61/208 (29%), Gaps = 41/208 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK---NMNALSKKEFVQQMQLLGKLKHENLAKI 378
G ++A VA+ V + +E + + L ++ +A++
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ +++ L++ E++ GSL ++ + + ++ A H+
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHR-- 147
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRL 498
V + S + + + L +P
Sbjct: 148 --AGVALSIDHPSRVRVSIDG---DVVLAYPATMP-----------------------DA 179
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPG 526
+ D+ G L ++ R P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGV 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 35/166 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-------RVKNMNALSKKEFVQQ-MQLLGKLKHE 373
+ LG G G A ++ VA+K + + V+ +++L KL H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 374 NLAKIVSFY--YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIK 425
I+ + E+ I+ E + G LFD + VG RL
Sbjct: 76 C---IIKIKNFFDAEDYYIVLELMEGGELFD-----KVVGN------KRLKEATCKLYFY 121
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
Q + +LH + + H +LK N+L+ + + K+T+FG
Sbjct: 122 QMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 5/106 (4%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS-LPNLTNLVNLETVFLSQNHFSD 129
L + I P + ++ L +L + ++ +PNL+ L +L + +S + D
Sbjct: 70 DLTINNIHATNYNP---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 130 GIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNLD 174
I LPK+ ++L N I P L N+ ++ +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 18/93 (19%), Positives = 43/93 (46%), Gaps = 8/93 (8%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
+ ++T++ L N ++ L + N++ + ++ H ++ P L L++L +
Sbjct: 43 MNSLTYIT---LANINVT-DLTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIM 96
Query: 148 ENYL-DGQIPPFNQ-TSLIDFNVSYNNLDGPIP 178
+ +IP + TSL ++S++ D I
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 13/79 (16%), Positives = 26/79 (32%), Gaps = 3/79 (3%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L++ + + +N + L N + L L L+++ + + D
Sbjct: 116 LLDISHSAH-DDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY 174
Query: 131 IPFGYIDLPKLKKLELQEN 149
D PKL +L
Sbjct: 175 RGIE--DFPKLNQLYAFSQ 191
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 50/223 (22%), Positives = 83/223 (37%), Gaps = 46/223 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ----MQLLGK-LK 371
+LGKG G+ + L VA+K RV + LS + +G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 372 HENLAKIVSFYYSKEEKLIIYEF-LPNGSLFDLLHESRGVGRIPLAWTTRLS------II 424
H + +++ ++ ++E +++ E LP LFD + +G L
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKG----------PLGEGPSRCFF 145
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGFLPLLPSRK---- 479
Q + H S V H ++K NILI KL +FG LL
Sbjct: 146 GQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCA---KLIDFGSGALLHDEPYTDF 198
Query: 480 -ASENLAIGRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+ + PE+ + A V+ GI+L +++ G IP
Sbjct: 199 DGTRVYS---PPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 18/109 (16%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L+L+ ++ + + L L+L+ N + + L+T+ LS N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL 203
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLD 174
+ + + + + L+ N L I +L F++ N
Sbjct: 204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 17/91 (18%), Positives = 37/91 (40%), Gaps = 7/91 (7%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLK 142
+ L T L L+L +N+L +L +L L T+ L+ N+ + + P ++
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQE-LL----VGPSIE 102
Query: 143 KLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
L N + ++ + ++ N +
Sbjct: 103 TLHAANNNI-SRVSCSRGQGKKNIYLANNKI 132
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 7/103 (6%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDG 130
++ + L Q+ + +L L N LS L LE + LS N +
Sbjct: 15 EKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET 73
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ L L+ L+L NY+ ++ S+ + + NN+
Sbjct: 74 LDLE--SLSTLRTLDLNNNYV-QELLVG--PSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 87 FLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKL 144
QN + ++ L +L + + N++ + LS N S I + KL+ L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKLELL 63
Query: 145 ELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
L N L + ++L +++ N +
Sbjct: 64 NLSSNVLY-ETLDLESLSTLRTLDLNNNYV 92
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 13/109 (11%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQNH 126
+ I LA +L + + L L+ N + ++ + LE + L N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNF 180
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNL 173
D + G + KLK L+L N L + P + + ++ N L
Sbjct: 181 IYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 15/89 (16%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
L + L NN +S + + + ++L+ N + +++ L+L+
Sbjct: 95 LLVGPSIETLHAANNNIS-RVS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 148 ENYLDG-QIPPF--NQTSLIDFNVSYNNL 173
N +D + +L N+ YN +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFI 181
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 31/159 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKHE 373
E +G+G G+ +KA E+ +VA+KRV+ +AL +++ LL +LKH+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHK 61
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGL 431
N+ ++ +S ++ +++EF DL +S L S + Q KGL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCN---GDLDPEIVKSFLFQLLKGL 114
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
F H S V H +LK N+LI R ++ KL NFG
Sbjct: 115 GFCH----SRNVLHRDLKPQNLLINRNGEL---KLANFG 146
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 26/156 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLA 376
+ LG+G + YK + +VA+K ++ L +E ++++ LL LKH N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ ++++ +++E+L DL + G + + Q +GLA+
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYC 116
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
H KV H +LK N+LI ++ KL +FG
Sbjct: 117 H----RQKVLHRDLKPQNLLINERGEL---KLADFG 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 25/133 (18%), Positives = 50/133 (37%), Gaps = 18/133 (13%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L+ + L + ++ L L + + N L +LE + ++ N F
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 129 DGIPFGY-IDLPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQTRVVQ 184
+ +L L L+L + L+ Q+ P + +SL N+S+NN
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF----------F 212
Query: 185 SFPSSSFEHNSGL 197
S + ++ + L
Sbjct: 213 SLDTFPYKCLNSL 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 29/153 (18%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLS-GSLPN 110
+ C++ + S+ ++L LP G +T L KLSL +N LS +
Sbjct: 12 IRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 111 LT--NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF----NQTSLI 164
+ +L+ + LS N + ++ L +L+ L+ Q + L Q+ F + +LI
Sbjct: 72 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 165 DFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
++S+ + + + F S L
Sbjct: 130 YLDISHTHT----------RVAFNGIFNGLSSL 152
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 21/110 (19%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L++ P + L L L L L +L +L+ + +S N+F
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 130 GIPFG-YIDLPKLKKLELQENYLDGQIPP--FN--QTSLIDFNVSYNNLD 174
+ Y L L+ L+ N++ +SL N++ N+
Sbjct: 214 -LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 5/95 (5%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGY-IDLPKL 141
T L L L N + N L LE + ++ F + L L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128
Query: 142 KKLELQENYLDGQIPPF---NQTSLIDFNVSYNNL 173
L++ + +SL ++ N+
Sbjct: 129 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 56/224 (25%)
Query: 324 VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ---------LLGKLKHE 373
+LG+G + A + A+K L K+ +++ + ++ +L H
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIK------ILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 374 NLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQT 427
V Y++ +EKL + NG L + R +G TR I+
Sbjct: 91 F---FVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDET-CTRFYTAEIV--- 140
Query: 428 AKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG 487
A + LH + H +LK NIL+ + I ++T+FG ++ S
Sbjct: 141 ---SALEY--LHGKGIIHRDLKPENILLNEDMHI---QITDFGT-----AKVLSPESKQA 187
Query: 488 R-----------SPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
R SPE K +D++ G I+ +++ G P
Sbjct: 188 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 42/220 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQ-MQLLGKLKHE-- 373
+LG G GS Y + VA+K R+ + L V + LL K+
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 374 NLAKIVSFYYSKEEKLIIYEF-LPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQ 426
+ +++ ++ + ++I E P LFD + RG L Q
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERG----------ALQEELARSFFWQ 157
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-----AS 481
+ + H + V H ++K NILI KL +FG LL +
Sbjct: 158 VLEAVRHCH----NCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYTDFDGT 211
Query: 482 ENLAIGRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+ PE+ R A V+ GI+L +++ G IP
Sbjct: 212 RVYS---PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 36/156 (23%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM-----QLLGKLKHENLA 376
+ LG+G+ + YKA + +VA+K++K + K+ + + +LL +L H N+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ + K ++++F+ DL + + + L + + + T +GL +L
Sbjct: 76 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYL 128
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
H H + H +LK +N+L+ + KL +FG
Sbjct: 129 H----QHWILHRDLKPNNLLLDENGVL---KLADFG 157
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 59/314 (18%), Positives = 110/314 (35%), Gaps = 71/314 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKHENLAK 377
+ +G G G A VA+K++ + ++ + L+ + H+N+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 378 IV------SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
++ ++ ++ E + L + V ++ L ++ Q G+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQ---VIQMELDHERMSYLLYQMLCGI 177
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---- 487
LH S + H +LK SNI++ + + K+ +FG +R A + +
Sbjct: 178 KHLH----SAGIIHRDLKPSNIVVKSDCTL---KILDFGL-----ARTAGTSFMMTPYVV 225
Query: 488 ----RSPEFPEGKRLTHKADVYCFGIILLEVITGRI--PGN-------------GSPGNN 528
R+PE G D++ G I+ E++ +I PG G+P
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-CP 284
Query: 529 ETSGDLSDWVRMVVDN-------DWSTDILDVEILAAREGQN----EMLRLTELALECTD 577
E L VR V+N + D A E + L L
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV--- 341
Query: 578 IAPEKRPKMSEVLR 591
I P KR + + L+
Sbjct: 342 IDPAKRISVDDALQ 355
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 19/107 (17%), Positives = 42/107 (39%), Gaps = 8/107 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ + + + + + L IT L+ ++ ++ + L NL + L N
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLS---AFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
+D P +L K+ +LEL N L + S+ +++ +
Sbjct: 76 TDLAPLK--NLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQI 119
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 26/106 (24%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
I +L+L Q+ + P L ++ L L L N ++ ++ L L NL+ + +
Sbjct: 108 SIKTLDLTSTQITDVTP---LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV 163
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
SD P +L KL L+ +N + P + +LI+ ++ N +
Sbjct: 164 SDLTPLA--NLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 26/107 (24%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+++ LEL++ Q+ + P L+N+T + +L L N L ++ + L +++T+ L+
Sbjct: 64 NLIGLELKDNQITDLAP---LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQI 119
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173
+D P L L+ L L N + I P T+L ++ +
Sbjct: 120 TDVTPLA--GLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 25/91 (27%), Positives = 36/91 (39%), Gaps = 4/91 (4%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
L N++ L L +N +S + L +L NL V L N SD P + L + L
Sbjct: 169 LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
Query: 148 ENYLDGQIPPFNQTSLIDFNVSYNNLDGPIP 178
+ P F +L+ NV PI
Sbjct: 226 NQTIT-NQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 18/109 (16%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L+L+ ++ + + L L+L+ N + + L+T+ LS N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL 203
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLD 174
+ + + + + L+ N L I +L F++ N
Sbjct: 204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKL 141
Q+ + +L L N LS L LE + LS N + + L L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLE--SLSTL 82
Query: 142 KKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ L+L NY+ ++ S+ + + NN+
Sbjct: 83 RTLDLNNNYV-QELLVG--PSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 89 QNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
QN + ++ L +L + + N++ + LS N S KL+ L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 148 ENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
N L + ++L +++ N +
Sbjct: 67 SNVLY-ETLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 23/108 (21%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQNH 126
+ I LA +L + + L L+ N + ++ + LE + L N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNF 180
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
D + + KLK L+L N L P F + ++ N L
Sbjct: 181 IYD-VKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 21/125 (16%), Positives = 44/125 (35%), Gaps = 29/125 (23%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLS-----GSLPNLT------------ 112
++E+ L+G + L T L L+L +N+L SL L
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQEL 95
Query: 113 -NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNV 168
++ET+ + N+ S + K + L N + + ++ + ++
Sbjct: 96 LVGPSIETLHAANNNISR-VSCSR--GQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDL 151
Query: 169 SYNNL 173
N +
Sbjct: 152 KLNEI 156
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 21/125 (16%), Positives = 40/125 (32%), Gaps = 27/125 (21%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNL---------------- 114
L L L L L L L L NN + L ++
Sbjct: 62 LLNLSSNVLYETLDLESLST---LRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCS 117
Query: 115 --VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF----NQTSLIDFNV 168
+ ++L+ N + +++ L+L+ N +D + + +L N+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNL 176
Query: 169 SYNNL 173
YN +
Sbjct: 177 QYNFI 181
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 48/299 (16%), Positives = 101/299 (33%), Gaps = 71/299 (23%)
Query: 189 SSFEHNSGLCGRPLEKLCPISPPPPSPAIPPPSPPPPPKEDKKKSLKIWSVALIAAGSAL 248
H+SG+ + ++ P+ + +SL+
Sbjct: 3 HHHHHSSGVDNKFNKE----RRRARREIRHLPNLNREQRRAFIRSLRDDPSQ-------- 50
Query: 249 VPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKT 308
+ ++ + + + E P+ EF+ K
Sbjct: 51 --------------SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK- 95
Query: 309 IPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVK-------RVKNMNALSKKEF 360
+D +V+G+G + +G AVK R+ +E
Sbjct: 96 ---YDPK-------DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 361 VQQ-MQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWT 418
++ +L ++ H ++ ++ Y S ++++ + G LFD L E +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KV--------- 195
Query: 419 TRLS------IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
LS I++ + ++FLH ++ + H +LK NIL+ I +L++FGF
Sbjct: 196 -ALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQI---RLSDFGF 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 7/106 (6%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ V L + + ++ + ++ + + N+ + SL + NL+ + LS N
Sbjct: 20 NAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQI 75
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
SD P DL KL++L + N L + L + N L
Sbjct: 76 SDLSPLK--DLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 65 SNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQ 124
+ + L L+ +L L ++ L LS+RNN L S+ L L LE + L
Sbjct: 104 PSACLSRLFLDNNELRDTDS---LIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHG 159
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175
N ++ L K+ ++L P + + + DG
Sbjct: 160 NEITNTGGLT--RLKKVNWIDLTGQKC--VNEPVKYQPELYITNTVKDPDG 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 29/125 (23%), Positives = 41/125 (32%), Gaps = 17/125 (13%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGI 131
L L E L L T L +L+L L+ L L L T+ LS N +
Sbjct: 36 LHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-L 92
Query: 132 PFGYIDLPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQSFPS 188
P LP L L++ N L +P L + + N L ++ P
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL----------KTLPP 141
Query: 189 SSFEH 193
Sbjct: 142 GLLTP 146
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/171 (25%), Positives = 67/171 (39%), Gaps = 17/171 (9%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L++ +L LP G L+ + L +L L+ N L +LP LT LE + L+ N+ ++
Sbjct: 105 LDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE 162
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLD---GPIPQTRVV 183
+P G ++ L L L LQEN L IP F L + N + R +
Sbjct: 163 -LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWL 220
Query: 184 QSFPSSSFEHNSGLCGRPLEK-----LCPISPPPPSPAIPPPSPPPPPKED 229
Q + + G+ + + C S P P P E
Sbjct: 221 QDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEG 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 71/314 (22%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKHENLAK 377
+ +G G G A VA+K++ + ++ + L+ + H+N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 378 IVSFYYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
+++ + ++ I+ E + +L + V ++ L ++ Q G+
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMD----ANL-CQ---VIQMELDHERMSYLLYQMLCGI 140
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---- 487
LH S + H +LK SNI++ + + K+ +FG +R A + +
Sbjct: 141 KHLH----SAGIIHRDLKPSNIVVKSDCTL---KILDFGL-----ARTAGTSFMMTPYVV 188
Query: 488 ----RSPEFPEGKRLTHKADVYCFGIILLEVITGRI--PGN-------------GSPGNN 528
R+PE G D++ G I+ E+I G + PG G+P
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-CP 247
Query: 529 ETSGDLSDWVRMVVDN-------DWSTDILDVEILAAREGQN----EMLRLTELALECTD 577
E L VR V+N + DV A E + L L
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV--- 304
Query: 578 IAPEKRPKMSEVLR 591
I KR + E L+
Sbjct: 305 IDASKRISVDEALQ 318
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 35/166 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK--------RVKNMNALSKKEFVQQ-MQLLGKLK- 371
E+LG+G + + AVK +E + + +L K+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 372 HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIK 425
H N+ ++ Y + ++++ + G LFD L E + LS I++
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KV----------TLSEKETRKIMR 131
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
+ + LH + H +LK NIL+ + +I KLT+FGF
Sbjct: 132 ALLEVICALH----KLNIVHRDLKPENILLDDDMNI---KLTDFGF 170
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLK 142
+ G + + L L+L + +PNLT LV LE + +S NHF + P + L LK
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245
Query: 143 KLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
KL + + + I SL++ N+++NNL S P F L
Sbjct: 246 KLWVMNSQVS-LIERNAFDGLASLVELNLAHNNL----------SSLPHDLFTPLRYL 292
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 27/127 (21%), Positives = 50/127 (39%), Gaps = 19/127 (14%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
V C+ + + + L ++ +++ L L L N + +
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQENYLDGQIPP--FNQ-TSLID 165
L +L T+ L N + IP G + L KL++L L+ N + IP FN+ SL+
Sbjct: 118 AFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMR 175
Query: 166 FNVSYNN 172
++
Sbjct: 176 LDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 10/108 (9%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
L ++L ++P G + ++ L +L LRNN + S+P+ + +L + L +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 128 SDGIPFG-YIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173
+ I G + L LK L L + +P L + +S N+
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHF 230
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 17/119 (14%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKL 141
+ G + ++ L L+L L +PNLT L+ L+ + LS NH S I G + L L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHL 233
Query: 142 KKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
+KL + ++ + I N SL++ N+++NNL P F L
Sbjct: 234 QKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL----------TLLPHDLFTPLHHL 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 31/111 (27%), Positives = 51/111 (45%), Gaps = 14/111 (12%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
LE +QL+ + G + LN L L +N L+ ++PN L L+ ++L N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 128 SDGIPFG-YIDLPKLKKLELQE-NYLDGQIPP--F-NQTSLIDFNVSYNNL 173
IP + +P L++L+L E L I F ++L N++ NL
Sbjct: 149 ES-IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNL 197
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 19/127 (14%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
V C ++ + + L I+ +++ L L L N + ++
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIG 106
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQENYLDGQIPP--FNQ-TSLID 165
L NL T+ L N + IP G ++ L KLK+L L+ N ++ IP FN+ SL
Sbjct: 107 AFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164
Query: 166 FNVSYNN 172
++
Sbjct: 165 LDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
LEL + +L I P G ++ L +L LRNN + S+P+ + +L + L +
Sbjct: 117 LELFDNRLTTI-PNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 130 GIPFG-YIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173
I G + L L+ L L L +IP L + ++S N+L
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHL 219
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ-------MQLLGKLKHEN 374
++GKG G KA VA+K +KN KK F+ Q ++L+ K E
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 375 LAKIV----SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
IV F + + +++E L + +L+DLL + G + L TR +Q
Sbjct: 115 KYYIVHLKRHFMF-RNHLCLVFEML-SYNLYDLLRNTNFRG-VSLN-LTR-KFAQQMCTA 169
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG--------FLPLLPSRKASE 482
L FL + H +LK NIL+ K+ +FG + SR
Sbjct: 170 LLFLAT--PELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQLGQRIYQYIQSRFY-- 224
Query: 483 NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI--PGN 522
RSPE G D++ G IL+E+ TG G
Sbjct: 225 -----RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRV--KNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+GKG A + +G VA+K + +N S ++ ++++++ L H N+ K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+++ +I E+ G +FD L GR+ +Q + + HQ
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARS--KFRQIVSAVQYCHQ----K 133
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEG 495
++ H +LK+ N+L+ + +I K+ +FGF + A +PE +G
Sbjct: 134 RIVHRDLKAENLLLDADMNI---KIADFGFSNEFTVGGKLDAFCGAPPYA---APELFQG 187
Query: 496 KRLT-HKADVYCFGIILLEVITGRIP 520
K+ + DV+ G+IL +++G +P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 31/161 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKHE 373
LG+G G YKA + VA+KR++ A+ +++ LL +L+H
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLLKELQHR 93
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQTAKGL 431
N+ ++ S + +I+E+ N DL + ++ S + Q G+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNP----DVSMRVIKSFLYQLINGV 145
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRA--KLTNFG 470
F H S + H +LK N+L+ + K+ +FG
Sbjct: 146 NFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 9/113 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
H+ ++L +A L + L L + + N L +L + L N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 126 HFSDGIPFGYID-LPKLKKLELQENYL-DGQIPPF---NQTSLIDFNVSYNNL 173
F + G + L L+ L L + L + TSL + NN+
Sbjct: 90 QFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 22/111 (19%), Positives = 45/111 (40%), Gaps = 10/111 (9%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF-S 128
L++E+ ++ + ++ L L L N L L NLE + L+Q +
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP----FNQTSLIDFNVSYNNLD 174
+ + L L+ L L++N + +I P N ++++N +
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 31/106 (29%), Positives = 42/106 (39%), Gaps = 18/106 (16%)
Query: 62 VSCSNGHIVSLE---------LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSL 108
S I +L LE++ LA + +T L KL+L N L S+
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SI 338
Query: 109 PN--LTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYL 151
+ NL LE + LS NH + LP LK+L L N L
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 24/163 (14%)
Query: 12 LVASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVS 71
+ S I +P + + +D+L T + +++ + +N I S
Sbjct: 4 TITVSTPIKQIFPDDAFAETI-KDNLKKK-----SVTDAVTQNELNSIDQIIANNSDIKS 57
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGI 131
++ +Q + + KL L N L+ + LTNL NL +FL +N D
Sbjct: 58 VQ-------------GIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDLS 103
Query: 132 PFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173
DL KLK L L+ N + I + L + N +
Sbjct: 104 SLK--DLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 7/109 (6%)
Query: 73 ELEEIQLAG--ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
+LE + L I L +T L+ LSL +N +S + L L L+ ++LS+NH SD
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHISDL 190
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQ 179
L L LEL P +Q++L+ N + N DG +
Sbjct: 191 RALA--GLKNLDVLELFSQECL-NKPINHQSNLVVPN-TVKNTDGSLVT 235
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 15/92 (16%), Positives = 28/92 (30%), Gaps = 5/92 (5%)
Query: 82 ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKL 141
+ + L L N+ ++ + + L L + + N+ + + L
Sbjct: 32 ATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT-LDLS--QNTNL 87
Query: 142 KKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
L N L + T L N N L
Sbjct: 88 TYLACDSNKL-TNLDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
+ + T L +L N + ++T L T+ S N ++ + L +L
Sbjct: 144 VSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKITE-LDVS--QNKLLNRLNCD 199
Query: 148 ENYLDGQIPPFNQTSLIDFNVSYNNL 173
N + ++ L + S N L
Sbjct: 200 TNNIT-KLDLNQNIQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 20/109 (18%), Positives = 44/109 (40%), Gaps = 9/109 (8%)
Query: 65 SNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQ 124
N ++ L + +L + + +T L L+ N L+ L ++ L + ++
Sbjct: 83 QNTNLTYLACDSNKLTNL----DVTPLTKLTYLNCDTNKLT-KLD-VSQNPLLTYLNCAR 136
Query: 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
N ++ I +L +L+ N ++ QT L + S+N +
Sbjct: 137 NTLTE-IDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 15/111 (13%), Positives = 33/111 (29%), Gaps = 19/111 (17%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFL 122
C ++ ++L + T L L ++T+ L +
Sbjct: 260 HCIQTDLLEIDLT--------------HNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDC 304
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
++ + PKL L L L ++ + T L + ++
Sbjct: 305 QAAGITE-LDLS--QNPKLVYLYLNNTELT-ELDVSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 5/86 (5%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
+ +T L N L+ L ++ L L T+ Q + I + +L + +
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELD-VSTLSKLTTLHCIQTDLLE-IDLTH--NTQLIYFQAE 283
Query: 148 ENYLDGQIPPFNQTSLIDFNVSYNNL 173
++ + T L + +
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 33/107 (30%), Positives = 46/107 (42%), Gaps = 10/107 (9%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
++++ + LPP QN+ L L L N LS SLP N L T+ +S N+
Sbjct: 95 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 153
Query: 128 SDGIPFG-YIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
I + L+ L+L N L + SL NVSYN L
Sbjct: 154 ER-IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 13/107 (12%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
+EE+ + ++ L L L++N L+ L N L V LS N
Sbjct: 207 VEELDASHNSINVVRGPVNVE---LTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEK 262
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNL 173
I + + +L++L + N L + + +L ++S+N+L
Sbjct: 263 -IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 22/121 (18%), Positives = 44/121 (36%), Gaps = 19/121 (15%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYI-DLP 139
LP L + + L+L + + + ++ +++ N +P ++P
Sbjct: 60 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVP 117
Query: 140 KLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSG 196
L L L+ N L +P N L ++S NNL + +F+ +
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL----------ERIEDDTFQATTS 166
Query: 197 L 197
L
Sbjct: 167 L 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 36/146 (24%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLS----GSLPNLTNL----------- 114
L + ++ + Q T L L L +N L+ +P+L +
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 202
Query: 115 --VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYN 171
+ +E + S N + + +L L+LQ N L N L++ ++SYN
Sbjct: 203 IPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYN 258
Query: 172 NLDGPIPQTRVVQSFPSSSFEHNSGL 197
L + F L
Sbjct: 259 EL----------EKIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 13/110 (11%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
+E + L + + KL + N + LP N+ L + L +N
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 128 SDGIPFG-YIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNL 173
S +P G + + PKL L + N L+ +I TSL + +S N L
Sbjct: 130 SS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL 177
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 18/68 (26%), Positives = 23/68 (33%), Gaps = 3/68 (4%)
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144
+ Q I L L L +N L N LE ++L N + LK L
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVT-LKLS--THHTLKNL 344
Query: 145 ELQENYLD 152
L N D
Sbjct: 345 TLSHNDWD 352
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 36/218 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQ----LLGKLKHENLAK 377
++LG+G G + E+ AVK +K ++ LL +L+H+N
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN--- 67
Query: 378 IVSFY--YSKEEKLIIY---EFLPNGS--LFDLLHESRGVGRIPLAWTTRLSIIKQTAKG 430
++ EEK +Y E+ G + D + E R P+ Q G
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPV-CQAH-GYFCQLIDG 121
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG--- 487
L +LH S + H ++K N+L+ + K++ G L A +
Sbjct: 122 LEYLH----SQGIVHKDIKPGNLLLTTGGTL---KISALGVAEALHPFAADDTCRTSQGS 174
Query: 488 ---RSPEFPEGKRLTH--KADVYCFGIILLEVITGRIP 520
+ PE G K D++ G+ L + TG P
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
+ L+L L+ + +T L+ L L +N L+ + + + NL + LS N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 126 HFSDGIPFGYID-LPKLKKLELQENYLDGQIPP--F-NQTSLIDFNVSYNNLDGPIPQTR 181
H + L L+ L L N++ + F + L +S N +
Sbjct: 99 HLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-------- 148
Query: 182 VVQSFPSSSFEHNSGL 197
FP + + L
Sbjct: 149 --SRFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID--- 137
L ++ L L L NN + + ++ L+ ++LSQN S P I
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGN 160
Query: 138 -LPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175
LPKL L+L N L ++P + L + + L
Sbjct: 161 KLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 19/84 (22%), Positives = 28/84 (33%), Gaps = 7/84 (8%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLS----GSLPNLTNLVNLETVFLSQNHF 127
L L + + +++ L KL L N +S + + L L + LS N
Sbjct: 117 LLLYNNHIVVV-DRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175
Query: 128 SDGIPFGYIDLPKLKK--LELQEN 149
LP K L L N
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 77 IQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN----LTNLVNLETVFLSQNHFSDGIP 132
+ + L L L N L S+ L L NL ++ +S+N F +P
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHP-MP 403
Query: 133 FGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174
K++ L L + + +L +VS NNLD
Sbjct: 404 DSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 22/121 (18%), Positives = 42/121 (34%), Gaps = 17/121 (14%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LP 139
+ ++ L L L +N LS SL + L +L+ + L N + L
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 140 KLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSG 196
L+ L + +I TSL + + +L +++ S S +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL----------RNYQSQSLKSIRD 173
Query: 197 L 197
+
Sbjct: 174 I 174
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 14/112 (12%), Positives = 32/112 (28%), Gaps = 8/112 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLT--NLVNLETVFLSQN 125
+ L L + N+T L L + N + + L +L + +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 126 HFSDGIPFGYID-LPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNL 173
+ + + + L L + + +S+ + NL
Sbjct: 159 SLRN-YQSQSLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNL 208
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 13/112 (11%)
Query: 73 ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQN 125
LE + L+ L + ++ L L+L N +L NL NL+T+ +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNV 133
Query: 126 HFSDGIPFGYI-DLPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNL 173
I L L +LE++ L + + +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSES 184
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 27/133 (20%), Positives = 49/133 (36%), Gaps = 18/133 (13%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
+ S+ ++ + L+ + G L+ L L L+++ ++ ++
Sbjct: 10 CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGD 68
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYLD--GQIPPF-NQTSLID 165
+L +LE + LS NH S + + L LK L L N G F N T+L
Sbjct: 69 AFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 166 FNVSYNNLDGPIP 178
+ I
Sbjct: 128 LRIGNVETFSEIR 140
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 16/90 (17%), Positives = 27/90 (30%), Gaps = 5/90 (5%)
Query: 84 PPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKK 143
L + L L + N + + + LS + L+
Sbjct: 379 TGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEV 435
Query: 144 LELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
L++ N LD F L + +S N L
Sbjct: 436 LDVSNNNLD-SFSLFL-PRLQELYISRNKL 463
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 19/158 (12%), Positives = 51/158 (32%), Gaps = 14/158 (8%)
Query: 29 DLLQIRDSLNSTANLHSRWTGPPCIDNVS-NWFGVSCSNGHIVSLELEEIQLAGILPPGF 87
+ ++ + A S T + + + + S L +
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 88 LQNITFLNKLSLRNNLLSG----SLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LPK 140
+ + + +++R + + + L ++ + + + +P + L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKS 335
Query: 141 LKKLELQENYL-DGQIPPF----NQTSLIDFNVSYNNL 173
L+ L+L EN + + + SL +S N+L
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 33/164 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQM-----QLLGKLKHEN-- 374
+G+G G +KA ++G VA+K+V N KE ++L LKHEN
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVV 79
Query: 375 -LAKIV----SFYYSKEEKL-IIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIKQ 426
L +I S Y + + ++++F + DL L + V + +++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLV---KFTLSEIKRVMQM 132
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
GL ++H +K+ H ++K++N+LI R+ + KL +FG
Sbjct: 133 LLNGLYYIH----RNKILHRDMKAANVLITRDGVL---KLADFG 169
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 35/167 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK-----------NMNALSKKEFVQQMQLLGKL 370
+G G G+ YKA SG VA+K V+ ++ + +E V ++ L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV--RE-VALLRRLEAF 71
Query: 371 KHENLAK----IVSFYYSKEEKL-IIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSI 423
+H N+ + + +E K+ +++E + DL + +P T +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAE--TIKDL 125
Query: 424 IKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
++Q +GL FLH ++ + H +LK NIL+ + KL +FG
Sbjct: 126 MRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTV---KLADFG 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 24/121 (19%), Positives = 45/121 (37%), Gaps = 19/121 (15%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LP 139
+PPG L ++ L NN +S L L +L ++ L N ++ +P + L
Sbjct: 47 IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLF 104
Query: 140 KLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSG 196
L+ L L N + + + +L ++ N L Q+ +F
Sbjct: 105 SLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKL----------QTIAKGTFSPLRA 153
Query: 197 L 197
+
Sbjct: 154 I 154
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSK--KEFVQQMQLLGKLKHEN 374
+ LG G G +G VAVK ++++++ + K +E +Q ++L +H +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE-IQNLKLF---RHPH 72
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ K+ + + ++ E++ G LFD + + GR+ RL +Q + +
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRL--FQQILSAVDYC 127
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGR 488
H H V H +LK N+L+ + K+ +FG ++ + S N A
Sbjct: 128 H----RHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYA--- 177
Query: 489 SPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE G+ + D++ G+IL ++ G +P
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
L+++ L LSL +N +S + L +L LE+++L N +D L KL L L+
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLE 164
Query: 148 ENYLDGQIPPF-NQTSLIDFNVSYNNL 173
+N + I P T L + +S N++
Sbjct: 165 DNQIS-DIVPLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 18/107 (16%), Positives = 43/107 (40%), Gaps = 8/107 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L++ + + + ++++ N+ + S+ + L N+ +FL+ N
Sbjct: 25 ETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKL 80
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
+D P +L L L L EN + + L ++ +N +
Sbjct: 81 TDIKPLA--NLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGI 124
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 5/91 (5%)
Query: 87 FLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146
L +T L+ LSL +N +S + L L L+ ++LS+NH SD L L LEL
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLEL 207
Query: 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPI 177
P +Q++L+ N + N DG +
Sbjct: 208 FSQECL-NKPINHQSNLVVPN-TVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
++ L L +L I P L N+ L L L N + L +L +L L+++ L N
Sbjct: 69 NVTKLFLNGNKLTDIKP---LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGI 124
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173
SD LP+L+ L L N + I T L ++ N +
Sbjct: 125 SDINGLV--HLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQI 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 58/269 (21%)
Query: 278 GSAHLSEKKMPDSW---SMEDPERRVELEFFDKTIPVFDLDD--LLRASAEVLGKGKVGS 332
G+A ++K + + ++ + LD ++ LG G G
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGR 56
Query: 333 TYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ---------LLGKLKHENLAKIVSFY 382
ESG A+K L K++ V+ Q +L + +V
Sbjct: 57 VMLVKHKESGNHYAMK------ILDKQKVVKLKQIEHTLNEKRILQAVNFPF---LVKLE 107
Query: 383 YS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFLHQ 436
+S L ++ E++ G +F L R +GR R I+ L F +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEP-HARFYAAQIV------LTFEY- 156
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS-----ENLAIGRSPE 491
LHS + + +LK N+LI ++ I ++T+FGF + R + E LA PE
Sbjct: 157 -LHSLDLIYRDLKPENLLIDQQGYI---QVTDFGFAKRVKGRTWTLCGTPEALA----PE 208
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIP 520
K D + G+++ E+ G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 33/107 (30%), Positives = 45/107 (42%), Gaps = 10/107 (9%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
++++ + LPP QN+ L L L N LS SLP N L T+ +S N+
Sbjct: 101 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 159
Query: 128 SDGIPFGYI-DLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
I L+ L+L N L + SL NVSYN L
Sbjct: 160 ER-IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 22/121 (18%), Positives = 44/121 (36%), Gaps = 19/121 (15%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYI-DLP 139
LP L + + L+L + + + ++ +++ N +P ++P
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVP 123
Query: 140 KLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSG 196
L L L+ N L +P N L ++S NNL + +F+ +
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL----------ERIEDDTFQATTS 172
Query: 197 L 197
L
Sbjct: 173 L 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 13/107 (12%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
+EE+ + ++ +T L L++N L+ L N L V LS N
Sbjct: 213 VEELDASHNSINVVRGPVNVELTILK---LQHNNLT-DTAWLLNYPGLVEVDLSYNELEK 268
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNL 173
I + + +L++L + N L + + +L ++S+N+L
Sbjct: 269 -IMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 13/106 (12%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPNLT--NLVNLETVFLSQNHF 127
L + L LP G N L LS+ NN L + + T +L+ + LS N
Sbjct: 125 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL 183
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ + +P L + N L + ++ + + S+N++
Sbjct: 184 TH-VDLSL--IPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSI 223
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 36/146 (24%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLS----GSLPNLTNL----------- 114
L + ++ + Q T L L L +N L+ +P+L +
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208
Query: 115 --VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYN 171
+ +E + S N + + +L L+LQ N L N L++ ++SYN
Sbjct: 209 IPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYN 264
Query: 172 NLDGPIPQTRVVQSFPSSSFEHNSGL 197
L + F L
Sbjct: 265 EL----------EKIMYHPFVKMQRL 280
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 18/68 (26%), Positives = 23/68 (33%), Gaps = 3/68 (4%)
Query: 85 PGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144
+ Q I L L L +N L N LE ++L N + LK L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVT-LKLS--THHTLKNL 350
Query: 145 ELQENYLD 152
L N D
Sbjct: 351 TLSHNDWD 358
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 23/132 (17%), Positives = 50/132 (37%), Gaps = 19/132 (14%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
L+ +++ + + L +L+L L+ S+P L++L L + L +
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNI 188
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQS 185
+ + + L +LK LE+ + P +L ++++ NL +
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL----------TA 238
Query: 186 FPSSSFEHNSGL 197
P + H L
Sbjct: 239 VPYLAVRHLVYL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 31/128 (24%), Positives = 50/128 (39%), Gaps = 19/128 (14%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
V C V++ E + L L + L +L L N++S ++
Sbjct: 16 VLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPG 74
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQENYLDGQIPPF---NQTSLID 165
NL NL T+ L N IP G + L L KL++ EN + + + + +L
Sbjct: 75 AFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKS 132
Query: 166 FNVSYNNL 173
V N+L
Sbjct: 133 LEVGDNDL 140
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 24/133 (18%), Positives = 47/133 (35%), Gaps = 21/133 (15%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
LE++ L +P L ++ L L LR+ ++ ++ + L L+ + +S +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPY 212
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQ 184
D + + L L + L +P + L N+SYN +
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI----------S 261
Query: 185 SFPSSSFEHNSGL 197
+ S L
Sbjct: 262 TIEGSMLHELLRL 274
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 15/86 (17%), Positives = 29/86 (33%), Gaps = 9/86 (10%)
Query: 73 ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNH 126
L + L+ + L + L ++ L L+ + L L + +S N
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307
Query: 127 FSDGIPFGYID-LPKLKKLELQENYL 151
+ + + L+ L L N L
Sbjct: 308 LTT-LEESVFHSVGNLETLILDSNPL 332
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 41/215 (19%), Positives = 79/215 (36%), Gaps = 32/215 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK--------RVKNMNALSKKEFVQQMQLLGKLKHE 373
LG G G + A E V VK + + ++ +L +++H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGS-LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
N+ K++ + ++ ++ E +G LF + + PLA I +Q +
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLA----SYIFRQLVSAVG 144
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK------ASENLAI 486
+L + H ++K NI+I + I KL +FG L K +
Sbjct: 145 YLR----LKDIIHRDIKDENIVIAEDFTI---KLIDFGSAAYLERGKLFYTFCGTIEYC- 196
Query: 487 GRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE G + +++ G+ L ++ P
Sbjct: 197 --APEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 41/215 (19%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G A + VAVK R + KKE + ++L HEN +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKML---NHEN---V 67
Query: 379 VSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V FY + E I Y E+ G LFD + +P R Q G+ +LH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL---------AI 486
+ H ++K N+L+ +++ K+++FG + L
Sbjct: 123 ----GIGITHRDIKPENLLLDERDNL---KISDFGLATVFRYNNRERLLNKMCGTLPYV- 174
Query: 487 GRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE + + DV+ GI+L ++ G +P
Sbjct: 175 --APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 33/165 (20%)
Query: 323 EVLGKGKVGSTYKA--TLESGAVVAVKRVK--------NMNALSKKEFVQQMQLLGKLKH 372
+G+G G +KA G VA+KRV+ ++ + +E V ++ L +H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--RE-VAVLRHLETFEH 73
Query: 373 ENLAK----IVSFYYSKEEKL-IIYEFLPNGSLFDL--LHESRGVGRIPLAWTTRLSIIK 425
N+ + +E KL +++E + DL + +P T ++
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTE--TIKDMMF 127
Query: 426 QTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
Q +GL FLH SH+V H +LK NIL+ I KL +FG
Sbjct: 128 QLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQI---KLADFG 165
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 45/220 (20%), Positives = 87/220 (39%), Gaps = 42/220 (19%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKHENLAK 377
+G G GS A SG VA+K++ + F ++ + LL ++HEN+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 378 IVSFYYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
++ + ++ F+ DL + + + + ++ Q KGL
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT----DL-QK---IMGLKFSEEKIQYLVYQMLKGL 139
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI----- 486
++H S V H +LK N+ + + ++ K+ +FG +R A +
Sbjct: 140 KYIH----SAGVVHRDLKPGNLAVNEDCEL---KILDFGL-----ARHADAEMTGYVVTR 187
Query: 487 -GRSPE-FPEGKRLTHKADVYCFGIILLEVITGRI--PGN 522
R+PE D++ G I+ E++TG+ G
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 30/136 (22%), Positives = 48/136 (35%), Gaps = 19/136 (13%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
++ L L LA I + L +L L +N S+ L L T+ L +
Sbjct: 57 NLTILWLHSNVLARI-DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 126 HFSDGIPFG-YIDLPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTR 181
+ + G + L L+ L LQ+N L +P F +L + N +
Sbjct: 116 GLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI-------- 165
Query: 182 VVQSFPSSSFEHNSGL 197
S P +F L
Sbjct: 166 --SSVPERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 32/152 (21%), Positives = 52/152 (34%), Gaps = 28/152 (18%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
SC + ++ + I L G +P + L L L +N+L+ +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQENYLDGQIPP--F-NQTSLID 165
T L LE + LS N + + L +L L L L ++ P F +L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQY 133
Query: 166 FNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
+ N L Q+ P +F L
Sbjct: 134 LYLQDNAL----------QALPDDTFRDLGNL 155
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 9/98 (9%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFG-YIDLP 139
LP +++ L L L N +S S+P L +L+ + L QN + + + DL
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLG 201
Query: 140 KLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLD 174
+L L L N L +P +L ++ N
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 9/83 (10%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
L + L G +P + + L++L L N ++ + +L L T++L N+
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNL 213
Query: 128 SDGIPFG-YIDLPKLKKLELQEN 149
S +P L L+ L L +N
Sbjct: 214 SA-LPTEALAPLRALQYLRLNDN 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/239 (17%), Positives = 81/239 (33%), Gaps = 55/239 (23%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+ LG G G + +ESG A+K+V +E + ++ L H N+ K+V +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS-----------------II 424
+Y+ ++ P+ + ++
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 425 KQTAKGL---------AFLHQTL------HSHKVPHANLKSSNILIFRENDIYRAKLTNF 469
K + +++Q HS + H ++K N+L+ +++ KL +F
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDF 186
Query: 470 GFLPLLPSRKASENLAIG---------RSPEFPEG-KRLTHKADVYCFGIILLEVITGR 518
G S K R+PE G T D++ G + E+I G+
Sbjct: 187 G------SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 13/166 (7%)
Query: 29 DLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFL 88
+ LQ +L + + + + + + + L L L + L
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL---CHL 459
Query: 89 QNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS--DGIPFGYIDLPKLKKLEL 146
+ + + L L +N L P L L LE + S N DG+ LP+L++L L
Sbjct: 460 EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVAN----LPRLQELLL 515
Query: 147 QENYLDG--QIPPFNQ-TSLIDFNVSYNNL-DGPIPQTRVVQSFPS 188
N L I P L+ N+ N+L Q R+ + PS
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 37/214 (17%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 266 EKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPV-FDLDDLLRASAEV 324
++ N G S E + P + D IP +++ +
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIR-------HL 60
Query: 325 LGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G G G +A VVA+K++ + + + K ++++ +L +L H+++ K++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 382 YYSKEEKL-----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
K+ + ++ E + D R + L +++ G+ +
Sbjct: 121 VIPKDVEKFDELYVVLEIADS----DFKKLFR--TPVYLTELHIKTLLYNLLVGVKY--- 171
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470
+HS + H +LK +N L+ ++ + K+ +FG
Sbjct: 172 -VHSAGILHRDLKPANCLVNQDCSV---KVCDFG 201
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 21/127 (16%), Positives = 40/127 (31%), Gaps = 15/127 (11%)
Query: 62 VSCSNGHIVSL-----ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN-- 110
++ + E + L+ + + L L L + ++
Sbjct: 9 AFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 111 LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYL-DGQIPPF---NQTSLIDF 166
NL NL + L + P + L L +L L L D + N +L
Sbjct: 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 167 NVSYNNL 173
++S N +
Sbjct: 129 DLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 25/145 (17%), Positives = 44/145 (30%), Gaps = 21/145 (14%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQN 125
+ LEL + +N+ L L L ++ + L L +L + L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFC 107
Query: 126 HFSDGI--PFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQT 180
SD + + +L L +L+L +N + SL + S N +
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI------- 160
Query: 181 RVVQSFPSSSFEHNSGLCGRPLEKL 205
L G+ L
Sbjct: 161 ---FLVCEHEL---EPLQGKTLSFF 179
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 28/137 (20%), Positives = 46/137 (33%), Gaps = 16/137 (11%)
Query: 57 SNWFGVSCSNGHIVSLELEEIQLA-GILPPGFLQNITFLNKLSLRNNLLS--GSLPNLTN 113
+ F H+ L L L+ +L G+ +N+ L +L L N + P+
Sbjct: 90 PDAF---QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146
Query: 114 LVNLETVFLSQNHFSDGIP--FGYIDLPKLKKLELQENYLDGQIP--------PFNQTSL 163
L +L+++ S N + L L N L ++ PF L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 164 IDFNVSYNNLDGPIPQT 180
+VS N I
Sbjct: 207 EILDVSGNGWTVDITGN 223
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 29/134 (21%), Positives = 48/134 (35%), Gaps = 21/134 (15%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
+ L E +L + FL + L L L N S + + +LE +FL +N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 129 DGIPFG-----YIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQT 180
+ L L+ L L NYL+ +PP + T+L +++ N L
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRL------- 516
Query: 181 RVVQSFPSSSFEHN 194
+ N
Sbjct: 517 ---TVLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 26/127 (20%), Positives = 44/127 (34%), Gaps = 8/127 (6%)
Query: 78 QLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN------LTNLVNLETVFLSQNHFSDGI 131
+ + L +L L N+L + L +L+ ++L+ N+ +
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 132 PFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSF 191
P + L L+ L L N L +L ++S N L P P S
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDV--FVSLSVLDI 554
Query: 192 EHNSGLC 198
HN +C
Sbjct: 555 THNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 19/105 (18%), Positives = 36/105 (34%), Gaps = 9/105 (8%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
+ I L I+ + + L L LR+N L+ + + ++ +FLS N
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVT 395
Query: 130 GIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174
+P + + E + LD L ++ N
Sbjct: 396 -LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 30/124 (24%), Positives = 49/124 (39%), Gaps = 19/124 (15%)
Query: 65 SNGHIVSLE---------LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
S+G + SL L+ + LA + + L L+L NLL L +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSS 332
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVS 169
L + + L +NH + + L KL+ L+L++N L S+ D +S
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT---IHFIPSIPDIFLS 389
Query: 170 YNNL 173
N L
Sbjct: 390 GNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 26/149 (17%), Positives = 45/149 (30%), Gaps = 28/149 (18%)
Query: 66 NGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLR------------NNLLSGSLPNLTN 113
N + L++ + F I+ SL +N+
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 114 LV--NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP---FNQTSLIDFNV 168
L ++ + LS + L LK L L N ++ +I + +L N+
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNL 321
Query: 169 SYNNLDGPIPQTRVVQSFPSSSFEHNSGL 197
SYN L SS+F +
Sbjct: 322 SYNLL----------GELYSSNFYGLPKV 340
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 27/129 (20%), Positives = 53/129 (41%), Gaps = 21/129 (16%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS- 128
L+L ++ + G Q+++ L+ L L N + SL + L +L+ + + + +
Sbjct: 57 LDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS 114
Query: 129 -DGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQ 184
+ P G L LK+L + N + P F+ T+L ++S N + Q
Sbjct: 115 LENFPIG--HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI----------Q 162
Query: 185 SFPSSSFEH 193
S +
Sbjct: 163 SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 29/140 (20%), Positives = 50/140 (35%), Gaps = 22/140 (15%)
Query: 51 PCIDNVSNWFGVSCSNGHIVS-----------LELEEIQLAGILPPGFLQNITFLNKLSL 99
PC++ V N C + L+L L L + L L L
Sbjct: 2 PCVEVVPN-ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDL 59
Query: 100 RNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYLDGQIP 156
+ ++ + +L +L T+ L+ N + G L L+KL E L +
Sbjct: 60 SRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLE 116
Query: 157 --PFNQ-TSLIDFNVSYNNL 173
P +L + NV++N +
Sbjct: 117 NFPIGHLKTLKELNVAHNLI 136
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/111 (25%), Positives = 42/111 (37%), Gaps = 10/111 (9%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLS----GSLPNLTNLVNLE-TVFLSQNH 126
L + + P + N+T L L L +N + L L + L ++ LS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLD 174
+ I G +LK+L L N L +P TSL + N D
Sbjct: 189 MNF-IQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 40/129 (31%), Positives = 58/129 (44%), Gaps = 20/129 (15%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L+L+ +L+ LP +T L L L +N L +LP L NLET++++ N
Sbjct: 41 KLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQ 184
+P G D L L +L L N L +PP F+ T L ++ YN L Q
Sbjct: 99 A-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL----------Q 146
Query: 185 SFPSSSFEH 193
S P F+
Sbjct: 147 SLPKGVFDK 155
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 36/133 (27%), Positives = 54/133 (40%), Gaps = 20/133 (15%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
+L + + +L LP G + L +L L N L SLP +L L + L N
Sbjct: 89 TLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQ 184
+P G D L LK+L L N L ++P F++ T L + N L +
Sbjct: 147 S-LPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQL----------K 194
Query: 185 SFPSSSFEHNSGL 197
P +F+ L
Sbjct: 195 RVPEGAFDSLEKL 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 54/323 (16%), Positives = 109/323 (33%), Gaps = 56/323 (17%)
Query: 225 PPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNE---GQAGEGSAH 281
+E S +I+ ++ A + +K+ + E +
Sbjct: 97 TEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQN 156
Query: 282 LSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDD--LLRASAEVLGKG---KV-GSTYK 335
L + R + + + I + ++D + R ++G+G +V G
Sbjct: 157 LRGDVFQKFIESDKFTRFCQWKNVELNIHL-TMNDFSVHR----IIGRGGFGEVYGCRKA 211
Query: 336 ATLESGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAKIVSFYYS--KEEKL- 389
T G + A+K + K+ + +L + + IV Y+ +KL
Sbjct: 212 DT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268
Query: 390 IIYEFLPNGSLFDLLHESRG----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPH 445
I + + G L L + R A II L H +H+ V +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAA-----EII------LGLEH--MHNRFVVY 315
Query: 446 ANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--SPEF--PE----GKR 497
+LK +NIL+ + ++++ G + S+ + + PE G
Sbjct: 316 RDLKPANILLDEHGHV---RISDLGL-----ACDFSKKKPHASVGTHGYMAPEVLQKGVA 367
Query: 498 LTHKADVYCFGIILLEVITGRIP 520
AD + G +L +++ G P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 11/109 (10%)
Query: 74 LEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHF 127
L E+ L + L + L +L L +N + + N L+ L L + L N
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLD 174
S +P G DL L+ + L N + ++ F YN +
Sbjct: 254 SR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/127 (19%), Positives = 52/127 (40%), Gaps = 20/127 (15%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLPN- 110
V CS+ + ++ + + L L + + L L L NN +S +
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEK 96
Query: 111 -LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQ-TSLIDF 166
+ L L+ +++S+NH + IP L +L + +N + ++P F+ ++
Sbjct: 97 AFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRI-RKVPKGVFSGLRNMNCI 152
Query: 167 NVSYNNL 173
+ N L
Sbjct: 153 EMGGNPL 159
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSK--KEFVQQMQLLGKLKHEN 374
+ LG G G +G VAVK ++++++ + K +E +Q ++L +H +
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE-IQNLKLF---RHPH 77
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ K+ + + ++ E++ G LFD + ++ GR+ + RL +Q G+ +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRL--FQQILSGVDYC 132
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGR 488
H H V H +LK N+L+ + K+ +FG ++ + S N A
Sbjct: 133 H----RHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYA--- 182
Query: 489 SPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE G+ + D++ G+IL ++ G +P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 43/231 (18%), Positives = 81/231 (35%), Gaps = 48/231 (20%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKH--ENL 375
+G G G +++ AVK V+N K++ + +L K+++ N
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINN 95
Query: 376 AKIV----SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
IV F Y + +I+E L SL++++ + G + + + K L
Sbjct: 96 NNIVKYHGKFMY-YDHMCLIFEPL-GPSLYEIITRNNYNG-FHIE-DIK-LYCIEILKAL 150
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI----- 486
+L + + H +LK NIL+ +++ I
Sbjct: 151 NYLRK----MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 487 G------------------RSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
G R+PE +D++ FG +L E+ TG +
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 55/234 (23%)
Query: 310 PVFDLDD--LLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ- 365
P + L D +LR LG G G + +G A+K L K+ V+ Q
Sbjct: 1 PKYSLQDFQILR----TLGTGSFGRVHLIRSRHNGRYYAMK------VLKKEIVVRLKQV 50
Query: 366 --------LLGKLKHENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIP 414
+L + H I+ + + +++ +I +++ G LF LL R R P
Sbjct: 51 EHTNDERLMLSIVTHPF---IIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP 104
Query: 415 LAWTTRL---SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
+ + LA + LHS + + +LK NIL+ + I K+T+FGF
Sbjct: 105 NP-VAKFYAAEVC------LALEY--LHSKDIIYRDLKPENILLDKNGHI---KITDFGF 152
Query: 472 LPLLPSRKAS-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+P + + +A PE K D + FGI++ E++ G P
Sbjct: 153 AKYVPDVTYTLCGTPDYIA----PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 21/114 (18%), Positives = 36/114 (31%), Gaps = 16/114 (14%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLT----NLVNLETVFLSQNHFSDGIPFGYID- 137
++T L L L+ N L L + + +L+ + +SQN S G
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 138 LPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSF 191
L L + N L I + ++ N + +S P
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI----------KSIPKQVV 441
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 8/107 (7%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNN-LLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L++ + ++ G L L++ +N L L ++ + L N
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS- 435
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLD 174
IP + L L++L + N L +P TSL + N D
Sbjct: 436 IPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140
L + +++ L L + +N + L LE + LS N I
Sbjct: 36 LWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KISCHP--TVN 91
Query: 141 LKKLELQENYLD--GQIPPF-NQTSLIDFNVSYNNL 173
LK L+L N D F N + L +S +L
Sbjct: 92 LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 9/124 (7%)
Query: 57 SNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSL-RNNLLSGSLPNLTNLV 115
F S ++ +S+ + G + + +N + + + + +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 116 NLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYLDGQIPPF-----NQTSLIDFNVS 169
+ S N +D F L +L+ L LQ N L ++ SL ++S
Sbjct: 325 PFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDIS 382
Query: 170 YNNL 173
N++
Sbjct: 383 QNSV 386
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/125 (16%), Positives = 40/125 (32%), Gaps = 6/125 (4%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGI 131
L + ++ L + L L L +N L + VNL+ + LS N F
Sbjct: 50 LIISHNRIQY-LDISVFKFNQELEYLDLSHNKLV-KIS-CHPTVNLKHLDLSFNAFDALP 106
Query: 132 PFGYID-LPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSS 190
+ +LK L L +L + + ++ + L + + +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHL--EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164
Query: 191 FEHNS 195
E
Sbjct: 165 TESLH 169
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LP 139
+P Q T LN + N +S L + +L L + +S N +
Sbjct: 15 VPKDLSQKTTILN---ISQNYIS-ELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQ 69
Query: 140 KLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174
+L+ L+L N L I +L ++S+N D
Sbjct: 70 ELEYLDLSHNKLVK-ISCHPTVNLKHLDLSFNAFD 103
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 63/254 (24%)
Query: 303 EFFDKTIPVFDLDDLLRASAE------VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL 355
E+ + P +R E V+G+G G L + V A+K L
Sbjct: 54 EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK------IL 107
Query: 356 SKKEFVQQMQ---------LLGKLKHENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDL 403
+K E +++ + +L + I + +Y+ + L ++ ++ G L L
Sbjct: 108 NKWEMLKRAETACFREERDVLVNGDSK---WITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 404 LHESRGVGRIPLAWTTRLSIIKQTAK------GLAFLHQTLHSHKVPHANLKSSNILIFR 457
L S+ R+P A+ +A +H H ++K NIL+
Sbjct: 165 L--SKFEDRLPEEM----------ARFYLAEMVIAIDS--VHQLHYVHRDIKPDNILMDM 210
Query: 458 ENDIYRAKLTNFGF-LPLLPSRKASENLAIGRSPEF--PE------GKRLTH--KADVYC 506
I +L +FG L L+ ++A+G +P++ PE G + + + D +
Sbjct: 211 NGHI---RLADFGSCLKLMEDGTVQSSVAVG-TPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 507 FGIILLEVITGRIP 520
G+ + E++ G P
Sbjct: 267 LGVCMYEMLYGETP 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 41/215 (19%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSKKEFVQQMQLLGKLKHENLAKI 378
LG+G G A + VAVK R + KKE + ++L HEN +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKML---NHEN---V 67
Query: 379 VSFYYSKEEKLIIY---EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
V FY + E I Y E+ G LFD + I + Q G+ +LH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL---------AI 486
+ H ++K N+L+ +++ K+++FG + L
Sbjct: 123 ----GIGITHRDIKPENLLLDERDNL---KISDFGLATVFRYNNRERLLNKMCGTLPYV- 174
Query: 487 GRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE + + DV+ GI+L ++ G +P
Sbjct: 175 --APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 38/207 (18%), Positives = 82/207 (39%), Gaps = 27/207 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
LG+GK ++A + + V VK +K + KK+ +++++L L+ N+ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 381 FYYSKEEKLIIY--EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ E + N L L + + K L + H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH--- 147
Query: 439 HSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL-PLLPSRKASENLAIG--RSPE-FP 493
S + H ++K N++I E+ + +L ++G P ++ + +A + PE
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKL---RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIP 520
+ + + D++ G +L +I + P
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 12/107 (11%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ ++++ L + P + L ++ NN L LP L NL L ++ N
Sbjct: 154 FLKIIDVDNNSLKKL--PDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSL 207
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNL 173
+P L+ + N L+ ++P L N L
Sbjct: 208 KK-LPDL---PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 21/81 (25%), Positives = 32/81 (39%), Gaps = 7/81 (8%)
Query: 94 LNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDG 153
L L + NN L LP L N L+ + + N +P P L+ + N L+
Sbjct: 133 LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE- 186
Query: 154 QIPPF-NQTSLIDFNVSYNNL 173
++P N L N+L
Sbjct: 187 ELPELQNLPFLTAIYADNNSL 207
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 12/106 (11%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ ++ + L + P + L + NN+L LP L NL L T++ N
Sbjct: 196 FLTAIYADNNSLKKL--PDLPLS---LESIVAGNNILE-ELPELQNLPFLTTIYADNNLL 249
Query: 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+P P L+ L +++NYL +P Q SL +VS N
Sbjct: 250 KT-LPDL---PPSLEALNVRDNYLT-DLPELPQ-SLTFLDVSENIF 289
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 25/107 (23%), Positives = 44/107 (41%), Gaps = 14/107 (13%)
Query: 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNH 126
+ L++ E +G+ N+ +LN S L P+L L +S N
Sbjct: 277 QSLTFLDVSENIFSGL--SELPPNLYYLNASSNEIRSLCDLPPSLEEL------NVSNNK 328
Query: 127 FSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ +P P+L++L N+L ++P +L +V YN L
Sbjct: 329 LIE-LPA---LPPRLERLIASFNHL-AEVPELP-QNLKQLHVEYNPL 369
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 50/243 (20%), Positives = 87/243 (35%), Gaps = 39/243 (16%)
Query: 303 EFFDKTIPVFDLDDLLRASAE------VLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL 355
+F P+ +R + V+G+G + ++G V A+K + + L
Sbjct: 41 DFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 356 SKKEFVQQMQ---LLGKLKHENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRG 409
+ E + +L I +++ E L ++ E+ G L LL S+
Sbjct: 101 KRGEVSCFREERDVLVNGDRR---WITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKF 155
Query: 410 VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469
RIP R + + +A +H H ++K NIL+ R I +L +F
Sbjct: 156 GERIPAEMA-RFYLAEIV---MAIDS--VHRLGYVHRDIKPDNILLDRCGHI---RLADF 206
Query: 470 GF-LPLLPSRKASENLAIGR----SPEFPEGKRLTHKADVY-------CFGIILLEVITG 517
G L L +A+G SPE + Y G+ E+ G
Sbjct: 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
Query: 518 RIP 520
+ P
Sbjct: 267 QTP 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 8e-07
Identities = 88/627 (14%), Positives = 177/627 (28%), Gaps = 148/627 (23%)
Query: 19 IADYYPA--ERYDLLQIRDSLN---STANLHSRWTGPPCIDNVSNWFGVSCSNG-HIVSL 72
++ + A + +D ++D S + + F S +V
Sbjct: 22 LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK 81
Query: 73 ELEEIQLAGILPPGFLQ-NITFL-NKLSLRNNLLSGSLPNLTNLVNLETVFLSQ--NHFS 128
+EE+ L+ N FL + + S +++ Q ++
Sbjct: 82 FVEEV----------LRINYKFLMSPIKTEQRQPSMM----------TRMYIEQRDRLYN 121
Query: 129 DGIPFGYIDLPKLKK--------LELQEN---YLDGQIPPFNQTSLIDFNVSYNNLDGPI 177
D F ++ +L+ LEL+ +DG +T + +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV-LGSGKTWVA--LDVCLSY---- 174
Query: 178 PQTRVVQSFPSSSFEHNSGLCGRP------LEKLCPISPPPPSPAIPPPSPPPPPKEDKK 231
+V F N C P L+KL P + S +
Sbjct: 175 ---KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 232 KSLK-----------------IWSVALIAAGSALVPFLVMLLFWCCYKKV----HEKEKS 270
L+ + + A F C K+ K+ +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNA------F----NLSC---KILLTTRFKQVT 278
Query: 271 NEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDK--TIPVFDL-DDLLRASAEVLGK 327
+ A + H+S S ++ E K DL ++L + L
Sbjct: 279 DFLSAATTT-HISLDHH--SMTLTPDE---VKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 328 -GKVGSTYKATLESGAVVAVKRVKNM-----NALSKKEFVQQMQLLGKL-KHENL-AKIV 379
+ AT ++ V ++ + N L E+ + L ++ ++
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392
Query: 380 SFYY---SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSI-IKQTAKGLAFLH 435
S + K + +++ L SL + IP + + +K + LH
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIPS-----IYLELKVKLENEYALH 446
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP--LLPSRKASENLAIGRSPEFP 493
+++ H S +++ D Y + + L R F
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYL-DQYF-----YSHIGHHLKNIEHP------ERMTLFR 494
Query: 494 EGKRLTHKADVYC-FGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL- 551
V+ F + ++ N S T L + + DND + L
Sbjct: 495 M---------VFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 552 -DVEILAAREGQN----EMLRLTELAL 573
+ + +N + L +AL
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 50/263 (19%), Positives = 99/263 (37%), Gaps = 59/263 (22%)
Query: 290 SWSMEDPERRVELEFFDKTIPVFDLDDLLRASAE------VLGKGKVGSTYKATL-ESGA 342
+ + ++ F + + LR AE V+G+G G +
Sbjct: 37 DFPALRKNKNID-NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 343 VVAVKRVKNMNALSKKEFVQQMQ---------LLGKLKHENLAKIVSFYYS--KEEKL-I 390
V A+K LSK E +++ ++ +V +Y+ + L +
Sbjct: 96 VYAMK------LLSKFEMIKRSDSAFFWEERDIMAFANSP---WVVQLFYAFQDDRYLYM 146
Query: 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFLHQTLHSHKVPHAN 447
+ E++P G L +L+ +P W R ++ LA +HS H +
Sbjct: 147 VMEYMPGGDLVNLMSN----YDVPEKWA-RFYTAEVV------LALDA--IHSMGFIHRD 193
Query: 448 LKSSNILIFRENDIYRAKLTNFGF-LPLLPSRKASENLAIGRSPEF--PE-----GKRLT 499
+K N+L+ + + KL +FG + + + A+G +P++ PE G
Sbjct: 194 VKPDNMLLDKSGHL---KLADFGTCMKMNKEGMVRCDTAVG-TPDYISPEVLKSQGGDGY 249
Query: 500 HKADV--YCFGIILLEVITGRIP 520
+ + + G+ L E++ G P
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTP 272
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 25/84 (29%), Positives = 33/84 (39%), Gaps = 1/84 (1%)
Query: 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS 128
+ L L+ + G L LSL N L S+ NL L L+ + LS+N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIF 84
Query: 129 DGIPFGYIDLPKLKKLELQENYLD 152
G+ LP L L L N L
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 20/132 (15%), Positives = 45/132 (34%), Gaps = 19/132 (14%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L L + + G + + L K++ NN ++ + + + L+ N +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN 95
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQS 185
+ L LK L L+ N + + F +S+ ++ N + +
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQI----------TT 143
Query: 186 FPSSSFEHNSGL 197
+F+ L
Sbjct: 144 VAPGAFDTLHSL 155
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 47/228 (20%), Positives = 77/228 (33%), Gaps = 46/228 (20%)
Query: 323 EVLGKGKVGSTYKA--TLESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKH---E 373
LG+G G + + VA+K ++N ++ + + +L K+K E
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKE 79
Query: 374 NLAKIV----SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK 429
N V F + I +E L + F+ L E+ PL R + Q
Sbjct: 80 NKFLCVLMSDWFNF-HGHMCIAFELL-GKNTFEFLKENNFQP-YPLP-HVR-HMAYQLCH 134
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-------S- 481
L FLH+ +++ H +LK NIL F ++ + + S
Sbjct: 135 ALRFLHE----NQLTHTDLKPENIL-FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 482 --ENLAIG--------RSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
++ R PE DV+ G IL E G
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 12/118 (10%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNI-TFLNKLSLRNNLLSGSLPNLTNLVN-----LETVF 121
+ L LE +++ G PP L+ LN L+LRN + L L L+ +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 122 LSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIP------PFNQTSLIDFNVSYNNL 173
++Q H + P L L+L +N G+ P +L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 29/104 (27%), Positives = 37/104 (35%), Gaps = 3/104 (2%)
Query: 74 LEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLT-NLVNLETVFLSQNHFSDGIP 132
L E L L P + L + SG L V L+ + LS N D
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 133 FGYIDLP-KLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175
D P +L L L L Q+P L ++SYN LD
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 13/122 (10%)
Query: 69 IVSLELEEIQLAGILPPGFLQ--NITFLNKLSLRNNLLSGSLP----NLTNLVNLETVFL 122
+ L + ++ + G L+ I+ L +L+L N ++G+ P T +L + L
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP-DLNILNL 128
Query: 123 SQNHFSDGIPF----GYIDLPKLKKLELQENYLDGQIPPFNQ--TSLIDFNVSYNNLDGP 176
++ + P LK L + + + + +L ++S N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 177 IP 178
Sbjct: 189 RG 190
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVK-----RVKNMNALSK--KEFVQQMQLLGKLKHEN 374
E LG+G G AT ++ VA+K +K + + +E + ++LL +H +
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE-ISYLKLL---RHPH 70
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ K+ + + +++ E+ G LFD + V + + +Q + +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYI-----VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGR 488
H HK+ H +LK N+L+ ++ K+ +FG ++ S N A
Sbjct: 125 H----RHKIVHRDLKPENLLLDDNLNV---KIADFGLSNIMTDGNFLKTSCGSPNYA--- 174
Query: 489 SPEFPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+PE GK + DV+ GI+L ++ GR+P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 5/83 (6%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L L+ ++ + L+ + L KL L N +S ++ N L N +L + L+ N
Sbjct: 196 ELHLDGNKITKV-DAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
Query: 129 DGIPFGYIDLPKLKKLELQENYL 151
+P G D ++ + L N +
Sbjct: 254 K-VPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 20/111 (18%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 68 HIVSLELEEIQL-AGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNH 126
++ +EL L + + G Q + L+ + + + ++ ++P +L + L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNK 203
Query: 127 FSDGIPFGYID-LPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNL 173
+ + + L L KL L N + + N L + +++ N L
Sbjct: 204 ITK-VDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 27/151 (17%), Positives = 50/151 (33%), Gaps = 42/151 (27%)
Query: 62 VSCSNGHIVSL------ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLS----GS 107
V CS+ + + + + L + G +N+ L+ L L NN +S G+
Sbjct: 36 VQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 108 LPNLTNLV------------------NLETVFLSQNHFSDGIP---FGYIDLPKLKKLEL 146
L L L+ + + +N + + F L ++ +EL
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK-VRKSVFN--GLNQMIVVEL 152
Query: 147 QENYL-DGQIPP--F-NQTSLIDFNVSYNNL 173
N L I F L ++ N+
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 27/135 (20%), Positives = 49/135 (36%), Gaps = 22/135 (16%)
Query: 62 VSCSNGHIVS-----------LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN 110
S+G + S L+L ++ + LQ L L L +N ++ ++
Sbjct: 36 CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 111 --LTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYLDGQIPPF----NQTSL 163
++L +LE + LS N+ S+ + + L L L L N + + T L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKL 151
Query: 164 IDFNVSYNNLDGPIP 178
V + I
Sbjct: 152 QILRVGNMDTFTKIQ 166
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 23/118 (19%), Positives = 38/118 (32%), Gaps = 15/118 (12%)
Query: 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLL---------SGSLPNLTNLVNLET 119
+ L L Q +L F+ + + L LR+ L +G +L
Sbjct: 200 VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 120 VFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVSYNNLD 174
V ++ + + L +LE N L +P TSL + N D
Sbjct: 259 VKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 15/133 (11%), Positives = 36/133 (27%), Gaps = 10/133 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L L + ++T L L + N + L LE + + +
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQ 184
+ + + L L + + +S+ + +LD +
Sbjct: 188 S-YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT--FHFSELS 243
Query: 185 SFPSSSFEHNSGL 197
+ ++S
Sbjct: 244 TGETNSLIKKFTF 256
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 1/85 (1%)
Query: 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127
+ L L+ + G L LS N L+ S+ NL L L+ + LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRV 76
Query: 128 SDGIPFGYIDLPKLKKLELQENYLD 152
S G+ P L L L N +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 54/260 (20%)
Query: 293 MEDPERRVELEFFDKTIPVFDLDD---LLRASAEVLGKGKVGSTYKATLESGAVVAVKRV 349
M+ + + + + R + G G+ G VA+KRV
Sbjct: 2 MQAKGEAAMRDLIAEL---HAMQSPYTVQR----FISSGSYGAVCAGVDSEGIPVAIKRV 54
Query: 350 KNMNALSKKEFVQQ-----------MQLLGKLKHENLAKIVSFYYSKEEKL-----IIYE 393
N + + + ++LL H N+ + + EE ++ E
Sbjct: 55 FNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453
+ DL + RI ++ + GL LH V H +L NI
Sbjct: 115 LMRT----DL-AQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNI 165
Query: 454 LIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG--------RSPEFPEG-KRLTHKADV 504
L+ NDI + +F +R+ + + R+PE K T D+
Sbjct: 166 LLADNNDI---TICDFNL-----AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217
Query: 505 YCFGIILLEVITGRI--PGN 522
+ G ++ E+ + G+
Sbjct: 218 WSAGCVMAEMFNRKALFRGS 237
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 32/83 (38%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L L QLA LP G ++T L+KL L N L SLP+ L L+ + L+ N
Sbjct: 88 LGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS 145
Query: 130 GIPFGYID-LPKLKKLELQENYL 151
IP G D L L+ L L N L
Sbjct: 146 -IPAGAFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 20/132 (15%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNL--TNLVNLETVFLSQNHFSD 129
L L+ QL L G ++T L L L NN L+ SLP +L L+ ++L N
Sbjct: 64 LNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK- 120
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQS 185
+P G D L KLK+L L N L IP F++ T+L ++S N L QS
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQL----------QS 169
Query: 186 FPSSSFEHNSGL 197
P +F+ L
Sbjct: 170 VPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 20/127 (15%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L+L+ LA L + +T L L+L N L +L +L L T+ L+ N +
Sbjct: 39 KLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 129 DGIPFGYID-LPKLKKLELQENYLDGQIPP--FNQ-TSLIDFNVSYNNLDGPIPQTRVVQ 184
+P G D L +L KL L N L +P F++ T L + ++ N L Q
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQL----------Q 144
Query: 185 SFPSSSF 191
S P+ +F
Sbjct: 145 SIPAGAF 151
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 32/104 (30%), Positives = 42/104 (40%), Gaps = 18/104 (17%)
Query: 62 VSCSNGHIVS-----------LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN 110
V CSN + L L+ Q L P L N L + L NN +S +L N
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRIS-TLSN 71
Query: 111 LT--NLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYL 151
+ N+ L T+ LS N IP D L L+ L L N +
Sbjct: 72 QSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDI 114
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 26/142 (18%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETV 120
CSN +E ++ I P +N +L L + + +LE +
Sbjct: 8 HCSNR---VFLCQESKVTEI-PSDLPRNAI---ELRFVLTKLR-VIQKGAFSGFGDLEKI 59
Query: 121 FLSQNHFSDGIPFGYID-LPKLKKLELQE-NYLDGQIPP--F-NQTSLIDFNVSYNNLDG 175
+SQN + I LPKL ++ +++ N L I P F N +L +S +
Sbjct: 60 EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-- 116
Query: 176 PIPQTRVVQSFPSSSFEHNSGL 197
+ P H+
Sbjct: 117 --------KHLPDVHKIHSLQK 130
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 13/111 (11%)
Query: 73 ELEEIQLAGI-----LPPGFLQNITFLNKLSLRNNLLSGSLPNLT--NLVNLETVFLSQN 125
+L EI++ + P QN+ L L + N + LP++ + + + + N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 126 HFSDGIPFGYID--LPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNN 172
I + L L +N + +I FN T L + N+S NN
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 5/84 (5%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L L + +L I G + L KL L+ N L+ + +++ + L +N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 129 DGIPFGYID-LPKLKKLELQENYL 151
+ I L +LK L L +N +
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQI 114
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 62/264 (23%), Positives = 97/264 (36%), Gaps = 47/264 (17%)
Query: 278 GSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDD--LLRASAEVLGKGKVGSTYK 335
G + E ++ ++ P ++ + P D L+ V+GKG G
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLL 56
Query: 336 ATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ----LLGKLKHENLAKIVSFYYS--KEEK 388
A AVK ++ L KKE M LL +KH +V ++S +K
Sbjct: 57 ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH---PFLVGLHFSFQTADK 113
Query: 389 L-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFLHQTLHSHKVP 444
L + +++ G LF H R R I A + LHS +
Sbjct: 114 LYFVLDYINGGELF--YHLQR-ERCFLEPRA-RFYAAEIA------SALGY--LHSLNIV 161
Query: 445 HANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS------ENLAIGRSPEFPEGK 496
+ +LK NIL+ + I LT+FG + + S E LA PE +
Sbjct: 162 YRDLKPENILLDSQGHI---VLTDFGLCKENIEHNSTTSTFCGTPEYLA----PEVLHKQ 214
Query: 497 RLTHKADVYCFGIILLEVITGRIP 520
D +C G +L E++ G P
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 49/230 (21%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLL 367
+++ + R + +G G G+ A +GA VA+K++ + L K ++++LL
Sbjct: 20 AWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 368 GKLKHENLAKIVSFYYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL 421
++HEN+ ++ + E ++ F+ DL + + L
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DL---GKLMKHEKLGEDRIQ 131
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481
++ Q KGL ++H + + H +LK N+ + + ++ K+ +FG +R+A
Sbjct: 132 FLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCEL---KILDFGL-----ARQAD 179
Query: 482 ENLAIG------RSPEFPEG-KRLTHKADVYCFGIILLEVITGRI--PGN 522
+ R+PE R T D++ G I+ E+ITG+ G+
Sbjct: 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 17/107 (15%)
Query: 61 GVSCSN-GHIVSLE-------LEEIQLAG-----ILPPGFLQNITFLNKLSLRNNLLSGS 107
G+ C+ G + SL L E+ + L L+ + L L++ + L
Sbjct: 12 GLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-F 70
Query: 108 LPNLT--NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLD 152
+ L + LS N + + + L++L L N L
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 25/136 (18%), Positives = 42/136 (30%), Gaps = 22/136 (16%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-----NLTNLVNLETVFLSQN 125
L + L + + L + +N S+P L N T+ L N
Sbjct: 109 FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNN 166
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FN--QTSLIDFNVSYNNLDGPIPQTR 181
F+ + + KL + L +N I F + +VS ++
Sbjct: 167 GFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-------- 217
Query: 182 VVQSFPSSSFEHNSGL 197
+ PS EH L
Sbjct: 218 --TALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 18/138 (13%), Positives = 41/138 (29%), Gaps = 17/138 (12%)
Query: 57 SNWFGVSCSNGHIVSL-----ELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGS 107
+ I + + ++L +P N+ ++++ + ++
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 108 LPN--LTNLVNLETVFLSQNHFSDGIPFGYID-LPKLKKLELQENYLDGQIPPFNQ---- 160
L + NL + + + I + LP LK L + L P +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYST 129
Query: 161 TSLIDFNVSYNNLDGPIP 178
++ N IP
Sbjct: 130 DIFFILEITDNPYMTSIP 147
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 51/224 (22%), Positives = 84/224 (37%), Gaps = 38/224 (16%)
Query: 323 EVLGKGKVGSTYKA--TLESGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKLKHENLAK 377
+ LG+G G + G VAVK VKN++ ++ E +Q ++ L + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-IQVLEHLNTTDPNSTFR 78
Query: 378 IV----SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
V F + I++E L S +D + E+ + L R + Q K + F
Sbjct: 79 CVQMLEWFEH-HGHICIVFELL-GLSTYDFIKENGFLP-FRLD-HIR-KMAYQICKSVNF 133
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA------------S 481
LH +K+ H +LK NIL F ++D A
Sbjct: 134 LHS----NKLTHTDLKPENIL-FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 482 ENLA--IG----RSPEFPEGKRLTHKADVYCFGIILLEVITGRI 519
E+ + + R+PE + DV+ G IL+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 44/197 (22%), Positives = 76/197 (38%), Gaps = 42/197 (21%)
Query: 412 RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471
+ L + Q AKG+ FL S K H +L + NIL+ E ++ K+ +FG
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL-SEKNV--VKICDFGL 239
Query: 472 LPLLPSRKASENL-----AIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRI 519
+R ++ R +PE + T ++DV+ FG++L E+ + G
Sbjct: 240 -----ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 520 PGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIA 579
P G + E L + RM R + + L+C
Sbjct: 295 PYPGVKIDEEFCRRLKEGTRM------------------RAPDYTTPEMYQTMLDCWHGE 336
Query: 580 PEKRPKMSEVLRRIEEI 596
P +RP SE++ + +
Sbjct: 337 PSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KHEN 374
+ LG+G G +A + VAVK +K + + ++++L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 375 LAKIVSFYYSKEEKL-IIYEFLPNGSLFDLLHESRG 409
+ ++ L +I EF G+L L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 61/278 (21%)
Query: 265 HEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEV 324
+K+ + E GS + S+ P+ RV + F+ L+ +
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE----------YLK----L 155
Query: 325 LGKGKVG----STYKATLESGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAK 377
LGKG G KAT G A+K +K ++K E + ++L +H
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH---PF 209
Query: 378 IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESR----GVGRIPLAWTTRLSIIKQTAKG 430
+ + YS ++L + E+ G LF L R R A +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 260
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS------E 482
L +LH V + +LK N+++ ++ I K+T+FG + E
Sbjct: 261 LDYLH---SEKNVVYRDLKLENLMLDKDGHI---KITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 483 NLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
LA PE E D + G+++ E++ GR+P
Sbjct: 315 YLA----PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 58/312 (18%), Positives = 112/312 (35%), Gaps = 37/312 (11%)
Query: 225 PPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSE 284
P + K + L G L+P + L C +++ + + Q H
Sbjct: 94 PDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYL 153
Query: 285 KKMPDSWSMEDPERRVELEFFDKTIPVFDLDD--LLRASAEVLGKG---KV-GSTYKATL 338
P + ++ L++ + R VLGKG +V +AT
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR----VLGKGGFGEVCACQVRAT- 208
Query: 339 ESGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395
G + A K+++ +K + Q+L K+ + + Y +K+ ++ +
Sbjct: 209 --GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455
G L H +G+ + + GL LH ++ + +LK NIL+
Sbjct: 267 NGGDLK--FHIYH-MGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILL 319
Query: 456 FRENDIYRAKLTNFGFLPLLPSRKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFG 508
I ++++ G +P + +A PE + +R T D + G
Sbjct: 320 DDHGHI---RISDLGLAVHVPEGQTIKGRVGTVGYMA----PEVVKNERYTFSPDWWALG 372
Query: 509 IILLEVITGRIP 520
+L E+I G+ P
Sbjct: 373 CLLYEMIAGQSP 384
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 60/297 (20%), Positives = 103/297 (34%), Gaps = 80/297 (26%)
Query: 265 HEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDD--LLRASA 322
H EG + G+A S + + + +++ LL+
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK--- 60
Query: 323 EVLGKG---KV----GSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN- 374
VLG G KV + T G + A+K L K VQ+ + + E
Sbjct: 61 -VLGTGAYGKVFLVRKISGHDT---GKLYAMK------VLKKATIVQKAKTTEHTRTERQ 110
Query: 375 -LAK------IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSII 424
L +V+ +Y+ E KL +I +++ G LF L + R +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----------RFTE- 158
Query: 425 KQTAK------GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478
+ LA H LH + + ++K NIL+ + LT+FG
Sbjct: 159 -HEVQIYVGEIVLALEH--LHKLGIIYRDIKLENILLDSNGHV---VLTDFGL------- 205
Query: 479 KASENLAIGRS--------PEF--PE---GKRLTHKADV--YCFGIILLEVITGRIP 520
+ E +A E+ P+ G H V + G+++ E++TG P
Sbjct: 206 -SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-----LTNLVNLETVFLSQNH 126
L L QL LP G ++T L L L N L+ LP+ L +L L F+ N
Sbjct: 69 LYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKEL---FMCCNK 123
Query: 127 FSDGIPFGYIDLPKLKKLELQENYL 151
+ +P G L L L L +N L
Sbjct: 124 LT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 6/84 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L L + Q+ L PG ++ L +L L +N L +LP +L L + L N +
Sbjct: 44 ILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 129 DGIPFGYID-LPKLKKLELQENYL 151
+P D L LK+L + N L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKL 124
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 25/121 (20%), Positives = 41/121 (33%), Gaps = 22/121 (18%)
Query: 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLV----------- 115
+ +LE+ QL + P + L+ S L L L
Sbjct: 81 PELRTLEVSGNQLTSL--PVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPV 138
Query: 116 ---NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNN 172
L+ + +S N + +P +L KL N L +P + L + +VS N
Sbjct: 139 LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPM-LPSGLQELSVSDNQ 192
Query: 173 L 173
L
Sbjct: 193 L 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 24/114 (21%), Positives = 37/114 (32%), Gaps = 19/114 (16%)
Query: 63 SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLS---GSLPNLTNLVNLET 119
+C N L + E L LP +IT L + +N L+ P L L
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCLPAHIT---TLVIPDNNLTSLPALPPELRTL----- 86
Query: 120 VFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+S N + +P L +L +L + L + N L
Sbjct: 87 -EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALP-----SGLCKLWIFGNQL 133
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 20/103 (19%), Positives = 37/103 (35%), Gaps = 10/103 (9%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG 130
L + +L LP + L +L + N L+ SLP L L ++ + +N +
Sbjct: 225 ELIVSGNRLTS-LPV----LPSELKELMVSGNRLT-SLPML--PSGLLSLSVYRNQLTR- 275
Query: 131 IPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+P I L + L+ N L + + +
Sbjct: 276 LPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 28/108 (25%), Positives = 42/108 (38%), Gaps = 16/108 (14%)
Query: 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQN 125
+ L QL LP + L +LS+ +N L+ SLP + L L N
Sbjct: 161 SELCKLWAYNNQLTS-LPM----LPSGLQELSVSDNQLA-SLPTLPSELYKLW---AYNN 211
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNL 173
+ +P LK+L + N L +P + L + VS N L
Sbjct: 212 RLTS-LP---ALPSGLKELIVSGNRL-TSLPVLP-SELKELMVSGNRL 253
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 20/114 (17%), Positives = 36/114 (31%), Gaps = 7/114 (6%)
Query: 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQN 125
+ L + +L LP + L LS+ N L+ LP +L +L + TV L N
Sbjct: 241 SELKELMVSGNRLT-SLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQ 179
S+ ++ D + + + + L
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 53/228 (23%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVS 380
+G+G G A + VA+K++ + + ++++++L + +HEN+ I
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 381 FYYSKEEKL-----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQTAK 429
+ + I+ + + DL + T LS + Q +
Sbjct: 93 IIRAPTIEQMKDVYIVQDLMET----DLYKLLK---------TQHLSNDHICYFLYQILR 139
Query: 430 GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-- 487
GL ++H S V H +LK SN+L+ D+ K+ +FG +R A +
Sbjct: 140 GLKYIH----SANVLHRDLKPSNLLLNTTCDL---KICDFGL-----ARVADPDHDHTGF 187
Query: 488 ----------RSPEFPEG-KRLTHKADVYCFGIILLEVITGRI--PGN 522
R+PE K T D++ G IL E+++ R PG
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 37/218 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIV 379
+G G GS A ++G VAVK++ + + K ++++LL +KHEN+ ++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 380 SFYYSKEEKL------IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+ ++ + DL + + L +I Q +GL +
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQ---KLTDDHVQFLIYQILRGLKY 147
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI------G 487
+H S + H +LK SN+ + + ++ K+ +FG +R ++ +
Sbjct: 148 IH----SADIIHRDLKPSNLAVNEDCEL---KILDFGL-----ARHTADEMTGYVATRWY 195
Query: 488 RSPE-FPEGKRLTHKADVYCFGIILLEVITGRI--PGN 522
R+PE D++ G I+ E++TGR PG
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/113 (20%), Positives = 48/113 (42%), Gaps = 9/113 (7%)
Query: 68 HIVSLELEEIQLAGILPP-----GFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFL 122
+V+ E E+++L G++PP L + L+L N + + +L+ + NL + L
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSL 77
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQ-TSLIDFNVSYNNLD 174
+N I L++L + N + + + +L +S N +
Sbjct: 78 GRNLIKK-IENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 2/65 (3%)
Query: 86 GFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKL 144
L +L + N ++ SL + LVNL +++S N ++ + L KL+ L
Sbjct: 87 NLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145
Query: 145 ELQEN 149
L N
Sbjct: 146 LLAGN 150
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 32/84 (38%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
LELE +L LP G +T L KLSL N + SLP+ L L ++L +N
Sbjct: 32 RLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 129 DGIPFGYID-LPKLKKLELQENYL 151
+P G D L +LK+L L N L
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQL 112
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 33/83 (39%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD 129
L L E QL LP G +T L L+L +N L SLP L NL + LS N
Sbjct: 114 LVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ- 170
Query: 130 GIPFGYID-LPKLKKLELQENYL 151
+P G D L +LK L L +N L
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 30/84 (35%), Positives = 38/84 (45%), Gaps = 6/84 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L L QL LP G +T L +L L N L SLP+ L NL + L+ N
Sbjct: 89 YLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 129 DGIPFGYID-LPKLKKLELQENYL 151
+P G D L L +L+L N L
Sbjct: 147 S-LPKGVFDKLTNLTELDLSYNQL 169
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 44/231 (19%), Positives = 84/231 (36%), Gaps = 50/231 (21%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+ LG G G + A + VA+K++ + S K +++++++ +L H+N+ K+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 382 YYSKEEKLIIYEFLPNGS-----LFDL----LHESRGVGRIPLAWTTRLS------IIKQ 426
+L + + L + L + Q
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--------VLEQGPLLEEHARLFMYQ 128
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
+GL ++H S V H +LK +N+ I E+ K+ +FG +R + +
Sbjct: 129 LLRGLKYIH----SANVLHRDLKPANLFINTED--LVLKIGDFGL-----ARIMDPHYSH 177
Query: 487 G------------RSPE-FPEGKRLTHKADVYCFGIILLEVITGRI--PGN 522
RSP T D++ G I E++TG+ G
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 46/268 (17%), Positives = 72/268 (26%), Gaps = 81/268 (30%)
Query: 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI--- 455
L + +S +PL + II+Q +GL +LH + H ++K NIL+
Sbjct: 130 HLLKWIIKSNY-QGLPLPCVKK--IIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVN 183
Query: 456 -----------------------FRENDIYRAKLTNFGFLPLLPSRKASENLAIG----- 487
A NF PL P + I
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243
Query: 488 ----------------RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531
RS E G AD++ + E+ TG G T
Sbjct: 244 CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
Query: 532 GDL-------------------SDWVRMVVDND---------WSTDILDVEILAAREGQN 563
+ + + + +V + Q
Sbjct: 304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363
Query: 564 EMLRLTELALECTDIAPEKRPKMSEVLR 591
E T+ L ++ PEKR +E LR
Sbjct: 364 EAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 51/233 (21%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVK----------------------RVKNMNALSKKEFV 361
+GKG G A A+K R + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 362 QQMQ----LLGKLKHENLAKIVSFYYSKEEKLI--IYEFLPNGSLFDLLHESRGVGRIPL 415
+Q+ +L KL H N+ K+V E + ++E + G + ++ PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPL 134
Query: 416 AWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475
+ + KG+ +LH K+ H ++K SN+L+ + I K+ +FG
Sbjct: 135 SEDQARFYFQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDGHI---KIADFGVSNEF 187
Query: 476 PSRKASENLAIGRSPEF--PEGKRLTHK------ADVYCFGIILLEVITGRIP 520
A + +G +P F PE T K DV+ G+ L + G+ P
Sbjct: 188 KGSDALLSNTVG-TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 32/86 (37%), Positives = 39/86 (45%), Gaps = 12/86 (13%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-----LTNLVNLETVFLSQNH 126
L L +L LP G +T L L+L N L SLPN LT L L L+ N
Sbjct: 57 LYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELA---LNTNQ 111
Query: 127 FSDGIPFGYID-LPKLKKLELQENYL 151
+P G D L +LK L L +N L
Sbjct: 112 LQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 32/84 (38%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFS 128
L+LE L LP G +T L +L L N L SLPN L +L + LS N
Sbjct: 32 YLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 129 DGIPFGYID-LPKLKKLELQENYL 151
+P G D L +LK+L L N L
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQL 112
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 34/210 (16%)
Query: 325 LGKGKVGSTYKAT-LESGAVVAVK---RVKNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+G G G + +VAVK R ++ ++E + + L +H N IV
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE-IINHRSL---RHPN---IVR 80
Query: 381 FY---YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
F + II E+ G L++ + + GR +Q G+++ H
Sbjct: 81 FKEVILTPTHLAIIMEYASGGELYERICNA---GRFSEDEARFF--FQQLLSGVSYCH-- 133
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LP----LLPSRKASENLAIGRSPE 491
S ++ H +LK N L+ + R K+ +FG+ S + +PE
Sbjct: 134 --SMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APE 187
Query: 492 FPEGKRLT-HKADVYCFGIILLEVITGRIP 520
+ ADV+ G+ L ++ G P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 316 DLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLK 371
D L+ +LGKG G +G A+K ++ ++K E + ++L +
Sbjct: 8 DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 372 HENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTA 428
H + + Y+ ++L + E+ G LF H SR R +
Sbjct: 64 H---PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSR-ERVFTEE-RARF-YGAEIV 115
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS----- 481
L +LH S V + ++K N+++ ++ I K+T+FG +
Sbjct: 116 SALEYLH----SRDVVYRDIKLENLMLDKDGHI---KITDFGLCKEGISDGATMKTFCGT 168
Query: 482 -ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
E LA PE E D + G+++ E++ GR+P
Sbjct: 169 PEYLA----PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 11/97 (11%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLT--NLVNLETVFLSQNHFSDGIPFGYIDLPK 140
L + ++ L L L +N + SL +LE + +S N I +
Sbjct: 67 LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMAS 122
Query: 141 LKKLELQENYLDGQIPPF----NQTSLIDFNVSYNNL 173
L+ L+L N D +P N T L +S
Sbjct: 123 LRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 21/111 (18%), Positives = 35/111 (31%), Gaps = 9/111 (8%)
Query: 72 LELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSD 129
L L ++ L L L + +N L ++ + +L +L+ LS N F
Sbjct: 81 LRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLD---LSFNDFDV 135
Query: 130 GIPFGYID-LPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQ 179
L KL L L Q+ L + + + I
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKG 185
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 64/262 (24%)
Query: 283 SEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVG----STYKATL 338
S K++ + +++ + + F+ LL+ VLG+G G +
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFE----------LLK----VLGQGSFGKVFLVKKISGS 49
Query: 339 ESGAVVAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAKIVSFYYS--KEEKL-IIY 392
++ + A+K +K + V+ +L ++ H IV +Y+ E KL +I
Sbjct: 50 DARQLYAMKVLKKATLKVRDR-VRTKMERDILVEVNH---PFIVKLHYAFQTEGKLYLIL 105
Query: 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAK------GLAFLHQTLHSHKVPHA 446
+FL G LF L + + + K LA H LHS + +
Sbjct: 106 DFLRGGDLFTRLSKEV-----------MFTE--EDVKFYLAELALALDH--LHSLGIIYR 150
Query: 447 NLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS------ENLAIGRSPEFPEGKRL 498
+LK NIL+ E I KLT+FG + +KA E +A PE +
Sbjct: 151 DLKPENILLDEEGHI---KLTDFGLSKESIDHEKKAYSFCGTVEYMA----PEVVNRRGH 203
Query: 499 THKADVYCFGIILLEVITGRIP 520
T AD + FG+++ E++TG +P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLP 225
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 56/319 (17%), Positives = 105/319 (32%), Gaps = 62/319 (19%)
Query: 230 KKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQAGEGSAHLSEKKMPD 289
+K+ + + L FL + + AHL + +
Sbjct: 104 PQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLF--QPLLRAVLAHLGQAPFQE 161
Query: 290 SWSMEDPERRVELEFFDKTIPVFDLDD--LLRASAEVLGKG---KV-GSTYKATLESGAV 343
R ++ ++ + P+ D R VLG+G +V KAT G +
Sbjct: 162 FLDSLYFLRFLQWKWLEAQ-PM-GEDWFLDFR----VLGRGGFGEVFACQMKAT---GKL 212
Query: 344 VAVKRVKNMNALSKKEFVQQM---QLLGKLKHENLAKIVSFYYS--KEEKL-IIYEFLPN 397
A K++ +K + M ++L K+ IVS Y+ + L ++ +
Sbjct: 213 YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS---RFIVSLAYAFETKTDLCLVMTIMNG 269
Query: 398 GSLF-DLLHESRGVGRIPLAWTTRL---SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453
G + + + I+ H LH + + +LK N+
Sbjct: 270 GDIRYHIYNVDEDNPGFQEP-RAIFYTAQIV------SGLEH--LHQRNIIYRDLKPENV 320
Query: 454 LIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS-------PEF--PE---GKRLTHK 501
L+ + ++ ++++ G A E A P F PE G+
Sbjct: 321 LLDDDGNV---RISDLGL--------AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 502 ADVYCFGIILLEVITGRIP 520
D + G+ L E+I R P
Sbjct: 370 VDYFALGVTLYEMIAARGP 388
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 58/238 (24%), Positives = 86/238 (36%), Gaps = 66/238 (27%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKHENLAK 377
+LG+G G AT +G +VA+K++ K F + +++L KHEN+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 378 IVSFYYSKEEKL-----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS------IIKQ 426
I + + II E + DL T LS I Q
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQT----DLHRVIS---------TQMLSDDHIQYFIYQ 120
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
T + + LH V H +LK SN+LI D+ K+ +FG +R E+ A
Sbjct: 121 TLRAVKVLH----GSNVIHRDLKPSNLLINSNCDL---KVCDFGL-----ARIIDESAAD 168
Query: 487 GRSPEF----------------PE----GKRLTHKADVYCFGIILLEVITGRI--PGN 522
P PE + + DV+ G IL E+ R PG
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 4/84 (4%)
Query: 72 LELEEIQLAGILPP---GFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFS 128
+ E+ L G P + + + +N + L L L+T+ ++ N
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRIC 77
Query: 129 DGIPFGYIDLPKLKKLELQENYLD 152
LP L +L L N L
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLV 101
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 54/233 (23%), Positives = 81/233 (34%), Gaps = 60/233 (25%)
Query: 316 DLLRASAEVLGKGKVG----STYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK 371
+LLR VLGKG G +G + A+K L K V+ + K
Sbjct: 20 ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMK------VLKKAMIVRNAKDTAHTK 69
Query: 372 HEN--LAK-----IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRL 421
E L + IV Y+ KL +I E+L G LF L
Sbjct: 70 AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-----------IF 118
Query: 422 SIIKQTAK------GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LP 473
TA +A H LH + + +LK NI++ + + KLT+FG
Sbjct: 119 ME--DTACFYLAEISMALGH--LHQKGIIYRDLKPENIMLNHQGHV---KLTDFGLCKES 171
Query: 474 LLPSRKAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+ E +A PE D + G ++ +++TG P
Sbjct: 172 IHDGTVTHTFCGTIEYMA----PEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 53/228 (23%)
Query: 316 DLLRASAEVLGKGKVG----STYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK 371
L + +LGKG G + +K T A+K AL KK+ V +
Sbjct: 20 ILHK----MLGKGSFGKVFLAEFKKT---NQFFAIK------AL-KKDVVLMDDDVECTM 65
Query: 372 HEN--LAK------IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTR 420
E L+ + + + +E L + E+L G L + + L+
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLS-RAT 121
Query: 421 LSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSR 478
+ GL FLH S + + +LK NIL+ ++ I K+ +FG +L
Sbjct: 122 F-YAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHI---KIADFGMCKENMLGDA 173
Query: 479 KAS------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
K + + +A PE G++ H D + FG++L E++ G+ P
Sbjct: 174 KTNTFCGTPDYIA----PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 15/103 (14%), Positives = 24/103 (23%), Gaps = 5/103 (4%)
Query: 83 LPPGFLQNI---TFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDL 138
LP ++N R N ++ +P N+ +L T+ L N S I
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 139 PKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTR 181
Y N +
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 29/128 (22%), Positives = 44/128 (34%), Gaps = 29/128 (22%)
Query: 64 CSNGHIVSLELEEIQLAGILPPGFLQNITFLN-----------------KLSLRNNLLSG 106
C L+L + L+ LP IT L L +N LS
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLPPQITVLEITQNALISLPELPASLEYLDACDNRLS- 113
Query: 107 SLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLID 165
+LP +L +L+ + N + +P L+ + N L +P TSL
Sbjct: 114 TLPELPASLKHLD---VDNNQLTM-LP---ELPALLEYINADNNQL-TMLPE-LPTSLEV 164
Query: 166 FNVSYNNL 173
+V N L
Sbjct: 165 LSVRNNQL 172
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 32/207 (15%), Positives = 59/207 (28%), Gaps = 62/207 (29%)
Query: 305 FDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATLESGAVVAVKRV-----KNMNALSKKE 359
F +P L E +G+G G ++ + VA+K + +N +K
Sbjct: 13 FSHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 360 FVQQ------MQLLGKLKHENLAKIVSFY------------------------------- 382
F + + L L E + F
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 383 -----YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ ++ I+ EF G + + + T SI+ Q LA
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAE-- 178
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRA 464
S + H +L N+L+ + +
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLH 204
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 46/236 (19%), Positives = 93/236 (39%), Gaps = 68/236 (28%)
Query: 316 DLLRASAEVLGKGKVGSTYKATLESGAVVAVKRVKN-----MNALSKKEFVQQMQ----- 365
++LR +GKG ++ G V V++ M ++K++ V++ +
Sbjct: 18 EILR----AIGKG----SF------GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 366 ----LLGKLKHENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWT 418
++ L+H +V+ +YS EE + ++ + L G L L ++
Sbjct: 64 KELQIMQGLEH---PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---------- 110
Query: 419 TRLSIIKQTAK------GLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472
+T K +A + L + ++ H ++K NIL+ + +T+F
Sbjct: 111 -HFKE--ETVKLFICELVMALDY--LQNQRIIHRDMKPDNILLDEHGHV---HITDFNIA 162
Query: 473 PLLPSRKASENLAIGRSPEF--PE------GKRLTHKADVYCFGIILLEVITGRIP 520
+LP +A G + + PE G + D + G+ E++ GR P
Sbjct: 163 AMLPRETQITTMA-G-TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 57/293 (19%), Positives = 103/293 (35%), Gaps = 58/293 (19%)
Query: 265 HEKEKSNEGQAGEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDD--LLRASA 322
H + + +E+ + + K L D LLR
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGS-----GIEEEKEAMNTRESGKASSSLGLQDFDLLR--- 58
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN--LAK-- 377
V+G+G L ++ + A++ VK KE V + + ++ E +
Sbjct: 59 -VIGRGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQAS 110
Query: 378 ----IVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS--IIKQTA 428
+V + E +L + E++ G L H R ++P S I
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQR-QRKLPEEHARFYSAEIS---- 163
Query: 429 KGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS----- 481
LA + LH + + +LK N+L+ E I KLT++G L P S
Sbjct: 164 --LALNY--LHERGIIYRDLKLDNVLLDSEGHI---KLTDYGMCKEGLRPGDTTSTFCGT 216
Query: 482 -ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGD 533
+A PE G+ D + G+++ E++ GR P + ++ +
Sbjct: 217 PNYIA----PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 21/122 (17%), Positives = 46/122 (37%), Gaps = 16/122 (13%)
Query: 64 CSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFL 122
+ V+LEL + L P ++ L +++ L LP+ + LET+ L
Sbjct: 78 ATQPGRVALELRSVPLPQF--PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-----------FNQTSLIDFNVSYN 171
++N +P L +L++L ++ ++P +L + +
Sbjct: 135 ARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 172 NL 173
+
Sbjct: 194 GI 195
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 45/224 (20%)
Query: 316 DLLRASAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ-----LLGK 369
DLLR V+G+G L ++ + A+K VK ++ + +Q
Sbjct: 12 DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQA 66
Query: 370 LKHENLAKIVSFYYS--KEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS--II 424
H +V + E +L + E++ G L H R ++P S I
Sbjct: 67 SNH---PFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQR-QRKLPEEHARFYSAEIS 120
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS- 481
LA + LH + + +LK N+L+ E I KLT++G L P S
Sbjct: 121 ------LALNY--LHERGIIYRDLKLDNVLLDSEGHI---KLTDYGMCKEGLRPGDTTST 169
Query: 482 -----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520
+A PE G+ D + G+++ E++ GR P
Sbjct: 170 FCGTPNYIA----PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 61/381 (16%), Positives = 114/381 (29%), Gaps = 52/381 (13%)
Query: 159 NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPISPPPPSPAIP 218
+ + + +T P + L ++ +
Sbjct: 194 DPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSR 253
Query: 219 ---PPSPPPPPKEDKKKSLKIWSVALIAAGSALVPFLVMLLFWCCYKKVHEKEKSNEGQA 275
S E +K + W L V +++ +K + +
Sbjct: 254 NDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQ 313
Query: 276 GEGSAHLSEKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYK 335
G + + R++L F+ L VLGKG G
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFN----------FLM----VLGKGSFGKVML 359
Query: 336 ATL-ESGAVVAVKRVKNMNALSKKEFVQQMQ----LLGKLKHENLAKIVSFYYS--KEEK 388
+ + + AVK +K + + M L K L + ++
Sbjct: 360 SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL---TQLHSCFQTMDR 416
Query: 389 L-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHAN 447
L + E++ G L H + VGR + A GL FL S + + +
Sbjct: 417 LYFVMEYVNGGDLM--YHIQQ-VGRFKEP-HAVF-YAAEIAIGLFFLQ----SKGIIYRD 467
Query: 448 LKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKAS------ENLAIGRSPEFPEGKRLT 499
LK N+++ E I K+ +FG + + +A PE +
Sbjct: 468 LKLDNVMLDSEGHI---KIADFGMCKENIWDGVTTKTFCGTPDYIA----PEIIAYQPYG 520
Query: 500 HKADVYCFGIILLEVITGRIP 520
D + FG++L E++ G+ P
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAP 541
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.84 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.77 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.67 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.59 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.57 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.56 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.56 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.56 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.55 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.53 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.5 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.5 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.48 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.48 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.48 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.47 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.47 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.46 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.46 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.46 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.46 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.45 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.45 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.45 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.44 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.44 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.44 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.44 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.43 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.43 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.42 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.42 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.41 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.41 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.4 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.4 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.39 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.39 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.38 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.37 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.37 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.36 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.36 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.35 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.34 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.34 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.32 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.32 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.32 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.32 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.31 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.31 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.31 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.3 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.3 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.3 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.28 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.28 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.28 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.27 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.27 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.24 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.24 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.23 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.2 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.12 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.06 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.03 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.01 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.97 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.82 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.54 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.54 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.15 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.76 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.37 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.34 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.89 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.9 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.77 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.47 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.76 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.22 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 85.92 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 84.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.67 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 80.23 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=438.80 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=204.8
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 578999999999999864 47899999998777667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 396 PNGSLFDLLHESRGV----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
++|+|.++++..... ...+++|.+++.|+.|||+||+|||+ ++||||||||+|||+ +.++.+|
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~----~~iiHRDLKp~NILl---~~~~~~K 198 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG----LHFVHRDLATRNCLV---GQGLVVK 198 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---ETTTEEE
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc----CCeecccccHhhEEE---CCCCcEE
Confidence 999999999865421 12469999999999999999999994 799999999999999 6678999
Q ss_pred EeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHH
Q 007427 466 LTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 466 l~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 538 (604)
|+|||+|+.+.... ...+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.. ..+.+
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~ 270 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTEAI 270 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998764332 2347789999999999999999999999999999999 899997532 12222
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
..+...... . .+..++.++.+|+.+||+.||++||||.||+++|+.+.+..
T Consensus 271 ~~i~~g~~~-~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 271 DCITQGREL-E----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHTCCC-C----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHcCCCC-C----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 222222111 1 11223456889999999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=436.25 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=207.2
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 578999999999999863 47899999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccc--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 396 PNGSLFDLLHESR--------GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 396 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
++|+|.++|+... ......++|.+++.|+.|||+||+|||+ ++|+||||||+|||+ +.++.+||+
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~----~~iiHRDlKp~NILl---~~~~~~Ki~ 170 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS----QHFVHRDLATRNCLV---GENLLVKIG 170 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEEC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCccCHhhEEE---CCCCcEEEC
Confidence 9999999998642 1223469999999999999999999994 799999999999999 777899999
Q ss_pred eccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHH
Q 007427 468 NFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 468 DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
|||+|+...... ...+++.|+|||++.+..|+.++|||||||++|||+| |+.||.+.. ..+.+..
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~~~ 242 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVIEC 242 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHH
Confidence 999998654332 1246788999999999999999999999999999999 899997632 1222333
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
+...... . .+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 243 i~~~~~~-~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVL-Q----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCC-C----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3222211 1 1122345688999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=425.91 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=200.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||+++|++.+ +..+||||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 578999999999999875 35999999743 33345789999999999999999999998864 56899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.++|+... .+++|.++..|+.|||+||+|||+ ++||||||||+|||+ ++++.+||+|||+|+......
T Consensus 118 L~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~----~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 118 LYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA----KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH----TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence 999997653 259999999999999999999994 799999999999999 667899999999998765321
Q ss_pred ------CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 ------ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...+|+.|+|||++. ...|+.++|||||||++|||+||+.||.+... ...+............
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRGYASPD 258 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTTCCCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCCC
Confidence 236889999999985 34689999999999999999999999975321 1122222222211110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
.. .....++..+.+|+.+||+.||++||||.||++.|+.+++.+.+
T Consensus 259 ~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 259 LS------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp ST------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred cc------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 00 11123445788999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=432.14 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=205.0
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 468999999999999862 5789999999753 233467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 395 LPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
|++|||.++|+..... ....++|.++++|+.|||+||+|||+ ++||||||||+|||+ +++++
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~----~~iiHRDLK~~NILl---~~~~~ 183 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS----HHVVHKDLATRNVLV---YDKLN 183 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh----CCCCCCCccccceEE---CCCCC
Confidence 9999999999754311 12359999999999999999999994 799999999999999 77789
Q ss_pred EEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhH
Q 007427 464 AKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 536 (604)
+||+|||+|+.+.... ...+++.|+|||++.+..|+.++|||||||++|||+| |+.||.+.. ..+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~~ 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 9999999998764321 2356789999999999999999999999999999999 899997632 122
Q ss_pred HHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+..+..... .. .+..++..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 256 ~~~~i~~~~~-~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 VVEMIRNRQV-LP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHHTTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHHHcCCC-CC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 2333322221 11 112344568899999999999999999999999997654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=421.50 Aligned_cols=262 Identities=19% Similarity=0.278 Sum_probs=199.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC----ceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE----EKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|++. |+.||||+++.... ....+.+|+..+.+++|||||+++++|.+.+ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 478999999999999984 89999999975432 2223445666677899999999999998754 57999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----CCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT----LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+|.++++.. +++|..+.+++.|+++||+|||+. .+.++|+||||||+|||+ +.++++||+|||+|+
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAV 156 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCc
Confidence 9999999864 389999999999999999999953 123599999999999999 777899999999997
Q ss_pred CCCCCC--------CCccccccCCCCCCCCC------CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-------CC
Q 007427 474 LLPSRK--------ASENLAIGRSPEFPEGK------RLTHKADVYCFGIILLEVITGRIPGNGSPGNNET-------SG 532 (604)
Q Consensus 474 ~~~~~~--------~~~~~~~y~aPE~~~~~------~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-------~~ 532 (604)
...... ...+|+.|+|||++.+. .++.++|||||||++|||+||+.||......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 664332 12578999999998764 3678999999999999999998887543221111 11
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.................+. ......+....+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCC-----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCCCCCC-----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 2223333333322222211 1112234566789999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=418.21 Aligned_cols=239 Identities=23% Similarity=0.365 Sum_probs=199.5
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5799999999999986 479999999997555445667899999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++... .+++.++..|+.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 160 ~~l~~~------~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 160 DIVTHT------RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp HHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred HHHHcC------CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCc
Confidence 999753 3899999999999999999999 4799999999999999 666789999999998765432
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. ..+....+.... ......
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~~~~~~----- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-PPRLKN----- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSS-CCCCSC-----
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-CCCCCc-----
Confidence 3468999999999999999999999999999999999999997531 122222222221 111100
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......++.+|+.+||+.||++|||+.|+++
T Consensus 293 ---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1123346889999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=419.21 Aligned_cols=241 Identities=20% Similarity=0.339 Sum_probs=196.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|||||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 46899999999999985 57999999999643 3334578999999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++...+ ...+++.++..|+.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 109 ~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 109 DLFKRINAQK---GVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp BHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred cHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 9999997654 234789999999999999999999 4799999999999999 66678999999999987643
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...||+.|+|||++.+..|+.++|||||||++|||+||+.||.+. ...+.+..+........
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~~~~----- 245 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGSFPPV----- 245 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCCCCC-----
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCCCCC-----
Confidence 2 235899999999999999999999999999999999999999753 23333444443332111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=418.45 Aligned_cols=242 Identities=20% Similarity=0.228 Sum_probs=197.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 46799999999999985 5799999999975322 24799999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc-eEEEeeccCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY-RAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~-~~kl~DFGla~~~~~~~ 479 (604)
.++++... .+++.++..|+.||+.||+||| +++|+||||||+|||+ +.++ ++||+|||+|+.+....
T Consensus 138 ~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 138 GQLIKQMG-----CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence 99998754 4999999999999999999999 5799999999999999 4443 59999999998765422
Q ss_pred ---------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 ---------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ---------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.... .+... +........
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~---i~~~~~~~~- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----PLCLK---IASEPPPIR- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-----CCHHH---HHHSCCGGG-
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHH---HHcCCCCch-
Confidence 125899999999999999999999999999999999999999864321 11111 111111000
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
..+......+.+++.+||+.||++|||+.|+++.|....
T Consensus 277 --------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 277 --------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp --------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011223456889999999999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=403.30 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=192.6
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEecC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEFL 395 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 395 (604)
+.||+|+||+||+|+. .+++.||+|++... .....+.|.+|++++++++|||||+++++|.+ .+..++|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 5799999999999985 46899999999643 33345779999999999999999999999865 34579999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
++|+|.+++.... .+++..+..|+.||+.||+|||+ ++ |+||||||+|||++. .++.+||+|||+|+
T Consensus 112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~----~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT----RTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 180 (290)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT----SSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCCEEecccChhheeEEC--CCCCEEEEeCcCCE
Confidence 9999999998754 58999999999999999999994 45 999999999999942 34689999999998
Q ss_pred CCCCCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 474 LLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 474 ~~~~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
...... ...||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+.. ........+..... ....
T Consensus 181 ~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i~~~~~-~~~~ 251 (290)
T 3fpq_A 181 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK-PASF 251 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC-CGGG
T ss_pred eCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHHHcCCC-CCCC
Confidence 765433 3368999999999865 69999999999999999999999997532 12222222222211 1111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 252 ~---------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 D---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112235889999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=417.90 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=204.6
Q ss_pred hhcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCC-CCcccEEEEEecC-CceEEE
Q 007427 321 SAEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSK-EEKLII 391 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~~lv 391 (604)
..+.||+|+||+||+|++. .++.||||+++... ....+.|.+|+++|.+++| ||||+++|+|.+. +..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 3578999999999999854 24689999997543 3345779999999999965 8999999999765 568999
Q ss_pred EecCCCCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 392 YEFLPNGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
||||++|+|.++|+.... .....++|.++..|+.|||+||+||| +++||||||||+|||+ ++
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NILl---~~ 220 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL---SE 220 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE---CG
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccceee---CC
Confidence 999999999999986432 11235899999999999999999999 4799999999999999 77
Q ss_pred cceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
++.+||+|||+|+.+..... ..+++.|+|||++.+..|+.++|||||||++|||+| |+.||.+....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------ 294 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------ 294 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH------
Confidence 78999999999997754332 246778999999999999999999999999999998 99999864221
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccccCC
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~d 604 (604)
+.+...+..+..... +...+.++.+++.+||+.||++|||+.||++.|+++.+.-.++|
T Consensus 295 --~~~~~~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~qD 353 (353)
T 4ase_A 295 --EEFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 353 (353)
T ss_dssp --HHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC---
T ss_pred --HHHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCCC
Confidence 112222222211111 11234468899999999999999999999999999876554443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=420.70 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=200.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 36799999999999985 57999999999765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..|+.||+.||+||| ++|||||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc
Confidence 9999754 3899999999999999999999 4799999999999999 666789999999998765432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. ..+.+..+.... .....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~~~~~----- 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-PPRLK----- 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCCS-----
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-CCCCc-----
Confidence 3468999999999999999999999999999999999999997531 222222222221 11110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+|+.+||+.||++|||+.|+++
T Consensus 369 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01123346889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=404.69 Aligned_cols=237 Identities=18% Similarity=0.267 Sum_probs=198.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+|||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 47899999999999985 579999999996432 23357799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 117 G~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 117 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCC
Confidence 99999998754 4999999999999999999999 4799999999999999 6667899999999987643
Q ss_pred CC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 478 RK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 478 ~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.. ...||+.|+|||++.+..|+.++||||+||++|||+||+.||.+. +..+....+.......
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~~~~--- 253 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEGLIFAKIIKLEYDF--- 253 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCC---
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCCC---
Confidence 21 235899999999999999999999999999999999999999753 2233333333332110
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
+.....++.+|+.+||+.||++|||+.|++
T Consensus 254 ---------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 ---------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011234688999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=393.33 Aligned_cols=237 Identities=20% Similarity=0.349 Sum_probs=185.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46899999999999985 579999999996432 223567999999999999999999999999999999999999 6
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ++++.++..++.||+.||+||| +++|+||||||+|||+ +.+..+||+|||+|+....
T Consensus 97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEE---CTTCCEEECCSSCC-----
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEE---CCCCCEEEeecCCCeecCC
Confidence 89999997653 4999999999999999999999 4799999999999999 6667899999999987654
Q ss_pred CC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.+. ........+.......
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~~~~~----- 231 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNGVYTL----- 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCC-----
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCCCCC-----
Confidence 32 3468999999999998876 57999999999999999999999752 2233333333322110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 232 -------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 -------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0112346889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=399.29 Aligned_cols=233 Identities=22% Similarity=0.294 Sum_probs=186.6
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+. .+++.||||+++... ......+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence 47899999999999975 257899999996432 223346889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+|+..
T Consensus 109 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 109 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKES 176 (304)
T ss_dssp TTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC-
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEE---cCCCCEEecccccceec
Confidence 9999999998754 4999999999999999999999 4799999999999999 66678999999999865
Q ss_pred CCC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+. +..+....+.......
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~~~--- 245 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILKAKLGM--- 245 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCC---
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHcCCCCC---
Confidence 432 2346899999999999999999999999999999999999999753 2233333333322111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
+...+.++.+|+.+||+.||++|||+
T Consensus 246 ---------p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 ---------PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---------CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 11223468899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=389.07 Aligned_cols=240 Identities=21% Similarity=0.315 Sum_probs=182.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------------c
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------------E 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------~ 387 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 46899999999999985 57999999999743 3334578999999999999999999999987644 3
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.|+|||||++|+|.+++..... ....++..++.|+.||+.||+||| +++|+||||||+|||+ +.+..+||+
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl---~~~~~vKl~ 160 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFF---TMDDVVKVG 160 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEE---CCCCcEEEc
Confidence 6899999999999999986542 123567778999999999999999 4799999999999999 566689999
Q ss_pred eccCCCCCCCCC----------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 007427 468 NFGFLPLLPSRK----------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531 (604)
Q Consensus 468 DFGla~~~~~~~----------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 531 (604)
|||+|+.+.... ...||+.|+|||++.+..|+.++|||||||++|||++ ||...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------- 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------- 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------
Confidence 999998775432 1248999999999999999999999999999999996 76531
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+........ .. ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~-p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 MERVRTLTDVRNLKF-PP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHHTTCC-CH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHHhcCCC-CC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111111111 00 01122345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.50 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=190.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEec------CCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS------KEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 392 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..|+||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 46899999999999985 579999999997532 3345678899999999999999999999764 35789999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
|||+ |+|.+++.... ++++.++..|+.||+.||+||| ++||+||||||+|||+ +..+.+||+|||+|
T Consensus 139 E~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 139 DLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp ECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred eCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 9995 68999997643 5999999999999999999999 4799999999999999 66678999999999
Q ss_pred CCCCCC--------CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 473 PLLPSR--------KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 473 ~~~~~~--------~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
+.+... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+... .+....+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--------~~~l~~I~~ 277 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--------VHQLQLIMM 277 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--------HHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--------HHHHHHHHH
Confidence 876432 234689999999998775 569999999999999999999999986321 111111111
Q ss_pred cCC--cccccc--------HHhhh----ccc-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 NDW--STDILD--------VEILA----ARE-----GQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ~~~--~~~~~~--------~~~~~----~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ...... ..... ... ......++.+|+.+||+.||++|||+.|+++
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000 00000 000 0112346889999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=379.66 Aligned_cols=187 Identities=22% Similarity=0.343 Sum_probs=161.3
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+.+ +++.||+|++.... ...++.+|+++++++ +||||+++++++.+.++.++||||++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 468999999999999753 47899999986543 346788999999998 69999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++. .+++.++..++.|++.||+||| ++||+||||||+|||++.+ ...+||+|||+|+...
T Consensus 104 g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~--~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 104 HESFLDILN--------SLSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQGTH 169 (361)
T ss_dssp CCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETT--TTEEEECCCTTCEECT
T ss_pred cccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCC--CCeEEECcCCCCcccC
Confidence 999999984 2889999999999999999999 4799999999999999533 2579999999997553
Q ss_pred CCC--------------------------------CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 477 SRK--------------------------------ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 477 ~~~--------------------------------~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
... ...+|+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 12478999999998875 589999999999999999999999975
Q ss_pred C
Q 007427 524 S 524 (604)
Q Consensus 524 ~ 524 (604)
.
T Consensus 250 ~ 250 (361)
T 4f9c_A 250 A 250 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=395.97 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=202.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|++++|||||+++++|.+.+..++|||||++|+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 47899999999999985 57999999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ ....+||+|||+|+.+.....
T Consensus 242 ~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~----~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 242 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE----NNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp HHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECCTTSE
T ss_pred HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH----CCeeeccCChhhccccCC-CCCCEEEeeccceeEccCCCc
Confidence 99997543 248999999999999999999994 799999999999999533 235799999999998765432
Q ss_pred ---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 481 ---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 481 ---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
..+++.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+....+....+... +.
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~~~~--~~---- 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMD--DS---- 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCCCC--SG----
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCCCCC--cc----
Confidence 358899999999999999999999999999999999999997532 2233333333222111 00
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+|+.+||+.||++|||+.|+++
T Consensus 379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00122346889999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=388.91 Aligned_cols=241 Identities=17% Similarity=0.208 Sum_probs=192.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhH---HHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSK---KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.++||+|+||+||+|+. .+|+.||||++++... ... ....+++.+++.++|||||+++++|.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 47899999999999985 5799999999964211 112 2234456778889999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
|+||+|.++|.... .+++..+..++.||+.||+||| ++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 274 ~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 274 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp CCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 99999999998754 4999999999999999999999 5799999999999999 6677899999999987
Q ss_pred CCCCC--CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 475 LPSRK--ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 475 ~~~~~--~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
+.... ...||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+... .+..............
T Consensus 342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~~i~~~~~~---- 412 (689)
T 3v5w_A 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAVE---- 412 (689)
T ss_dssp CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHHHHHHCCCC----
T ss_pred cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhhcCCCCC----
Confidence 75443 3478999999999964 5799999999999999999999999975321 1222323333222211
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.+.....++.+|+.+||+.||.+|++ +.||++
T Consensus 413 --------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01122346889999999999999998 566653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.24 Aligned_cols=269 Identities=28% Similarity=0.474 Sum_probs=220.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..+|+.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46899999999999998889999999998665556788999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++..... ....+++.++..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++......
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~----~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT----RAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCC
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC----CCeecCCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence 99976542 23358999999999999999999994 699999999999999 667789999999987643221
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++|||||||++|||+||+.||...... .......|..............++..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccccHHHhcChhh
Confidence 224678999999998888999999999999999999999999865432 22334445444333333333333222
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
. ..........+.+++.+||+.||++|||+.|+++.|+.+....+
T Consensus 274 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 274 A-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp T-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred c-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 1 12345677889999999999999999999999999999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.34 Aligned_cols=250 Identities=25% Similarity=0.454 Sum_probs=206.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 47899999999999986 46899999999776666778899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~----~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS----MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC----
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccc
Confidence 99998743 248999999999999999999994 699999999999999 666789999999997664322
Q ss_pred -----------------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC-CchhHHHHHH
Q 007427 480 -----------------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS-GDLSDWVRMV 541 (604)
Q Consensus 480 -----------------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~ 541 (604)
...++..|+|||.+.+..++.++|||||||++|||++|..||.......... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 2347788999999999999999999999999999999999987643322111 1111111111
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. ....+..+.+++.+||+.||++|||+.|+++.|++++..+
T Consensus 244 ~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 C------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp C------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 1112235889999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=365.66 Aligned_cols=281 Identities=32% Similarity=0.552 Sum_probs=223.3
Q ss_pred CccCHHHHHHHh-----hcccCcCCcceEEEEEecCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 310 PVFDLDDLLRAS-----AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 310 ~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
..+++.++.... .+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 345555655442 468999999999999988899999999975432 22346899999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
..+..++||||+++|+|.+++..... ...++++..+..++.|++.||+|||+.+ ..+|+||||||+|||+ +....
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~---~~~~~ 172 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILL---DEEFE 172 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEE---CTTCC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEE---CCCCC
Confidence 99999999999999999999987653 2335999999999999999999999521 1299999999999999 66678
Q ss_pred EEEeeccCCCCCCCCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 464 AKLTNFGFLPLLPSRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+||+.||..............+|+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998765332 22478899999999888899999999999999999999999964322233344556666
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.............+.... ..........+.+++.+||+.||.+|||+.||+++|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 555554444444443322 233466778899999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=357.23 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=201.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc----eEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE----KLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+.. ++.||||+++... .....+.+|+.++++++||||+++++++..... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 478999999999999876 8999999997543 234556779999999999999999999987543 6999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT------LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
|+|.++++.. .+++..+..++.|++.||+|||+. +|+.+|+||||||+|||+ +....+||+|||+
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~ 177 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGL 177 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCc
Confidence 9999999764 389999999999999999999942 112299999999999999 6667899999999
Q ss_pred CCCCCCCC------CCccccccCCCCCCCCC-----CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC--------CC
Q 007427 472 LPLLPSRK------ASENLAIGRSPEFPEGK-----RLTHKADVYCFGIILLEVITGRIPGNGSPGNNET--------SG 532 (604)
Q Consensus 472 a~~~~~~~------~~~~~~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--------~~ 532 (604)
++...... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.+....... ..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97654322 23578899999998863 4567899999999999999999999865332111 01
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
....+............. . ...........+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVL-R----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCC-C----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCc-c----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222222111111 1 1111234556799999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.77 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=204.7
Q ss_pred hcccCcCCcceEEEEEec--------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 478999999999999852 45689999997543 33456799999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 392 YEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
|||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||+ +.
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~ 238 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS----QKCIHRDLAARNVLV---TE 238 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEE---CT
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh----CCeeccccchhhEEE---CC
Confidence 9999999999999875421 12348999999999999999999994 699999999999999 66
Q ss_pred cceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
+..+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+... ..
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----~~ 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----EE 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence 6789999999998654322 1234568999999999999999999999999999999 9999975321 11
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccccCC
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~d 604 (604)
+. ....... ... .+......+.+++.+||+.||++||++.|+++.|+++.....++|
T Consensus 314 ~~---~~~~~~~-~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~~e 370 (370)
T 2psq_A 314 LF---KLLKEGH-RMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 370 (370)
T ss_dssp HH---HHHHTTC-CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HH---HHHhcCC-CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhccCC
Confidence 21 2211111 111 011233468899999999999999999999999999987665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=347.74 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=198.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 36899999999999984 67999999999765555677899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||++.......
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHS----NQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh----CCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 9999764 38999999999999999999994 699999999999999 666789999999987665432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||.+.+..++.++|||||||++|||+||+.||.... ............... ...
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~~-~~~---- 238 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE-LQN---- 238 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC-CSC----
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC-CCC----
Confidence 2357889999999999999999999999999999999999997531 111111111111111 000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122345889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.13 Aligned_cols=240 Identities=22% Similarity=0.335 Sum_probs=198.2
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 47999999999999865 79999999997665556778999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC---
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--- 478 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~--- 478 (604)
+++... .+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++.....
T Consensus 131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 131 DIVSQV------RLNEEQIATVCEAVLQALAYLHA----QGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp HHHTTC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc
Confidence 998753 38999999999999999999995 699999999999999 66678999999998766543
Q ss_pred -CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 479 -KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 479 -~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......... .....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~-~~~~~----- 263 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAMKRLRDSPP-PKLKN----- 263 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSSC-CCCTT-----
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCC-CCcCc-----
Confidence 23357889999999999999999999999999999999999997531 1122222222111 11000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 264 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 ---SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123458899999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=347.86 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=195.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 57899999999999987 48899999997543 3334678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|.+++..... ...+++..+..++.|++.||+|||+ ++ |+||||||+|||+ +....+||+|||+++....
T Consensus 121 L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~----~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 121 LYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN----RNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp HHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT----SSSCCCCTTCCGGGEEE---CTTCCEEECCCC-------
T ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc----CCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccc
Confidence 9999986431 1238999999999999999999994 67 9999999999999 6667899999999976544
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||.+.+..++.++|||||||++|||+||+.||.... ..+.............
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~---- 259 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKRLE---- 259 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHSCCCCC----
T ss_pred cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCC----
Confidence 3 23357889999999999999999999999999999999999997532 1122221111111111
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 260 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 ------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0112334688999999999999999999999999988653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.32 Aligned_cols=273 Identities=28% Similarity=0.506 Sum_probs=214.5
Q ss_pred CCccCHHHHHHHhh-----------cccCcCCcceEEEEEecCCcEEEEEEeccc----chhhHHHHHHHHHHHccCCCC
Q 007427 309 IPVFDLDDLLRASA-----------EVLGKGKVGSTYKATLESGAVVAVKRVKNM----NALSKKEFVQQMQLLGKLKHE 373 (604)
Q Consensus 309 ~~~~~~~~~~~~~~-----------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~ 373 (604)
...|+++++..++. +.||+|+||.||+|+. +++.||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34567777776642 6799999999999987 5889999998642 223457899999999999999
Q ss_pred CcccEEEEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 007427 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453 (604)
Q Consensus 374 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NI 453 (604)
||+++++++...+..++||||+++|+|.+++..... ..++++..+..++.|++.||+|||+ ++|+||||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~----~~i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE----NHHIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc----CCeecCCCCHHHE
Confidence 999999999999999999999999999999976442 2358999999999999999999994 6999999999999
Q ss_pred EEeecCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCC
Q 007427 454 LIFRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGN 527 (604)
Q Consensus 454 Ll~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~ 527 (604)
++ +....+||+|||+++...... ...++..|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 165 li---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~- 239 (307)
T 2nru_A 165 LL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE- 239 (307)
T ss_dssp EE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS-
T ss_pred EE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc-
Confidence 99 666789999999987664322 2356889999998865 588999999999999999999999986432
Q ss_pred CCCCCchhHHHHHHHhcCC-ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 528 NETSGDLSDWVRMVVDNDW-STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
...+..+......... ....++... ..........+.+++.+||+.||.+|||+.||++.|++++.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 240 ---PQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp ---SSBTTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ---hHHHHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1222333222222111 011111111 12235566789999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.78 Aligned_cols=251 Identities=20% Similarity=0.358 Sum_probs=202.3
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 478999999999999863 4556999999754 34445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.++++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++...
T Consensus 134 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 134 NGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD----LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred CCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH----CCeeCCCCCcceEEE---CCCCCEEECCCCcccccc
Confidence 999999997543 248999999999999999999994 699999999999999 666789999999998765
Q ss_pred CCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 SRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ..++..|+|||++.+..++.++|||||||++|||++ |+.||.+.. ..+............
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRLP 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCCCC
Confidence 4321 123457999999988889999999999999999999 999997532 122222222211111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
........+.+++.+||+.||++|||+.||++.|+.+....++
T Consensus 275 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 275 -----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112334688999999999999999999999999998766553
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.48 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=199.4
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 394 (604)
.+.||+|+||+||+|++ .+++.||||+++.......+.+.+|++++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 46899999999999984 36899999999876666667899999999999999999999998653 568999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++..... .+++.++..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||+++.
T Consensus 95 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGT----KRYIHRDLATRNILV---ENENRVKIGDFGLTKV 163 (295)
T ss_dssp CTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---EETTEEEECCCCSCC-
T ss_pred CCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhc----CCcccCCCCHhhEEE---cCCCeEEEccCccccc
Confidence 999999999987542 48999999999999999999994 699999999999999 4456799999999987
Q ss_pred CCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCC-------CCCCCCchhHHHHH
Q 007427 475 LPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG-------NNETSGDLSDWVRM 540 (604)
Q Consensus 475 ~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~-------~~~~~~~~~~~~~~ 540 (604)
..... ...++..|+|||.+.+..++.++|||||||++|||+||..|+..... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 65432 22345569999999988999999999999999999999999764210 00000000001111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
........ ......+..+.+++.+||+.||++|||+.|++++|+++++.+.
T Consensus 244 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 244 LLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHhccCcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 11111100 0112334568999999999999999999999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=349.14 Aligned_cols=239 Identities=22% Similarity=0.385 Sum_probs=198.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46899999999999986 67999999999643 3334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++.....
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~----~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQ----KRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 9999998754 48999999999999999999994 699999999999999 66678999999999765433
Q ss_pred C---CCccccccCCCCCCCCCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K---ASENLAIGRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s-~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+++.|+|||.+.+..++ .++|||||||++|||++|+.||.+. ...+.............
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~p----- 234 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--------NLKELRERVLRGKYRIP----- 234 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCC-----
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCC-----
Confidence 2 33578899999999888775 7999999999999999999999753 22333333333322111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 -------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 -------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1123357899999999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=339.04 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..+++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 468999999999999988899999999975432 4577999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||+++......
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~----~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHH
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh----CCeecCCcchheEEE---cCCCCEEeccccccccccccccc
Confidence 9997643 258999999999999999999994 699999999999999 666789999999998664322
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+........... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~~~-~------ 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRL-Y------ 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCC-C------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCccC-C------
Confidence 2234567999999988899999999999999999999 999987532 12222222221110 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 228 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0111234588999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.38 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=205.1
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++......++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 468999999999999843 4678999999753 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 395 LPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE----NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh----CCeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999876522 12358999999999999999999994 79999999999999976666678999999998
Q ss_pred CCCC------CCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLP------SRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~------~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.........
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~i~~~~ 303 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEFVTSGG 303 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHTTC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC
Confidence 6432 1222345778999999988899999999999999999998 999987532 122222222221
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.... .......+.+++.+||+.||++||++.||++.|+.+...
T Consensus 304 ~~~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 RMDP-----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC-----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1110 112234588999999999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.55 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCcccEEEEEecC----CceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGK--LKHENLAKIVSFYYSK----EEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46899999999999987 5899999999653 23555666666655 8999999999997543 4578999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL----HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
++|+|.++++.. .+++..+..++.|++.||+|||... ++++|+||||||+|||+ +....+||+|||+
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGL 159 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTT
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCC
Confidence 999999999643 4899999999999999999999321 13699999999999999 6667899999999
Q ss_pred CCCCCCCC--------CCccccccCCCCCCCCC------CCCccchhHhHHHHHHHHHhC----------CCCCCCCCCC
Q 007427 472 LPLLPSRK--------ASENLAIGRSPEFPEGK------RLTHKADVYCFGIILLEVITG----------RIPGNGSPGN 527 (604)
Q Consensus 472 a~~~~~~~--------~~~~~~~y~aPE~~~~~------~~s~ksDVwSfGvvl~elltg----------~~p~~~~~~~ 527 (604)
++...... ...++..|+|||.+.+. .++.++|||||||++|||+|| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 86654322 22578899999999876 455799999999999999999 7787654322
Q ss_pred CCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
. ..................... ..........+.+++.+||+.||++|||+.||++.|++|
T Consensus 240 ~---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 D---PSFEDMRKVVCVDQQRPNIPN-----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp S---CCHHHHHHHHTTSCCCCCCCG-----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred C---cchhhhhHHHhccCCCCCCCh-----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 122222222222211111111 111224566799999999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=360.95 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=201.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 578999999999999975 78999999997542 2234578899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.++++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 199 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~----~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 199 FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES----KCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp HHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence 999998653 248999999999999999999994 799999999999999 666789999999997654332
Q ss_pred C------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 480 A------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 480 ~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
. ...+..|+|||.+.+..++.++|||||||++|||+| |+.||.+... .+ ............
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~-~~~~~~~~~~~~--- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQ-TREFVEKGGRLP--- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HH-HHHHHHTTCCCC---
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcCCCCC---
Confidence 1 123557999999988889999999999999999999 9999875321 11 111222211111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.+...+..+.+++.+||+.||++|||+.++++.|+++++.
T Consensus 336 -------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 -------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0112334688999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=356.47 Aligned_cols=248 Identities=23% Similarity=0.400 Sum_probs=192.5
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 578999999999999864 5778999999754 33445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.++++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++...
T Consensus 130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD----MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH----CCeeCCCCCcceEEE---cCCCCEEECcCccccccc
Confidence 999999998643 258999999999999999999995 699999999999999 666789999999998765
Q ss_pred CCCCC-------ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 477 SRKAS-------ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 477 ~~~~~-------~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... .++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~-~~~~ 269 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDE-GYRL 269 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHT-TEEC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHc-CCCC
Confidence 43211 23457999999998899999999999999999998 999997532 1122222211 1110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
. .....+..+.+++.+||+.||++||++.||++.|+++...
T Consensus 270 ~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 P----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0 0112334688999999999999999999999999988543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.31 Aligned_cols=249 Identities=28% Similarity=0.467 Sum_probs=204.2
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 47899999999999999889999999998643 35688999999999999999999999986 66789999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
++++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++......
T Consensus 271 ~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~----~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 271 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ----RNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp HHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHH
T ss_pred HHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCcee
Confidence 99986531 248899999999999999999994 699999999999999 666789999999998765421
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+....++.++|||||||++|||+| |+.||.+.. ..+....+... ....
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~-~~~~------ 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERG-YRMP------ 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHT-CCCC------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC-CCCC------
Confidence 2234567999999988899999999999999999999 999997532 12222222221 1111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.+...+..+.+++.+||+.||++|||+.+|++.|+++....+
T Consensus 406 ----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 406 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 111234468899999999999999999999999999876544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=348.38 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=182.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 36899999999999986 46899999999653 3467889999999997 9999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||+++......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMHD----VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999998753 58999999999999999999994 699999999999999777666789999999998664432
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++|||||||++|||++|+.||....... ......+....+........ ...
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~~~~--~~~- 239 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDFSFE--GEA- 239 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCC--SHH-
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCCCCC--ccc-
Confidence 2346789999999999999999999999999999999999998643211 11222333333332221111 000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 240 -----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 -----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0123346889999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.40 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..++..||+|+++.... ..+++.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 468999999999999998888999999975432 4577999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||+++......
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES----HQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH----TTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEE
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCcCcceEEE---CCCCCEEEccCccceecchhhhh
Confidence 9998753 248999999999999999999994 699999999999999 666789999999997665432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+.............
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~------ 226 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHRLYR------ 226 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCCCCC------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCCCCCC------
Confidence 1234457999999988889999999999999999999 999987532 1122222221111000
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
+......+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 -----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0112335889999999999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.75 Aligned_cols=246 Identities=18% Similarity=0.258 Sum_probs=200.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 57899999999999986 46899999999643 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++....+||+|||+++.....
T Consensus 114 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~----~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 114 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHS----NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp BHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999987643 48999999999999999999994 69999999999999976666667999999999877644
Q ss_pred C---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 K---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. .......+......... +
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~--~-- 252 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGAYDYPS--P-- 252 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCT--T--
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCCc--c--
Confidence 3 2367889999999999999999999999999999999999997531 12222222222211110 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+++.+||+.||++||++.|+++.
T Consensus 253 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001223468899999999999999999998763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.91 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=199.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 57899999999999975 578999999997533 334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++....+||+|||+++.....
T Consensus 96 ~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~----~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 96 ELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQ----MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp BHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999998654 48999999999999999999994 69999999999999976556678999999999877543
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.........
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~---- 234 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKAGAYDFPS---- 234 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCCT----
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhCCCCCCc----
Confidence 3 2367889999999999999999999999999999999999997531 22222222222211110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 ----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 001122346889999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=339.01 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=201.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 46899999999999985 46899999998532 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ++++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++....
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHD----MRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC--
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEE---CCCCCEEEEeCCCcccccc
Confidence 99999998754 48999999999999999999994 699999999999999 6667899999999987654
Q ss_pred CC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 478 RK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ...++..|+|||.+.+..++.++|||||||++|||+||+.||.+.. .............. .. .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~-~~-~ 233 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSVP-NV-T 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCCC-CH-H
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccCC-Cc-c
Confidence 32 2247889999999999999999999999999999999999997532 11111122221111 00 0
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcccc
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRP-KMSEVLRRIEEIQPMI 600 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 600 (604)
. ......+..+.+++.+||+.||++|| +++++.+.|+++....
T Consensus 234 ~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 T-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp H-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred h-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 01112344688999999999999999 9999999999876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.05 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=203.1
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 468999999999999864 35899999997543 33457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 395 LPNGSLFDLLHESRGV-------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++|+||||||+|||+
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~----~~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE----RKFVHRDLATRNCLV 207 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCcceEEE
Confidence 9999999999874311 11468999999999999999999994 699999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCC------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSR------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNN 528 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~ 528 (604)
+.+..+||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.+..
T Consensus 208 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--- 281 (343)
T 1luf_A 208 ---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 281 (343)
T ss_dssp ---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---
T ss_pred ---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC---
Confidence 66678999999998654322 22345678999999988889999999999999999999 999987532
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
..+........... .. .......+.+++.+||+.||++||++.|+++.|+++.+..+.
T Consensus 282 -----~~~~~~~~~~~~~~-~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 282 -----HEEVIYYVRDGNIL-AC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp -----HHHHHHHHHTTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred -----hHHHHHHHhCCCcC-CC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 12222222222211 10 112234688999999999999999999999999999877654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=348.53 Aligned_cols=249 Identities=19% Similarity=0.290 Sum_probs=200.1
Q ss_pred hhcccCcCCcceEEEEEe-cCCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 321 SAEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 357899999999999985 478999999986321 12457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++....+||+|||+++.
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~----~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHD----NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH----CCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999988875432 12348999999999999999999994 6999999999999997666666799999999987
Q ss_pred CCCCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 475 LPSRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 475 ~~~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..............
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~~~-- 251 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKYKM-- 251 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCCCC--
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCCCC--
Confidence 65432 2357889999999999999999999999999999999999997521 12222222222111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+... ......+.+++.+||+.||++|||+.|+++
T Consensus 252 -~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 -NPRQW-----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -Ccccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01000 112346889999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=348.83 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=198.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 468999999999999864 699999999975322 1357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-cceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-IYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~~~~kl~DFGla~ 473 (604)
+++|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++. ...+||+|||+++
T Consensus 97 ~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~----~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT----KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999997543 58999999999999999999994 69999999999999954332 2279999999998
Q ss_pred CCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~~~~~-- 237 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAVSYDF-- 237 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCCC--
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCC--
Confidence 765432 3357889999999999999999999999999999999999997531 122222222222111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.... ......+.+++.+||..||++|||+.|+++
T Consensus 238 -~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 -DEEFF-----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Cchhc-----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11100 112346889999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.66 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=204.6
Q ss_pred hcccCcCCcceEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
.+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 478999999999999852 3468999999754 333457789999999999 999999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 392 YEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
|||+++|+|.+++...... ....+++.++..|+.|++.||+|||+ ++|+||||||+|||+ +.
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~ 226 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS----KKCIHRDLAARNVLV---TE 226 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CT
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh----CCEecCCCCcceEEE---cC
Confidence 9999999999999875421 12358999999999999999999994 699999999999999 66
Q ss_pred cceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
...+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-------- 298 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 298 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--------
Confidence 6789999999998765422 2234568999999999999999999999999999999 999987532
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
..+.......... ... .......+.+++.+||+.||++|||+.||++.|+++.....
T Consensus 299 ~~~~~~~~~~~~~-~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 299 VEELFKLLKEGHR-MDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHHTTCC-CCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHcCCC-CCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2222222222211 110 11223468899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.96 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=200.8
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC-ceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE-EKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 478999999999999986 7899999998653 4578999999999999999999999987765 78999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~----~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG----NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccccc
Confidence 99998754 2247899999999999999999994 699999999999999 666789999999998654332
Q ss_pred CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 ~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
....+..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..+.. ... .+....
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~---~i~-~~~~~~--------- 406 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP---RVE-KGYKMD--------- 406 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHH---HHH-TTCCCC---------
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---HHH-cCCCCC---------
Confidence 2245678999999999999999999999999999999 9999976432 11221 111 111111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.+..++..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 407 -~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 -APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1112344688999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.56 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=195.6
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5799999999999985 579999999998766566788999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+..+ ....+||+|||+++......
T Consensus 175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQ----MYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEEEET-TTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCcccccCCHHHEEEecC-CCCcEEEEeCCCceecCCcccc
Confidence 9987543 248999999999999999999994 699999999999999543 33579999999998765433
Q ss_pred -CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 -ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 -~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+....+... ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~~~--~~~---- 311 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRWDLE--DEE---- 311 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCSC--SGG----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCCCC--hhh----
Confidence 2357889999999999999999999999999999999999997532 1222333333222111 000
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 312 --~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 --FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0122346889999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=342.91 Aligned_cols=238 Identities=18% Similarity=0.250 Sum_probs=196.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+.. +|+.||+|++++. .......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999864 6999999999753 222356788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||+ +....+||+|||+++....
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS----RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 99999998654 48999999999999999999994 699999999999999 6667899999999986432
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. .......+.......
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~----- 224 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRF----- 224 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC-----
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCC-----
Confidence 2 23357889999999999999999999999999999999999997531 222222222221110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.|+++
T Consensus 225 -------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111234688999999999999999 8888875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.79 Aligned_cols=266 Identities=20% Similarity=0.332 Sum_probs=205.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--ceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--EKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 468999999999999865 58999999997533 234577889999999999999999999998765 67999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee-cCCcceEEEeeccCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR-ENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~~~~kl~DFGla~~~~ 476 (604)
|+|.+++..... ...+++.++..++.|++.||+|||+ ++|+||||||+|||+.. ++....+||+|||+++...
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE----NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999987642 2248999999999999999999994 69999999999999733 3455679999999998765
Q ss_pred CCC---CCccccccCCCCCCC--------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 477 SRK---ASENLAIGRSPEFPE--------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 477 ~~~---~~~~~~~y~aPE~~~--------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
... ...++..|+|||++. +..++.++|||||||++|||+||+.||....... ...+.+.......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMYKIITGK 243 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHHHHHHHC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHHHHhcCC
Confidence 443 235788999999875 5778999999999999999999999997543221 2222222222221
Q ss_pred Ccc---ccc---------cHHh-hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 546 WST---DIL---------DVEI-LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 546 ~~~---~~~---------~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
... ... .... ............+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 100 000 0000 011223456678999999999999999999999999988654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=339.33 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=200.2
Q ss_pred hcccCcCCcceEEEEEec-CC-------cEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-SG-------AVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 468999999999999854 33 5799999987666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc-----ceEEEee
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI-----YRAKLTN 468 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~-----~~~kl~D 468 (604)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.. ..+||+|
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE----NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh----CCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999998653 238999999999999999999994 699999999999999765432 2289999
Q ss_pred ccCCCCCCCCCCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 469 FGFLPLLPSRKASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 469 FGla~~~~~~~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
||++..........++..|+|||.+.+ ..++.++|||||||++|||++|..|+.... ...............
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-------DSQRKLQFYEDRHQL 237 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-------CHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-------chHHHHHHhhccCCC
Confidence 999987766555567889999999987 678999999999999999999655544321 111111111111111
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.. .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 238 ~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 238 PA-------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CC-------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CC-------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 012247899999999999999999999999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=338.45 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=195.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+.. ++.||+|++.... ..+.+.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 478999999999999876 7899999997533 4578999999999999999999999886 4589999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-C
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-A 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-~ 480 (604)
+++..... ...+++..++.++.|+++||+|||+. +.++|+||||||+||+++.++ ..+||+|||++....... .
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~~ivH~dlkp~NIll~~~~--~~~kl~Dfg~~~~~~~~~~~ 162 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSM-QPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACDIQTHMTN 162 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTC-SSSCCCCCCCSGGGEEEETTT--TEEEECCCCC----------
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeecCCCChhHEEEeCCC--CEEEEccccccccccccccc
Confidence 99986542 22478899999999999999999952 116999999999999995332 248999999997665432 3
Q ss_pred CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhccc
Q 007427 481 SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAARE 560 (604)
Q Consensus 481 ~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (604)
..++..|+|||.+.+..++.++|||||||++|||+||+.||..... ............. ....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~~~~---------- 225 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVHNGT-RPPL---------- 225 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHHTTC-CCCC----------
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHhcCC-CCCc----------
Confidence 3578899999999999999999999999999999999999975321 1111111111111 1111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 561 GQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 561 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
....+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 011234688999999999999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=337.00 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=199.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+++..++..||+|+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 478999999999999998888999999975432 3577999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||+++......
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLES----KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHH
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH----CCccCCCCccceEEE---cCCCCEEEccccccccccccccc
Confidence 9998643 248999999999999999999994 699999999999999 666789999999998664322
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+........... .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~~-~------ 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRL-Y------ 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCCC-C------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhcccCC-C------
Confidence 2244567999999998889999999999999999999 999987532 11222222221110 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 242 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 242 ----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 001122468899999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.83 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=195.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhh-------HHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALS-------KKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 46899999999999986 578999999986432211 167899999999999999999999986554 79999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCC--cceEEEeec
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFREND--IYRAKLTNF 469 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~--~~~~kl~DF 469 (604)
|+++|+|.+++.... .++++..+..++.|++.||+|||+ ++ |+||||||+||+++.++. ...+||+||
T Consensus 102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~----~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN----QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHT----SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHh----CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 999999999987643 258999999999999999999994 67 999999999999954432 234899999
Q ss_pred cCCCCCCCCC-CCccccccCCCCCCC--CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 470 GFLPLLPSRK-ASENLAIGRSPEFPE--GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 470 Gla~~~~~~~-~~~~~~~y~aPE~~~--~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
|+++...... ...++..|+|||.+. ...++.++|||||||++|||++|+.||..... .-............
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFINMIREEGL 247 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHHHHHHHSCC
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHHHHHhccCC
Confidence 9998655432 346788999999984 45678999999999999999999999975321 11122222222222
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.... .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 248 ~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTI----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCC----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 112334688999999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=343.79 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=198.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 468999999999999864 68999999997543 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ..+++.++..++.|++.||+|||+ +||+||||||+|||++.+ ....+||+|||+++.......
T Consensus 89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~----~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHS----HNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCc
Confidence 99997543 258999999999999999999994 699999999999999542 156899999999987754432
Q ss_pred ---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 481 ---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 481 ---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
..+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+........ ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~---~~~-- 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFD---EEA-- 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCC---HHH--
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCCCC---hhh--
Confidence 347889999999998889999999999999999999999997531 2223333333222111 000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 ---FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112346889999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=342.28 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=197.6
Q ss_pred hhcccCcCCcceEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 321 SAEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
..+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 3578999999999999864 689999999964322 236789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL 472 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla 472 (604)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ ....+||+|||++
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHH----CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999997543 58999999999999999999994 7999999999999995443 2237999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+............
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~- 236 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNYEF- 236 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHTCCCC-
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhcCCCc-
Confidence 8765332 3357889999999999999999999999999999999999997531 112222222211110
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .... ......+.+++.+||+.||++|||+.|+++
T Consensus 237 -~-~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 -E-DEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -C-HHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C-cccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000 112346889999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=331.90 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=199.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. ++.||||+++.. .....+.+.+|+.++++++||||+++++++... +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 468999999999999986 899999999753 233456799999999999999999999999887 778999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
|+|.+++.... ...+++.++..++.|++.||+|||+ ++ |+||||||+||++ +....++|+|||++...
T Consensus 94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~----~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHT----LEPLIPRHALNSRSVMI---DEDMTARISMADVKFSF 163 (271)
T ss_dssp CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTT----SSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTT
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc----CCCceecCCCccceEEE---cCCcceeEEeccceeee
Confidence 99999998654 2358999999999999999999994 57 9999999999999 66677899998887654
Q ss_pred CCCCCCccccccCCCCCCCCCCCCc---cchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 476 PSRKASENLAIGRSPEFPEGKRLTH---KADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 476 ~~~~~~~~~~~y~aPE~~~~~~~s~---ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....++..|+|||.+.+..++. ++|||||||++|||+||+.||.+.. ..+..............
T Consensus 164 ~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~-- 232 (271)
T 3kmu_A 164 QS-PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGLRPTI-- 232 (271)
T ss_dssp SC-TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCCCCCC--
T ss_pred cc-cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCCCCCC--
Confidence 33 2345788999999988765544 8999999999999999999997532 12222222222211111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.......+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 233 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 --------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223468899999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=350.35 Aligned_cols=241 Identities=16% Similarity=0.259 Sum_probs=190.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchh---hHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNAL---SKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.++||+|+||+||+|+.. +++.||+|++++.... ..+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 478999999999999864 6889999999754222 224578899999887 89999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++...
T Consensus 137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~----~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE----RGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCEEeccCCHHHEEE---CCCCCEEEeecceeeecc
Confidence 999999998754 48999999999999999999994 699999999999999 666789999999998632
Q ss_pred C----CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH-HHHHHhcCCccccc
Q 007427 477 S----RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW-VRMVVDNDWSTDIL 551 (604)
Q Consensus 477 ~----~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 551 (604)
. .....+++.|+|||++.+..++.++|||||||++|||++|+.||..............+. ...+......
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 280 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 280 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----
Confidence 2 123357889999999999999999999999999999999999997543222211112222 2222222111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+......+.+++.+||+.||++||++
T Consensus 281 --------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 --------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011223468899999999999999996
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=359.34 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=199.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 46899999999999999888889999998543 345789999999999999999999999876 6789999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++....+ ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 267 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~----~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 267 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVER----MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCcee
Confidence 99976431 248999999999999999999994 799999999999999 667789999999998765432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+....... .....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~-~~~~~------ 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVER-GYRMP------ 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHT-TCCCC------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHc-CCCCC------
Confidence 1234567999999988899999999999999999999 999987532 1122222221 11111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
.+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 402 ----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 402 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11123446889999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.68 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=200.1
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCc-eEEEE
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEE-KLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~ 392 (604)
.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 47899999999999973 346899999997543 33456799999999999 79999999999987654 89999
Q ss_pred ecCCCCCHHHHhhcccCCC-------------------------------------------------------------
Q 007427 393 EFLPNGSLFDLLHESRGVG------------------------------------------------------------- 411 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------- 411 (604)
||+++|+|.++++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998754210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC------CCcccc
Q 007427 412 RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK------ASENLA 485 (604)
Q Consensus 412 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~ 485 (604)
...+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||+++...... ...++.
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~----~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 1128899999999999999999994 699999999999999 666789999999998764332 224566
Q ss_pred ccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHH
Q 007427 486 IGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNE 564 (604)
Q Consensus 486 ~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (604)
.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ..+ ............ ....
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~----~~~~~~~~~~~~----------~~~~ 321 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEF----CRRLKEGTRMRA----------PDYT 321 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHH----HHHHHHTCCCCC----------CTTC
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHH----HHHHHcCCCCCC----------CCCC
Confidence 8999999998899999999999999999999 99999764221 111 111111111110 1112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 565 MLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
...+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 34688999999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.86 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=203.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|++. ++..||||+++... ...++|.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 478999999999999876 48899999997543 3467899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.++++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++.......
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~----~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK----KNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce
Confidence 99998643 2358999999999999999999994 799999999999999 6677899999999987654321
Q ss_pred -----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 -----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 -----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..+.+. ........
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~----~~~~~~~~----- 439 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL----LEKDYRME----- 439 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHH----HHTTCCCC-----
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHH----HHcCCCCC-----
Confidence 233467999999988889999999999999999999 9999876421 112221 11111111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 440 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 -----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1112334688999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.39 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=188.8
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch----hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA----LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. ++.||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 468999999999999975 89999999864322 2246789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCceEEeecC-----CcceEEEeec
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK---VPHANLKSSNILIFREN-----DIYRAKLTNF 469 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~---ivHrDlkp~NILl~~~~-----~~~~~kl~DF 469 (604)
++|.+++... .+++..+..++.|++.||+|||+ ++ |+||||||+||+++.+. ....+||+||
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~----~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 91 GPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHD----EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHH----SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred CCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh----CCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999998643 48999999999999999999995 46 99999999999995432 2567999999
Q ss_pred cCCCCCCCCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 470 GFLPLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 470 Gla~~~~~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
|+++...... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.+.. -.............
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAMNKLA 232 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHTSCCC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhcCCCC
Confidence 9998765432 3357889999999998889999999999999999999999997532 11111111111111
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
... .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 LPI----------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC----------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 112234688999999999999999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=339.09 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=193.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+..+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 46899999999999998889999999997432 2234678899999999999999999999999999999999997 48
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||+++.....
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~----~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ----HRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCC
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCchHhEEE---CCCCCEEEccCcCceecCCCc
Confidence 988887643 248999999999999999999994 699999999999999 66678999999999776432
Q ss_pred ---CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH-
Q 007427 479 ---KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV- 553 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 553 (604)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+... ...............
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKI-FSILGTPNPREWPQVQ 248 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHH-HHHHCCCCTTTSGGGT
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHH-HHHHCCCChHHhhhhh
Confidence 22356889999999876 56899999999999999999999999864321 122222 111111111000000
Q ss_pred --Hh-h-----------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 --EI-L-----------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 --~~-~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. . ..........++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0 00000112346889999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.64 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=195.3
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC--CCCCcccEEEEEecC----CceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL--KHENLAKIVSFYYSK----EEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 578999999999999876 8999999986432 34455566666554 999999999999877 6789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL----HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
++|+|.++++.. .+++..+..++.|++.||+|||+.. +..+|+||||||+|||+ +....+||+|||+
T Consensus 118 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 118 ENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGL 188 (337)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCC
Confidence 999999999754 3899999999999999999999420 11299999999999999 6667899999999
Q ss_pred CCCCCCCC--------CCccccccCCCCCCCCCCCCcc------chhHhHHHHHHHHHhC----------CCCCCCCCCC
Q 007427 472 LPLLPSRK--------ASENLAIGRSPEFPEGKRLTHK------ADVYCFGIILLEVITG----------RIPGNGSPGN 527 (604)
Q Consensus 472 a~~~~~~~--------~~~~~~~y~aPE~~~~~~~s~k------sDVwSfGvvl~elltg----------~~p~~~~~~~ 527 (604)
++...... ...++..|+|||.+.+...+.+ +|||||||++|||+|| +.||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97654332 2357889999999987776665 9999999999999999 5565543221
Q ss_pred CCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
. ................... . ...........+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 269 ~---~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 D---PSYEDMREIVCIKKLRPSF-P----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp S---CCHHHHHHHHTTSCCCCCC-C----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred C---CchhhhHHHHhhhccCccc-c----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1 1122222222111111111 1 01112256678999999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.07 Aligned_cols=245 Identities=21% Similarity=0.355 Sum_probs=200.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 46899999999999986 46899999999866555667899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+ ....+||+|||+++......
T Consensus 136 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~----~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 136 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHE----HSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh----CCeeecccchHHeEEecC-CCCceEEEecccceecCCCcc
Confidence 99997543 248999999999999999999994 699999999999999432 23579999999998775443
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.........+....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~~~~~~------- 271 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDE------- 271 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCS-------
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc-------
Confidence 2357889999999999999999999999999999999999997531 12222222222211100
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++|||+.|+++
T Consensus 272 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 -DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001122346889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.19 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=194.6
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+.||+|+||.||+|+. .+++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999984 57999999999766555577899999999885 799999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||+++......
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHN----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh----CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99998754 48999999999999999999994 699999999999999666555569999999987654221
Q ss_pred ----------CCccccccCCCCCCCC-----CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCC---c----hhHH
Q 007427 480 ----------ASENLAIGRSPEFPEG-----KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSG---D----LSDW 537 (604)
Q Consensus 480 ----------~~~~~~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~---~----~~~~ 537 (604)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+......... . ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 1237889999999864 4578999999999999999999999986543211100 0 0111
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......... ...... ......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~i~~~~~~--~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGKYE--FPDKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCCCC--CCHHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccCcc--cCchhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1112111111 000000 012346889999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=345.13 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=184.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 468999999999999865 58899999997543 346788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++..+....+||+|||+++......
T Consensus 136 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 136 FDRIVEKG-----YYSERDAADAVKQILEAVAYLHE----NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp HHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99997643 48999999999999999999994 699999999999999654457789999999998765432
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ............... ..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~~~~~~~--~~----- 272 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRILNCEYYF--IS----- 272 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHHTTCCCC--CT-----
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHHhCCCcc--CC-----
Confidence 33578899999999999999999999999999999999999975321 111122222221110 00
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++|||+.|+++
T Consensus 273 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123346889999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=342.61 Aligned_cols=254 Identities=17% Similarity=0.207 Sum_probs=199.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46899999999999985 6799999999875432 34688999999999 9999999999999999999999999 999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC--cceEEEeeccCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND--IYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--~~~~kl~DFGla~~~~~ 477 (604)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. ...+||+|||+++....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~----~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 91 LEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS----KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999998642 259999999999999999999994 69999999999999943321 11299999999986533
Q ss_pred C-----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 478 R-----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 478 ~-----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.+... ....+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHHHHhhhc
Confidence 2 233578899999999999999999999999999999999999986422 222222222211110
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
... .... ....+ ++.+++..||+.||.+||++.+|.+.|+++...
T Consensus 238 ~~~---~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 238 ATP---IEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HSC---HHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---HHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000 0000 00112 689999999999999999999999999987644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=339.37 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 47899999999999984 357899999997543 23457899999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 394 FLPNGSLFDLLHESRGV-------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
|+++|+|.+++...... ...++++..+..++.|++.||+|||+ ++|+||||||+||++ +.
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~---~~ 180 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS----KNCIHRDLAARNILL---TH 180 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---ET
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCccceEEE---cC
Confidence 99999999999875421 12258999999999999999999994 699999999999999 55
Q ss_pred cceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
...+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ...
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~ 256 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----DSK 256 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----SHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc----hhH
Confidence 57899999999987754432 234567999999988899999999999999999999 9999875421 111
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.. .......... ........+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 257 ~~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FY----KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HH----HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HH----HHhccCCCCC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 11 1111111110 011223468899999999999999999999999998865443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=339.93 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=201.7
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 47899999999999985 24589999999753 333457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 395 LPNGSLFDLLHESRGV-------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
+++|+|.+++...... ....+++.++..++.|++.||+|||+ ++|+||||||+||++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~dikp~NIli 183 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE----MKLVHRDLAARNILV 183 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH----CCCcccccchheEEE
Confidence 9999999999875421 11248899999999999999999994 699999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNN 528 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~ 528 (604)
+....+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+...
T Consensus 184 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 258 (314)
T 2ivs_A 184 ---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-- 258 (314)
T ss_dssp ---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred ---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 555689999999997664332 2234567999999988889999999999999999999 9999975321
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
..+... ... ..... ........+.+++.+||+.||++||++.|+++.|+++...
T Consensus 259 ---~~~~~~---~~~-~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ---ERLFNL---LKT-GHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ---GGHHHH---HHT-TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHH---hhc-CCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 112221 111 11111 0112334688999999999999999999999999988643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.52 Aligned_cols=241 Identities=16% Similarity=0.258 Sum_probs=191.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999864 68999999997532 22345688999999887 89999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++...
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE----RGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCHHHEEE---CCCCCEEEEecccccccc
Confidence 999999998654 48999999999999999999994 699999999999999 666789999999998643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHH-HHHHHhcCCccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDW-VRMVVDNDWSTDIL 551 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 551 (604)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||................ ..........
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 237 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 237 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----
Confidence 22 23357889999999999999999999999999999999999997532211111111111 2222222111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+......+.+++.+||+.||++||++
T Consensus 238 --------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 --------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011223468899999999999999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.28 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=202.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..+++.||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 468999999999999988889999999976433 3578999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC---
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--- 478 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~--- 478 (604)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++.....
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHH
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCchheEEE---CCCCCEEEccccccccccccccc
Confidence 9998653 248999999999999999999994 699999999999999 66678999999998876432
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+......... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~-~~~------ 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF-RLY------ 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC-CCC------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCC-cCC------
Confidence 12344567999999988889999999999999999999 899987531 122222222211 100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
........+.+++.+||+.||++||++.|+++.|+++.+
T Consensus 226 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011123468899999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=336.72 Aligned_cols=238 Identities=19% Similarity=0.264 Sum_probs=197.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 468999999999999864 79999999997532 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence 99999998654 4899999999999999999999 5799999999999999 6667899999999987654
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~-------- 222 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAELRF-------- 222 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCCCC--------
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC--------
Confidence 33 3467899999999999999999999999999999999999997531 222233333222110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.|+++
T Consensus 223 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 011233588999999999999999 8888874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=340.89 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=190.6
Q ss_pred hcccCcCCcceEEEEEecC-C---cEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce------E
Q 007427 322 AEVLGKGKVGSTYKATLES-G---AVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK------L 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~ 389 (604)
.+.||+|+||.||+|+... + ..||||+++.. .....+.+.+|++++++++||||+++++++...+.. +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 5789999999999998543 3 38999999753 333457899999999999999999999999877655 9
Q ss_pred EEEecCCCCCHHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 390 IIYEFLPNGSLFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
+||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~----~~ivH~Dikp~NIli---~~~~~~kl~D 180 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS----RNFIHRDLAARNCML---AEDMTVCVAD 180 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTSCEEECC
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc----CCcccCCCCcceEEE---cCCCCEEEee
Confidence 99999999999999976542 122358999999999999999999994 699999999999999 6667899999
Q ss_pred ccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 469 FGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 469 FGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... . +.....
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~---~~~~~~ 252 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----A---EIYNYL 252 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G---GHHHHH
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----H---HHHHHH
Confidence 99998764432 2234567999999998899999999999999999999 9999875321 1 112222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
....... ........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 253 ~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGGNRLK-----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTCCCC-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCCCCC-----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2221111 01123346889999999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=348.25 Aligned_cols=260 Identities=16% Similarity=0.185 Sum_probs=195.6
Q ss_pred hcccCcCCcceEEEEEecC------CcEEEEEEecccchhh-----------HHHHHHHHHHHccCCCCCcccEEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLES------GAVVAVKRVKNMNALS-----------KKEFVQQMQLLGKLKHENLAKIVSFYYS 384 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~ 384 (604)
.+.||+|+||.||+|.... ++.||||++....... ...+.+|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4689999999999998754 4789999987543211 1234456677888899999999999876
Q ss_pred C----CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 385 K----EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 385 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
. ...++||||+ +++|.+++.... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.+ .
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~----~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHE----HEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEEESS-C
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCeEEecCCHHHEEEecC-C
Confidence 5 3479999999 999999998642 259999999999999999999994 699999999999999532 4
Q ss_pred cceEEEeeccCCCCCCCCC-----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCC
Q 007427 461 IYRAKLTNFGFLPLLPSRK-----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE 529 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~-----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~ 529 (604)
...+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||+||+.||.+...
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~--- 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK--- 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT---
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 5689999999997654321 22378899999999999999999999999999999999999985321
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
............... .....+.... ....+..+.+++..||+.||++||++.++++.|+++....
T Consensus 267 -~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 -DPKYVRDSKIRYREN-IASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp -CHHHHHHHHHHHHHC-HHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CHHHHHHHHHHhhhh-HHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111111111111111 1111111110 0122446889999999999999999999999999886543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=332.69 Aligned_cols=252 Identities=20% Similarity=0.356 Sum_probs=199.2
Q ss_pred hcccCcCCcceEEEEEec-CC---cEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce-EEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SG---AVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK-LIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~ 395 (604)
.++||+|+||+||+|+.. ++ ..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999853 22 379999997543 33457889999999999999999999999876655 9999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+|+|.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||+++..
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~----~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE----QKFVHRDLAARNCML---DESFTVKVADFGLARDI 174 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence 9999999997643 258999999999999999999994 699999999999999 66678999999999865
Q ss_pred CCCC--------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSRK--------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~~--------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
.... ...++..|+|||...+..++.++|||||||++|||+||..|+.... ....+... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~~~~~~---~~~~~~~ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHF---LAQGRRL 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGGGHHHH---HHTTCCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHHHHHHH---hhcCCCC
Confidence 4322 2345678999999999999999999999999999999666654321 11122221 1111110
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
. ........+.+++.+||+.||.+|||+.|++++|+++...+..
T Consensus 248 ~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 P-----------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp C-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred C-----------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0 0111234688999999999999999999999999998766543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=342.63 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=193.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46899999999999985 678999999996431 112357899999999999999999999999999999999999 7
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||++.....
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~----~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHR----HKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----HTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEecCCchhhEEE---cCCCCEEEEEeccceeccC
Confidence 89999987654 48999999999999999999995 699999999999999 6667899999999987654
Q ss_pred CC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...+++.|+|||.+.+..+ +.++|||||||++|||++|+.||.+........ .+ ... ...
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-~i--------~~~-~~~---- 226 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-KV--------NSC-VYV---- 226 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-CC--------CSS-CCC----
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-HH--------HcC-CCC----
Confidence 43 3357889999999988776 789999999999999999999997643211100 00 000 000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+......+.+++.+||+.||.+|||+.|+++
T Consensus 227 ------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 227 ------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01112345789999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.91 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=189.0
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. .+..||+|+++.. .....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 478999999999999864 2567999998753 3334577999999999999999999999984 567899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 99 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES----KRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYME 167 (281)
T ss_dssp TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEEE---ETTEEEECC--------
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh----CCeecccccHHHEEEC---CCCCEEECccccccccC
Confidence 999999997643 248999999999999999999994 6999999999999994 44679999999998765
Q ss_pred CCCC-----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 477 SRKA-----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 477 ~~~~-----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.... ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... .... ......... .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~---~~i~~~~~~-~- 237 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI---GRIENGERL-P- 237 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH---HHHHTTCCC-C-
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHH---HHHHcCCCC-C-
Confidence 4321 234567999999988889999999999999999997 9999975321 1121 122111111 0
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.....+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 238 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112334688999999999999999999999999988643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.60 Aligned_cols=240 Identities=19% Similarity=0.307 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc------------
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE------------ 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------------ 387 (604)
.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 478999999999999865 7999999999743 33356789999999999999999999999865432
Q ss_pred ---------------------------------------------eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHH
Q 007427 388 ---------------------------------------------KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLS 422 (604)
Q Consensus 388 ---------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 422 (604)
.++||||+++|+|.+++..... ....++..+..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHH
Confidence 7899999999999999987542 23467778999
Q ss_pred HHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC----------------CCccccc
Q 007427 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK----------------ASENLAI 486 (604)
Q Consensus 423 i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~----------------~~~~~~~ 486 (604)
++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++...... ...++..
T Consensus 169 i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS----KGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHh----CCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 99999999999994 699999999999999 666689999999998765431 2347889
Q ss_pred cCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHH
Q 007427 487 GRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEML 566 (604)
Q Consensus 487 y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (604)
|+|||.+.+..++.++|||||||++|||++|..|+.. ............ ... .......
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~-~~~----------~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLK-FPL----------LFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTC-CCH----------HHHHHCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccC-CCc----------ccccCCh
Confidence 9999999999999999999999999999998766421 111111111111 000 0122334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 567 RLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 567 ~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=343.48 Aligned_cols=247 Identities=22% Similarity=0.414 Sum_probs=192.1
Q ss_pred hcccCcCCcceEEEEEec-CCc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGA----VVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+.. +++ .||+|.++.. .....+.+.+|+.++++++||||++++++|... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEec
Confidence 478999999999999853 444 4688888643 233457899999999999999999999999875 478999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++..... .+++..++.|+.|++.||+|||+ ++|+||||||+|||+ +....+||+|||+++..
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~----~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED----RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 167 (327)
T ss_dssp TTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---EETTEEEECCTTHHHHH
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhh----CCeeCCCCChheEEE---CCCCCEEEccCcceeEc
Confidence 99999999987542 48999999999999999999994 699999999999999 44567999999998765
Q ss_pred CCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+ ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~----~~~~~~ 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSIL----EKGERL 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHH----HTTCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHH----HcCCCC
Confidence 4322 1234568999999999999999999999999999999 9999975321 1222221 111110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
. ........+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 239 ~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred C----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0 0112334688999999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.72 Aligned_cols=257 Identities=16% Similarity=0.176 Sum_probs=202.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46899999999999985 679999999986543 234678899999999 7999999999999999999999999 999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC--CcceEEEeeccCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--DIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--~~~~~kl~DFGla~~~~~ 477 (604)
|.+++.... .++++..+..++.|++.||+||| +++|+||||||+||+++.++ ....+||+|||+++....
T Consensus 92 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 92 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999998643 24899999999999999999999 57999999999999995542 233499999999976643
Q ss_pred C-----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 478 R-----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 478 ~-----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
. ....++..|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-----ccHHHHHHHHhhcc
Confidence 2 2235788999999999999999999999999999999999999864321 11111111111100
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
... ... .....+..+.+++.+||+.||++||++.+|++.|+++.+...
T Consensus 239 ~~~--~~~-----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 239 STP--LRE-----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HSC--HHH-----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Ccc--HHH-----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000 000 001223468899999999999999999999999999876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.29 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=191.5
Q ss_pred hcccCcCCcceEEEEEec--C--CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE--S--GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+.. + +..||+|.++... ....+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 468999999999999853 2 2468999987532 3345789999999999999999999998754 45789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++..+..++.|+++||+|||+ ++|+||||||+|||+ +....+||+|||+++..
T Consensus 174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS----KKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH----CCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 9999999997643 248899999999999999999994 699999999999999 66678999999999866
Q ss_pred CCCC--------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 476 PSRK--------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 476 ~~~~--------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.... ...++..|+|||.+.+..++.++|||||||++|||+| |..||..... ...... ......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~---~~~~~~ 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVY---LLQGRR 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHH---HHTTCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHH---HHcCCC
Confidence 4322 1234567999999998999999999999999999999 6777764321 122221 111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
.. .+...+..+.+++.+||+.||++||++.|+++.|+++...+..
T Consensus 315 ~~-----------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 315 LL-----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00 0112234688999999999999999999999999998766554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=344.48 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=198.7
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 57899999999999985 246689999997532 23346789999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 394 FLPNGSLFDLLHESRGV------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+ +||+||||||+|||+
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIll 205 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF----KSCVHRDLAARNVLV 205 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH----TTEEETTCSGGGEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCChhhEEE
Confidence 99999999999865421 01247999999999999999999994 699999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNN 528 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~ 528 (604)
+....+||+|||++........ ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+....
T Consensus 206 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 281 (344)
T 1rjb_A 206 ---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD- 281 (344)
T ss_dssp ---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred ---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-
Confidence 5556899999999986643322 234567999999988889999999999999999998 99999764221
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
............... .......+.+++.+||+.||.+|||+.|+++.|+.+....++
T Consensus 282 -------~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 282 -------ANFYKLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp -------HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -------HHHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 111122222211110 111234688999999999999999999999999998876654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.44 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=193.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHH--HccCCCCCcccEEEEEec-----CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQL--LGKLKHENLAKIVSFYYS-----KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++++.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 47899999999999977 58999999997432 3344444444 556899999999986542 2256899999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCceEEeecCCcceEE
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH---------KVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---------~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
+++|+|.+++.... .++..+..++.|++.||+||| +. +|+||||||+|||+ +....+|
T Consensus 94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~k 160 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLV---KNDGTCV 160 (336)
T ss_dssp CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEE
T ss_pred CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEE---cCCCcEE
Confidence 99999999997653 689999999999999999999 45 99999999999999 6667899
Q ss_pred EeeccCCCCCCCCC------------CCccccccCCCCCCCC-------CCCCccchhHhHHHHHHHHHhCCCCCCCCCC
Q 007427 466 LTNFGFLPLLPSRK------------ASENLAIGRSPEFPEG-------KRLTHKADVYCFGIILLEVITGRIPGNGSPG 526 (604)
Q Consensus 466 l~DFGla~~~~~~~------------~~~~~~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~ 526 (604)
|+|||+++.+.... ...++..|+|||++.+ ..++.++|||||||++|||+||..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997664321 2247889999999887 3566789999999999999999877754332
Q ss_pred CCCCCCch----------hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 527 NNETSGDL----------SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 527 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.......+ .................. ...........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 22211111 111111111111111100 0011234566799999999999999999999999999999
Q ss_pred ccccccC
Q 007427 597 QPMIEEN 603 (604)
Q Consensus 597 ~~~~~~~ 603 (604)
....+++
T Consensus 317 l~~~~~~ 323 (336)
T 3g2f_A 317 MMIWERN 323 (336)
T ss_dssp HHCCCC-
T ss_pred HHHHHhc
Confidence 8877664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.33 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=188.5
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHc-cCCCCCcccEEEEEec----CCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLG-KLKHENLAKIVSFYYS----KEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 396 (604)
++||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++. ..+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 5799999999999985 46899999999642 45678888874 4589999999999875 557899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ...+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++....+||+|||+++...
T Consensus 143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH----CCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999998643 2358999999999999999999994 699999999999999655446789999999998765
Q ss_pred CCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 477 SRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 477 ~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+........ .....+ ........ .
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i---~~~~~~~~--~- 288 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRI---RMGQYEFP--N- 288 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHH---HHTCCCCC--T-
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHH---HcCcccCC--C-
Confidence 432 3356889999999999999999999999999999999999998654322111 111111 11111100 0
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 289 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 -----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011233468899999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.81 Aligned_cols=246 Identities=18% Similarity=0.251 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 468999999999999865 799999999975432 346788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++ ...+||+|||+++.....
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~----~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHS----MQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCSCCCCGGGEEECSSS-SCCEEECCCCCC--------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEEcCCC-CceEEEeecCccccccccCC
Confidence 99997654 48999999999999999999994 7999999999999994322 235999999998754322
Q ss_pred -CCCccccccCCCCCCCCCCCCcc-chhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 -KASENLAIGRSPEFPEGKRLTHK-ADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 -~~~~~~~~y~aPE~~~~~~~s~k-sDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....++..|+|||++.+..++.+ +|||||||++|||++|+.||.+... ....................
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~------ 243 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVKYSIPD------ 243 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCCCCT------
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCCCCCCC------
Confidence 23467889999999988877665 8999999999999999999986422 22333434333332211100
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ----DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00123468899999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.52 Aligned_cols=241 Identities=22% Similarity=0.351 Sum_probs=196.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999985 679999999996432 2234678999999999999999999999999999999999996
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .++++..+..++.|+++||+|||+ ++|+||||||+|||+ +....+||+|||+++....
T Consensus 138 g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 138 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS----HNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC
Confidence 68988886543 258999999999999999999995 699999999999999 5556899999999988877
Q ss_pred CCCCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....++..|+|||++. ...++.++|||||||++|||+||+.||.... ............... ..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~~~-~~--- 274 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPA-LQ--- 274 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCC-CC---
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCC-CC---
Confidence 76778899999999874 5678999999999999999999999987531 122222222221111 00
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 275 ------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01123458899999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.44 Aligned_cols=238 Identities=20% Similarity=0.264 Sum_probs=193.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 47899999999999985 46899999999753 222346688999999988 79999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++...
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHD----KGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 999999998764 48999999999999999999994 699999999999999 666789999999998643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~---- 243 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVY---- 243 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC----
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCC----
Confidence 22 22357889999999988889999999999999999999999997532 223333333322111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKM------SEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 591 (604)
+......+.+++.+||+.||++||++ .|+++
T Consensus 244 --------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 --------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11123357899999999999999998 66654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.87 Aligned_cols=239 Identities=20% Similarity=0.304 Sum_probs=186.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHccCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL--------------------------SKKEFVQQMQLLGKLKHEN 374 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 374 (604)
.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46899999999999985 56899999999643211 1256889999999999999
Q ss_pred cccEEEEEec--CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 007427 375 LAKIVSFYYS--KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSN 452 (604)
Q Consensus 375 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~N 452 (604)
|+++++++.. .+..++||||+++++|.+++.. .++++.++..++.|++.||+|||+ ++|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~N 167 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY----QKIIHRDIKPSN 167 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGG
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHH
Confidence 9999999986 5678999999999999876543 258999999999999999999994 699999999999
Q ss_pred eEEeecCCcceEEEeeccCCCCCCCCC----CCccccccCCCCCCCCCC---CCccchhHhHHHHHHHHHhCCCCCCCCC
Q 007427 453 ILIFRENDIYRAKLTNFGFLPLLPSRK----ASENLAIGRSPEFPEGKR---LTHKADVYCFGIILLEVITGRIPGNGSP 525 (604)
Q Consensus 453 ILl~~~~~~~~~kl~DFGla~~~~~~~----~~~~~~~y~aPE~~~~~~---~s~ksDVwSfGvvl~elltg~~p~~~~~ 525 (604)
||+ +.+..+||+|||+++...... ...++..|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 168 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~- 243 (298)
T 2zv2_A 168 LLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE- 243 (298)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred EEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-
Confidence 999 666789999999998765432 335788999999998765 378899999999999999999999752
Q ss_pred CCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 526 GNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
................. ........+.+++.+||+.||++|||+.|+++
T Consensus 244 -------~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 -------RIMCLHSKIKSQALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -------SHHHHHHHHHHCCCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------cHHHHHHHHhcccCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 12222222222211100 00112346889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.92 Aligned_cols=242 Identities=19% Similarity=0.312 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 468999999999999865 799999999964322 234678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... .+++.++..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++.+...
T Consensus 92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~----~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG----IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccccchHHEEE---eCCCCEEEEEeeccceeccCC
Confidence 999987543 48999999999999999999994 799999999999999 66678999999999765322
Q ss_pred -----CCCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 479 -----KASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 479 -----~~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
....++..|+|||++.+..+ +.++|||||||++|||++|+.||...... ......+ .........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----~~~~~~~~~-- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKKTYLNP-- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHHH----HTTCTTSTT--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hcccccCCc--
Confidence 23357889999999987765 77999999999999999999999754221 1111111 111110000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 --------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123457899999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.57 Aligned_cols=244 Identities=18% Similarity=0.300 Sum_probs=199.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 478999999999999864 5789999999865555678899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++..++....+||+|||++.......
T Consensus 94 ~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~----~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 94 FERVVHKR-----VFRESDAARIMKDVLSAVAYCHK----LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99998754 48999999999999999999994 699999999999999766667789999999997665432
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...++..|+|||.+.+. ++.++||||||+++|||++|+.||.... ..+............. ....
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~--~~~~-- 231 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIREGTFTFP--EKDW-- 231 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC--HHHH--
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCCC--chhh--
Confidence 33578899999998764 8999999999999999999999997531 1222222222221110 0000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 ----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012346889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.45 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=194.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 57899999999999985 468999999997543 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++...... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++....+||+|||+++......
T Consensus 107 L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 107 LLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS----QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp HHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred HHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh----CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998654211 1258999999999999999999994 699999999999999766666789999999998765432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||.+. ..++.++|||||||++|||++|+.||.+.. ..+.............. .
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~~-~---- 247 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPNYAV-E---- 247 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCC------
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCccccc-c----
Confidence 335788999999886 568999999999999999999999997532 12222211111111000 0
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 248 ----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012345789999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.93 Aligned_cols=241 Identities=17% Similarity=0.277 Sum_probs=194.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 47899999999999985 468999999996432 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||+ +..+.+||+|||+++.+..
T Consensus 100 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 100 GDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQN----QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceeccCcHHHeEE---CCCCCEEEeccceeeeccC
Confidence 99999998643 48999999999999999999994 799999999999999 6667899999999987654
Q ss_pred CC---CCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 478 RK---ASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.. ...++..|+|||++.. ..++.++|||||||++|||++|+.||..... ................
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~---- 238 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFETTVVT---- 238 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHHHCCCC----
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhhcccC----
Confidence 32 3467889999999874 4589999999999999999999999975322 1222222222221111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPK-MSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 591 (604)
.+......+.+++.+||+.||.+||+ +.++.+
T Consensus 239 --------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 --------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122346889999999999999998 666543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.72 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=203.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++|+||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 57899999999999999888899999998643 345789999999999999999999999876 6789999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
++++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++......
T Consensus 350 ~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~----~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 350 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVER----MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHH
T ss_pred HHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCcee
Confidence 99976431 248999999999999999999994 799999999999999 667789999999998775421
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+....+. ......
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~-~~~~~~------ 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVE-RGYRMP------ 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHH-TTCCCC------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH-cCCCCC------
Confidence 2234567999999988899999999999999999999 999987532 122222222 111111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
........+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 01123346889999999999999999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=331.25 Aligned_cols=245 Identities=19% Similarity=0.307 Sum_probs=197.5
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 478999999999999864 7999999999865544556789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++..++....+||+|||+++.......
T Consensus 94 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 94 FDRILERG-----VYTEKDASLVIQQVLSAVKYLHE----NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99997654 48999999999999999999994 6999999999999996656667899999999977654322
Q ss_pred --CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 481 --SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 481 --~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
..++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+..............
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~-------- 228 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKEGYYEFES-------- 228 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHCCCCCCT--------
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCc--------
Confidence 247889999999999999999999999999999999999997531 12222222222111100
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122346889999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=336.95 Aligned_cols=249 Identities=22% Similarity=0.393 Sum_probs=196.2
Q ss_pred hcccCcCCcceEEEEEecC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLES-----GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+... +..||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4789999999999998542 346999999754 3334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++..
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN----MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCChheEEE---CCCCcEEECCCCcchhh
Confidence 9999999997643 258999999999999999999995 699999999999999 66678999999999876
Q ss_pred CCCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
..... ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFRL 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCcC
Confidence 54321 123567999999998899999999999999999999 999997532 12222222222111
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
.. .......+.+++.+||+.||++||++.|+++.|+++....
T Consensus 270 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 PT-----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CC-----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CC-----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 10 1122346889999999999999999999999999886544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.23 Aligned_cols=245 Identities=19% Similarity=0.263 Sum_probs=199.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 46899999999999985 46899999999643 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++....+||+|||++......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHS----NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999987654 48999999999999999999995 69999999999999976666667999999999776544
Q ss_pred CC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 KA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ..++..|+|||.+.+..++.++||||||+++|||++|+.||.+.. ..................
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~---- 229 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGAYDYPSP---- 229 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCTT----
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHhccccCCch----
Confidence 32 357889999999999999999999999999999999999997531 122222222222111100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00122346889999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.97 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=195.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|.. .+|+.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 47899999999999985 57999999999742 233457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++..... ....+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++....
T Consensus 117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~----~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS----RRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCC--------
T ss_pred CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh----CCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecC
Confidence 999999976431 12358999999999999999999994 699999999999999 6667899999999887654
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||.+.. .................. .
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~-~-- 259 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQCDYPPL-P-- 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTTCSCCC-C--
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhhcccCCCC-c--
Confidence 32 2356788999999999999999999999999999999999997532 122223332222221110 0
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.......+.+++.+||+.||++|||+.+|++.|+++++...
T Consensus 260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 01123468899999999999999999999999999986544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.63 Aligned_cols=238 Identities=17% Similarity=0.235 Sum_probs=197.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999864 79999999996432 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||+ +....+||+|||+++....
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS----LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence 99999998754 48999999999999999999994 799999999999999 6667899999999987654
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~-------- 257 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGKVRF-------- 257 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC--------
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCCCCC--------
Confidence 43 3467899999999999999999999999999999999999997531 222233333222110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
+......+.+++.+||+.||.+||+ +.|+++
T Consensus 258 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0112346889999999999999998 777764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.50 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=196.2
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||.||+|++ .+++.||+|+++.. .....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46899999999999983 46899999999743 233457899999999999999999999999876 66899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++..... .+++.++..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++
T Consensus 106 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGS----RQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174 (302)
T ss_dssp CCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEE---ETTEEEECCCTTCE
T ss_pred eCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhc----CCcccCCCchheEEEc---CCCCEEECcccccc
Confidence 9999999999976542 48999999999999999999994 6999999999999994 44589999999998
Q ss_pred CCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCC-------CCCCCCchhHHHH
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG-------NNETSGDLSDWVR 539 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~-------~~~~~~~~~~~~~ 539 (604)
...... ...++..|+|||.+.+..++.++||||||+++|||+||+.|+..... .............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 765432 23456679999999888899999999999999999999988643100 0000001111111
Q ss_pred HHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
... ..... .........+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 255 ~~~-~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLK-EGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH-TTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-ccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 11000 011223456889999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=330.89 Aligned_cols=249 Identities=26% Similarity=0.446 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+.. ..||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 478999999999999865 35999999743 233457799999999999999999999965 4567899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||+++......
T Consensus 106 L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~----~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 106 LYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA----KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---ETTTEEEECCCC---------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh----CCcccccCccceEEE---CCCCCEEEccceecccccccc
Confidence 999997543 258999999999999999999994 699999999999999 555689999999997654321
Q ss_pred ------CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 ------ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...++..|+|||.+. +..++.++|||||||++|||++|+.||..... .................
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCCCCT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccCcch
Confidence 235788999999986 66788999999999999999999999975321 11222222222111111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
. ......+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 248 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 S-------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp T-------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h-------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 0011234568999999999999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=364.09 Aligned_cols=245 Identities=20% Similarity=0.333 Sum_probs=196.7
Q ss_pred ccCcCCcceEEEEEec---CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLE---SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999764 46789999997543 3356889999999999999999999999976 56899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++.+....
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~----~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE----KNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC---
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCC
Confidence 999997543 258999999999999999999994 699999999999999 455689999999998775332
Q ss_pred C-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 480 A-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 480 ~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
. ..++..|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+.... ...
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~-~~~-- 559 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGK-RME-- 559 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHHHHTTC-CCC--
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCC-CCC--
Confidence 1 123467999999998899999999999999999998 9999976421 12222222211 111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.+..++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 560 --------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp --------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1112345688999999999999999999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.78 Aligned_cols=253 Identities=22% Similarity=0.399 Sum_probs=201.4
Q ss_pred hcccCcCCcceEEEEEe--------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATL--------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 57899999999999985 357789999997543 33456789999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 392 YEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||||+||++ +.
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~ 192 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS----QKCIHRDLAARNVLV---TE 192 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CT
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCCccceEEE---cC
Confidence 9999999999999875421 11248999999999999999999994 699999999999999 66
Q ss_pred cceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
...+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------- 264 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------- 264 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--------
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC--------
Confidence 6789999999997765432 2234567999999988889999999999999999999 999987532
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
..+.......... .. ........+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 265 ~~~~~~~~~~~~~-~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 265 VEELFKLLKEGHR-MD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHHHHTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCC-CC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 2222222222111 11 01122346889999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.80 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+..+|+.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 468999999999999988899999999964322 2346788999999999999999999999999999999999975 9
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+||++ +.+..+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD----RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence 999987643 248999999999999999999994 699999999999999 66678999999998654322
Q ss_pred ---CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc----
Q 007427 479 ---KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI---- 550 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 550 (604)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+... ...+..... ..........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFR-ILGTPNSKNWPNVT 229 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH-HHCCCCTTTSTTGG
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH-HHCCCChhhchhhh
Confidence 22356889999999876 4589999999999999999999999975321 111111111 1110000000
Q ss_pred ----ccHHhh------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 ----LDVEIL------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ----~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.++... ...........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00001123346889999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.87 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=200.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 47899999999999986 6799999999976655667889999999999999999999999873 347789999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++...... ...+++.++..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||++....
T Consensus 114 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~----~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 114 RGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA----KGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp TCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTSCEEECCCSSCEESC
T ss_pred CCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEE---cCCCCEEEEecCcchhcc
Confidence 99999999874321 2358999999999999999999995 699999999999999 666789999999987654
Q ss_pred CCCC-------------CccccccCCCCCCCCCC---CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 477 SRKA-------------SENLAIGRSPEFPEGKR---LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 477 ~~~~-------------~~~~~~y~aPE~~~~~~---~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
.... ..++..|+|||.+.+.. ++.++|||||||++|||++|+.||..... .........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~-- 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ---KGDSVALAV-- 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH---TTSCHHHHH--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc---ccchhhHHh--
Confidence 3211 12478899999987654 68899999999999999999999853110 001111111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
...... .........+.+++.+||+.||.+||++.|+++.|+.++.....
T Consensus 261 --~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 --QNQLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp --HCC--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred --hccCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 111000 00112234688999999999999999999999999999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=333.59 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=192.6
Q ss_pred hhcccCcCCcceEEEEEec----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc-----eE
Q 007427 321 SAEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE-----KL 389 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~ 389 (604)
..+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++...+. .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 3578999999999999753 3558999999743 23345678999999999999999999999987553 49
Q ss_pred EEEecCCCCCHHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEee
Q 007427 390 IIYEFLPNGSLFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTN 468 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~D 468 (604)
+||||+++|+|.+++..... .....+++..++.++.|++.||.||| +++|+||||||+||++ +....+||+|
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli---~~~~~~kl~D 190 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCML---RDDMTVCVAD 190 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEE---CTTSCEEECS
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEE---cCCCcEEEee
Confidence 99999999999999864321 12346999999999999999999999 5799999999999999 6667899999
Q ss_pred ccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 469 FGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 469 FGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+++...... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.+... ..+ ....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~---~~~~ 262 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HEM---YDYL 262 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGH---HHHH
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHH---HHHH
Confidence 99998764332 2245668999999999999999999999999999999 8889875321 111 1222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
........ .......+.+++.+||+.||++|||+.++++.|+++.+.+.
T Consensus 263 ~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHGHRLKQ-----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTCCCCC-----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcCCCCCC-----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 22111100 11223468899999999999999999999999999876554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=340.29 Aligned_cols=258 Identities=20% Similarity=0.344 Sum_probs=201.5
Q ss_pred hcccCcCCcceEEEEEec-----CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-----SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (604)
.+.||+|+||+||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 468999999999998642 68899999997543 33457799999999999999999999999874 56789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++ +....+||+|||+++
T Consensus 116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~----~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA----QHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 182 (318)
T ss_dssp CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCchheEEE---cCCCCEEECCccccc
Confidence 99999999999764 38999999999999999999995 699999999999999 666789999999998
Q ss_pred CCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCC-----CCCCch-hHHHHH
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN-----ETSGDL-SDWVRM 540 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~-----~~~~~~-~~~~~~ 540 (604)
...... ...++..|+|||.+.+..++.++|||||||++|||+||+.||....... ...... ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 775432 2245667999999998889999999999999999999999986421000 000000 000111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
........ .........+.+++.+||+.||++|||+.|+++.|+++.+.++.
T Consensus 263 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 263 LLERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHhcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11111100 01122345689999999999999999999999999999876654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.79 Aligned_cols=237 Identities=20% Similarity=0.290 Sum_probs=193.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999864 68999999997532 22346678899999877 99999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||+ +..+.+||+|||+++...
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS----KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 999999998754 48999999999999999999994 699999999999999 666789999999998653
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~---- 237 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDNPFY---- 237 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC----
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCCCC----
Confidence 22 23357889999999999999999999999999999999999997531 122222222221100
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMS-EVL 590 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 590 (604)
+......+.+++.+||+.||++||++. |++
T Consensus 238 --------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 --------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011234688999999999999999997 554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=330.52 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=202.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|... ++..||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 468999999999999865 58899999997543 3457899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||++........
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~----~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK----KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH----HTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSS
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH----CCccCCCCCcceEEE---cCCCCEEEccCccceeccCCcc
Confidence 99998643 2358999999999999999999995 699999999999999 6667899999999987654432
Q ss_pred C-----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 481 S-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 481 ~-----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. .++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.+ . ......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~---~-~~~~~~----- 232 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELL---E-KDYRME----- 232 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHH---H-TTCCCC-----
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH---h-ccCCCC-----
Confidence 1 34567999999988899999999999999999999 9999875321 1122211 1 111111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.....+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 233 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 233 -----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234688999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.46 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=193.6
Q ss_pred hcccCcC--CcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKG--KVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+| +||.||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4689999 99999999865 79999999997432 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||.+....
T Consensus 110 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~----~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 110 YGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHH----MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp TCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECE
T ss_pred CCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEE---cCCCCEEEcccccceeec
Confidence 9999999987532 248999999999999999999994 799999999999999 666789999999875432
Q ss_pred C-----------CCCCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 477 S-----------RKASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 477 ~-----------~~~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+..........+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 1 112356778999999987 678999999999999999999999997643221100000000000000
Q ss_pred cCC------------------cccccc--------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 544 NDW------------------STDILD--------VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 544 ~~~------------------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
... ...... ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 000000 0000000112234568999999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=346.01 Aligned_cols=261 Identities=15% Similarity=0.188 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEecccchh-----------hHHHHHHHHHHHccCCCCCcccEEEEEec--
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNMNAL-----------SKKEFVQQMQLLGKLKHENLAKIVSFYYS-- 384 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 384 (604)
.+.||+|+||.||+|+.. ++..||+|++...... ....+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 478999999999999864 5789999998754321 12346788899999999999999999987
Q ss_pred --CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc
Q 007427 385 --KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462 (604)
Q Consensus 385 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~ 462 (604)
....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++. .
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll~~~~~-~ 190 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE----NEYVHGDIKAANLLLGYKNP-D 190 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEESSST-T
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeeCCCcCHHHEEEccCCC-C
Confidence 67889999999 999999998654 48999999999999999999994 69999999999999965432 2
Q ss_pred eEEEeeccCCCCCCCC-----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 007427 463 RAKLTNFGFLPLLPSR-----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS 531 (604)
Q Consensus 463 ~~kl~DFGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~ 531 (604)
.+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||+||+.||.+... .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~ 266 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK----D 266 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----C
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----c
Confidence 7999999999765322 223578899999999999999999999999999999999999964211 0
Q ss_pred CchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 532 GDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
................. ...........+..+.+++.+||+.||++||++.+|++.|+++.-....
T Consensus 267 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQ-----SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp HHHHHHHHHHHHHTTTH-----HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred cHHHHHHHHhhcccccH-----HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 01111111111111100 0000000012334689999999999999999999999999987654443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=335.65 Aligned_cols=238 Identities=20% Similarity=0.265 Sum_probs=186.4
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 47899999999999986 478999999997542 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++
T Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~----~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 102 YLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQ----KGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh----CCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 999999999998654 48899999999999999999994 699999999999999 666789999999987
Q ss_pred CCCCC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 474 LLPSR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 474 ~~~~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~- 240 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCKLNL- 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCC-
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCC-
Confidence 64322 22357889999999999999999999999999999999999997531 122222222221110
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.|+++
T Consensus 241 -----------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 -----------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011234688999999999999999 6667765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.91 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=200.1
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 47899999999999984 4688999999987766667789999999999999999999999874 4568899999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++++|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||+++.
T Consensus 108 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 108 LPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGS----RRCVHRDLAARNILV---ESEAHVKIADFGLAKL 176 (327)
T ss_dssp CTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---EETTEEEECCGGGCEE
T ss_pred cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCChhhEEE---CCCCCEEEccccccee
Confidence 999999999987532 48999999999999999999994 699999999999999 4456799999999987
Q ss_pred CCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCC-------CCCCCchhHHHHH
Q 007427 475 LPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGN-------NETSGDLSDWVRM 540 (604)
Q Consensus 475 ~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~-------~~~~~~~~~~~~~ 540 (604)
..... ...++..|+|||.+.+..++.++|||||||++|||++|+.||...... .............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65332 224566799999998888999999999999999999999998642100 0000011111111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
....... .........+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 257 -~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 -LEEGQRL----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred -hhcccCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111100 011223456899999999999999999999999999886543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.69 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=197.4
Q ss_pred hcccCcCCcceEEEEEecC----CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEe-cCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLES----GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYY-SKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+..+ +..||+|.++... ....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4789999999999998532 3368999987533 334577999999999999999999999865 456789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||+++..
T Consensus 110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~----~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS----KKFVHRDLAARNCML---DEKFTVKVADFGLARDM 178 (298)
T ss_dssp TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCC
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCchheEEE---CCCCCEEECcccccccc
Confidence 9999999997643 248999999999999999999994 699999999999999 66678999999999876
Q ss_pred CCCC--------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 476 PSRK--------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 476 ~~~~--------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.... ...++..|+|||.+.+..++.++||||||+++|||++ |.+||..... ..... .......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~~~~---~~~~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITV---YLLQGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-----TTHHH---HHHTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-----HHHHH---HHhcCCC
Confidence 4432 2234567999999998899999999999999999999 5555543211 11111 1111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccccC
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 603 (604)
.. ........+.+++.+||+.||++|||+.|+++.|+++......+
T Consensus 251 ~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 251 LL-----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp CC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CC-----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00 01112336889999999999999999999999999998766543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.89 Aligned_cols=247 Identities=19% Similarity=0.333 Sum_probs=198.9
Q ss_pred cccCcCCcceEEEEEec---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATLE---SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999753 6788999999864 334467899999999999999999999999 556789999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++.....
T Consensus 95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE----KNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTC
T ss_pred CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHH----CCEeeCCCchheEEEc---CCCCEEECcccceeeeccC
Confidence 9999997543 258999999999999999999994 6999999999999994 4468999999999876433
Q ss_pred C-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 K-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.......... ..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~i~~~~~-~~- 233 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKR-ME- 233 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCC-CC-
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHhcCCc-CC-
Confidence 2 1234678999999988889999999999999999999 9999975321 122222222111 11
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
.....+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 234 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 234 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01123346889999999999999999999999999886443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.50 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEec-CCcE----EEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAV----VAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 468999999999999853 4443 7888875432 222356788999999999999999999986 56789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||+++..
T Consensus 97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE----HGMVHRNLAARNVLL---KSPSQVQVADFGVADLL 165 (325)
T ss_dssp TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH----TTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh----CCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence 9999999998653 248899999999999999999994 699999999999999 66678999999999876
Q ss_pred CCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..+... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~---~~~~~~~- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDL---LEKGERL- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHH---HHTTCBC-
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHH---HHcCCCC-
Confidence 5432 2235568999999998899999999999999999999 9999986421 112221 1111110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.. .......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 237 ~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQ----------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CC----------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CC----------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 001122477899999999999999999999999988643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.88 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=185.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+..+.++ +||||++++++|.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 468999999999999865 79999999986432 22334555666665555 8999999999999999999999999 7
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS----QGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC-
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCEecCCCCHHHEEE---CCCCCEEEccceeeeeccc
Confidence 79999988754 259999999999999999999995 699999999999999 6677899999999877654
Q ss_pred CC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ...++..|+|||++.+ .++.++|||||||++|||++|..|+... ..+ ..... .. ....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~-~~~~~-~~----~~~~ 272 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGW-QQLRQ-GY----LPPE 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH-HHHTT-TC----CCHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH-HHHhc-cC----CCcc
Confidence 32 2357889999999876 7899999999999999999997776531 111 11111 11 1111
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ......+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FT-----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 112346889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.64 Aligned_cols=268 Identities=21% Similarity=0.320 Sum_probs=206.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--ceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--EKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 468999999999999865 58999999997533 234577889999999999999999999998765 67999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee-cCCcceEEEeeccCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR-ENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~~~~kl~DFGla~~~~ 476 (604)
|+|.+++..... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+.. ++....+||+|||+++...
T Consensus 94 g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE----NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp EEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH----CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999987542 2238999999999999999999994 69999999999999843 3445679999999998765
Q ss_pred CCC---CCccccccCCCCCCCC--------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 477 SRK---ASENLAIGRSPEFPEG--------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 477 ~~~---~~~~~~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||....... ...+.+.......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMYKIITGK 243 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----TCHHHHHHHHHSC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----chHHHHHHHhcCC
Confidence 543 2357889999998764 457789999999999999999999997543222 1222222222221
Q ss_pred Ccccc---c---------cHH-hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 546 WSTDI---L---------DVE-ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 546 ~~~~~---~---------~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
..... . ... .............+.+++.+||+.||++||++.|+++.++++.+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11000 0 000 001112355667889999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=333.83 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=186.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 46899999999999985 468999999997433 2234678899999999999999999999999999999999997 59
Q ss_pred HHHHhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 400 LFDLLHESRG-VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 400 L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
|.+++..... .....+++..+..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++.....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~----~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE----NKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCChHHeEE---cCCCCEEECcCccceecCCC
Confidence 9999876531 122358999999999999999999994 699999999999999 66678999999999766432
Q ss_pred ----CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC---cccc
Q 007427 479 ----KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW---STDI 550 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 550 (604)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+... ......+........ ....
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTCGGG
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHhhhh
Confidence 23356889999999876 4689999999999999999999999975321 111111111110000 0000
Q ss_pred -----cc-----------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 -----LD-----------VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 -----~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ...............+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 000000001122346899999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.74 Aligned_cols=251 Identities=18% Similarity=0.257 Sum_probs=193.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 468999999999999864 789999999975422 2347789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... ++++.++..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++.....
T Consensus 119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHA----AGATHRDVKPENILV---SADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECSCCC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CcCCcCCCChHHEEE---cCCCCEEEecCccCccccc
Confidence 99999998754 48999999999999999999994 699999999999999 5566899999999877654
Q ss_pred CC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 478 RK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||.+.. ...............
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~--- 254 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---------LSVMGAHINQAIPRP--- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---------HHHHHHHHHSCCCCG---
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---------HHHHHHHhccCCCCc---
Confidence 32 2356788999999999999999999999999999999999997521 111222222211110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhccccc
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRP-KMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~ 601 (604)
. ......+..+.+++.+||+.||++|| ++.++++.|+++.....
T Consensus 255 -~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 -S----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -G----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -c----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 00112233688999999999999999 99999999998765543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.53 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=196.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec----------------
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS---------------- 384 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------------- 384 (604)
.+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 478999999999999875 79999999997543 356789999999999999999998854
Q ss_pred CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 385 KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 385 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ....+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~---~~~~~ 161 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHS----KKLINRDLKPSNIFLV---DTKQV 161 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEE---ETTEE
T ss_pred cceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCCHHHEEEc---CCCCE
Confidence 3457899999999999999976531 258999999999999999999994 6999999999999994 45679
Q ss_pred EEeeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 465 KLTNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 465 kl~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||++|..|+.. ........
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----------~~~~~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----------TSKFFTDL 231 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH----------HHHHHHHH
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh----------HHHHHHHh
Confidence 999999987765432 33578899999999998999999999999999999999988642 11111111
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccccC
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 603 (604)
.. ..... .....+.+++.+||+.||++|||+.|+++.|+.+++..+.+
T Consensus 232 ~~-~~~~~-------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 232 RD-GIISD-------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HT-TCCCT-------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred hc-ccccc-------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 11 11111 12235789999999999999999999999999998876654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=328.33 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=195.7
Q ss_pred hcccCcCCcceEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLES----GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+... +..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 4789999999999998542 346999999754 33346789999999999999999999999764 45789999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++...
T Consensus 96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES----INCVHRDIAVRNILVA---SPECVKLGDFGLSRYIE 164 (281)
T ss_dssp TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC-
T ss_pred CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCccceEEEC---CCCcEEeCccCCCcccc
Confidence 999999998653 248999999999999999999994 6999999999999994 44589999999998765
Q ss_pred CCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 477 SRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 477 ~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+ .......
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~---~~~~~~~-- 234 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVL---EKGDRLP-- 234 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHH---HHTCCCC--
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHH---hcCCCCC--
Confidence 432 2234568999999988889999999999999999998 9999975321 1222211 1111110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 235 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0111234588999999999999999999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.85 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=190.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 46899999999999986 468999999997432 23357788999999999999999999999999999999999975
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
++.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||+++.....
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~----~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS----RNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEE---cCCCCEEEeecccceecCCc
Confidence 6766665532 258999999999999999999994 699999999999999 66678999999999766432
Q ss_pred ----CCCccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---cCCcccc
Q 007427 479 ----KASENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---NDWSTDI 550 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 550 (604)
....++..|+|||.+.+.. ++.++|||||||++|||+||..||.... ...+....... .......
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-------~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTTC
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-------CHHHHHHHHHHHhCCCChhhh
Confidence 2335678899999988765 7999999999999999999998865321 11122221111 1000000
Q ss_pred ccHH--------------hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVE--------------ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.... .............+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000001123446889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.68 Aligned_cols=258 Identities=19% Similarity=0.331 Sum_probs=201.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCCcccEEEEEecCC----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGK--LKHENLAKIVSFYYSKE----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++.. ++||||+++++++.... ..++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 578999999999999984 899999999643 34667888888877 79999999999998876 789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----CCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT----LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
++|+|.+++... .+++.++..++.|++.||+|||.. .++++|+||||||+|||+ +.+..+||+|||+
T Consensus 123 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 123 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGL 193 (342)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCC
Confidence 999999999754 389999999999999999999932 113699999999999999 6667899999999
Q ss_pred CCCCCCCC--------CCccccccCCCCCCCCCC------CCccchhHhHHHHHHHHHhC----------CCCCCCCCCC
Q 007427 472 LPLLPSRK--------ASENLAIGRSPEFPEGKR------LTHKADVYCFGIILLEVITG----------RIPGNGSPGN 527 (604)
Q Consensus 472 a~~~~~~~--------~~~~~~~y~aPE~~~~~~------~s~ksDVwSfGvvl~elltg----------~~p~~~~~~~ 527 (604)
++...... ...++..|+|||.+.+.. ++.++|||||||++|||+|| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 87654322 235788999999987652 34689999999999999999 6777654221
Q ss_pred CCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
......+............... .....+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 274 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 274 ---DPSVEEMRKVVCEQKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp ---SCCHHHHHHHHTTSCCCCCCCG-----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ---cccHHHHHHHHHHHHhCCCCcc-----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 1223333333333222222111 1112355667999999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.55 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=190.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce----EEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK----LIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++...... ++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 47899999999999985 678999999997542 22346789999999999999999999998766543 99999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++.... ++++.++..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++
T Consensus 97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ----NGIIHRDVKPANIMI---SATNAVKVMDFGIAR 164 (311)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---ETTSCEEECCCSCC-
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCCcCCCCHHHEEE---cCCCCEEEeeccCcc
Confidence 999999999998654 48999999999999999999994 699999999999999 455679999999998
Q ss_pred CCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.+.... ...++..|+|||.+.+..++.++|||||||++|||+||+.||.+.. .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~ 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDP 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCC
Confidence 764432 1246889999999999999999999999999999999999997532 1222222222211
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHH-HHHHHHhhc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSE-VLRRIEEIQ 597 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~i~ 597 (604)
.. +... .......+.+++.+||+.||++||++.+ +...+.++.
T Consensus 237 ~~----~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 237 IP----PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CC----HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC----cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11 0000 1112346889999999999999996555 445565553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.24 Aligned_cols=256 Identities=15% Similarity=0.166 Sum_probs=200.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEE-ecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY-YSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++++++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46899999999999985 6799999999865432 34688999999999998877766666 5566779999999 899
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS----KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999997543 258999999999999999999994 69999999999999965446678999999999766443
Q ss_pred ----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 479 ----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 479 ----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.+..... ....+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-hhhhhhhhcccccCCc---
Confidence 23357889999999999999999999999999999999999998643221 1111222111111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
... .....+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 239 ---~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 ---IEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ---HHH-----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---hHH-----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000 00112346889999999999999999999999999986543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=335.06 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=201.5
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCC-ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKE-EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 57899999999999974 356899999997543 33456789999999999 7999999999987755 489999
Q ss_pred ecCCCCCHHHHhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 393 EFLPNGSLFDLLHESRGVG-----------RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
||+++|+|.+++....... ...+++..+..++.|++.||+|||+ ++|+||||||+||++ +..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~----~~i~H~dikp~Nil~---~~~ 184 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILL---SEK 184 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGG
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh----CCcccccCccceEEE---CCC
Confidence 9999999999998754210 1237899999999999999999994 699999999999999 666
Q ss_pred ceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCch
Q 007427 462 YRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 534 (604)
..+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+....
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------- 257 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------- 257 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-------
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-------
Confidence 7899999999987654322 234567999999988899999999999999999998 99999753211
Q ss_pred hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccccCC
Q 007427 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEND 604 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~d 604 (604)
........... .... .......+.+++.+||+.||.+|||+.|+++.|+++.+.....|
T Consensus 258 ~~~~~~~~~~~-~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~d 316 (316)
T 2xir_A 258 EEFCRRLKEGT-RMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316 (316)
T ss_dssp HHHHHHHHHTC-CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHhccCc-cCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhccCC
Confidence 11111111111 1110 11123468899999999999999999999999999876654443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.06 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=200.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++......++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 478999999999999864 7999999998642 2234578899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++..+....+||+|||+++.....
T Consensus 107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK----HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999987654 48999999999999999999994 69999999999999977666778999999999876543
Q ss_pred C---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 K---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ...+++.|+|||++.+ .++.++|||||||++|||++|+.||.+.. ..+....+...........
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~--- 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAFDLPQ--- 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSCSGG---
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCCcc---
Confidence 2 3357889999999876 59999999999999999999999997532 2222333333222211110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 246 -----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01223468899999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.27 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=200.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||.||+|+..++..||+|+++... ...+.+.+|++++++++||||+++++++. .+..++||||+++++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 46899999999999998888899999997543 34678999999999999999999999986 45689999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++..... ..+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||+++......
T Consensus 96 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE----RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEE
T ss_pred HHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHhhEEE---cCCCCEEECCCcccccccCcccc
Confidence 99976431 248999999999999999999994 699999999999999 666789999999998765432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.. ..+........ ....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~-~~~~------ 230 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERG-YRMV------ 230 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTT-CCCC------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcc-cCCC------
Confidence 2234567999999988889999999999999999999 999987532 11222222211 1110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
........+.+++.+||+.||++|||+.++++.|+++....
T Consensus 231 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 231 ----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 01122346889999999999999999999999999886543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.24 Aligned_cols=233 Identities=18% Similarity=0.232 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 468999999999999865 58899999997532 22356788999999988 89999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||+ +..+.+||+|||+++...
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS----KGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 999999998654 48999999999999999999994 699999999999999 666789999999998643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+.......
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~---- 240 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAY---- 240 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC----
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCCCCC----
Confidence 22 23357889999999999999999999999999999999999997531 222333333322110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
+......+.+++.+||+.||++||++
T Consensus 241 --------p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 241 --------PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11223468899999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.24 Aligned_cols=238 Identities=21% Similarity=0.374 Sum_probs=196.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999864 79999999996432 12346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 101 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 101 GELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCT
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEE---ecCCCeEEEeccchhhccc
Confidence 99999997543 4899999999999999999999 5799999999999999 6667899999999987654
Q ss_pred CC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...+++.|+|||.+.+..+ +.++|||||||++|||++|+.||.+.. .......+.......
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~----- 235 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDGIFYT----- 235 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTTCCCC-----
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCcCC-----
Confidence 32 3457889999999988765 689999999999999999999997532 222223332222110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+......+.+++.+||+.||++|||+.|+++
T Consensus 236 -------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 -------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0112235889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.00 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=188.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 47899999999999985 5689999999864321 11235789999999999999999999975 45589999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||++
T Consensus 219 e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~----~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 219 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE----NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp ECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999887543 58999999999999999999994 69999999999999977666678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
+...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+.+.+. ....
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~i~---~~~~ 362 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQIT---SGKY 362 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCHHHHHH---TTCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHHHHHHh---cCCC
Confidence 8876543 2357889999999863 6688899999999999999999999975322 112222211 1111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .+... ......+.+++.+||+.||++|||+.|+++
T Consensus 363 -~~--~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 -NF--IPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -CC--CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CC--Cchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00000 112346889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=327.16 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=195.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|+++.. .......+.+|+..+.++ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 478999999999999865 7999999999753 233456788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC----------------Cc
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN----------------DI 461 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----------------~~ 461 (604)
|+|.+++...... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ ..
T Consensus 96 ~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 96 GSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS----MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp CBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEC--------------------C
T ss_pred CcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh----CCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999865311 1258999999999999999999994 6999999999999996543 55
Q ss_pred ceEEEeeccCCCCCCCCCCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 462 YRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
..+||+|||.+..........++..|+|||.+.+. .++.++|||||||++|||++|..|+... . . ...
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~--~-~~~ 239 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--------D--Q-WHE 239 (289)
T ss_dssp CCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--------H--H-HHH
T ss_pred eEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--------h--H-HHH
Confidence 67999999999888777777789999999998865 5678999999999999999999876431 1 1 111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~-~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 IRQGR-LPRI----------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHTTC-CCCC----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCC-CCCC----------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111 1110 0112346889999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.54 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=200.8
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++...+..++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 47899999999999983 35789999999743 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 395 LPNGSLFDLLHESRGV--GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+++|+|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||++
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~----~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE----NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh----CCeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 9999999999876421 11348999999999999999999994 69999999999999976656678999999988
Q ss_pred CCCCCC------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSR------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~~~~~~~ 262 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEFVTSGG 262 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHTTC
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHHHHhcCC
Confidence 643221 12245678999999988889999999999999999999 999987531 122222222221
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.. .. .......+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 263 ~~-~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 263 RM-DP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-CC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 00 112234688999999999999999999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.10 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=197.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 578999999999999864 689999999964322 1367899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-cceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-IYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~~~~kl~DFGla~ 473 (604)
+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. ...+||+|||+++
T Consensus 97 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~----~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT----KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999997643 48999999999999999999994 69999999999999954332 1279999999998
Q ss_pred CCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.+.. ..+...........
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~--- 236 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSVSYD--- 236 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCC---
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcccc---
Confidence 765432 3357889999999999999999999999999999999999997531 12222222221111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 FDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111110 012345889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.07 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=201.1
Q ss_pred hcccCcCCcceEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC--ceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-----ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE--EKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~ 394 (604)
.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 47899999999999984 368999999998766556678999999999999999999999987654 78999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++.
T Consensus 126 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 126 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT----KRYIHRDLATRNILVE---NENRVKIGDFGLTKV 194 (326)
T ss_dssp CTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh----CCEeccCCCcceEEEc---CCCcEEEecCcchhh
Confidence 99999999998653 248999999999999999999994 6999999999999994 446899999999987
Q ss_pred CCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCC-------CCCCCCchhHHHHH
Q 007427 475 LPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPG-------NNETSGDLSDWVRM 540 (604)
Q Consensus 475 ~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~-------~~~~~~~~~~~~~~ 540 (604)
..... ...++..|+|||.+.+..++.++|||||||++|||+||..||..... ..............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65432 12345579999999888899999999999999999999998763210 00000000001111
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
........ ......+..+.+++.+||+.||++|||+.|+++.|+++++.+
T Consensus 275 ~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 275 LLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhhcCCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111000 011223456889999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.11 Aligned_cols=239 Identities=18% Similarity=0.241 Sum_probs=188.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+|+.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 47899999999999985 57899999999743 222345678899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+|||+. +||+||||||+|||+ +.+..+||+|||+++....
T Consensus 233 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 233 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc---CCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence 99999998754 489999999999999999999941 699999999999999 6667899999999986433
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.+.. .......+.......
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~----- 368 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRF----- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC-----
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC-----
Confidence 2 23357889999999999999999999999999999999999997531 222222222222110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+......+.+++.+||+.||++|| ++.|+++
T Consensus 369 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 -------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111234688999999999999999 9999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.67 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=195.7
Q ss_pred cccCcCCcceEEEEEec---CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE---SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46889999997532 234678999999999999999999999986 4568999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..|+.||+.||+|||+ ++|+||||||+|||++ ....+||+|||+++.+..
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~----~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHH----CCEeCCCCChHhEEEe---CCCCEEEEEcCCcccccc
Confidence 99999997643 48999999999999999999994 6999999999999994 456899999999976643
Q ss_pred CCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 478 RKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 478 ~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
... ..++..|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+. ......
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~-~~~~~~ 592 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLE-KGERMG 592 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHH-TTCCCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-cCCCCC
Confidence 321 134567999999998899999999999999999999 9999975321 12222222 211111
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
. +...+..+.+++.+||+.||++||++.+|+++|+++..
T Consensus 593 ~----------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 C----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp C----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 11234568899999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.22 Aligned_cols=244 Identities=20% Similarity=0.304 Sum_probs=193.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +|+.||+|+++.... ...+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 478999999999999864 689999999975432 245688888887 79999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec-CCcceEEEeeccCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~~~~kl~DFGla~~~~~~ 478 (604)
|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||+..+ +....+||+|||+++.....
T Consensus 103 L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~----~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 103 LLDKILRQK-----FFSEREASAVLFTITKTVEYLHA----QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp HHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999997643 48999999999999999999994 699999999999998543 33456999999999866433
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+... ....+....+.........
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~~~~~---- 244 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKFSLSG---- 244 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCCCCCS----
T ss_pred CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCcccCc----
Confidence 2 33568899999999887789999999999999999999999975321 2233333333332221100
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++||++.|+++
T Consensus 245 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 ----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001123346889999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=328.92 Aligned_cols=246 Identities=25% Similarity=0.417 Sum_probs=192.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC-CceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-EEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+++.. |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 478999999999999875 8999999997543 457899999999999999999999997654 478999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++......
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG----NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh----CCccccCCCcceEEE---eCCCcEEEeecccccccccccc
Confidence 99997653 1237899999999999999999994 699999999999999 666789999999987665432
Q ss_pred CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 ~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+...... ......
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~-~~~~~~--------- 234 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVE-KGYKMD--------- 234 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHT-TTCCCC---------
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHh-cCCCCC---------
Confidence 2345678999999988889999999999999999998 9999875321 11111111 111111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.....+..+.+++.+||+.||++||++.|+++.|++++..
T Consensus 235 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0112334688999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.71 Aligned_cols=247 Identities=22% Similarity=0.406 Sum_probs=191.6
Q ss_pred hcccCcCCcceEEEEEe-cCCc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGA----VVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+. .+++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 47899999999999985 3454 3577777533 3345678999999999999999999999998654 88999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++ ....+||+|||+++..
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED----RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 167 (327)
T ss_dssp SSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEEE---ETTEEEECCTTC----
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhh----CCCcCCCCCHHHEEEc---CCCCEEEccCcceeEc
Confidence 99999999987542 48999999999999999999994 6999999999999994 4457999999999876
Q ss_pred CCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... ..+...+ .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~---~~~~~~~ 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSIL---EKGERLP 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHH---HTTCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHH---HcCCCCC
Confidence 43321 234567999999999999999999999999999999 9999976421 1222211 1111110
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 240 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 -----------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0112233588999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.79 Aligned_cols=239 Identities=22% Similarity=0.382 Sum_probs=193.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 46899999999999985 467899999986432 22356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||++ +....+||+|||++.....
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC--
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEE---cCCCCEEEEeccccccCCc
Confidence 99999998754 4899999999999999999999 5799999999999999 6667899999999876544
Q ss_pred CC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 478 RK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 478 ~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+............
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~------- 226 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTF------- 226 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCC-------
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCCCCC-------
Confidence 32 3367889999999999999999999999999999999999997531 222222222111110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 227 -----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123357899999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.51 Aligned_cols=256 Identities=15% Similarity=0.189 Sum_probs=198.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEE-ecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY-YSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||||++..... ...+.+|++++++++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 47899999999999985 6789999998764322 24578899999999988877777666 5566789999999 999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||+++......
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~----~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS----KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999998543 248999999999999999999994 699999999999999655566789999999997664332
Q ss_pred -----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 480 -----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.+...... ...+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccccch---
Confidence 23578899999999999999999999999999999999999986433211 111222111111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
... .....+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 239 ----~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 239 ----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----hhh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 00112346889999999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=329.43 Aligned_cols=245 Identities=21% Similarity=0.334 Sum_probs=195.4
Q ss_pred cccCcCCcceEEEEEe---cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATL---ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 3899999999999964 347899999997542 22357899999999999999999999999 56778999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++....
T Consensus 102 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~----~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 102 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCT
T ss_pred CCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHh----CCeEcCCCCcceEEEe---CCCcEEEccCCcceeecc
Confidence 99999998653 48999999999999999999994 6999999999999995 445899999999987654
Q ss_pred CCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 478 RKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 478 ~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
... ..++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.. ..+......... ...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~-~~~ 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGE-RMG 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTC-CCC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-CCC
Confidence 322 123467999999988889999999999999999999 999997532 111222221111 111
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........+.+++.+||+.||++||++.|+++.|+++-..
T Consensus 241 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 241 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0112334688999999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=333.31 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=201.0
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 478999999999999754 47889999997543 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 395 LPNGSLFDLLHESRG-----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+++|+|.+++..... ....++++..+..++.|++.||+|||+ +||+||||||+||++ +.+..+||+||
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dikp~NIli---~~~~~~kl~Df 182 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA----NKFVHRDLAARNCMV---AEDFTVKIGDF 182 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH----TTCBCSCCSGGGEEE---CTTCCEEECCT
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH----CCCccCCCccceEEE---cCCCeEEECcC
Confidence 999999999976431 111357899999999999999999994 699999999999999 66678999999
Q ss_pred cCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~ 254 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVLRFVM 254 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHHHHHHH
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--------HHHHHHHHH
Confidence 9997654322 1234567999999988889999999999999999999 889987531 122222222
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
....... .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 255 ~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 EGGLLDK-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTCCCCC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCcCCC-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2221110 11233468899999999999999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.88 Aligned_cols=240 Identities=20% Similarity=0.308 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCC--CCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKH--ENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| +||+++++++...+..++|||| .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 4689999999999999888999999998643 33345778999999999976 9999999999999999999995 58
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++ + ..+||+|||+++....
T Consensus 93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~----~~iiHrDikp~NIll~---~-~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ----HGIVHSDLKPANFLIV---D-GMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEEE---T-TEEEECCCSSSCCC--
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCcceEEEE---C-CcEEEeecccccccCc
Confidence 89999998754 48999999999999999999995 6999999999999994 2 4699999999987754
Q ss_pred CC------CCccccccCCCCCCCC-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 478 RK------ASENLAIGRSPEFPEG-----------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 478 ~~------~~~~~~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
.. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~ 232 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHA 232 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHHHH
Confidence 32 2357899999999754 678999999999999999999999997531 11122222
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........... ......+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~----------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNHEIEFP----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTSCCCCC----------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCcccCCc----------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 22222111111 0112357899999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.94 Aligned_cols=246 Identities=15% Similarity=0.173 Sum_probs=193.6
Q ss_pred hcccCcCCcceEEEEE------ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKAT------LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK---HENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||+||+|. ..+++.||+|+++... ..++.+|++++.+++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4689999999999994 4568999999997643 456777888777776 999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEee--------cCCcceE
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFR--------ENDIYRA 464 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~--------~~~~~~~ 464 (604)
||+++|+|.+++..........+++..++.|+.|++.||+||| +++|+||||||+|||++. ++....+
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999999998654333446999999999999999999999 579999999999999944 1226789
Q ss_pred EEeeccCCCCCC---CC---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 465 KLTNFGFLPLLP---SR---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 465 kl~DFGla~~~~---~~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
||+|||+|+.+. .. ....++..|+|||++.+..++.++|||||||++|||+||+.||........ .
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~----- 294 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---K----- 294 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---E-----
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---e-----
Confidence 999999996543 11 233578999999999999999999999999999999999999864321000 0
Q ss_pred HHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHHhhcc
Q 007427 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR-PKMSEVLRRIEEIQP 598 (604)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~~ 598 (604)
...... . . .....+.+++..|++.+|.+| |+++++.+.|+++.+
T Consensus 295 --------~~~~~~----~--~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 --------PEGLFR----R--L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------ECSCCT----T--C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------echhcc----c--c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000000 0 0 112356789999999999999 578888888887643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=348.22 Aligned_cols=244 Identities=15% Similarity=0.206 Sum_probs=193.0
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+.. +++.||+|++++... .....+.+|..++.+++||||++++++|.+.+..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 468999999999999865 588999999975321 1123488999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +..+.+||+|||+++....
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~----~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ----LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh----CCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence 99999998632 248999999999999999999994 799999999999999 6667899999999976644
Q ss_pred CC-----CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 478 RK-----ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
.. ...+++.|+|||++. ...++.++|||||||++|||++|+.||.+.. ..+....+......
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKER 299 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHHHH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHHhhhhcccc
Confidence 32 235789999999986 5678999999999999999999999997531 12222222211000
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLR 591 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 591 (604)
... ..........+.+++.+||..+|++ ||++.|+++
T Consensus 300 ~~~-------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQF-------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCC-------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccC-------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 0000112346889999999988888 999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.76 Aligned_cols=242 Identities=16% Similarity=0.230 Sum_probs=193.5
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+.. +++.||+|++++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999864 689999999964221 1224578999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.++++.. .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +..+.+||+|||+++....
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~----~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS----MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH----CCeEeccCCHHHeeE---CCCCCEEEeccceeEeecc
Confidence 9999999754 38999999999999999999994 699999999999999 6667899999999987654
Q ss_pred CC-----CCccccccCCCCCCCCCC----CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 478 RK-----ASENLAIGRSPEFPEGKR----LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~~~~----~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.. ...+++.|+|||++.+.. ++.++|||||||++|||+||+.||.+.. ..+....+.......
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMNHKNSL 292 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHHHHC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHHHHhccccc
Confidence 32 346889999999987655 7899999999999999999999997531 222222222111000
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEK--RPKMSEVLRR 592 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 592 (604)
... ........+.+|+.+||+.+|.+ ||++.||++.
T Consensus 293 ~~p--------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCC--------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCC--------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 00112346889999999999988 9999998863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.57 Aligned_cols=240 Identities=19% Similarity=0.299 Sum_probs=190.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCC--CCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLK--HENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++|||+ .+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CC
Confidence 4689999999999999888999999998643 3334578999999999996 59999999999999999999994 58
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||+ ++ ..+||+|||+++.+..
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll---~~-~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLI---VD-GMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEE---SS-SCEEECCCSSSCCC--
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEE---EC-CeEEEEecCccccccC
Confidence 89999998654 4889999999999999999999 5799999999999999 33 4799999999987754
Q ss_pred CC------CCccccccCCCCCCCC-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 478 RK------ASENLAIGRSPEFPEG-----------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 478 ~~------~~~~~~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
.. ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~~ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHA 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHHH
Confidence 32 2357899999999864 468999999999999999999999997532 11122222
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........... ......+.+++.+||+.||++|||+.|+++.
T Consensus 280 ~~~~~~~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEIEFP----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCCCCC----------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccCCCC----------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22222111110 0112358899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=339.09 Aligned_cols=240 Identities=19% Similarity=0.250 Sum_probs=186.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHH-HccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQL-LGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +++.||+|++++... .....+.+|..+ ++.++||||+++++++.+.+..++||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999864 688999999975432 223456677776 577899999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++...
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS----LNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 999999998754 48899999999999999999994 799999999999999 666789999999997632
Q ss_pred C----CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 S----RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~----~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||.+. ...+....+.......
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~~~~---- 258 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNKPLQL---- 258 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------BHHHHHHHHHHSCCCC----
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcccCC----
Confidence 2 22345788999999999999999999999999999999999999753 1223333333322110
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRI 593 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 593 (604)
.......+.+++.+||+.||.+||++.+.++.+
T Consensus 259 --------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 259 --------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 011233588999999999999999986544433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.19 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=194.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+.. ++..||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 478999999999999864 78999999997532 233577899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++..+....+||+|||+++.....
T Consensus 122 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 122 ELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHK----HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999987654 48999999999999999999994 69999999999999976666677999999999776543
Q ss_pred C---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 K---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ...+++.|+|||++. ..++.++|||||||++|||++|+.||.+.. ..+....+......... +.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~--~~- 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGKYTFDS--PE- 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCS--GG-
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc--hh-
Confidence 2 335788999999986 469999999999999999999999997532 22233333322221110 00
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 261 -----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 -----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0122346889999999999999999999885
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.21 Aligned_cols=189 Identities=25% Similarity=0.427 Sum_probs=154.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCC-CCCcccEEEEEecCC--ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKE--EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 395 (604)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46899999999999985 57999999998643 3344567889999999997 999999999997544 689999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+ |+|.+++... .+++..+..++.|++.||+|||+ .||+||||||+|||+ +.+..+||+|||+|+.+
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~----~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS----GGLLHRDMKPSNILL---NAECHVKVADFGLSRSF 159 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEES
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh----CCEEeCCCCHHHeEE---cCCCCEEecCCcccccc
Confidence 7 6999999764 38999999999999999999994 699999999999999 66678999999999765
Q ss_pred CCC-------------------------CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 476 PSR-------------------------KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 476 ~~~-------------------------~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 12357889999999876 67899999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=337.60 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=200.0
Q ss_pred hcccCcCCcceEEEEEec-C-----CcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-S-----GAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|... + .+.||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 478999999999999853 2 3489999997543 33457799999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceE
Q 007427 394 FLPNGSLFDLLHESRGV---------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRA 464 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~ 464 (604)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~NIl~---~~~~~~ 203 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS----KNCIHRDVAARNVLL---TNGHVA 203 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGCEE---EGGGEE
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc----CCcccCCcccceEEE---CCCCeE
Confidence 99999999999764310 12358999999999999999999994 699999999999999 556789
Q ss_pred EEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHH
Q 007427 465 KLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDW 537 (604)
Q Consensus 465 kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 537 (604)
||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |..||.+... ...+.
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~-- 277 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----NSKFY-- 277 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----SHHHH--
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----hHHHH--
Confidence 999999998654322 1234567999999988889999999999999999999 9999875321 11111
Q ss_pred HHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
........... .......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 278 --~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 278 --KLVKDGYQMAQ----------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp --HHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHhcCCCCCC----------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11111111110 111234688999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=320.72 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=199.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 478999999999999865 699999999864321 2367899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC-CcceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla~ 473 (604)
+++++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++ ....+||+|||++.
T Consensus 90 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 90 VSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS----KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999997654 48999999999999999999994 6999999999999995443 23379999999997
Q ss_pred CCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.+.. ..+...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~--- 229 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAVNYD--- 229 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCC---
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhcccC---
Confidence 765432 2357789999999999999999999999999999999999997531 11222222111111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHHhhccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR--RIEEIQPM 599 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 599 (604)
...... ......+.+++.+||+.||++||++.|+++ .++.++..
T Consensus 230 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 230 FDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred Ccchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 011110 012346889999999999999999999997 46665443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.61 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=195.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-----NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 57899999999999985 56889999998643 2334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 007427 396 PNGSLFDLLHESRGV-----------------------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 440 (604)
++|+|.+++...... ....+++..+..++.|++.||+|||+
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---- 186 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---- 186 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH----
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH----
Confidence 999999998632110 01124567788999999999999994
Q ss_pred CCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC--------CCCCccccccCCCCCCCC--CCCCccchhHhHHHH
Q 007427 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS--------RKASENLAIGRSPEFPEG--KRLTHKADVYCFGII 510 (604)
Q Consensus 441 ~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvv 510 (604)
++|+||||||+||+++.++ ...+||+|||+++.+.. .....++..|+|||.+.+ ..++.++|||||||+
T Consensus 187 ~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 187 QGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp TTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred CCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 6999999999999995432 23799999999975432 123357889999999875 678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 511 LLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 511 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
+|||++|+.||.+.. ..+................ .......+.+++.+||+.||++||++.|++
T Consensus 266 l~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 266 LHLLLMGAVPFPGVN--------DADTISQVLNKKLCFENPN--------YNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCTTSGG--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHCCCCCCCCC--------hHHHHHHHHhcccccCCcc--------cccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 999999999997532 1222233332221111000 011234688999999999999999999998
Q ss_pred H--HHHhhccc
Q 007427 591 R--RIEEIQPM 599 (604)
Q Consensus 591 ~--~L~~i~~~ 599 (604)
+ .++++...
T Consensus 330 ~hp~~~~~~~~ 340 (345)
T 3hko_A 330 QHPWISQFSDK 340 (345)
T ss_dssp HSHHHHTTSSC
T ss_pred cChhhccChHh
Confidence 7 35555443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=326.25 Aligned_cols=239 Identities=22% Similarity=0.346 Sum_probs=175.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46899999999999986 579999999996432 12246789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .++++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++.....
T Consensus 96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS----HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC-
T ss_pred CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHEEE---cCCCCEEEEeecceeeccC
Confidence 99999998643 258999999999999999999994 699999999999999 6667899999999877643
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~------ 230 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVVLADYE------ 230 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCC------
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHhhcccC------
Confidence 22 23567899999999998999999999999999999999999975432110 0100000000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 231 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 ------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01112336789999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.45 Aligned_cols=233 Identities=19% Similarity=0.276 Sum_probs=192.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 47899999999999984 5789999999975321 12345778999999999999999999999999999999
Q ss_pred ecCCCC-CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 393 EFLPNG-SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 393 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||+.+| +|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+
T Consensus 109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRL----KDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 999777 9999998654 48999999999999999999994 699999999999999 6667899999999
Q ss_pred CCCCCCCCC---CccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 472 LPLLPSRKA---SENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 472 a~~~~~~~~---~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
++....... ..++..|+|||++.+..+ +.++|||||||++|||++|+.||...... ......
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~~~ 242 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAAIH 242 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTCCC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------HhhccC
Confidence 987655432 347889999999988776 78999999999999999999999742110 000000
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
. +......+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 P------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00122358899999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.84 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=182.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEe--------cCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYY--------SKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~~~lv 391 (604)
.++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.++. ||||+++++++. .....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 57899999999999985 478999999997666666678999999999996 999999999984 23347899
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeec
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
|||++ |+|.+++..... ..++++.++..++.|++.||+|||+ ++ |+||||||+|||+ +....+||+||
T Consensus 113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~----~~~~ivH~Dikp~NIl~---~~~~~~kl~Df 182 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR----QKPPIIHRDLKVENLLL---SNQGTIKLCDF 182 (337)
T ss_dssp EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT----SSSCCBCCCCCGGGCEE---CTTSCEEBCCC
T ss_pred EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh----CCCCEEEccCCcccEEE---CCCCCEEEecC
Confidence 99995 799999876432 2259999999999999999999994 57 9999999999999 66678999999
Q ss_pred cCCCCCCCCC----------------CCccccccCCCCCC---CCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC
Q 007427 470 GFLPLLPSRK----------------ASENLAIGRSPEFP---EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530 (604)
Q Consensus 470 Gla~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~ 530 (604)
|+++...... ...++..|+|||.+ .+..++.++|||||||++|||+||+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765432 22367889999998 5677899999999999999999999999753211
Q ss_pred CCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
... ........ .......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 260 -----~~~----~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 -----RIV----NGKYSIPP----------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ---------------CCCCT----------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----Hhh----cCcccCCc----------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000 01000000 001112377999999999999999999999999988654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.20 Aligned_cols=241 Identities=23% Similarity=0.344 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 35799999999999985 56889999998743 33445778999999999999999999999865 3457999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
+++|+|.+++.... .+++..+..++.|++.||+|||+ ++ |+||||||+||+++. ....+||+|||++
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT----RTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLA 179 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT----SSSCCCCSCCCGGGEEESS--TTSCEEECCTTGG
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHc----CCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCc
Confidence 99999999998754 48999999999999999999994 56 999999999999941 4568999999999
Q ss_pred CCCCCCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 473 PLLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 473 ~~~~~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
....... ...++..|+|||.+.+ .++.++|||||||++|||++|+.||.... .............. ...
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~-~~~ 250 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK-PAS 250 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC-CGG
T ss_pred ccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHhccCC-ccc
Confidence 7655433 2357889999998864 58999999999999999999999997532 12222222222111 111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+ ......+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC---------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 011235889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.65 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=198.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEE--EEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVV--AVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+. .++..+ |+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 57899999999999985 456644 99998743 233456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 397 NGSLFDLLHESRG-----------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 397 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
+|+|.+++..... .....+++.+++.++.|++.||+|||+ ++|+||||||+||++ +....+|
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~NIl~---~~~~~~k 182 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ----KQFIHRDLAARNILV---GENYVAK 182 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CGGGCEE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCccceEEE---cCCCeEE
Confidence 9999999976430 112358999999999999999999994 799999999999999 6667899
Q ss_pred EeeccCCCCCCCC---CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 466 LTNFGFLPLLPSR---KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 466 l~DFGla~~~~~~---~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
|+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+.....
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~ 254 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKL 254 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHG
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHHHHh
Confidence 9999998754322 22345678999999988889999999999999999998 999997532 12222222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
... .... ........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 255 ~~~-~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 PQG-YRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGT-CCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcC-CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 211 1110 01122346889999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.99 Aligned_cols=251 Identities=18% Similarity=0.263 Sum_probs=186.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 46899999999999985 46899999999753 3344577899999999999999999999996543 569999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++ +|.+.+.. .+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||++
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~----~~iiHrDlkp~NIll---~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVV---KSDCTLKILDFGLA 211 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCCCCC
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCChHhEEE---eCCCCEEEEEEEee
Confidence 99965 67777643 38899999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH----------
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR---------- 539 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 539 (604)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+... ...+...+.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 8775432 34578899999999999999999999999999999999999986421 001111110
Q ss_pred --------HHHhcCCc-cccccHHhhhc-------ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 540 --------MVVDNDWS-TDILDVEILAA-------REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 540 --------~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........ .....+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11110000 00000000000 000122557899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.34 Aligned_cols=182 Identities=21% Similarity=0.374 Sum_probs=146.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 393 (604)
.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 47899999999999985 47899999999643 333457889999999999999999999999543 56899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+ +|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++
T Consensus 138 ~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~----~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 138 IA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHS----AGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred cc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHh----CCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 98 579999997643 48999999999999999999994 699999999999999 666789999999998
Q ss_pred CCCCCC-------------------------------CCccccccCCCCCC-CCCCCCccchhHhHHHHHHHHHh
Q 007427 474 LLPSRK-------------------------------ASENLAIGRSPEFP-EGKRLTHKADVYCFGIILLEVIT 516 (604)
Q Consensus 474 ~~~~~~-------------------------------~~~~~~~y~aPE~~-~~~~~s~ksDVwSfGvvl~ellt 516 (604)
...... ...++..|+|||++ ....++.++|||||||++|||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 764221 12457889999975 56679999999999999999999
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.09 Aligned_cols=194 Identities=21% Similarity=0.285 Sum_probs=167.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-----CCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-----HENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+. .+++.||||+++... ...+.+..|+.++++++ ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 47899999999999986 578999999997532 34567788999999886 999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec-----------------
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE----------------- 458 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~----------------- 458 (604)
+++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 119 -~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 119 -GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRK----MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp -CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred -CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 8999999987542 248999999999999999999994 799999999999999531
Q ss_pred -----CCcceEEEeeccCCCCCCCC-CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 459 -----NDIYRAKLTNFGFLPLLPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 459 -----~~~~~~kl~DFGla~~~~~~-~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.....+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 12567999999999865543 2346788999999999999999999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.54 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=199.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 478999999999999864 79999999986432 33467899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++..+....+||+|||+++....
T Consensus 111 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 111 GELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHK----NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999997653 48999999999999999999994 6999999999999997666677899999999876654
Q ss_pred CC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ...+++.|+|||++.+ .++.++||||+||++|||++|+.||.+.. ..+....+...........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~-- 250 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKGKYTFELPQ-- 250 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCSGG--
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCCcc--
Confidence 33 2357889999999876 68999999999999999999999997532 2222333333322211110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 251 ------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 ------WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0122346889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=348.00 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=195.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch-------------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCc
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-------------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 387 (604)
.+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 478999999999999864 689999999974321 234678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++....+||+
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHK----HNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999997654 48999999999999999999994 699999999999999766665689999
Q ss_pred eccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 468 NFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 468 DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
|||+++...... ...+++.|+|||++. ..++.++|||||||++|||++|+.||.+.. ..+....+...
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~ 262 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIKKVEKG 262 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC
Confidence 999998765432 345788999999987 468999999999999999999999997532 22233333332
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... .. .......+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~---~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYYFDF---ND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCCH---HH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCc---cc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 221110 00 0112346889999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=341.31 Aligned_cols=255 Identities=15% Similarity=0.161 Sum_probs=196.3
Q ss_pred hcccCcCCcceEEEEEec---------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCccc---------------
Q 007427 322 AEVLGKGKVGSTYKATLE---------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAK--------------- 377 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 377 (604)
.+.||+|+||.||+|+.. +++.||+|++... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 468999999999999865 3789999999753 46789999999999999987
Q ss_pred EEEEEec-CCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEe
Q 007427 378 IVSFYYS-KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIF 456 (604)
Q Consensus 378 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 456 (604)
+++++.. .+..++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE----NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH----TTCBCSCCCGGGEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh----CCccCCCCCHHHEEEc
Confidence 6777776 67889999999 999999998652 1259999999999999999999994 6999999999999994
Q ss_pred ecCCcc--eEEEeeccCCCCCCCCC-----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCC
Q 007427 457 RENDIY--RAKLTNFGFLPLLPSRK-----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNG 523 (604)
Q Consensus 457 ~~~~~~--~~kl~DFGla~~~~~~~-----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~ 523 (604)
... .+||+|||+++.+.... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 194 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 194 ---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp ---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 444 89999999997764321 22577899999999999999999999999999999999999975
Q ss_pred CCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 524 SPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
... ....+........... ....+.... .......+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 271 ~~~---~~~~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLP---NTEDIMKQKQKFVDKP--GPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTT---CHHHHHHHHHHHHHSC--CCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCc---CHHHHHHHHHhccCCh--hhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 321 1111222222111111 111110000 00123468899999999999999999999999999875543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.44 Aligned_cols=244 Identities=19% Similarity=0.259 Sum_probs=197.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 36899999999999986 479999999996432 22346688999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ...+++..+..++.||+.||+|||+ +||+||||||+|||+ +..+.+||+|||+++....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~----~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR----ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH----CCEeccCCchheEEE---eCCCCeEEEecccceeccc
Confidence 99999997643 2248999999999999999999994 699999999999999 6667899999999987754
Q ss_pred CC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.+.... ............... .
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~i~~~~~--~----- 407 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVPE--E----- 407 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHHHHHCCC--C-----
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHHhhcccc--c-----
Confidence 32 346789999999999989999999999999999999999999864221 111222222221110 0
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
........+.+++.+||+.||.+|| ++.||++
T Consensus 408 -----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 -----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0111234688999999999999999 6788764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.33 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=190.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-----hhhHHHHHHHHHHHccC---CCCCcccEEEEEecCC-----c
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-----ALSKKEFVQQMQLLGKL---KHENLAKIVSFYYSKE-----E 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~-----~ 387 (604)
.+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|+++++++ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46899999999999985 578999999986322 11234667788777766 4999999999998755 4
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.++||||++ |+|.+++..... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +....+||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dlkp~Nil~---~~~~~~kl~ 162 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHA----NCIVHRDLKPENILV---TSGGTVKLA 162 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCTTTEEE---CTTSCEEEC
T ss_pred EEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEE---cCCCCEEEe
Confidence 789999996 599999987542 248999999999999999999994 699999999999999 666789999
Q ss_pred eccCCCCCCCCCC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH--
Q 007427 468 NFGFLPLLPSRKA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV-- 542 (604)
Q Consensus 468 DFGla~~~~~~~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 542 (604)
|||+++....... ..++..|+|||.+.+..++.++|||||||++|||++|+.||.+... ...+........
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----HHHHHHHHHHHCCC
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 9999987654332 3568899999999999999999999999999999999999975321 111111111110
Q ss_pred -hcCCccccccH--Hhhh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 -DNDWSTDILDV--EILA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 -~~~~~~~~~~~--~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+......+ .... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00111000000 0000 0000122346889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.51 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=190.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 468999999999999864 59999999986433 223567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||+++.....
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~----~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHK----HNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHH----CCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCc
Confidence 9999887543 48999999999999999999994 699999999999999 66678999999999776533
Q ss_pred C----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc---------
Q 007427 479 K----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN--------- 544 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 544 (604)
. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+... ......+......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhccccccccccc
Confidence 2 2356788999999875 6689999999999999999999999976321 1111111111100
Q ss_pred ---CCcc--ccccHHhh--hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 ---DWST--DILDVEIL--AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ---~~~~--~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.. ...++... ...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000000 00000123446889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.68 Aligned_cols=192 Identities=26% Similarity=0.381 Sum_probs=167.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 468999999999999864 7899999999754 33445789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC--
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS-- 477 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~-- 477 (604)
|.+++.... .+++..+..++.|++.||+|||+. ++|+||||||+|||+ +.+..+||+|||+++....
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHh---CCEEcCCccHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 999998754 489999999999999999999952 489999999999999 6667899999999865422
Q ss_pred CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22336788999999999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.05 Aligned_cols=243 Identities=18% Similarity=0.203 Sum_probs=185.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecc---cchhhHHHHHHHH---HHHccCCCCCcccEE-------EEEecCCc
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKN---MNALSKKEFVQQM---QLLGKLKHENLAKIV-------SFYYSKEE 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~~~ 387 (604)
.+.||+|+||+||+|+. .+|+.||||+++. ......+.+.+|+ +++++++||||++++ +++...+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999995 5799999999973 2333457889999 555666899999998 76665532
Q ss_pred -----------------eEEEEecCCCCCHHHHhhcccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 007427 388 -----------------KLIIYEFLPNGSLFDLLHESRGVG--RIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL 448 (604)
Q Consensus 388 -----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl 448 (604)
.++||||+ +|+|.+++....... ...+++..+..|+.||+.||+|||+ ++|+||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivHrDi 232 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYL 232 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH----TTEECSCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh----CCeecCCC
Confidence 78999999 689999998653211 1224468889999999999999994 69999999
Q ss_pred CCCceEEeecCCcceEEEeeccCCCCCCCCC-CCccccccCCCCCCCCC-----------CCCccchhHhHHHHHHHHHh
Q 007427 449 KSSNILIFRENDIYRAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEGK-----------RLTHKADVYCFGIILLEVIT 516 (604)
Q Consensus 449 kp~NILl~~~~~~~~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl~ellt 516 (604)
||+|||+ +.+..+||+|||+++...... ...+ ..|+|||++.+. .++.++|||||||++|||+|
T Consensus 233 kp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 233 RPVDIVL---DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEE---cCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 9999999 566789999999998755432 2345 899999999877 89999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHH
Q 007427 517 GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR--RIE 594 (604)
Q Consensus 517 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 594 (604)
|+.||.+......... ... . .......+.+++.+||+.||++|||+.|+++ .++
T Consensus 309 g~~Pf~~~~~~~~~~~--------~~~-~---------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 309 ADLPITKDAALGGSEW--------IFR-S---------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp SSCCC------CCSGG--------GGS-S---------------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred CCCCCcccccccchhh--------hhh-h---------------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 9999975432111000 000 0 0112345889999999999999999999986 455
Q ss_pred hhc
Q 007427 595 EIQ 597 (604)
Q Consensus 595 ~i~ 597 (604)
+++
T Consensus 365 ~~~ 367 (377)
T 3byv_A 365 QLR 367 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.90 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=186.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 47899999999999984 5789999999974432 224567899999999999999999999999999999999997 5
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC--CcceEEEeeccCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--DIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--~~~~~kl~DFGla~~~~ 476 (604)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ ....+||+|||+++...
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS----RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999998654 48999999999999999999995 6999999999999996543 34569999999987654
Q ss_pred CC----CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC---C--
Q 007427 477 SR----KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND---W-- 546 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 546 (604)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+........... +
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTTSTT
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHHhCCCchhhhhh
Confidence 22 223468899999998874 489999999999999999999999975321 111111111100000 0
Q ss_pred -------cccc---ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 -------STDI---LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 -------~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.... ..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTL-KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCH-HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccH-hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000 00000012346889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=319.76 Aligned_cols=241 Identities=19% Similarity=0.311 Sum_probs=193.2
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 468999999999999864 78999999996432 3345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++......
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG----IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHh----CCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCCc
Confidence 999987542 48999999999999999999994 699999999999999 66678999999998765322
Q ss_pred -----CCCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 479 -----KASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 479 -----~~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
....++..|+|||.+.+..+ +.++||||||+++|||++|+.||...... ...+..+ .........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~-- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKKTYLNP-- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHH----HTTCTTSTT--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHh----hhcccccCc--
Confidence 23356788999999987665 77999999999999999999999764221 1111111 111100000
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 231 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 --------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112335789999999999999999999976
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=347.98 Aligned_cols=240 Identities=17% Similarity=0.261 Sum_probs=194.8
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
++||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 56999999999999864 69999999996432 123467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++..... ....+++..+..++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~----~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ----RNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH----cCCcccCCChHHEEE---eCCCCEEEeecceeeeccCC
Confidence 99999976532 12358999999999999999999994 699999999999999 66678999999999876543
Q ss_pred C----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 479 K----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 479 ~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
. ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+... ..................
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~~~~------ 412 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQAVTY------ 412 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCCCCC------
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcccCC------
Confidence 2 23688999999999999999999999999999999999999986421 112223333333222110
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
+......+.+++.+||+.||++||++
T Consensus 413 ------p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 ------PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11223468899999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.76 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=194.6
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999864 69999999997532 23367899999999999 5699999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... ...+++.++..++.|++.||+|||+ +||+||||||+|||++.......+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~----~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ----NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH----CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999986542 2358999999999999999999994 69999999999999965444678999999999876543
Q ss_pred C---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 K---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+............. .
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~--~--- 254 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLNISQVNVDYS--E--- 254 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCC--T---
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHHHHhcccccC--c---
Confidence 2 2357889999999999999999999999999999999999997532 1111111111111000 0
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+.+++.+||+.||++|||+.|+++
T Consensus 255 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 255 ---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 001122346889999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.65 Aligned_cols=243 Identities=15% Similarity=0.194 Sum_probs=191.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||+|++++... ...+.+.+|..++.+++||||+++++++.+.+..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 46899999999999986 4799999999975321 1224578999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +..+.+||+|||+++....
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~----~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR----LGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 99999998653 148999999999999999999994 799999999999999 6667899999999987654
Q ss_pred CC-----CCccccccCCCCCCC-------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 478 RK-----ASENLAIGRSPEFPE-------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 478 ~~-----~~~~~~~y~aPE~~~-------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
.. ...+++.|+|||++. ...++.++|||||||++|||++|+.||.+.. ..+....+....
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~ 286 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAETYGKIVHYK 286 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHH
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcc
Confidence 32 236789999999987 4568999999999999999999999997532 112222221110
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKR---PKMSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 591 (604)
..... .........++.+++.+||. +|.+| |++.|+++
T Consensus 287 ~~~~~-------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EHLSL-------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHCCC-------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCcCC-------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00000 00001223468899999999 99998 58888864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.32 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=192.3
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+||+|+||.||+|+. .+++.||+|.++.......+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4899999999999985 568999999998665555678999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC---
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR--- 478 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~--- 478 (604)
+++..... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.. ...+||+|||+++.....
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD----NQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC----
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh----CCEEccCCChhhEEEECC--CCCEEEeecccccccCCCCCc
Confidence 99986532 2347789999999999999999994 699999999999999531 457999999999766432
Q ss_pred -CCCccccccCCCCCCCCCC--CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 -KASENLAIGRSPEFPEGKR--LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 -~~~~~~~~y~aPE~~~~~~--~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ........... .....
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~~~~~------ 246 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF-KVHPE------ 246 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH-CCCCC------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc-ccccc------
Confidence 2335778999999987543 78999999999999999999999864211 11111111110 10011
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........+.+++.+||+.||++||++.|+++
T Consensus 247 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 ----IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01122346889999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=330.75 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=195.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 468999999999999864 5889999998643 233457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||+++....
T Consensus 126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR----NRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCEecCCCchhEEE---cCCCCEEEeeccCceeccc
Confidence 99999987654 48999999999999999999994 699999999999999 6667899999999976643
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+............
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~----- 260 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNEYSI----- 260 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCC-----
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCCCCC-----
Confidence 2 22357789999999998889999999999999999999999997531 122222222221110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++||++.|+++
T Consensus 261 -------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -------PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112235789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=321.77 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=196.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 478999999999999865 5889999998643 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++.....
T Consensus 100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR----NRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCccccCCChHhEEE---cCCCCEEEEeccCceeccc
Confidence 99999987654 48999999999999999999995 699999999999999 6667899999999976643
Q ss_pred C----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 R----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+............
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~----- 234 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNEYSI----- 234 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCC-----
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhccCCC-----
Confidence 2 22356788999999999889999999999999999999999997531 122222222211110
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 235 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01122357899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=321.12 Aligned_cols=238 Identities=22% Similarity=0.368 Sum_probs=195.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 478999999999999864 68899999996432 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++ +....+||+|||++.....
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSS
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEE---cCCCCEEEecccccccCcc
Confidence 99999998754 4899999999999999999999 5799999999999999 6666899999999866543
Q ss_pred C--CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 478 R--KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 478 ~--~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+............
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~------- 231 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNVDLKF------- 231 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCC-------
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhccccCC-------
Confidence 2 23457889999999999999999999999999999999999997531 122222222211110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+......+.+++.+||+.||.+||++.|+++
T Consensus 232 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 -----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0112345789999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.75 Aligned_cols=197 Identities=24% Similarity=0.390 Sum_probs=153.8
Q ss_pred hcccCcCCcceEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE---SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
+++||+|+||+||+|+.. +++.||||++..... ...+.+|++++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999865 578999999975432 3568899999999999999999999954 667899999996
Q ss_pred CCCHHHHhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec-CCcceEEEeeccC
Q 007427 397 NGSLFDLLHESRG----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE-NDIYRAKLTNFGF 471 (604)
Q Consensus 397 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~~~~kl~DFGl 471 (604)
|+|.+++..... .....+++..+..|+.||+.||+|||+ ++|+||||||+|||+..+ +....+||+|||+
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~----~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA----NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh----CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 589888764321 112248999999999999999999994 699999999999999654 3557899999999
Q ss_pred CCCCCCC-------CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCC
Q 007427 472 LPLLPSR-------KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSP 525 (604)
Q Consensus 472 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~ 525 (604)
++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||.+..
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9876532 123568899999998874 58999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.36 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=186.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46899999999999986 57999999999642 2334567899999999999999999999997653 469999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+ +++|.+++... .+++..+..++.|+++||+|||+ +||+||||||+|||+ +.+..+||+|||++
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~----~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA----AGIIHRDLKPGNLAV---NEDCELKILDFGLA 175 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH----CCccccCcCHHHEEE---cCCCCEEEEeeecc
Confidence 999 88999999763 38999999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc-CCcc-
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN-DWST- 548 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 548 (604)
+...... ...++..|+|||++.+ ..++.++||||+||++|||++|+.||.+... .+....+... +...
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCCCH
T ss_pred cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCCCCH
Confidence 8765432 3467889999999876 6799999999999999999999999986321 1111111110 0000
Q ss_pred cc----ccH---H-hh---------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DI----LDV---E-IL---------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~----~~~---~-~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+. ... . +. ...........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00 000 0 00 00001122456889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.23 Aligned_cols=243 Identities=18% Similarity=0.262 Sum_probs=193.4
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 47899999999999986 478999999997432 22345677899999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||++
T Consensus 139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK----LGIIYRDIKLENILL---DSNGHVVLTDFGLS 206 (355)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEESCSSEE
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEEE---CCCCcEEEeeCCCC
Confidence 9999999999998754 48999999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC-----CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRK-----ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~-----~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ...............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhccC
Confidence 7654322 2357889999999885 3478999999999999999999999975321 122333333332221
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLRR 592 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 592 (604)
.. ........+.+++.+||+.||++|| ++.|+++.
T Consensus 283 ~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 PP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 0112234578999999999999999 89998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=324.80 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEec--CCc--EEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE--SGA--VVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|++. +++ .||+|+++.. .....+.+.+|++++++++||||+++++++.... .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 468999999999999853 333 6899998743 2234578899999999999999999999998654 8899999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ....+||+|||+++.
T Consensus 102 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 102 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES----KRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA 170 (291)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred ccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh----CCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence 99999999998653 248999999999999999999994 6999999999999994 445799999999987
Q ss_pred CCCCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
...... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.. ..+..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccCC
Confidence 654321 234557999999988888999999999999999999 999997532 1222222222211
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
... .....+..+.+++.+||+.||++|||+.++++.|+++++...
T Consensus 243 ~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 243 RLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 111 011233468899999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.60 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNAL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 468999999999999865 7899999999743321 11245679999999999999999999999999999999996 59
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++......
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~----~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHR----QKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence 999988653 258999999999999999999994 699999999999999 666789999999987654322
Q ss_pred ----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc---cccc
Q 007427 480 ----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS---TDIL 551 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 551 (604)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+... ......+......... ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhhh
Confidence 2246889999999876 5689999999999999999999999976321 1111111111111100 0000
Q ss_pred -cHHhhh-----------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 -DVEILA-----------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 -~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0001122346889999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=323.79 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=195.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46899999999999985 568999999997432 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++... ++++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||++.......
T Consensus 107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 107 ALDLLEPG------PLDETQIATILREILKGLDYLHS----EKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH----CCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 99998753 48999999999999999999995 699999999999999 666789999999997664432
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~----- 239 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPKNN-PPTL----- 239 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCC-----
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhcCC-CCCC-----
Confidence 3356788999999999999999999999999999999999987531 111111111111 1110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 240 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 -----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01123358899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.44 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=190.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 468999999999999864 58999999986432 233566889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||+++.....
T Consensus 110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~----~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHS----HNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH----CCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 9988876543 48999999999999999999994 699999999999999 66678999999999776432
Q ss_pred ----CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH----------HHh
Q 007427 479 ----KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM----------VVD 543 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~ 543 (604)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+...... .+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhhhHhh
Confidence 233578889999998875 789999999999999999999999975321 1111111100 000
Q ss_pred -cCCccccccHHhh----hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 -NDWSTDILDVEIL----AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 -~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.........+... ...........+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000 00001123457899999999999999999999886
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.75 Aligned_cols=239 Identities=19% Similarity=0.352 Sum_probs=189.3
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 468999999999999865 79999999996432 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++ +....+||+|||++.....
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHR----HMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----HCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCccCCCChhhEEE---CCCCCEEEeecccccccCC
Confidence 99999998754 48999999999999999999995 699999999999999 6667899999999987654
Q ss_pred CC---CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK---ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...++..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ...............
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~----- 230 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRGGVFYI----- 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCC-----
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcCcccC-----
Confidence 32 2356788999999988765 689999999999999999999997521 122222222211100
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 -------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122358899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.73 Aligned_cols=254 Identities=16% Similarity=0.252 Sum_probs=198.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.++||+|+||.||+|+. .+++.||||+++.... ..++.+|+++++.++| ++|..+..++...+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 46899999999999985 6799999998864332 2457899999999987 55666666667778889999999 999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++....+||+|||+++.+....
T Consensus 89 L~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~----~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 89 LEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH----CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999998543 249999999999999999999994 699999999999999655566789999999997764432
Q ss_pred -----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 480 -----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.+.... .....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVAT 235 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhccccc
Confidence 335788999999999999999999999999999999999999864321 1112111111111000
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
. .. .+ . .....++.+++..||+.||++||++.+|++.|+++..
T Consensus 236 ~-~~-~l-~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 S-IE-AL-C----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp C-HH-HH-H----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred c-HH-HH-h----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0 00 00 0 1123468999999999999999999999999998854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.29 Aligned_cols=241 Identities=21% Similarity=0.373 Sum_probs=193.5
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccch--------hhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.+++++ +||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 78999999999999875 799999999864321 1245678999999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .||+||||||+||++ +.++.+||+|||++
T Consensus 180 e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~----~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 180 DLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA----NNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 9999999999998653 48999999999999999999995 699999999999999 66678999999998
Q ss_pred CCCCCCC---CCccccccCCCCCCC------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPE------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD 543 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 543 (604)
..+.... ...++..|+|||++. ...++.++|||||||++|||+||+.||.... ..........
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~~~~i~~ 319 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QILMLRMIME 319 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh
Confidence 7765432 335788999999875 3358899999999999999999999997521 1222222222
Q ss_pred cCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... .+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 320 ~~~~~~--~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQFS--SPEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCCCC--HHHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCC--Cccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221111 0000 012345889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.74 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=197.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 478999999999999865 78999999986432 234678999999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++....+||+|||++......
T Consensus 107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~----~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK----HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999987654 48999999999999999999994 69999999999999976666678999999998776543
Q ss_pred CC---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 479 KA---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 479 ~~---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ..++..|+|||.+.+ .++.++||||||+++|||++|+.||.+.. ..+................
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~--- 245 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAFDLPQ--- 245 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCSGG---
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCchh---
Confidence 32 246778999999876 48999999999999999999999997531 1222233322222111100
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0112346889999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.38 Aligned_cols=188 Identities=22% Similarity=0.350 Sum_probs=159.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|++++++++||||+++++++... +..++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 47899999999999985 46899999999753 333457889999999999999999999999766 56899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|++ |+|.+++.... .+++..+..++.||++||+|||+ +||+||||||+|||+ +.+..+||+|||+++
T Consensus 111 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~----~givHrDlkp~NILl---~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 111 IAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHE----SGIIHRDLKPANCLL---NQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence 996 59999997643 48999999999999999999994 699999999999999 666789999999998
Q ss_pred CCCCC--------------------------CCCccccccCCCCCC-CCCCCCccchhHhHHHHHHHHHhCCCCCC
Q 007427 474 LLPSR--------------------------KASENLAIGRSPEFP-EGKRLTHKADVYCFGIILLEVITGRIPGN 522 (604)
Q Consensus 474 ~~~~~--------------------------~~~~~~~~y~aPE~~-~~~~~s~ksDVwSfGvvl~elltg~~p~~ 522 (604)
..... ....++..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76432 233568899999985 56679999999999999999998655554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=327.58 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=190.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++...+ .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 57899999999999986 4689999999864321 12245889999999999999999999987654 89999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++....+||+|||++
T Consensus 94 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 94 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE----NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999987543 58999999999999999999994 69999999999999976666667999999999
Q ss_pred CCCCCCC---CCccccccCCCCCC---CCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 473 PLLPSRK---ASENLAIGRSPEFP---EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~---~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
+...... ...++..|+|||++ ....++.++|||||||++|||++|+.||..... ...+...+. ....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~---~~~~ 237 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQIT---SGKY 237 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHHH---HTCC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHHH---hCcc
Confidence 8775442 22468899999986 356789999999999999999999999975422 112222221 1111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ..+... ......+.+++.+||+.||++||++.|+++
T Consensus 238 ~---~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 N---FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C---CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c---cCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 001100 012346889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.42 Aligned_cols=246 Identities=14% Similarity=0.011 Sum_probs=175.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---hhHHHHHHHH---HHHccCCCCCcccEE-------EEEecC--
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---LSKKEFVQQM---QLLGKLKHENLAKIV-------SFYYSK-- 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~-- 385 (604)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+ +.++. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 47899999999999985 4789999999986432 3345677885 45555 799988755 444332
Q ss_pred ---------------CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCCce
Q 007427 386 ---------------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTR------LSIIKQTAKGLAFLHQTLHSHKVP 444 (604)
Q Consensus 386 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~iv 444 (604)
...++||||++ |+|.+++..... .+.+..+ ..++.|++.||+|||+ ++|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~----~~iv 216 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS----KGLV 216 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH----TTEE
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH----CCCc
Confidence 23799999998 899999987532 2455556 7888999999999994 7999
Q ss_pred ecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCC
Q 007427 445 HANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPG 521 (604)
Q Consensus 445 HrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~ 521 (604)
||||||+|||+ +.+..+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 217 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFI---MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEE---CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEE---CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999 666789999999998876554 4456699999999987 67999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 522 NGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+............ ............ .........+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWKRP-----SLRVPGTDSLAF------GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCCBC-----CTTSCCCCSCCC------TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchhhh-----hhhhccccccch------hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 86532211100000 000000000000 000123346889999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.21 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=189.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 467999999999999865 6899999999766555678899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC----
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP---- 476 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~---- 476 (604)
.+++.... ..+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||++....
T Consensus 104 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~----~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 104 DAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS----KRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHH
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc----CCcccCCCCHHHEEE---CCCCCEEEEECCCCcccccccc
Confidence 99987643 248999999999999999999994 699999999999999 566689999999864321
Q ss_pred CCCCCccccccCCCCCC-----CCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 477 SRKASENLAIGRSPEFP-----EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 477 ~~~~~~~~~~y~aPE~~-----~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
......++..|+|||.+ .+..++.++|||||||++|||++|+.||.... ............... ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~-~~ 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPPT-LL 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCC-CS
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCcc-cC
Confidence 12234578899999987 46778999999999999999999999987532 112222222221111 10
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 T--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0112346889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.29 Aligned_cols=250 Identities=16% Similarity=0.250 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEec--CCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYS--KEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.. ....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 47899999999999985 578999999997533 477899999999997 9999999999987 5678999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.. +++.++..++.|++.||+|||+ +||+||||||+|||++.+ ...+||+|||+++....
T Consensus 118 ~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 118 TDFKQLYQT--------LTDYDIRFYMYEILKALDYCHS----MGIMHRDVKPHNVMIDHE--HRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEETT--TTEEEECCCTTCEECCT
T ss_pred hhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHh----CCeeeCCCCHHHEEEcCC--CCEEEEEeCCCceEcCC
Confidence 999999853 7889999999999999999994 699999999999999433 23799999999986654
Q ss_pred CC---CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH--------Hh-c
Q 007427 478 RK---ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV--------VD-N 544 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~-~ 544 (604)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+....... .. .
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHHhcCCchhhhHHHHh
Confidence 32 3357788999999877 67899999999999999999999999643211 11111111000 00 0
Q ss_pred CCccc-ccc-----------HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTD-ILD-----------VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~-~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ... ...............+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000 000000001113457899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.44 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=194.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC--------CCCcccEEEEEe----cCCce
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK--------HENLAKIVSFYY----SKEEK 388 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~----~~~~~ 388 (604)
.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 46899999999999985 56899999999754 334577889999999885 788999999987 55678
Q ss_pred EEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCceEEeecC--------
Q 007427 389 LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH-KVPHANLKSSNILIFREN-------- 459 (604)
Q Consensus 389 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-~ivHrDlkp~NILl~~~~-------- 459 (604)
++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~----~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT----KCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH----TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 9999999 667777766543 1258999999999999999999994 6 999999999999995442
Q ss_pred --------------------------------------CcceEEEeeccCCCCCCCCC-CCccccccCCCCCCCCCCCCc
Q 007427 460 --------------------------------------DIYRAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEGKRLTH 500 (604)
Q Consensus 460 --------------------------------------~~~~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~~~s~ 500 (604)
....+||+|||+++...... ...++..|+|||++.+..++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 22479999999997765432 345788999999999999999
Q ss_pred cchhHhHHHHHHHHHhCCCCCCCCCCCCCCC-CchhHHHHHHHh---------cCCccccc------------------c
Q 007427 501 KADVYCFGIILLEVITGRIPGNGSPGNNETS-GDLSDWVRMVVD---------NDWSTDIL------------------D 552 (604)
Q Consensus 501 ksDVwSfGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~------------------~ 552 (604)
++|||||||++|||+||+.||.......... ......+..... ..+..... .
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999998654322110 000111111100 00000000 0
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...............+.+|+.+||+.||++|||+.|+++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000011123556678999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.84 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=194.9
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 468999999999999864 7899999999743 23345779999999999999999999998853 567899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK-----VPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-----ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
+++|.+++..... ....+++..+..++.|++.||+|||+. + |+||||||+||++ +....+||+|||+
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGL 162 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEE---CSSSCEEECCCCH
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEE---cCCCCEEEecCch
Confidence 9999999986542 123589999999999999999999964 6 9999999999999 6667899999999
Q ss_pred CCCCCCCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 472 LPLLPSRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 472 a~~~~~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
++...... ...++..|+|||.+.+..++.++||||||+++|||+||+.||.... ..+..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~~- 233 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKF- 233 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC-
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHhhccc-
Confidence 87765432 1246788999999998899999999999999999999999987531 1222222222211
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
... .......+.+++.+||+.||++||++.|+++.+..-
T Consensus 234 ~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 RRI----------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccC----------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 110 112234688999999999999999999999866443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=353.55 Aligned_cols=233 Identities=18% Similarity=0.237 Sum_probs=192.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.++||+|+||.||+|+. .+++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 46899999999999985 468899999997431 22346678899999988 79999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~----~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS----KGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence 999999998754 48999999999999999999994 699999999999999 666789999999998643
Q ss_pred CC----CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SR----KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~----~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.+. +..+....+.......
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~~~---- 561 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHNVAY---- 561 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHSSCCCC----
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCCCCC----
Confidence 22 2335789999999999999999999999999999999999999753 1233333333332111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
+.....++.+|+.+||+.||++||++
T Consensus 562 --------p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 562 --------PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --------CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11223468899999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.03 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=184.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEe--------------cCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYY--------------SKE 386 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------------~~~ 386 (604)
.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++. +..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 468999999999999865 58999999998666666788999999999999999999999874 345
Q ss_pred ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEE
Q 007427 387 EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKL 466 (604)
Q Consensus 387 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl 466 (604)
..++||||++ |+|.+++... ++++..+..++.|++.||+|||+ +||+||||||+||+++. +...+||
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~~--~~~~~kl 162 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHS----ANVLHRDLKPANLFINT--EDLVLKI 162 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSGGGEEEET--TTTEEEE
T ss_pred ceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHh----CCEecCCCCHHHEEEcC--CCCeEEE
Confidence 7799999997 6999999643 48999999999999999999994 69999999999999953 3467999
Q ss_pred eeccCCCCCCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH
Q 007427 467 TNFGFLPLLPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538 (604)
Q Consensus 467 ~DFGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 538 (604)
+|||+++...... ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+... .+..
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~ 234 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------LEQM 234 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 9999998764321 2234778999998765 6789999999999999999999999975321 1111
Q ss_pred HHHHhcCCcc-------------ccccHHhhhcc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 539 RMVVDNDWST-------------DILDVEILAAR-----EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 539 ~~~~~~~~~~-------------~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......... ........... ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111110000 00000000000 00123456899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.30 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=179.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hh-hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-AL-SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+. .+|+.||+|+++... .. ..+.+.++...++.++||||+++++++.+.+..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 46899999999999986 579999999997532 22 22344555566888999999999999999999999999997 5
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH-KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+|.+++..... ....+++..+..++.|++.||+|||+ + ||+||||||+||++ +....+||+|||+++....
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~----~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS----KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH----HSCCCCCCCSGGGCEE---CTTCCEEBCCC--------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh----cCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccc
Confidence 99888765321 12359999999999999999999995 5 99999999999999 6667899999999987654
Q ss_pred CCC---CccccccCCCCCC----CCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 478 RKA---SENLAIGRSPEFP----EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 478 ~~~---~~~~~~y~aPE~~----~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
... ..++..|+|||.+ .+..++.++|||||||++|||+||+.||..... . ................
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------P-FQQLKQVVEEPSPQLP 235 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------H-HHHHHHHHHSCCCCCC
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------h-HHHHHHHhccCCCCcc
Confidence 332 3578899999995 566789999999999999999999999974211 1 1122222222211110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 236 ----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0112346889999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=328.85 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=169.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 396 (604)
.++||+|+||.||+|+.. +|+.||||++.... ....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 357999999999999865 79999999996532 222223334566799999999999876 345799999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++....+||+|||+++...
T Consensus 110 gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~----~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS----HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh----CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 999999998653 2358999999999999999999995 699999999999999766666789999999997665
Q ss_pred CCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 477 SRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 477 ~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
... ...++..|+|||++.+..++.++|||||||++|||++|+.||.......... ..............
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~----- 253 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLGQYGFP----- 253 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCC-----
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhccccccC-----
Confidence 432 3356889999999988889999999999999999999999997543211100 00000000000000
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..........+.+++.+||+.||++|||+.|+++
T Consensus 254 ---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 254 ---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001123346889999999999999999999997
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=329.20 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=189.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL-----SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 47899999999999986 46899999999743211 1246789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++ +|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||+++..
T Consensus 95 ~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 95 ET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ----HWILHRDLKPNNLLL---DENGVLKLADFGLAKSF 162 (346)
T ss_dssp SE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred CC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH----CCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence 75 8999887643 248889999999999999999994 699999999999999 66678999999999876
Q ss_pred CCCC----CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---cCCc
Q 007427 476 PSRK----ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD---NDWS 547 (604)
Q Consensus 476 ~~~~----~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 547 (604)
.... ...++..|+|||.+.+. .++.++|||||||++|||++|..||.+... ...+......... ..+.
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHcCCCChhhhh
Confidence 4332 23568899999998754 589999999999999999999999875321 1111111111100 0000
Q ss_pred cccccHHh---------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 548 TDILDVEI---------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 548 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.....+.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 0000001223568999999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=318.56 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=190.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 468999999999999865 58999999997543 346789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||++ +....+||+|||++......
T Consensus 112 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 112 SDIIRLRN----KTLTEDEIATILQSTLKGLEYLHF----MRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp HHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh----CCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 99997433 258999999999999999999994 699999999999999 56678999999999765433
Q ss_pred --CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 479 --KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ......
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~~~---- 247 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTNP-PPTFRK---- 247 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCCSS----
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC-CcccCC----
Confidence 23356788999999999899999999999999999999999997531 111111111111 111100
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0112346889999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.85 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=184.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 46899999999999985 46899999999743 2334567889999999999999999999997654 679999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||++ |+|.+++.. .+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||++
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~----~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS----AGIIHRDLKPSNIVV---KSDCTLKILDFGLA 174 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECCCCC-
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH----CCeecccCCHHHEEE---cCCCCEEEEEeecc
Confidence 9996 588888853 38899999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-------C-------Cchh
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET-------S-------GDLS 535 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-------~-------~~~~ 535 (604)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.+....... . ..+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 8765432 335788999999999999999999999999999999999999763210000 0 0000
Q ss_pred HHHHHHHhcCC--ccccccH---Hhhhcc---cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 536 DWVRMVVDNDW--STDILDV---EILAAR---EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 536 ~~~~~~~~~~~--~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........... ....... ...... ........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000 0000000 000000 01123567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.03 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=174.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 46899999999999984 57899999999643 333457788999999999999999999998754 5679999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+ +++|.+++... .+++..+..++.||++||+|||+ +||+||||||+|||+ +.+..+||+|||++
T Consensus 114 e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~----~givH~Dlkp~NIll---~~~~~~kL~DFG~a 179 (367)
T 2fst_X 114 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS----ADIIHRDLKPSNLAV---NEDCELKILDFGLA 179 (367)
T ss_dssp ECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEEECC----
T ss_pred ccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH----CCeeeCCCCHhhEEE---CCCCCEEEeecccc
Confidence 999 78999988753 48999999999999999999994 799999999999999 66678999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC---c
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW---S 547 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 547 (604)
+...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+... ...+..... ...... .
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~-~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILR-LVGTPGAELL 254 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH-HHCSCCHHHH
T ss_pred ccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH-HhCCCCHHHH
Confidence 8765432 3467889999999876 6789999999999999999999999976321 011111111 100000 0
Q ss_pred cccccHH---hh-h----cc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 TDILDVE---IL-A----AR-----EGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ~~~~~~~---~~-~----~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+.... .. . .. ........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 00 0 00 00112346889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.86 Aligned_cols=193 Identities=23% Similarity=0.335 Sum_probs=163.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC------CCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL------KHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|.. .+++.||||+++... ...+.+.+|+++++.+ +|+||+++++++...+..++||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 47899999999999985 468999999997542 3346677888887776 577999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+. ++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. ..+||+|||+++.
T Consensus 181 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlKp~NILl~~~~~-~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 181 LS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHK----NRIIHCDLKPENILLKQQGR-SGIKVIDFGSSCY 251 (429)
T ss_dssp CC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH----HTEECSCCSGGGEEESSTTS-CCEEECCCTTCEE
T ss_pred cC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEEccCCC-cceEEeeccccee
Confidence 95 699999987542 248999999999999999999995 69999999999999943322 2389999999976
Q ss_pred CCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 475 LPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 475 ~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
..... ...++..|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65433 346788999999999999999999999999999999999999763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.00 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=196.7
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||.||+|... .+..||+|+++.. .....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 578999999999999863 2568999998753 3334578999999999999999999999985 467899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++...
T Consensus 474 ~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~----~givHrDikp~NILl~---~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 474 LGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES----KRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYME 542 (656)
T ss_dssp TCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCC
T ss_pred CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh----CCccccccchHhEEEe---CCCCEEEEecCCCeecC
Confidence 999999998643 248999999999999999999994 6999999999999994 44689999999998875
Q ss_pred CCCC-----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 477 SRKA-----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 477 ~~~~-----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.... ..++..|+|||.+.+..++.++|||||||++|||++ |..||.+.. ..+....+.......
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~~~-- 612 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENGERLP-- 612 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHTCCCC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCCCCC--
Confidence 4432 234568999999988899999999999999999997 999987532 112222222211110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 613 ---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011233468899999999999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=325.31 Aligned_cols=247 Identities=19% Similarity=0.338 Sum_probs=190.2
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+... .||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4789999999999998763 49999986432 2223567889999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ +..+||+|||+++.....
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~----~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA----KGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH----TTCCCCCCCSTTEEEC------CCEECCCSCCC------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh----CCccccCCChhhEEEe----CCCEEEeecCCcccccccc
Confidence 999997643 258999999999999999999994 6999999999999994 347899999998765321
Q ss_pred --------CCCccccccCCCCCCCC---------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 479 --------KASENLAIGRSPEFPEG---------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 479 --------~~~~~~~~y~aPE~~~~---------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~ 255 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------AEAIIWQM 255 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------HHHHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHh
Confidence 12246788999998864 457889999999999999999999997532 11222222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccc
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMI 600 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 600 (604)
.... ...... ......+.+++.+||+.||++|||+.|++++|+++....
T Consensus 256 ~~~~-~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 GTGM-KPNLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HTTC-CCCCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ccCC-CCCCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 2111 111100 011235889999999999999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.11 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=194.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc---------hhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEE
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN---------ALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 390 (604)
.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++++++. ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 468999999999999864 68999999996432 122456889999999995 9999999999999999999
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+++++|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+|||
T Consensus 102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~dfg 169 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK----LNIVHRDLKPENILL---DDDMNIKLTDFG 169 (298)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCcceEEE---cCCCcEEEeccc
Confidence 999999999999998653 48999999999999999999994 699999999999999 666789999999
Q ss_pred CCCCCCCCC---CCccccccCCCCCCC------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSRK---ASENLAIGRSPEFPE------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~~---~~~~~~~y~aPE~~~------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
++....... ...++..|+|||.+. ...++.++||||||+++|||++|+.||.... ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~ 241 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMI 241 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHHHH
Confidence 997765432 235678999999874 4568899999999999999999999997531 12222222
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......... + ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~--~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQFGS--P------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCCCCT--T------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcccCc--c------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 222211110 0 00122346889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.67 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=189.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecC--------CceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------EEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~l 390 (604)
.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46899999999999986 579999999986432 22346788999999999999999999999773 46899
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+++ +|.+.+.... ..+++.++..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||
T Consensus 102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~----~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 169 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR----NKILHRDMKAANVLI---TRDGVLKLADFG 169 (351)
T ss_dssp EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCT
T ss_pred EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH----CCeeCCCCCHHHEEE---cCCCCEEEccch
Confidence 9999975 8888877543 248999999999999999999994 699999999999999 666789999999
Q ss_pred CCCCCCCC--------CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSR--------KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~--------~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
+++.+... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.+.. .......+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 99765421 12346788999998876 458999999999999999999999997532 11111111111
Q ss_pred HhcCCc---cccccHHhhh-------cccC-H------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDWS---TDILDVEILA-------AREG-Q------NEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~~---~~~~~~~~~~-------~~~~-~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...... .......... .... . .....+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000 0000000000 0000 0 01245889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.82 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=183.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch-----------hhHHHHHHHHHHHccCCCCCcccEEEEEecC-----
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA-----------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSK----- 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 385 (604)
.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 468999999999999988899999999864221 1237789999999999999999999998543
Q ss_pred CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEE
Q 007427 386 EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAK 465 (604)
Q Consensus 386 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~k 465 (604)
...++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +....+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHE----AGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEE
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH----CcCEecCCChHHEEE---cCCCCEE
Confidence 35799999997 69999887543 258999999999999999999995 699999999999999 6667899
Q ss_pred EeeccCCCCCCCCC---CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 466 LTNFGFLPLLPSRK---ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 466 l~DFGla~~~~~~~---~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
|+|||+++...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+... .+.....
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~i 246 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--------YNQLNKI 246 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 99999997654332 2356778999998876 6789999999999999999999999975321 1111111
Q ss_pred HhcCCcccccc------HHh--------------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDWSTDILD------VEI--------------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~~~~~~~------~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..........+ ... ............+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11000000000 000 000001112346889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.13 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=185.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC---------------
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK--------------- 385 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------- 385 (604)
.+.||+|+||.||+|+. .+|+.||||++..... ...+|++++++++||||+++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 47899999999999985 6799999999865422 234799999999999999999998543
Q ss_pred -----------------------CceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007427 386 -----------------------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442 (604)
Q Consensus 386 -----------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ 442 (604)
...++||||++ |+|.+.+...... ...+++..+..++.|+++||+||| ++|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH----~~g 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIH----SLG 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH----TTT
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCc
Confidence 23789999997 5888887653211 235899999999999999999999 579
Q ss_pred ceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC---CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCC
Q 007427 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK---ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGR 518 (604)
Q Consensus 443 ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~ 518 (604)
|+||||||+|||++. ....+||+|||+++...... ...++..|+|||.+.+. .++.++|||||||++|||++|+
T Consensus 162 i~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 999999999999942 34689999999998664432 33567889999988765 4899999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHh----------cCCc----cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC
Q 007427 519 IPGNGSPGNNETSGDLSDWVRMVVD----------NDWS----TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP 584 (604)
Q Consensus 519 ~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 584 (604)
.||.+... ...+...+..... ..+. ........ ...........+.+++.+||+.||++||
T Consensus 240 ~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 240 PLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW-RKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp CSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH-HhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99986321 1111111111000 0000 00000000 0001112334688999999999999999
Q ss_pred CHHHHHH
Q 007427 585 KMSEVLR 591 (604)
Q Consensus 585 s~~evl~ 591 (604)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.64 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=177.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 46899999999999985 478999999986432 2335678899999999999999999999999999999999999999
Q ss_pred HHHHhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 400 LFDLLHESRG---VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 400 L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++....
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK----NGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh----CCCCCCCCChhhEEE---cCCCCEEEEeccchheec
Confidence 9999875211 112358999999999999999999994 699999999999999 666789999999886554
Q ss_pred CC---------CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 477 SR---------KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 477 ~~---------~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .. .........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~-~~~~~~~~~ 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KV-LMLTLQNDP 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------GH-HHHHHTSSC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-------hH-HHHHhccCC
Confidence 32 12346788999998865 56899999999999999999999999753211 11 111111111
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. .... ..............+.+++.+||+.||++||++.|+++
T Consensus 245 ~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 P-SLET-GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-CTTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred C-cccc-ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0000 00000001122346889999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.12 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=185.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +|+.||||++.... ....+|++++++++||||+++++++.... ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 468999999999999864 69999999986532 22347999999999999999999985421 25799999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++ +|.+.+..... ....+++..+..++.||++||+||| +++|+||||||+|||++. +...+||+|||+++.
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~--~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQ 206 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEET--TTTEEEECCCTTCEE
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeC--CCCeEEeccchhhhh
Confidence 975 77776654221 1235899999999999999999999 579999999999999953 235689999999986
Q ss_pred CCCCC---CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH--------
Q 007427 475 LPSRK---ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV-------- 542 (604)
Q Consensus 475 ~~~~~---~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 542 (604)
+.... ...++..|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.+.+...-
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHH
Confidence 64332 34578899999998764 789999999999999999999999986321 111222221100
Q ss_pred --hcCCccccccHHhhh----cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 543 --DNDWSTDILDVEILA----AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 543 --~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
...+. +...+.... ..........+.+|+.+||+.||++||++.|+++
T Consensus 283 ~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYT-EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCC-CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhh-hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 000000000 0001122356899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.80 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=195.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhh-----------------HHHHHHHHHHHccCCCCCcccEEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALS-----------------KKEFVQQMQLLGKLKHENLAKIVSFYYS 384 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~~~~~~ 384 (604)
.+.||+|+||.||+|+. +|+.||+|++....... .+.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46899999999999998 89999999996432111 1789999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHH------hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec
Q 007427 385 KEEKLIIYEFLPNGSLFDL------LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE 458 (604)
Q Consensus 385 ~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 458 (604)
.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ .+||+||||||+||++
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dl~p~Nil~--- 185 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHN---EKNICHRDVKPSNILM--- 185 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHH---TSCEECCCCCGGGEEE---
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhc---cCCEeecCCChHhEEE---
Confidence 9999999999999999998 44321 2369999999999999999999995 2699999999999999
Q ss_pred CCcceEEEeeccCCCCCCCC--CCCccccccCCCCCCCCC-CCCc-cchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCch
Q 007427 459 NDIYRAKLTNFGFLPLLPSR--KASENLAIGRSPEFPEGK-RLTH-KADVYCFGIILLEVITGRIPGNGSPGNNETSGDL 534 (604)
Q Consensus 459 ~~~~~~kl~DFGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~s~-ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~ 534 (604)
+.+..+||+|||++...... ....++..|+|||.+.+. .++. ++|||||||++|||++|+.||..... .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~ 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-------L 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-------S
T ss_pred cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-------H
Confidence 66678999999999775433 234678899999999877 6666 99999999999999999999975322 1
Q ss_pred hHHHHHHHhcCCcccc-----ccHHh--hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 535 SDWVRMVVDNDWSTDI-----LDVEI--LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.+.............. ..... ............+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222222222111000 00000 000000123346889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.42 Aligned_cols=259 Identities=19% Similarity=0.302 Sum_probs=194.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCCcccEEEEEecCC---
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-----------HENLAKIVSFYYSKE--- 386 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~~--- 386 (604)
.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 47899999999999985 57899999999753 234567889999998886 899999999988654
Q ss_pred -ceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCceEEeec---CCc
Q 007427 387 -EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH-KVPHANLKSSNILIFRE---NDI 461 (604)
Q Consensus 387 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-~ivHrDlkp~NILl~~~---~~~ 461 (604)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ + ||+||||||+|||++.+ +..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~----~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR----RCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH----TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHh----cCCEEecCCChHHeEEeccCCCcCc
Confidence 689999999 8899999987542 248999999999999999999994 5 99999999999999654 345
Q ss_pred ceEEEeeccCCCCCCCC-CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 462 YRAKLTNFGFLPLLPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~-~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
..+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||......... .-.+....
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 252 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT--KDDDHIAQ 252 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC--ChHHHHHH
Confidence 68999999999776543 2346788999999999999999999999999999999999999864321110 01111111
Q ss_pred HHh--cCCccc--------------------c--------ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 007427 541 VVD--NDWSTD--------------------I--------LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 541 ~~~--~~~~~~--------------------~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 590 (604)
... ...... + .+...............+.+|+.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 110 000000 0 0000001122345677899999999999999999999998
Q ss_pred H
Q 007427 591 R 591 (604)
Q Consensus 591 ~ 591 (604)
+
T Consensus 333 ~ 333 (373)
T 1q8y_A 333 N 333 (373)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.39 Aligned_cols=240 Identities=21% Similarity=0.348 Sum_probs=188.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCCcccEEEEEe--cCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKLKHENLAKIVSFYY--SKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~ 394 (604)
.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++. +.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46899999999999986 468999999997432 234577999999999999999999999984 45578999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++++ |.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+|||++..
T Consensus 90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~----~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS----QGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH----CCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 9875 877776543 2258999999999999999999994 699999999999999 6667899999999976
Q ss_pred CCCC------CCCccccccCCCCCCCCCC--CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSR------KASENLAIGRSPEFPEGKR--LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~------~~~~~~~~y~aPE~~~~~~--~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.... ....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.+. ...+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------NIYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--------hHHHHHHHHhcCCC
Confidence 6432 1235788999999987644 377999999999999999999999753 12222222222211
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AI------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 01123468899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.71 Aligned_cols=255 Identities=19% Similarity=0.301 Sum_probs=184.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc------eEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE------KLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~~ 395 (604)
.++||+|+||.||+|+...+..||+|++..... ...+|++++++++||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 478999999999999987777799998864322 22379999999999999999999965443 78999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++ ++.+.+..... ....+++..+..++.|+++||+|||+ +||+||||||+|||++. ....+||+|||+++..
T Consensus 121 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~----~~ivHrDlkp~Nill~~--~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 121 PE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS----IGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKIL 192 (394)
T ss_dssp SE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEET--TTTEEEECCCTTCEEC
T ss_pred Cc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH----CCccCCCCCHHHEEEcC--CCCcEEEeeCCCcccc
Confidence 76 44444432211 12258999999999999999999994 69999999999999941 4568999999999876
Q ss_pred CCCC---CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---------
Q 007427 476 PSRK---ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV--------- 542 (604)
Q Consensus 476 ~~~~---~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 542 (604)
.... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+...+...-
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHHh
Confidence 4332 34568889999998764 589999999999999999999999986321 111111111100
Q ss_pred -hcCCccccc---cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 543 -DNDWSTDIL---DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 543 -~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...+..... ................+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000 00000000011233478999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=325.79 Aligned_cols=248 Identities=20% Similarity=0.296 Sum_probs=187.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCce------EEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEK------LIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv~ 392 (604)
.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 46899999999999985 46899999999753 233357789999999999999999999999877654 9999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||++ ++|.+++.. .+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||++
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHS----AGVVHRDLKPGNLAV---NEDCELKILDFGLA 191 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECSTTCC
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH----CCCcCCCcCHHHeEE---CCCCCEEEEecCcc
Confidence 9996 699888742 38999999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc-CCc-c
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN-DWS-T 548 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~ 548 (604)
+...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.. ..+........ +.. .
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVTGVPGT 263 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCCCCH
T ss_pred cccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCcH
Confidence 8765443 3357889999999887 778999999999999999999999997532 11111111110 000 0
Q ss_pred ----ccccH---Hh----hh------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 549 ----DILDV---EI----LA------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 549 ----~~~~~---~~----~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
...+. .. .. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 00 00 00001224578999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.07 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=185.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++||||++ |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 46899999999988777789999999986532 35678999999876 89999999999999999999999995 699
Q ss_pred HHHhhcccCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec----------CCcceEEEee
Q 007427 401 FDLLHESRGVGR--IPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE----------NDIYRAKLTN 468 (604)
Q Consensus 401 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~----------~~~~~~kl~D 468 (604)
.+++........ ...++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +....+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS----LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH----CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999986542111 011333467899999999999994 699999999999999654 2456899999
Q ss_pred ccCCCCCCCCC--------CCccccccCCCCCCCC-------CCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 007427 469 FGFLPLLPSRK--------ASENLAIGRSPEFPEG-------KRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSG 532 (604)
Q Consensus 469 FGla~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~ 532 (604)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------ 245 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------ 245 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT------
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh------
Confidence 99998765432 2357889999999865 678999999999999999999 9999864311
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ............ ..........++.+++.+||+.||++|||+.||++
T Consensus 246 ~~~----~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES----NIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH----HHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH----HHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 111111111100 01122345667999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=323.05 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=172.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHH-HHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQ-LLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|.. .+|+.||||+++... .....++.+|+. +++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 46899999999999986 478999999997542 233445666665 77888999999999999999999999999975
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH-KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
+|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+||++ +....+||+|||+++....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~----~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE----NLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH----HHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC---
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc----cCCEeECCCCHHHEEE---cCCCCEEEccCCCceeccc
Confidence 88888764322222358999999999999999999995 5 99999999999999 5566899999999987654
Q ss_pred CC---CCccccccCCCCCC----CCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 478 RK---ASENLAIGRSPEFP----EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~----~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
.. ...++..|+|||.+ .+..++.++|||||||++|||++|+.||........ ......... ....
T Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~-~~~~ 250 (327)
T 3aln_A 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGD-PPQL 250 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSC-CCCC
T ss_pred ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHhcCC-CCCC
Confidence 32 22577889999998 456789999999999999999999999975321100 000000000 0000
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ..........+.+++.+||+.||++||++.|+++
T Consensus 251 ~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 S------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 0001122346889999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.27 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=189.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 46899999999999985 468899999997533 33347789999999999999999999999754 368999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++ |+|.+++... .+++.++..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++.
T Consensus 112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS----ANVLHRDLKPSNLLL---NTTCDLKICDFGLARV 177 (364)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCChHhEEE---CCCCCEEEEeCcceEe
Confidence 96 5999999764 38999999999999999999994 699999999999999 6667899999999987
Q ss_pred CCCCC-------CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSRK-------ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~~-------~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
..... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+... ......+........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 252 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 65332 2357889999998654 4589999999999999999999999976421 111111111111000
Q ss_pred cc---ccccH---Hhh----------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 ST---DILDV---EIL----------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~---~~~~~---~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ...+. ... ...........+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000 000 00000112346889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=321.18 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=198.2
Q ss_pred hcccCcCCcceEEEEEe--cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC------CcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL--ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE------NLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++|+ +++++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46899999999999985 368999999997543 3456788999999888665 49999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-------------
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND------------- 460 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~------------- 460 (604)
|+ +++|.+++.... ..++++..+..++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~----~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS----NKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH----CCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99 889999998654 2358999999999999999999994 69999999999999954321
Q ss_pred ---cceEEEeeccCCCCCCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhH
Q 007427 461 ---IYRAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 461 ---~~~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 536 (604)
...+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..... .....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~ 244 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-----KEHLA 244 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-----HHHHH
T ss_pred cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence 4579999999998765433 34678899999999999999999999999999999999999975321 11111
Q ss_pred HHHHHHhcCCccccc------------------------------cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 007427 537 WVRMVVDNDWSTDIL------------------------------DVEILAAREGQNEMLRLTELALECTDIAPEKRPKM 586 (604)
Q Consensus 537 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 586 (604)
.+...... ...... ................+.+++.+||+.||++|||+
T Consensus 245 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111110 000000 00000001123456679999999999999999999
Q ss_pred HHHHHH--HHhhc
Q 007427 587 SEVLRR--IEEIQ 597 (604)
Q Consensus 587 ~evl~~--L~~i~ 597 (604)
.|+++. +++++
T Consensus 324 ~ell~hp~f~~~~ 336 (339)
T 1z57_A 324 REALKHPFFDLLK 336 (339)
T ss_dssp HHHTTSGGGGGGG
T ss_pred HHHhcCHHHHHHh
Confidence 999853 44444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=322.48 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=188.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 394 (604)
.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 468999999999999864 68999999997432 33456788999999999999999999998754 678999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++ |+|.+++... .+++..+..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+++.
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~----~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHG----SNVIHRDLKPSNLLI---NSNCDLKVCDFGLARI 161 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH----CCeecCCCCHHHeEE---cCCCcEEEEecccccc
Confidence 96 6999998763 38999999999999999999994 699999999999999 6667899999999987
Q ss_pred CCCCC--------------CCccccccCCCCCCC-CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH
Q 007427 475 LPSRK--------------ASENLAIGRSPEFPE-GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539 (604)
Q Consensus 475 ~~~~~--------------~~~~~~~y~aPE~~~-~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 539 (604)
..... ...++..|+|||.+. +..++.++|||||||++|||++|+.||.+... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~ 236 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLIF 236 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHH
Confidence 64321 124578899999865 46789999999999999999999999976321 00000111
Q ss_pred HHHhcCCc----cccccHHh----h---------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 540 MVVDNDWS----TDILDVEI----L---------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 540 ~~~~~~~~----~~~~~~~~----~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
........ ........ . ...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11100000 00000000 0 00000123456889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.12 Aligned_cols=240 Identities=20% Similarity=0.306 Sum_probs=188.4
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCC--CCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLK--HENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+++..+++.||||++... .....+.+.+|++++.+++ |+||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999888999999999643 3334578899999999997 5999999999999999999999 458
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++ + ..+||+|||+++....
T Consensus 112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~----~~ivH~dlkp~NIl~~---~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ----HGIVHSDLKPANFLIV---D-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEEE---T-TEEEECCCSSSCC---
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCceecCCCcccEEEE---C-CeEEEeeccccccccC
Confidence 89999998653 48999999999999999999994 6999999999999993 2 5799999999987654
Q ss_pred CC------CCccccccCCCCCCCC-----------CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH
Q 007427 478 RK------ASENLAIGRSPEFPEG-----------KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM 540 (604)
Q Consensus 478 ~~------~~~~~~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 540 (604)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... . ......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~-~~~~~~ 251 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------Q-ISKLHA 251 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------H-HHHHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------H-HHHHHH
Confidence 32 2246889999999875 4688899999999999999999999975321 1 112222
Q ss_pred HHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 541 VVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........... ......+.+++.+||+.||++||++.|+++.
T Consensus 252 ~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHEIEFP----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSCCCCC----------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccccCCc----------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 22222111110 0112358899999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=318.83 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=186.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEec------CCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS------KEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e 393 (604)
.+.||+|+||.||+|+. .+|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 47899999999999986 578999999986543 2346789999999999 89999999999976 457899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+ +||+||||||+||++ +.+..+||+|||++.
T Consensus 108 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ----HKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp CCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred cCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH----CCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 999999999998653 2258999999999999999999995 699999999999999 666789999999988
Q ss_pred CCCCC----CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc
Q 007427 474 LLPSR----KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544 (604)
Q Consensus 474 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 544 (604)
..... ....++..|+|||.+. +..++.++|||||||++|||+||+.||.... ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 249 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMRALFLIPRN 249 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcC
Confidence 76432 2235788999999987 5678999999999999999999999997532 11111111111
Q ss_pred CCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. .... .......+.+++.+||+.||.+||++.|+++
T Consensus 250 ~~-~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PA-PRLK---------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CC-CCCS---------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-ccCC---------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1100 0112346889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.22 Aligned_cols=195 Identities=25% Similarity=0.336 Sum_probs=164.8
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CC-----CcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HE-----NLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|+.. +++.||||+++... ....++.+|+.+++.++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 468999999999999854 68899999997542 23466788888888874 44 499999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
++ |+|.+++..... ..+++..+..++.|++.||+|||.. ..+|+||||||+|||++.+ ....+||+|||+++.
T Consensus 138 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~-~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQ 210 (382)
T ss_dssp CC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred CC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecC-CCCcEEEEeccCcee
Confidence 95 599999987542 2489999999999999999999952 4699999999999999432 245799999999987
Q ss_pred CCCC-CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 475 LPSR-KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 475 ~~~~-~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
.... ....++..|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6543 2346788999999999999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.95 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=178.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc-------eEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE-------KLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~e 393 (604)
.+.||+|+||.||+|+. .+|+.||||++..... ....+.+|++.+..++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 46899999999999986 4689999999865322 23456778888899999999999999976443 789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++ +|.+.+..... ....+++..+..++.|++.||.|||.. +++|+||||||+|||++. .+..+||+|||+++
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~--~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNE--ADGTLKLCDFGSAK 180 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEET--TTTEEEECCCTTCB
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeC--CCCcEEEeeCCCce
Confidence 9976 66655543221 123589999999999999999999932 579999999999999943 25689999999998
Q ss_pred CCCCCC---CCccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH-------
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV------- 542 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 542 (604)
...... ...++..|+|||++.+.. ++.++|||||||++|||+||+.||.+... ...+....+...
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS----AGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh----HHHHHHHHHHcCCCCHHHH
Confidence 775443 235688899999986654 89999999999999999999999976321 111111111100
Q ss_pred ----hcCCccccc-----cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 543 ----DNDWSTDIL-----DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 543 ----~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
......... ................+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 00000000111235578999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.39 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=183.9
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec-------------CCc
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-------------KEE 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------~~~ 387 (604)
.+.||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 46899999999999986 47999999999643 2345778999999999999999999999865 346
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEe
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLT 467 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~ 467 (604)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.+..+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~----~~i~H~dlkp~Nil~---~~~~~~kl~ 158 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS----QGIIHRDLKPMNIFI---DESRNVKIG 158 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEEC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh----CCeecccCCHHhEEE---cCCCCEEEe
Confidence 789999999999999998643 247889999999999999999994 699999999999999 666789999
Q ss_pred eccCCCCCCCC------------------CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCC
Q 007427 468 NFGFLPLLPSR------------------KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNN 528 (604)
Q Consensus 468 DFGla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~ 528 (604)
|||+++..... ....++..|+|||.+.+. .++.++|||||||++|||++ ||...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 99999876422 122467789999998764 68999999999999999998 54321
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+........... . . ..........+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~~~~~--~-~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 ---MERVNILKKLRSVSIE--F-P-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHHHHHHHSTTCC--C-C-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhHHHHHHhccccccc--c-C-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111122222111100 0 0 0011223345789999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=319.43 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=189.5
Q ss_pred hcccCcCCcceEEEEEe--cCCcEEEEEEecccch--hhHHHHHHHHHHHccC---CCCCcccEEEEEe-----cCCceE
Q 007427 322 AEVLGKGKVGSTYKATL--ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKL---KHENLAKIVSFYY-----SKEEKL 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~~~~ 389 (604)
.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|+.+++++ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46899999999999986 4688999999864321 1223566777777666 8999999999987 456789
Q ss_pred EEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+||||++ |+|.+++..... ..+++..+..++.|++.||+|||+ +||+||||||+||++ +....+||+||
T Consensus 96 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~----~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS----HRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred EEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH----CCceeccCCHHHeEE---cCCCCEEEecC
Confidence 9999997 699999986542 248999999999999999999994 699999999999999 66678999999
Q ss_pred cCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---h
Q 007427 470 GFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---D 543 (604)
Q Consensus 470 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 543 (604)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.+... ...+........ .
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCG
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCCCc
Confidence 9998765432 33567899999999999999999999999999999999999975321 011111111100 0
Q ss_pred cCCccccccHHh--------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 544 NDWSTDILDVEI--------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 544 ~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+......+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011000000000 000001123446889999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=328.28 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=183.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||++ |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 468999999997766666799999999965332 2356899999999 79999999999999999999999995 699
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec--CCcceEEEeeccCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE--NDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--~~~~~~kl~DFGla~~~~~~ 478 (604)
.+++..... ...+..+..++.||+.||+|||+ ++|+||||||+|||++.+ +....+||+|||+++.....
T Consensus 105 ~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~----~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHS----LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHH----TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcCC----CccchhHHHHHHHHHHHHHHHHH----CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999986542 24455667899999999999994 699999999999999643 23457899999999876533
Q ss_pred C-------CCccccccCCCCCCC---CCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 479 K-------ASENLAIGRSPEFPE---GKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 479 ~-------~~~~~~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
. ...++..|+|||++. ...++.++|||||||++|||+| |+.||.... .......... ..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~---------~~~~~~~~~~-~~ 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL---------QRQANILLGA-CS 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT---------THHHHHHTTC-CC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh---------HHHHHHHhcc-CC
Confidence 1 235789999999997 4567889999999999999999 899985421 1111111111 11
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ........+.+++.+||+.||++|||+.||++
T Consensus 247 ~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111 11233445789999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=319.06 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEec-CC-cEEEEEEecccchhhHHHHHHHHHHHccCCCCC------cccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE-SG-AVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN------LAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e 393 (604)
.+.||+|+||+||+|... ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 468999999999999864 34 789999997542 34567889999999987665 9999999999999999999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeec---------------
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRE--------------- 458 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--------------- 458 (604)
|+ +++|.+++.... ..++++.++..++.|++.||+||| +++|+||||||+|||++..
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 99 668888776643 225899999999999999999999 5799999999999999543
Q ss_pred -CCcceEEEeeccCCCCCCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhH
Q 007427 459 -NDIYRAKLTNFGFLPLLPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536 (604)
Q Consensus 459 -~~~~~~kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 536 (604)
+....+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~ 249 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-----REHLV 249 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred ccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 245689999999998654432 34678899999999999999999999999999999999999975321 11111
Q ss_pred HHHHHHhcC--------------------CccccccHHh---------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 007427 537 WVRMVVDND--------------------WSTDILDVEI---------LAAREGQNEMLRLTELALECTDIAPEKRPKMS 587 (604)
Q Consensus 537 ~~~~~~~~~--------------------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (604)
.+....... +.....+... ............+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 111111000 0000000000 00011223456789999999999999999999
Q ss_pred HHHH
Q 007427 588 EVLR 591 (604)
Q Consensus 588 evl~ 591 (604)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.83 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=186.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc------eEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE------KLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 392 (604)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46899999999999985 46999999999653 23335678999999999999999999999987654 49999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||++ ++|.+++.. .+++..+..++.|++.||+|||+ +||+||||||+||++ +.+..+||+|||++
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~----~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHS----AGVVHRDLKPGNLAV---NEDCELKILDFGLA 173 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSSCCGGGEEE---CTTCCEEECSTTCT
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH----CCcccCCCCHHHEeE---CCCCcEEEeecccc
Confidence 9996 688877642 38999999999999999999994 699999999999999 66678999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhc-CCc--
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN-DWS-- 547 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 547 (604)
+...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+... .+........ +..
T Consensus 174 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGVPGT 245 (353)
T ss_dssp TC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHHCBCCH
T ss_pred cCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCCH
Confidence 8765432 2357889999999876 6789999999999999999999999975321 1111111110 000
Q ss_pred ---cccccHH---hh----------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 ---TDILDVE---IL----------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 ---~~~~~~~---~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..+.+.. .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 00 00001123457899999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.44 Aligned_cols=270 Identities=19% Similarity=0.251 Sum_probs=199.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEec------CCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS------KEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e 393 (604)
.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 57899999999999985 56899999998753 34445779999999999999999999999765 667899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++..... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++....+||+|||+++
T Consensus 99 y~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs----~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE----NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH----TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred eCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH----CCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 9999999999987542 2248889999999999999999994 699999999999999877777789999999998
Q ss_pred CCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHH--HHhcCCcc
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM--VVDNDWST 548 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 548 (604)
...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||............+...... ........
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 775443 2357889999999999999999999999999999999999997531100000000000000 00000000
Q ss_pred cc-ccHHhh-hcccCHHHHHHHHHHHHhcccCCCCCCCCHHH-----HHHHHHhhc
Q 007427 549 DI-LDVEIL-AAREGQNEMLRLTELALECTDIAPEKRPKMSE-----VLRRIEEIQ 597 (604)
Q Consensus 549 ~~-~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~ 597 (604)
.. ...... ...........+.+++.+||+.||++|||+.| ..+.++.+.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00 000000 00112234567899999999999999999988 455555553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.34 Aligned_cols=233 Identities=24% Similarity=0.383 Sum_probs=183.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh------hHHHHHHHHHHHccC----CCCCcccEEEEEecCCceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL------SKKEFVQQMQLLGKL----KHENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~l 390 (604)
.+.||+|+||.||+|+. .+++.||||+++..... ....+.+|+.++.++ +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 47899999999999985 57899999999654321 223456788888888 89999999999999999999
Q ss_pred EEec-CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 391 IYEF-LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 391 v~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
|||| +++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++. ....+||+||
T Consensus 116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~~--~~~~~kl~df 184 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHS----RGVVHRDIKDENILIDL--RRGCAKLIDF 184 (312)
T ss_dssp EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----HTEECCCCSGGGEEEET--TTTEEEECCC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeeecCCChhhEEEeC--CCCeEEEEEc
Confidence 9999 78999999998754 48999999999999999999995 69999999999999942 4567999999
Q ss_pred cCCCCCCCCC--CCccccccCCCCCCCCCCCC-ccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 470 GFLPLLPSRK--ASENLAIGRSPEFPEGKRLT-HKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 470 Gla~~~~~~~--~~~~~~~y~aPE~~~~~~~s-~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
|+++...... ...++..|+|||++.+..+. .++|||||||++|||++|+.||... .+ ......
T Consensus 185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------~~----~~~~~~ 250 (312)
T 2iwi_A 185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------QE----ILEAEL 250 (312)
T ss_dssp SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HH----HHHTCC
T ss_pred chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------HH----Hhhhcc
Confidence 9998765432 33578899999998766654 5899999999999999999998641 11 111110
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 H------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp C------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00112335789999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.26 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=188.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchh------hHHHHHHHHHHHccCC--CCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL------SKKEFVQQMQLLGKLK--HENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 47899999999999985 57899999999643211 2245678999999996 599999999999999999999
Q ss_pred ecCCC-CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 393 EFLPN-GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 393 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||+.+ ++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++. +...+||+|||+
T Consensus 128 e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~----~~ivH~Dlkp~NIll~~--~~~~~kL~Dfg~ 196 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN----CGVLHRDIKDENILIDL--NRGELKLIDFGS 196 (320)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEET--TTTEEEECCCTT
T ss_pred EcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCcEeCCCCHHHEEEeC--CCCCEEEeeCcc
Confidence 99976 89999998754 48999999999999999999994 69999999999999942 446799999999
Q ss_pred CCCCCCCC--CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 472 LPLLPSRK--ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 472 a~~~~~~~--~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
++...... ...++..|+|||++.+..+ +.++|||||||++|||+||+.||... .. ........
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----------~~----~~~~~~~~ 262 (320)
T 3a99_A 197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EE----IIRGQVFF 262 (320)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HH----HHHCCCCC
T ss_pred ccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----------hh----hhcccccc
Confidence 98765432 2357889999999876665 67899999999999999999998642 01 11111000
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 263 ------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 263 ------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112235889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.29 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=173.1
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.++..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 468999999999999864 799999999975432 12234455556788889999999999999999999999999 55
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
.+..+..... ..+++..+..++.|++.||+|||+. +||+||||||+||++ +.+..+||+|||++......
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhh---CCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCC
Confidence 6666554432 2589999999999999999999951 399999999999999 66678999999999766443
Q ss_pred C---CCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 479 K---ASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 479 ~---~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
. ...++..|+|||.+. ...++.++|||||||++|||++|+.||.... ...+.............
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~- 250 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEPPLL- 250 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCCCCC-
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCCCCC-
Confidence 2 235788999999984 5568899999999999999999999997521 11222222222211100
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ........+.+++.+||+.||.+||++.|+++
T Consensus 251 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 P--------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 00112335889999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.42 Aligned_cols=229 Identities=13% Similarity=0.093 Sum_probs=176.4
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccch---hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 368999999999999865 589999999975432 2347789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|.+++... ....++.+|+.|++.||+|||+ +||+||||||+|||+ +.+..+||+++|.
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~----~givH~Dikp~NIll---~~~g~~kl~~~~~------ 175 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR----AGVALSIDHPSRVRV---SIDGDVVLAYPAT------ 175 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCSGGGEEE---ETTSCEEECSCCC------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH----CCCccCCCCcccEEE---cCCCCEEEEeccc------
Confidence 9999999542 3556788999999999999994 699999999999999 4556789986543
Q ss_pred CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
++ .++.++|||||||++|||+||+.||.+........... ............
T Consensus 176 ----------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~-- 227 (286)
T 3uqc_A 176 ----------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQPIEPAD-- 227 (286)
T ss_dssp ----------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSCBCCHHH--
T ss_pred ----------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccCCCChhh--
Confidence 22 36899999999999999999999998653321100000 000000000000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
........+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 228 --~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 228 --IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp --HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred --cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 011233468899999999999999 99999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.14 Aligned_cols=227 Identities=20% Similarity=0.320 Sum_probs=173.7
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCCcccEEEEEec----CCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLL-GKLKHENLAKIVSFYYS----KEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 396 (604)
+.||+|+||.||+|.. .+++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999985 57899999999642 4567888887 55699999999999876 667899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++....+||+|||++....
T Consensus 99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~----~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999998753 2358999999999999999999994 699999999999999655446789999999976543
Q ss_pred CCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 477 SRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 477 ~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
+..++.++|||||||++|||+||+.||.............. ...... .......
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~--~~~~~~~-- 225 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQ--YEFPNPE-- 225 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----SSCTTC--CSSCHHH--
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----HHhhcc--ccCCchh--
Confidence 24568899999999999999999999975432110000000 000000 0000000
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 226 ----~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 226 ----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----cccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112346889999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=341.81 Aligned_cols=233 Identities=19% Similarity=0.237 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEec--CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc-----eEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLE--SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE-----KLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e 393 (604)
.+.||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++...+. .++|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 468999999999999864 6899999998643 33345678999999999999999999999987665 699999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.. .+++.+++.|+.||+.||+|||+ +||+||||||+|||++ .. .+||+|||+++
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~----~giiHrDlkp~NIll~---~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS----IGLVYNDLKPENIMLT---EE-QLKLIDLGAVS 229 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEEC---SS-CEEECCCTTCE
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH----CCCeecccChHHeEEe---CC-cEEEEecccch
Confidence 9999999987653 48999999999999999999994 6999999999999994 33 78999999998
Q ss_pred CCCCCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 474 LLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 474 ~~~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.........++..|+|||++.+. ++.++|||||||++|||++|..||.+..... .... .+
T Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~~~~--~~ 289 (681)
T 2pzi_A 230 RINSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPED--DP 289 (681)
T ss_dssp ETTCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------CCTT--CH
T ss_pred hcccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------cccc--cc
Confidence 88776666789999999998765 4889999999999999999998876421100 0000 00
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHhh
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPK-MSEVLRRIEEI 596 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i 596 (604)
.......+.+++.+||+.||++||+ ++++...|..+
T Consensus 290 -------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 290 -------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0112346889999999999999994 66677767655
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.61 Aligned_cols=237 Identities=16% Similarity=0.160 Sum_probs=173.2
Q ss_pred hcccCcCCcceEEEEE-ecCCcEEEEEEecccch---hhHHHHHHHHHHHccCCC-CCccc-------------------
Q 007427 322 AEVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNA---LSKKEFVQQMQLLGKLKH-ENLAK------------------- 377 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~------------------- 377 (604)
.++||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+.+++.++| +|...
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 4689999999999998 45799999999973322 224779999999999987 32211
Q ss_pred --EEEEEec-----CCceEEEEecCCCCCHHHHhhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 007427 378 --IVSFYYS-----KEEKLIIYEFLPNGSLFDLLHESR--GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL 448 (604)
Q Consensus 378 --l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl 448 (604)
++.++.. ....+++|+++ +++|.+++.... ......+++..++.++.|+++||+|||+ ++|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH----TTEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh----CCcccCCc
Confidence 1111111 22456777776 679999985221 0112347889999999999999999994 79999999
Q ss_pred CCCceEEeecCCcceEEEeeccCCCCCCCCCC-CccccccCCCCCC----------CCCCCCccchhHhHHHHHHHHHhC
Q 007427 449 KSSNILIFRENDIYRAKLTNFGFLPLLPSRKA-SENLAIGRSPEFP----------EGKRLTHKADVYCFGIILLEVITG 517 (604)
Q Consensus 449 kp~NILl~~~~~~~~~kl~DFGla~~~~~~~~-~~~~~~y~aPE~~----------~~~~~s~ksDVwSfGvvl~elltg 517 (604)
||+|||+ +.+..+||+|||+++....... ..+ ..|+|||++ ....++.++|||||||++|||+||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999 6666799999999877654432 345 899999998 666788999999999999999999
Q ss_pred CCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 518 RIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 518 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.||.......... ..+.. ....+..+.+++.+||+.||++||++.|+++
T Consensus 314 ~~Pf~~~~~~~~~~--------~~~~~----------------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 314 DLPNTDDAALGGSE--------WIFRS----------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SCCCCTTGGGSCSG--------GGGSS----------------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcchhhhHH--------HHHhh----------------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99997642211000 00000 0012246889999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.40 Aligned_cols=241 Identities=14% Similarity=0.141 Sum_probs=179.2
Q ss_pred HhhcccCcCCcceEEEEEecCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCC---------CCCcccEEEEE
Q 007427 320 ASAEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--------ALSKKEFVQQMQLLGKLK---------HENLAKIVSFY 382 (604)
Q Consensus 320 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~~~~ 382 (604)
...+.||+|+||+||+|+. +|+.||||+++... ....+.+.+|+.++++++ ||||+++.+++
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 4568999999999999988 68999999997432 223477889999988885 77877777764
Q ss_pred e------------------------------cCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 007427 383 Y------------------------------SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432 (604)
Q Consensus 383 ~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 432 (604)
. ..+..++||||+++|++.+.+... .+++..+..++.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHHHHH
Confidence 3 267899999999999776666432 4899999999999999999
Q ss_pred HHH-hcCCCCCceecCCCCCceEEeecC-----------------CcceEEEeeccCCCCCCCCCCCccccccCCCCCCC
Q 007427 433 FLH-QTLHSHKVPHANLKSSNILIFREN-----------------DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPE 494 (604)
Q Consensus 433 yLH-~~~~~~~ivHrDlkp~NILl~~~~-----------------~~~~~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~ 494 (604)
||| + ++|+||||||+|||++.++ ....+||+|||+|+..... ...++..|+|||++.
T Consensus 176 ~lH~~----~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEAS----LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHH----HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGC
T ss_pred HHHHh----CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhc
Confidence 999 5 5999999999999997654 1248999999999876543 346789999999998
Q ss_pred CCCCCccchhHhHHHH-HHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHH
Q 007427 495 GKRLTHKADVYCFGII-LLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELAL 573 (604)
Q Consensus 495 ~~~~s~ksDVwSfGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 573 (604)
+.. +.++||||+|++ .+++++|..||... ...................... ........++.+|+.
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFKTKCNT-----PAMKQIKRKIQEFHR 317 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCSSCCCS-----HHHHHHHHHHHHHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccCcccch-----hhhhhcCHHHHHHHH
Confidence 766 899999998777 78888899987420 0000011111111111100000 011345668999999
Q ss_pred hcccCCCCCCCCHHHHH
Q 007427 574 ECTDIAPEKRPKMSEVL 590 (604)
Q Consensus 574 ~cl~~dP~~RPs~~evl 590 (604)
+||+.| |+.|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999977 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=274.53 Aligned_cols=181 Identities=13% Similarity=0.085 Sum_probs=126.6
Q ss_pred ccCcCCcceEEEEE-ecCCcEEEEEEeccc----------chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 324 VLGKGKVGSTYKAT-LESGAVVAVKRVKNM----------NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
..+.|+.|.+..++ .-.|+.||+|++... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777777664 446899999999643 122346799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 392 YEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
|||++|++|.++|.... +++.. +|+.||+.||+|+| ++|||||||||+|||+ +.++++||+|||+
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL---~~dg~vKL~DFGl 385 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMV---DARQHARLIDFGS 385 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEE---CTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEE---CCCCCEEEeeccc
Confidence 99999999999998653 46554 58999999999999 4799999999999999 6667899999999
Q ss_pred CCCCCCCCC----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCC
Q 007427 472 LPLLPSRKA----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520 (604)
Q Consensus 472 a~~~~~~~~----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p 520 (604)
|+....... ..+++.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 987765432 247889999999876 467789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=250.12 Aligned_cols=178 Identities=16% Similarity=0.193 Sum_probs=143.0
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch--------hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA--------LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.++||+|+||+||+|+. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 56899999999999954 478899998643211 123558999999999999999966666667788899999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||+ +. .+||+|||+++
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~----~gIiHrDiKp~NILl---~~--~~kL~DFGla~ 477 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK----NDVIHNDLTTSNFIF---DK--DLYIIDFGLGK 477 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH----TTEECTTCCTTSEEE---SS--SEEECCCTTCE
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH----CcCccCCCCHHHEEE---CC--eEEEEECccCE
Confidence 9999999999875 34899999999999994 799999999999999 55 89999999999
Q ss_pred CCCCCC-----------CCccccccCCCCCCCC--CCCCccchhHhHHHHHHHHHhCCCCCC
Q 007427 474 LLPSRK-----------ASENLAIGRSPEFPEG--KRLTHKADVYCFGIILLEVITGRIPGN 522 (604)
Q Consensus 474 ~~~~~~-----------~~~~~~~y~aPE~~~~--~~~s~ksDVwSfGvvl~elltg~~p~~ 522 (604)
...... ...+++.|+|||++.. ..|+.++|+||..+-.++.+.++.+|.
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 886532 2357889999999986 567888999999999999988877763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=215.36 Aligned_cols=156 Identities=28% Similarity=0.555 Sum_probs=139.9
Q ss_pred CCCHhHHHHHHHHHHhcCCCCCCCCCCCC-CCCCCCCCCeeeEEecC----CcEeEEEeCCCCcee--cCChhhhcCCcc
Q 007427 21 DYYPAERYDLLQIRDSLNSTANLHSRWTG-PPCIDNVSNWFGVSCSN----GHIVSLELEEIQLAG--ILPPGFLQNITF 93 (604)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~c~~~~~~w~gv~c~~----~~~~~l~l~~~~l~g--~~p~~~~~~l~~ 93 (604)
.|.++|++||++||+++.+|. .+.+|.. .+||. +.|.||+|.. ++|+.|+|++|+++| .+|+. ++++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~--~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~-l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTT--TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-GGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCc--CCCcceEeCCCCCCceEEEEECCCCCccCCcccChh-HhCCCC
Confidence 589999999999999998776 5678953 22321 2499999974 799999999999999 99998 899999
Q ss_pred CCeeeCcc-CCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEcc
Q 007427 94 LNKLSLRN-NLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVS 169 (604)
Q Consensus 94 L~~l~l~~-n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls 169 (604)
|++|+|++ |+++|.+| .++++++|++|+|++|+++|.+|..+.++++|++|+|++|+++|.+|.. .+++|+.|+++
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 99999995 99999999 5999999999999999999999999999999999999999999999973 68999999999
Q ss_pred CCcccccCCCC
Q 007427 170 YNNLDGPIPQT 180 (604)
Q Consensus 170 ~n~l~g~~p~~ 180 (604)
+|+++|.+|..
T Consensus 158 ~N~l~~~~p~~ 168 (313)
T 1ogq_A 158 GNRISGAIPDS 168 (313)
T ss_dssp SSCCEEECCGG
T ss_pred CCcccCcCCHH
Confidence 99999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.2e-23 Score=204.69 Aligned_cols=140 Identities=16% Similarity=0.197 Sum_probs=110.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch------------------hhHHHHHHHHHHHccCCCCCcccEEEEEe
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA------------------LSKKEFVQQMQLLGKLKHENLAKIVSFYY 383 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 383 (604)
.+.||+|+||.||+|+..+|+.||+|+++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999987799999999964221 13467899999999999 4 55555543
Q ss_pred cCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcce
Q 007427 384 SKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463 (604)
Q Consensus 384 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~ 463 (604)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+ +||+||||||+|||++ +..
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~----~giiHrDlkp~NILl~----~~~ 230 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH----RGIVHGDLSQYNVLVS----EEG 230 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH----TTEECSCCSTTSEEEE----TTE
T ss_pred c-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH----CCCEeCCCCHHHEEEE----CCc
Confidence 3 56799999999999988 421 1234799999999999994 7999999999999994 568
Q ss_pred EEEeeccCCCCCCCCCCCccccccCCCCCCC
Q 007427 464 AKLTNFGFLPLLPSRKASENLAIGRSPEFPE 494 (604)
Q Consensus 464 ~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~ 494 (604)
+||+|||+|+.. ..+.|||++.
T Consensus 231 vkl~DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEET---------TSTTHHHHHH
T ss_pred EEEEECCCCeEC---------CCCCHHHHHH
Confidence 999999998643 3456777754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-22 Score=224.17 Aligned_cols=133 Identities=23% Similarity=0.305 Sum_probs=107.5
Q ss_pred cCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCeeeEEecCCcEeEEEeCCCCceec---CChh----------
Q 007427 20 ADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGI---LPPG---------- 86 (604)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~c~~~~~~w~gv~c~~~~~~~l~l~~~~l~g~---~p~~---------- 86 (604)
....++|++||++||+++.+|. .+.+|... .+||.|.||+|+.++|+.|+|++++++|. +|++
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~---~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSN---KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT---SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCCC---CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 4446789999999999999887 78899632 23468999999989999999999999997 6542
Q ss_pred ------------hhcCCccCCeeeCccCCCcccCCC---CCCCCCccEEeCCCCcccccCCccC-CCCCCCCEEeccCCc
Q 007427 87 ------------FLQNITFLNKLSLRNNLLSGSLPN---LTNLVNLETVFLSQNHFSDGIPFGY-IDLPKLKKLELQENY 150 (604)
Q Consensus 87 ------------~~~~l~~L~~l~l~~n~l~g~~p~---~~~l~~L~~l~l~~N~l~g~iP~~~-~~l~~l~~l~l~~N~ 150 (604)
.++.+++|++|||++|.++|.+|. +++|++|++|||++|+++|.+|..+ .++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 267788999999999999998874 7888888899998888888888765 667777777777777
Q ss_pred ccccCC
Q 007427 151 LDGQIP 156 (604)
Q Consensus 151 l~g~ip 156 (604)
++|.+|
T Consensus 163 l~~~~~ 168 (768)
T 3rgz_A 163 ISGANV 168 (768)
T ss_dssp CEEETH
T ss_pred cCCcCC
Confidence 766555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7e-22 Score=224.64 Aligned_cols=119 Identities=39% Similarity=0.601 Sum_probs=111.7
Q ss_pred CCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEE
Q 007427 90 NITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDF 166 (604)
Q Consensus 90 ~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l 166 (604)
.+++|++|||++|+|+|.|| .++++++|+.|||++|+|+|.||.+++++++|+.|||++|+|+|.||.. .+++|+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 35789999999999999999 5999999999999999999999999999999999999999999999984 68999999
Q ss_pred EccCCcccccCCCCccccCCCCCccCCCCCCcCCCCCCCCCCC
Q 007427 167 NVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLCPIS 209 (604)
Q Consensus 167 ~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~c~~~ 209 (604)
|+|+|+|+|.||...++.+++..+|.||++|||.|+. .|+..
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 9999999999999999999999999999999999875 77643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.4e-22 Score=223.09 Aligned_cols=155 Identities=21% Similarity=0.332 Sum_probs=133.3
Q ss_pred cCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCC----CCCCCCCe------------eeEEec-CCcEeEEEeCCCCceec
Q 007427 20 ADYYPAERYDLLQIRDSLNSTANLHSRWTGPP----CIDNVSNW------------FGVSCS-NGHIVSLELEEIQLAGI 82 (604)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~----c~~~~~~w------------~gv~c~-~~~~~~l~l~~~~l~g~ 82 (604)
+.+...|+.||++||+++.+| +|+.+. +....|.| .||+|+ .++|+.|+|++|+++|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 345568999999999999766 564321 11123789 999997 48999999999999999
Q ss_pred CChhhhcCCccCCeeeC-ccCCCccc------------------------------------------------------
Q 007427 83 LPPGFLQNITFLNKLSL-RNNLLSGS------------------------------------------------------ 107 (604)
Q Consensus 83 ~p~~~~~~l~~L~~l~l-~~n~l~g~------------------------------------------------------ 107 (604)
||++ +++|++|+.||| ++|.++|.
T Consensus 339 ip~~-l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 339 VPDA-IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp ECGG-GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred CchH-HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 9998 899999999999 88877666
Q ss_pred ----------------------CC-CCCCCCCccEEeCCCCcccc-----------------cCCccCC--CCCCCCEEe
Q 007427 108 ----------------------LP-NLTNLVNLETVFLSQNHFSD-----------------GIPFGYI--DLPKLKKLE 145 (604)
Q Consensus 108 ----------------------~p-~~~~l~~L~~l~l~~N~l~g-----------------~iP~~~~--~l~~l~~l~ 145 (604)
|| .+++|++|++|+|++|+|+| .||.+++ +|++|+.|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 67 48899999999999999999 5999998 999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCc-ccc-cCCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNN-LDG-PIPQT 180 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~-l~g-~~p~~ 180 (604)
|++|++.|.+|.. .+++|+.|+|++|+ |+| .+|..
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~ 536 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHH
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHH
Confidence 9999999999973 68999999999998 999 88753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-21 Score=215.66 Aligned_cols=169 Identities=20% Similarity=0.311 Sum_probs=141.0
Q ss_pred CCHhHHHHHHHHHHhcCCCCCCC--------CCCCCCCCCCCCCCe---eeEEecC-CcEeEEEeCCCCceecCChhhhc
Q 007427 22 YYPAERYDLLQIRDSLNSTANLH--------SRWTGPPCIDNVSNW---FGVSCSN-GHIVSLELEEIQLAGILPPGFLQ 89 (604)
Q Consensus 22 ~~~~~~~~l~~~~~~~~~~~~~~--------~~w~~~~c~~~~~~w---~gv~c~~-~~~~~l~l~~~~l~g~~p~~~~~ 89 (604)
....|+.||.+|+++++++++.. .+|+.+ .++|.| .||+|+. ++|+.|+|++|+++|.+|++ ++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~---~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~-l~ 102 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN---KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA-IG 102 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS---SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGG-GG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC---CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChH-Hh
Confidence 44579999999999997664321 268642 334689 9999964 79999999999999999998 89
Q ss_pred CCccCCeeeCccC-------------------------------------------------------------------
Q 007427 90 NITFLNKLSLRNN------------------------------------------------------------------- 102 (604)
Q Consensus 90 ~l~~L~~l~l~~n------------------------------------------------------------------- 102 (604)
+|++|++|||++|
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 9999999999998
Q ss_pred -----------CCcccCC-CCCCCCCccEEeCCCCccccc-----------------CCccCC--CCCCCCEEeccCCcc
Q 007427 103 -----------LLSGSLP-NLTNLVNLETVFLSQNHFSDG-----------------IPFGYI--DLPKLKKLELQENYL 151 (604)
Q Consensus 103 -----------~l~g~~p-~~~~l~~L~~l~l~~N~l~g~-----------------iP~~~~--~l~~l~~l~l~~N~l 151 (604)
+|+| || .++++++|++|+|++|+|+|. ||.+++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 4556 77 599999999999999999997 999999 999999999999999
Q ss_pred cccCCCC--CCCCCcEEEccCCc-ccc-cCCCCcc-------ccCCCCCccCCCC
Q 007427 152 DGQIPPF--NQTSLIDFNVSYNN-LDG-PIPQTRV-------VQSFPSSSFEHNS 195 (604)
Q Consensus 152 ~g~ip~~--~~~~l~~l~ls~n~-l~g-~~p~~~~-------~~~~~~~~~~~n~ 195 (604)
+|.+|.. .+++|+.|++++|+ ++| .+|.... +.++..+.+.+|.
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~ 316 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence 9999973 68999999999998 999 8886421 1445555555553
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=175.41 Aligned_cols=134 Identities=20% Similarity=0.243 Sum_probs=103.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcE--EEEEEecccch------------------------hhHHHHHHHHHHHccCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAV--VAVKRVKNMNA------------------------LSKKEFVQQMQLLGKLKHEN 374 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~n 374 (604)
.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+.++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 36799999999999987 78999 99998753211 11236889999999998876
Q ss_pred c--ccEEEEEecCCceEEEEecCCC-C----CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 007427 375 L--AKIVSFYYSKEEKLIIYEFLPN-G----SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHAN 447 (604)
Q Consensus 375 i--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrD 447 (604)
+ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.|||. +.||+|||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~---~~givHrD 196 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ---EAELVHAD 196 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH---TSCEECSS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH---HCCEEeCC
Confidence 4 444443 367899999942 4 77776543 2234567899999999999993 26999999
Q ss_pred CCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 448 LKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 448 lkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
|||+|||+ +. .++|+|||+|...
T Consensus 197 lkp~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEE---SS--SEEECCCTTCEET
T ss_pred CCHHHEEE---cC--cEEEEECcccccC
Confidence 99999999 54 7999999998654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-20 Score=187.70 Aligned_cols=172 Identities=18% Similarity=0.280 Sum_probs=140.5
Q ss_pred cccCCCHhHHHHHHHHHHhc-CCCCCCCCCCC-CCCCCCCCCCeeeEEec----------CCcEeEEEeCCCCceecCCh
Q 007427 18 QIADYYPAERYDLLQIRDSL-NSTANLHSRWT-GPPCIDNVSNWFGVSCS----------NGHIVSLELEEIQLAGILPP 85 (604)
Q Consensus 18 ~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~w~-~~~c~~~~~~w~gv~c~----------~~~~~~l~l~~~~l~g~~p~ 85 (604)
+......+|+.||++||..+ .++.+...+|. ...|..++|.|.|+.|. ..+|+.|+|++|+++ .||+
T Consensus 20 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp C--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred eccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 34667889999999999988 45555566784 22345567789999994 268999999999998 8999
Q ss_pred hhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCCC-----
Q 007427 86 GFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFN----- 159 (604)
Q Consensus 86 ~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~----- 159 (604)
. ++.+++|++|+|++|+++ .+| .++++++|++|+|++|+++ .||..++++++|+.|+|++|++.|.+|..-
T Consensus 99 ~-l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 99 Q-AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp C-GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred h-hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 8 788999999999999999 777 5999999999999999999 799999999999999999999999999742
Q ss_pred ------CCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 160 ------QTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 160 ------~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
+++|+.|++++|+++ .+|.. ..+.++..+.+.+|
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N 216 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESS
T ss_pred hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCC
Confidence 889999999999998 77754 12233344444444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-18 Score=171.61 Aligned_cols=135 Identities=30% Similarity=0.483 Sum_probs=98.9
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|+++|.+|.. ++.++ |+.|+|++|++++.+| .++++++|+.|+|++|++++.+|. +..+++|++|+|
T Consensus 175 ~L~~L~L~~N~l~~~~~~~-~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 251 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPT-FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251 (313)
T ss_dssp TCCEEECCSSEEEEECCGG-GGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred cCcEEECcCCeeeccCChH-HhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence 3445555555555545444 44444 5555555555555555 366777788888888888776665 777888888888
Q ss_pred cCCcccccCCCC--CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCCcCCCCCCCC
Q 007427 147 QENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLC 206 (604)
Q Consensus 147 ~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~c 206 (604)
++|+++|.+|.. .+++|+.|+|++|+++|.+|....+.++....+.+|+.+||.|.. .|
T Consensus 252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 888888888873 588999999999999999999877888888999999999998764 35
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=5.2e-18 Score=158.68 Aligned_cols=123 Identities=24% Similarity=0.345 Sum_probs=107.6
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|++++..+..+++.+++|++|+|++|+|++.+| .++++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6788888864 2788999999999875554457899999999999999999888 599999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCC
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++++..|..+.++++|++|+|++|++++.+|.. .+++|+.|+|++|.+++..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9999977777999999999999999999988863 588999999999999988764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.7e-17 Score=154.57 Aligned_cols=142 Identities=18% Similarity=0.220 Sum_probs=120.8
Q ss_pred CCeeeEEecCC-----------cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSNG-----------HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~~-----------~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+.. .++.|+|++|++++..|..+++.+++|+.|+|++|++++..| .++++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 67999999642 577999999999987776668899999999999999999888 699999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCCCCCc
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n~~lc 198 (604)
|++++..|..+.++++|++|+|++|++++..|.. .+++|+.|+|++|++++..|... .+.++..+.+.+|+.-|
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 9999976777999999999999999999887763 58999999999999999887642 23445556677776555
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=153.85 Aligned_cols=140 Identities=21% Similarity=0.193 Sum_probs=115.4
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~ 124 (604)
|+|.+|.|+. .+++.|+|++|++++..|.. +..+++|++|+|++|+|++..+. +.++++|++|+|++
T Consensus 19 Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGV-FDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTT-TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHH-hhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 5799999964 36889999999999876766 89999999999999999766554 78999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
|++++-.|..+..+++|+.|+|++|+|+ .||.. .+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.-|
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999855556789999999999999999 88874 6899999999999999765532 223445555667776544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=150.10 Aligned_cols=140 Identities=21% Similarity=0.309 Sum_probs=117.2
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|++++ +|+..+..+++|++|+|++|++++..| .|.++++|++|+|++
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 6899999964 268999999999996 554448999999999999999999888 599999999999999
Q ss_pred CcccccCCcc-CCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 125 NHFSDGIPFG-YIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 125 N~l~g~iP~~-~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
|++++ ||.. +..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..+.. ..+.++....+.+|+.-|
T Consensus 90 N~l~~-l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCc-cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99997 6655 688999999999999999877763 5899999999999999877753 224455556677887655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.2e-16 Score=146.47 Aligned_cols=141 Identities=25% Similarity=0.251 Sum_probs=116.0
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~ 124 (604)
|.|.+|.|+. .+++.|+|++|++++ +|+..++.+++|++|+|++|++++..+. ++++++|++|+|++
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 6899999954 268999999999995 6665588999999999999999977664 78999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
|++++..|..+.++++|+.|+|++|++++..|. ..+++|+.|++++|++++..+.. ..+.++....+.+|+..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 999985555679999999999999999976554 25899999999999999766542 234555666777776554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.8e-16 Score=157.93 Aligned_cols=137 Identities=15% Similarity=0.149 Sum_probs=96.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccch--------------hhH--------HHHHHHHHHHccCCCCCcccEE
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNA--------------LSK--------KEFVQQMQLLGKLKHENLAKIV 379 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~h~niv~l~ 379 (604)
.+.||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 578999999999999988999999998753110 001 1124567777777554442221
Q ss_pred EEEecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC
Q 007427 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459 (604)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 459 (604)
-+.. ...++||||+++++|.++... .....++.|++.+|.|||+ .|||||||||.|||++.++
T Consensus 180 p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~----~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 180 PIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK----HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp EEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH----TTEECSCCSTTSEEEEEEE
T ss_pred eeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH----CCCcCCCCCHHHEEEeCCC
Confidence 1111 234799999999888654321 1235688999999999995 6999999999999997654
Q ss_pred C-------cceEEEeeccCCCCC
Q 007427 460 D-------IYRAKLTNFGFLPLL 475 (604)
Q Consensus 460 ~-------~~~~kl~DFGla~~~ 475 (604)
+ ...+.|+||+-+-..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 2 135899999976443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=139.93 Aligned_cols=122 Identities=28% Similarity=0.365 Sum_probs=103.4
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~ 124 (604)
|.|.++.|+. .+++.|+|++|++++ +|+..++.+++|++|+|++|++++..+. ++++++|++|+|++
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 6899999954 368899999999985 5555578999999999999999987765 78999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCCC
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++++..|..+.++++|+.|+|++|++++..+. + .+++|+.|++++|.+++..|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999985556678999999999999999954443 2 488999999999999988773
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.3e-15 Score=138.18 Aligned_cols=117 Identities=26% Similarity=0.298 Sum_probs=79.7
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|+++ .+|.. +..+++|+.|+|++|++++..| .|.++++|++|+|++
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~-~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKE-LSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGG-GGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHH-hhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 4566677743 25667777777776 66755 6777777777777777777665 377777777777777
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccc
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g 175 (604)
|++++-.|..+..+++|+.|+|++|++++..+. + .+++|+.|++++|.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 777775555677777777777777777743332 2 46677777777777654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.5e-15 Score=145.70 Aligned_cols=126 Identities=22% Similarity=0.204 Sum_probs=101.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++..|.. ++.+++|++|+|++|++++..|. +.++++|++|+|++|++++..|..+.++++|+.|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDAT-FRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTTT-TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHhH-hcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 5789999999999766655 88999999999999999998774 889999999999999999866667889999999999
Q ss_pred cCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 147 QENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
++|++++..|. ..+++|+.|+|++|++++..|.. ..+.++..+.+.+|
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 99999965554 25889999999999998766632 23344555555555
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=9.4e-15 Score=136.42 Aligned_cols=130 Identities=19% Similarity=0.280 Sum_probs=109.1
Q ss_pred EEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC--CCCCCCccEEeCCCCcccccCCccCCCCC
Q 007427 62 VSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSDGIPFGYIDLP 139 (604)
Q Consensus 62 v~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~--~~~l~~L~~l~l~~N~l~g~iP~~~~~l~ 139 (604)
..|.. +.|++++|+++ .||.. +. .+|+.|+|++|++++..|. ++++++|++|+|++|++++.+|..+.+++
T Consensus 6 C~C~~---~~l~~s~~~l~-~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 78 (192)
T 1w8a_A 6 CHCEG---TTVDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78 (192)
T ss_dssp SEEET---TEEECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred CEECC---CEEEcCCCCcC-cCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcc
Confidence 45643 68999999995 89987 43 4999999999999998885 89999999999999999998899999999
Q ss_pred CCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCCCCCc
Q 007427 140 KLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 140 ~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n~~lc 198 (604)
+|+.|+|++|+|++..|. + .+++|+.|+|++|++++.+|... .+.++..+.+.+|+.-|
T Consensus 79 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 999999999999988876 3 58999999999999999988652 23445556667776444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.9e-15 Score=143.15 Aligned_cols=112 Identities=18% Similarity=0.213 Sum_probs=101.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. ++.+++|++|+|++|++++..|. ++++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGA-FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCEEECCCCcCCEECHHH-hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 57999999999999755555 89999999999999999998885 89999999999999999998899999999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|++++..|.. .+++|+.|++++|.+++..+-
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 9999999887863 589999999999999987653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.2e-15 Score=150.47 Aligned_cols=111 Identities=23% Similarity=0.290 Sum_probs=63.4
Q ss_pred CcEeEEEeCCCCceecCChhhhc---------CCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQ---------NITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYI 136 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~---------~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~ 136 (604)
.+++.|+|++|++.|.+|.. ++ .+++|++|+|++|+++ .+| .++++++|++|+|++|++++ +|..++
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~-~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEP-LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSC-SEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG
T ss_pred cCCCEEECCCCCCccccChh-HhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhc
Confidence 35666666666666666654 32 2556666666666665 444 35555566666666666654 555555
Q ss_pred CCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC
Q 007427 137 DLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 137 ~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
++++|+.|+|++|++.|.+|.. .+++|+.|++++|++.|.+|..
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 5666666666666665555542 3555666666665555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.3e-14 Score=139.90 Aligned_cols=131 Identities=24% Similarity=0.258 Sum_probs=107.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. +..+++|++|+|++|++++..|. ++++++|++|+|++|++++-.|..+.++++|+.|+
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGV-FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTT-TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccCHhH-hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 47999999999999755554 89999999999999999987774 78999999999999999985555578999999999
Q ss_pred ccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 146 LQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 146 l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
|++|++++..|. + .+++|+.|+|++|++++..|.. ..+.++....+.+|+.-|
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 999999966553 3 5899999999999999777643 233455556677776544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-14 Score=140.87 Aligned_cols=107 Identities=25% Similarity=0.295 Sum_probs=49.5
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++ ++ . ++.+++|++|+|++|++++..|. ++++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 64 ~L~~L~l~~n~l~~-~~-~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 64 NVRYLALGGNKLHD-IS-A-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TCCEEECTTSCCCC-CG-G-GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCC-ch-h-hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 44555555555543 22 2 44455555555555555544432 344555555555555555433333444555555555
Q ss_pred cCCcccccCCCC--CCCCCcEEEccCCcccccC
Q 007427 147 QENYLDGQIPPF--NQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 147 ~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~ 177 (604)
++|++++..|.. .+++|+.|++++|++++..
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 555554333321 2444555555555444433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=155.14 Aligned_cols=144 Identities=21% Similarity=0.247 Sum_probs=117.6
Q ss_pred CCCCCCCCCeee--EEecC----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCC
Q 007427 50 PPCIDNVSNWFG--VSCSN----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLV 115 (604)
Q Consensus 50 ~~c~~~~~~w~g--v~c~~----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~ 115 (604)
+||.. .|.|.+ |.|+. .+++.|+|++|++++..|.. ++++++|++|+|++|.+++.+| .+++++
T Consensus 2 ~p~~~-~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~ 79 (455)
T 3v47_A 2 DPGTS-ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETS-FSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTT-TSSCTTCCEEECCCCSTTCEECTTTTTTCT
T ss_pred CCccc-eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhH-hccCccccEEECcCCcccceECcccccccc
Confidence 35543 455666 88864 36899999999999877776 8999999999999999998886 499999
Q ss_pred CccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC---C-CCCCCcEEEccCCcccccCCCC--ccccCCCCC
Q 007427 116 NLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP---F-NQTSLIDFNVSYNNLDGPIPQT--RVVQSFPSS 189 (604)
Q Consensus 116 ~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~---~-~~~~l~~l~ls~n~l~g~~p~~--~~~~~~~~~ 189 (604)
+|++|+|++|++++.+|..++++++|++|+|++|+++|.+|. + .+++|+.|++++|++++..|.. ..+.++...
T Consensus 80 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L 159 (455)
T 3v47_A 80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159 (455)
T ss_dssp TCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEE
T ss_pred cCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEE
Confidence 999999999999998899999999999999999999987664 2 5899999999999999988864 234555555
Q ss_pred ccCCCC
Q 007427 190 SFEHNS 195 (604)
Q Consensus 190 ~~~~n~ 195 (604)
.+.+|.
T Consensus 160 ~L~~n~ 165 (455)
T 3v47_A 160 DLTFNK 165 (455)
T ss_dssp ECTTCC
T ss_pred eCCCCc
Confidence 566653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.6e-15 Score=132.38 Aligned_cols=110 Identities=22% Similarity=0.182 Sum_probs=99.4
Q ss_pred CcEeEEEeCCCCce-ecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLA-GILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~-g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ |.+|.. ++.+++|++|+|++|++++. +.++++++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGL-TDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSC-CTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHH-HhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 36999999999999 899986 79999999999999999987 8899999999999999999999998888899999999
Q ss_pred ccCCccccc-CCC--CCCCCCcEEEccCCcccccCC
Q 007427 146 LQENYLDGQ-IPP--FNQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 146 l~~N~l~g~-ip~--~~~~~l~~l~ls~n~l~g~~p 178 (604)
|++|++++. .|. ..+++|+.|++++|.+++..+
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999973 323 358999999999999998755
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.5e-15 Score=135.37 Aligned_cols=110 Identities=24% Similarity=0.223 Sum_probs=98.8
Q ss_pred CcEeEEEeCCCCce-ecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLA-GILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~-g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ |.+|.. +..+++|++|+|++|.+++. +.++.+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSC-CGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHH-HHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 36999999999998 899987 78999999999999999987 8899999999999999999999998888899999999
Q ss_pred ccCCcccccC--CC-CCCCCCcEEEccCCcccccCC
Q 007427 146 LQENYLDGQI--PP-FNQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 146 l~~N~l~g~i--p~-~~~~~l~~l~ls~n~l~g~~p 178 (604)
|++|++++.- +. ..+++|+.|++++|.+++..+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 9999999632 23 368999999999999997765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=167.12 Aligned_cols=132 Identities=22% Similarity=0.219 Sum_probs=104.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccC-----C-CCCCCCCccEEeCCCCcccccCCccCCCCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSL-----P-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~-----p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~ 140 (604)
.+++.|+|++|++++..+...+..+++|+.|+|++|.+++.. | .+.++++|+.|+|++|+|++..|..+.++++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 356777777777776544433455777788888888776432 2 3788999999999999999988888999999
Q ss_pred CCEEeccCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCCcCC
Q 007427 141 LKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGR 200 (604)
Q Consensus 141 l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~lcg~ 200 (604)
|+.|+|++|+|++..|....++|+.|+|++|+|+|.+|.. +.++....+.+|+..|..
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred hheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccc
Confidence 9999999999997655554589999999999999999976 556777788889888843
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=6.7e-14 Score=144.28 Aligned_cols=127 Identities=24% Similarity=0.177 Sum_probs=105.1
Q ss_pred CCCCCCCC-CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhc-CCccCCeeeCccCCCcccCC-CCCCC
Q 007427 49 GPPCIDNV-SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQ-NITFLNKLSLRNNLLSGSLP-NLTNL 114 (604)
Q Consensus 49 ~~~c~~~~-~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~-~l~~L~~l~l~~n~l~g~~p-~~~~l 114 (604)
...|-..| |.|..+.|+. ..++.|+|++|++++..+.. +. ++++|+.|+|++|+|++..| .|.++
T Consensus 9 ~~~Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~-~~~~l~~L~~L~L~~N~i~~i~~~~~~~l 87 (361)
T 2xot_A 9 VVSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEW-TPTRLTNLHSLLLSHNHLNFISSEAFVPV 87 (361)
T ss_dssp CTTCCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTS-SSSCCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCCCCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhh-hhhcccccCEEECCCCcCCccChhhccCC
Confidence 34453333 6788899954 25789999999999754444 65 89999999999999999887 49999
Q ss_pred CCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCccccc
Q 007427 115 VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 115 ~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~ 176 (604)
++|++|+|++|+|++-.|..+.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++-
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l 151 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF 151 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee
Confidence 99999999999999866667899999999999999999776652 589999999999999873
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-14 Score=157.48 Aligned_cols=130 Identities=25% Similarity=0.320 Sum_probs=103.6
Q ss_pred CCCCCCCCCCeeeE-EecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcc
Q 007427 49 GPPCIDNVSNWFGV-SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHF 127 (604)
Q Consensus 49 ~~~c~~~~~~w~gv-~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l 127 (604)
.++|......|.|+ .|..++++.|+|++|++++ ||+. + +++|++|+|++|+|+ .|| +.+++|++|+|++|+|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N~l 112 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP--ELPASLEYLDACDNRL 112 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC--CCCTTCCEEECCSSCC
T ss_pred CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc--cccCCCCEEEccCCCC
Confidence 34554222269999 7887899999999999997 9987 4 388999999999999 677 6788999999999999
Q ss_pred cccCCccCCCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 128 SDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 128 ~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++ ||. +.+ +|+.|+|++|+|++ ||. .+++|+.|+|++|+|++ +|. .+.++..+.+.+|
T Consensus 113 ~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 113 ST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNN 170 (571)
T ss_dssp SC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSS
T ss_pred CC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCC
Confidence 98 888 665 89999999999987 887 78888889999988887 665 2444555555555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-15 Score=162.30 Aligned_cols=126 Identities=18% Similarity=0.221 Sum_probs=110.5
Q ss_pred CcEeEEEeCCCCceec-----------------CChhhhc--CCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCc
Q 007427 67 GHIVSLELEEIQLAGI-----------------LPPGFLQ--NITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNH 126 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~-----------------~p~~~~~--~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~ 126 (604)
.+++.|+|++|+++|. +|++ ++ ++++|++|+|++|+++|.+| .++++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 5899999999999996 9998 78 99999999999999999999 59999999999999999
Q ss_pred -ccc-cCCccCCCC------CCCCEEeccCCcccccCCC----CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 127 -FSD-GIPFGYIDL------PKLKKLELQENYLDGQIPP----FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 127 -l~g-~iP~~~~~l------~~l~~l~l~~N~l~g~ip~----~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++| .+|..++++ ++|+.|+|++|+++ .||. ..+++|+.|++++|+++|.+|....+.++..+.+.+|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 999 999999887 99999999999999 8998 3689999999999999999994333444444555555
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.7e-13 Score=136.72 Aligned_cols=104 Identities=28% Similarity=0.296 Sum_probs=58.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|+++ .+|.. +..+++|++|+|++|++++..| .+.++++|++|+|++|++++-.|..+..+++|+.|+|
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TCCEEECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-cCchh-hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 4555555555555 45554 4555666666666666665544 2555666666666666666533333455666666666
Q ss_pred cCCcccccCCC--C-CCCCCcEEEccCCccc
Q 007427 147 QENYLDGQIPP--F-NQTSLIDFNVSYNNLD 174 (604)
Q Consensus 147 ~~N~l~g~ip~--~-~~~~l~~l~ls~n~l~ 174 (604)
++|+|+ .+|. + .+++|+.|+|++|+|+
T Consensus 156 ~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 666665 3333 1 3556666666666665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.3e-14 Score=152.54 Aligned_cols=124 Identities=15% Similarity=0.047 Sum_probs=75.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCC-CCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~-~l~~l~~l 144 (604)
.+++.|+|++|++++..+. .+++|+.|+|++|.+++.+| .++++++|++|+|++|+++|.+|..+. ++++|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 3556666666666653322 24666777777777776665 466667777777777777766666664 56677777
Q ss_pred eccCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 145 ELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 145 ~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
+|++|+|++..+...+++|+.|+|++|.++|.+|....+.++..+.+.+|
T Consensus 175 ~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N 224 (487)
T 3oja_A 175 NLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN 224 (487)
T ss_dssp ECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS
T ss_pred ecCCCccccccccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC
Confidence 77777776654444566677777777777665554333334444444444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=147.08 Aligned_cols=132 Identities=19% Similarity=0.174 Sum_probs=112.3
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++.+|.. ++.+++|+.|+|++|++++.+| .++++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSV-FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTTT-TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchhh-cccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 47999999999999887776 8999999999999999999888 689999999999999999997788899999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
|++|++++.+|.. .+++|+.|++++|++++..+.. ..+.++....+.+|+.-|.
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 9999999888863 5899999999999999755543 2345556667777765553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=131.20 Aligned_cols=109 Identities=20% Similarity=0.264 Sum_probs=97.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. +..+++|++|+|++|+|++..+. +.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDA-FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp TTCCEEECCSSCCCEECTTT-TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcCHHH-hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 47999999999999877776 89999999999999999976554 78999999999999999998889999999999999
Q ss_pred ccCCcccccCCC-C-CCCCCcEEEccCCccccc
Q 007427 146 LQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 146 l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~ 176 (604)
|++|+|++..|. + .+++|+.|+|++|.+...
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999999976664 3 588999999999998753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=153.25 Aligned_cols=127 Identities=19% Similarity=0.147 Sum_probs=103.3
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.++.|+|++|++++ ||+..+.++++|++|||++|+|++..| .|.+|++|++|+|++|+|++-.|..+.+|++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 68999999999995 555448999999999999999999877 5999999999999999999844456899999999999
Q ss_pred cCCcccccCCC--CCCCCCcEEEccCCcccc-cCCCC-ccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPP--FNQTSLIDFNVSYNNLDG-PIPQT-RVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g-~~p~~-~~~~~~~~~~~~~n~ 195 (604)
++|++++..|. ..+++|+.|+|++|.+++ .+|.. ..+..+..+.+.+|.
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 99999965443 358999999999999986 45543 223444445555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=125.41 Aligned_cols=107 Identities=23% Similarity=0.230 Sum_probs=91.7
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
.+.|++++|+++ .||.. + .++|++|+|++|+|++..| .++++++|++|+|++|+|++-.|..+.++++|+.|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 357888899998 58876 4 4899999999999999988 48999999999999999998444456899999999999
Q ss_pred CCcccccCCC-C-CCCCCcEEEccCCcccccCCC
Q 007427 148 ENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 148 ~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
+|+|++..|. + .+++|+.|+|++|.+++..+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9999976554 3 589999999999999887653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=131.96 Aligned_cols=110 Identities=28% Similarity=0.333 Sum_probs=98.3
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .+|+..+..+++|++|+|++|+|++..+. +..+++|++|+|++|+|+ .||..+.++++|+.|+
T Consensus 64 ~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 64 INLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred cCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 47999999999996 67776678999999999999999987775 789999999999999999 6999999999999999
Q ss_pred ccCCcccccCCC-C-CCCCCcEEEccCCcccccCC
Q 007427 146 LQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 146 l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p 178 (604)
|++|+|++..+. + .+++|+.|++++|.+++..+
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999965444 2 58899999999999998765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.5e-13 Score=128.37 Aligned_cols=112 Identities=27% Similarity=0.275 Sum_probs=97.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .+|+..+..+++|++|+|++|++++..+. ++++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 52 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 47999999999999 46666578999999999999999987765 79999999999999999985555689999999999
Q ss_pred ccCCcccccCCC-C-CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|++++..+. + .+++|+.|++++|.+.+..|.
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 999999965554 2 588999999999999988775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.1e-13 Score=132.45 Aligned_cols=127 Identities=24% Similarity=0.264 Sum_probs=84.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .+|+..+..+++|++|+|++|++++..+. +.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 36778888888777 46665567777888888888887765553 57777777777777777775555667777777777
Q ss_pred ccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 146 LQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 146 l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
|++|++++..+. ..+++|+.|++++|.+++..+.. ..+.++..+.+.+|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 777777743333 24677777777777777654432 12233333444444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=136.80 Aligned_cols=127 Identities=20% Similarity=0.190 Sum_probs=91.7
Q ss_pred CcEeEEEeCCCC-ceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQ-LAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~-l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|+ ++ .+++..+..+++|++|+|++|++++..| .+.++++|++|+|++|++++..+..+.++++|+.|
T Consensus 80 ~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp TTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEEeCCCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 468888888887 54 4544347888888888888888888766 47788888888888888887555567888888888
Q ss_pred eccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCC
Q 007427 145 ELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHN 194 (604)
Q Consensus 145 ~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n 194 (604)
+|++|++++..+. + .+++|+.|++++|.+++..|... .+.++..+.+.+|
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 8888888855443 2 47788888888888888766542 2233334444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=8e-14 Score=151.80 Aligned_cols=107 Identities=27% Similarity=0.343 Sum_probs=97.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.++.|+|++|++++ +|. ++.+++|+.|+|++|+|+ .+| .+++|++|+.|+|++|+|++ || .+++|++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 58899999999996 775 789999999999999999 677 69999999999999999998 88 8999999999999
Q ss_pred cCCcccccC-CC--CCCCCCcEEEccCCcccccCCCC
Q 007427 147 QENYLDGQI-PP--FNQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 147 ~~N~l~g~i-p~--~~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
++|+|++.+ |. ..+++|+.|+|++|.|++.+|..
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999999886 76 36899999999999999988754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=5.1e-14 Score=153.69 Aligned_cols=111 Identities=23% Similarity=0.167 Sum_probs=96.0
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++..|.. ++++++|++|+|++|++++..| .++++++|++|||++|++++..|..++++++|++|+|
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGD-LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TCCEEECCSSCCCEECSST-TSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CccEEECcCCccCccChhh-hhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 7899999999999877776 7899999999999999999887 5899999999999999999966666999999999999
Q ss_pred cCCcccc-cCCC--CCCCCCcEEEccCCcccccCCC
Q 007427 147 QENYLDG-QIPP--FNQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 147 ~~N~l~g-~ip~--~~~~~l~~l~ls~n~l~g~~p~ 179 (604)
++|++++ .+|. ..+++|+.|++++|.+.+.+|.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~ 141 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCH
Confidence 9999986 4554 3588999999999987777764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=126.83 Aligned_cols=130 Identities=22% Similarity=0.282 Sum_probs=106.0
Q ss_pred EEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCC
Q 007427 62 VSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140 (604)
Q Consensus 62 v~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~ 140 (604)
..|.. +.+++++|+++ .||.. + .++|+.|+|++|+++ .+| .+.++++|+.|+|++|++++-.|..+.++++
T Consensus 8 C~C~~---~~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~ 79 (193)
T 2wfh_A 8 CTCLD---TVVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79 (193)
T ss_dssp CEEET---TEEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CEeCC---CEEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCC
Confidence 45643 47899999998 78976 3 368999999999998 555 7999999999999999999977778999999
Q ss_pred CCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 141 LKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 141 l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
|+.|+|++|++++..|. + .+++|+.|+|++|++++..+.. ..+.++....+.+|+..|.
T Consensus 80 L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999999999977664 3 5899999999999999755532 2344555667778876653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-13 Score=137.05 Aligned_cols=128 Identities=19% Similarity=0.234 Sum_probs=93.3
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccc-cCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSD-GIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g-~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|++++..+...+..+++|++|+|++|.+++.+|. ++++++|++|+|++|++++ .+|..+..+++|+.|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 57888888888887644423477888888888888888887774 7788888888888888887 578888888888888
Q ss_pred eccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 145 ELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 145 ~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
+|++|++++..|.. .+++|+.|++++|.+++..+.. ..+.++..+.+.+|
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 233 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC
Confidence 88888888766653 4778888888888887655422 12233444445555
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.1e-13 Score=131.79 Aligned_cols=148 Identities=25% Similarity=0.298 Sum_probs=107.0
Q ss_pred CCCCCCCCCCCCCCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CC
Q 007427 45 SRWTGPPCIDNVSNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LT 112 (604)
Q Consensus 45 ~~w~~~~c~~~~~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~ 112 (604)
..|.+..|.- ...|..+.|+. ..++.|+|++|++++ +|+..++.+++|++|+|++|++++..+. +.
T Consensus 5 C~~~~~~C~c-~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~ 82 (270)
T 2o6q_A 5 CKKDGGVCSC-NNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK 82 (270)
T ss_dssp BGGGTCSBEE-ETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTS
T ss_pred CCCCCCCCEe-CCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhc
Confidence 4566666531 12466777753 257889999999885 5543478899999999999999865554 68
Q ss_pred CCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCC
Q 007427 113 NLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSS 189 (604)
Q Consensus 113 ~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~ 189 (604)
++++|++|+|++|++++..|..+.++++|+.|+|++|++++..|. ..+++|+.|++++|.+++..+.. ..+.++..+
T Consensus 83 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 162 (270)
T 2o6q_A 83 ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKEL 162 (270)
T ss_dssp SCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccccee
Confidence 899999999999999885455678899999999999999876554 25889999999999988655432 223344444
Q ss_pred ccCCC
Q 007427 190 SFEHN 194 (604)
Q Consensus 190 ~~~~n 194 (604)
.+.+|
T Consensus 163 ~L~~n 167 (270)
T 2o6q_A 163 RLYNN 167 (270)
T ss_dssp ECCSS
T ss_pred EecCC
Confidence 44454
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.2e-13 Score=148.85 Aligned_cols=150 Identities=17% Similarity=0.204 Sum_probs=115.1
Q ss_pred CCCCCC-CCCCCCCCCeeeEEecC------------------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCC
Q 007427 44 HSRWTG-PPCIDNVSNWFGVSCSN------------------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLL 104 (604)
Q Consensus 44 ~~~w~~-~~c~~~~~~w~gv~c~~------------------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l 104 (604)
+.+|.. ..|+.....|.++.|.. .++..|++++|.++ .+|+.+++.+++|++|+|++|.+
T Consensus 9 l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp --CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCC
T ss_pred ccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCC
Confidence 456764 46665555687776631 35688999999886 57877788999999999999999
Q ss_pred cccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-
Q 007427 105 SGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT- 180 (604)
Q Consensus 105 ~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~- 180 (604)
++.+| .++++++|++|+|++|.+++..|..++++++|++|+|++|+|++..|. ..+++|+.|+|++|.+++.+|..
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 99887 699999999999999999997777789999999999999999954443 25889999999999999887753
Q ss_pred ccccCCCCCccCCC
Q 007427 181 RVVQSFPSSSFEHN 194 (604)
Q Consensus 181 ~~~~~~~~~~~~~n 194 (604)
..+.++..+.+.+|
T Consensus 168 ~~l~~L~~L~L~~N 181 (597)
T 3oja_B 168 QATTSLQNLQLSSN 181 (597)
T ss_dssp TTCTTCCEEECTTS
T ss_pred hcCCcCcEEECcCC
Confidence 23344444555555
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3.5e-13 Score=133.11 Aligned_cols=132 Identities=24% Similarity=0.243 Sum_probs=111.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++ +|+..++.+++|++|+|++|++++..|. ++++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 479999999999996 4544479999999999999999988775 79999999999999999986666679999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
|++|++++..|.. .+++|+.|++++|++++.+|.. ..+.++....+.+|+..|.
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 9999999766643 5899999999999999977753 3355566677788876654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=123.78 Aligned_cols=104 Identities=30% Similarity=0.452 Sum_probs=90.8
Q ss_pred eEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEEecc
Q 007427 70 VSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQ 147 (604)
Q Consensus 70 ~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l~l~ 147 (604)
+.+++++|+++ .||.. +. ++|++|+|++|+|++.+| .++++++|++|+|++|+|++ ||.. +.++++|+.|+|+
T Consensus 15 ~~l~~~~n~l~-~iP~~-~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAG-IP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCS-SCCSC-CC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCC-ccCCC-cC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECC
Confidence 68899999995 89987 43 899999999999999988 58999999999999999999 6655 6899999999999
Q ss_pred CCcccccCCC-C-CCCCCcEEEccCCcccccCC
Q 007427 148 ENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 148 ~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p 178 (604)
+|+|++..|. + .+++|+.|+|++|.+....+
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9999965554 3 58999999999999986654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.8e-13 Score=149.73 Aligned_cols=135 Identities=19% Similarity=0.176 Sum_probs=113.4
Q ss_pred eeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCc
Q 007427 59 WFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNH 126 (604)
Q Consensus 59 w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~ 126 (604)
+..+.|.. .+++.|+|++|++++..|.. ++++++|++|+|++|++++..| .|+++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTT-FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTT-STTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhH-hccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 45678843 37899999999999766666 8999999999999999999888 59999999999999999
Q ss_pred ccccCCccCCCCCCCCEEeccCCccccc--CCCCCCCCCcEEEccCCcccc-cCCCCccccCCCCCccCCC
Q 007427 127 FSDGIPFGYIDLPKLKKLELQENYLDGQ--IPPFNQTSLIDFNVSYNNLDG-PIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 127 l~g~iP~~~~~l~~l~~l~l~~N~l~g~--ip~~~~~~l~~l~ls~n~l~g-~~p~~~~~~~~~~~~~~~n 194 (604)
+++..|..++++++|++|+|++|++++. .+-..+++|+.|++++|.+++ .+|....+.++....+.+|
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 163 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSS
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccC
Confidence 9998899999999999999999999974 333578999999999999998 5565544555555556555
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.44 E-value=5.4e-13 Score=133.00 Aligned_cols=124 Identities=23% Similarity=0.161 Sum_probs=91.4
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|++++..|.. +..+++|++|+|++|++++..+ .+.+++|++|+|++|+++ .+|..+..+++|+.|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLAT-LMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGG-GTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHH-hhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 6889999999998766665 7889999999999999887544 477888888888888887 488888888888888888
Q ss_pred CCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 148 ENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 148 ~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
+|++++..|. ..+++|+.|+|++|++++..|.. ..+.++..+.+.+|
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 8888855444 24778888888888887654432 12233334444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.1e-13 Score=121.81 Aligned_cols=126 Identities=22% Similarity=0.193 Sum_probs=101.2
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
.+.+++++|+++ .+|.. + .++|+.|+|++|++++..+. ++++++|++|+|++|++++-.|..+.++++|+.|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTT-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCC-C--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 468999999998 68865 3 47999999999999987764 7999999999999999998555567999999999999
Q ss_pred CCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 148 ENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 148 ~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
+|++++..|. ..+++|+.|++++|++++..+.. ..+.++..+.+.+|+..|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 9999976664 25899999999999999655533 224455556667775443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=128.67 Aligned_cols=105 Identities=20% Similarity=0.301 Sum_probs=60.5
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|.++ .++. +..+++|++|+|++|++++..| .++++++|++|+|++|++++.+|..++++++|+.|+|
T Consensus 67 ~L~~L~l~~n~~~--~~~~-l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 67 NIKDLTINNIHAT--NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TCSEEEEESCCCS--CCGG-GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCEEEccCCCCC--cchh-hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 4556666666443 2233 5556666666666666665333 4566666666666666666655666666666666666
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccc
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g 175 (604)
++|++.+.+|.. .+++|+.|++++|.+++
T Consensus 144 ~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 144 SYNGAITDIMPLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred cCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence 666533345543 35566666666666654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-13 Score=155.73 Aligned_cols=109 Identities=26% Similarity=0.333 Sum_probs=93.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++. .||+. +..+++|++|+|++|+|+ .|| .|++|++|++|||++|+|+ .||.++++|++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 45778999999988 78887 668999999999999999 677 5889999999999999999 6899999999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
|++|.|+ .||.. .+++|+.|+|++|.|+|.+|..
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~ 335 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKI 335 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHH
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHH
Confidence 9999987 78863 5888999999999999888754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.43 E-value=5e-14 Score=159.91 Aligned_cols=126 Identities=16% Similarity=0.173 Sum_probs=106.8
Q ss_pred CcEeEEEeCCCCcee-----------------cCChhhhc--CCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCc
Q 007427 67 GHIVSLELEEIQLAG-----------------ILPPGFLQ--NITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNH 126 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g-----------------~~p~~~~~--~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~ 126 (604)
.+++.|+|++|+|+| .||++ ++ ++++|++|+|++|++.|.+| .+++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 589999999999999 49998 67 99999999999999999999 59999999999999998
Q ss_pred -ccc-cCCccCCCCC-------CCCEEeccCCcccccCCC----CCCCCCcEEEccCCcccccCCCCccccCCCCCccCC
Q 007427 127 -FSD-GIPFGYIDLP-------KLKKLELQENYLDGQIPP----FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEH 193 (604)
Q Consensus 127 -l~g-~iP~~~~~l~-------~l~~l~l~~N~l~g~ip~----~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~ 193 (604)
|+| .||..+++++ +|+.|+|++|+|+ .||. ..+++|+.|+|++|+++ .+|....+.++..+.+.+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 999 9998777665 9999999999999 8998 36899999999999999 888443344444455555
Q ss_pred CC
Q 007427 194 NS 195 (604)
Q Consensus 194 n~ 195 (604)
|.
T Consensus 605 N~ 606 (876)
T 4ecn_A 605 NQ 606 (876)
T ss_dssp SC
T ss_pred Cc
Confidence 53
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=5e-13 Score=141.66 Aligned_cols=116 Identities=27% Similarity=0.322 Sum_probs=80.9
Q ss_pred CChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CC
Q 007427 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQ 160 (604)
Q Consensus 83 ~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~ 160 (604)
+|+..+.++++|++|+|++|+++ .+|.+..+++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|.. .+
T Consensus 176 i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 176 ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp ECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred eCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 33333556666666777777666 4566777777888888888888766777888888888888888888666652 57
Q ss_pred CCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 161 TSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 161 ~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
++|+.|+|++|++++..+.. ..+.++..+.+.+|+..|.
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 88888888888888655543 2234455566778877664
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=3.2e-13 Score=149.28 Aligned_cols=112 Identities=18% Similarity=0.133 Sum_probs=63.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCccccc-CCccCCCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDG-IPFGYIDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~-iP~~~~~l~~l~~l~ 145 (604)
+++.|+|++|++++..|...++.+++|+.|+|++|++++.+| .++++++|++|+|++|++++. +|..+.++++|+.|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 456666666666655552235556666666666666666555 355555666666666665552 455555555666666
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|++++.+|.. .+++|+.|++++|++++.+|.
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 515 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH
Confidence 6666555555541 355555555555555555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.42 E-value=1e-13 Score=155.71 Aligned_cols=170 Identities=18% Similarity=0.206 Sum_probs=100.6
Q ss_pred cCCCHhHHHHHHHHHHhcCCC-CCCCCCCCCCCCCCCCCCeeeEEecCCcEeEEEeCCCCce------------------
Q 007427 20 ADYYPAERYDLLQIRDSLNST-ANLHSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLA------------------ 80 (604)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~-~~~~~~w~~~~c~~~~~~w~gv~c~~~~~~~l~l~~~~l~------------------ 80 (604)
......++++|+++....... ......|...+ .....|.+++++.++++.|+|.+|++.
T Consensus 127 ~s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~ 204 (727)
T 4b8c_D 127 KSLVDCTKQALMEMADTLTDSKTAKKQQPTGDS--TPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSID 204 (727)
T ss_dssp -----CCCHHHHHHHHHHHHHHTTC-------------------------------------------------------
T ss_pred hhccccchhhhhhhhhhcccccCcccCCCcCCC--CccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCccccc
Confidence 345667889999998876321 11223464321 123468888877666666666544432
Q ss_pred e--------cCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcc
Q 007427 81 G--------ILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYL 151 (604)
Q Consensus 81 g--------~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l 151 (604)
+ .+|+..+..++.|+.|+|++|.++ .|| .+.++++|++|+|++|+|+ .||..+++|++|+.|+|++|+|
T Consensus 205 ~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 205 EDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred CccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 2 133444788999999999999999 565 6889999999999999999 7999999999999999999999
Q ss_pred cccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCC
Q 007427 152 DGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNS 195 (604)
Q Consensus 152 ~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~ 195 (604)
+ .||.. .+.+|+.|+|++|.|+ .||.. ..+.++..+.+.+|.
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 9 88874 6899999999999996 77764 234455556666664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=7.8e-13 Score=130.83 Aligned_cols=126 Identities=18% Similarity=0.149 Sum_probs=101.4
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++..+.. ++++++|++|+|++|++++..+ .++++++|++|+|++|++++..|..+.++++|+.|+|
T Consensus 29 ~l~~L~ls~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYS-FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTT-TTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhH-hccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 5899999999999655445 8889999999999999998777 5899999999999999999977788999999999999
Q ss_pred cCCcccccCCC--CCCCCCcEEEccCCcccc-cCCCC-ccccCCCCCccCCC
Q 007427 147 QENYLDGQIPP--FNQTSLIDFNVSYNNLDG-PIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g-~~p~~-~~~~~~~~~~~~~n 194 (604)
++|++++..+. ..+++|+.|++++|.+++ .+|.. ..+.++..+.+.+|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence 99999976553 358899999999999987 45643 12233334444444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=4.4e-13 Score=137.34 Aligned_cols=107 Identities=22% Similarity=0.210 Sum_probs=90.3
Q ss_pred CCeeeEEecCCcEeEEEeCCC-CceecCChhhhcCCccCCeeeCcc-CCCcccCC-CCCCCCCccEEeCCCCcccccCCc
Q 007427 57 SNWFGVSCSNGHIVSLELEEI-QLAGILPPGFLQNITFLNKLSLRN-NLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPF 133 (604)
Q Consensus 57 ~~w~gv~c~~~~~~~l~l~~~-~l~g~~p~~~~~~l~~L~~l~l~~-n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~ 133 (604)
|.|..|.|+ ++ +|+ .||. ++.+++|+.|+|++ |+|++.+| .|++|++|+.|+|++|+|+|..|.
T Consensus 8 C~~~~v~~~----------~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC----------SSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC----------CCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 567766664 44 676 4887 78999999999996 99999887 599999999999999999998888
Q ss_pred cCCCCCCCCEEeccCCcccccCCC-CCCCCCcEEEccCCccccc
Q 007427 134 GYIDLPKLKKLELQENYLDGQIPP-FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 134 ~~~~l~~l~~l~l~~N~l~g~ip~-~~~~~l~~l~ls~n~l~g~ 176 (604)
.+.+|++|+.|+|++|+|++..|. +....|+.|+|++|.|...
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 899999999999999999964443 3444599999999998754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.2e-13 Score=140.35 Aligned_cols=129 Identities=23% Similarity=0.236 Sum_probs=106.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. +.++++|++|+|++|+|++..+ .|.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEA-FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp TTCCEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcCCccChhh-ccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 47999999999999655554 8999999999999999998877 489999999999999999997789999999999999
Q ss_pred ccCCcccccCCCC------CCCCCcEEEccCCcccccCCCCccccCC-----CCCccCCCCCCcC
Q 007427 146 LQENYLDGQIPPF------NQTSLIDFNVSYNNLDGPIPQTRVVQSF-----PSSSFEHNSGLCG 199 (604)
Q Consensus 146 l~~N~l~g~ip~~------~~~~l~~l~ls~n~l~g~~p~~~~~~~~-----~~~~~~~n~~lcg 199 (604)
|++|+|++ +|.. .+++|+.|+|++|+|++..+.. +..+ ..+.+.+|+..|.
T Consensus 143 L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~--~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 143 LSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD--LQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHH--HHHSCHHHHTTEECCSSCEECC
T ss_pred CCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHH--hhhccHhhcceEEecCCCccCC
Confidence 99999995 6642 4889999999999998643321 2222 2356778877664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=8.9e-13 Score=130.42 Aligned_cols=108 Identities=20% Similarity=0.333 Sum_probs=59.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++..+.. ++.+++|++|+|++|++++..| .++++++|++|+|++|++++..+..++++++|+.|+|
T Consensus 53 ~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 53 ELQVLDLSRCEIQTIEDGA-YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TCSEEECTTCCCCEECTTT-TTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCcEEECCCCcCCccCHHH-ccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 4666666666665433323 5556666666666666665554 3555666666666666665544445555566666666
Q ss_pred cCCcccc-cCCCC--CCCCCcEEEccCCccccc
Q 007427 147 QENYLDG-QIPPF--NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 147 ~~N~l~g-~ip~~--~~~~l~~l~ls~n~l~g~ 176 (604)
++|++++ .+|.. .+++|+.|++++|++++.
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 6665554 24431 345555555555555544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.40 E-value=7.8e-13 Score=140.65 Aligned_cols=132 Identities=25% Similarity=0.300 Sum_probs=94.7
Q ss_pred cEeEEEeCCCCcee------------------------cCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCC
Q 007427 68 HIVSLELEEIQLAG------------------------ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLS 123 (604)
Q Consensus 68 ~~~~l~l~~~~l~g------------------------~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~ 123 (604)
+++.|+|++|++++ .+|+..+..+++|++|+|++|++++ +|.+..+++|+.|+|+
T Consensus 148 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls 226 (452)
T 3zyi_A 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMS 226 (452)
T ss_dssp TCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECT
T ss_pred CCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cccccccccccEEECc
Confidence 56777777776663 2333335566777777777777775 4677788888888888
Q ss_pred CCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcCC
Q 007427 124 QNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCGR 200 (604)
Q Consensus 124 ~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg~ 200 (604)
+|++++..|..+.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.-|..
T Consensus 227 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 88888877888888888888888888888776652 5788899999999888655543 22344555677788766643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=126.00 Aligned_cols=124 Identities=16% Similarity=0.226 Sum_probs=104.4
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|+++ .+| . +..+++|++|+|++|.++. ++.++++++|++|+|++|++++..|..++.+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-G-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-T-GGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-H-HhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 36999999999998 788 4 8899999999999997654 457999999999999999999999999999999999999
Q ss_pred cCCcccccCCC--CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|++++.+|. ..+++|+.|++++|.+-+.+|....+.++..+.+.+|
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD 169 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTB
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCC
Confidence 99999987776 4689999999999996666764434444444555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=6.1e-13 Score=121.41 Aligned_cols=99 Identities=23% Similarity=0.236 Sum_probs=86.7
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|++++..|.. ++.+++|++|+|++|+|++..|. +.++++|++|+|++
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGV-FDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTT-TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhh-hcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 6788898854 36889999999999766665 89999999999999999987775 68999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCC
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIP 156 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip 156 (604)
|+|++-.|..+.++++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99998555568999999999999999997655
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.9e-12 Score=128.68 Aligned_cols=126 Identities=21% Similarity=0.180 Sum_probs=89.0
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCc-ccccCCccCCCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNH-FSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~-l~g~iP~~~~~l~~l~~l~ 145 (604)
+++.|+|++|++++..+.. ++.+++|++|+|++|++++..| .++++++|++|+|++|+ +++..|..+.++++|+.|+
T Consensus 33 ~l~~L~l~~n~i~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAAS-FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TCSEEECTTSCCCEECTTT-TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CceEEEeeCCcCCccCHHH-cccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 6778888888887644443 7778888888888888887766 57788888888888887 6654467778888888888
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
|++|++++..|.. .+++|+.|++++|.+++..+.. ..+.++..+.+.+|
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 8888888665642 4778888888888887655432 22333444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-12 Score=144.05 Aligned_cols=127 Identities=17% Similarity=0.139 Sum_probs=104.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. ++++++|++|+|++|++++..| .|+++++|++|+|++|++++..|..++++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYS-FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTT-TTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhh-ccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 47899999999999766655 8899999999999999999888 589999999999999999997799999999999999
Q ss_pred ccCCcccccCCC--CCCCCCcEEEccCCcccc-cCCCC-ccccCCCCCccCCC
Q 007427 146 LQENYLDGQIPP--FNQTSLIDFNVSYNNLDG-PIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 146 l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g-~~p~~-~~~~~~~~~~~~~n 194 (604)
|++|++++..|. ..+.+|+.|++++|.+++ .+|.. ..+.++..+.+.+|
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 999999865544 368899999999999986 66763 22334444455555
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-13 Score=136.96 Aligned_cols=124 Identities=15% Similarity=0.197 Sum_probs=92.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCccc--C-CC--CCCCCCccEEeCCCCcccccCCc---c-CCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS--L-PN--LTNLVNLETVFLSQNHFSDGIPF---G-YID 137 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~--~-p~--~~~l~~L~~l~l~~N~l~g~iP~---~-~~~ 137 (604)
.+++.|+|++|++++..|.. ++.+++|++|||++|++.|. + +. ++++++|++|+|++|+++. +|. . +++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQ-VRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTS-CCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHH-hccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 47999999999998655555 88999999999999998873 2 22 4678888888888888873 333 2 467
Q ss_pred CCCCCEEeccCCcccccCCCC--CC---CCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 138 LPKLKKLELQENYLDGQIPPF--NQ---TSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 138 l~~l~~l~l~~N~l~g~ip~~--~~---~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
+++|+.|+|++|++++.+|.. .+ ++|+.|+|++|+++ .+|... ..++..+.+.+|
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N 282 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL-PAKLRVLDLSSN 282 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC-CSCCSCEECCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh-cCCCCEEECCCC
Confidence 788888888888888877752 23 68888888888888 666653 244555555555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.38 E-value=7e-13 Score=128.20 Aligned_cols=126 Identities=16% Similarity=0.165 Sum_probs=99.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCC-CcccCC-CCCCCCCccEEeCCC-CcccccCCccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL-LSGSLP-NLTNLVNLETVFLSQ-NHFSDGIPFGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~-l~g~~p-~~~~l~~L~~l~l~~-N~l~g~iP~~~~~l~~l~~ 143 (604)
.+++.|+|++|++++ +|+..++.+++|++|+|++|+ +++..+ .+.++++|++|+|++ |++++-.|..+.++++|+.
T Consensus 31 ~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 479999999999996 555448899999999999997 877666 589999999999998 9999855567889999999
Q ss_pred EeccCCcccccCCCC-CCCCCc---EEEccCC-cccccCCCC-ccccCCC-CCccCCC
Q 007427 144 LELQENYLDGQIPPF-NQTSLI---DFNVSYN-NLDGPIPQT-RVVQSFP-SSSFEHN 194 (604)
Q Consensus 144 l~l~~N~l~g~ip~~-~~~~l~---~l~ls~n-~l~g~~p~~-~~~~~~~-~~~~~~n 194 (604)
|+|++|++++ +|.+ .+.+|+ .|++++| ++++-.+.. ..+.++. ...+.+|
T Consensus 110 L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 110 LGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred EeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 9999999997 8874 467777 9999999 887765542 1223333 4444444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=143.75 Aligned_cols=110 Identities=17% Similarity=0.190 Sum_probs=59.1
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|.+++ +|+. ++.+++|+.|+|++|.+++.+| .+.++++|++|+|++|++++.+|..+.++++|+.|
T Consensus 373 ~~L~~L~l~~n~l~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEEE-EEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCcccc-cccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 356666666666654 3333 4555555555555555555544 34555555555555555555555555555555555
Q ss_pred eccCCccc-ccCCCC--CCCCCcEEEccCCcccccCC
Q 007427 145 ELQENYLD-GQIPPF--NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 145 ~l~~N~l~-g~ip~~--~~~~l~~l~ls~n~l~g~~p 178 (604)
+|++|+++ |.+|.. .+++|+.|++++|++++.+|
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 487 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCCh
Confidence 55555554 345532 34555555555555555444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.5e-13 Score=153.01 Aligned_cols=120 Identities=19% Similarity=0.123 Sum_probs=84.2
Q ss_pred CeeeEEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCccC
Q 007427 58 NWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPFGY 135 (604)
Q Consensus 58 ~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~~~ 135 (604)
+|..|-+...+++.|+|++|++++..|.. ++++++|++|||++|.+.+.|+ .|++|++|++|+|++|++++..|..+
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~-~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASS-FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSS-CSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhH-CcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 34444442356777888888777665655 6777777777777777777664 47777777777777777777667777
Q ss_pred CCCCCCCEEeccCCcccccCCC---C-CCCCCcEEEccCCcccccCC
Q 007427 136 IDLPKLKKLELQENYLDGQIPP---F-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 136 ~~l~~l~~l~l~~N~l~g~ip~---~-~~~~l~~l~ls~n~l~g~~p 178 (604)
+++++|+.|+|++|++++.+|. + .+++|+.|+|++|.+++..|
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~ 140 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc
Confidence 7777777777777777776654 2 46777777777777776554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.3e-13 Score=144.68 Aligned_cols=136 Identities=22% Similarity=0.166 Sum_probs=87.4
Q ss_pred eeeEEecC-CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCC-CCCCccEEeCCCCcccccCCccC
Q 007427 59 WFGVSCSN-GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLT-NLVNLETVFLSQNHFSDGIPFGY 135 (604)
Q Consensus 59 w~gv~c~~-~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~-~l~~L~~l~l~~N~l~g~iP~~~ 135 (604)
+.++.|.. .+++.|+|++|+++|..|.. ++.+++|+.|+|++|.|+|.+| .+. ++++|+.|+|++|+|++. |. +
T Consensus 111 l~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~ 187 (487)
T 3oja_A 111 ISRVSCSRGQGKKNIYLANNKITMLRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (487)
T ss_dssp CCCEEECCCSSCEEEECCSSCCCSGGGBC-GGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred CCCCCccccCCCCEEECCCCCCCCCCchh-hcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-c
Confidence 34444432 46777777777777665655 6677777777777777777666 343 677777777777777773 32 3
Q ss_pred CCCCCCCEEeccCCcccccCCCC-CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 136 IDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 136 ~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
..+++|+.|+|++|+|+|..|.+ .+++|+.|+|++|.|++ +|.. ..+.++..+.+.+|+..|
T Consensus 188 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred ccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 45777777777777777655543 46777777777777776 3432 223344445556665444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-12 Score=134.74 Aligned_cols=126 Identities=18% Similarity=0.275 Sum_probs=105.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|++++|.++ .+|+.++..+++|++|+|++|++++..| .++++++|++|+|++|++++..|..++++++|+.|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 36789999999987 6888878899999999999999999877 699999999999999999997778899999999999
Q ss_pred ccCCcccccCCC---CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 146 LQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 146 l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
|++|+++ .+|. ..+++|+.|++++|.+++..|.. ..+.++..+.+.+|
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence 9999999 5665 25899999999999999877653 22344444455555
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-13 Score=137.09 Aligned_cols=107 Identities=23% Similarity=0.252 Sum_probs=67.4
Q ss_pred cEeEEEeCCCCceecCChhhh-cCCccCCeeeCccCCCcccCCCCCCC-----CCccEEeCCCCcccccCCccCCCCCCC
Q 007427 68 HIVSLELEEIQLAGILPPGFL-QNITFLNKLSLRNNLLSGSLPNLTNL-----VNLETVFLSQNHFSDGIPFGYIDLPKL 141 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~-~~l~~L~~l~l~~n~l~g~~p~~~~l-----~~L~~l~l~~N~l~g~iP~~~~~l~~l 141 (604)
+++.|+|++|+++|.+|..++ +.+++|++|+|++|++++..+.++++ ++|++|+|++|++++..|..++++++|
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 175 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence 566777777777766666522 66677777777777777662234444 666777777777766555666666777
Q ss_pred CEEeccCCcccccCC---C---CCCCCCcEEEccCCccc
Q 007427 142 KKLELQENYLDGQIP---P---FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 142 ~~l~l~~N~l~g~ip---~---~~~~~l~~l~ls~n~l~ 174 (604)
+.|+|++|+++|.++ . ..+++|+.|++++|+++
T Consensus 176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 777777776665522 1 24566666666666665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=139.20 Aligned_cols=122 Identities=22% Similarity=0.225 Sum_probs=105.0
Q ss_pred CeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCC
Q 007427 58 NWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQN 125 (604)
Q Consensus 58 ~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N 125 (604)
.|..|.|.. .+++.|+|++|++++..|.. +.++++|++|+|++|++++..| .|+++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDE-FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTT-TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhH-ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 477899953 36889999999999766665 8999999999999999999888 5999999999999999
Q ss_pred cccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC
Q 007427 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 126 ~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
++++-.+..+.++++|+.|+|++|++++.+|.. .+++|+.|++++|.+++..|..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 147 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTS
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhh
Confidence 999833345789999999999999999887763 5899999999999998877643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=130.71 Aligned_cols=127 Identities=17% Similarity=0.196 Sum_probs=107.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|+++ .+|.. +..+++|++|+|++|++++..+ .+.++++|++|+|++|++++.+|..+.++++|+.|
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp SCCCEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred cccCEEECCCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 57999999999998 57877 7889999999999999998765 58999999999999999999899999999999999
Q ss_pred eccCCcccc-cCCCC--CCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCCC
Q 007427 145 ELQENYLDG-QIPPF--NQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHNS 195 (604)
Q Consensus 145 ~l~~N~l~g-~ip~~--~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n~ 195 (604)
+|++|++++ .+|.. .+++|+.|++++|++++..|... .+.++..+.+.+|.
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 210 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence 999999998 56763 58999999999999999877542 23344445555553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=143.89 Aligned_cols=132 Identities=20% Similarity=0.185 Sum_probs=110.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcc-cCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG-SLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g-~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
..+..++++.|.+++..|.. +..+++|+.|+|++|++.+ .+| .+..+++|++|||++|++++.+|..+.++++|+.|
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~-~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp TTCCEEECTTSCCEECCTTT-TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccccccccccccccccccc-cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 36778899999998877765 7889999999999998554 466 48999999999999999999889999999999999
Q ss_pred eccCCcccccCCC--CCCCCCcEEEccCCcccccCCCCcc-c-cCCCCCccCCCCCCcC
Q 007427 145 ELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRV-V-QSFPSSSFEHNSGLCG 199 (604)
Q Consensus 145 ~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~~~-~-~~~~~~~~~~n~~lcg 199 (604)
+|++|+|++..|. ..+++|+.|+|++|+|++.+|.... + .++....+.+|+.-|.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999987665 3589999999999999999887532 1 3455567788887774
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.36 E-value=3.9e-12 Score=135.23 Aligned_cols=122 Identities=20% Similarity=0.179 Sum_probs=103.0
Q ss_pred CeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCC
Q 007427 58 NWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQN 125 (604)
Q Consensus 58 ~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N 125 (604)
.|..|.|.. .+++.|+|++|++++..|.. ++++++|++|+|++|++++..| .+.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADT-FRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHH-cCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 467899954 36899999999999866766 8999999999999999999887 5999999999999999
Q ss_pred cccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC
Q 007427 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 126 ~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
++++-.|..+.++++|+.|+|++|++++..+. ..+++|+.|++++|+.-+.+|..
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~ 190 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh
Confidence 99985555689999999999999999954332 25889999999987766777653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-13 Score=137.05 Aligned_cols=106 Identities=24% Similarity=0.249 Sum_probs=65.7
Q ss_pred EeEEEeCCCCc-eecCChhhhc-------CCccCCeeeCccCCCcccCCC-C--CCCCCccEEeCCCCcccccCCccCCC
Q 007427 69 IVSLELEEIQL-AGILPPGFLQ-------NITFLNKLSLRNNLLSGSLPN-L--TNLVNLETVFLSQNHFSDGIPFGYID 137 (604)
Q Consensus 69 ~~~l~l~~~~l-~g~~p~~~~~-------~l~~L~~l~l~~n~l~g~~p~-~--~~l~~L~~l~l~~N~l~g~iP~~~~~ 137 (604)
++.|+|++|++ .+.+|.. +. ++++|++|+|++|+++|.+|. + +++++|++|+|++|++++. |..+++
T Consensus 65 L~~L~L~~n~l~~~~~~~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSR-ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHCCCCEEEEEEEECBHH-HHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HhhcccccccccCCCcCHH-HHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 56666666666 4555654 33 566666666666666666663 2 6666666666666666664 655555
Q ss_pred C-----CCCCEEeccCCcccccCCCC--CCCCCcEEEccCCccccc
Q 007427 138 L-----PKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 138 l-----~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~ 176 (604)
+ ++|++|+|++|++++..|.. .+++|+.|++++|++.|.
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc
Confidence 5 66666666666666555432 466666666666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=140.40 Aligned_cols=126 Identities=18% Similarity=0.176 Sum_probs=95.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCccc--CC-CCCCCCCccEEeCCCCcccccCCcc-CCCCCCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS--LP-NLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLK 142 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~--~p-~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~ 142 (604)
.+++.|+|++|++++.+|.. ++.+++|++|+|++|++++. +| .++++++|++|+|++|++++.+|.. +..+++|+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQG-CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTT-CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccchhhh-hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 47889999999999888876 78889999999999999873 34 4788889999999999998878865 67788888
Q ss_pred EEeccCCcccccCCCCCCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCC
Q 007427 143 KLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHN 194 (604)
Q Consensus 143 ~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n 194 (604)
.|+|++|+++|.+|..-.++|+.|++++|+++ .||... .+.++....+.+|
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N 483 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence 88888888888777653367888888888887 565532 2233333444444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.34 E-value=8.5e-13 Score=121.20 Aligned_cols=106 Identities=18% Similarity=0.264 Sum_probs=89.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccC-CCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGY-IDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~-~~l~~l~~l~l 146 (604)
+++.|+|++|+++ .+|. +....++|++|+|++|++++. +.++++++|++|+|++|++++ +|+.+ ..+++|+.|+|
T Consensus 20 ~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELIL 95 (176)
T ss_dssp SCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEEC
T ss_pred CceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEEC
Confidence 6999999999998 5664 234444999999999999986 889999999999999999997 66555 89999999999
Q ss_pred cCCcccccCCC---C-CCCCCcEEEccCCcccccCCC
Q 007427 147 QENYLDGQIPP---F-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 147 ~~N~l~g~ip~---~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
++|+++ .+|. . .+++|+.|++++|.++. +|.
T Consensus 96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~ 130 (176)
T 1a9n_A 96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKH 130 (176)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STT
T ss_pred CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHh
Confidence 999995 5675 2 58899999999999974 443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=141.07 Aligned_cols=99 Identities=24% Similarity=0.300 Sum_probs=91.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccC-CccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGI-PFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~i-P~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .||.. ++.|++|+.|+|++|+|++ +|.+++|++|+.|+|++|+|++.+ |..+++|++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 57999999999999 89997 8999999999999999998 789999999999999999999976 99999999999999
Q ss_pred ccCCcccccCCCC-----CCCCCcEEEc
Q 007427 146 LQENYLDGQIPPF-----NQTSLIDFNV 168 (604)
Q Consensus 146 l~~N~l~g~ip~~-----~~~~l~~l~l 168 (604)
|++|+|+|.+|.. .+++|+.||+
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999887753 3788998875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-12 Score=139.80 Aligned_cols=126 Identities=19% Similarity=0.203 Sum_probs=101.4
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcc--cCC-CCCCCCCccEEeCCCCcccccCCcc-CCCCCCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG--SLP-NLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLK 142 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g--~~p-~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~ 142 (604)
.+++.|+|++|++++.+|.. ++.+++|++|+|++|++++ .+| .++++++|++|+|++|++++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFEN-CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTT-CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhhh-hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 47889999999999888887 7889999999999999997 566 4888999999999999999888875 77888999
Q ss_pred EEeccCCcccccCCCCCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 143 KLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 143 ~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
.|+|++|+++|.+|..-.++|+.|++++|+++ .+|.. ..+.++......+|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N 454 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence 99999999988888654478888899888888 66653 22334444455555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=143.67 Aligned_cols=114 Identities=22% Similarity=0.180 Sum_probs=86.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccc---cCCccCCCCCCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSD---GIPFGYIDLPKLK 142 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g---~iP~~~~~l~~l~ 142 (604)
.+++.|+|++|++++..|+..+..+++|+.|+|++|.+++.+|. ++++++|+.|+|++|++++ ..+..+..+++|+
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 46788888888888777666577788888888888888887774 7778888888888888876 2335577788888
Q ss_pred EEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC
Q 007427 143 KLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 143 ~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
.|+|++|++++.+|.. .+++|+.|++++|++++.+|..
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 8888888888776652 5777888888888888776643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=140.97 Aligned_cols=124 Identities=21% Similarity=0.240 Sum_probs=100.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccc--cCCccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSD--GIPFGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g--~iP~~~~~l~~l~~ 143 (604)
.+++.|++++|++.+ ++ +...+++|++|+|++|++++.+| .++++++|++|+|++|++++ .+|..+.++++|+.
T Consensus 302 ~~L~~L~l~~n~l~~-~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~ 378 (520)
T 2z7x_B 302 MNIKNFTVSGTRMVH-ML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378 (520)
T ss_dssp CCCSEEEEESSCCCC-CC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCE
T ss_pred CceeEEEcCCCcccc-cc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCE
Confidence 358999999999864 32 13678999999999999999777 58999999999999999997 77888999999999
Q ss_pred EeccCCcccccCCCC---CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 144 LELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 144 l~l~~N~l~g~ip~~---~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
|+|++|++++.+|.. .+++|+.|++++|.++|.+|.... .++....+.+|
T Consensus 379 L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N 431 (520)
T 2z7x_B 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSN 431 (520)
T ss_dssp EECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSS
T ss_pred EECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCC
Confidence 999999999888853 478999999999999988876522 34444555555
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.9e-12 Score=139.35 Aligned_cols=108 Identities=26% Similarity=0.367 Sum_probs=96.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l 144 (604)
.+|+.|+|++|++++..|.. ++.+++|++|+|++|.+++.+|. ++++++|++|+|++|++++ +|.. ++++++|++|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYA-FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTL 152 (597)
T ss_dssp CCCSEEECTTSCCCEECTTT-TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCcEEECCCCCCCCCChHH-hcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCC-CCHHHhccCCCCCEE
Confidence 47999999999999866666 89999999999999999998885 7999999999999999997 6655 5899999999
Q ss_pred eccCCcccccCCC-C-CCCCCcEEEccCCccccc
Q 007427 145 ELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 145 ~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~ 176 (604)
+|++|++++..|. + .+++|+.|++++|.+++.
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 9999999988775 2 589999999999999875
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.6e-12 Score=141.95 Aligned_cols=125 Identities=23% Similarity=0.267 Sum_probs=90.2
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCc-cCCCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPF-GYIDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~~l~~l~ 145 (604)
+++.|+|++|++++ +|+..++++++|++|+|++|++++.+|. ++++++|++|+|++|++++ +|. .++++++|++|+
T Consensus 26 ~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 26 NITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELH 103 (680)
T ss_dssp TCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEE
T ss_pred CCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc-cChhhhccCCCCCEEE
Confidence 67888888888886 4443477888888888888888887774 7788888888888888886 554 578888888888
Q ss_pred ccCCcccccCCC--CCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 146 LQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 146 l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
|++|++++..|. ..+++|+.|++++|.+++.+|.. ..+.++..+.+.+|
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 155 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence 888888755444 25778888888888888776653 12333333444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=8.5e-13 Score=132.96 Aligned_cols=128 Identities=14% Similarity=0.052 Sum_probs=99.8
Q ss_pred CcEeEEEeCCCCceecCCh---hhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCccccc--CC--ccCCCC
Q 007427 67 GHIVSLELEEIQLAGILPP---GFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDG--IP--FGYIDL 138 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~---~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~--iP--~~~~~l 138 (604)
.+++.|+|++|++++.+|. ..+..+++|++|+|++|++++.+| .++++++|++|||++|+++|. +| ..++++
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 4799999999999987662 224579999999999999998887 588999999999999998873 33 334789
Q ss_pred CCCCEEeccCCcccccCCC------CCCCCCcEEEccCCcccccCCCCc-cc---cCCCCCccCCCC
Q 007427 139 PKLKKLELQENYLDGQIPP------FNQTSLIDFNVSYNNLDGPIPQTR-VV---QSFPSSSFEHNS 195 (604)
Q Consensus 139 ~~l~~l~l~~N~l~g~ip~------~~~~~l~~l~ls~n~l~g~~p~~~-~~---~~~~~~~~~~n~ 195 (604)
++|++|+|++|+++ .+|. ..+++|+.|+|++|++++.+|... .+ .++..+.+.+|.
T Consensus 197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~ 262 (310)
T 4glp_A 197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAG 262 (310)
T ss_dssp CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSC
T ss_pred CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCC
Confidence 99999999999997 3332 147899999999999999877542 22 345555555553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-12 Score=139.42 Aligned_cols=124 Identities=17% Similarity=0.224 Sum_probs=90.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccc--cCCccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSD--GIPFGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g--~iP~~~~~l~~l~~ 143 (604)
.+++.|++++|++.. ++ +.+.+++|++|+|++|++++.+| .++++++|+.|+|++|++++ .+|..+.++++|+.
T Consensus 331 ~~L~~L~l~~n~~~~-~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~ 407 (562)
T 3a79_B 331 MNIKMLSISDTPFIH-MV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407 (562)
T ss_dssp CCCSEEEEESSCCCC-CC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCE
T ss_pred CcceEEEccCCCccc-cc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCE
Confidence 357888888888753 22 12567888888888888888776 57888888888888888887 45567788888888
Q ss_pred EeccCCcccccCCCC---CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 144 LELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 144 l~l~~N~l~g~ip~~---~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
|+|++|++++.+|.. .+++|+.|++++|+++|.+|.... .++..+.+.+|
T Consensus 408 L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N 460 (562)
T 3a79_B 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNN 460 (562)
T ss_dssp EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-TTCSEEECCSS
T ss_pred EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-CcCCEEECCCC
Confidence 888888888777753 467888888888888887776421 33444444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.6e-12 Score=118.26 Aligned_cols=105 Identities=24% Similarity=0.188 Sum_probs=92.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCC--ccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIP--FGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP--~~~~~l~~l~~ 143 (604)
.+++.|+|++|++++. .. ++.+++|++|+|++|++++.+|. +.++++|++|+|++|++++ +| ..+..+++|+.
T Consensus 49 ~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGCCEEEEESSCCCCC--SS-CCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCEEeCcCCCCCCh--hh-hccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 5799999999999975 44 88999999999999999998886 5569999999999999998 55 78999999999
Q ss_pred EeccCCcccccCC----C-CCCCCCcEEEccCCcccc
Q 007427 144 LELQENYLDGQIP----P-FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 144 l~l~~N~l~g~ip----~-~~~~~l~~l~ls~n~l~g 175 (604)
|+|++|++++..+ . ..+++|+.|++++|.+..
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9999999997655 2 368999999999998764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.31 E-value=7.7e-12 Score=127.20 Aligned_cols=119 Identities=20% Similarity=0.277 Sum_probs=99.0
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|++++..|.. ++++++|++|+|++|++++..| .++++++|++|+|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDD-FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTT-TTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhH-hhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 6799999953 26889999999998655555 8899999999999999999877 589999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccc--cCCC
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDG--PIPQ 179 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g--~~p~ 179 (604)
|+++ .+|..+. ++|+.|+|++|++++..+. ..+++|+.|++++|.++. ..|.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 167 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTT
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcc
Confidence 9998 5888776 7999999999999854443 358899999999999963 4443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.7e-12 Score=141.59 Aligned_cols=113 Identities=20% Similarity=0.224 Sum_probs=102.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccc-cCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSD-GIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g-~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|++++..|.. ++.+++|++|+|++|++++.+|. ++++++|++|+|++|++++ .+|..++++++|+.|
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDA-FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp TTCCEEECTTSCCCEECTTT-TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CcccEEECCCCCcCccChhh-ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 57999999999999866666 89999999999999999998886 9999999999999999997 578899999999999
Q ss_pred eccCCcccccCCC---CCCCCCcEEEccCCcccccCCCC
Q 007427 145 ELQENYLDGQIPP---FNQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 145 ~l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
+|++|++.+.+|. ..+++|+.|++++|.+++.+|..
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence 9999998888885 25889999999999999988865
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.31 E-value=6e-12 Score=136.44 Aligned_cols=111 Identities=27% Similarity=0.301 Sum_probs=88.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|+|+ .|| . .+++|+.|+|++|+|++ ||.+++ +|++|+|++|+|++ ||. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 46899999999998 688 3 47899999999999998 776655 89999999999998 887 6888999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|+|++ ||. .+++|+.|+|++|+|++ +|. . ..++..+.+.+|
T Consensus 148 s~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp~-l-~~~L~~L~Ls~N 190 (571)
T 3cvr_A 148 DNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LPE-L-PESLEALDVSTN 190 (571)
T ss_dssp CSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC-C-CTTCCEEECCSS
T ss_pred CCCccCc-CCC-cCCCcCEEECCCCCCCC-cch-h-hCCCCEEECcCC
Confidence 9999986 777 67889999999999888 666 2 244444555555
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=125.34 Aligned_cols=101 Identities=27% Similarity=0.417 Sum_probs=56.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|++++ +|+ ++.+++|+.|+|++|++++ +|.+.. ++|+.|+|++|++++ +| .+.++++|+.|+|+
T Consensus 64 ~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 64 NLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 45566666666653 333 4556666666666666655 333333 556666666666655 33 35566666666666
Q ss_pred CCcccccCCCC-CCCCCcEEEccCCccccc
Q 007427 148 ENYLDGQIPPF-NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 148 ~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~ 176 (604)
+|++++ +|.. .+++|+.|++++|++++.
T Consensus 137 ~N~i~~-~~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 137 NNKLKS-IVMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp TSCCCB-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCcCCC-ChHHccCCCCCEEECCCCcCcch
Confidence 666654 2332 355666666666666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.6e-12 Score=138.76 Aligned_cols=133 Identities=18% Similarity=0.216 Sum_probs=114.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCccc-ccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFS-DGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~-g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|.+++..|...+.++++|++|+|++|.+++.+| .+.++++|++|+|++|+++ |.+|..+..+++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 5799999999999987775558899999999999999999988 5899999999999999998 7899999999999999
Q ss_pred eccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 145 ELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 145 ~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
+|++|++++.+|.. .+++|+.|++++|++++.+|.. ..+.++....+.+|+..|.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 99999999988863 5899999999999999987753 2344555667777776554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.6e-12 Score=114.14 Aligned_cols=98 Identities=23% Similarity=0.312 Sum_probs=83.3
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~ 124 (604)
|.+..+.|++ .+++.|+|++|++++..|.. ++.+++|++|+|++|+|++..+. +.++++|++|+|++
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGV-FDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTT-TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHH-hcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 4456667743 36889999999999766665 89999999999999999997665 68999999999999
Q ss_pred CcccccCCc-cCCCCCCCCEEeccCCcccccCC
Q 007427 125 NHFSDGIPF-GYIDLPKLKKLELQENYLDGQIP 156 (604)
Q Consensus 125 N~l~g~iP~-~~~~l~~l~~l~l~~N~l~g~ip 156 (604)
|+|++ +|. .+.++++|+.|+|++|.++...+
T Consensus 91 N~l~~-l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKS-IPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCC-CCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred Cccce-eCHHHhccccCCCEEEeCCCCcccccc
Confidence 99998 555 58999999999999999986543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.5e-12 Score=130.91 Aligned_cols=108 Identities=23% Similarity=0.221 Sum_probs=92.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEEe
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLE 145 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l~ 145 (604)
+++.|+|++|++++ +|+..++++++|++|+|++|++++..| .++++++|++|+|++|++++ +|.. +.++++|++|+
T Consensus 53 ~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 53 AVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEE
T ss_pred cCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEE
Confidence 78999999999996 555348999999999999999999877 49999999999999999997 6665 89999999999
Q ss_pred ccCCcccccCCC---C-CCCCCcEEEccCCc-ccccCC
Q 007427 146 LQENYLDGQIPP---F-NQTSLIDFNVSYNN-LDGPIP 178 (604)
Q Consensus 146 l~~N~l~g~ip~---~-~~~~l~~l~ls~n~-l~g~~p 178 (604)
|++|+++ .+|. + .+++|+.|++++|+ +.+..|
T Consensus 131 L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 131 LLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred CCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCH
Confidence 9999999 4665 2 58999999999996 444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.30 E-value=7.9e-13 Score=117.75 Aligned_cols=101 Identities=24% Similarity=0.189 Sum_probs=88.4
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccc-cCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSD-GIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g-~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|++++. .. ++.+++|++|+|++|++++.+|. ++++++|++|+|++|++++ ..|..+.++++|+.|
T Consensus 42 ~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--AN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp TTCCEEECTTSCCCCC--TT-CCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred CCCcEEECcCCCCCCc--hh-hhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 5899999999999975 44 89999999999999999998885 5669999999999999998 345889999999999
Q ss_pred eccCCcccccCC---C--CCCCCCcEEEccC
Q 007427 145 ELQENYLDGQIP---P--FNQTSLIDFNVSY 170 (604)
Q Consensus 145 ~l~~N~l~g~ip---~--~~~~~l~~l~ls~ 170 (604)
+|++|++++..+ . ..+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999997655 1 2589999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.9e-12 Score=123.04 Aligned_cols=120 Identities=20% Similarity=0.243 Sum_probs=99.4
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|+++ .+| . ++.+++|+.|+|++|++++..| ++++++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-G-MQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-H-HhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 47999999999998 577 4 7899999999999999999776 9999999999999999998 775444 99999999
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|++++ +|.. .+++|+.|++++|++++. |....+.++..+.+.+|.
T Consensus 114 ~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 114 DNNELRD-TDSLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp CSSCCSB-SGGGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSC
T ss_pred cCCccCC-ChhhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCc
Confidence 9999997 5654 689999999999999875 433334445555555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3.1e-12 Score=127.59 Aligned_cols=120 Identities=26% Similarity=0.372 Sum_probs=89.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +++ ++.+++|++|+|++|++++ +|.++++++|+.|+|++|++++ + +.+.++++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 478888888888886 444 6788888888888888887 5668888888888888888887 4 46778888888888
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|++++. +.. .+++|+.|++++|++++..| ...+.++..+.+.+|
T Consensus 142 ~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 142 GNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 188 (291)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred cCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCC
Confidence 88888864 443 57788888888888877655 333344444445555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=125.31 Aligned_cols=115 Identities=25% Similarity=0.357 Sum_probs=96.8
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..+.|+. .+++.|+|++|++++..+.. ++++++|++|+|++|++++..| .++++++|++|+|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGD-FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTT-TTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhh-hccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 6799999953 36789999999999644444 8899999999999999999877 599999999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccc
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g 175 (604)
|+++. +|..+. ++|+.|+|++|++++..|. ..+++|+.|++++|.+..
T Consensus 110 n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 110 NQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159 (330)
T ss_dssp SCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred CcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence 99984 888775 7899999999999865553 468899999999999864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.28 E-value=4e-12 Score=139.27 Aligned_cols=120 Identities=26% Similarity=0.381 Sum_probs=76.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+|+.|+|++|++++ +|+ +..|++|+.|+|++|+|++ +|.+++|++|+.|+|++|++++ +| .+.+|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEEC
Confidence 467777777777775 333 5667777777777777775 4567777777777777777776 33 4667777777777
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|+|++. +.+ .+++|+.|+|++|.+++.+| ...+.++..+.+.+|
T Consensus 139 s~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 139 GNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 185 (605)
T ss_dssp CSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred CCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC
Confidence 77777653 432 46667777777777766555 223333444444444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-12 Score=136.24 Aligned_cols=130 Identities=22% Similarity=0.147 Sum_probs=68.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|.+.+.+|+. .....+|+.|+|++|++++..+ .+.++++|+.|+|++|++++..|..+.++++|+.|+|
T Consensus 201 ~L~~L~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (477)
T 2id5_A 201 RLKVLEISHWPYLDTMTPN-CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279 (477)
T ss_dssp TCCEEEEECCTTCCEECTT-TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred ccceeeCCCCccccccCcc-cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence 4566666666665556555 3334456666666666653222 3555666666666666666544445555666666666
Q ss_pred cCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 147 QENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 147 ~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
++|++++..|.. .+++|+.|+|++|++++..+.. ..+.++..+.+.+|+..|
T Consensus 280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 666666554442 3555666666666655433321 112233344445554444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=126.61 Aligned_cols=105 Identities=24% Similarity=0.377 Sum_probs=72.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +|+ +..+++|++|+|++|++++ +|.++++++|+.|+|++|++++ +|. +.++++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-chhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 467777777777764 444 5667777777777777776 4567777777777777777776 553 677777777777
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~ 177 (604)
++|++++..|-..+++|+.|++++|.+++..
T Consensus 137 ~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~ 167 (308)
T 1h6u_A 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLT 167 (308)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCCG
T ss_pred CCCccCcCccccCCCCccEEEccCCcCCCCh
Confidence 7777775443334667777777777776543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=131.04 Aligned_cols=117 Identities=21% Similarity=0.246 Sum_probs=84.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|+++| +| + ++.+++|++|+|++|++++. | ++++++|++|+|++|++++ +| ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~-~~-~-l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT-G-IEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCC-CT-T-GGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCccc-Ch-h-hcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 468888888888886 45 4 67788888888888888874 4 7788888888888888887 55 778888888888
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|++++ +|-..+++|+.|++++|++++ +| ...+..+....+.+|
T Consensus 114 ~~N~l~~-l~~~~l~~L~~L~l~~N~l~~-l~-l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 114 DTNKLTK-LDVSQNPLLTYLNCARNTLTE-ID-VSHNTQLTELDCHLN 158 (457)
T ss_dssp CSSCCSC-CCCTTCTTCCEEECTTSCCSC-CC-CTTCTTCCEEECTTC
T ss_pred CCCcCCe-ecCCCCCcCCEEECCCCccce-ec-cccCCcCCEEECCCC
Confidence 8888886 565567788888888888877 33 222333333444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.27 E-value=6.5e-12 Score=125.22 Aligned_cols=119 Identities=26% Similarity=0.347 Sum_probs=78.8
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|++++|+++. +|. +..+++|+.|+|++|++++..| ++++++|++|+|++|++++ +| .+.++++|+.|+|+
T Consensus 47 ~L~~L~l~~~~i~~-~~~--~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKS-VQG--IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred cccEEEccCCCccc-Chh--HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence 57777777777763 443 5667777777777777777555 7777777777777777776 44 37777777777777
Q ss_pred CCcccccCCCC-CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 148 ENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 148 ~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
+|++++ +|.. .+++|+.|++++|++++. +....+.++..+.+.+|
T Consensus 121 ~n~i~~-~~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 121 HNGISD-INGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp TSCCCC-CGGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSS
T ss_pred CCcCCC-ChhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCC
Confidence 777775 3443 467777777777777764 33223334444444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.6e-11 Score=129.96 Aligned_cols=121 Identities=22% Similarity=0.197 Sum_probs=97.5
Q ss_pred CeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCC
Q 007427 58 NWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQN 125 (604)
Q Consensus 58 ~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N 125 (604)
.|..|.|.. .+++.|+|++|++++..+.. +.++++|++|+|++|++++..| .|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~-~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNS-FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTT-TSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHH-hhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 467899954 36789999999999766665 8899999999999999998776 5889999999999999
Q ss_pred cccccCCccCCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCCcccccCCC
Q 007427 126 HFSDGIPFGYIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 126 ~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~ 179 (604)
++++-.+..+..+++|+.|+|++|++++..+. ..+++|+.|++++|+..+.+|.
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 178 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence 99974445788999999999999999854442 2477888888888666666664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.9e-12 Score=127.79 Aligned_cols=129 Identities=21% Similarity=0.169 Sum_probs=101.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-C-CCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-L-TNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~-~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|++++..|.. ++.+++|++|+|++|.+++..|. + ..+++|++|+|++|++++ +|. ...+++|+.|
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L 196 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTL 196 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBC-TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEE
T ss_pred CCCCEEECCCCCCCCccchh-hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEE
Confidence 46899999999999755555 78899999999999999997764 4 478999999999999988 453 4468999999
Q ss_pred eccCCcccccCCCC-CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCcC
Q 007427 145 ELQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 145 ~l~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lcg 199 (604)
+|++|++++..|.+ .+++|+.|++++|++++ +|.. ..+.++....+.+|+..|+
T Consensus 197 ~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 197 DLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp ECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 99999999655543 57899999999999985 4543 3344556667778876654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.7e-12 Score=125.04 Aligned_cols=121 Identities=19% Similarity=0.324 Sum_probs=97.4
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +| . ++.+++|+.|+|++|++++ +|.++++++|+.|+|++|++++ +|. +.++++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~~-~-~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS-A-IAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-CG-G-GTTCTTCCEEECTTSCCCC-CGGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-ch-h-hcCCCCCCEEECCCCCCCC-chhhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 579999999999986 44 4 7889999999999999988 4569999999999999999998 554 889999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|++++..|-..+++|+.|++++|++++..| ...+.++..+.+.+|
T Consensus 159 ~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNN 205 (308)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTS
T ss_pred cCCcCCCChhhcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCC
Confidence 99999964443468899999999999987554 233344444555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=3.9e-12 Score=128.56 Aligned_cols=125 Identities=15% Similarity=0.047 Sum_probs=100.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCC-CCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYI-DLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~-~l~~l~~l 144 (604)
.+++.|+|++|++++..+ ..+++|+.|+|++|++++..| .++++++|++|+|++|++++..|..+. ++++|+.|
T Consensus 99 ~~L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 456777777777775433 237899999999999999877 689999999999999999997777774 79999999
Q ss_pred eccCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 145 ELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 145 ~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
+|++|++++.-+...+++|+.|++++|++++..|....+.++....+.+|.
T Consensus 175 ~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 175 NLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNK 225 (317)
T ss_dssp ECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSC
T ss_pred ECCCCcCcccccccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCc
Confidence 999999997643456899999999999999876654445555556666663
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1e-11 Score=135.99 Aligned_cols=122 Identities=25% Similarity=0.341 Sum_probs=98.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+|+.|+|++|++++ +| . ++.|++|+.|+|++|+|++ +|.+++|++|+.|+|++|++++ + ..+..|++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-S-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-T-STTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-h-hccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEEC
Confidence 578899999999985 55 4 7889999999999999987 5778999999999999999998 4 57889999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|+|++.+|-..+++|+.|+|++|+|++. |....+.++..+.+.+|.
T Consensus 161 s~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 161 EDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEE
T ss_pred cCCcCCCchhhccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCc
Confidence 999999877755688999999999999874 443334444445555553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=3.2e-11 Score=125.48 Aligned_cols=108 Identities=25% Similarity=0.337 Sum_probs=95.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l 144 (604)
.+++.|+|++|++++..|.. ++.+++|++|+|++|++++..|. ++++++|++|+|++|+++. +|.. +.++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYA-FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEECTTT-TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccChhh-ccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc-CCHHHhcCCCCCcEE
Confidence 47999999999998655555 89999999999999999998885 8999999999999999996 7776 5899999999
Q ss_pred eccCCcccccCCC--CCCCCCcEEEccCCccccc
Q 007427 145 ELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 145 ~l~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~ 176 (604)
+|++|++++..|. ..+++|+.|++++|.+++.
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 9999999977665 2589999999999999875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=125.11 Aligned_cols=122 Identities=22% Similarity=0.282 Sum_probs=102.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.+++++++++ .+|.. + .++|+.|+|++|++++..| .++++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKE-I--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSC-C--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCC-C--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 5788999999998 79987 4 3799999999999999877 6999999999999999999988999999999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n 194 (604)
++|+++ .+|....++|+.|++++|++++..+.. ..+.++....+.+|
T Consensus 110 ~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 157 (332)
T 2ft3_A 110 SKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157 (332)
T ss_dssp CSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSC
T ss_pred CCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCC
Confidence 999999 788765689999999999998654432 22344444455555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=137.25 Aligned_cols=112 Identities=20% Similarity=0.208 Sum_probs=87.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++++..|.. ++++++|++|+|++|++++..+ .|+++++|++|+|++|++++-.|..++++++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPEL-CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTH-HHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCHHH-HhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 46888888888888766665 7788888888888888886555 488888888888888888875556788888888888
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|++++..|.. .+++|+.|++++|.+++..|.
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 8888888777653 577888888888888776553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.23 E-value=2.1e-14 Score=134.82 Aligned_cols=106 Identities=22% Similarity=0.239 Sum_probs=53.4
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.|+|++|++++ +| . ++.+++|++|+|++|+++ .+|. +..+++|++|+|++|++++ +| .+.++++|+.|+|
T Consensus 49 ~L~~L~ls~n~l~~-l~-~-~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-S-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCSEEECSEEEESC-CC-C-HHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCEEECCCCCCcc-cc-c-cccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 45555555555554 44 3 455555555555555555 2332 3334555555555555554 44 3455555555555
Q ss_pred cCCcccccCC--C-CCCCCCcEEEccCCcccccCCC
Q 007427 147 QENYLDGQIP--P-FNQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 147 ~~N~l~g~ip--~-~~~~~l~~l~ls~n~l~g~~p~ 179 (604)
++|++++.-+ . ..+++|+.|++++|.+++.+|.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 5555553111 1 2345555555555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=127.34 Aligned_cols=112 Identities=19% Similarity=0.188 Sum_probs=96.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCc--cCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPF--GYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~--~~~~l~~l~~ 143 (604)
.+++.|+|++|++++..|.. ++++++|++|+|++|++++..+. ++++++|++|+|++|++++ +|. .+.++++|+.
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDS-FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCEECTTT-TTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCccCHhh-cCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcE
Confidence 47999999999999866665 89999999999999999976555 8999999999999999996 876 7899999999
Q ss_pred EeccCCc-ccccCCC--CCCCCCcEEEccCCcccccCCCC
Q 007427 144 LELQENY-LDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 144 l~l~~N~-l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
|+|++|+ +++..|. ..+++|+.|++++|.+++.+|..
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHH
Confidence 9999995 5544343 25889999999999999987764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.22 E-value=4.6e-12 Score=116.22 Aligned_cols=104 Identities=14% Similarity=0.204 Sum_probs=91.8
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCC-CCCCCccEEeCCCCcccccCCc--cCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNL-TNLVNLETVFLSQNHFSDGIPF--GYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~-~~l~~L~~l~l~~N~l~g~iP~--~~~~l~~l~~l 144 (604)
+++.|+|++|++++. +. ++.+++|++|+|++|++++..|.+ +++++|++|+|++|+++. +|. .+.++++|+.|
T Consensus 43 ~L~~L~Ls~N~l~~~--~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYL 118 (176)
T ss_dssp CCSEEECCSSCCCEE--CC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEE
T ss_pred CCCEEECCCCCCCcc--cc-cccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEE
Confidence 799999999999974 34 889999999999999999876665 899999999999999954 887 89999999999
Q ss_pred eccCCcccccCCCC------CCCCCcEEEccCCccccc
Q 007427 145 ELQENYLDGQIPPF------NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 145 ~l~~N~l~g~ip~~------~~~~l~~l~ls~n~l~g~ 176 (604)
+|++|.++ .+|.. .+++|+.||++.|.....
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 99999998 56762 589999999999987643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.1e-11 Score=122.56 Aligned_cols=108 Identities=22% Similarity=0.272 Sum_probs=93.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .+|.. + .++|+.|+|++|++++..| .++++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 171 ~~L~~L~l~~n~l~-~l~~~-~--~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 246 (330)
T 1xku_A 171 KKLSYIRIADTNIT-TIPQG-L--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246 (330)
T ss_dssp TTCCEEECCSSCCC-SCCSS-C--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred CCcCEEECCCCccc-cCCcc-c--cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence 47899999999998 57776 3 3899999999999999877 589999999999999999997777889999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|+++ .+|.. .+++|+.|++++|++++..+.
T Consensus 247 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~ 281 (330)
T 1xku_A 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281 (330)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChh
Confidence 9999999 78863 578999999999999875544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=130.18 Aligned_cols=118 Identities=16% Similarity=0.197 Sum_probs=85.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +| ++.+++|+.|+|++|++++. +++++++|+.|+|++|+++| || ++.+++|+.|+|
T Consensus 170 ~~L~~L~ls~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD---VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TTCCEEECCSSCCCC-CC---CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred CcCCEEECCCCccce-ec---cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 468888999988886 65 56788888888888888885 47888888888888888888 77 788888888888
Q ss_pred cCCcccccCCCCCCC----------CCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPPFNQT----------SLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~----------~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|+|+|. |...++ +|+.|++++|.+.|.+|.. .+.++....+.+|.
T Consensus 241 ~~N~l~~~-~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~-~l~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 241 SVNPLTEL-DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAE-GCRKIKELDVTHNT 297 (457)
T ss_dssp CSSCCSCC-CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT-TCTTCCCCCCTTCT
T ss_pred eCCcCCCc-CHHHCCCCCEEeccCCCCCEEECCCCccCCccccc-ccccCCEEECCCCc
Confidence 88888874 432233 4556666777777777642 33444455555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.8e-11 Score=126.60 Aligned_cols=97 Identities=26% Similarity=0.324 Sum_probs=64.2
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|++++ +|.. .++|++|+|++|++++ +|+++++++|++|++++|++++ +|..+ .+|++|+|+
T Consensus 112 ~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~ 181 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAG 181 (454)
T ss_dssp TCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECC
T ss_pred CCcEEECCCCccCc-ccCC----CCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECc
Confidence 44455555555543 3221 1577777777777776 6777777777777777777776 66543 467777777
Q ss_pred CCcccccCCCC-CCCCCcEEEccCCcccc
Q 007427 148 ENYLDGQIPPF-NQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 148 ~N~l~g~ip~~-~~~~l~~l~ls~n~l~g 175 (604)
+|++++ +|.+ .+++|+.|++++|++++
T Consensus 182 ~n~l~~-l~~~~~l~~L~~L~l~~N~l~~ 209 (454)
T 1jl5_A 182 NNQLEE-LPELQNLPFLTAIYADNNSLKK 209 (454)
T ss_dssp SSCCSS-CCCCTTCTTCCEEECCSSCCSS
T ss_pred CCcCCc-CccccCCCCCCEEECCCCcCCc
Confidence 777776 6654 46777777777777776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=118.16 Aligned_cols=136 Identities=13% Similarity=0.072 Sum_probs=104.2
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
..++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888999999865 6899999987432222346889999998884 677889999998888899999999999998
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL------------------------------------------- 438 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 438 (604)
+.+.. ......++.+++++|+.||+.-
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76321 1223478899999999999710
Q ss_pred ------------CCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 439 ------------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 439 ------------~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
....++|+|++|.||+++ +...+.|+||+.+
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a 211 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTC
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhc
Confidence 014589999999999993 3345679999875
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.7e-11 Score=118.36 Aligned_cols=110 Identities=16% Similarity=0.168 Sum_probs=83.2
Q ss_pred CcEeEEEeCCCC-ceecCChhhhcCCccCCeeeCcc-CCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCC-
Q 007427 67 GHIVSLELEEIQ-LAGILPPGFLQNITFLNKLSLRN-NLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLK- 142 (604)
Q Consensus 67 ~~~~~l~l~~~~-l~g~~p~~~~~~l~~L~~l~l~~-n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~- 142 (604)
.+++.|+|++|+ ++ .+|+..+..+++|++|+|++ |++++..| .+.++++|++|+|++|++++ +|. +.++++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 468888888886 66 45554477888888888888 88887665 47788888888888888887 886 77777777
Q ss_pred --EEeccCC-cccccCCC-C-CCCCCc-EEEccCCcccccCCCC
Q 007427 143 --KLELQEN-YLDGQIPP-F-NQTSLI-DFNVSYNNLDGPIPQT 180 (604)
Q Consensus 143 --~l~l~~N-~l~g~ip~-~-~~~~l~-~l~ls~n~l~g~~p~~ 180 (604)
.|+|++| ++++..+. + .+++|+ .|++++|+++ .+|..
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence 8888888 77754443 2 477888 8888888887 56543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.1e-11 Score=122.53 Aligned_cols=104 Identities=30% Similarity=0.356 Sum_probs=51.3
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|++++|++++. ++ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++ + +.+..+++|+.|+|+
T Consensus 200 ~L~~L~l~~n~l~~~-~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~ 273 (347)
T 4fmz_A 200 SLHYFTAYVNQITDI-TP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVG 273 (347)
T ss_dssp TCCEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECC
T ss_pred ccceeecccCCCCCC-ch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEcc
Confidence 455555555555532 21 3445555555555555554333 5555555555555555554 2 234555555555555
Q ss_pred CCcccccCCCC-CCCCCcEEEccCCcccccCC
Q 007427 148 ENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 148 ~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p 178 (604)
+|++++ +|.+ .+++|+.|++++|.+++..|
T Consensus 274 ~n~l~~-~~~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 274 SNQISD-ISVLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp SSCCCC-CGGGGGCTTCSEEECCSSCCCGGGH
T ss_pred CCccCC-ChhhcCCCCCCEEECcCCcCCCcCh
Confidence 555553 2332 34455555555555544443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4.1e-11 Score=127.84 Aligned_cols=104 Identities=27% Similarity=0.344 Sum_probs=75.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|.+++..| +..+++|+.|+|++|++++..| ++.+++|+.|+|++|++++ +|. +.++++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED-ISP-ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccC-chh-hcCCCCCCEEEC
Confidence 467788888888876433 5677888888888888877554 7777777777777777777 333 677777777777
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCccccc
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~ 176 (604)
++|++++..|-..+++|+.|++++|.+++.
T Consensus 317 ~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 317 YFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 777777766644567777777777777664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-10 Score=123.16 Aligned_cols=115 Identities=25% Similarity=0.299 Sum_probs=84.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|+++| +|.. +++|+.|+|++|++++ +|.+ .++|++|+|++|++++ || +++++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 367777787777776 6653 3678888888888876 3332 1688999999999987 88 5889999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|++++ +|.. ..+|+.|++++|++++ +|....+.++....+.+|
T Consensus 161 ~~N~l~~-lp~~-~~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N 205 (454)
T 1jl5_A 161 DNNSLKK-LPDL-PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNN 205 (454)
T ss_dssp CSSCCSC-CCCC-CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSS
T ss_pred CCCcCcc-cCCC-cccccEEECcCCcCCc-CccccCCCCCCEEECCCC
Confidence 9999986 7754 3588999999999988 665444444444445554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.5e-11 Score=126.86 Aligned_cols=122 Identities=30% Similarity=0.382 Sum_probs=102.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ ++ . +..+++|+.|+|++|.+++..| ++++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~-~~-~-l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG-T-LASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCC-CG-G-GGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCccc-ch-h-hhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEc
Confidence 479999999999986 44 3 7889999999999999998776 8999999999999999998 554 889999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|++++..|-..+++|+.|++++|++++..| ...+.++..+.+.+|.
T Consensus 295 ~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 295 NENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSC
T ss_pred CCCcccCchhhcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCc
Confidence 99999986665568999999999999999877 3344555555666663
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.12 E-value=4e-11 Score=122.58 Aligned_cols=122 Identities=24% Similarity=0.330 Sum_probs=103.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +|+ +..+++|+.|+|++|.+++ ++.+..+++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITD-LSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCC-Ccc--hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 579999999999985 554 7889999999999999998 5789999999999999999998 54 5889999999999
Q ss_pred cCCcccccCCC--CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~--~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|++++..|. ..+++|+.|++++|.+++..| ...+.++....+.+|+
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 99999988776 368999999999999999877 3345555566666663
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-11 Score=134.03 Aligned_cols=115 Identities=27% Similarity=0.384 Sum_probs=77.4
Q ss_pred CCCCCC-CCCCCCCCCeeeE--------EecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCC
Q 007427 44 HSRWTG-PPCIDNVSNWFGV--------SCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNL 114 (604)
Q Consensus 44 ~~~w~~-~~c~~~~~~w~gv--------~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l 114 (604)
+..|.. .+| |.|.|. .|....++.|++++|+++ .||.. +. ++|+.|+|++|+|++ ||. .+
T Consensus 12 w~~W~~~~~~----~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~~-lp~--~l 80 (622)
T 3g06_A 12 WSAWRRAAPA----EESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA--LP 80 (622)
T ss_dssp HHHHHHTCCG----GGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCSC-CCC--CC
T ss_pred HHHHHhcCCc----chhccccccCcccccccCCCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCCC-CCC--cC
Confidence 445743 343 368664 333456888888888887 78876 33 788888888888874 555 56
Q ss_pred CCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCCcccc
Q 007427 115 VNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 115 ~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g 175 (604)
++|++|+|++|++++ ||. .+++|++|+|++|++++ +|. .+++|+.|++++|++++
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~N~l~~ 135 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFGNQLTS 135 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCSSCCSC
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCCCCCCc
Confidence 778888888888775 776 56777777777777774 454 44556666666665554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.1e-10 Score=111.95 Aligned_cols=129 Identities=16% Similarity=0.133 Sum_probs=94.9
Q ss_pred CcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--cccEEEEEecCCceEEEEecCCCCCHHHH
Q 007427 326 GKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN--LAKIVSFYYSKEEKLIIYEFLPNGSLFDL 403 (604)
Q Consensus 326 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 403 (604)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998877888999997653 2245778999998886544 556888888878889999999998884
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 007427 404 LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL--------------------------------------------- 438 (604)
Q Consensus 404 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 438 (604)
... .+ ...++.++++.|+.||+..
T Consensus 104 ~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356778888888888531
Q ss_pred ---------CCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 439 ---------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 439 ---------~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
....++|+|++|.||+++ +...++|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 012399999999999993 33456799999853
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.07 E-value=2.8e-10 Score=116.38 Aligned_cols=104 Identities=20% Similarity=0.207 Sum_probs=85.2
Q ss_pred CeeeCccC-CCcccCCCCCCCCCccEEeCCC-CcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccC
Q 007427 95 NKLSLRNN-LLSGSLPNLTNLVNLETVFLSQ-NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSY 170 (604)
Q Consensus 95 ~~l~l~~n-~l~g~~p~~~~l~~L~~l~l~~-N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~ 170 (604)
..+++++| +|++ ||.|+.+++|+.|+|++ |+|++-.|..+++|++|+.|+|++|+|+|..|.. .+++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~-ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTT-TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCc-cCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 45799998 8997 55599999999999996 9999966678999999999999999999988863 699999999999
Q ss_pred CcccccCCCCccccCCCCCccCCCCCCcC
Q 007427 171 NNLDGPIPQTRVVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 171 n~l~g~~p~~~~~~~~~~~~~~~n~~lcg 199 (604)
|+|++..|.......+..+.+.+|+.-|.
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 99997665543323355566777776553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.06 E-value=7.6e-13 Score=124.04 Aligned_cols=125 Identities=19% Similarity=0.256 Sum_probs=103.0
Q ss_pred CcEeEEEeCCCCceecCCh------hhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCC
Q 007427 67 GHIVSLELEEIQLAGILPP------GFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPK 140 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~------~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~ 140 (604)
.+++.++|++++++|.+|+ . ++.+++|++|+|++|++++ +|.++++++|++|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~-~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDAT-LSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHH-HHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHH-HhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3677788888888888886 6 7899999999999999999 789999999999999999999 59998888999
Q ss_pred CCEEeccCCcccccCCCC-CCCCCcEEEccCCcccccCC--CCccccCCCCCccCCCC
Q 007427 141 LKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIP--QTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 141 l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p--~~~~~~~~~~~~~~~n~ 195 (604)
|+.|+|++|++++ +|.+ .+++|+.|++++|++++..+ ....+.++....+.+|+
T Consensus 95 L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 95 LEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp CSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred CCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 9999999999997 6653 47899999999999986322 22234445555666664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-11 Score=128.22 Aligned_cols=109 Identities=19% Similarity=0.327 Sum_probs=74.4
Q ss_pred CcEeEEEeCCCCce-ecCCh--hhhcCCccCCeeeCccCCCc--c---cCC-CCCCCCCccEEeCCCCccc----ccCCc
Q 007427 67 GHIVSLELEEIQLA-GILPP--GFLQNITFLNKLSLRNNLLS--G---SLP-NLTNLVNLETVFLSQNHFS----DGIPF 133 (604)
Q Consensus 67 ~~~~~l~l~~~~l~-g~~p~--~~~~~l~~L~~l~l~~n~l~--g---~~p-~~~~l~~L~~l~l~~N~l~----g~iP~ 133 (604)
.+++.|+|++|+++ +.+|. ..+..+++|+.|+|++|+++ | .+| .+.++++|++|+|++|+++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 36667777777775 44442 12556777777777777776 3 345 5677777777777777776 66777
Q ss_pred cCCCCCCCCEEeccCCccccc----CCC----CCCCCCcEEEccCCcccc
Q 007427 134 GYIDLPKLKKLELQENYLDGQ----IPP----FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 134 ~~~~l~~l~~l~l~~N~l~g~----ip~----~~~~~l~~l~ls~n~l~g 175 (604)
.+.++++|+.|+|++|++++. +|. ..+++|+.|+|++|.+++
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 777777777777777777765 343 236777777777777777
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.03 E-value=1.9e-10 Score=117.71 Aligned_cols=121 Identities=15% Similarity=0.161 Sum_probs=89.0
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCC--CCCCCCccE-EeC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPN--LTNLVNLET-VFL 122 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~--~~~l~~L~~-l~l 122 (604)
|.|..|.|+. .+++.|+|++|+++ .||+..+.++++|++|+|++|++.+.||. |.++++|.. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 6788899964 25788899999888 57776578888999999999998888873 778877664 677
Q ss_pred CCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCC
Q 007427 123 SQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 123 ~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p 178 (604)
++|++++-.|..+.++++|++|++++|++++..+.. ....+..|++++|.--..+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 778888855677888889999999999888544332 34456667776543333444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.3e-11 Score=122.56 Aligned_cols=114 Identities=15% Similarity=0.197 Sum_probs=67.5
Q ss_pred CeeeEEecCCcEeEEEeCCCCceecCChhhhcCC--ccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCccccc-CCcc
Q 007427 58 NWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNI--TFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDG-IPFG 134 (604)
Q Consensus 58 ~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~~l--~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~-iP~~ 134 (604)
.|.++.|....++.|+|++|++. |. .+..+ ++|+.|+|++|.+++.+|.+.++++|+.|+|++|++++. +|..
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~-~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PD-VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HH-HHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HH-HHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHH
Confidence 56666554444566666666554 22 24444 566666666666666666666666666666666666654 6666
Q ss_pred CCCCCCCCEEeccCCcccccCCC--CCCCCCcEEEccCC-cccc
Q 007427 135 YIDLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYN-NLDG 175 (604)
Q Consensus 135 ~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~n-~l~g 175 (604)
+.++++|+.|+|++|++++.+|. ..+++|+.|++++| .+++
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~ 157 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCH
Confidence 66666666666666666655554 24566666666666 4554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.01 E-value=8.4e-10 Score=121.06 Aligned_cols=34 Identities=32% Similarity=0.390 Sum_probs=17.8
Q ss_pred CCCCEEeccCCcccccCCCCCCCCCcEEEccCCccc
Q 007427 139 PKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 139 ~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~ 174 (604)
++|+.|+|++|+|++ || ..+++|+.|++++|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp-~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP-VLPSELKELMVSGNRLT 254 (622)
T ss_dssp TTCCEEECCSSCCSC-CC-CCCTTCCEEECCSSCCS
T ss_pred CCCCEEEccCCccCc-CC-CCCCcCcEEECCCCCCC
Confidence 445555555555553 44 23455555555555555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-09 Score=112.79 Aligned_cols=143 Identities=14% Similarity=0.219 Sum_probs=104.5
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEec--ccc-hhhHHHHHHHHHHHccCC--CCCcccEEEEEecC---CceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--NMN-ALSKKEFVQQMQLLGKLK--HENLAKIVSFYYSK---EEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 394 (604)
+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468899999999998764 678888876 322 122456888999999886 45688899988766 458999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL------------------------------------ 438 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 438 (604)
++|..+.+... ..++..++..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99877743111 13678888999999999999999731
Q ss_pred ------------------CCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 439 ------------------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 439 ------------------~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
....++|+|+++.||+++.++. ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 0257999999999999954332 2468999998754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.97 E-value=5.4e-11 Score=123.61 Aligned_cols=111 Identities=19% Similarity=0.248 Sum_probs=95.5
Q ss_pred CcEeEEEeCCCCce--e---cCChhhhcCCccCCeeeCccCCCc----ccCC-CCCCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEEIQLA--G---ILPPGFLQNITFLNKLSLRNNLLS----GSLP-NLTNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~~~l~--g---~~p~~~~~~l~~L~~l~l~~n~l~----g~~p-~~~~l~~L~~l~l~~N~l~g~----iP 132 (604)
.+++.|+|++|+++ | .+|.. +..+++|+.|+|++|.++ +.+| .+.++++|+.|+|++|++++. +|
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~-l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTT-GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHH-hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 48999999999998 4 33434 788999999999999997 6677 488999999999999999986 67
Q ss_pred ccC--CCCCCCCEEeccCCcccc----cCCCC---CCCCCcEEEccCCcccccCC
Q 007427 133 FGY--IDLPKLKKLELQENYLDG----QIPPF---NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 133 ~~~--~~l~~l~~l~l~~N~l~g----~ip~~---~~~~l~~l~ls~n~l~g~~p 178 (604)
..+ +++++|+.|+|++|++++ .+|.. .+++|+.|++++|.+++..|
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 777 459999999999999998 58863 47999999999999987654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.3e-10 Score=118.09 Aligned_cols=108 Identities=16% Similarity=0.153 Sum_probs=93.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCccc-CC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS-LP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKL 144 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~-~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l 144 (604)
.+++.|+|++|.+++.+|. +..+++|++|+|++|.+++. +| .+.++++|++|+|++|++++.+|..++++++|+.|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 5789999999999987665 56799999999999999886 77 47889999999999999999999999999999999
Q ss_pred eccCC-ccccc-CCC--CCCCCCcEEEccCC-ccccc
Q 007427 145 ELQEN-YLDGQ-IPP--FNQTSLIDFNVSYN-NLDGP 176 (604)
Q Consensus 145 ~l~~N-~l~g~-ip~--~~~~~l~~l~ls~n-~l~g~ 176 (604)
+|++| .+++. +|. ..+++|+.|++++| .+++.
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 184 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence 99999 78863 665 25789999999999 88864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=9e-10 Score=110.37 Aligned_cols=185 Identities=17% Similarity=0.160 Sum_probs=120.6
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCC--cccEEEEEecCC---ceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HEN--LAKIVSFYYSKE---EKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~ 396 (604)
+.++.|....||++. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+||||++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 457889999999864 45889986533 33567889999998873 332 445555543333 3489999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL-------------------------------------- 438 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 438 (604)
|.+|.+.... .++..++..++.++++.|+.||+.-
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9888754332 2677788888999999999998610
Q ss_pred ----------------CCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCCCcccccc---CCCCCCC-----
Q 007427 439 ----------------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---RSPEFPE----- 494 (604)
Q Consensus 439 ----------------~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~y---~aPE~~~----- 494 (604)
....++|+|++|.||+++.++ ...+.|+||+.+..-...........+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 013579999999999995431 346789999987553322111001110 1111100
Q ss_pred -CC--------CCCccchhHhHHHHHHHHHhCCCCC
Q 007427 495 -GK--------RLTHKADVYCFGIILLEVITGRIPG 521 (604)
Q Consensus 495 -~~--------~~s~ksDVwSfGvvl~elltg~~p~ 521 (604)
+. ......+.|++|.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0112368999999999999998764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.2e-10 Score=114.04 Aligned_cols=108 Identities=22% Similarity=0.205 Sum_probs=72.1
Q ss_pred cEeEEEeCCCCceecCCh---hhhcCCc-cCCeeeCccCCCcccCC-CCCCC-----CCccEEeCCCCcccccCCccCCC
Q 007427 68 HIVSLELEEIQLAGILPP---GFLQNIT-FLNKLSLRNNLLSGSLP-NLTNL-----VNLETVFLSQNHFSDGIPFGYID 137 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~---~~~~~l~-~L~~l~l~~n~l~g~~p-~~~~l-----~~L~~l~l~~N~l~g~iP~~~~~ 137 (604)
+++.|+|++|++++.-+. ..+..++ +|++|+|++|++++..+ .+..+ ++|++|+|++|++++..|..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 477888888887743331 2356677 78888888888877655 33333 77888888888887766654433
Q ss_pred ----C-CCCCEEeccCCcccccCCCC------C-CCCCcEEEccCCcccc
Q 007427 138 ----L-PKLKKLELQENYLDGQIPPF------N-QTSLIDFNVSYNNLDG 175 (604)
Q Consensus 138 ----l-~~l~~l~l~~N~l~g~ip~~------~-~~~l~~l~ls~n~l~g 175 (604)
+ ++|+.|+|++|++++..+.. . ..+|+.|+|++|.+++
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 3 67888888888877554421 2 2577888888887774
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.5e-10 Score=113.89 Aligned_cols=107 Identities=13% Similarity=0.104 Sum_probs=92.0
Q ss_pred EEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-----CCCCCC-CccEEeCCCCcccccCCccCCCC-----C
Q 007427 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-----NLTNLV-NLETVFLSQNHFSDGIPFGYIDL-----P 139 (604)
Q Consensus 71 ~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-----~~~~l~-~L~~l~l~~N~l~g~iP~~~~~l-----~ 139 (604)
.++|+.|+++|.+|.. +...++|++|||++|++++..+ .+.+++ +|++|+|++|++++..|..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEF-TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHH-HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHH-HhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 4689999999988874 7777789999999999998775 377888 99999999999999888887775 9
Q ss_pred CCCEEeccCCcccccCCC-----C-CC-CCCcEEEccCCcccccCC
Q 007427 140 KLKKLELQENYLDGQIPP-----F-NQ-TSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 140 ~l~~l~l~~N~l~g~ip~-----~-~~-~~l~~l~ls~n~l~g~~p 178 (604)
+|+.|+|++|++++..+. . .. ++|+.|+|++|.+++..+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 126 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSS 126 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHH
Confidence 999999999999987765 1 33 799999999999987654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.4e-10 Score=112.64 Aligned_cols=124 Identities=17% Similarity=0.100 Sum_probs=86.2
Q ss_pred CCCeeeEEecC--CcEeEEEeCC---CCceecCChhhh-----------------------cCCccCCe--eeCccCCC-
Q 007427 56 VSNWFGVSCSN--GHIVSLELEE---IQLAGILPPGFL-----------------------QNITFLNK--LSLRNNLL- 104 (604)
Q Consensus 56 ~~~w~gv~c~~--~~~~~l~l~~---~~l~g~~p~~~~-----------------------~~l~~L~~--l~l~~n~l- 104 (604)
.|.|.|++|.. .+|+.+...+ ..+.|.++++.+ ...+.|.. ++++.|..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 35699999964 3777776655 455566665422 22223333 55666632
Q ss_pred --cccCCC-CCCCCCccEEeCCCCcccc--cCCccCCCCCCCCEEeccCCccccc--CCCCCCCCCcEEEccCCcccccC
Q 007427 105 --SGSLPN-LTNLVNLETVFLSQNHFSD--GIPFGYIDLPKLKKLELQENYLDGQ--IPPFNQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 105 --~g~~p~-~~~l~~L~~l~l~~N~l~g--~iP~~~~~l~~l~~l~l~~N~l~g~--ip~~~~~~l~~l~ls~n~l~g~~ 177 (604)
.+.++. ..++++|+.|+|++|+|++ .||..+.++++|+.|+|++|+|++. +......+|+.|+|++|.+++.+
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCcccc
Confidence 222221 2468899999999999999 7778888999999999999999974 22222128999999999999988
Q ss_pred CC
Q 007427 178 PQ 179 (604)
Q Consensus 178 p~ 179 (604)
|.
T Consensus 237 ~~ 238 (267)
T 3rw6_A 237 RD 238 (267)
T ss_dssp SS
T ss_pred Cc
Confidence 84
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=6.7e-09 Score=100.78 Aligned_cols=78 Identities=26% Similarity=0.243 Sum_probs=64.5
Q ss_pred cCCccCCeeeCccCCCcc--cCCC-CCCCCCccEEeCCCCcccccCCccCCCCC--CCCEEeccCCcccccCCC------
Q 007427 89 QNITFLNKLSLRNNLLSG--SLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLP--KLKKLELQENYLDGQIPP------ 157 (604)
Q Consensus 89 ~~l~~L~~l~l~~n~l~g--~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~--~l~~l~l~~N~l~g~ip~------ 157 (604)
.++++|+.|+||+|+|++ .+|. ++.+++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999999 5664 67899999999999999984 4455555 999999999999999884
Q ss_pred ---CCCCCCcEEEc
Q 007427 158 ---FNQTSLIDFNV 168 (604)
Q Consensus 158 ---~~~~~l~~l~l 168 (604)
..+++|+.||-
T Consensus 245 ~il~~~P~L~~LDg 258 (267)
T 3rw6_A 245 AIRERFPKLLRLDG 258 (267)
T ss_dssp HHHHHCTTCCEESS
T ss_pred HHHHHCcccCeECC
Confidence 14677777653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.59 E-value=9.3e-08 Score=97.65 Aligned_cols=124 Identities=11% Similarity=0.135 Sum_probs=86.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccC-CCcccCC-CCCCCC-CccEEeCCCCcccccCCccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNN-LLSGSLP-NLTNLV-NLETVFLSQNHFSDGIPFGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n-~l~g~~p-~~~~l~-~L~~l~l~~N~l~g~iP~~~~~l~~l~~ 143 (604)
.+++.|++++|++++..+.. +....++..|++++| +++...+ .+..+. .|+.|+|++|+++. ||..+.+..+|+.
T Consensus 104 ~~L~~L~l~~n~l~~~~~~~-~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~ 181 (350)
T 4ay9_X 104 PNLQYLLISNTGIKHLPDVH-KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDE 181 (350)
T ss_dssp TTCCEEEEEEECCSSCCCCT-TCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEE
T ss_pred cccccccccccccccCCchh-hcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhH
Confidence 47889999999998544433 455667788888664 4444333 355554 68889999999986 8888888888999
Q ss_pred EeccCCcccccCCCC---CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 144 LELQENYLDGQIPPF---NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 144 l~l~~N~l~g~ip~~---~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
|++++|+.-+.||.. .+++|+.|+||+|+|+. +|.. .+.++..+...++
T Consensus 182 l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~-lp~~-~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-LPSY-GLENLKKLRARST 233 (350)
T ss_dssp EECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC-CCSS-SCTTCCEEECTTC
T ss_pred HhhccCCcccCCCHHHhccCcccchhhcCCCCcCc-cChh-hhccchHhhhccC
Confidence 999876555588862 57889999999998874 4443 2444444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.54 E-value=1.3e-08 Score=108.09 Aligned_cols=108 Identities=20% Similarity=0.246 Sum_probs=71.3
Q ss_pred cEeEEEeCCCCcee----cCChhhhcCCccCCeeeCccCCCcccCC-CC-CCCC----CccEEeCCCCccc----ccCCc
Q 007427 68 HIVSLELEEIQLAG----ILPPGFLQNITFLNKLSLRNNLLSGSLP-NL-TNLV----NLETVFLSQNHFS----DGIPF 133 (604)
Q Consensus 68 ~~~~l~l~~~~l~g----~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~-~~l~----~L~~l~l~~N~l~----g~iP~ 133 (604)
+++.|+|++|++++ .++.. +..+++|++|+|++|.+++..+ .+ ..+. +|++|+|++|+++ +.+|.
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~-l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSA-LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHH-HHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHH-HHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 57777777777764 34444 6667777777777777766433 22 1233 5777788777777 35677
Q ss_pred cCCCCCCCCEEeccCCcccccCCC-------CCCCCCcEEEccCCccccc
Q 007427 134 GYIDLPKLKKLELQENYLDGQIPP-------FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 134 ~~~~l~~l~~l~l~~N~l~g~ip~-------~~~~~l~~l~ls~n~l~g~ 176 (604)
.+.++++|+.|+|++|++++..+. ....+|+.|++++|++++.
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 157 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHH
Confidence 777777777888877777654332 1245677777777777653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.54 E-value=3.5e-09 Score=112.48 Aligned_cols=128 Identities=17% Similarity=0.135 Sum_probs=98.8
Q ss_pred CcEeEEEeCCCCceec----CChhhhcCCccCCeeeCccCCCcccCCC-C-----CCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEEIQLAGI----LPPGFLQNITFLNKLSLRNNLLSGSLPN-L-----TNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~-----~~l~~L~~l~l~~N~l~g~----iP 132 (604)
.+++.|+|++|++++. ++.. +..+++|+.|+|++|.+++..+. + ...++|+.|+|++|++++. +|
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~-l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRV-LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHH-HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHH-HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 5799999999999864 6766 77899999999999999875442 2 2346999999999999976 67
Q ss_pred ccCCCCCCCCEEeccCCcccccCCCC-------CCCCCcEEEccCCcccc----cCCCC-ccccCCCCCccCCCC
Q 007427 133 FGYIDLPKLKKLELQENYLDGQIPPF-------NQTSLIDFNVSYNNLDG----PIPQT-RVVQSFPSSSFEHNS 195 (604)
Q Consensus 133 ~~~~~l~~l~~l~l~~N~l~g~ip~~-------~~~~l~~l~ls~n~l~g----~~p~~-~~~~~~~~~~~~~n~ 195 (604)
..+.++++|+.|+|++|++++..+.. ..++|+.|++++|.+++ .+|.. ..+.++....+.+|.
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 77888999999999999998764431 26799999999999986 66543 113344455666663
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.44 E-value=2.1e-08 Score=103.16 Aligned_cols=109 Identities=21% Similarity=0.184 Sum_probs=79.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CC-----CCCCCccEEeCCCCcccc----cCCccCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NL-----TNLVNLETVFLSQNHFSD----GIPFGYI 136 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~-----~~l~~L~~l~l~~N~l~g----~iP~~~~ 136 (604)
.+++.|+|++|+++..-...+...+++|+.|+|++|+|+..-. .+ ...++|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4799999999998754444434456788999999998876433 12 346789999999998875 3555567
Q ss_pred CCCCCCEEeccCCcccccC----CC--CCCCCCcEEEccCCcccc
Q 007427 137 DLPKLKKLELQENYLDGQI----PP--FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 137 ~l~~l~~l~l~~N~l~g~i----p~--~~~~~l~~l~ls~n~l~g 175 (604)
.+++|++|+|++|+++..- +. ...++|+.|+|++|.++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 7888999999999887421 21 134678899999998875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.5e-08 Score=104.29 Aligned_cols=109 Identities=16% Similarity=0.145 Sum_probs=63.1
Q ss_pred CcEeEEEeCCCCceecCChhh---hc-CCccCCeeeCccCCCcccCC-CC-CCCCCccEEeCCCCcccccCCccC-----
Q 007427 67 GHIVSLELEEIQLAGILPPGF---LQ-NITFLNKLSLRNNLLSGSLP-NL-TNLVNLETVFLSQNHFSDGIPFGY----- 135 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~---~~-~l~~L~~l~l~~n~l~g~~p-~~-~~l~~L~~l~l~~N~l~g~iP~~~----- 135 (604)
.+++.|+|++|+++..-...+ +. +.++|+.|+|++|.++..-. .+ ..+.+|+.|||++|+++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 357777777777764322220 11 22577777777777754322 22 235567777777777765333333
Q ss_pred CCCCCCCEEeccCCccccc----CCC--CCCCCCcEEEccCCcccc
Q 007427 136 IDLPKLKKLELQENYLDGQ----IPP--FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 136 ~~l~~l~~l~l~~N~l~g~----ip~--~~~~~l~~l~ls~n~l~g 175 (604)
...++|+.|+|++|.++.. ++. ...++|+.|+|++|.++.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 2456677777777777531 211 135667777777777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.2e-06 Score=85.63 Aligned_cols=139 Identities=17% Similarity=0.106 Sum_probs=94.3
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC---CcccEEEEEe-cCCceEEEEecCCCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE---NLAKIVSFYY-SKEEKLIIYEFLPNG 398 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g 398 (604)
+.++.|....||+. |..+++|+-.. ......+.+|.++|+.+.+. .+.+++.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45778888899988 56788888532 22356789999999998653 3566777764 445678999999998
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL---------------------------------------- 438 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 438 (604)
++.+.... .++..++..++.++++.|+.||+.-
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88763221 1344555556666666666665421
Q ss_pred ----------------CCCCceecCCCCCceEEeecCCcc-eEEEeeccCCCC
Q 007427 439 ----------------HSHKVPHANLKSSNILIFRENDIY-RAKLTNFGFLPL 474 (604)
Q Consensus 439 ----------------~~~~ivHrDlkp~NILl~~~~~~~-~~kl~DFGla~~ 474 (604)
....++|+|++|.||+++.++... ...|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123569999999999995421123 358999997643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=7e-06 Score=80.21 Aligned_cols=135 Identities=18% Similarity=0.211 Sum_probs=93.6
Q ss_pred ccCcCCcc-eEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 324 VLGKGKVG-STYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 324 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 68988754 4678899987543 3456888999888774 33467889999888999999999999888
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL------------------------------------------ 438 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 438 (604)
.+...... .....++.+++..|+-||..-
T Consensus 108 ~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 77654321 223345666666666666420
Q ss_pred ------------CCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 439 ------------HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 439 ------------~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
....++|+|+.+.|||++ +...+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 011268999999999994 44456799999753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.15 E-value=2.2e-07 Score=85.49 Aligned_cols=107 Identities=17% Similarity=0.227 Sum_probs=82.7
Q ss_pred CcEeEEEeCCC-Cceec----CChhhhcCCccCCeeeCccCCCccc----CC-CCCCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEEI-QLAGI----LPPGFLQNITFLNKLSLRNNLLSGS----LP-NLTNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~~-~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~----~p-~~~~l~~L~~l~l~~N~l~g~----iP 132 (604)
.+++.|+|++| +++.. +... +...++|++|+|++|+++.. +. .+...+.|++|+|++|+++.. |.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~-L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEA-LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHH-HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHH-HHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 47999999999 88632 3333 66789999999999999753 11 255668899999999999864 56
Q ss_pred ccCCCCCCCCEEec--cCCcccccCCC------CCCCCCcEEEccCCccc
Q 007427 133 FGYIDLPKLKKLEL--QENYLDGQIPP------FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 133 ~~~~~l~~l~~l~l--~~N~l~g~ip~------~~~~~l~~l~ls~n~l~ 174 (604)
..+...++|+.|+| ++|.++..--. ...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 67788889999999 88998753221 13578999999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-07 Score=103.61 Aligned_cols=110 Identities=7% Similarity=-0.058 Sum_probs=66.7
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCc----cCCCccc-----CCC-CCCCCCccEEeCCCC--cccccCCcc
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLR----NNLLSGS-----LPN-LTNLVNLETVFLSQN--HFSDGIPFG 134 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~----~n~l~g~-----~p~-~~~l~~L~~l~l~~N--~l~g~iP~~ 134 (604)
.+++.|+|+.|++++..+..+...+++|+.|+|+ .|++++. ++. +.++++|+.|+|+++ .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 4678888888888877666633347788888885 6777764 221 445666666666532 355555544
Q ss_pred CCC-CCCCCEEeccCCcccc-cCCC--CCCCCCcEEEccCCccccc
Q 007427 135 YID-LPKLKKLELQENYLDG-QIPP--FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 135 ~~~-l~~l~~l~l~~N~l~g-~ip~--~~~~~l~~l~ls~n~l~g~ 176 (604)
++. +++|+.|+|++|++++ .+|. ..+++|+.|++++|.+++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 433 5666666666666655 2332 2456666666666666543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=3.2e-06 Score=86.30 Aligned_cols=79 Identities=5% Similarity=0.050 Sum_probs=55.3
Q ss_pred ccc-CcCCcceEEEEEec-------CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC---CCcccEEEEEecC---
Q 007427 323 EVL-GKGKVGSTYKATLE-------SGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKH---ENLAKIVSFYYSK--- 385 (604)
Q Consensus 323 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 385 (604)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998764 26788999875432 1112457788888887742 3577788887655
Q ss_pred CceEEEEecCCCCCHH
Q 007427 386 EEKLIIYEFLPNGSLF 401 (604)
Q Consensus 386 ~~~~lv~e~~~~gsL~ 401 (604)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.7e-05 Score=76.94 Aligned_cols=142 Identities=13% Similarity=0.185 Sum_probs=77.2
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-----CCCcccEE-E--EEecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-----HENLAKIV-S--FYYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 394 (604)
+.|+.|..+.||++...+| .+++|+.... ...+..|..+++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466678899999987655 4899998752 233444555554442 24433310 0 11235667899999
Q ss_pred CCCCCHH--------------HHhhcccC-C--C-C-----CCCCHHHHH------------------------------
Q 007427 395 LPNGSLF--------------DLLHESRG-V--G-R-----IPLAWTTRL------------------------------ 421 (604)
Q Consensus 395 ~~~gsL~--------------~~l~~~~~-~--~-~-----~~l~~~~~~------------------------------ 421 (604)
++|.++. ..+|.... . . . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11222111 0 0 0 011332210
Q ss_pred -HHHHHHHHHHHHHHh--------c-CCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 422 -SIIKQTAKGLAFLHQ--------T-LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 422 -~i~~~ia~gL~yLH~--------~-~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
.+...+..++++|++ . .....++|+|+++.||++ +....+.|+||+.+
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a 250 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhc
Confidence 111223445666653 0 014689999999999999 44456899999975
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.5e-06 Score=93.48 Aligned_cols=101 Identities=13% Similarity=0.154 Sum_probs=65.6
Q ss_pred cEeEEEeCCCC-cee-cCChhhhcCCccCCeeeCccCCCccc----CCC-CCCCCCccEEeCCCCccc----ccCCccCC
Q 007427 68 HIVSLELEEIQ-LAG-ILPPGFLQNITFLNKLSLRNNLLSGS----LPN-LTNLVNLETVFLSQNHFS----DGIPFGYI 136 (604)
Q Consensus 68 ~~~~l~l~~~~-l~g-~~p~~~~~~l~~L~~l~l~~n~l~g~----~p~-~~~l~~L~~l~l~~N~l~----g~iP~~~~ 136 (604)
+++.|+|++|. ++. .++. +..++++|++|+|++|.+++. ++. +.++++|+.|+|++|.++ +.++..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 37888887775 221 1222 244677888888888877765 332 346777888888888876 44555566
Q ss_pred CCCCCCEEeccCCcccccCCCC--CCCCCcEEEccC
Q 007427 137 DLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSY 170 (604)
Q Consensus 137 ~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~ 170 (604)
++++|+.|+|++|.+++ +|.. .+++|+.|+++.
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 77788888888877775 4432 356677777764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.6e-06 Score=93.32 Aligned_cols=103 Identities=12% Similarity=0.067 Sum_probs=76.1
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccC-CCccc-CCCC-CCCCCccEEeCCCCcccccCCccC----CCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNN-LLSGS-LPNL-TNLVNLETVFLSQNHFSDGIPFGY----IDLP 139 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n-~l~g~-~p~~-~~l~~L~~l~l~~N~l~g~iP~~~----~~l~ 139 (604)
.+++.|+|++|.+++..+..+...+++|+.|+|++| .++.. ++.+ .++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 478899999998888777663336889999999988 55543 4543 478899999999999887554444 3677
Q ss_pred CCCEEeccCCcccccCCC-------CCCCCCcEEEccCC
Q 007427 140 KLKKLELQENYLDGQIPP-------FNQTSLIDFNVSYN 171 (604)
Q Consensus 140 ~l~~l~l~~N~l~g~ip~-------~~~~~l~~l~ls~n 171 (604)
+|+.|+|++|. +.++. ..+++|+.|++++|
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 89999999887 33332 13688889999888
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6.7e-05 Score=77.70 Aligned_cols=74 Identities=11% Similarity=0.120 Sum_probs=49.0
Q ss_pred cccCcCCcceEEEEEec-CCcEEEEEEecccch-------hhHHHHHHHHHHHccCCC--C-CcccEEEEEecCCceEEE
Q 007427 323 EVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNA-------LSKKEFVQQMQLLGKLKH--E-NLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lv 391 (604)
+.||.|.++.||+++.. +++.++||....... .....+..|.++++.+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 468899998653211 123456778888887732 3 34456644 34567899
Q ss_pred EecCCCC
Q 007427 392 YEFLPNG 398 (604)
Q Consensus 392 ~e~~~~g 398 (604)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.80 E-value=3.3e-05 Score=77.78 Aligned_cols=80 Identities=16% Similarity=0.142 Sum_probs=46.0
Q ss_pred CccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCc-cCCCCCCCC-EEeccCCcccccCCC--C-CCCCCc
Q 007427 91 ITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPF-GYIDLPKLK-KLELQENYLDGQIPP--F-NQTSLI 164 (604)
Q Consensus 91 l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~~l~-~l~l~~N~l~g~ip~--~-~~~~l~ 164 (604)
+++|+.|+|++|+++...+ .|.+|++|+.|+|++| ++- |+. .+.+|++|+ .|+|.+ +++ .|+. + .+.+|+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~-I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKT-IGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCE-ECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cce-ehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence 5666666666666653222 3666666666666665 443 443 355666666 666666 444 4443 1 356666
Q ss_pred EEEccCCccc
Q 007427 165 DFNVSYNNLD 174 (604)
Q Consensus 165 ~l~ls~n~l~ 174 (604)
.+++++|+++
T Consensus 301 ~l~l~~n~i~ 310 (329)
T 3sb4_A 301 YVLATGDKIT 310 (329)
T ss_dssp EEEECSSCCC
T ss_pred EEEeCCCccC
Confidence 6666666554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=4.1e-06 Score=85.42 Aligned_cols=105 Identities=17% Similarity=0.168 Sum_probs=69.4
Q ss_pred CcEeEEEeCCCC-ceecCChhhhcCCccCCeeeCccCCCcccCC-CC--CCCCCccEEeCCC--Cccccc-----CCccC
Q 007427 67 GHIVSLELEEIQ-LAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NL--TNLVNLETVFLSQ--NHFSDG-----IPFGY 135 (604)
Q Consensus 67 ~~~~~l~l~~~~-l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~--~~l~~L~~l~l~~--N~l~g~-----iP~~~ 135 (604)
.+++.|+|++|. + .+|+ +. +++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. |-..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 579999998873 3 3444 33 7889999998877654322 23 3688888888853 332222 11122
Q ss_pred --CCCCCCCEEeccCCcccccCCC-----CCCCCCcEEEccCCccccc
Q 007427 136 --IDLPKLKKLELQENYLDGQIPP-----FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 136 --~~l~~l~~l~l~~N~l~g~ip~-----~~~~~l~~l~ls~n~l~g~ 176 (604)
..+++|+.|+|++|.+++..+. ..+++|+.|+||+|.+.+.
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 3578899999988888754432 2467888999998888763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.68 E-value=2.6e-06 Score=93.25 Aligned_cols=107 Identities=12% Similarity=-0.019 Sum_probs=54.9
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCc--c----CCCcccCC-----C-CCCCCCccEEeCCCCcccccCCccC
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLR--N----NLLSGSLP-----N-LTNLVNLETVFLSQNHFSDGIPFGY 135 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~--~----n~l~g~~p-----~-~~~l~~L~~l~l~~N~l~g~iP~~~ 135 (604)
+++.|.+..|++++..+..+...+++|+.|+|+ + |++++... . +.++++|+.|+|++ ++++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 455555555555544444322245566666665 2 34442211 1 34455666666654 4554444444
Q ss_pred CC-CCCCCEEeccCCcccccCCC---CCCCCCcEEEccCCcccc
Q 007427 136 ID-LPKLKKLELQENYLDGQIPP---FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 136 ~~-l~~l~~l~l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~g 175 (604)
+. +++|+.|+|++|.+++..+. ..+++|+.|++++|.+++
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 44 56666666666666543332 125666666666666643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0004 Score=69.03 Aligned_cols=74 Identities=19% Similarity=0.160 Sum_probs=59.4
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK---HENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.+. ...+.+++.++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46789999999999864 678889987543 3567889999888873 3668889998887888999999999876
Q ss_pred H
Q 007427 400 L 400 (604)
Q Consensus 400 L 400 (604)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00027 Score=69.60 Aligned_cols=74 Identities=14% Similarity=0.180 Sum_probs=54.8
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC---CCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH---ENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.+|.|..+.||+.+..+|+.|++|+...........|..|++.|+.+.. --+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 46799999999999999999999998765443334568889998887742 2345555542 3479999998764
Q ss_pred H
Q 007427 400 L 400 (604)
Q Consensus 400 L 400 (604)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00042 Score=72.19 Aligned_cols=75 Identities=9% Similarity=-0.015 Sum_probs=46.0
Q ss_pred CCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCCCc-----cccccCCCCCCCC---CCCCccchhHhHHHHH
Q 007427 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE-----NLAIGRSPEFPEG---KRLTHKADVYCFGIIL 511 (604)
Q Consensus 440 ~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~~-----~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl 511 (604)
...++|+|++|.|||++. .. ++++||+.+..-+...... -...|.+|+.... ..-....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~---~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQ---DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECS---SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeC---CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 478999999999999943 32 8999999876543221110 0123444444321 1112245666888888
Q ss_pred HHHHhCC
Q 007427 512 LEVITGR 518 (604)
Q Consensus 512 ~elltg~ 518 (604)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.49 E-value=1.5e-05 Score=73.02 Aligned_cols=86 Identities=17% Similarity=0.148 Sum_probs=68.0
Q ss_pred CCcEeEEEeCCCCceec----CChhhhcCCccCCeeeCccCCCccc----CC-CCCCCCCccEEeC--CCCccccc----
Q 007427 66 NGHIVSLELEEIQLAGI----LPPGFLQNITFLNKLSLRNNLLSGS----LP-NLTNLVNLETVFL--SQNHFSDG---- 130 (604)
Q Consensus 66 ~~~~~~l~l~~~~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~----~p-~~~~l~~L~~l~l--~~N~l~g~---- 130 (604)
+.+++.|+|++|+++.. |... +...++|++|+|++|.++.. +. .+...+.|++|+| ++|.++..
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~-L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~ 142 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEM-LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 142 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHH-HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHH-HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH
Confidence 35799999999999642 3333 56678999999999999864 22 4777889999999 88999864
Q ss_pred CCccCCCCCCCCEEeccCCccc
Q 007427 131 IPFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 131 iP~~~~~l~~l~~l~l~~N~l~ 152 (604)
|-..+...++|+.|+|++|.+.
T Consensus 143 l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 143 IANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCcCEEeccCCCCC
Confidence 4445566789999999999985
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00029 Score=70.75 Aligned_cols=56 Identities=16% Similarity=0.190 Sum_probs=35.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
.+++.|+|++ +++ .|++..+.++++|+.|+|++|.++...+ .|.++.+|..+.++.
T Consensus 101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 4688888888 776 5777667888888888888887753222 244444444444433
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0029 Score=63.24 Aligned_cols=144 Identities=14% Similarity=0.159 Sum_probs=80.0
Q ss_pred ccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--CcccEEEE-----EecCCceEEEEecCC
Q 007427 324 VLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHE--NLAKIVSF-----YYSKEEKLIIYEFLP 396 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~ 396 (604)
.++ |....||++...+|+.+++|...... .....+..|..++..+... .+.+++.. ....+..+++|||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789999887778789999986321 1345667788877776422 23444432 112345678999998
Q ss_pred CCCHH-----HH---------hhcccC----CCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhcC-
Q 007427 397 NGSLF-----DL---------LHESRG----VGRIPLAWTTR----LSI---------------IKQTAKGLAFLHQTL- 438 (604)
Q Consensus 397 ~gsL~-----~~---------l~~~~~----~~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~~- 438 (604)
|..+. .+ +|.... ......++... ..+ ...+...++.+.+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 11 222110 00111222211 001 111112233333221
Q ss_pred --CCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 439 --HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 439 --~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
....++|+|+++.||++ ++ .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~---~~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILW---RD--GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEE---SS--SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeE---cC--CCEEEECCCCCc
Confidence 23568999999999999 42 689999987644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0041 Score=62.38 Aligned_cols=76 Identities=12% Similarity=0.092 Sum_probs=40.4
Q ss_pred ccCcCCcce-EEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--CCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 324 VLGKGKVGS-TYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH--ENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 324 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.|+.|.... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+.... -+++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 455554444 6777765467788876643221 233456666655532 2356677664333 3789999977666
Q ss_pred HHHh
Q 007427 401 FDLL 404 (604)
Q Consensus 401 ~~~l 404 (604)
.+++
T Consensus 100 ~~~l 103 (333)
T 3csv_A 100 TEVI 103 (333)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 5544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0023 Score=63.80 Aligned_cols=144 Identities=14% Similarity=0.138 Sum_probs=76.5
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCC--cccEEEE------EecCCceEEEEec
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN--LAKIVSF------YYSKEEKLIIYEF 394 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~ 394 (604)
+.|+.|....+|+....+| .+++|+..... ....+..|+.++..+.... +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3567788889999987766 58899886521 1234556777766653212 2333321 1123556899999
Q ss_pred CCCCCHHH--------------HhhcccCC-CC---CCC---CHHHHHH------------HHHHHHHHHHHHHhcCC--
Q 007427 395 LPNGSLFD--------------LLHESRGV-GR---IPL---AWTTRLS------------IIKQTAKGLAFLHQTLH-- 439 (604)
Q Consensus 395 ~~~gsL~~--------------~l~~~~~~-~~---~~l---~~~~~~~------------i~~~ia~gL~yLH~~~~-- 439 (604)
++|..+.. .+|..... .. ... .|..... +...+...++++++...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98764311 12221100 00 001 1322111 01124445566654321
Q ss_pred -CCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 440 -SHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 440 -~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
..+++|+|+.+.|||++ +...+.|+||+.+
T Consensus 185 ~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a 215 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFL---GDELSGLIDFYFA 215 (322)
T ss_dssp SCEEEECSCCCGGGEEEE---TTEEEEECCCTTC
T ss_pred CCcccCCCCCCccCEEEe---CCceEEEecchhc
Confidence 35799999999999994 3334579999865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.001 Score=69.31 Aligned_cols=71 Identities=14% Similarity=0.233 Sum_probs=48.8
Q ss_pred cccCcCCcceEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-ccEEEEEecCCceEEEEe
Q 007427 323 EVLGKGKVGSTYKATLES--------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL-AKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 393 (604)
+.|+.|....||++...+ +..+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998753 5789999884321 12455678888888753333 667776542 38999
Q ss_pred cCCCCC
Q 007427 394 FLPNGS 399 (604)
Q Consensus 394 ~~~~gs 399 (604)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00056 Score=69.53 Aligned_cols=108 Identities=19% Similarity=0.212 Sum_probs=74.4
Q ss_pred CcEeEEEeCCCCc---------eecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCC-
Q 007427 67 GHIVSLELEEIQL---------AGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI- 136 (604)
Q Consensus 67 ~~~~~l~l~~~~l---------~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~- 136 (604)
.+|..|.+.++.+ .+.+++ ++..+++|+.|+|++|.- -.+|.+. +++|+.|+|..|.++...-..+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~-l~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNN-LSIGKKP-RPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBT-CBCCSCB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCC-ceecccc-CCCCcEEEEecCCCChHHHHHHHH
Confidence 5789999876543 123444 478889999999998831 1345543 88999999998887654444443
Q ss_pred -CCCCCCEEeccC--Cccccc--C-------CCCCCCCCcEEEccCCcccccC
Q 007427 137 -DLPKLKKLELQE--NYLDGQ--I-------PPFNQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 137 -~l~~l~~l~l~~--N~l~g~--i-------p~~~~~~l~~l~ls~n~l~g~~ 177 (604)
++++|+.|+|+. |...|. + ....+++|+.|+|++|.+.+..
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence 789999999863 332222 1 1124789999999999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0059 Score=62.24 Aligned_cols=145 Identities=14% Similarity=0.183 Sum_probs=82.4
Q ss_pred cccCcCCcceEEEEEec--------CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEe
Q 007427 323 EVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 393 (604)
+.+..|-...+|++... +++.+++|+.... ........+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35667888899999864 3578999986432 123456678999888774 3223567766643 39999
Q ss_pred cCCCCCHHH--------------H---hhcccC-CCCCCC-CHHHHHHHHHHHHH-------------------HHHHHH
Q 007427 394 FLPNGSLFD--------------L---LHESRG-VGRIPL-AWTTRLSIIKQTAK-------------------GLAFLH 435 (604)
Q Consensus 394 ~~~~gsL~~--------------~---l~~~~~-~~~~~l-~~~~~~~i~~~ia~-------------------gL~yLH 435 (604)
|++|.+|.. . +|.... .++.+. -|.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998755431 1 222111 111111 24555556544422 233443
Q ss_pred hc----CCCCCceecCCCCCceEEeecC-CcceEEEeeccCC
Q 007427 436 QT----LHSHKVPHANLKSSNILIFREN-DIYRAKLTNFGFL 472 (604)
Q Consensus 436 ~~----~~~~~ivHrDlkp~NILl~~~~-~~~~~kl~DFGla 472 (604)
+. -....++|+|+.+.||+++.++ ....+.++||..+
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 22 1234689999999999996541 1246799999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0024 Score=65.16 Aligned_cols=72 Identities=8% Similarity=0.105 Sum_probs=43.4
Q ss_pred cccCcCCcceEEEEEecC---------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-cccEEEEEecCCceEEEE
Q 007427 323 EVLGKGKVGSTYKATLES---------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN-LAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 392 (604)
+.++.|....+|++...+ +..+++|+....... ..+...|.++++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 357788889999998654 268889887543211 112356777777774333 44666554 2 37899
Q ss_pred ecCCCCC
Q 007427 393 EFLPNGS 399 (604)
Q Consensus 393 e~~~~gs 399 (604)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.62 E-value=0.00032 Score=62.92 Aligned_cols=82 Identities=15% Similarity=0.170 Sum_probs=48.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCC-Cccc-CCCCCCC----CCccEEeCCCCc-ccccCCccCCCCCC
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL-LSGS-LPNLTNL----VNLETVFLSQNH-FSDGIPFGYIDLPK 140 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~-l~g~-~p~~~~l----~~L~~l~l~~N~-l~g~iP~~~~~l~~ 140 (604)
+++.|||+++.++..=-.. +..+++|+.|+|+++. +|.. +-.++.+ ++|+.|||+++. +|..==..+.++++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~-L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDH-MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGG-GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHHH-hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 5777777777765321122 5667777777777774 5542 2234443 367777777763 55322234566777
Q ss_pred CCEEeccCCc
Q 007427 141 LKKLELQENY 150 (604)
Q Consensus 141 l~~l~l~~N~ 150 (604)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0033 Score=62.04 Aligned_cols=70 Identities=3% Similarity=0.023 Sum_probs=42.9
Q ss_pred cccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-ccEEEEEecCCceEEEEecC-CCCCH
Q 007427 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL-AKIVSFYYSKEEKLIIYEFL-PNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 400 (604)
+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+....+ .++++++ .+.-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 46788999999999 55888887643211 1123457777766643233 4566543 44457899999 65444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.003 Score=53.81 Aligned_cols=36 Identities=25% Similarity=0.411 Sum_probs=18.7
Q ss_pred CccEEeCCCCcccccCCcc-CCCCCCCCEEeccCCccc
Q 007427 116 NLETVFLSQNHFSDGIPFG-YIDLPKLKKLELQENYLD 152 (604)
Q Consensus 116 ~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l~l~~N~l~ 152 (604)
+|+.|||++|+|+. ||.. +..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCee
Confidence 34555555555554 4432 345556666666666543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.015 Score=60.78 Aligned_cols=73 Identities=18% Similarity=0.133 Sum_probs=46.9
Q ss_pred cccCcCCcceEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc-ccEEEEEecCCceEEEEecCCCCCH
Q 007427 323 EVLGKGKVGSTYKATLES-GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL-AKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+.|+.|-...+|++...+ +..+++|+........ -+..+|..++..+...++ .++++++. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457788889999998765 5788899875422111 112578888888865444 56777663 2 359999987443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.40 E-value=0.006 Score=62.89 Aligned_cols=97 Identities=15% Similarity=0.247 Sum_probs=56.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccc----cCC-ccCCCCCC
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSD----GIP-FGYIDLPK 140 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g----~iP-~~~~~l~~ 140 (604)
+|+.|+|.++ ++ .|+...+.+ ++|+.++|. |+++- |+ .|.+|++|+.+++.+|.+.. .|+ ..+.+|++
T Consensus 227 ~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~lp-~~i~~-I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~ 301 (401)
T 4fdw_A 227 QLKTIEIPEN-VS-TIGQEAFRE-SGITTVKLP-NGVTN-IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK 301 (401)
T ss_dssp TCCCEECCTT-CC-EECTTTTTT-CCCSEEEEE-TTCCE-ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred CCCEEecCCC-cc-Ccccccccc-CCccEEEeC-CCccE-EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence 5667777653 43 455544444 667777773 33432 33 36677777777777766541 133 34566777
Q ss_pred CCEEeccCCcccccCCCC---CCCCCcEEEccCC
Q 007427 141 LKKLELQENYLDGQIPPF---NQTSLIDFNVSYN 171 (604)
Q Consensus 141 l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~n 171 (604)
|+.++|.+ +++ .|+.. .+.+|+.+++.+|
T Consensus 302 L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 302 LARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp CCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT
T ss_pred CCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc
Confidence 77777763 354 45542 3566777777544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.02 Score=52.67 Aligned_cols=103 Identities=13% Similarity=0.129 Sum_probs=62.7
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
-+|.++|.... .|+++++++.++.|.+.+|.-+-.. ..-..+=+.|..|++..++ .+.+.+ ..
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~---~~~~~~i~~~~~i~l~~dG---~V~f~~-~~------ 95 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARR---RQPRHRVRSAAQIRVWRDG---AVTLAP-AA------ 95 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSGGGEEEETTS---CEEECC-C-------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhc---ccCCceecCCcceEEecCC---ceeccc-cc------
Confidence 48999998765 3799999999999999998766211 1111223346788884443 334332 11
Q ss_pred CCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCC
Q 007427 478 RKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP 520 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p 520 (604)
.......+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus 96 --s~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 96 --DDAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 111233455888763 3456788999999999999975554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0054 Score=52.14 Aligned_cols=35 Identities=31% Similarity=0.317 Sum_probs=16.3
Q ss_pred cCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcc
Q 007427 93 FLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHF 127 (604)
Q Consensus 93 ~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l 127 (604)
+|+.|+|++|+|+...+ .|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 34455555555544333 244444555555555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0011 Score=59.30 Aligned_cols=90 Identities=17% Similarity=0.170 Sum_probs=63.2
Q ss_pred cCChhhhcCCccCCeeeCccCCCccc-CCCCCCCCCccEEeCCCCc-ccccCCccCCCC----CCCCEEeccCCc-ccc-
Q 007427 82 ILPPGFLQNITFLNKLSLRNNLLSGS-LPNLTNLVNLETVFLSQNH-FSDGIPFGYIDL----PKLKKLELQENY-LDG- 153 (604)
Q Consensus 82 ~~p~~~~~~l~~L~~l~l~~n~l~g~-~p~~~~l~~L~~l~l~~N~-l~g~iP~~~~~l----~~l~~l~l~~N~-l~g- 153 (604)
.+|....+ --.|+.|||+++.++.. +..+.+|++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. +|.
T Consensus 52 ~LP~~~~~-~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~ 130 (176)
T 3e4g_A 52 HLPTGPLD-KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDK 130 (176)
T ss_dssp GSCCCSTT-CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHH
T ss_pred cCCcccCC-CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHH
Confidence 45654223 25799999999998753 5568899999999999995 665333345554 479999999984 652
Q ss_pred -cCCCCCCCCCcEEEccCCc
Q 007427 154 -QIPPFNQTSLIDFNVSYNN 172 (604)
Q Consensus 154 -~ip~~~~~~l~~l~ls~n~ 172 (604)
-..-..+++|+.|+|++..
T Consensus 131 Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 131 GIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHHGGGCTTCCEEEEESCT
T ss_pred HHHHHhcCCCCCEEECCCCC
Confidence 1111257899999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0024 Score=58.36 Aligned_cols=82 Identities=12% Similarity=0.173 Sum_probs=44.6
Q ss_pred CcEeEEEeCCC-Ccee----cCChhhhcCCccCCeeeCccCCCccc--CC---CCCCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEEI-QLAG----ILPPGFLQNITFLNKLSLRNNLLSGS--LP---NLTNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~~-~l~g----~~p~~~~~~l~~L~~l~l~~n~l~g~--~p---~~~~l~~L~~l~l~~N~l~g~----iP 132 (604)
..++.|+|++| ++.. .|-.. +..-+.|+.|+|++|+++.. .. .+..=+.|+.|+|+.|+++.. |=
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~a-L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEA-ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHH-HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHH-HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 35777777764 5431 12222 44556777777777777632 11 133345677777777777632 22
Q ss_pred ccCCCCCCCCEEeccCC
Q 007427 133 FGYIDLPKLKKLELQEN 149 (604)
Q Consensus 133 ~~~~~l~~l~~l~l~~N 149 (604)
..+..-+.|+.|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 23444445677777654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.04 Score=55.25 Aligned_cols=68 Identities=18% Similarity=0.156 Sum_probs=42.2
Q ss_pred CcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCCcccEEEE------EecCCceEEEEecCC
Q 007427 326 GKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK---HENLAKIVSF------YYSKEEKLIIYEFLP 396 (604)
Q Consensus 326 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 396 (604)
|.|....||+....+| .+++|+...... ..|+..+..+. -+++.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999998777 899998765432 24444444442 1224444432 123456789999999
Q ss_pred CCCH
Q 007427 397 NGSL 400 (604)
Q Consensus 397 ~gsL 400 (604)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.51 E-value=0.034 Score=57.22 Aligned_cols=36 Identities=17% Similarity=0.229 Sum_probs=16.5
Q ss_pred CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 111 LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 111 ~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
|.+|.+|+.++|++|+++- ||.....+++|+.+.|.
T Consensus 176 F~~c~~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp 211 (401)
T 4fdw_A 176 FYYCYNLKKADLSKTKITK-LPASTFVYAGIEEVLLP 211 (401)
T ss_dssp TTTCTTCCEEECTTSCCSE-ECTTTTTTCCCSEEECC
T ss_pred hhCcccCCeeecCCCcceE-echhhEeecccCEEEeC
Confidence 4444445555554444443 44333334444444444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.90 E-value=0.16 Score=52.47 Aligned_cols=73 Identities=10% Similarity=0.076 Sum_probs=46.9
Q ss_pred cccCcCCcceEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEe
Q 007427 323 EVLGKGKVGSTYKATLES--------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 393 (604)
+.+..|-...+|+....+ ++.+++|+....... .-+..+|..+++.+. +.-..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 356678889999998753 578999987543211 112356777777774 222455665432 378999
Q ss_pred cCCCCCH
Q 007427 394 FLPNGSL 400 (604)
Q Consensus 394 ~~~~gsL 400 (604)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.77 E-value=0.018 Score=52.49 Aligned_cols=84 Identities=21% Similarity=0.297 Sum_probs=59.8
Q ss_pred hcCCccCCeeeCccC-CCccc----CC-CCCCCCCccEEeCCCCcccc----cCCccCCCCCCCCEEeccCCcccccCCC
Q 007427 88 LQNITFLNKLSLRNN-LLSGS----LP-NLTNLVNLETVFLSQNHFSD----GIPFGYIDLPKLKKLELQENYLDGQIPP 157 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n-~l~g~----~p-~~~~l~~L~~l~l~~N~l~g----~iP~~~~~l~~l~~l~l~~N~l~g~ip~ 157 (604)
+.+-+.|+.|+|++| ++... |- .+..-+.|+.|+|++|++.. .|-..+..-+.|+.|+|++|+++..=-.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 566789999999986 76532 11 25666789999999999973 2333444567899999999999732111
Q ss_pred ------CCCCCCcEEEccCC
Q 007427 158 ------FNQTSLIDFNVSYN 171 (604)
Q Consensus 158 ------~~~~~l~~l~ls~n 171 (604)
..-..|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 12456999999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.47 E-value=0.6 Score=47.16 Aligned_cols=96 Identities=15% Similarity=0.287 Sum_probs=51.1
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCc-cCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPF-GYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~~l~~l 144 (604)
.+..+.+..+ +. .|+...+.++..|+.+.+..+ ++ .|+ .+.++.+|+.+.+..+ ++- |+. .+.++++|+.+
T Consensus 218 ~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~-i~~~aF~~c~~L~~i 291 (379)
T 4h09_A 218 NLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKT-VPYLLCSGCSNLTKV 291 (379)
T ss_dssp SCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSE-ECTTTTTTCTTCCEE
T ss_pred ccceeeeccc-ee-EEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-cee-ccccccccccccccc
Confidence 4555555433 22 244433556677777776554 22 122 3556666666666533 332 332 34566667777
Q ss_pred eccCCcccccCCCC---CCCCCcEEEccC
Q 007427 145 ELQENYLDGQIPPF---NQTSLIDFNVSY 170 (604)
Q Consensus 145 ~l~~N~l~g~ip~~---~~~~l~~l~ls~ 170 (604)
.+.+|.++ .|+.. .+.+|+.++|..
T Consensus 292 ~l~~~~i~-~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 292 VMDNSAIE-TLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp EECCTTCC-EECTTTTTTCTTCCEEECCT
T ss_pred cccccccc-eehhhhhcCCCCCCEEEcCc
Confidence 66666665 45542 356666666643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.76 E-value=1.2 Score=45.22 Aligned_cols=56 Identities=14% Similarity=0.371 Sum_probs=23.2
Q ss_pred hcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCc-cCCCCCCCCEEecc
Q 007427 88 LQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPF-GYIDLPKLKKLELQ 147 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~~l~~l~l~ 147 (604)
+.+++.|+.+.+.++..+ |. .+.++.+|+.+.+. +.++- |+. .+.++.+|+.++|.
T Consensus 261 F~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~-~~i~~-I~~~aF~~c~~L~~i~lp 319 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFS-SRITE-LPESVFAGCISLKSIDIP 319 (394)
T ss_dssp TTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECC-TTCCE-ECTTTTTTCTTCCEEECC
T ss_pred eeecccccEEecccccce--ecCcccccccccccccCC-Ccccc-cCceeecCCCCcCEEEeC
Confidence 344555555555443322 22 24444444444443 22222 332 23344444444444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.25 E-value=0.6 Score=47.55 Aligned_cols=99 Identities=15% Similarity=0.311 Sum_probs=71.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCC-ccCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIP-FGYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP-~~~~~l~~l~~l 144 (604)
.++.+.+.++-. .|....+.+++.|+.+.+.. .++ .|+ .|.+|.+|+.++|..| ++- |. ..+.+|.+|+.+
T Consensus 266 ~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~~-~i~-~I~~~aF~~c~~L~~i~lp~~-v~~-I~~~aF~~C~~L~~i 339 (394)
T 4gt6_A 266 YLASVKMPDSVV--SIGTGAFMNCPALQDIEFSS-RIT-ELPESVFAGCISLKSIDIPEG-ITQ-ILDDAFAGCEQLERI 339 (394)
T ss_dssp SCCEEECCTTCC--EECTTTTTTCTTCCEEECCT-TCC-EECTTTTTTCTTCCEEECCTT-CCE-ECTTTTTTCTTCCEE
T ss_pred cccEEecccccc--eecCcccccccccccccCCC-ccc-ccCceeecCCCCcCEEEeCCc-ccE-ehHhHhhCCCCCCEE
Confidence 577787776544 36655578889999999963 343 355 4888999999999765 443 44 457789999999
Q ss_pred eccCCcccccCCC---CCCCCCcEEEccCCccc
Q 007427 145 ELQENYLDGQIPP---FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 145 ~l~~N~l~g~ip~---~~~~~l~~l~ls~n~l~ 174 (604)
.|..| ++ .|+. .++.+|+.+++.+|...
T Consensus 340 ~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 340 AIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp EECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred EECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence 99755 55 6765 25889999999887543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.22 E-value=1.5 Score=44.75 Aligned_cols=31 Identities=19% Similarity=0.397 Sum_probs=23.9
Q ss_pred ceecCCCCCceEEeec---CCcceEEEeeccCCC
Q 007427 443 VPHANLKSSNILIFRE---NDIYRAKLTNFGFLP 473 (604)
Q Consensus 443 ivHrDlkp~NILl~~~---~~~~~~kl~DFGla~ 473 (604)
++|+|+.+.|||+..+ ++...++++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999542 234568999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=85.92 E-value=1.2 Score=45.28 Aligned_cols=55 Identities=13% Similarity=0.156 Sum_probs=24.3
Q ss_pred CCCCCCccEEeCCCCcccccCC-ccCCCCCCCCEEeccCCcccccCCCC---CCCCCcEEEcc
Q 007427 111 LTNLVNLETVFLSQNHFSDGIP-FGYIDLPKLKKLELQENYLDGQIPPF---NQTSLIDFNVS 169 (604)
Q Consensus 111 ~~~l~~L~~l~l~~N~l~g~iP-~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls 169 (604)
+.++++|+.++|.++ ++- |+ ..+.++++|+.++|..| ++ .|+.. .+.+|+.+++.
T Consensus 316 F~~c~~L~~i~lp~~-v~~-I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 316 FESCTSLVSIDLPYL-VEE-IGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEE
T ss_pred hcCCCCCCEEEeCCc-ccE-EhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEEC
Confidence 444555555555432 322 32 23445555555555444 33 34331 34455555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=84.98 E-value=1.2 Score=45.29 Aligned_cols=76 Identities=14% Similarity=0.223 Sum_probs=56.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCC-ccCCCCCCCCEE
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIP-FGYIDLPKLKKL 144 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP-~~~~~l~~l~~l 144 (604)
.++.+.+.++ ++ .|+...+.++++|+.++|.++ ++ .|+ .|.+|++|+.++|..| ++- |+ ..+.++++|+.+
T Consensus 298 ~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 298 SLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRK-IGANAFQGCINLKKV 371 (394)
T ss_dssp TCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCE-ECTTTBTTCTTCCEE
T ss_pred cccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccE-ehHHHhhCCCCCCEE
Confidence 5666766543 44 466655788999999999754 44 354 4889999999999877 653 55 467899999999
Q ss_pred eccCC
Q 007427 145 ELQEN 149 (604)
Q Consensus 145 ~l~~N 149 (604)
+|..|
T Consensus 372 ~lp~~ 376 (394)
T 4fs7_A 372 ELPKR 376 (394)
T ss_dssp EEEGG
T ss_pred EECCC
Confidence 99765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.67 E-value=3.2 Score=37.94 Aligned_cols=116 Identities=6% Similarity=0.031 Sum_probs=77.7
Q ss_pred CCCCCcccEEEEEecCCceEEEEecCCCC-CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 007427 370 LKHENLAKIVSFYYSKEEKLIIYEFLPNG-SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANL 448 (604)
Q Consensus 370 l~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl 448 (604)
..||+.+.. .+-.+.+...+.|+.-+.+ ++.. ++ .++...+++++.+|+....+++ .-+|--|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~------~r~tf~L 105 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNR------TRYTFVL 105 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGG------SSEECCC
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhc------CceEEEE
Confidence 368888876 5556666655656554322 2222 32 2678899999999988776555 4568889
Q ss_pred CCCceEEeecCCcceEEEeeccCCCCCCCCCCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCC
Q 007427 449 KSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGN 522 (604)
Q Consensus 449 kp~NILl~~~~~~~~~kl~DFGla~~~~~~~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~ 522 (604)
.|+||++ +.+..+++.-.|+-..+ +|. ..++..=.-.+=+++..+++++..|.
T Consensus 106 ~P~NL~f---~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 106 APDELFF---TRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SGGGEEE---CTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ecceEEE---cCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999 77788999888763322 222 12222334467788899999998875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=80.23 E-value=2.5 Score=42.46 Aligned_cols=97 Identities=19% Similarity=0.269 Sum_probs=71.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCC-ccCCCCCCCCE
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIP-FGYIDLPKLKK 143 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP-~~~~~l~~l~~ 143 (604)
..+..+.+..+ ++ .|....+.++.+|+.+.+..+ ++ .|+ .+.++++|+.+++.+|.++- |+ ..+.++.+|+.
T Consensus 240 ~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~-I~~~aF~~c~~L~~ 314 (379)
T 4h09_A 240 KALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIET-LEPRVFMDCVKLSS 314 (379)
T ss_dssp SSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCE-ECTTTTTTCTTCCE
T ss_pred ccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccce-ehhhhhcCCCCCCE
Confidence 36778888765 44 466655788999999999755 33 344 48899999999999988875 54 56789999999
Q ss_pred EeccCCcccccCCCC---CCCCCcEEEccC
Q 007427 144 LELQENYLDGQIPPF---NQTSLIDFNVSY 170 (604)
Q Consensus 144 l~l~~N~l~g~ip~~---~~~~l~~l~ls~ 170 (604)
+.|.+| ++ .|+.. ++.+|+.+.+..
T Consensus 315 i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 315 VTLPTA-LK-TIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EECCTT-CC-EECTTTTTTCTTCCCCCCCT
T ss_pred EEcCcc-cc-EEHHHHhhCCCCCCEEEECC
Confidence 999765 55 56652 467888777643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 604 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-47
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 35/279 (12%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
E LG G+ G + VAVK +K ++S F+ + L+ +L+H+ L ++ +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
++E II E++ NGSL D L G I L L + Q A+G+AF+
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE----ERN 129
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-----RSPEFPEGKR 497
H +L+++NIL+ D K+ +FG L+ + + +PE
Sbjct: 130 YIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
T K+DV+ FGI+L E++T N E +L RMV ++ ++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ----- 241
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
L C PE RP + +E+
Sbjct: 242 -------------LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-47
Identities = 59/289 (20%), Positives = 115/289 (39%), Gaps = 35/289 (12%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +G G G+ YK V + V + F ++ +L K +H N+ + +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ + I+ ++ SL+ LH + I +QTA+G+ +LH
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA----KS 124
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SPEF---P 493
+ H +LKS+NI + + K+ +FG + S +PE
Sbjct: 125 IIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553
+ + ++DVY FGI+L E++TG++P + + D + +V + + L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIFMVGRGYLSPDLS- 232
Query: 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602
+ N + L EC ++RP ++L IE + + +
Sbjct: 233 -----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-46
Identities = 57/277 (20%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +GKG+ G G VAVK +KN + + F+ + ++ +L+H NL +++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 383 YSKEEKL-IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
++ L I+ E++ GSL D L GR L L + + +L +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE----GN 122
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKRLTH 500
H +L + N+L+ +N AK+++FG S + + L + +PE K+ +
Sbjct: 123 NFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 501 KADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAARE 560
K+DV+ FGI+L E+ + + + +M + + +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE-------- 231
Query: 561 GQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ C + RP ++ ++E I+
Sbjct: 232 ----------VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-46
Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ +G G+ G + + VA+K ++ A+S+++F+++ +++ KL H L ++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ +++EF+ +G L D L R A T L + +G+A+L +
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE----AC 121
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-----RSPEFPEGKR 497
V H +L + N L+ + K+++FG + + + + SPE R
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
+ K+DV+ FG+++ EV + + N+E D+S R+ ST +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ----- 233
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
+ C PE RP S +LR++ EI
Sbjct: 234 -------------IMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-45
Identities = 53/279 (18%), Positives = 112/279 (40%), Gaps = 35/279 (12%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
+ LG G+ G VA+K +K ++S+ EF+++ +++ L HE L ++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
+ II E++ NG L + L E R L + K + + +L +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES----KQ 120
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS-----PEFPEGKR 497
H +L + N L+ ND K+++FG + + + ++ PE +
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
+ K+D++ FG+++ E+ + N+ET+ ++ +R+ + S +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----- 232
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ C ++RP +L I ++
Sbjct: 233 -------------IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-43
Identities = 55/301 (18%), Positives = 100/301 (33%), Gaps = 35/301 (11%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
E +GKG+ G ++ G VAVK ++ L+HEN+ ++
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 383 YSKEEKL----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ-- 436
++ ++ +GSLFD L+ R + + + TA GLA LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 437 --TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------ 488
T + H +LKS NIL+ + + G S + ++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 489 --SPEFPEGK------RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLS--DWV 538
+PE + +AD+Y G++ E+ G DL D
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
+ L I + + + ++ EC R + + + ++
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 599 M 599
Sbjct: 298 Q 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-42
Identities = 56/297 (18%), Positives = 108/297 (36%), Gaps = 39/297 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV-KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
LG G G +K + SG V+A K + + + + ++++Q+L + +
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+YS E I E + GSL +L ++ + + KGL +L
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EK 123
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG--RSPEFPEGKRL 498
HK+ H ++K SNIL+ +I KL +FG L A+ + SPE +G
Sbjct: 124 HKIMHRDVKPSNILVNSRGEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPGNN-------ETSGDLSDWVRMVVDNDWSTDIL 551
+ ++D++ G+ L+E+ GR P + GD ++
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 552 DVEILAAREGQNEMLR-----------------LTELALECTDIAPEKRPKMSEVLR 591
++ + + +C P +R + +++
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-41
Identities = 54/279 (19%), Positives = 102/279 (36%), Gaps = 33/279 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G G G K G ++ K + +M K+ V ++ LL +LKH N+ +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 380 SFYYSKEEKL--IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ- 436
+ I+ E+ G L ++ + R L L ++ Q L H+
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS----RKASENLAIGRSPEF 492
+ H V H +LK +N+ + + ++ KL +FG +L KA SPE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNV---KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552
K+D++ G +L E+ P E +G + + + +S ++ +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNE 244
Query: 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ ++ RP + E+L
Sbjct: 245 ------------------IITRMLNLKDYHRPSVEEILE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 3e-41
Identities = 63/322 (19%), Positives = 125/322 (38%), Gaps = 50/322 (15%)
Query: 289 DSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKATL----ESGAVV 344
D ++ EDP V F K I + + +V+G G+ G L + V
Sbjct: 5 DPFTFEDPNEAVRE--FAKEIDISCVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFV 57
Query: 345 AVKRVK-NMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDL 403
A+K +K +++F+ + ++G+ H N+ + +II EF+ NGSL
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 404 LHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYR 463
L ++ G + +++ A G+ +L H +L + NIL+
Sbjct: 118 LRQNDG----QFTVIQLVGMLRGIAAGMKYLAD----MNYVHRDLAARNILVNSN---LV 166
Query: 464 AKLTNFGFLPLLPSRKASENLAIGR---------SPEFPEGKRLTHKADVYCFGIILLEV 514
K+++FG L + +PE + ++ T +DV+ +GI++ EV
Sbjct: 167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 226
Query: 515 ITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALE 574
++ P + T+ D+ + + D L +L L+
Sbjct: 227 MSYGER----PYWDMTNQDVINAIEQDYRLPPPMDCPS--------------ALHQLMLD 268
Query: 575 CTDIAPEKRPKMSEVLRRIEEI 596
C RPK +++ ++++
Sbjct: 269 CWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-40
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 35/279 (12%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFY 382
LG+G G + T VA+K +K +S + F+Q+ Q++ KL+HE L ++ +
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-V 80
Query: 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK 442
S+E I+ E++ GSL D L G L + + Q A G+A++ +
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER----MN 133
Query: 443 VPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-----RSPEFPEGKR 497
H +L+++NIL+ + K+ +FG L+ + + +PE R
Sbjct: 134 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
T K+DV+ FGI+L E+ T N E + RM + + D
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD----- 245
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
L +C PE+RP + +E+
Sbjct: 246 -------------LMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 3e-40
Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 35/280 (12%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G+ G Y+ + VAVK +K + + +EF+++ ++ ++KH NL +++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ II EF+ G+L D L E R ++ L + Q + + L
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSA----MEYLEKK 134
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-----SPEFPEGK 496
H +L + N L+ + + K+ +FG L+ + + +PE
Sbjct: 135 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
+ + K+DV+ FG++L E+ T + ++ L RM + +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE---- 247
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
L C P RP +E+ + E +
Sbjct: 248 --------------LMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 2e-39
Identities = 55/306 (17%), Positives = 111/306 (36%), Gaps = 57/306 (18%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
+G+G G ++A E +VAVK +K +A + +F ++ L+ + + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRG-------------------VGRIPLA 416
K++ + +++E++ G L + L G PL+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 417 WTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476
+L I +Q A G+A+ L K H +L + N L+ K+ +FG +
Sbjct: 139 CAEQLCIARQVAAGMAY----LSERKFVHRDLATRNCLVGEN---MVVKIADFGLSRNIY 191
Query: 477 SRKASENLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530
S + PE R T ++DV+ +G++L E+ + + + E
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
+ D + + ++ + L C P RP +
Sbjct: 252 IYYVRDGNILACPENCPLELYN------------------LMRLCWSKLPADRPSFCSIH 293
Query: 591 RRIEEI 596
R ++ +
Sbjct: 294 RILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 61/299 (20%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLK-HEN 374
+ LG G G +AT ++ VAVK +K + + ++ + ++++L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGV-------------GRIPLAWTTRL 421
+ ++ L+I E+ G L + L R + L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481
S Q AKG+AF L S H +L + NIL+ + +
Sbjct: 149 SFSYQVAKGMAF----LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 482 ENLAIG---RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGN-GSPGNNETSGDLSDW 537
N + +PE T ++DV+ +GI L E+ + G P +++ + +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
RM+ ++ D + C D P KRP ++++ IE+
Sbjct: 265 FRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 47/298 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G G YKA E+ + A K + + ++++ ++ +L H N+ K++
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+Y + I+ EF G++ ++ E PL + + KQT L + LH +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNY----LHDN 129
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEF----- 492
K+ H +LK+ NIL + DI KL +FG + IG +PE
Sbjct: 130 KIIHRDLKAGNILFTLDGDI---KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL-SDWVRMVVDNDWSTDIL 551
+ + +KADV+ GI L+E+ P + S+ + + WS++
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR-------RIEEIQPMIEE 602
D +C + + R S++L+ + I+ +I E
Sbjct: 247 D------------------FLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAE 286
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (365), Expect = 5e-39
Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E LG G G ++ T +G A K V + K+ +++Q + L+H L +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ E ++IYEF+ G LF+ + + ++ + ++Q KGL +H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCH----MHEN 143
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---RSPEFPEGKRL 498
H +LK NI+ + KL +FG L +++ + +PE EGK +
Sbjct: 144 NYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
+ D++ G++ +++G P G + + +R V DW+ D ++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ + P R + + L
Sbjct: 255 --------DGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 1e-38
Identities = 55/315 (17%), Positives = 110/315 (34%), Gaps = 56/315 (17%)
Query: 284 EKKMPDSWSMEDPERRVELEFFDKTIPVFDLDDLLRASAEVLGKGKVGSTYKAT-LESGA 342
+ + + + +DPE+ +G G G+ Y A + +
Sbjct: 1 DPDVAELFFKDDPEKLFSDL-------------------REIGHGSFGAVYFARDVRNSE 41
Query: 343 VVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399
VVA+K++ S ++ +++++ L KL+H N + Y + ++ E+ +
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN 459
L + PL ++ +GLA+ LHSH + H ++K+ NIL+
Sbjct: 102 SDLLEVHKK-----PLQEVEIAAVTHGALQGLAY----LHSHNMIHRDVKAGNILLSEPG 152
Query: 460 DIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVIT 516
+ KL +FG ++ + +PE + K DV+ GI +E+
Sbjct: 153 LV---KLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 517 GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECT 576
+ P + + + WS + C
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN------------------FVDSCL 251
Query: 577 DIAPEKRPKMSEVLR 591
P+ RP +L+
Sbjct: 252 QKIPQDRPTSEVLLK 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 44/308 (14%)
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNALSK-KEFVQQMQ 365
V L+ EV+G+G G Y TL AVK + + + + +F+ +
Sbjct: 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 366 LLGKLKHENLAKIVSFYYSKEEK-LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSII 424
++ H N+ ++ E L++ ++ +G L + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFG 136
Query: 425 KQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL 484
Q AKG+ FL K H +L + N ++ ++ + K+ +FG + ++
Sbjct: 137 LQVAKGMKFLAS----KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 485 AIGR--------SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSD 536
+ E + ++ T K+DV+ FG++L E++T P + + L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
R++ + + + L+C E RP SE++ RI I
Sbjct: 250 GRRLLQPEYCPDPLYE------------------VMLKCWHPKAEMRPSFSELVSRISAI 291
Query: 597 -QPMIEEN 603
I E+
Sbjct: 292 FSTFIGEH 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 60/287 (20%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 323 EVLGKGKVGSTYKATLESG-----AVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+V+G G+ G YK L++ VA+K +K + +F+ + ++G+ H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
++ + +II E++ NG+L L E G + + +++ A G +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG----MK 124
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-------S 489
L + H +L + NIL+ N K+++FG +L + G +
Sbjct: 125 YLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 490 PEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549
PE ++ T +DV+ FGI++ EV+T N+E ++D R+ D +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
I L ++C +RPK ++++ ++++
Sbjct: 242 IYQ------------------LMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 48/297 (16%), Positives = 107/297 (36%), Gaps = 42/297 (14%)
Query: 311 VFDLDDLLRASAEVLGKGKVGSTYKATL---ESGAVVAVKRVK-NMNALSKKEFVQQMQL 366
D+LL A E LG G GS + + VA+K +K +E +++ Q+
Sbjct: 4 FLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 367 LGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQ 426
+ +L + + +++ ++ +++ E G L L R + + ++ Q
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQ 117
Query: 427 TAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI 486
+ G+ +L + H +L + N+L+ + +++FG L + +
Sbjct: 118 VSMGMKYLEE----KNFVHRDLAARNVLLVNRHYAK---ISDFGLSKALGADDSYYTARS 170
Query: 487 GR-------SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR 539
+PE ++ + ++DV+ +G+ + E ++ E + R
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 230
Query: 540 MVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
M + ++ L +C E RP V +R+
Sbjct: 231 MECPPECPPELYA------------------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 56/280 (20%), Positives = 108/280 (38%), Gaps = 40/280 (14%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G+G + YK E+ VA +++ + ++ F ++ ++L L+H N+ +
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 380 SFYYS----KEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ S K+ +++ E + +G+L L + + S +Q KGL FLH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPE 491
+ + H +LK NI I K+ + G L + A IG +PE
Sbjct: 130 T--RTPPIIHRDLKCDNIFITGPT--GSVKIGDLGLATLKRASFAKAV--IGTPEFMAPE 183
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
E K DVY FG+ +LE+ T P + + ++ V+ + +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP-- 240
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ E+ C ++R + ++L
Sbjct: 241 ---------------EVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-38
Identities = 64/293 (21%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E +G+G G+ Y A + +G VA++++ K+ + ++ ++ + K+ N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
Y +E ++ E+L GSL D++ E+ ++ ++ + L F LHS+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEF----LHSN 135
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEFPEGKR 497
+V H ++KS NIL+ + + KLT+FGF + ++ + +G +PE K
Sbjct: 136 QVIHRDIKSDNILLGMDGSV---KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557
K D++ GI+ +E+I G P + + ++ N L
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPE-------LQ 237
Query: 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVL--------RRIEEIQPMIEE 602
E + + R + C D+ EKR E+L + + + P+I
Sbjct: 238 NPEKLSAIFR--DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 45/290 (15%)
Query: 323 EVLGKGKVGSTYKATLES----GAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENL 375
E LG G G + ++ VAVK +K +F++++ + L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
++ + K ++ E P GSL D L + +G T Q A+G+ +L
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------- 488
S + H +L + N+L+ + + K+ +FG + LP + R
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLV---KIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547
+PE + + +H +D + FG+ L E+ T G+ P G G+ + R+ D
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597
DI + + ++C PE RP + + E Q
Sbjct: 242 QDIYN------------------VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 51/284 (17%), Positives = 108/284 (38%), Gaps = 40/284 (14%)
Query: 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNALSKKE-FVQQMQLLGKLKHENLAK 377
+G+G+ G ++ VA+K KN + S +E F+Q+ + + H ++ K
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
++ ++ II E G L L + L + + Q + LA+L
Sbjct: 73 LIG-VITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLE-- 125
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFP---- 493
S + H ++ + N+L+ + KL +FG + + ++
Sbjct: 126 --SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 494 -EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552
+R T +DV+ FG+ + E++ + NN+ G + + R+ + + +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
L +C P +RP+ +E+ ++ I
Sbjct: 241 ------------------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 51/285 (17%), Positives = 104/285 (36%), Gaps = 43/285 (15%)
Query: 324 VLGKGKVGSTYKATLE---SGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKI 378
LG G G+ K + VAVK +KN + K E + + ++ +L + + ++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ E +++ E G L L ++R + + ++ Q + G+ +L +
Sbjct: 74 IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-------SPE 491
H +L + N+L+ ++ K+++FG L + + +PE
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
+ + K+DV+ FG+++ E + +E + L RM ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
D L C E RP + V R+
Sbjct: 241 D------------------LMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 61/306 (19%), Positives = 119/306 (38%), Gaps = 46/306 (15%)
Query: 310 PVFDLDDLLRASAEVLGKGKVGSTYKATLESGA---VVAVKRVKNMNALS-KKEFVQQMQ 365
PV D +D+ +V+G+G G KA ++ A+KR+K + ++F +++
Sbjct: 5 PVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 366 LLGKL-KHENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIP---------- 414
+L KL H N+ ++ + + E+ P+G+L D L +SR + P
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 415 -LAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473
L+ L A+G+ +L + H +L + NIL+ + Y AK+ +FG
Sbjct: 123 TLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILV---GENYVAKIADFGLSR 175
Query: 474 LLPSRKASENLAIGR---SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET 530
+ + E T +DV+ +G++L E+++ E
Sbjct: 176 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 531 SGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVL 590
L R+ + ++ D L +C P +RP +++L
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYD------------------LMRQCWREKPYERPSFAQIL 277
Query: 591 RRIEEI 596
+ +
Sbjct: 278 VSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 9e-37
Identities = 53/275 (19%), Positives = 108/275 (39%), Gaps = 38/275 (13%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKI 378
LGKGK G+ Y A +S ++A+K + + +++++ L+H N+ ++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+++ +I E+ P G+++ L + + I + A L++
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSY----C 122
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG--RSPEFPEGK 496
HS +V H ++K N+L+ ++ K+ +FG+ PS + + PE EG+
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGEL---KIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
K D++ G++ E + G+ P + + + V + + D
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFTFPDFVTEGARD---- 233
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
L P +RP + EVL
Sbjct: 234 --------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 1e-36
Identities = 52/273 (19%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E LG G G ++ +G V K + L K ++ ++ +L H L +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ K E ++I EFL G LFD + ++ ++ ++Q +GL +H H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKH----MHEH 146
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEFPEGKRL 498
+ H ++K NI+ K+ +FG L + + +PE + + +
Sbjct: 147 SIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
D++ G++ +++G P G D + ++ V DW D ++
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ P KR + + L
Sbjct: 258 --------EAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 57/305 (18%), Positives = 104/305 (34%), Gaps = 58/305 (19%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRV-KNMNALSKKEFVQQMQLLGKL-KHEN 374
+VLG G G AT VAVK + + ++ ++ + +++++ +L HEN
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 375 LAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRG------------------VGRIPLA 416
+ ++ +I+E+ G L + L R L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 417 WTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476
+ L Q AKG+ F L H +L + N+L+ + + +FG +
Sbjct: 163 FEDLLCFAYQVAKGMEF----LEFKSCVHRDLAARNVLVTHGKVVK---ICDFGLARDIM 215
Query: 477 SRKASENLAIGR------SPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNE 529
S R +PE T K+DV+ +GI+L E+ + G P G P +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEV 589
+ + +M + +I + C KRP +
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYI------------------IMQSCWAFDSRKRPSFPNL 317
Query: 590 LRRIE 594
+
Sbjct: 318 TSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 54/299 (18%), Positives = 112/299 (37%), Gaps = 44/299 (14%)
Query: 323 EVLGKGKVGSTYKATL------ESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENL 375
LG+G G Y+ E VA+K V ++ + EF+ + ++ + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVG-----RIPLAWTTRLSIIKQTAKG 430
+++ + L+I E + G L L R P + + + + + A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-- 488
+A+ L+++K H +L + N ++ + + K+ +FG + G
Sbjct: 146 MAY----LNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 489 ----SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDN 544
SPE + T +DV+ FG++L E+ T N + + + + +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 545 DWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE-IQPMIEE 602
+ + + L C P+ RP E++ I+E ++P E
Sbjct: 259 NCPDMLFE------------------LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 48/273 (17%), Positives = 105/273 (38%), Gaps = 30/273 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
E LG+G+ G ++ S K VK + + +++ +L +H N+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ S EE ++I+EF+ +F+ ++ S L +S + Q + L F LHSH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQF----LHSH 121
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEFPEGKRL 498
+ H +++ NI+ ++ K+ FG L L +PE + +
Sbjct: 122 NIGHFDIRPENII-YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 499 THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558
+ D++ G ++ +++G P + +++ +++ D + ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ + R SE L+
Sbjct: 233 --------EAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 57/301 (18%), Positives = 114/301 (37%), Gaps = 46/301 (15%)
Query: 323 EVLGKGKVGSTYKATL--------ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKL-KH 372
+ LG+G G A VAVK +K + + + +M+++ + KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVG-----------RIPLAWTTRL 421
+N+ ++ +I E+ G+L + L R G L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 422 SIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKAS 481
S Q A+G+ +L S K H +L + N+L+ +N + A + + K +
Sbjct: 139 SCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 482 ENLAIG---RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV 538
N + +PE + TH++DV+ FG++L E+ T E L +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254
Query: 539 RMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598
RM ++ + ++ + +C P +RP +++ ++ I
Sbjct: 255 RMDKPSNCTNELYM------------------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 599 M 599
+
Sbjct: 297 L 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 54/286 (18%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 323 EVLGKGKVGSTYKATL-----ESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENLA 376
+VLG G G+ YK + VA+K ++ + + KE + + ++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+++ +I + +P G L D + E + + L+ Q AKG+ +L
Sbjct: 75 RLL-GICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED 129
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR------SP 490
++ H +L + N+L+ K+T+FG LL + + + G+ +
Sbjct: 130 ----RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
E + TH++DV+ +G+ + E++T +E S L R+ + D+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++C I + RPK E++ ++
Sbjct: 243 YM------------------IMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 2e-33
Identities = 48/275 (17%), Positives = 97/275 (35%), Gaps = 32/275 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE-FVQQMQLLGKLKHENLAKIVS 380
+VLG G A + +VA+K + K+ ++ +L K+KH N+ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
Y S +I + + G LFD + E +I Q + + LH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKY----LHD 125
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEFPEGK 496
+ H +LK N+L + ++ + +++FG + G +PE K
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQK 184
Query: 497 RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556
+ D + G+I ++ G P + + ++ ++ D + +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDE--------NDAKLFEQILKAEYEFDSPYWDDI 236
Query: 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ + + PEKR + L+
Sbjct: 237 SD--------SAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 3e-33
Identities = 50/278 (17%), Positives = 96/278 (34%), Gaps = 38/278 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRV-KNMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
+ LG+G G A + VAVK V + +++ + L HEN+ K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
+ + E+ G LFD + I + Q G+ + LH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVY----LHG 121
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL--AIG----RSPEFPE 494
+ H ++K N+L+ +++ K+++FG + L G +PE +
Sbjct: 122 IGITHRDIKPENLLLDERDNL---KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 495 GKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553
+ DV+ GI+L ++ G +P +++ + SDW + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDS- 234
Query: 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
L + P R + ++ +
Sbjct: 235 -------------APLALLHKILVENPSARITIPDIKK 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (307), Expect = 6e-32
Identities = 59/288 (20%), Positives = 102/288 (35%), Gaps = 38/288 (13%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKI 378
E+LG G + + A L VAVK ++ A F ++ Q L H + +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 379 VSFYYSKEEKL----IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ I+ E++ +L D++H P+ + +I + L F
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSP 490
H + + H ++K +NI+I N + + + IG SP
Sbjct: 128 H----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
E G + ++DVY G +L EV+TG P G V D
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDPIPPS 235
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPK-MSEVLRRIEEIQ 597
E L+A L + L+ PE R + +E+ + +
Sbjct: 236 ARHEGLSA--------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 7e-32
Identities = 60/301 (19%), Positives = 109/301 (36%), Gaps = 52/301 (17%)
Query: 323 EVLGKGKVGSTYKAT------LESGAVVAVKRVK-NMNALSKKEFVQQMQLLGKLKHENL 375
+ LG+G G +A + VAVK +K + + ++++L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 376 AKIVSFYYSKEEK--LIIYEFLPNGSLFDLLHESRG-----------VGRIPLAWTTRLS 422
+ +K ++I EF G+L L R + + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 423 IIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASE 482
Q AKG+ FL S K H +L + NIL+ ++ K+ +FG +
Sbjct: 139 YSFQVAKGMEFLA----SRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYV 191
Query: 483 NLAIGRSP------EFPEGKRLTHKADVYCFGIILLEVITG-RIPGNGSPGNNETSGDLS 535
R P E + T ++DV+ FG++L E+ + P G + E L
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 536 DWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEE 595
+ RM + + ++ L+C P +RP SE++ +
Sbjct: 252 EGTRMRAPDYTTPEMYQ------------------TMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 596 I 596
+
Sbjct: 294 L 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-31
Identities = 47/278 (16%), Positives = 98/278 (35%), Gaps = 33/278 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVS 380
+VLG G G + + A+K +++ + ++++L + + ++ +IV
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD 72
Query: 381 FYYSKEEK----LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
Y + LI+ E L G LF + + G I+K + + +LH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR---SPEFP 493
S + H ++K N+L + KLT+FGF S + +PE
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553
++ D++ G+I+ ++ G P N + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS----NHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
++ + L P +R ++E +
Sbjct: 242 SEVSE--------EVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (299), Expect = 9e-31
Identities = 53/289 (18%), Positives = 110/289 (38%), Gaps = 48/289 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALS---------KKEFVQQMQLLGKLK- 371
E+LG+G + + AVK + S ++ ++++ +L K+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 372 HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
H N+ ++ Y + ++++ + G LFD L E ++ L+ I++ + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVI 123
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA---IGR 488
LH + H +LK NIL+ + +I KLT+FGF L + +
Sbjct: 124 CA----LHKLNIVHRDLKPENILLDDDMNI---KLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 489 SPEFPEGKRL------THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV 542
+PE E + D++ G+I+ ++ G P +RM++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLMLRMIM 228
Query: 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
++ + + + + +L + P+KR E L
Sbjct: 229 SGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 2e-30
Identities = 41/208 (19%), Positives = 83/208 (39%), Gaps = 22/208 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSK---KEFVQQMQLLGKLKHENLAKI 378
++LG+G + A L + A+K ++ + + + ++ ++ +L H K+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ E+ + NG L + + T + L + L
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSAL----EYL 124
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGF--LPLLPSRKASENLAIG----RSPEF 492
H + H +LK NIL+ + I ++T+FG + S++A N +G SPE
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHI---QITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIP 520
K +D++ G I+ +++ G P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 1e-28
Identities = 39/293 (13%), Positives = 86/293 (29%), Gaps = 36/293 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G G G Y T + +G VA+K + + ++ ++ + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
++ + ++ L SL DL + + T L + Q + ++H S
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIH----SK 122
Query: 442 KVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-----------RSP 490
H ++K N L+ + +FG + +++ S
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
G + + D+ G +L+ G P + + + ST I
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGS-----LPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEEN 603
+ E C + + +P S + + +
Sbjct: 238 EVLCKGYPSE-------FATYLNFCRSLRFDDKPDYSYLRQLFR--NLFHRQG 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 61/290 (21%), Positives = 116/290 (40%), Gaps = 34/290 (11%)
Query: 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+V+G G G Y+A L +SG +VA+K+V K+ +++Q++ KL H N+ ++ F
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 382 YYSKEEK------LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+YS EK ++ +++P H SR +P + Q + LA++H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP--VIYVKLYMYQLFRSLAYIH 139
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR----SPE 491
S + H ++K N+L+ + + KL +FG L + + + R
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVL--KLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN------ETSGDLSDWVRMVVDND 545
T DV+ G +L E++ G+ G G + + G + ++ +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 546 WSTDILDVEILAAREGQNEMLRLTELALE----CTDIAPEKRPKMSEVLR 591
++ +I A + R A+ + P R E
Sbjct: 254 YTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 59/282 (20%), Positives = 102/282 (36%), Gaps = 47/282 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQ----LLGKLKHENLAK 377
++LGKG G + A ++ A+K +K L + M L +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 378 IVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT 437
+ + +KE + E+L G L + + + GL F
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQF---- 118
Query: 438 LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEFP 493
LHS + + +LK NIL+ + K+ +FG A N G +PE
Sbjct: 119 LHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 494 EGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRM---VVDNDWSTDI 550
G++ H D + FG++L E++ G+ P +G + +L +RM +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-----QDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592
D L ++ PEKR + +R+
Sbjct: 231 KD------------------LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (278), Expect = 6e-28
Identities = 54/285 (18%), Positives = 106/285 (37%), Gaps = 28/285 (9%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIVS 380
E +G+G G YKA G A+K+++ + ++++ +L +LKH N+ K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 381 FYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHS 440
++K+ ++++E L L L T S + Q G+A+ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAY----CHD 118
Query: 441 HKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRS-----PEFPEG 495
+V H +LK N+LI RE ++ K+ +FG I
Sbjct: 119 RRVLHRDLKPQNLLINREGEL---KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 496 KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE--------TSGDLSDWVRMVVDNDWS 547
K+ + D++ G I E++ G G ++ + + +W + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 548 TDILDVEILAAREGQNEMLR-LTELALECTDIAPEKRPKMSEVLR 591
+ E L + +L + + P +R + L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 9e-28
Identities = 57/288 (19%), Positives = 111/288 (38%), Gaps = 31/288 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE-----FVQQMQLLGKLKHENLA 376
+ LG+G+ + YKA + +VA+K++K + K+ +++++LL +L H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 377 KIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
++ + K ++++F+ + S L + + + T +GL +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEY--- 115
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEF 492
LH H + H +LK +N+L+ ++ KL +FG S + + R+PE
Sbjct: 116 -LHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171
Query: 493 PEGKRL-THKADVYCFGIILLEVITGRIPGNGSPG--------NNETSGDLSDWVRMVVD 543
G R+ D++ G IL E++ G + W M
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 544 NDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
D+ T I L +L P R ++ L+
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (281), Expect = 1e-27
Identities = 31/216 (14%), Positives = 74/216 (34%), Gaps = 22/216 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSK------KEFVQQMQLLGKLKHENL 375
++G+G G Y ++G + A+K + K + L+ +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ +++ ++ I + + G L L + + + GL
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEH-- 122
Query: 436 QTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN---LAIGRSPEF 492
+H+ V + +LK +NIL+ ++ ++++ G +K +
Sbjct: 123 --MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 177
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN 528
+G AD + G +L +++ G P +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (276), Expect = 1e-27
Identities = 40/288 (13%), Positives = 89/288 (30%), Gaps = 36/288 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
+G+G G ++ T L + VA+K + + + + L V +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 382 YYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSH 441
+ + ++ L SL DLL + T KQ + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIH----EK 120
Query: 442 KVPHANLKSSNILIFRENDIY--RAKLTNFGFLPLLPSRKASENLAIGR----------- 488
+ + ++K N LI R N + +FG + +++
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 489 SPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548
S G+ + + D+ G + + + G +P G + + + ST
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG-----LKAATNKQKYERIGEKKQST 235
Query: 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596
+ ++ E + ++A + P + ++
Sbjct: 236 PLRELCAGFPEE-------FYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 27/288 (9%)
Query: 323 EVLGKGKVGSTYKAT--LESGAVVAVKRVKNMNA-----LSKKEFVQQMQLLGKLKHENL 375
+G+G G +KA G VA+KRV+ LS V ++ L +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLF-DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
++ L + DL V + T ++ Q +GL FL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG---RSPE 491
H SH+V H +LK NIL+ + KL +FG + + A ++ + R+PE
Sbjct: 133 H----SHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI- 550
D++ G I E+ + GS + + G + D + + + DW D+
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIA-------PEKRPKMSEVLR 591
L + ++ Q +T++ D+ P KR L
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 8e-27
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 36/280 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK------NMNALSKKEFVQQMQLLGKLKHENL 375
E LG G+ K +G A K +K + +S+++ +++ +L +++H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 376 AKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLH 435
+ Y +K + ++I E + G LFD L E L +KQ G+ +LH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130
Query: 436 QTLHSHKVPHANLKSSNILIFRENDI-YRAKLTNFGFLPLLPSRKASENLAIG---RSPE 491
S ++ H +LK NI++ N R K+ +FG + +N+ +PE
Sbjct: 131 ----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 492 FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551
+ L +AD++ G+I +++G P G ET ++S D +S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFS---- 241
Query: 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
N + P+KR + + L+
Sbjct: 242 -----------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 55/294 (18%), Positives = 110/294 (37%), Gaps = 38/294 (12%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALS-KKEFVQQMQLLGKLKHENLAKIVS 380
+G+G G A + VA+K++ + + ++++++L + +HEN+ I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 381 FYYSKE----EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQ 436
+ + + + L L+ LL L+ + Q +GL ++H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 126
Query: 437 TLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-------RS 489
S V H +LK SN+L+ D+ K+ +FG + R+
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDL---KICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 490 PE-FPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNE-----------TSGDLSDW 537
PE K T D++ G IL E+++ R G ++ + DL+
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 538 VRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
+ + N + ++ R N + +L + P KR ++ + L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-25
Identities = 58/286 (20%), Positives = 102/286 (35%), Gaps = 28/286 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E +G+G G YKA +G VVA+K+++ ++++ LL +L H N+ K++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+++ + +++EFL + + + S + Q +GLAF H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCH---- 119
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-----SPEFPE 494
SH+V H +LK N+LI E KL +FG + +
Sbjct: 120 SHRVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGS--------PGNNETSGDLSDWVRMVVDNDW 546
K + D++ G I E++T R G + D W + D+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 547 STDILDVEILAAREGQNEMLR-LTELALECTDIAPEKRPKMSEVLR 591
+ + L + P KR L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 30/287 (10%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
E +G+G G+ +KA E+ +VA+KRV+ + + ++++ LL +LKH+N+ ++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+S ++ +++EF + L S + Q KGL F H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS--- 119
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR-----SPEFPE 494
V H +LK N+LI R ++ KL NFG + +
Sbjct: 120 -RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST------ 548
K + D++ G I E+ P ++ + + + W +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 549 DILDVEILAAREGQNEMLRLTELALE----CTDIAPEKRPKMSEVLR 591
A N + +L + P +R E L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 4e-25
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 17/207 (8%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
LG G G + +G A+K +K + K+ + +L + H + ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ ++ +I +++ G LF LL + + L +LH
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKR 497
S + + +LK NIL+ + I K+T+FGF +P + +PE K
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHI---KITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGS 524
D + FGI++ E++ G P S
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDS 204
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 7e-25
Identities = 54/281 (19%), Positives = 90/281 (32%), Gaps = 48/281 (17%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE------FVQQMQLLGKLK--HE 373
+LG G GS Y + VA+K V+ E ++ LL K+
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+ +++ ++ + ++I E RG L S Q + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENL--AIGRSPE 491
H + V H ++K NILI KL +FG LL ++ + PE
Sbjct: 126 CH----NCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 492 FPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550
+ R A V+ GI+L +++ G IP G + S++
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRGQV------FFRQRVSSEC 231
Query: 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591
L C + P RP E+
Sbjct: 232 QH------------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 9e-25
Identities = 43/211 (20%), Positives = 82/211 (38%), Gaps = 20/211 (9%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
++LGKG G +G A+K ++ ++K E V + ++L +H L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ + + + E+ G LF L + L +LH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLH--- 122
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG----RSPEFPE 494
S V + ++K N+++ ++ I K+T+FG S A+ G +PE E
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHI---KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGSP 525
D + G+++ E++ GR+P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-23
Identities = 54/301 (17%), Positives = 117/301 (38%), Gaps = 44/301 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVK--NMNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G+G G +KA ++G VA+K+V N ++++++L LKHEN+ ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 380 SFYYSKEEK--------LIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGL 431
+K ++++F + L + + + +++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGL 130
Query: 432 AFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASEN-------- 483
++H +K+ H ++K++N+LI R+ + KL +FG K S+
Sbjct: 131 YYIH----RNKILHRDMKAANVLITRDGVL---KLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 484 -LAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNN------ETSGDLSD 536
L + D++ G I+ E+ T G+ + + G ++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLT------ELALECTDIAPEKRPKMSEVL 590
V VDN + L++ R+ ++ + +L + + P +R + L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 591 R 591
Sbjct: 304 N 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 52/285 (18%), Positives = 110/285 (38%), Gaps = 24/285 (8%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ +G G G+ A +GA VA+K++ + L K ++++LL ++HEN+ ++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 380 SFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH 439
+ E +F + L ++ Q KGL ++H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIH---- 138
Query: 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--SPEFPEGKR 497
+ + H +LK N+ + N+ K+ +FG S + R
Sbjct: 139 AAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDL-------SDWVRMVVDNDWSTDI 550
T D++ G I+ E+ITG+ GS ++ + +++V+ + ++ +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 551 LDVEILAAREGQNEMLRLTELALE----CTDIAPEKRPKMSEVLR 591
+ L ++ + + + LA+ + E+R E L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 17/207 (8%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKE---FVQQMQLLGKLKHENLAKI 378
+ LG G G ESG A+K + + K+ + + ++L + L K+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 379 VSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ ++ E++ G +F L + Q +LH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH--- 158
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIG-RSPEFPEGKR 497
S + + +LK N+LI ++ I +T+FGF + R + +PE K
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQ---VTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214
Query: 498 LTHKADVYCFGIILLEVITGRIPGNGS 524
D + G+++ E+ G P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFAD 241
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.1 bits (233), Expect = 1e-21
Identities = 47/295 (15%), Positives = 98/295 (33%), Gaps = 43/295 (14%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVS 380
LG+GK ++A + + V VK +K + KK+ +++++L L+ N+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97
Query: 381 FYYSKEEKLI--IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL 438
+ ++E + N L L + + K L + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH--- 146
Query: 439 HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFPE---- 494
S + H ++K N++I E+ + +L ++G + R + PE
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 495 GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS------- 547
+ + D++ G +L +I + P N + ++ + D+
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 548 ----TDILDVEILAAREGQNEMLRLTELALECTDIA-------PEKRPKMSEVLR 591
DIL E ++ E D + R E +
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 3e-20
Identities = 50/290 (17%), Positives = 103/290 (35%), Gaps = 34/290 (11%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIV 379
+G G GS A ++G VAVK++ + + K ++++LL +KHEN+ ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 380 SFYYSKE-----EKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFL 434
+ + + L L +++ + L +I Q +GL ++
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYI 137
Query: 435 HQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGR--SPEF 492
H S + H +LK SN+ + N+ K+ +FG
Sbjct: 138 H----SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 190
Query: 493 PEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGN-------NETSGDLSDWVRMVVDND 545
D++ G I+ E++TGR G+ ++ ++ +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 546 WSTDILDVEILAAREGQNEMLRLTELALE----CTDIAPEKRPKMSEVLR 591
I + + N + LA++ + +KR ++ L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (211), Expect = 1e-18
Identities = 52/313 (16%), Positives = 108/313 (34%), Gaps = 48/313 (15%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSF 381
LG G + + A + + VA+K V+ + + + +++LL ++ + K S
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 382 YYSKEEKLIIY--EFLPNGSLFDLLHESRG---------VGRIPLAWTTRLSIIKQTAKG 430
+ KL+ + PNG ++ E G + I KQ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 431 LAFLHQTLHSHKVPHANLKSSNILIFREN---DIYRAKLTNFGFLPLLPSRKASENLAIG 487
L ++H + H ++K N+L+ + ++ + K+ + G +
Sbjct: 138 LDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 488 -RSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546
RSPE G AD++ ++ E+ITG G++ T D + + +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 547 STDIL----------------------------DVEILAAREGQNEMLRLTELALECTDI 578
+ +L DV + ++E +++ +
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 579 APEKRPKMSEVLR 591
P KR ++
Sbjct: 315 DPRKRADAGGLVN 327
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-18
Identities = 38/222 (17%), Positives = 82/222 (36%), Gaps = 28/222 (12%)
Query: 323 EVLGKGKVGSTYKATL----ESGAVVAVKRVKNMNALSKKEFVQQ----MQLLGKLKHE- 373
+VLG G G + ++G + A+K +K + K + + Q+L ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 374 NLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
L + + ++ + +I +++ G LF L + R + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAIGRSPEFP 493
LH+ + + ++K NIL+ + LT+FG + + + E+
Sbjct: 145 LHK----LGIIYRDIKLENILLDSNGHVV---LTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 494 EGKRL-------THKADVYCFGIILLEVITGRIPGNGSPGNN 528
+ D + G+++ E++TG P N
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 5e-17
Identities = 51/303 (16%), Positives = 98/303 (32%), Gaps = 49/303 (16%)
Query: 323 EVLGKGKVGSTYKAT-LESGAVVAVKRVKN--MNALSKKEFVQQMQLLGKLKHENLAKIV 379
+ +G G G A VA+K++ N K +++ L+ + H+N+ ++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 380 SFYYSK------EEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAF 433
+ + + ++ ++ E + + E ++ Q G+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIKH 134
Query: 434 LHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLAI---GRSP 490
LH H+ +LK SNI++ + K+ +FG + + R+P
Sbjct: 135 LHSAGIIHR----DLKPSNIVVKSDC---TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 491 EFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS--------------PGNNETSGDLSD 536
E G D++ G I+ E++ +I G E L
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 537 WVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALE--------CTDIAPEKRPKMSE 588
VR V+N L L +L I P KR + +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 589 VLR 591
L+
Sbjct: 308 ALQ 310
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 2e-11
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 44 HSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL 103
+ T +N + ++ L L ++ I P L L +L NN
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK---LQRLFFANNK 340
Query: 104 LSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQEN 149
+S + +L NL N+ + N SD P +L ++ +L L +
Sbjct: 341 VSD-VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 2e-09
Identities = 37/197 (18%), Positives = 68/197 (34%), Gaps = 40/197 (20%)
Query: 6 LPKNVVLVASSVQIADYYPAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCS 65
L L+A++ QI+D P L L+ N + + +++N + +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLD---ELSLNGN---QLKDIGTLASLTNLTDLDLA 249
Query: 66 NGHI------------VSLELEEIQLAGILPPGFLQNITF-------------------L 94
N I L+L Q++ I P L +T L
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 95 NKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQ 154
L+L N +S + +++L L+ +F + N SD +L + L N +
Sbjct: 310 TYLTLYFNNISD-ISPVSSLTKLQRLFFANNKVSDVSSLA--NLTNINWLSAGHNQISDL 366
Query: 155 IPPFNQTSLIDFNVSYN 171
P N T + ++
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 30/153 (19%), Positives = 50/153 (32%), Gaps = 21/153 (13%)
Query: 44 HSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL 103
++ T + +N G + +L+ + + G L ++T L L L NN
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 252
Query: 104 LSGSLPNLTNLVNLETVFLSQNHFSDGIPFG--------------------YIDLPKLKK 143
+S L L+ L L + L N S+ P +L L
Sbjct: 253 ISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 144 LELQENYLDGQIPPFNQTSLIDFNVSYNNLDGP 176
L L N + P + T L + N +
Sbjct: 312 LTLYFNNISDISPVSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 6e-05
Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 6/75 (8%)
Query: 70 VSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
+ L + + + L +T L + S+ + L NL + S N +D
Sbjct: 25 MKTVLGKTNVTDTVSQTDLDQVT---TLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 80
Query: 130 GIPFGYIDLPKLKKL 144
P +L KL +
Sbjct: 81 ITPLK--NLTKLVDI 93
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 24/59 (40%), Positives = 32/59 (54%), Gaps = 2/59 (3%)
Query: 146 LQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPL 202
L+ N + G +P L NVS+NNL G IPQ +Q F S++ +N LCG PL
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 4e-11
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 11/166 (6%)
Query: 24 PAERYDLLQIRDSLNSTANLHSRWTGPPCIDNVSNWFGVSCSN----GHIVSLELEEIQL 79
P ++ LLQI+ L + L S C + W GV C + +L+L + L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 80 AGILP-PGFLQNITFLNKLSLRN--NLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI 136
P P L N+ +LN L + NL+ P + L L ++++ + S IP
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 137 DLPKLKKLELQENYLDGQIPP--FNQTSLIDFNVSYNNLDGPIPQT 180
+ L L+ N L G +PP + +L+ N + G IP +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.2 bits (126), Expect = 3e-08
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 1/89 (1%)
Query: 44 HSRWTGPPCIDNVSNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNL 103
+ ++++ G + ++ L+L ++ G LP G + FL+ L++ N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL-TQLKFLHSLNVSFNN 279
Query: 104 LSGSLPNLTNLVNLETVFLSQNHFSDGIP 132
L G +P NL + + N G P
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.4 bits (143), Expect = 8e-11
Identities = 26/203 (12%), Positives = 59/203 (29%), Gaps = 29/203 (14%)
Query: 323 EVLGKGKVGSTYKATLESGAVVAVK----------RVKNMNALSKKEFVQQMQLLGKLKH 372
+++G+GK + + E VK +VK F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 373 ENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLA 432
L K+ K +Y + N L +L+ ++ + +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVR---VENPDEVLDMILEEVA 117
Query: 433 FLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKASENLA--IGRSP 490
+ + H +L N+L+ + +F + E L +
Sbjct: 118 KFYH----RGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWREILERDVRNII 169
Query: 491 EFPEGKRLTHKADVYCFGIILLE 513
+ + + D+ +L+
Sbjct: 170 TY-FSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 31/129 (24%), Positives = 49/129 (37%), Gaps = 17/129 (13%)
Query: 49 GPPCIDNVS-NWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGS 107
GP C + V CS+ + + P + L+ L+NN ++
Sbjct: 1 GPVCPFRCQCHLRVVQCSDLGLEKV-----------PKDLPPDTALLD---LQNNKITEI 46
Query: 108 LPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDF 166
NL NL T+ L N S P + L KL++L L +N L +P +L +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQEL 105
Query: 167 NVSYNNLDG 175
V N +
Sbjct: 106 RVHENEITK 114
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 83 LPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLK 142
L N++ L L +N +S + L +L NL V L N SD P + L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLF 220
Query: 143 KLEL 146
+ L
Sbjct: 221 IVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 109 PNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNV 168
L NL L T+ N SD P LP L ++ L+ N + P N ++L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSPLANTSNLFIVTL 224
Query: 169 S 169
+
Sbjct: 225 T 225
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 85 PGFLQNITFLNKLSLRNNLLSG----SLPN-LTNLVNLETVFLSQNHFSDGIPFGYID-- 137
G Q + L L L + +S SL L +L + LS N D ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 138 ---LPKLKKLELQENYLDGQIPPF 158
L++L L + Y ++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 13/112 (11%), Positives = 34/112 (30%), Gaps = 10/112 (8%)
Query: 71 SLELEEI-----QLAGILPPGFLQNITFLNKLSLRNNLLSG----SLPN-LTNLVNLETV 120
SL+++ + +L+ L + + L + L+ + + L L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 121 FLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNN 172
L N D + + ++Q+ L ++ +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP 112
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 16/87 (18%), Positives = 26/87 (29%), Gaps = 6/87 (6%)
Query: 94 LNKLSLRNNLLSGSLPN--LTNLVNLETVFLSQNHFSD----GIPFGYIDLPKLKKLELQ 147
+ L ++ LS + L L + V L ++ I P L +L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 148 ENYLDGQIPPFNQTSLIDFNVSYNNLD 174
N L L + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 3e-04
Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 6/105 (5%)
Query: 88 LQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147
L+ + + L L +N L P L L LE + + + G +LP+L++L L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPALAALRCLEVL--QASDNALENVDGVANLPRLQELLLC 73
Query: 148 ENYLDGQIPP---FNQTSLIDFNVSYNNLDG-PIPQTRVVQSFPS 188
N L + L+ N+ N+L Q R+ + PS
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.4 bits (85), Expect = 0.002
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 6/63 (9%)
Query: 70 VSLELEEIQLAGILPP-----GFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQ 124
V+ E E+++L G++PP L + L+L N + + +L+ + NL + L +
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGR 79
Query: 125 NHF 127
N
Sbjct: 80 NLI 82
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 13/78 (16%), Positives = 26/78 (33%), Gaps = 3/78 (3%)
Query: 83 LPPGFLQNITFLNKLSLR--NNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYI-DLP 139
L P + ++ R + + L + ++ + LS + G +
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 71
Query: 140 KLKKLELQENYLDGQIPP 157
KL+ L L+ L I
Sbjct: 72 KLQNLSLEGLRLSDPIVN 89
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 12/65 (18%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 70 VSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129
+ L++ + + L +I + N+ + S+ + L N+ +FL+ N +D
Sbjct: 27 IKDNLKKKSVTDAVTQNELNSIDQII---ANNSDIK-SVQGIQYLPNVTKLFLNGNKLTD 82
Query: 130 GIPFG 134
P
Sbjct: 83 IKPLA 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.57 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.32 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.28 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.28 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.27 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.23 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.23 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.16 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.13 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.1 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.04 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.0 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.87 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.82 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.76 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.66 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.64 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.36 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.33 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.15 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.06 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.88 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.67 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.62 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.6 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.23 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.69 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.19 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=404.54 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=195.9
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 46899999999999999889999999997643 34678999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++.... ..+++..+..|+.|||+||+|||+ ++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~----~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE----ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH----TTCCCTTCSGGGEEE---CGGGCEEECSCC-----------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhc----cceeecccchhheee---cCCCCeEecccchheeccCCCce
Confidence 9987653 258999999999999999999994 799999999999999 777899999999998775432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||++.+..++.++|||||||++|||+|+..|+.... ...+....+..... ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~-~~------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDISTGFR-LY------- 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHHTCC-CC-------
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHhcCC-CC-------
Confidence 2346778999999999999999999999999999999654543211 12222222222211 11
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+.....++.+++.+||+.||++||||+||++.|++|++
T Consensus 223 ---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 ---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 011223468899999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=404.29 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=198.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++||||+++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 468999999999999865 36999999643 34456789999999999999999999998754 56899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... ..+++.++..|+.||++||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+......
T Consensus 90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~----~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHA----KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-----
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhc----CCEeccccCHHHEEE---cCCCCEEEccccceeeccccC
Confidence 999997643 259999999999999999999994 799999999999999 566789999999998765322
Q ss_pred ------CCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 480 ------ASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 480 ------~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...+++.|+|||++.+ ..++.++|||||||++|||+||+.||.+... ...+............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLSPD 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCCc
Confidence 2357889999999864 3589999999999999999999999975321 1112222222211110
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIE 601 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 601 (604)
.. ......+..+.+++.+||+.||++||||+||++.|+.++..++
T Consensus 231 ~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 231 LS------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp GG------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ch------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00 0112234568899999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-50 Score=402.95 Aligned_cols=247 Identities=22% Similarity=0.416 Sum_probs=193.8
Q ss_pred hcccCcCCcceEEEEEec-CC---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE-SG---AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.++||+|+||+||+|+.. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 468999999999999864 23 36899998653 34445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ..++|.++..|+.||++||+|||+ ++|+||||||+|||+ +.++++||+|||+|+.+.
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~----~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD----MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh----CCCccCccccceEEE---CCCCcEEECCcccceEcc
Confidence 999999988643 258999999999999999999994 799999999999999 677889999999998775
Q ss_pred CCCC---------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 477 SRKA---------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 477 ~~~~---------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
.... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+....+.....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 4321 134678999999999999999999999999999998 899987532 1222222222211
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.. .+...+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 252 ~~-----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 LP-----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 112234568899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=400.95 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=204.7
Q ss_pred hcccCcCCcceEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLE-SGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+.+..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 468999999999999865 68899999997543 3467899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ...+++..+..|+.||++||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~----~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK----KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSS
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH----CCcccCccccCeEEE---CCCCcEEEccccceeecCCCCc
Confidence 99997653 2358999999999999999999994 699999999999999 6778899999999998765432
Q ss_pred C-----ccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 S-----ENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ~-----~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
. .++..|+|||++.+..++.++|||||||++|||++|..||.... ....... ..........
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-------~~~~~~~-~i~~~~~~~~----- 237 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYE-LLEKDYRMER----- 237 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-------CHHHHHH-HHHTTCCCCC-----
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-------hHHHHHH-HHhcCCCCCC-----
Confidence 2 35678999999999999999999999999999999877765321 1222222 2222221111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
+...+.++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 238 -----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112334688999999999999999999999999987543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=397.20 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=199.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 36799999999999985 57999999999765555678899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++... .+++.++..++.||+.||+|||+ +||+||||||+|||+ +.++++||+|||+|+.+....
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~----~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHS----NQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH----CCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc
Confidence 9988753 38999999999999999999994 799999999999999 566789999999998764332
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+............ ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~-~~~---- 238 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE-LQN---- 238 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC-CSS----
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC-CCC----
Confidence 3358899999999999999999999999999999999999997532 112222222221111 100
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......+.+++.+||+.||++|||+.|+++
T Consensus 239 ----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=399.34 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=200.1
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence 46799999999999999888999999997543 346789999999999999999999998754 5679999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC--
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK-- 479 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~-- 479 (604)
+++..... .++++.++++|+.||++||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 96 ~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~----~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE----RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEE
T ss_pred HHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh----CCcccCccchhheee---ecccceeeccccceEEccCCccc
Confidence 98876542 248999999999999999999994 799999999999999 677889999999998875432
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...++..|+|||++.+..++.++|||||||++|||+||..|+.... ...+....+.... ....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~~~~-~~~~------ 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGY-RMVR------ 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTC-CCCC------
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcC-CCCC------
Confidence 2356778999999998899999999999999999999766654321 1222222222211 1111
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
+...+.++.+|+.+||+.||++||||+||++.|+++-
T Consensus 232 ----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1123346889999999999999999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=391.68 Aligned_cols=238 Identities=21% Similarity=0.381 Sum_probs=199.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||+|++... .....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 47899999999999986 46899999998642 223457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.+..+||+|||+|+....
T Consensus 91 g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~----~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 91 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHS----KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCC
T ss_pred CcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH----CCeeeeeecccccee---cCCCCEeecccceeeecCC
Confidence 99999998754 48999999999999999999994 799999999999999 6667899999999988765
Q ss_pred CC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 478 RK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 478 ~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+.......
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~------- 223 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTF------- 223 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCC-------
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCC-------
Confidence 43 3368899999999999999999999999999999999999997531 222223322222110
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 224 -----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112346889999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=390.31 Aligned_cols=244 Identities=21% Similarity=0.360 Sum_probs=203.5
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCHH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSLF 401 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 401 (604)
.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 468999999999999998899999999986433 4678999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC-
Q 007427 402 DLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA- 480 (604)
Q Consensus 402 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~- 480 (604)
+++..... .+++..+.+++.|+++||+|||+ +||+||||||+|||+ +....+||+|||+++.+.....
T Consensus 88 ~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~----~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 88 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLES----KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp HHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHH----TTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC
T ss_pred Hhhhcccc----CCcHHHHHHHHHHHHHHHHHHhh----cCcccccccceeEEE---cCCCcEEECcchhheeccCCCce
Confidence 99776542 58999999999999999999994 799999999999999 6677899999999987654332
Q ss_pred ----CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 481 ----SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 481 ----~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+....+.... ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~-~~~~----- 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL-RLYR----- 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTC-CCCC-----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCC-CCCC-----
Confidence 346778999999999999999999999999999998 899987532 122222222221 1111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
+...+.++.+++.+||+.||++|||++|+++.|.+|
T Consensus 223 -----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112234688999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=394.78 Aligned_cols=249 Identities=21% Similarity=0.386 Sum_probs=196.3
Q ss_pred hcccCcCCcceEEEEEecCC-----cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLESG-----AVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.++||+|+||+||+|.++.. ..||||+++.. ......+|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 47899999999999986532 47999999743 3334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+|++.+++.... ..++|.++..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~----~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN----MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc----cccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 9999999887653 259999999999999999999994 799999999999999 67789999999999876
Q ss_pred CCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
.... ...++..|+|||++.+..++.++|||||||++|||+||..|+.... ...+....+... ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~-~~~ 232 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDG-FRL 232 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTT-CCC
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhcc-CCC
Confidence 5432 1245778999999999999999999999999999999776655321 112222222222 111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
. .+...+.++.+|+.+||+.||++||||.||+++|+++.+.
T Consensus 233 ~----------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 P----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 1112334688999999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=394.55 Aligned_cols=242 Identities=21% Similarity=0.350 Sum_probs=195.3
Q ss_pred cccCcCCcceEEEEEec---CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 323 EVLGKGKVGSTYKATLE---SGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
++||+|+||+||+|.++ .++.||||+++.. .....++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 3568999999643 22335789999999999999999999999864 567899999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.++++... ++++.+++.|+.||++||+|||+ ++|+||||||+|||+ +..+.+||+|||+++.+..
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~----~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---EETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHh----CCcccCCCcchhhcc---cccCcccccchhhhhhccc
Confidence 99999998654 59999999999999999999994 799999999999999 5556899999999987654
Q ss_pred CCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccc
Q 007427 478 RKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTD 549 (604)
Q Consensus 478 ~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (604)
... ..+++.|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ..+....+.... ...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~i~~~~-~~~ 230 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGE-RMG 230 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTC-CCC
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHHHHcCC-CCC
Confidence 321 246778999999999999999999999999999998 899997532 122222222211 111
Q ss_pred cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 550 ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
. +...+.++.+|+.+||+.||++|||++||+++|+..
T Consensus 231 ~----------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 C----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp C----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1 112344688999999999999999999999998875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=395.18 Aligned_cols=243 Identities=20% Similarity=0.345 Sum_probs=197.2
Q ss_pred ccCcCCcceEEEEEec---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 324 VLGKGKVGSTYKATLE---SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 324 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.||+|+||+||+|.+. ++..||||+++.. .....++|.+|++++++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999753 4568999999754 33446789999999999999999999999865 56899999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++...+ ..+++.++..++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~----~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE----KNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCS
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh----CCeecCcCchhheee---ccCCceeeccchhhhcccccc
Confidence 999986543 258999999999999999999994 799999999999999 455689999999998765432
Q ss_pred -------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 480 -------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 480 -------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+.... ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~-~~~~- 233 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGK-RMEC- 233 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTC-CCCC-
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC-CCCC-
Confidence 2246678999999998899999999999999999998 8999975321 12222222221 1111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
+...+.++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1223456889999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=384.78 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=192.1
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec----CCceEEEEecC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS----KEEKLIIYEFL 395 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 395 (604)
+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++|||||++++++.+ ....++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 5799999999999986 46889999998643 33345679999999999999999999999865 34578999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHK--VPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
++|+|.+++.... .+++..+..++.||++||+|||+ ++ |+||||||+|||++. ++..+||+|||+|+
T Consensus 95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~----~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT----RTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 163 (270)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT----SSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHH----CCCCEEeCCcChhhceeeC--CCCCEEEeecCcce
Confidence 9999999998754 48999999999999999999995 45 999999999999942 34679999999998
Q ss_pred CCCCCC--CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 474 LLPSRK--ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 474 ~~~~~~--~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
...... ...+|+.|+|||++.+ .++.++|||||||++|||+||+.||.+.. ......+.+..... ....
T Consensus 164 ~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~-~~~~ 234 (270)
T d1t4ha_ 164 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK-PASF 234 (270)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC-CGGG
T ss_pred eccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCC-Cccc
Confidence 765433 3468999999999865 59999999999999999999999997532 12222222222211 1111
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+ ....+++.+++.+||+.||++|||+.|+++
T Consensus 235 ~---------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 D---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 112235889999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=390.11 Aligned_cols=241 Identities=18% Similarity=0.269 Sum_probs=192.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++||||+++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 46899999999999986 579999999996433 2234678999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.... .+++.++..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+|+.....
T Consensus 90 L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~----~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 90 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG----IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH----cCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 999997543 59999999999999999999994 799999999999999 56668999999999876422
Q ss_pred -----CCCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 479 -----KASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 479 -----~~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
....+|+.|+|||++.+..+ +.++|||||||++|||+||+.||...... ... .............
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~-~~~~~~~~~~~~~-- 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQE-YSDWKEKKTYLNP-- 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------SHH-HHHHHTTCTTSTT--
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------HHH-HHHHhcCCCCCCc--
Confidence 23358899999999988776 57899999999999999999999753211 111 1111111111100
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......++.+|+.+||+.||++|||++|+++
T Consensus 229 --------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112346789999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=393.04 Aligned_cols=242 Identities=22% Similarity=0.327 Sum_probs=197.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 46799999999999985 57899999999766555567899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC--
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR-- 478 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~-- 478 (604)
.+++.... .++++.++..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 97 ~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~----~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 97 DAVMLELE----RPLTESQIQVVCKQTLDALNYLHD----NKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc
Confidence 99987643 259999999999999999999994 799999999999999 66678999999999766432
Q ss_pred --CCCccccccCCCCCCC-----CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 479 --KASENLAIGRSPEFPE-----GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 479 --~~~~~~~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
....+++.|+|||++. ...|+.++|||||||++|||+||+.||.+... .+........... ...
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~~~-~~~ 236 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPP-TLA 236 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSCCC-CCS
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCC-CCC
Confidence 2446889999999874 45689999999999999999999999975321 1112222222211 110
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~--------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 Q--------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp S--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1122346889999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-49 Score=395.15 Aligned_cols=245 Identities=19% Similarity=0.276 Sum_probs=188.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||||++|+
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 47899999999999986 478999999997433 2234668899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+...+++..+||+|||+|+......
T Consensus 94 L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~----~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 94 LFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD----LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp HHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred HHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhh----ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999997643 59999999999999999999994 799999999999999776667789999999998775443
Q ss_pred ---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 480 ---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 480 ---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+.........
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~------ 230 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEYEFDS------ 230 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCCCCCT------
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCCCCCC------
Confidence 3358899999999999999999999999999999999999997531 22222333332221110
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 --PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001123346889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-49 Score=394.32 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 46799999999999985 578999999997533 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... ++++.++..++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~----~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS----HNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh----CCEeccCCCcceEEE---CCCCCEEEeecccccccCC
Confidence 99987765543 59999999999999999999994 799999999999999 5567899999999998887
Q ss_pred CCCCccccccCCCCCCCC---CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHH
Q 007427 478 RKASENLAIGRSPEFPEG---KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVE 554 (604)
Q Consensus 478 ~~~~~~~~~y~aPE~~~~---~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (604)
.....+++.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ..+............ ..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~~~-~~--- 235 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPA-LQ--- 235 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCCC-CS---
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCC-CC---
Confidence 777889999999999864 468999999999999999999999997531 122222222222111 10
Q ss_pred hhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 555 ILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 555 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112346889999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=390.57 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=187.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec--CCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--KEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+ .+..++||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 36899999999999985 57999999999743 33345678999999999999999999999865 456899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTL-HSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+|+|.+++...... ...+++..++.++.|++.||+|||+.- ..++|+||||||+|||+ +.+..+||+|||+|+.+
T Consensus 89 ~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 89 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARIL 164 (269)
T ss_dssp TEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC
T ss_pred CCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeec
Confidence 99999998754321 235999999999999999999999641 12359999999999999 66678999999999876
Q ss_pred CCCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 476 PSRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 476 ~~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.... ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+...... .+
T Consensus 165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i~~~~~~-~~- 234 (269)
T d2java1 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFR-RI- 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCC-CC-
T ss_pred ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCC-CC-
Confidence 5432 3457889999999999999999999999999999999999997531 22222222222211 11
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122346889999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=403.66 Aligned_cols=192 Identities=26% Similarity=0.379 Sum_probs=169.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+.++++++|||||+++++|.+.++.++||||+++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 36899999999999985 57899999999743 33345789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
|.+++.+.. .+++..+..++.|++.||+|||+. ++|+||||||+|||+ +.++++||+|||+|+.....
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh---CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc
Confidence 999998654 489999999999999999999952 489999999999999 66678999999999865432
Q ss_pred -CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCC
Q 007427 479 -KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGS 524 (604)
Q Consensus 479 -~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~ 524 (604)
....++..|+|||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2346899999999999999999999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=387.90 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=199.1
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
..+.||+|+||+||+|+.++++.||||+++... ...+.|.+|+.++++++|||||+++++|. .+..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 357899999999999999888899999997543 34678999999999999999999999985 4568999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
..++..... ..++|.+++.|+.||+.||+|||+ ++|+||||||+|||+ +.++++||+|||+|+......
T Consensus 99 ~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~----~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 99 LDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER----MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp HHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-------
T ss_pred hhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh----hheecccccceEEEE---CCCCcEEEcccchhhhccCCCc
Confidence 999876542 248999999999999999999994 699999999999999 677889999999998765332
Q ss_pred ----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHh
Q 007427 480 ----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEI 555 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (604)
...++..|+|||++....++.++|||||||++|||+||..|+.... ...+....+.... ....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i~~~~-~~~~----- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGY-RMPC----- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTC-CCCC-----
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcC-CCCC-----
Confidence 2356788999999999999999999999999999999776665321 2222333322221 1111
Q ss_pred hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 556 LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 556 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
....+.++.+++.+||+.||++||+|++|+++|++....
T Consensus 236 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 112344688999999999999999999999999986543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=385.04 Aligned_cols=245 Identities=24% Similarity=0.414 Sum_probs=193.3
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 478999999999999985 7899999997643 45789999999999999999999999865 4568999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... ...++|..+++|+.||+.||+|||+ ++|+||||||+|||+ +.++.+|++|||+++......
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~----~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG----NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc----CceeccccchHhhee---cCCCCEeecccccceecCCCCc
Confidence 99997653 1248999999999999999999994 799999999999999 667789999999998765443
Q ss_pred CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhhc
Q 007427 480 ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILAA 558 (604)
Q Consensus 480 ~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (604)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+...+ . .....+.
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i---~-~~~~~~~-------- 221 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV---E-KGYKMDA-------- 221 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHH---T-TTCCCCC--------
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHH---H-cCCCCCC--------
Confidence 3356779999999999999999999999999999999 67777643 122233322 1 1111111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 559 REGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 559 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
+.....++.+|+.+||+.||++||||.|++++|++++.
T Consensus 222 --~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11223468899999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=396.10 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=197.1
Q ss_pred hhcccCcCCcceEEEEEecC-C-----cEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLES-G-----AVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (604)
..++||+|+||+||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 35789999999999998542 2 37999998643 233446789999999998 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceE
Q 007427 393 EFLPNGSLFDLLHESRGV------------------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNIL 454 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 454 (604)
|||++|+|.++++..+.. ....+++..++.|+.||++||+|||+ ++|+||||||+|||
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~----~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF----KSCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH----TTEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCchhccc
Confidence 999999999999865421 11348999999999999999999994 79999999999999
Q ss_pred EeecCCcceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCC
Q 007427 455 IFRENDIYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGN 527 (604)
Q Consensus 455 l~~~~~~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~ 527 (604)
+ +.+..+||+|||+|+....... ..+++.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 197 l---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 197 V---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp E---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred c---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 9 5667899999999987654332 235788999999999999999999999999999998 8999976422
Q ss_pred CCCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 007427 528 NETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIE 594 (604)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 594 (604)
...+ ..........+. +...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 273 ---~~~~----~~~~~~~~~~~~----------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 ---DANF----YKLIQNGFKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---SHHH----HHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHH----HHHHhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1112 222222221111 1123346889999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-48 Score=396.22 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=203.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++|||||++|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 47899999999999985 57999999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... ..+++..+..|+.||+.||+|||+ +||+||||||+|||++.+. ...+||+|||+|+.+.....
T Consensus 111 ~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~----~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 111 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE----NNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp HHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCTTSC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh----cCCeeeeechhHeeeccCC-CCeEEEeecchheecccccc
Confidence 99996543 259999999999999999999994 7999999999999995432 35799999999988765443
Q ss_pred ---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 481 ---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 481 ---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
..+++.|+|||++.+..++.++|||||||++|||+||+.||.+. ...+....+....+.....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~~~~------ 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNMDDS------ 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCSCCG------
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCCcc------
Confidence 36789999999999999999999999999999999999999753 1223333333332211100
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
........+.+|+.+||+.||++|||++|+++.
T Consensus 248 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001223468899999999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=386.83 Aligned_cols=238 Identities=18% Similarity=0.263 Sum_probs=196.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 47899999999999986 579999999996422 23356799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ ++++.+||+|||+|+.+..
T Consensus 93 g~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~----~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 93 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG----KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC-
T ss_pred CCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcc----ccEEcCcCCcccccc---CCCceEEecccccceeccc
Confidence 99999988764 49999999999999999999994 799999999999999 6667899999999987653
Q ss_pred CC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 478 RK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 478 ~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
.. ...||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+...... +
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~--~- 229 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLEYD--F- 229 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTCCC--C-
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCCCC--C-
Confidence 22 2358899999999999999999999999999999999999997531 22222333322211 0
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+.....++.+|+.+||+.||++|||++|+++
T Consensus 230 ---------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 ---------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0112346889999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=384.33 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=199.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN------ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 47899999999999986 579999999986421 22357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC-cceEEEeeccCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND-IYRAKLTNFGFLP 473 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~~~~kl~DFGla~ 473 (604)
|++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. ...+|++|||+|+
T Consensus 95 ~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~----~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 95 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhh----cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999998754 49999999999999999999994 79999999999999965542 2469999999998
Q ss_pred CCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 474 LLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 474 ~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
...... ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+........
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~~- 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNYEFE- 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTCCCCC-
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCC-
Confidence 775432 3367889999999999999999999999999999999999997532 1222222222221111
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 237 --~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 --DEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HHHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --chhc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 112346889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-48 Score=392.81 Aligned_cols=245 Identities=21% Similarity=0.354 Sum_probs=202.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++|||||++|+|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 47899999999999985 57999999999876656677889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCCC
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRKA 480 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~~ 480 (604)
.+++.... .++++.++..|+.||+.||+|||+ +||+||||||+|||++.. ....+||+|||+|+.+.....
T Consensus 114 ~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~----~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 114 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHE----HSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----CCeeeccccccccccccc-CCCeEEEeecccceecCCCCc
Confidence 99876543 258999999999999999999994 799999999999999432 346899999999988765432
Q ss_pred ---CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 481 ---SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 481 ---~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
..+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+.........
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~------- 249 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDE------- 249 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCS-------
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc-------
Confidence 367889999999999999999999999999999999999997532 22222333322211100
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 250 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 -DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123346889999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=386.83 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=201.1
Q ss_pred hcccCcCCcceEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEec-CCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLES----GAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS-KEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 395 (604)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 236899999743 44455789999999999999999999999875 45789999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
++|+|.+++.... ..+++..+++++.|+++||.|||+ ++|+||||||+|||+ ++.+.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~----~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS----KKFVHRDLAARNCML---DEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcc----cCcccCCccHHhEeE---CCCCCEEEecccchhhc
Confidence 9999999988654 247889999999999999999994 799999999999999 67789999999999876
Q ss_pred CCCCC--------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSRKA--------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~~~--------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
..... ..++..|+|||.+.+..++.++||||||+++|||+||+.||..... ..++. ..+......
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~---~~i~~g~~~ 253 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDIT---VYLLQGRRL 253 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CH---HHHHTTCCC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHH---HHHHcCCCC
Confidence 54321 2467789999999999999999999999999999998888764321 11222 222222111
Q ss_pred cccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcccccc
Q 007427 548 TDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPMIEE 602 (604)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 602 (604)
. . +......+.+|+.+||+.||++||+|.||++.|+++.+....
T Consensus 254 ~---~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 254 L---Q--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp C---C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C---C--------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1 0 112234688999999999999999999999999999766543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-48 Score=386.72 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=201.9
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|+.. +++.||||+++... ....++|.+|++++++++||||++++++|...+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 468999999999999864 45789999997543 33457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEE
Q 007427 395 LPNGSLFDLLHESRG-------------------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILI 455 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 455 (604)
+++|+|.++++.... .....+++..++.|+.|++.||+|||+ ++|+||||||+|||+
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~----~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE----RKFVHRDLATRNCLV 173 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc----CCeEeeEEcccceEE
Confidence 999999999975321 112348999999999999999999994 799999999999999
Q ss_pred eecCCcceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC-CCCCCCCCCC
Q 007427 456 FRENDIYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR-IPGNGSPGNN 528 (604)
Q Consensus 456 ~~~~~~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~-~p~~~~~~~~ 528 (604)
+.++.+||+|||+|+.+.... ...++..|+|||.+.+..++.++|||||||++|||++|. .||.+.
T Consensus 174 ---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~---- 246 (301)
T d1lufa_ 174 ---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---- 246 (301)
T ss_dssp ---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----
T ss_pred ---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC----
Confidence 677899999999987653321 234667899999999999999999999999999999986 566542
Q ss_pred CCCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 529 ETSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
...+....+..... ... +...+.++.+|+.+||+.||++||||.||+++|++|.+
T Consensus 247 ----~~~e~~~~v~~~~~-~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 ----AHEEVIYYVRDGNI-LAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ----CHHHHHHHHHTTCC-CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----CHHHHHHHHHcCCC-CCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12223333332221 111 11233468899999999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=388.36 Aligned_cols=261 Identities=19% Similarity=0.279 Sum_probs=197.6
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCC----ceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE----EKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+.+++|||||++++++.+.+ ..++|||||++
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 46799999999999997 489999999965432 1222344555667789999999999998654 57899999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----CCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQT----LHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+|.++++.. +++|.++.+++.|+|.||+|||+. +++++|+||||||+|||+ +.++.+||+|||+++
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAV 156 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccc
Confidence 9999999864 389999999999999999999964 335799999999999999 677899999999997
Q ss_pred CCCCCC--------CCccccccCCCCCCCCCC------CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC-------CC
Q 007427 474 LLPSRK--------ASENLAIGRSPEFPEGKR------LTHKADVYCFGIILLEVITGRIPGNGSPGNNET-------SG 532 (604)
Q Consensus 474 ~~~~~~--------~~~~~~~y~aPE~~~~~~------~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~-------~~ 532 (604)
...... ...+++.|+|||++.+.. ++.++|||||||++|||+||..||......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 764322 235789999999987643 577999999999999999999887543321111 11
Q ss_pred chhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 533 DLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.................+.+ .....+....+.+++.+||+.||++|||+.||++.|+++..
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG-----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCc-----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 22222222222222111111 11122455678999999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=378.13 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=190.6
Q ss_pred hcccCcCCcceEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATLE----SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|++. .+..||||.++.. .....+.+.+|++++++++|||||++++++. .+..++||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 478999999999999864 2457999998753 3334577999999999999999999999986 567899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .++++..++.++.||++||+|||+ ++|+||||||+||++ +....+||+|||+|+...
T Consensus 91 ~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 91 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES----KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---EETTEEEECC--------
T ss_pred CCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc----cCeeccccchhheee---cCCCcEEEccchhheecc
Confidence 999999887643 258999999999999999999994 799999999999999 455689999999998765
Q ss_pred CCC-----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccc
Q 007427 477 SRK-----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDI 550 (604)
Q Consensus 477 ~~~-----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (604)
... ...+++.|+|||.+.+..++.++|||||||++|||+| |..||.+... ..+.. .+...... .
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~---~i~~~~~~-~- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIG---RIENGERL-P- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH---HHHTTCCC-C-
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHH---HHHcCCCC-C-
Confidence 432 2245778999999999999999999999999999998 8889875421 12222 22222111 1
Q ss_pred ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 551 LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
.+...+..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 230 ---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1112345689999999999999999999999999988643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=378.21 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred hcccCcCCcceEEEEEec--CC--cEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE--SG--AVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|++. ++ ..||||+++.. .....++|.+|++++++++||||++++|+|.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 467999999999999853 22 37899998643 22335689999999999999999999999975 467899999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|++.+++....+ ++++..++.++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+++.
T Consensus 92 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~----~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 92 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES----KRFIHRDLAARNLLLAT---RDLVKIGDFGLMRA 160 (273)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCCGGGEEEEE---TTEEEECCCTTCEE
T ss_pred ecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhh----CCEeeeeecHHHhcccc---ccceeeccchhhhh
Confidence 999999998876542 49999999999999999999994 79999999999999954 46899999999987
Q ss_pred CCCCCC-------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 475 LPSRKA-------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 475 ~~~~~~-------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
...... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+. ...+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCCC
Confidence 754322 235668999999999999999999999999999998 89998753 22233333333332
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
.... ....+..+.+|+.+||+.||++||||.||.+.|++.+
T Consensus 233 ~~~~----------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 233 RLPR----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 2111 1122346889999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=384.65 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=203.3
Q ss_pred CccCHHHHHHHhhcccCcCCcceEEEEEec-CCc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEec
Q 007427 310 PVFDLDDLLRASAEVLGKGKVGSTYKATLE-SGA--VVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS 384 (604)
Q Consensus 310 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 384 (604)
|.++++|+. ..++||+|+||+||+|++. +|. .||||+++.. .....+.|.+|+++++++ +|||||+++++|.+
T Consensus 5 ~~i~~~~~~--~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 5 PVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp SBCCGGGCE--EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CccCHHHcE--EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 344555542 3578999999999999864 444 5788888643 333456799999999999 79999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhhccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 007427 385 KEEKLIIYEFLPNGSLFDLLHESR-----------GVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNI 453 (604)
Q Consensus 385 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NI 453 (604)
.+..++||||+++|+|.++++... ......+++.++.+++.||++||.|||+ ++|+||||||+||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~----~~iiHrDlkp~NI 158 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ----KQFIHRDLAARNI 158 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc----CCccccccccceE
Confidence 999999999999999999997542 1122359999999999999999999994 7999999999999
Q ss_pred EEeecCCcceEEEeeccCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCC-CCCCCCCCCC
Q 007427 454 LIFRENDIYRAKLTNFGFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRI-PGNGSPGNNE 529 (604)
Q Consensus 454 Ll~~~~~~~~~kl~DFGla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~-p~~~~~~~~~ 529 (604)
|+ +....+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++|.. ||.+.
T Consensus 159 L~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----- 230 (309)
T d1fvra_ 159 LV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----- 230 (309)
T ss_dssp EE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----
T ss_pred EE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----
Confidence 99 677789999999997765432 2357789999999999999999999999999999999765 55432
Q ss_pred CCCchhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhccc
Q 007427 530 TSGDLSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQPM 599 (604)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 599 (604)
...+....+.... ... .+...+.++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 231 ---~~~~~~~~i~~~~-~~~----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 231 ---TCAELYEKLPQGY-RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ---CHHHHHHHGGGTC-CCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CHHHHHHHHHhcC-CCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2223333322221 111 1112334689999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=382.26 Aligned_cols=246 Identities=22% Similarity=0.418 Sum_probs=194.6
Q ss_pred hcccCcCCcceEEEEEec-CCc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATLE-SGA----VVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (604)
.++||+|+||+||+|++. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.+. ..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 478999999999999853 444 6899988643 334567899999999999999999999999864 567889999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+|+|.+++.... ..+++..+++|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+|+..
T Consensus 93 ~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~----~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 93 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED----RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp TTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred cCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH----cCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 9999999887653 258999999999999999999994 799999999999999 55568999999999876
Q ss_pred CCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 476 PSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 476 ~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
..... ..++..|+|||++.++.++.++|||||||++|||+| |+.||.+.. ...+...+. .....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~---~~~~~- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE---KGERL- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHH---HTCCC-
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH---cCCCC-
Confidence 44322 246789999999999999999999999999999999 788887532 122222221 11111
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
. .+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 233 ~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp C----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1 111233468899999999999999999999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=378.81 Aligned_cols=238 Identities=18% Similarity=0.238 Sum_probs=197.8
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+|||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 47899999999999985 579999999997432 22357789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEe---cCCCCEEEeeccccccccc
Confidence 99999998765 4899999999999999999999 4799999999999999 6667899999999987644
Q ss_pred CC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 478 RK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 478 ~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
.. ...||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+...........
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~~~~------ 223 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIR------ 223 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC------
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcCCCC------
Confidence 32 2357899999999999999999999999999999999999998632 22223333222211
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.+...+.++.+|+.+||+.||++||+ +.|+++
T Consensus 224 ------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01122346889999999999999995 777765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=385.25 Aligned_cols=245 Identities=19% Similarity=0.289 Sum_probs=193.0
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCCcccEEEEEec----CCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKL-KHENLAKIVSFYYS----KEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~ 396 (604)
++||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||+++++|.+ ....|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5699999999999985 67999999999642 4577899987655 89999999999865 456899999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... ...+++.++..|+.||+.||+|||+ +||+||||||+|||++.++....+||+|||+|+...
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~----~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH----cCCccccccccccccccccccccccccccceeeecc
Confidence 999999998643 2359999999999999999999994 799999999999999776667789999999998765
Q ss_pred CCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH
Q 007427 477 SRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV 553 (604)
Q Consensus 477 ~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (604)
... ...+++.|+|||++.+..|+.++|||||||++|||+||+.||.+..... ....+........ .....+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~~i~~~~-~~~~~~ 239 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIRMGQ-YEFPNP 239 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCS-SSCCTT
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHHHHHhcCC-CCCCCc
Confidence 432 3468999999999999999999999999999999999999997643211 1111110000000 000000
Q ss_pred HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 240 ------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01123456899999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-46 Score=373.46 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=196.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCc----eEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEE----KLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e 393 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46899999999999985 579999999997532 2334678999999999999999999999976543 789999
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+++|+|.+++.... ++++.++..++.||+.||+|||+ +||+||||||+|||+ +.....+++|||.++
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~----~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ----NGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHh----CCccCccccCccccc---Cccccceeehhhhhh
Confidence 999999999987764 49999999999999999999994 799999999999999 555678999999886
Q ss_pred CCCCCC-------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 474 LLPSRK-------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 474 ~~~~~~-------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
...... ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcCC
Confidence 553321 2357899999999999999999999999999999999999997532 1222222332221
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhhcc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRP-KMSEVLRRIEEIQP 598 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 598 (604)
.... ......+..+.+++.+||+.||++|| |++++++.|.++++
T Consensus 232 ~~~~--------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 232 IPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCGG--------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CCCc--------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1100 00112334688999999999999999 89999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-46 Score=376.58 Aligned_cols=238 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM---NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||||+++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 47899999999999986 57999999999642 223357789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|..++.... .+++..+..++.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred ccccccccccc-----cccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeE---cCCCCEEEecCccceEecc
Confidence 99999988755 4788999999999999999999 5799999999999999 6667899999999988765
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+. ...+....+.......
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~~~~-------- 220 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAELRF-------- 220 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCCCCC--------
T ss_pred ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHcCCCCC--------
Confidence 43 346899999999999999999999999999999999999999753 1223333333322111
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+...+.++.+++.+||+.||.+|| |++|+++
T Consensus 221 ----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111234588999999999999996 8888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=377.12 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=189.5
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCCcccEEEEEecCC-ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKE-EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~ 392 (604)
.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+.+ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 478999999999999853 3568999999753 333456788888888777 6899999999987654 689999
Q ss_pred ecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCc
Q 007427 393 EFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDI 461 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 461 (604)
|||++|+|.++++..... ....+++.++..++.||++||+|||+ ++|+||||||+|||+ +.+
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~----~~ivHrDlKp~NILl---~~~ 170 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILL---SEK 170 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CGG
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh----CCCcCCcCCccceeE---CCC
Confidence 999999999999765321 12358999999999999999999994 799999999999999 677
Q ss_pred ceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC-CCCCCCCCCCCCCCch
Q 007427 462 YRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR-IPGNGSPGNNETSGDL 534 (604)
Q Consensus 462 ~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~-~p~~~~~~~~~~~~~~ 534 (604)
+.+||+|||+|+...... ...+++.|+|||++.+..++.++|||||||++|||+||. .||.+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-------- 242 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------- 242 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--------
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--------
Confidence 889999999998764332 235778999999999999999999999999999999975 56654321
Q ss_pred hHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 535 SDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
.+.+......+...... ...+.++.+++.+||+.||++|||+.||+++|+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SHHHHHHHHHTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCC----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11122222222211111 1223468899999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=374.90 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=196.6
Q ss_pred hcccCcCCcceEEEEEec--------CCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEE
Q 007427 322 AEVLGKGKVGSTYKATLE--------SGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (604)
.+.||+|+||.||+|+.. ++..||||+++... .....++.+|...+.++ +|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 478999999999999853 23579999997543 33457888999999888 899999999999999999999
Q ss_pred EecCCCCCHHHHhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 392 YEFLPNGSLFDLLHESRGV-----------GRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 392 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
|||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||+ +.
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~----~~ivHrDiKp~NiLl---~~ 170 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS----KKCIHRDLAARNVLV---TE 170 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---CT
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh----CCEEeeeecccceee---cC
Confidence 9999999999999765421 12358999999999999999999994 799999999999999 66
Q ss_pred cceEEEeeccCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVIT-GRIPGNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~ellt-g~~p~~~~~~~~~~~~~ 533 (604)
++.+||+|||+++...... ...++..|+|||.+.+..|+.++|||||||++|||+| |..||.+..
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-------- 242 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 242 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--------
Confidence 6789999999998764332 2356778999999999999999999999999999998 688876432
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
..+.. ..+..+..... +...+..+.+|+.+||+.||++||||.||+++|++|.+
T Consensus 243 ~~~~~-~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 VEELF-KLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHH-HHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-HHHHcCCCCCC----------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222 22222221111 11223468999999999999999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.4e-46 Score=367.56 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=196.0
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch---------hhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA---------LSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 390 (604)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 47899999999999985 5799999999864321 12346889999999997 9999999999999999999
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||+++|+|.++++... ++++.++..++.||++||+|||+ +||+||||||+|||+ +.+..+||+|||
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~----~~ivHrDlkp~Nill---~~~~~~kl~DFG 155 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK----LNIVHRDLKPENILL---DDDMNIKLTDFG 155 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH----cCCcccccccceEEE---cCCCCeEEccch
Confidence 999999999999998654 59999999999999999999995 699999999999999 667789999999
Q ss_pred CCCCCCCC---CCCccccccCCCCCCC------CCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSR---KASENLAIGRSPEFPE------GKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~---~~~~~~~~y~aPE~~~------~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
+++.+... ....++..|+|||++. ...++.++||||+||++|||+||+.||.+.. .......+
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMI 227 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHHHH
Confidence 99877643 2345788999999875 3457889999999999999999999998532 12222333
Q ss_pred HhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.......... .....++++.+++.+||+.||++|||+.||++
T Consensus 228 ~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQFGSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCCCCTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCc--------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3332211100 01123346889999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=375.22 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.2
Q ss_pred hcccCcCCcceEEEEEe------cCCcEEEEEEecccc-hhhHHHHHHHHHHHccC-CCCCcccEEEEEecCCceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL------ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKL-KHENLAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 393 (604)
.++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||+++++|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 57899999999999985 346799999997543 33456799999999999 69999999999999999999999
Q ss_pred cCCCCCHHHHhhcccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC
Q 007427 394 FLPNGSLFDLLHESRG-------------VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND 460 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 460 (604)
||++|+|.++++.... .....+++..+..++.||++||+|||+ ++|+||||||+||++ +.
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~----~~ivHrDLKp~NIl~---~~ 180 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS----KNCIHRDLAARNILL---TH 180 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCSGGGEEE---ET
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh----CCeeecccccccccc---cc
Confidence 9999999999986542 122358999999999999999999994 799999999999999 55
Q ss_pred cceEEEeeccCCCCCCCCCC------CccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCC-CCCCCCCCCCCCc
Q 007427 461 IYRAKLTNFGFLPLLPSRKA------SENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIP-GNGSPGNNETSGD 533 (604)
Q Consensus 461 ~~~~kl~DFGla~~~~~~~~------~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p-~~~~~~~~~~~~~ 533 (604)
...+|++|||+++....... ..+++.|+|||++.+..++.++|||||||++|||+|+..| |..... ...
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~----~~~ 256 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----DSK 256 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----SHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH----HHH
Confidence 67889999999988764322 2467889999999999999999999999999999995444 443211 111
Q ss_pred hhHHHHHHHhcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 534 LSDWVRMVVDNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
+.+ ....+..... +...+..+.+|+.+||+.||++||||.||+++|+++..
T Consensus 257 ~~~----~i~~~~~~~~----------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 FYK----MIKEGFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHH----HHHHTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HHhcCCCCCC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 222 2222211111 11223468899999999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=374.77 Aligned_cols=244 Identities=20% Similarity=0.296 Sum_probs=199.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+++|++++|||||++++++.+.+..|+|||||++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 47899999999999986 478999999997653 3346788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC-
Q 007427 401 FDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK- 479 (604)
Q Consensus 401 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~- 479 (604)
.+++.... .++++.++..|+.||+.||+|||+ +||+||||||+|||++.+ ....+||+|||+++......
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~----~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHS----HNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH----cCCCcccccccceeecCC-CceEEEEcccchhhccccCCc
Confidence 99997643 248999999999999999999994 799999999999999543 34579999999998775443
Q ss_pred --CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhhh
Q 007427 480 --ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEILA 557 (604)
Q Consensus 480 --~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (604)
...+++.|+|||...+..++.++||||+||++|||++|+.||.+.. ..+....+........ ....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~~~---~~~~- 227 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFD---EEAF- 227 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCC---HHHH-
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCC---hhhc-
Confidence 2357789999999999999999999999999999999999997532 2233333333322111 1000
Q ss_pred cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 558 AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 558 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 228 ----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 ----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012346889999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=374.15 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=203.1
Q ss_pred hcccCcCCcceEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATLE------SGAVVAVKRVKNM-NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++||||++++++|...+..++||||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 578999999999999853 3678999999753 333446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 395 LPNGSLFDLLHESRG-----VGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
+++|+|.+++..... .....+++..+.+++.|+++||.|||+ ++|+||||||+|||+ +.++++||+||
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~----~~ivHrDlk~~NiLl---d~~~~~Kl~DF 177 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA----NKFVHRDLAARNCMV---AEDFTVKIGDF 177 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH----TTCBCSCCSGGGEEE---CTTCCEEECCT
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh----CCeeeceEcCCceee---cCCceEEEeec
Confidence 999999999875431 122357999999999999999999994 699999999999999 77789999999
Q ss_pred cCCCCCCCCC------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCC-CCCCCCCCCCCCCCchhHHHHHHH
Q 007427 470 GFLPLLPSRK------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGR-IPGNGSPGNNETSGDLSDWVRMVV 542 (604)
Q Consensus 470 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 542 (604)
|+|+.+.... ...+++.|+|||.+.+..++.++|||||||++|||+||. .||.+. ...+....+.
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~~~~i~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVLRFVM 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHHHHHHH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHH
Confidence 9998764432 224678999999999999999999999999999999985 666532 2233333333
Q ss_pred hcCCccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhcc
Q 007427 543 DNDWSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQP 598 (604)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 598 (604)
..... .. +...+..+.+++.+||+.||++||||.||+++|++..+
T Consensus 250 ~~~~~-~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLL-DK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCC-CC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 32221 11 11233468999999999999999999999999987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-46 Score=377.49 Aligned_cols=238 Identities=18% Similarity=0.240 Sum_probs=198.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++...+..++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46899999999999986 579999999996421 22346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~----~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS----LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh----CCEecCcCCHHHccc---CCCCCEEeeeceeeeeccc
Confidence 99999998764 48999999999999999999994 799999999999999 6667899999999988765
Q ss_pred CC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccHHhh
Q 007427 478 RK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDVEIL 556 (604)
Q Consensus 478 ~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (604)
.. ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+. ........+.......
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~~~~-------- 257 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGKVRF-------- 257 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCC--------
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcCCCCC--------
Confidence 43 346889999999999999999999999999999999999999753 1222333333222111
Q ss_pred hcccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 007427 557 AAREGQNEMLRLTELALECTDIAPEKRP-----KMSEVLR 591 (604)
Q Consensus 557 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 591 (604)
+.....++.+++.+||+.||.+|+ |++|+++
T Consensus 258 ----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112234688999999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=378.06 Aligned_cols=241 Identities=17% Similarity=0.212 Sum_probs=191.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHH---HHHHHHHccCCCCCcccEEEEEecCCceEEEEec
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEF---VQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEF 394 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (604)
.++||+|+||+||+|+. .+|+.||||++.... ......+ .+|+++++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 47899999999999986 479999999986321 1112233 3457788888999999999999999999999999
Q ss_pred CCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCC
Q 007427 395 LPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPL 474 (604)
Q Consensus 395 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~ 474 (604)
+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +..+.+||+|||+|+.
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~----~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN----RFVVYRDLKPANILL---DEHGHVRISDLGLACD 156 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CSSSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHH----CCccceeeccceeEE---cCCCcEEEeeeceeee
Confidence 99999999998764 48899999999999999999994 799999999999999 6667899999999987
Q ss_pred CCCCC--CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 475 LPSRK--ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 475 ~~~~~--~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
+.... ...+++.|+|||++.. ..++.++|||||||++|||+||+.||.+... .......+....... .
T Consensus 157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~--~-- 227 (364)
T d1omwa3 157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAV--E-- 227 (364)
T ss_dssp CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSCCC--C--
T ss_pred cCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccCCC--C--
Confidence 75443 3468999999999864 5689999999999999999999999986422 122222222111110 0
Q ss_pred cHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 552 DVEILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 228 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112346889999999999999999 577764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=372.81 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=188.2
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNAL-----SKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++...+..++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999985 57999999999643221 12468899999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
++++..+..... .+++.++..++.||+.||+|||+ +||+||||||+|||+ +....+||+|||+|+...
T Consensus 84 ~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~----~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 84 TDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ----HWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred chHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhhc----cceecccCCcceEEe---cCCCccccccCccccccC
Confidence 887776655332 48889999999999999999994 799999999999999 666789999999998765
Q ss_pred CCC----CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccc
Q 007427 477 SRK----ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDIL 551 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (604)
... ...+++.|+|||++.. ..++.++|||||||++|||+||+.||.+... ...+.... ............
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~l~~i~-~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIF-ETLGTPTEEQWP 226 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HHHCCCCTTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH----HHHHHHHH-HhcCCCChhhcc
Confidence 432 2357889999998865 4579999999999999999999999975321 11111111 111000000000
Q ss_pred cH-------------HhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 552 DV-------------EILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 552 ~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
+. ..............+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00000000112346899999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=371.63 Aligned_cols=238 Identities=20% Similarity=0.293 Sum_probs=193.2
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc---hhhHHHHHHHHHHHc-cCCCCCcccEEEEEecCCceEEEEecCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN---ALSKKEFVQQMQLLG-KLKHENLAKIVSFYYSKEEKLIIYEFLP 396 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (604)
.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|..++. .++|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 47899999999999985 479999999996421 223456677777665 6899999999999999999999999999
Q ss_pred CCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCC
Q 007427 397 NGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLP 476 (604)
Q Consensus 397 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~ 476 (604)
+|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+ +....+||+|||+++...
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~----~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS----KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 154 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH----TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh----CCeeeccCcccceee---cCCCceeccccchhhhcc
Confidence 999999998765 48999999999999999999994 799999999999999 666789999999998664
Q ss_pred CCC----CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcccccc
Q 007427 477 SRK----ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILD 552 (604)
Q Consensus 477 ~~~----~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (604)
... ...+++.|+|||++.+..++.++|||||||++|||+||+.||.+.. ..+....+......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~----- 221 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDNPF----- 221 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC-----
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC-----
Confidence 332 3367889999999999999999999999999999999999997532 12222222222111
Q ss_pred HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 007427 553 VEILAAREGQNEMLRLTELALECTDIAPEKRPKMS-EVLR 591 (604)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 591 (604)
.+...+.++.+|+.+||+.||++||++. |+++
T Consensus 222 -------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0112234688999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=360.77 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=191.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA--LSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (604)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 36899999999999985 6799999999964322 2346789999999999999999999999999999999999965
Q ss_pred CHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC
Q 007427 399 SLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR 478 (604)
Q Consensus 399 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~ 478 (604)
++.+++.... ...+++..+..++.|++.||+|||+ +||+||||||+|||+ +.+..+||+|||+|+.....
T Consensus 86 ~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~----~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 86 DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS----HRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc----CCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence 5555554432 2249999999999999999999994 799999999999999 56668899999998765432
Q ss_pred ----CCCccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC--Cccccc
Q 007427 479 ----KASENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND--WSTDIL 551 (604)
Q Consensus 479 ----~~~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 551 (604)
....+++.|+|||...... ++.++|||||||++|||++|+.||.+... ...+........... ......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhccccc
Confidence 2336789999999877655 57899999999999999999999975321 011111111100000 000000
Q ss_pred c-----HHhhh-cc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhc
Q 007427 552 D-----VEILA-AR-----EGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQ 597 (604)
Q Consensus 552 ~-----~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 597 (604)
. ..... .. .......++.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0 00000 00 001123468899999999999999999999874 55443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=361.49 Aligned_cols=233 Identities=23% Similarity=0.330 Sum_probs=188.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccch------hhHHHHHHHHHHHccCC--CCCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNA------LSKKEFVQQMQLLGKLK--HENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||+||+|+. .+|+.||||+++.... ....++.+|+.++++++ |||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 46899999999999985 5799999999864321 11234678999999986 899999999999999999999
Q ss_pred ecCCC-CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccC
Q 007427 393 EFLPN-GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGF 471 (604)
Q Consensus 393 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGl 471 (604)
||+.+ +++.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++. +...+||+|||+
T Consensus 89 e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~----~~iiHrDiKp~NIll~~--~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN----CGVLHRDIKDENILIDL--NRGELKLIDFGS 157 (273)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH----TTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred EeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH----CCCccccCcccceEEec--CCCeEEECcccc
Confidence 99976 68888887654 48999999999999999999994 79999999999999953 335799999999
Q ss_pred CCCCCCCC--CCccccccCCCCCCCCCCC-CccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 472 LPLLPSRK--ASENLAIGRSPEFPEGKRL-THKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 472 a~~~~~~~--~~~~~~~y~aPE~~~~~~~-s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
|+...... ...++..|+|||++.+..+ +.++|||||||++|||+||+.||.+.. .........
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~~~~ 223 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQVFF 223 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCCCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhcccCC
Confidence 98765443 3468899999999887665 567999999999999999999997420 111111100
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
....+.++.+++.+||+.||++|||++|+++
T Consensus 224 ------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 224 ------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0112346889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=357.59 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=190.7
Q ss_pred hcccCcCCcceEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATLESGAVVAVKRVKNMN--ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
-+.||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.++++++||||+++++++...+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 36799999999999999999999999996532 2235789999999999999999999999999999999999998776
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCC-
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSR- 478 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~- 478 (604)
+..+..... .+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.+..+|++|||.+......
T Consensus 87 ~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~----~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 87 KKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD----RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp HHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred HHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhcc----CcEEecCCCCceeeE---cCCCCEEecccccceecccCc
Confidence 666655432 59999999999999999999994 699999999999999 66678999999998765432
Q ss_pred ---CCCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCccccccH-
Q 007427 479 ---KASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWSTDILDV- 553 (604)
Q Consensus 479 ---~~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 553 (604)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+...... ..........+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~-~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRI-LGTPNSKNWPNVT 229 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHH-HCCCCTTTSTTGG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHh-hCCCChhhccchh
Confidence 233577889999998754 568999999999999999999999975321 0111111111 000000000000
Q ss_pred -------Hh------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 554 -------EI------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 554 -------~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.. ............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000001122346889999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-43 Score=353.64 Aligned_cols=252 Identities=15% Similarity=0.177 Sum_probs=192.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccE-EEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKI-VSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. .+|+.||||++..... .+++.+|++++++++|+|++.. .+++.+.+..++||||+ +++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 46899999999999985 5789999999875432 3457899999999987765555 55556777889999999 567
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|.+.+.... ..+++..+..++.|++.||+||| ++||+||||||+|||++..+....+||+|||+|+.+....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 89 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred hhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 777765543 25899999999999999999999 4799999999999999766677789999999998764321
Q ss_pred -----------CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCcc
Q 007427 480 -----------ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWST 548 (604)
Q Consensus 480 -----------~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (604)
...+++.|+|||.+.+..++.++|||||||++|||+||+.||......... ..............
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP--- 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSC---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCCCC---
Confidence 235789999999999999999999999999999999999999864332111 11111111111000
Q ss_pred ccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhh
Q 007427 549 DILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEI 596 (604)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 596 (604)
.. ......+.++.+++..||+.||++||+++++.+.|+.+
T Consensus 237 ----~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ----IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----hh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 00112334688999999999999999999999988876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=355.50 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=188.4
Q ss_pred hcccCcCCcceEEEEEe-cC-CcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCCcccEEEEEec-----CCceE
Q 007427 322 AEVLGKGKVGSTYKATL-ES-GAVVAVKRVKNMN--ALSKKEFVQQMQLLGKL---KHENLAKIVSFYYS-----KEEKL 389 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~~~ 389 (604)
.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 36899999999999986 34 6789999986422 22233566777776665 89999999999853 34678
Q ss_pred EEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeec
Q 007427 390 IIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNF 469 (604)
Q Consensus 390 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DF 469 (604)
++|||++++++........ ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+||
T Consensus 92 ~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~----~~ivHrDiKp~NILi---~~~~~~kl~df 160 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS----HRVVHRDLKPQNILV---TSSGQIKLADF 160 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred EEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHh----CCEEecCCCccEEEE---cCCCCeeecch
Confidence 9999998876655444322 248999999999999999999994 799999999999999 66678999999
Q ss_pred cCCCCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh---
Q 007427 470 GFLPLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD--- 543 (604)
Q Consensus 470 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 543 (604)
|+++...... ...+|+.|+|||++.+..|+.++||||+||++|||+||+.||.+... ...+.........
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCG
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCch
Confidence 9998765432 34688999999999999999999999999999999999999975321 1111111111100
Q ss_pred cCCccccccHHh--------hhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhc
Q 007427 544 NDWSTDILDVEI--------LAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQ 597 (604)
Q Consensus 544 ~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 597 (604)
..+......... ............+.+|+.+||+.||++|||+.|+++. |+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 000000000000 0000011223468899999999999999999999873 55443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=355.94 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=185.9
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEEecC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIYEFL 395 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~ 395 (604)
++||+|+||+||+|+. .+|+.||||+++.... ...+|++++++++||||++++++|... ...++|||||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 6899999999999986 4799999999975432 234799999999999999999998643 2468999999
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
+++.+..+..... ....+++.++..++.||+.||+||| ++||+||||||+|||++.+ ...+||+|||+++..
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~--~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQL 173 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTT--TCCEEECCCTTCEEC
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecC--CCceeEecccchhhc
Confidence 7654443333222 1235999999999999999999999 5799999999999999433 246899999999876
Q ss_pred CCCC---CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHH-----------H
Q 007427 476 PSRK---ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVR-----------M 540 (604)
Q Consensus 476 ~~~~---~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~ 540 (604)
.... ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..... .
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHHhhhh
Confidence 5433 3357889999998765 5689999999999999999999999975321 111111111 0
Q ss_pred HHhcCCcccccc--HHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhc
Q 007427 541 VVDNDWSTDILD--VEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQ 597 (604)
Q Consensus 541 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 597 (604)
............ ..............++.+|+.+||+.||++|||+.|+++. +++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000000000 0000000111234468899999999999999999999863 55554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-42 Score=350.66 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=185.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCCcccEEEEEecCC----ceEEEEecC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMN-ALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE----EKLIIYEFL 395 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 395 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 37899999999999985 589999999997543 334567899999999999999999999997653 235556667
Q ss_pred CCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCC
Q 007427 396 PNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLL 475 (604)
Q Consensus 396 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~ 475 (604)
.+|+|.+++... .+++..+..++.|++.||+|||+ +||+||||||+|||+ +....+||+|||+|+..
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~----~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS----ANVLHRDLKPSNLLL---NTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH----CCCcCCCCCcceEEE---CCCCCEEEcccCceeec
Confidence 799999999754 38999999999999999999994 799999999999999 66678999999999766
Q ss_pred CCC-------CCCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCCc
Q 007427 476 PSR-------KASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDWS 547 (604)
Q Consensus 476 ~~~-------~~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (604)
... ....+++.|+|||.+.. ..++.++||||+||++|||++|+.||.+... .+..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCCh
Confidence 432 22347789999999854 5678999999999999999999999975321 0111111000000000
Q ss_pred cc---ccc----HHhh---h------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 548 TD---ILD----VEIL---A------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 548 ~~---~~~----~~~~---~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
.. ... .... . .........++.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 0000 0 00001122468899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=351.34 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=187.7
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCC------ceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKE------EKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 392 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 36899999999999985 57999999999743 3334567899999999999999999999997654 569999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+ +.+|..+++.. .+++..+..++.|++.||+||| ++||+||||||+|||+ +.+..+|++|||+|
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAV---NEDCELKILDFGLA 168 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhc---ccccccccccccce
Confidence 999 66888887653 3999999999999999999999 4799999999999999 66778999999999
Q ss_pred CCCCCCC-CCccccccCCCCCCCC-CCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHh------c
Q 007427 473 PLLPSRK-ASENLAIGRSPEFPEG-KRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVD------N 544 (604)
Q Consensus 473 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~ 544 (604)
+...... ...+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+... ...+......... .
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHHHhccCCCcHHHHh
Confidence 8876543 3467889999999876 4568999999999999999999999976321 0111111100000 0
Q ss_pred CCccccccHHhh---------hcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhhc
Q 007427 545 DWSTDILDVEIL---------AAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRR--IEEIQ 597 (604)
Q Consensus 545 ~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 597 (604)
............ ...........+.+|+.+||+.||++|||+.|+++. |+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000000 000011223467899999999999999999999874 55543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=343.89 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=192.8
Q ss_pred cccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecCCceEEEEecCCCCC
Q 007427 323 EVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
+.||+|+||+||+|+. .+|+.||||+++.. ......++.+|+.++++++||||+++++++......++|+||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 6899999999999985 57899999999643 23346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPSRK 479 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~~~ 479 (604)
|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+ +....+||+|||.++......
T Consensus 88 l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~----~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 88 KKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS----RNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp HHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH----TTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCC
T ss_pred ccccccccc-----ccchhHHHHHHHHHHHHHHHhhc----CCEeeecccCccccc---ccCCceeeeecchhhcccCCC
Confidence 988877543 48899999999999999999994 799999999999999 556678999999998765433
Q ss_pred ----CCccccccCCCCCCCCCC-CCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHH---hcCCcccc-
Q 007427 480 ----ASENLAIGRSPEFPEGKR-LTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVV---DNDWSTDI- 550 (604)
Q Consensus 480 ----~~~~~~~y~aPE~~~~~~-~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 550 (604)
...++..|+|||.+.... ++.++|||||||++|||++|+.||.... +..+....+. ........
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-------CHHHHHHHHHhhcCCCChhhhh
Confidence 234567888999887655 6899999999999999999999975422 1222222111 11000000
Q ss_pred -------------ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 551 -------------LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 551 -------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
.................+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000011122346889999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=347.32 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=184.5
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEec--------CCceEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYS--------KEEKLI 390 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~l 390 (604)
.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 46899999999999985 57999999998643 23345778999999999999999999999865 345799
Q ss_pred EEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeecc
Q 007427 391 IYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFG 470 (604)
Q Consensus 391 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFG 470 (604)
||||++++.+..+..... .++...+..++.|++.||+||| ++||+||||||+|||+ +.+..+||+|||
T Consensus 95 v~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl---~~~~~~kl~dfg 162 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLI---TRDGVLKLADFG 162 (318)
T ss_dssp EEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEE---CTTSCEEECCCT
T ss_pred EEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheee---cCCCcEEeeecc
Confidence 999998776665544322 4888999999999999999999 4799999999999999 666789999999
Q ss_pred CCCCCCCCC--------CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHH
Q 007427 471 FLPLLPSRK--------ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMV 541 (604)
Q Consensus 471 la~~~~~~~--------~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 541 (604)
+++.+.... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHHh
Confidence 997654321 23478899999998765 689999999999999999999999975321 1111111111
Q ss_pred HhcCC---ccccc----cHHhh---hcccC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VDNDW---STDIL----DVEIL---AAREG-------QNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~~~~---~~~~~----~~~~~---~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
..... ..... ..... ..... ......+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11000 00000 00000 00000 011235789999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.2e-42 Score=340.60 Aligned_cols=253 Identities=16% Similarity=0.184 Sum_probs=197.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CCcccEEEEEecCCceEEEEecCCCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSKEEKLIIYEFLPNGS 399 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gs 399 (604)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+|++.++.++| +|++.+++++......++||||+ +++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 46899999999999985 4789999999865332 3457788999999865 89999999999999999999999 789
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecC--CcceEEEeeccCCCCCCC
Q 007427 400 LFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREN--DIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 400 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~--~~~~~kl~DFGla~~~~~ 477 (604)
|.+++.... ..+++.++..++.|++.||+||| ++||+||||||+|||++.+. ....+||+|||+|+....
T Consensus 87 l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 87 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 999987643 25899999999999999999999 57999999999999996532 245799999999986543
Q ss_pred C-----------CCCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcCC
Q 007427 478 R-----------KASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDNDW 546 (604)
Q Consensus 478 ~-----------~~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (604)
. ....||+.|+|||.+.+..++.++|||||||++|||+||+.||.+.... ..............
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEKKQ 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----hHHHHHHHHHhccC
Confidence 2 1235789999999999999999999999999999999999999864321 11111111111100
Q ss_pred ccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhhc
Q 007427 547 STDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLRRIEEIQ 597 (604)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 597 (604)
... ..++ ....+.++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 234 ~~~--~~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STP--LREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSC--HHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCC--hHHh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 000 0000 0112346889999999999999999999999888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=345.97 Aligned_cols=253 Identities=16% Similarity=0.216 Sum_probs=187.4
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecC--CceEEEEecCCC
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSK--EEKLIIYEFLPN 397 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~ 397 (604)
.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||||+++
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 47899999999999985 579999999997543 467899999999995 99999999998743 568999999999
Q ss_pred CCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCCCCCC
Q 007427 398 GSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLPLLPS 477 (604)
Q Consensus 398 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~~~~~ 477 (604)
++|..+.+ .+++..+..++.||+.||+||| ++||+||||||+|||++.++ ..+||+|||+|+....
T Consensus 117 ~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 117 TDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCT
T ss_pred CcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCC--CeeeecccccceeccC
Confidence 99976542 3899999999999999999999 47999999999999995433 3689999999987654
Q ss_pred CC---CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHH-----HHHHh-cCCc
Q 007427 478 RK---ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWV-----RMVVD-NDWS 547 (604)
Q Consensus 478 ~~---~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~ 547 (604)
.. ...++..|+|||.+.+. .++.++||||+||++|||++|+.||............+.... ..... ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 32 33578899999998765 479999999999999999999999975322100000000000 00000 0000
Q ss_pred --ccc----------ccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 548 --TDI----------LDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 548 --~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
... ................++.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000011123346889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=347.64 Aligned_cols=242 Identities=18% Similarity=0.263 Sum_probs=191.7
Q ss_pred hcccCcCCcceEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCC-CCcccEEEEEecCCceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL----ESGAVVAVKRVKNMN----ALSKKEFVQQMQLLGKLKH-ENLAKIVSFYYSKEEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 392 (604)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....+++|
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 57899999999999974 258999999986422 2234678899999999976 89999999999999999999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+.+|+|.+++.... .+....+..++.|++.||+|||+ ++|+||||||+|||+ +.+..+||+|||++
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~----~~ivHrDiKp~Nill---~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK----LGIIYRDIKLENILL---DSNGHVVLTDFGLS 176 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH----TTCCCCCCCGGGEEE---CTTSCEEESCSSEE
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc----CCEEeccCCccceee---cCCCCEEEeeccch
Confidence 9999999999998765 37788999999999999999994 799999999999999 66678999999999
Q ss_pred CCCCCCC-----CCccccccCCCCCCCCC--CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC
Q 007427 473 PLLPSRK-----ASENLAIGRSPEFPEGK--RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND 545 (604)
Q Consensus 473 ~~~~~~~-----~~~~~~~y~aPE~~~~~--~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (604)
+.+.... ...+++.|+|||.+.+. .++.++|||||||+||||+||+.||.+.... ..............
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcccCC
Confidence 8765332 23577899999998754 4688999999999999999999999864321 22222222222211
Q ss_pred CccccccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 007427 546 WSTDILDVEILAAREGQNEMLRLTELALECTDIAPEKRPK-----MSEVLR 591 (604)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 591 (604)
.. .+.....++.+++.+||+.||++||| ++|+++
T Consensus 253 ~~------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 01123446889999999999999995 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=341.47 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=181.3
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC------CceEEEE
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK------EEKLIIY 392 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 392 (604)
.++||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+.++++++||||++++++|... ...|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 36899999999999985 47999999999743 233446789999999999999999999999643 5789999
Q ss_pred ecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 393 EFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 393 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
||+.+ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+|||+ +.+..+|++|||++
T Consensus 102 Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~---~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred eccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhh----hcccccccCCcccccc---ccccceeeechhhh
Confidence 99966 55555432 3899999999999999999999 4799999999999999 66667899999998
Q ss_pred CCCCCCC---CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCC--------------CCchh
Q 007427 473 PLLPSRK---ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNET--------------SGDLS 535 (604)
Q Consensus 473 ~~~~~~~---~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~--------------~~~~~ 535 (604)
+...... ...++..|+|||++.+..+++++||||+||++|||++|+.||.+....... .....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 7765432 335788999999999999999999999999999999999999753210000 00000
Q ss_pred HHHHHHHhcCCc-cccccHHhh----hc---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 007427 536 DWVRMVVDNDWS-TDILDVEIL----AA---REGQNEMLRLTELALECTDIAPEKRPKMSEVLRR 592 (604)
Q Consensus 536 ~~~~~~~~~~~~-~~~~~~~~~----~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 592 (604)
............ .....+... .. .........+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001111111100 000000000 00 0112345678999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=343.37 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=187.6
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCCcccEEEEEecC-----CceEEEEe
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNM--NALSKKEFVQQMQLLGKLKHENLAKIVSFYYSK-----EEKLIIYE 393 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 393 (604)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 46899999999999985 57999999999743 233456789999999999999999999998643 34567778
Q ss_pred cCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 394 FLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 394 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
|+.+|+|.+++... .+++.++..++.||+.||+||| ++||+||||||+|||+ +.++.+|++|||++.
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAV---NEDCELKILDFGLAR 169 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccc---cccccccccccchhc
Confidence 88899999999653 3999999999999999999999 4799999999999999 666788999999997
Q ss_pred CCCCCC-CCccccccCCCCCCCCC-CCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCCCchhHHHHHHHhcC------
Q 007427 474 LLPSRK-ASENLAIGRSPEFPEGK-RLTHKADVYCFGIILLEVITGRIPGNGSPGNNETSGDLSDWVRMVVDND------ 545 (604)
Q Consensus 474 ~~~~~~-~~~~~~~y~aPE~~~~~-~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 545 (604)
...... ...++..|+|||...+. .++.++|||||||++|||++|+.||.+... ......+.......
T Consensus 170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCHHHHT
T ss_pred ccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCChHHhh
Confidence 765433 34578899999987665 468899999999999999999999975321 11111111000000
Q ss_pred -CccccccHHhh---h------cccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHHhh
Q 007427 546 -WSTDILDVEIL---A------AREGQNEMLRLTELALECTDIAPEKRPKMSEVLR--RIEEI 596 (604)
Q Consensus 546 -~~~~~~~~~~~---~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 596 (604)
........... . ..........+.+|+.+||+.||++|||+.|+++ .++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000000 0 0000112346889999999999999999999987 34443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-36 Score=311.22 Aligned_cols=264 Identities=18% Similarity=0.253 Sum_probs=185.1
Q ss_pred hcccCcCCcceEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCCcccEEEEEecC--Cc
Q 007427 322 AEVLGKGKVGSTYKATL-ESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-----------HENLAKIVSFYYSK--EE 387 (604)
Q Consensus 322 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~--~~ 387 (604)
.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 47899999999999985 579999999997643 23467788999888775 57899999988643 45
Q ss_pred eEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCC---cceE
Q 007427 388 KLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFREND---IYRA 464 (604)
Q Consensus 388 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~~~~ 464 (604)
.+++|+++..+.......... ....+++..+..++.|++.||+|||+ ..||+||||||+|||++.++. ...+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCccccccee
Confidence 566676665554333332222 12358899999999999999999995 369999999999999966543 2358
Q ss_pred EEeeccCCCCCCCCC-CCccccccCCCCCCCCCCCCccchhHhHHHHHHHHHhCCCCCCCCCCCCCCC--CchhHHHHHH
Q 007427 465 KLTNFGFLPLLPSRK-ASENLAIGRSPEFPEGKRLTHKADVYCFGIILLEVITGRIPGNGSPGNNETS--GDLSDWVRMV 541 (604)
Q Consensus 465 kl~DFGla~~~~~~~-~~~~~~~y~aPE~~~~~~~s~ksDVwSfGvvl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~ 541 (604)
|++|||.+....... ...++..|+|||.+....++.++||||+||+++||++|+.||.......... ..+...+...
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l 251 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence 999999987654433 3468889999999999999999999999999999999999997543211111 0111111100
Q ss_pred Hh--------cC----------Cccc--------cccHHhhhcccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 007427 542 VD--------ND----------WSTD--------ILDVEILAAREGQNEMLRLTELALECTDIAPEKRPKMSEVLR 591 (604)
Q Consensus 542 ~~--------~~----------~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 591 (604)
-. .. .... ..+...............+.+|+.+||+.||.+|||++|+++
T Consensus 252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00 0000 000000111223456778999999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=7.1e-29 Score=249.41 Aligned_cols=181 Identities=32% Similarity=0.581 Sum_probs=140.9
Q ss_pred CCCHhHHHHHHHHHHhcCCCCCCCCCCC-CCCCCCCCCCeeeEEecC----CcEeEEEeCCCCcee--cCChhhhcCCcc
Q 007427 21 DYYPAERYDLLQIRDSLNSTANLHSRWT-GPPCIDNVSNWFGVSCSN----GHIVSLELEEIQLAG--ILPPGFLQNITF 93 (604)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~-~~~c~~~~~~w~gv~c~~----~~~~~l~l~~~~l~g--~~p~~~~~~l~~ 93 (604)
-|.|+|++||++||+++.+|. .+.+|. +.+||. +.|.||+|+. .||+.|+|++|+++| .||++ +++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~--~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~-l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTT--TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-GGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCC--CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChH-HhcCcc
Confidence 489999999999999998876 467785 333321 3699999964 389999999999998 58888 899999
Q ss_pred CCeeeCcc-CCCcccCC-CCCCCCCccEEeCCCCcccc------------------------------------------
Q 007427 94 LNKLSLRN-NLLSGSLP-NLTNLVNLETVFLSQNHFSD------------------------------------------ 129 (604)
Q Consensus 94 L~~l~l~~-n~l~g~~p-~~~~l~~L~~l~l~~N~l~g------------------------------------------ 129 (604)
|++|||++ |+|+|.|| +|++|++|++|||++|+++|
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999986 89999998 47777777776665555433
Q ss_pred ------cCCc----------------------------------------------------------------------
Q 007427 130 ------GIPF---------------------------------------------------------------------- 133 (604)
Q Consensus 130 ------~iP~---------------------------------------------------------------------- 133 (604)
.+|.
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222
Q ss_pred -cCCCCCCCCEEeccCCcccccCCCC--CCCCCcEEEccCCcccccCCCCccccCCCCCccCCCCCCcCCCCCCCC
Q 007427 134 -GYIDLPKLKKLELQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNSGLCGRPLEKLC 206 (604)
Q Consensus 134 -~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~c 206 (604)
.++.+++|+.|+|++|+|+|.||.. .+++|+.|+|++|+|+|.||....+.++....+.+|+.+||.|+ +.|
T Consensus 238 ~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl-p~c 312 (313)
T d1ogqa_ 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312 (313)
T ss_dssp GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS-SCC
T ss_pred cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC-CCC
Confidence 2333556667777777777777763 57788999999999999999877778888889999999999876 345
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.2e-23 Score=194.78 Aligned_cols=167 Identities=14% Similarity=0.157 Sum_probs=118.5
Q ss_pred hhcccCcCCcceEEEEEecCCcEEEEEEecccc------------------hhhHHHHHHHHHHHccCCCCCcccEEEEE
Q 007427 321 SAEVLGKGKVGSTYKATLESGAVVAVKRVKNMN------------------ALSKKEFVQQMQLLGKLKHENLAKIVSFY 382 (604)
Q Consensus 321 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 382 (604)
.+++||+|+||+||+|+..+|+.||||+++... ........+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 367899999999999998889999999875211 01123456788999999999999988763
Q ss_pred ecCCceEEEEecCCCCCHHHHhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceEEeecCCcc
Q 007427 383 YSKEEKLIIYEFLPNGSLFDLLHESRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLHSHKVPHANLKSSNILIFRENDIY 462 (604)
Q Consensus 383 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~~ 462 (604)
..+++|||+++..+.+ ++......++.|++++|+|||+ +||+||||||+|||++. .
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~----~giiHrDiKP~NILv~~---~- 139 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH----RGIVHGDLSQYNVLVSE---E- 139 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH----TTEECSCCSTTSEEEET---T-
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh----CCEEEccCChhheeeeC---C-
Confidence 2479999998755432 3344556899999999999995 69999999999999952 2
Q ss_pred eEEEeeccCCCCCCCCCCCccccc--cCCCCCCCCCCCCccchhHhHHHHHH
Q 007427 463 RAKLTNFGFLPLLPSRKASENLAI--GRSPEFPEGKRLTHKADVYCFGIILL 512 (604)
Q Consensus 463 ~~kl~DFGla~~~~~~~~~~~~~~--y~aPE~~~~~~~s~ksDVwSfGvvl~ 512 (604)
.++|+|||.|..........-... ..-.+++ .+.|+.++|+||..--++
T Consensus 140 ~~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 140 GIWIIDFPQSVEVGEEGWREILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EEEECCCTTCEETTSTTHHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CEEEEECCCcccCCCCCcHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 489999999876543221100000 0000111 355788999999765443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=2.8e-16 Score=144.60 Aligned_cols=122 Identities=25% Similarity=0.379 Sum_probs=98.2
Q ss_pred CCeeeEEecC-----------CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCC
Q 007427 57 SNWFGVSCSN-----------GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQ 124 (604)
Q Consensus 57 ~~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~ 124 (604)
|.|..|.|+. .+++.|+|++|++++.++...++.+++|+.|+|++|++++.++ .+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 5688888853 2678899999999877777667888999999999999988877 478888999999999
Q ss_pred CcccccCCccCCCCCCCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCC
Q 007427 125 NHFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 125 N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p 178 (604)
|++++-.|..+.++++|+.|+|++|+|++..|. + .+++|+.|+|++|.+.+..+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999885556678899999999999999865554 2 57888999999988876544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.57 E-value=6.8e-16 Score=153.59 Aligned_cols=110 Identities=25% Similarity=0.233 Sum_probs=99.4
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccC
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQE 148 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~ 148 (604)
...+++.++.+.|.+|.. ++.+++|+.|++++|.++|.+|.++.+++|+.|||++|+|+|.||.++++|++|++|+|++
T Consensus 199 ~~~l~l~~~~~~~~~~~~-~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 199 LAFVDLSRNMLEGDASVL-FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CSEEECCSSEEEECCGGG-CCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 346777788888888776 7889999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCC-CCCCCcEEEccCCc-cccc-CCC
Q 007427 149 NYLDGQIPPF-NQTSLIDFNVSYNN-LDGP-IPQ 179 (604)
Q Consensus 149 N~l~g~ip~~-~~~~l~~l~ls~n~-l~g~-~p~ 179 (604)
|+|+|.||.+ .+++|+.+++++|+ ++|. +|.
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCCCCCC
Confidence 9999999986 58899999999997 7875 553
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.49 E-value=5.6e-14 Score=128.88 Aligned_cols=132 Identities=19% Similarity=0.257 Sum_probs=107.5
Q ss_pred eeEEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCCCCcccccCCccCCC
Q 007427 60 FGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLSQNHFSDGIPFGYID 137 (604)
Q Consensus 60 ~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~~N~l~g~iP~~~~~ 137 (604)
.|-+|+. +.++.++++|+ .||.. +. +++++|+|++|+|++.++ .++++++|+.|+|++|++++..|..+..
T Consensus 4 ~~C~C~~---~~v~Cs~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG---TTVDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET---TEEECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC---CEEEEeCCCcC-ccCCC-CC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 3456753 47899999999 89987 43 789999999999999776 4789999999999999999988899999
Q ss_pred CCCCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 138 LPKLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 138 l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
+++|++|+|++|++++..|. + .+++|+.|+|++|+|++-.|.. ..+.++....+.+|+..|
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 99999999999999965554 3 5899999999999999877754 123344455566665443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=4.5e-14 Score=119.29 Aligned_cols=100 Identities=28% Similarity=0.381 Sum_probs=87.0
Q ss_pred EEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCc
Q 007427 71 SLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENY 150 (604)
Q Consensus 71 ~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~ 150 (604)
.|+|++|+++ .+|. ++.+++|++|||++|+++...+.++.+++|++|++++|++++ +| .+.++++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 6899999998 6664 789999999999999998643469999999999999999997 76 58999999999999999
Q ss_pred ccccCCC----CCCCCCcEEEccCCccccc
Q 007427 151 LDGQIPP----FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 151 l~g~ip~----~~~~~l~~l~ls~n~l~g~ 176 (604)
++. +|. ..+++|+.|++++|.++..
T Consensus 77 i~~-~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQ-SAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCS-SSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCC-CCCchhhcCCCCCCEEECCCCcCCcC
Confidence 984 443 3578999999999999854
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=9.9e-13 Score=116.54 Aligned_cols=104 Identities=19% Similarity=0.240 Sum_probs=88.6
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCcc-CCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFG-YIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~-~~~l~~l~~l~l 146 (604)
++..|+|++|+++ .||.. +..+++|+.|||++|+++. ++.+..+++|++|+|++|+++. +|.. +..+++|+.|+|
T Consensus 19 ~lr~L~L~~n~I~-~i~~~-~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENL-GATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCC-SCCCG-GGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCC-ccCcc-ccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccC-CCcccccccccccccee
Confidence 6889999999998 67754 6789999999999999984 6889999999999999999998 6654 467999999999
Q ss_pred cCCcccccCCC----CCCCCCcEEEccCCccccc
Q 007427 147 QENYLDGQIPP----FNQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 147 ~~N~l~g~ip~----~~~~~l~~l~ls~n~l~g~ 176 (604)
++|+++. ++. ..+++|+.|++++|.++..
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred ccccccc-cccccccccccccchhhcCCCccccc
Confidence 9999983 443 2589999999999988643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=7.4e-12 Score=120.75 Aligned_cols=108 Identities=26% Similarity=0.207 Sum_probs=88.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|++++ +|+..+.++++|++|+|++|+|+ .+|.++.+++|++|+|++|++++ +|..+.++++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCC-cCHHHhhcccccccccccccccc-ccccccccccccccccccccccc-ccccccccccccccccc
Confidence 68899999999985 66555889999999999999998 46778899999999999999998 68888999999999999
Q ss_pred CCcccccCCCC--CCCCCcEEEccCCcccccCC
Q 007427 148 ENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 148 ~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p 178 (604)
+|.+.+..+.. .+.++..|++++|.+++..+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~ 141 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred ccccceeeccccccccccccccccccccceecc
Confidence 99988544432 46677777777777765443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=1.1e-11 Score=119.43 Aligned_cols=129 Identities=24% Similarity=0.221 Sum_probs=77.5
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCC---------------------
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQN--------------------- 125 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N--------------------- 125 (604)
.+++.|+|++|+++ .||. ++.+++|+.|+|++|++++..+.+.++++|+.|++++|
T Consensus 55 ~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l 131 (266)
T d1p9ag_ 55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (266)
T ss_dssp TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred cccccccccccccc-cccc--ccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccc
Confidence 35777777777776 4543 35667777777777777665555555555555555555
Q ss_pred ---cccccCCccCCCCCCCCEEeccCCcccccCCC-C-CCCCCcEEEccCCcccccCCCCc-cccCCCCCccCCCCCCcC
Q 007427 126 ---HFSDGIPFGYIDLPKLKKLELQENYLDGQIPP-F-NQTSLIDFNVSYNNLDGPIPQTR-VVQSFPSSSFEHNSGLCG 199 (604)
Q Consensus 126 ---~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~~n~~lcg 199 (604)
.+++--|..+..+++|+.|++++|+|++..|. + .+++|+.|+|++|+|+ .||... .+..+....+.+|+..|.
T Consensus 132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 44442233345566777777777777754443 2 3677777777777777 666542 223344455667766653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.27 E-value=2.8e-12 Score=107.98 Aligned_cols=98 Identities=21% Similarity=0.238 Sum_probs=79.7
Q ss_pred CeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC-CCCCCcEEEccCCcc
Q 007427 95 NKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQTSLIDFNVSYNNL 173 (604)
Q Consensus 95 ~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~n~l 173 (604)
++|||++|+++ .+|.++++++|++|||++|+++. +|+.++.+++|+.|++++|++++ +|.. .+++|+.|++++|++
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 77 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cCccccccccCeEECCCCcc
Confidence 58999999998 66789999999999999999986 99999999999999999999994 6764 689999999999999
Q ss_pred cccCCC--CccccCCCCCccCCCC
Q 007427 174 DGPIPQ--TRVVQSFPSSSFEHNS 195 (604)
Q Consensus 174 ~g~~p~--~~~~~~~~~~~~~~n~ 195 (604)
+..... ...+.++....+.+|+
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CCCCCchhhcCCCCCCEEECCCCc
Confidence 854321 1223344445556664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=7.6e-12 Score=121.88 Aligned_cols=131 Identities=22% Similarity=0.318 Sum_probs=107.8
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|++.+..+. .++.+++|+.+++++|+|++..+ .+..+++|+.|+|++|++++-.|..+.++++|+.|+
T Consensus 105 ~~L~~L~l~~n~~~~~~~~-~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPG-LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCccccccccc-ccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 4799999999999754444 47889999999999999998666 488899999999999999996677889999999999
Q ss_pred ccCCcccccCCCC--CCCCCcEEEccCCcccccCCCC-ccccCCCCCccCCCCCCc
Q 007427 146 LQENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT-RVVQSFPSSSFEHNSGLC 198 (604)
Q Consensus 146 l~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~~n~~lc 198 (604)
+++|++++..|.. .+++|+.|++++|.+++..|.. ....++....+.+|+.-|
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 9999999877763 5789999999999999876643 123445556677887655
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=1e-11 Score=120.95 Aligned_cols=113 Identities=19% Similarity=0.184 Sum_probs=90.0
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+..++...++....+++..+.++++|++|+|++|.+.+..+ .++.+.+|+.+++++|++++-.|..+..+++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 566666654443345655558899999999999999987666 4778899999999999999844566788999999999
Q ss_pred cCCcccccCCCC--CCCCCcEEEccCCcccccCCCC
Q 007427 147 QENYLDGQIPPF--NQTSLIDFNVSYNNLDGPIPQT 180 (604)
Q Consensus 147 ~~N~l~g~ip~~--~~~~l~~l~ls~n~l~g~~p~~ 180 (604)
++|+|++..|.. .+++|+.+++++|++++..|..
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~ 196 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhH
Confidence 999998655542 5889999999999999887765
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.16 E-value=5.7e-11 Score=116.79 Aligned_cols=102 Identities=23% Similarity=0.287 Sum_probs=65.0
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+++.+++++|+++ .+|.. .+++|+.|+|++|..++.+| .+.+++.+++|++++|.+++-.|..+.++++|++|+|
T Consensus 151 ~L~~l~l~~n~l~-~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 151 KLSYIRIADTNIT-TIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TCCEEECCSSCCC-SCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccCccccccCCcc-ccCcc---cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 4666666666665 45543 24666666777666666665 3666666666777766666655556666666677777
Q ss_pred cCCcccccCCCC--CCCCCcEEEccCCccc
Q 007427 147 QENYLDGQIPPF--NQTSLIDFNVSYNNLD 174 (604)
Q Consensus 147 ~~N~l~g~ip~~--~~~~l~~l~ls~n~l~ 174 (604)
++|+|+ .||.. .+++|+.|+|++|+++
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cccccc-ccccccccccCCCEEECCCCccC
Confidence 777666 45542 3566666777666666
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=6.6e-11 Score=103.78 Aligned_cols=97 Identities=21% Similarity=0.149 Sum_probs=78.6
Q ss_pred CCCCceecCChhhhcCCccCCeeeCccCC-CcccCC-CCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCccc
Q 007427 75 EEIQLAGILPPGFLQNITFLNKLSLRNNL-LSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 75 ~~~~l~g~~p~~~~~~l~~L~~l~l~~n~-l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~ 152 (604)
.++++. .+|.. +..+++|+.|+|++|+ ++..-+ .|.++++|+.|+|++|+++.--|..+..+++|++|+|++|+|+
T Consensus 16 ~~~~~~-~~p~~-l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 16 TRDGAL-DSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CSSCCC-TTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred cCCCCc-cCccc-ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 444554 56766 7788999999998765 776444 5899999999999999999855677899999999999999999
Q ss_pred ccCCC--CCCCCCcEEEccCCccc
Q 007427 153 GQIPP--FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 153 g~ip~--~~~~~l~~l~ls~n~l~ 174 (604)
.||. +...+|+.|+|++|.|.
T Consensus 94 -~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 -SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp -CCCSTTTCSCCCCEEECCSSCCC
T ss_pred -ccChhhhccccccccccCCCccc
Confidence 6776 34557999999999874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=7.5e-11 Score=103.43 Aligned_cols=95 Identities=22% Similarity=0.243 Sum_probs=79.8
Q ss_pred CCCeeeEEecC-------------CcEeEEEeCCCC-ceecCChhhhcCCccCCeeeCccCCCcccCCC-CCCCCCccEE
Q 007427 56 VSNWFGVSCSN-------------GHIVSLELEEIQ-LAGILPPGFLQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETV 120 (604)
Q Consensus 56 ~~~w~gv~c~~-------------~~~~~l~l~~~~-l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l 120 (604)
++.+.+++|.. .+++.|+|++|+ ++ .|++..+.++++|+.|+|++|+|+...|. |.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 34678888853 378899998775 66 67766688999999999999999987774 8899999999
Q ss_pred eCCCCcccccCCccCCCCCCCCEEeccCCccc
Q 007427 121 FLSQNHFSDGIPFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 121 ~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~ 152 (604)
||++|+|+. ||..+....+|+.|+|++|.|.
T Consensus 86 ~Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCcc-cChhhhccccccccccCCCccc
Confidence 999999995 8888777778999999999885
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=6.9e-11 Score=109.42 Aligned_cols=120 Identities=25% Similarity=0.325 Sum_probs=69.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|+|++|.+++ +++ ++.+++|++|+|++|++++ +|.+.++++|+.|++++|.++. ++ .+..+++|+.++++
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~~-~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-cccccccccccccccccccccc-cc-cccccccccccccc
Confidence 56666666666664 443 4566666666666666664 4556666666666666666653 32 45566666666666
Q ss_pred CCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 148 ENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 148 ~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
+|.+++..+...+++|+.+++++|++++. +....+.++..+.+.+|
T Consensus 143 ~n~l~~~~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 143 NNKITDITVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKN 188 (210)
T ss_dssp SSCCCCCGGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccc-ccccCCCCCCEEECCCC
Confidence 66665433333466777777777777653 22222333334444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.10 E-value=1.2e-10 Score=106.78 Aligned_cols=101 Identities=23% Similarity=0.372 Sum_probs=59.0
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
+++.|++++|+++ .++. +..+++|++|+|++|++++.. .++++++|+.|++++|.+.. +| .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~-~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCcc-cccCCccccccccccccccc-cc-cccccccccccccc
Confidence 4566666666665 3432 555666666666666666533 36666666666666666554 44 25566666666666
Q ss_pred CCcccccCCCCCCCCCcEEEccCCccc
Q 007427 148 ENYLDGQIPPFNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 148 ~N~l~g~ip~~~~~~l~~l~ls~n~l~ 174 (604)
+|.+....+-..+++|+.|++++|++.
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccccchhhhhHHhhhhhhhhc
Confidence 666654333334566666666666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.04 E-value=2e-10 Score=106.14 Aligned_cols=119 Identities=25% Similarity=0.339 Sum_probs=96.4
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEecc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQ 147 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~ 147 (604)
.++.|++++|+++. ++. +..+++|++|+|++|++++ ++.+++|++|++|++++|++++ +| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~-l~~--l~~l~~L~~L~L~~n~i~~-l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQG--IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-chh--HhhCCCCCEEeCCCccccC-ccccccCccccccccccccccc-cc-cccccccccccccc
Confidence 68999999999984 543 7889999999999999998 5568999999999999999997 77 58999999999999
Q ss_pred CCcccccCCCC-CCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 148 ENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 148 ~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
+|.++ .++.. .++.|+.+++++|.+++..+ ...+.++....+.+|
T Consensus 121 ~~~~~-~~~~l~~l~~l~~l~~~~n~l~~~~~-~~~l~~L~~l~l~~n 166 (210)
T d1h6ta2 121 HNGIS-DINGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTLSLEDN 166 (210)
T ss_dssp TSCCC-CCGGGGGCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSS
T ss_pred ccccc-cccccccccccccccccccccccccc-ccccccccccccccc
Confidence 99987 45543 58899999999999986432 223344444445544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.00 E-value=5e-10 Score=102.54 Aligned_cols=120 Identities=28% Similarity=0.414 Sum_probs=95.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|+|++|++++ +++ ++++++|+.|++++|.+.. +|.++++++|+.|++++|.+.. ++ .+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred CCcCcCccccccccC-ccc--ccCCccccccccccccccc-cccccccccccccccccccccc-cc-ccchhhhhHHhhh
Confidence 589999999999996 444 7889999999999999875 5668899999999999999887 33 4788999999999
Q ss_pred cCCcccccCCC-CCCCCCcEEEccCCcccccCCCCccccCCCCCccCCC
Q 007427 147 QENYLDGQIPP-FNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 147 ~~N~l~g~ip~-~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
++|+++ .+|. ..+.+|+.|++++|++++..| -..+.++..+.+.+|
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N 182 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSN 182 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred hhhhhc-ccccccccccccccccccccccCCcc-ccCCCCCCEEECCCC
Confidence 999987 4564 468899999999999987432 233444445555555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=3.2e-10 Score=100.00 Aligned_cols=85 Identities=20% Similarity=0.205 Sum_probs=72.7
Q ss_pred hcCCccCCeeeCccCCCcccCCC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC--CCCCCc
Q 007427 88 LQNITFLNKLSLRNNLLSGSLPN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF--NQTSLI 164 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n~l~g~~p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~ 164 (604)
+.+...|+.|||++|+++.. |. +..+++|+.|||++|+++. |+ .+..+++|+.|+|++|+++...|.. .+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 56788999999999999875 55 4679999999999999995 75 5899999999999999999543332 589999
Q ss_pred EEEccCCcccc
Q 007427 165 DFNVSYNNLDG 175 (604)
Q Consensus 165 ~l~ls~n~l~g 175 (604)
.|++++|+++.
T Consensus 91 ~L~L~~N~i~~ 101 (162)
T d1a9na_ 91 ELILTNNSLVE 101 (162)
T ss_dssp EEECCSCCCCC
T ss_pred cceeccccccc
Confidence 99999999874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.97 E-value=9.1e-10 Score=107.91 Aligned_cols=106 Identities=28% Similarity=0.356 Sum_probs=87.3
Q ss_pred CCeeeEEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCccC
Q 007427 57 SNWFGVSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFGY 135 (604)
Q Consensus 57 ~~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~~ 135 (604)
|.|.+|.|++ ++|+ .||+. + .+.|++|+|++|+++...+ +|.++++|++|++++|.++.-.|..+
T Consensus 10 c~~~~~~C~~----------~~L~-~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCSD----------LGLE-KVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECTT----------SCCC-SCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEecC----------CCCC-ccCCC-C--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh
Confidence 5688888864 4455 78876 4 3679999999999988766 58899999999999999998667789
Q ss_pred CCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCCcccccC
Q 007427 136 IDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYNNLDGPI 177 (604)
Q Consensus 136 ~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~ 177 (604)
.++++|+.|+|++|+++ .||......+..|++++|.+.+..
T Consensus 76 ~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~ 116 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVR 116 (305)
T ss_dssp TTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBC
T ss_pred hCCCccCEecccCCccC-cCccchhhhhhhhhccccchhhhh
Confidence 99999999999999998 688877788899999999887643
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.96 E-value=4.2e-10 Score=113.91 Aligned_cols=105 Identities=28% Similarity=0.407 Sum_probs=84.9
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|++++|++++ +++ +..++.++.++++.|.+++ ++.+..+++|+.|+|++|++++ ++ .+..+++|+.|+|
T Consensus 263 ~~L~~L~l~~~~l~~-~~~--~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISN-ISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCC-CCc--ccccccccccccccccccc-ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEEC
Confidence 478999999999986 443 5678889999999999887 5567888889999999999988 44 3788889999999
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCcccccCC
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIP 178 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p 178 (604)
++|++++ +|.. .+++|+.|++++|++++-+|
T Consensus 337 ~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 337 ANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence 9998884 5653 57889999999999887665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.87 E-value=1.2e-09 Score=110.35 Aligned_cols=122 Identities=25% Similarity=0.317 Sum_probs=98.0
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.|++++|.+++. ++ ++.+++|+.|++++|++++. +.+.++..++.++++.|++++ ++ .+..+++++.|+|
T Consensus 241 ~~L~~L~l~~n~l~~~-~~--~~~~~~L~~L~l~~~~l~~~-~~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~l 314 (384)
T d2omza2 241 TNLTDLDLANNQISNL-AP--LSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLED-IS-PISNLKNLTYLTL 314 (384)
T ss_dssp TTCSEEECCSSCCCCC-GG--GTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEEC
T ss_pred cccchhccccCccCCC-Cc--ccccccCCEeeccCcccCCC-Ccccccccccccccccccccc-cc-ccchhcccCeEEC
Confidence 4789999999999974 33 67899999999999999875 458889999999999999998 43 5888999999999
Q ss_pred cCCcccccCCCCCCCCCcEEEccCCcccccCCCCccccCCCCCccCCCC
Q 007427 147 QENYLDGQIPPFNQTSLIDFNVSYNNLDGPIPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 147 ~~N~l~g~ip~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~ 195 (604)
++|++++..|-..+++|+.|++++|++++ +|.-..+.++......+|.
T Consensus 315 s~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 315 YFNNISDISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQ 362 (384)
T ss_dssp CSSCCSCCGGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCcccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCc
Confidence 99999975444568999999999999986 4433334455555666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.82 E-value=2e-11 Score=111.75 Aligned_cols=106 Identities=23% Similarity=0.267 Sum_probs=70.6
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCC-CCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNL-TNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~-~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
.+++.|+|++|+++ .|+. +..+++|+.|+|++|.++. +|.+ ..+.+|+.|++++|+++. ++ .+.++++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred cccceeECcccCCC-Cccc--ccCCccccChhhccccccc-ccccccccccccccccccccccc-cc-cccccccccccc
Confidence 46777777777776 5653 6667777777777777763 4443 334567777777777775 43 466777777777
Q ss_pred ccCCcccccCC---C-CCCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIP---P-FNQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip---~-~~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|+++. ++ . ..+++|+.|++++|.++...+.
T Consensus 122 L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 122 MSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence 77777763 22 2 3467777777777777665443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.81 E-value=1.3e-11 Score=113.08 Aligned_cols=110 Identities=16% Similarity=0.182 Sum_probs=85.3
Q ss_pred cCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCC-CC
Q 007427 82 ILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPF-NQ 160 (604)
Q Consensus 82 ~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~-~~ 160 (604)
.+|.+ ++.|++|+.|+|++|+++ .|+.+.+|++|+.|+|++|+++. ||.....+++|+.|++++|+++. ++.. .+
T Consensus 39 ~l~~s-l~~L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l 114 (198)
T d1m9la_ 39 KMDAT-LSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LSGIEKL 114 (198)
T ss_dssp CCHHH-HHHTTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HHHHHHH
T ss_pred hhhhH-HhcccccceeECcccCCC-CcccccCCccccChhhccccccc-ccccccccccccccccccccccc-ccccccc
Confidence 34555 889999999999999998 57889999999999999999985 88766667789999999999984 5543 57
Q ss_pred CCCcEEEccCCccccc--CCCCccccCCCCCccCCCC
Q 007427 161 TSLIDFNVSYNNLDGP--IPQTRVVQSFPSSSFEHNS 195 (604)
Q Consensus 161 ~~l~~l~ls~n~l~g~--~p~~~~~~~~~~~~~~~n~ 195 (604)
++|+.|++++|+++.. +..-..+.++..+.+.+|+
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCc
Confidence 8999999999998743 1111223344445556664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=3.7e-09 Score=98.72 Aligned_cols=103 Identities=25% Similarity=0.396 Sum_probs=76.2
Q ss_pred CcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 67 GHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
.+++.++++++...+..+ +...+.+..+.++++.+.... .+.++++|+.|++++|.+++. + .+.++++|+.|+|
T Consensus 107 ~~L~~l~l~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~L 180 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDVTP---LAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKA 180 (227)
T ss_dssp TTCCEEECTTSCCCCCGG---GTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred ccccccccccccccccch---hccccchhhhhchhhhhchhh-hhccccccccccccccccccc-h-hhcccccceeccc
Confidence 367888888888775322 456778888888888877644 366778888888888888763 2 3778888888888
Q ss_pred cCCcccccCCCC-CCCCCcEEEccCCccccc
Q 007427 147 QENYLDGQIPPF-NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 147 ~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~ 176 (604)
++|++++ +|.+ .+++|+.|+|++|++++-
T Consensus 181 s~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 181 DDNKISD-ISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CSSCCCC-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCC-ChhhcCCCCCCEEECcCCcCCCC
Confidence 8888875 5543 578888888888888753
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.76 E-value=9.1e-09 Score=95.94 Aligned_cols=58 Identities=28% Similarity=0.548 Sum_probs=29.7
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccc
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSD 129 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g 129 (604)
+++.|+|++|++++. ++ +..+++|++|++++|.++ .++.+.++++|++|++++|...+
T Consensus 64 ~L~~L~ls~n~i~~~-~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~ 121 (227)
T d1h6ua2 64 NLIGLELKDNQITDL-AP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITD 121 (227)
T ss_dssp TCCEEECCSSCCCCC-GG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCC
T ss_pred CCcEeecCCceeecc-cc--cccccccccccccccccc-ccccccccccccccccccccccc
Confidence 455555555555532 21 344555555555555554 34445555555555555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.66 E-value=2.4e-08 Score=99.05 Aligned_cols=101 Identities=26% Similarity=0.347 Sum_probs=82.3
Q ss_pred CCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEe
Q 007427 66 NGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLE 145 (604)
Q Consensus 66 ~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~ 145 (604)
..+++.|+|++++++ .||+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++. |+.- .+.|++|+
T Consensus 37 ~~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 37 DRQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG 104 (353)
T ss_dssp HHTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred HcCCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccch-hhhh---cccccccc
Confidence 346889999999998 68863 578999999999999 67753 5689999999999985 6532 24699999
Q ss_pred ccCCcccccCCCC-CCCCCcEEEccCCcccccCCC
Q 007427 146 LQENYLDGQIPPF-NQTSLIDFNVSYNNLDGPIPQ 179 (604)
Q Consensus 146 l~~N~l~g~ip~~-~~~~l~~l~ls~n~l~g~~p~ 179 (604)
|++|+++ .+|.. .+++|+.|++++|.+++..+.
T Consensus 105 L~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 105 VSNNQLE-KLPELQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp CCSSCCS-SCCCCTTCTTCCEEECCSSCCSCCCCC
T ss_pred ccccccc-cccchhhhccceeeccccccccccccc
Confidence 9999998 67764 589999999999998765543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=1.3e-08 Score=95.71 Aligned_cols=95 Identities=17% Similarity=0.260 Sum_probs=46.8
Q ss_pred CCeeeEEecCC-----------cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC--CCCCCCCccEEeCC
Q 007427 57 SNWFGVSCSNG-----------HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP--NLTNLVNLETVFLS 123 (604)
Q Consensus 57 ~~w~gv~c~~~-----------~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p--~~~~l~~L~~l~l~ 123 (604)
|.+..|.|+.. +++.|+|++|+++ .||+..+.++++|++|+|++|.+...+| .+.++++++.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 45666677431 3445555555554 3443334445555555555555554444 24445555555443
Q ss_pred -CCcccccCCccCCCCCCCCEEeccCCccc
Q 007427 124 -QNHFSDGIPFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 124 -~N~l~g~iP~~~~~l~~l~~l~l~~N~l~ 152 (604)
.|+++...|..+.++++|+.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ccccccccccccccccccccccccchhhhc
Confidence 24444444444455555555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=3.8e-07 Score=85.37 Aligned_cols=108 Identities=22% Similarity=0.238 Sum_probs=87.8
Q ss_pred EEecCCcEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCc-cCCCCC
Q 007427 62 VSCSNGHIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPF-GYIDLP 139 (604)
Q Consensus 62 v~c~~~~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~ 139 (604)
..|.. ..++.++.+++ .+|++ + .+++++|||++|+++...+ .|.++++|++|+|++|.+...+|. .+.+++
T Consensus 6 C~C~~---~~i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~ 78 (242)
T d1xwdc1 6 CHCSN---RVFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78 (242)
T ss_dssp EEECS---SEEEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT
T ss_pred CCCcC---CEEEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccc
Confidence 45643 46788899998 89987 3 3689999999999987555 489999999999999999987775 467899
Q ss_pred CCCEEeccC-CcccccCCCC--CCCCCcEEEccCCccccc
Q 007427 140 KLKKLELQE-NYLDGQIPPF--NQTSLIDFNVSYNNLDGP 176 (604)
Q Consensus 140 ~l~~l~l~~-N~l~g~ip~~--~~~~l~~l~ls~n~l~g~ 176 (604)
+++.|++.. |+++...|.. .+++|+.+++++|.+...
T Consensus 79 ~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred ccccccccccccccccccccccccccccccccchhhhccc
Confidence 999998864 7787666653 689999999999998753
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.33 E-value=7.3e-07 Score=88.01 Aligned_cols=93 Identities=27% Similarity=0.316 Sum_probs=71.0
Q ss_pred ccCCeeeCccCCCcccCCCCCCCCCccEEeCCCCcccccCCccCCCCCCCCEEeccCCcccccCCCCCCCCCcEEEccCC
Q 007427 92 TFLNKLSLRNNLLSGSLPNLTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLELQENYLDGQIPPFNQTSLIDFNVSYN 171 (604)
Q Consensus 92 ~~L~~l~l~~n~l~g~~p~~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~n 171 (604)
.+|++|||++|+|+. +|++ +++|++|+|++|+|+ .||..+ .+|+.|++++|+++ .|+.. .+.|+.|++++|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l-p~~L~~L~L~~n 108 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL-PPLLEYLGVSNN 108 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC-CTTCCEEECCSS
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh-cccccccccccc
Confidence 478999999999985 7763 578999999999999 699764 57899999999998 56643 256999999999
Q ss_pred cccccCCCCccccCCCCCccCCC
Q 007427 172 NLDGPIPQTRVVQSFPSSSFEHN 194 (604)
Q Consensus 172 ~l~g~~p~~~~~~~~~~~~~~~n 194 (604)
.++ .+|....+..+......+|
T Consensus 109 ~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 109 QLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp CCS-SCCCCTTCTTCCEEECCSS
T ss_pred ccc-cccchhhhccceeeccccc
Confidence 997 4665544444444444333
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.15 E-value=5.8e-06 Score=77.97 Aligned_cols=132 Identities=14% Similarity=0.087 Sum_probs=88.6
Q ss_pred CCcceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCCcccEEEEEecCCceEEEEecCCCCCHHHHhhc
Q 007427 328 GKVGSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK-HENLAKIVSFYYSKEEKLIIYEFLPNGSLFDLLHE 406 (604)
Q Consensus 328 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 406 (604)
++.+.||+...+ ++.+++|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 334689998754 5667888886544334445778888877663 43467788888888889999999999888665432
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 007427 407 SRGVGRIPLAWTTRLSIIKQTAKGLAFLHQTLH----------------------------------------------- 439 (604)
Q Consensus 407 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----------------------------------------------- 439 (604)
. .....++.++++.++.||+...
T Consensus 104 ~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 104 E----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp C----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred c----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 1 1123345566666666664210
Q ss_pred --------CCCceecCCCCCceEEeecCCcceEEEeeccCCC
Q 007427 440 --------SHKVPHANLKSSNILIFRENDIYRAKLTNFGFLP 473 (604)
Q Consensus 440 --------~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla~ 473 (604)
...++|+|+.|.||+++ +....-|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhcc
Confidence 11268999999999994 44445699998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=2.9e-07 Score=94.43 Aligned_cols=108 Identities=22% Similarity=0.230 Sum_probs=82.2
Q ss_pred cEeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcc----cCC-CCCCCCCccEEeCCCCcccc----cCCccCC-C
Q 007427 68 HIVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSG----SLP-NLTNLVNLETVFLSQNHFSD----GIPFGYI-D 137 (604)
Q Consensus 68 ~~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g----~~p-~~~~l~~L~~l~l~~N~l~g----~iP~~~~-~ 137 (604)
+|+.||+++|++++.-=..++..+++|+.|+|++|+++- .|+ .+..+++|+.|||++|+++. .+...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 589999999999874323346778999999999999873 233 26788999999999999863 1333333 3
Q ss_pred CCCCCEEeccCCccccc----CCC--CCCCCCcEEEccCCcccc
Q 007427 138 LPKLKKLELQENYLDGQ----IPP--FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 138 l~~l~~l~l~~N~l~g~----ip~--~~~~~l~~l~ls~n~l~g 175 (604)
..+|+.|+|++|+++.. ++. ..+++|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999753 232 257899999999999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=1.1e-06 Score=76.74 Aligned_cols=79 Identities=27% Similarity=0.193 Sum_probs=49.1
Q ss_pred hcCCccCCeeeCccCCCcccC--CC-CCCCCCccEEeCCCCcccccCCc-cCCCCCCCCEEeccCCcccccCCC------
Q 007427 88 LQNITFLNKLSLRNNLLSGSL--PN-LTNLVNLETVFLSQNHFSDGIPF-GYIDLPKLKKLELQENYLDGQIPP------ 157 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n~l~g~~--p~-~~~l~~L~~l~l~~N~l~g~iP~-~~~~l~~l~~l~l~~N~l~g~ip~------ 157 (604)
...+++|++|+|++|+++..- +. +..+++|+.|||++|+++. +++ ......+|+.|+|++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 456777777777777777532 22 4567777777777777775 443 222334577777777777665443
Q ss_pred ---CCCCCCcEEE
Q 007427 158 ---FNQTSLIDFN 167 (604)
Q Consensus 158 ---~~~~~l~~l~ 167 (604)
..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 1356666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.82 E-value=2.7e-06 Score=83.94 Aligned_cols=86 Identities=20% Similarity=0.350 Sum_probs=44.7
Q ss_pred cCCccCCeeeCccCCCccc-----C-CCCCCCCCccEEeCCCCccccc----CCccCCCCCCCCEEeccCCcccccCC--
Q 007427 89 QNITFLNKLSLRNNLLSGS-----L-PNLTNLVNLETVFLSQNHFSDG----IPFGYIDLPKLKKLELQENYLDGQIP-- 156 (604)
Q Consensus 89 ~~l~~L~~l~l~~n~l~g~-----~-p~~~~l~~L~~l~l~~N~l~g~----iP~~~~~l~~l~~l~l~~N~l~g~ip-- 156 (604)
...+.|+.|+|++|+++.. + ..+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|++++.-.
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 4455566666666665431 1 1245556666666666665432 33344555666666666666553211
Q ss_pred ------CCCCCCCcEEEccCCccc
Q 007427 157 ------PFNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 157 ------~~~~~~l~~l~ls~n~l~ 174 (604)
......|+.|++++|+++
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCB
T ss_pred HHHHhhhccCCCCCEEECCCCcCC
Confidence 112345666666666654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=4.6e-05 Score=71.13 Aligned_cols=73 Identities=14% Similarity=0.135 Sum_probs=52.9
Q ss_pred cCcCCc-ceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC--CCCcccEEEEEecCCceEEEEecCCCCCH
Q 007427 325 LGKGKV-GSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLK--HENLAKIVSFYYSKEEKLIIYEFLPNGSL 400 (604)
Q Consensus 325 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 400 (604)
+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444543 679999988888899998765432 34567777776663 33367788888888889999999987654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.67 E-value=3.1e-06 Score=83.48 Aligned_cols=109 Identities=17% Similarity=0.094 Sum_probs=80.9
Q ss_pred CcEeEEEeCCCCceec----CChhhhcCCccCCeeeCccCCCccc----C-CCCCCCCCccEEeCCCCcccccCCccC--
Q 007427 67 GHIVSLELEEIQLAGI----LPPGFLQNITFLNKLSLRNNLLSGS----L-PNLTNLVNLETVFLSQNHFSDGIPFGY-- 135 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~----~-p~~~~l~~L~~l~l~~N~l~g~iP~~~-- 135 (604)
..++.|+|++|+++.. +-...+..+++|+.|+|++|.++.. + ..+..+++|+.|+|++|.+++.-...+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 5799999999998632 1122367789999999999998754 2 247789999999999999986422222
Q ss_pred --C--CCCCCCEEeccCCcccccC----CC---CCCCCCcEEEccCCcccc
Q 007427 136 --I--DLPKLKKLELQENYLDGQI----PP---FNQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 136 --~--~l~~l~~l~l~~N~l~g~i----p~---~~~~~l~~l~ls~n~l~g 175 (604)
. ....|+.|+|++|+++..- .. ...++|+.|++++|+|..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 2 2367999999999987431 11 136789999999999864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=4.2e-06 Score=72.82 Aligned_cols=83 Identities=27% Similarity=0.309 Sum_probs=63.0
Q ss_pred CcEeEEEeCCCCceecCCh--hhhcCCccCCeeeCccCCCcccCC-CCCCCCCccEEeCCCCcccccCCcc-------CC
Q 007427 67 GHIVSLELEEIQLAGILPP--GFLQNITFLNKLSLRNNLLSGSLP-NLTNLVNLETVFLSQNHFSDGIPFG-------YI 136 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~--~~~~~l~~L~~l~l~~n~l~g~~p-~~~~l~~L~~l~l~~N~l~g~iP~~-------~~ 136 (604)
.+++.|+|++|+++. +++ ..+..+++|+.|||++|.++..-+ ......+|+.|+|++|.++...... +.
T Consensus 65 ~~L~~L~Ls~N~i~~-l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 65 PELLSLNLSNNRLYR-LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp TTCCCCCCCSSCCCC-CSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCEeeCCCccccC-CchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 579999999999984 432 236789999999999999997433 2223447999999999999866643 56
Q ss_pred CCCCCCEEeccCCccc
Q 007427 137 DLPKLKKLELQENYLD 152 (604)
Q Consensus 137 ~l~~l~~l~l~~N~l~ 152 (604)
.+++|+.|| ++.+.
T Consensus 144 ~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 144 RFPKLLRLD--GHELP 157 (162)
T ss_dssp TSTTCCEET--TEECC
T ss_pred HCCCCCEEC--cCCCc
Confidence 789999886 55443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=4.7e-06 Score=85.02 Aligned_cols=109 Identities=18% Similarity=0.136 Sum_probs=67.4
Q ss_pred CcEeEEEeCCCCceecCChh----hhcCCccCCeeeCccCCCcccCC-C----CCCCCCccEEeCCCCcccc----cCCc
Q 007427 67 GHIVSLELEEIQLAGILPPG----FLQNITFLNKLSLRNNLLSGSLP-N----LTNLVNLETVFLSQNHFSD----GIPF 133 (604)
Q Consensus 67 ~~~~~l~l~~~~l~g~~p~~----~~~~l~~L~~l~l~~n~l~g~~p-~----~~~l~~L~~l~l~~N~l~g----~iP~ 133 (604)
..+..+++++|.++..-... +....+.|+.+++++|.++..-. . +....+|+.|||++|+++. .++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 46778888888776422111 11234577888888887765422 1 3345678888888888764 2444
Q ss_pred cCC-CCCCCCEEeccCCccccc----CCCC--CCCCCcEEEccCCcccc
Q 007427 134 GYI-DLPKLKKLELQENYLDGQ----IPPF--NQTSLIDFNVSYNNLDG 175 (604)
Q Consensus 134 ~~~-~l~~l~~l~l~~N~l~g~----ip~~--~~~~l~~l~ls~n~l~g 175 (604)
.+. ..+.|+.|+|++|+++.. |+.. ..++|+.|+|++|+++.
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 443 356688888888887642 2221 35678888888887764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.46 E-value=2.5e-05 Score=74.53 Aligned_cols=101 Identities=16% Similarity=0.155 Sum_probs=69.9
Q ss_pred EeEEEeCCCCceecCChhhhcCCccCCeeeCccCCCcccC-CC-CCCCCCccEEeCCCCcccccCCccCCCCCCCCEEec
Q 007427 69 IVSLELEEIQLAGILPPGFLQNITFLNKLSLRNNLLSGSL-PN-LTNLVNLETVFLSQNHFSDGIPFGYIDLPKLKKLEL 146 (604)
Q Consensus 69 ~~~l~l~~~~l~g~~p~~~~~~l~~L~~l~l~~n~l~g~~-p~-~~~l~~L~~l~l~~N~l~g~iP~~~~~l~~l~~l~l 146 (604)
+..+.++.......+.. .....+|++|||+++.+++.. +. +.++++|++|+|++|.+++..+..++++++|+.|+|
T Consensus 25 ~~~lrl~~~~~~~~~~~--~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 102 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102 (284)
T ss_dssp CSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred ceEeeccccccccchhh--hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc
Confidence 34555555444433322 345678889999888887653 33 677888999999999888888888888888999999
Q ss_pred cCC-ccccc-CCC--CCCCCCcEEEccCC
Q 007427 147 QEN-YLDGQ-IPP--FNQTSLIDFNVSYN 171 (604)
Q Consensus 147 ~~N-~l~g~-ip~--~~~~~l~~l~ls~n 171 (604)
+++ +++.. +.. ..+++|+.|+++++
T Consensus 103 s~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 103 SGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred cccccccccccchhhHHHHhccccccccc
Confidence 884 55521 111 24678888888874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.45 E-value=1.2e-05 Score=76.93 Aligned_cols=105 Identities=16% Similarity=0.097 Sum_probs=76.4
Q ss_pred CcEeEEEeCCC-Cceec-CChhhhcCCccCCeeeCccC--CCccc-CCC-CCCCCCccEEeCCCC-cccccCCccCCCCC
Q 007427 67 GHIVSLELEEI-QLAGI-LPPGFLQNITFLNKLSLRNN--LLSGS-LPN-LTNLVNLETVFLSQN-HFSDGIPFGYIDLP 139 (604)
Q Consensus 67 ~~~~~l~l~~~-~l~g~-~p~~~~~~l~~L~~l~l~~n--~l~g~-~p~-~~~l~~L~~l~l~~N-~l~g~iP~~~~~l~ 139 (604)
.+++.|+|+++ +++.. +...+....++|+.|+|++. .++.. +.. +.++++|+.|||++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 47999999985 45432 23322234578999999864 34432 333 356899999999985 58888888999999
Q ss_pred CCCEEeccC-CcccccCCC--CCCCCCcEEEccCC
Q 007427 140 KLKKLELQE-NYLDGQIPP--FNQTSLIDFNVSYN 171 (604)
Q Consensus 140 ~l~~l~l~~-N~l~g~ip~--~~~~~l~~l~ls~n 171 (604)
+|++|+|++ +++++.... ..+++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999999 467654433 35789999999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.23 E-value=0.00071 Score=67.26 Aligned_cols=75 Identities=12% Similarity=0.138 Sum_probs=48.1
Q ss_pred cccCcCCcceEEEEEecC-CcEEEEEEeccc-------chhhHHHHHHHHHHHccCC-C--CCcccEEEEEecCCceEEE
Q 007427 323 EVLGKGKVGSTYKATLES-GAVVAVKRVKNM-------NALSKKEFVQQMQLLGKLK-H--ENLAKIVSFYYSKEEKLII 391 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 391 (604)
+.||.|....||++...+ ++.|+||.-... -.....+...|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965321 1112334566777776652 2 345666654 45567899
Q ss_pred EecCCCCC
Q 007427 392 YEFLPNGS 399 (604)
Q Consensus 392 ~e~~~~gs 399 (604)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.00 E-value=0.00012 Score=63.55 Aligned_cols=105 Identities=12% Similarity=0.185 Sum_probs=70.2
Q ss_pred CcEeEEEeCCC-Cceec----CChhhhcCCccCCeeeCccCCCccc-CC----CCCCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEEI-QLAGI----LPPGFLQNITFLNKLSLRNNLLSGS-LP----NLTNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~~-~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~-~p----~~~~l~~L~~l~l~~N~l~g~----iP 132 (604)
.+++.|+|+++ .++.. +-.. +...+.|+.|+|++|.++.. +. .+...+.|+.|+|++|.++.. |=
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~-L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEA-ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHH-HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHH-HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 46889999874 45421 2112 56678899999999988743 12 245567899999999988753 22
Q ss_pred ccCCCCCCCCEEeccCCcccccCCC----------CCCCCCcEEEccCCcc
Q 007427 133 FGYIDLPKLKKLELQENYLDGQIPP----------FNQTSLIDFNVSYNNL 173 (604)
Q Consensus 133 ~~~~~l~~l~~l~l~~N~l~g~ip~----------~~~~~l~~l~ls~n~l 173 (604)
..+...++|+.|+|++|.+.. +.. ...++|+.|+++++..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~-~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSV-LGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCC-CCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCC-ccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 346667889999999887552 211 1246788888877653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0019 Score=62.21 Aligned_cols=67 Identities=12% Similarity=0.143 Sum_probs=44.1
Q ss_pred ceEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCCc--ccEE-----EEEecCCceEEEEecCCCC
Q 007427 331 GSTYKATLESGAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHENL--AKIV-----SFYYSKEEKLIIYEFLPNG 398 (604)
Q Consensus 331 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g 398 (604)
-.||+++.++|+.|++|+.+... .+.+++..|...+..|....+ +..+ ..+...+..+.+++|++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999999999999999986532 245667788888777642222 1111 1122345678899998763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.53 E-value=0.00032 Score=60.69 Aligned_cols=87 Identities=18% Similarity=0.262 Sum_probs=63.3
Q ss_pred hcCCccCCeeeCccC-CCccc-CC----CCCCCCCccEEeCCCCccccc----CCccCCCCCCCCEEeccCCcccccCCC
Q 007427 88 LQNITFLNKLSLRNN-LLSGS-LP----NLTNLVNLETVFLSQNHFSDG----IPFGYIDLPKLKKLELQENYLDGQIPP 157 (604)
Q Consensus 88 ~~~l~~L~~l~l~~n-~l~g~-~p----~~~~l~~L~~l~l~~N~l~g~----iP~~~~~l~~l~~l~l~~N~l~g~ip~ 157 (604)
..+.++|+.|+|+++ .++.. +. .+...+.|+.|+|++|.++.. +-..+...+.|+.|+|++|.++..--.
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 456789999999974 46432 11 377788999999999999742 223445678899999999998743111
Q ss_pred ------CCCCCCcEEEccCCccc
Q 007427 158 ------FNQTSLIDFNVSYNNLD 174 (604)
Q Consensus 158 ------~~~~~l~~l~ls~n~l~ 174 (604)
....+|+.|++++|.++
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 24578999999998654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.0053 Score=60.71 Aligned_cols=72 Identities=14% Similarity=0.209 Sum_probs=48.4
Q ss_pred cccCcCCcceEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCC-cccEEEEEecCCceEEEEe
Q 007427 323 EVLGKGKVGSTYKATLES--------GAVVAVKRVKNMNALSKKEFVQQMQLLGKLKHEN-LAKIVSFYYSKEEKLIIYE 393 (604)
Q Consensus 323 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 393 (604)
+.|+.|-.-.+|++...+ .+.|.+++..... ......+|..+++.+.-.+ ..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 457788889999998653 3567777765322 2345567888888874334 4577777643 68999
Q ss_pred cCCCCCH
Q 007427 394 FLPNGSL 400 (604)
Q Consensus 394 ~~~~gsL 400 (604)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.01 E-value=0.0014 Score=56.39 Aligned_cols=106 Identities=16% Similarity=0.228 Sum_probs=69.6
Q ss_pred CcEeEEEeCC-CCceec----CChhhhcCCccCCeeeCccCCCcccCC-----CCCCCCCccEEeCCCCccccc----CC
Q 007427 67 GHIVSLELEE-IQLAGI----LPPGFLQNITFLNKLSLRNNLLSGSLP-----NLTNLVNLETVFLSQNHFSDG----IP 132 (604)
Q Consensus 67 ~~~~~l~l~~-~~l~g~----~p~~~~~~l~~L~~l~l~~n~l~g~~p-----~~~~l~~L~~l~l~~N~l~g~----iP 132 (604)
..++.|+|++ +.++.. +-.. +...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~a-l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEA-LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHH-HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHH-HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 4688899987 455422 1122 4577889999999998876422 255678899999999988643 33
Q ss_pred ccCCCCCCCCEEec--cCCccccc----CCC--CCCCCCcEEEccCCcc
Q 007427 133 FGYIDLPKLKKLEL--QENYLDGQ----IPP--FNQTSLIDFNVSYNNL 173 (604)
Q Consensus 133 ~~~~~l~~l~~l~l--~~N~l~g~----ip~--~~~~~l~~l~ls~n~l 173 (604)
..+...++|+.++| ++|.+... |-. ...++|+.|+++.|..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 45667788887555 56666421 111 1467888888877754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.69 E-value=0.14 Score=47.97 Aligned_cols=30 Identities=27% Similarity=0.324 Sum_probs=24.4
Q ss_pred CCCceecCCCCCceEEeecCCcceEEEeeccCC
Q 007427 440 SHKVPHANLKSSNILIFRENDIYRAKLTNFGFL 472 (604)
Q Consensus 440 ~~~ivHrDlkp~NILl~~~~~~~~~kl~DFGla 472 (604)
..|+||+|+.++||+++ .+...-|.||+.+
T Consensus 182 ~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFL---GDELSGLIDFYFA 211 (316)
T ss_dssp CEEEECSCCCGGGEEEE---TTEEEEECCCTTC
T ss_pred ccccccCCcchhhhhcc---cccceeEeccccc
Confidence 46899999999999994 3434579999975
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.19 E-value=0.017 Score=49.17 Aligned_cols=87 Identities=15% Similarity=0.103 Sum_probs=63.8
Q ss_pred CCcEeEEEeCCCCceecCCh---hhhcCCccCCeeeCccCCCcccCC-----CCCCCCCccEEeC--CCCcccc----cC
Q 007427 66 NGHIVSLELEEIQLAGILPP---GFLQNITFLNKLSLRNNLLSGSLP-----NLTNLVNLETVFL--SQNHFSD----GI 131 (604)
Q Consensus 66 ~~~~~~l~l~~~~l~g~~p~---~~~~~l~~L~~l~l~~n~l~g~~p-----~~~~l~~L~~l~l--~~N~l~g----~i 131 (604)
+.+++.|+|++|+++..--. ..+...++|+.|++++|.++..-- .+...++|+.++| ++|.+.. .|
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~L 124 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 124 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHH
Confidence 46899999999998643211 125667999999999999975421 4777888987554 6777753 35
Q ss_pred CccCCCCCCCCEEeccCCccc
Q 007427 132 PFGYIDLPKLKKLELQENYLD 152 (604)
Q Consensus 132 P~~~~~l~~l~~l~l~~N~l~ 152 (604)
-..+...++|+.|+|+.|+..
T Consensus 125 a~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 125 ANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeCcCCCCc
Confidence 555668899999999888654
|